<SEC-DOCUMENT>0001601485-25-000074.txt : 20250513
<SEC-HEADER>0001601485-25-000074.hdr.sgml : 20250513
<ACCEPTANCE-DATETIME>20250513163141
ACCESSION NUMBER:		0001601485-25-000074
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		88
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250513
DATE AS OF CHANGE:		20250513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elicio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001601485
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				113430072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39990
		FILM NUMBER:		25940675

	BUSINESS ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(857) 209-0050

	MAIL ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Angion Biomedica Corp.
		DATE OF NAME CHANGE:	20140228
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>angn-20250331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b5a770-ce93-4e1a-8551-4667fc149643,g:e550b526-85cb-4940-ae39-7686e99f6d4a,d:90e86c78fdd244088832607d0b0ad2ca-->
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:angn="http://www.angn.com/20250331" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>angn-20250331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-26">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-28">12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-29">0001601485</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-30">False</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-40" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="f-279">0.1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="angn-20250331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="agreement"><xbrli:measure>angn:agreement</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="entity"><xbrli:measure>angn:entity</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:PurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:AngionCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:RegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:A2024RegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:JulySharesAndJulyCommonWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:The2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:Inducement2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-05</xbrli:startDate><xbrli:endDate>2025-03-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-02</xbrli:startDate><xbrli:endDate>2024-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-02</xbrli:startDate><xbrli:endDate>2024-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-02</xbrli:startDate><xbrli:endDate>2024-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i90e86c78fdd244088832607d0b0ad2ca_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March 31, 2025</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;to </span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39990</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">Elicio Therapeutics, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:34.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">11-3430072</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">451 D Street, 5th Floor</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Boston</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Massachusetts</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">02210</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">857</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">209-0050</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.737%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $0.01</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">ELTX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> &#9746; No &#9744;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric> &#9746; No &#9744;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-21">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-22">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-24">&#9746;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding as of May&#160;9, 2025 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">15,996,976</ix:nonFraction>.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_19">PART I FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_22">Item 1. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_25">Condensed Consolidated Balance Sheets (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_31">Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_34">Condensed Consolidated Statements of</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_34"> Stockholders&#8217;</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_34"> Equity</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_34"> (Deficit)</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_34"> (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_40">Condensed Consolidated Statements of Cash Flows (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_40">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_43">Notes to Unaudited Interim Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_43">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_103">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_103">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_127">Item 3. Quantitative and Qualitative Disclosures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_127">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_130">Item 4. Controls and Procedures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_130">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_133">PART II OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_136">Item 1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_136">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_139">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_139">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_142">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_142">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_145">Item 3. Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_145">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_148">Item 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_148">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_151">Item 5. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_151">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_154">Item 6. Exhibits </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_154">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_157">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_157">34</a></span></div></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q, including the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements concerning our business strategy and plans, future operating results and financial position, as well as our objectives and expectations for our future operations, are forward-looking statements. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In some cases, you can identify forward-looking statements by terminology such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;positioned,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our financial condition, including our ability to obtain the funding necessary to advance the development of ELI-002 and any other current or future product candidates, our ability to continue as a going concern and our cash runway;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability of our clinical trials to demonstrate safety and efficacy of our product candidates, and other positive results; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to utilize our platform to develop a pipeline of product candidates to address unmet needs in cancer; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timing, progress and results of clinical trials for ELI-002, and other current or future product candidates we may develop, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the studies or trials will become available, and the timing, progress and results of our research and development programs; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timing, scope and likelihood of regulatory filings and approvals, including timing of Investigational New Drug applications and U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval of ELI-002 and any current or future product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timing, scope or likelihood of foreign regulatory filings and approvals; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to develop and advance our current product candidates and programs into, and successfully complete, clinical studies; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our manufacturing, commercialization, and marketing capabilities and strategy; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the need to hire additional personnel and our ability to attract and retain such personnel; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the size of the market opportunity for our product candidates, including estimates of the number of patients who suffer from the diseases we are targeting; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expectations regarding the approval and use of our product candidates in combination with other drugs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expectations regarding potential for accelerated approval or other expedited regulatory designation; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our competitive position and the success of competing therapies that are or may become available; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our anticipated research and development activities and projected expenditures; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">existing regulations and regulatory developments in the United States, Europe and other jurisdictions; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the extent to which global economic and political developments, including the ongoing conflict between Ukraine and Russia, the conflicts in the Middle East, geopolitical tensions with China, and other geopolitical events, as well as the macroeconomic conditions, including inflation, volatility in interest rates, potential for economic slowdown or recession and potential governmental shutdowns, will affect our business operations, clinical trials, or financial condition;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our expectations regarding other macroeconomic trends; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our intellectual property position, including the scope of protection we are able to establish and maintain for intellectual property rights covering ELI-002, other current or future product candidates we may develop, including the extensions of existing patent terms where available, the validity of intellectual property rights held by third parties, and our ability not to infringe, misappropriate or otherwise violate any third-party intellectual property rights; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our continued reliance on third parties to conduct additional clinical trials of our product candidates, and for the manufacture of our product candidates for clinical trials; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to have manufactured sufficient supplies of drug product for clinical testing and commercialization; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to obtain, and negotiate favorable terms of, any collaboration, licensing or other arrangements that may be necessary or desirable to develop, manufacture or commercialize our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our projected financial performance; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our anticipated use of proceeds from potential financing activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our planned operating expenses and capital expenditure requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the potential impact of anticipated funding pressures and the expected effect from U.S. export controls and tariffs; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the impact of laws and regulations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in our Annual Report on Form 10-K for the year ended December 31, 2024 (the &#8220;Form 10-K&#8221;) filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on March 31, 2025 and elsewhere in this Quarterly Report on Form 10-Q. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s beliefs and assumptions only as of the date of this Quarterly Report on Form 10-Q. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. In addition, statements such as &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into or review of all relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely on these statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q also contains estimates, projections and other information concerning our industry, our business and the markets for certain drugs, including data regarding the estimated size of those markets, their projected growth rates and the incidence of certain medical conditions. Information that is based on estimates, forecasts, projections or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by third parties, industry, medical and general publications, government data and similar sources. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In this Quarterly Report on Form 10-Q, unless the context indicates otherwise, the terms &#8220;Company,&#8221; &#8220;Elicio,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Elicio Therapeutics, Inc. and our wholly-owned subsidiaries. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Trademarks</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q includes trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included in this Quarterly Report on Form 10-Q are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I FINANCIAL INFORMATION</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_22"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_25"></div><div style="margin-top:10pt;text-align:center;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">18,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">17,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Restricted cash, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="f-33">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">1,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">20,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">20,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-39">430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-40">483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Operating lease, right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-41">5,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-42">5,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Restricted cash, noncurrent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-43">698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-44">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Other long-term prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="3" id="f-45">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="3" id="f-46">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-47">28,144</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-48">28,178</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Liabilities and stockholders&#8217; equity (deficit)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accounts payable</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">4,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">5,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">8,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Deferred research obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="f-53">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Operating lease liability, current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-55">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-56">901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">11,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">11,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Warrant liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:WarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-59">2,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:WarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-60">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">4,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">5,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Convertible note - related party</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:fixed-zero" scale="3" id="f-63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-64">20,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-65">19,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-66">39,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Commitments and contingencies - Note 10</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-67"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-68"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Stockholders' equity (deficit):</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-69"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-70">0.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-71"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-72">300,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-73">15,983,191</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-74">11,043,837</ix:nonFraction> shares issued at March&#160;31, 2025 and December&#160;31, 2024, respectively; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-75">15,968,736</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-76">11,029,382</ix:nonFraction> outstanding as of March&#160;31, 2025 and December&#160;31, 2024, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-77">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-78">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-79"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-80">14,455</ix:nonFraction></ix:nonFraction> shares outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-81">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-82">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-83">214,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-84">183,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-85">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-86">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-87">205,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-88">194,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Total stockholders' equity (deficit)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-89">8,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-90">11,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total liabilities and stockholders' equity (deficit)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-91">28,144</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-92">28,178</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Research and development</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-93">7,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-94">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">General and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-95">2,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-96">2,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-97">10,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-98">10,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-99">10,736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-100">10,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other (expense) income</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrant liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="f-101">507</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-102">1,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Loss on issuance of pre-funded warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="3" id="f-104">578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gain on sale of equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="f-105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="f-106">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Foreign exchange transaction gain</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-108">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Interest income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeOperatingAndNonoperating" scale="3" id="f-109">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestIncomeOperatingAndNonoperating" scale="3" id="f-110">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-111">176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-112">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total other expense, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-113">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-114">1,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Net loss</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-115">11,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-116">11,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other comprehensive loss:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30.6pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-117">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-118">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive loss</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-119">11,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-120">11,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net loss per common share, basic and diluted</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-121"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-122">0.87</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-123"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-124">1.15</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted average common shares and pre-funded warrants outstanding, basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-125"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-126">12,950,574</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-127"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-128">10,273,925</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_34"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.229%"><tr><td style="width:1.0%"/><td style="width:34.743%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.277%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.432%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Common Stock</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Treasury Stock</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Paid-in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Capital</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated Other <br/>Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Deficit</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Stockholders'</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Equity (Deficit)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-129">11,043,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-130">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-131">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-132">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-133">183,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-134">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-135">194,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-136">11,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from At-the-Market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-137">0</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-138">106,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-139">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-140">834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-141">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-142">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-143">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-144">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of senior note payable into common stock, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="f-145">0.3</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-146">3,500,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-147">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-148">20,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-149">20,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock and warrants from the January Offering, net of fees of $<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-150">0.8</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="INF" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-151">1,261,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" id="f-152">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="3" id="f-153">9,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="3" id="f-154">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon the exercise of common warrants</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-155">68,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-156">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-157">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-158">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-159">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-160">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-161">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-162">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-163">11,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-164">11,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of March 31, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-165">15,983,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-166">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-167">14,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-168">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-169">214,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-170">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-171">205,310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-172">8,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:34.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.428%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Common Stock</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Treasury Stock</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Paid-in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated Other <br/>Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Stockholders'</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Equity (Deficit)</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of December 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-173">9,603,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-174">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-175">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-176">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-177">153,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-178">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-179">142,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-180">11,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from At-the-Market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-181">0.1</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-182">615,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-183">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-184">5,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-185">5,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon settlement of restricted stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="f-186">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-187">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-188">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-189">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-190">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-191">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-192">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-193">11,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-194">11,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of March 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-195">10,219,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-196">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-35" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-197">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-198">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-199">159,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-200">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-201">154,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-202">4,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_40"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.472%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cash flows from operating activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">11,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-204">11,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Adjustments to reconcile net loss to net cash used in operating activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-205">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-206">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Amortization of right-of-use assets, operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-207">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-208">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:InterestExpenseNoncash" scale="3" id="f-209">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:InterestExpenseNoncash" format="ixt:fixed-zero" scale="3" id="f-210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-211">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:fixed-zero" scale="3" id="f-212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="f-213">507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-214">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-215">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-216">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Loss on issuance of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-217">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="3" id="f-218">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Gain on disposal of property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="f-219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-220">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-221">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-222">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Other long-term prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:fixed-zero" scale="3" id="f-223">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-224">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accounts payable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-225">2,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-226">3,264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accrued expenses and other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="angn:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-227">2,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="angn:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="f-228">432</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Deferred research obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="f-229">489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="f-230">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-231">215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-232">244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net cash used in operating activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-233">10,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-234">12,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cash flows from investing activities</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-236">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net cash provided by investing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:fixed-zero" scale="3" id="f-237">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-238">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cash flows from financing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from exercise of common warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" scale="3" id="f-239">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="f-240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock and common warrants  from the January Offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="f-241">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="f-242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from issuance of common warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-244">5,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-245">835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-246">5,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from the exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-247">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="f-248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net cash provided by financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-249">10,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-250">11,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Effect of foreign currency on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-251">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-252">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net increase (decrease) in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="f-253">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-254">1,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Cash, cash equivalents and restricted cash at the beginning of the period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-255">19,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-256">14,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cash, cash equivalents and restricted cash at the end of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-257">19,732</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-258">13,206</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Components of cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-259">18,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-260">11,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-261">1,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-262">1,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-263">19,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-264">13,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Supplemental disclosure of noncash investing and financing activities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Fair value of pre-funded warrants at issuance date</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:FairValueOfPreFundedWarrants" format="ixt:fixed-zero" scale="3" id="f-265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:FairValueOfPreFundedWarrants" format="ixt:num-dot-decimal" scale="3" id="f-266">6,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Fair value of common warrants upon settlement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:FairValueOfCommonStockWarrants" scale="3" id="f-267">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:FairValueOfCommonStockWarrants" format="ixt:fixed-zero" scale="3" id="f-268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Conversion of related-party senior note payable into equity</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:SettlementOfPromissoryNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-269">20,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:SettlementOfPromissoryNotesPayable" format="ixt:fixed-zero" scale="3" id="f-270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Non-cash vesting of restricted common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:NonCashVestingOfRestrictedCommonStock" format="ixt:fixed-zero" scale="3" id="f-271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:NonCashVestingOfRestrictedCommonStock" scale="3" id="f-272">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Table of Contents</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_46"></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-273" continuedAt="f-273-1" escape="true">Description of the Business and Financial Condition</ix:nonNumeric></span></div><ix:continuation id="f-273-1"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#8220;ESC&#8221;), an investment company, Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;), and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#8220;Elicio&#8221; throughout these condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Liquidity and Going Concern</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has experienced net losses and negative cash flows from operating activities since inception. As of March&#160;31, 2025, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-274">205.3</ix:nonFraction> million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2025, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-275">18.4</ix:nonFraction> million in cash and cash equivalents. The Company&#8217;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it might have to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_49"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-276" continuedAt="f-276-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-276-1" continuedAt="f-276-2"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Please refer to "Note 2 &#8211; Summary of Basis of Significant Accounting Policies," to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's significant accounting policies.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-277" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated interim financial statements include the accounts of the Company and its wholly owned subsidiaries, Elicio Pty, ESC, and Former Elicio.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-278" continuedAt="f-278-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-276-2"><ix:continuation id="f-278-1" continuedAt="f-278-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#8217;s consolidated financial statements, once adopted.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes of the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amount that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><ix:continuation id="f-278-2" continuedAt="f-278-3"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments</span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-278-3">. This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact of this adoption on the consolidated financial statements and related disclosures</ix:continuation>.</span></div></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_58"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 3&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-280" continuedAt="f-280-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-280-1" continuedAt="f-280-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-281" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-282">11,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-285">11,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-286">11,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-289">11,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-290">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-291">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="angn:WarrantsFairValueDisclosure" scale="3" id="f-292">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-293">2,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-295">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-296">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-297">2,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-298">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-299">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-301">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-302">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-304">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-305">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-307">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="angn:WarrantsFairValueDisclosure" scale="3" id="f-308">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-309">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-311">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-312">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-313">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash equivalents at March&#160;31, 2025 and December&#160;31, 2024 were held in U.S. Treasury securities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There were no transfers made among the three levels in the fair value hierarchy during the periods presented.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-280-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The fair value of the warrants assumed in the merger (the &#8220;Merger&#8221;) with Angion Biomedica Corp. (&#8220;Angion&#8221; and the warrants, the &#8220;Angion warrants&#8221;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-314" continuedAt="f-314-1" escape="true">The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-314-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:72.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-315">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-316">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="f-317">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="f-318">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-319">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-320">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion warrants issued by the Company has been estimated using Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-321" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion warrant liability was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:59.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.409%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-54" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="f-322">76.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-55" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="f-323">76.00</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-56" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-324">3.4</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-57" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-325">3.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-58" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-326">79.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-59" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-327">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-60" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-328">4.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-61" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-329">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-62" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="f-330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-63" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="f-331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed an underwritten public offering (the &#8220;Public Offering&#8221;), consisting of (i) <ix:nonFraction unitRef="shares" contextRef="c-64" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-332">500,000</ix:nonFraction> shares of the Company&#8217;s common stock (the &#8220;July Shares&#8221;), (ii) pre-funded warrants exercisable for <ix:nonFraction unitRef="shares" contextRef="c-65" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-333">1,800,000</ix:nonFraction> shares of common stock (the &#8220;July Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-66" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-334">2,300,000</ix:nonFraction> shares of common stock (the &#8220;July Common Warrants&#8221;). Each July Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-67" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-335">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July Pre-Funded Warrants. As of reporting period end, the outstanding July Pre-Funded Warrants are equity classified. Refer to Note 6 and 8 for further discussion. Each July Common Warrant is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-66" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-336">5.00</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July Common Warrants. At the Company&#8217;s annual stockholder&#8217;s meeting in November 2024, the Company obtained stockholder approval for GKCC, LLC (&#8220;GKCC&#8221;), together with its affiliates, to exceed the <ix:nonFraction unitRef="number" contextRef="c-3" decimals="INF" name="angn:SaleOfStockBeneficialOwnershipLimitationPercentage" scale="-2" id="f-337">19.99</ix:nonFraction>% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) (&#8220;Stockholder Approval&#8221;). As a result of obtaining Stockholder Approval, certain July Common Warrants are equity classified while the remainder of the outstanding July Common Warrants are liability classified and are subsequently remeasured at each reporting period end. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company identified the July Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. For the three months ended March 31, 2025, the Company recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-338">0.5</ix:nonFraction> million in fair value remeasurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company records the change in the fair value of the outstanding warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.</span></div></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_64"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 4&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-339" continuedAt="f-339-1" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="f-339-1" continuedAt="f-339-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prepaid and Other Current Assets</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-339-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="f-340" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:PrepaidResearchAndDevelopmentExpenses" format="ixt:num-dot-decimal" scale="3" id="f-341">1,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:PrepaidResearchAndDevelopmentExpenses" format="ixt:num-dot-decimal" scale="3" id="f-342">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:AdvancedProfessionalFees" scale="3" id="f-343">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AdvancedProfessionalFees" scale="3" id="f-344">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-345">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-346">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:OtherPrepaidExpensesAndOtherAssetsCurrent" scale="3" id="f-347">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:OtherPrepaidExpensesAndOtherAssetsCurrent" scale="3" id="f-348">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-349">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-350">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment, Net</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-351" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-352">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-353">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-354">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-355">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-356">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-357">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-358">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-359">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-360">1,605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-361">1,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-362">430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-363">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense for each of the three months ended March 31, 2025 and 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-364"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-365">0.1</ix:nonFraction></ix:nonFraction> million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other long-term prepaid assets </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="6" id="f-366"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="6" id="f-367">0.6</ix:nonFraction></ix:nonFraction> million for both March&#160;31, 2025 and December&#160;31, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Expenses</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-368" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-369">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-370">1,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="f-371">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-372">2,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-373">4,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-374">4,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:AccruedOtherOperatingLiabilitiesCurrent" scale="3" id="f-375">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AccruedOtherOperatingLiabilitiesCurrent" scale="3" id="f-376">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-377">5,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-378">8,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_67"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="f-379" continuedAt="f-379-1" escape="true">Research Grant</ix:nonNumeric></span></div><ix:continuation id="f-379-1" continuedAt="f-379-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-380">2.8</ix:nonFraction> million award, $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-381">2.3</ix:nonFraction> million was received in September 2022 and the remaining $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-382">0.5</ix:nonFraction> million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-383">0.5</ix:nonFraction> million payment was applied as a credit to the second grant agreement described below. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-384">3.1</ix:nonFraction> million, with such amount received net of the $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="angn:ResearchAndDevelopmentArrangementCredit" scale="6" id="f-385">0.5</ix:nonFraction> million credit, described above.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> For the three months ended March 31, 2024, the Company incurred </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-386">1.4</ix:nonFraction>&#160;million in research and development expenses related to this project, of which $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" format="ixt:num-dot-decimal" scale="6" id="f-387">0.1</ix:nonFraction>&#160;million was reimbursed from available grant funds. As of March 31, 2024, the grant funds available for the second grant agreement were</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-388">0.7</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the deferred research obligation was </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="0" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-389">0.6</ix:nonFraction> million. The second grant agreement activities were completed in the third quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-390">1.5</ix:nonFraction> million. The grant funds available as of March&#160;31, 2025 were $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-391">0.7</ix:nonFraction> million which are reflected in restricted cash in the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-379-2" continuedAt="f-379-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">accompanying condensed consolidated balance sheets. The deferred research obligation as of March&#160;31, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-392">0.7</ix:nonFraction> million, which was reflected in the deferred research obligation in the accompanying condensed consolidated balance sheets. For the three months ended March 31, 2025, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-393"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-394">0.5</ix:nonFraction></ix:nonFraction> million in research and development expenses related to this project, of which $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" scale="6" id="f-395"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" scale="6" id="f-396">0.5</ix:nonFraction></ix:nonFraction> million was reimbursed from available grant funds. </span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-379-3">The award money for the <ix:nonFraction unitRef="agreement" contextRef="c-3" decimals="INF" name="angn:NumberOfResearchGrantAgreements" format="ixt-sec:numwordsen" scale="0" id="f-397">three</ix:nonFraction> agreements was earned and recognized as a contra research and development expense as the expenses were incurred.</ix:continuation>  </span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_70"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 6&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-398" continuedAt="f-398-1" escape="true">Convertible Preferred Stock, Common Stock and Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="f-398-1" continuedAt="f-398-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-399">300,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-400">0.01</ix:nonFraction> per share, and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-401">10,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-402">0.01</ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a registration statement on Form S-3 (the &#8220;Prior Shelf Registration St</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">atement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-403">100</ix:nonFraction>&#160;million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-404">21</ix:nonFraction> million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#8220;2022 ATM Program"). During the three months ended March 31, 2024, the Company issued and sold a total of <ix:nonFraction unitRef="shares" contextRef="c-86" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-405">615,363</ix:nonFraction> shares of common stock under the 2022 ATM Program for aggregate net sale proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-406">5.1</ix:nonFraction> million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, the Company filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-407">200</ix:nonFraction>&#160;million. Simultaneously, the Company entered into the Capital on Demand</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services LLC, as agent, to provide for the issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-408">40</ix:nonFraction>&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221;). During the three months ended March 31, 2025, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-89" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-409">106,823</ix:nonFraction> shares of common stock under the 2024 ATM Program for aggregate net sale proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-410">0.8</ix:nonFraction> million after deducting sales commissions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the Company entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, providing for the issuance and sale by the Company to GKCC of pre-funded warrants (the &#8220;March Pre-Funded Warrants&#8221;) (the &#8220;March Offering&#8221;). Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-411">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. The net proceeds to the Company from the March Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-412">6.0</ix:nonFraction> million. Refer to Note 8 for additional information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offerings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed the Public Offering, which resulted in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-413">10.9</ix:nonFraction>&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Public Offering consisted of the July Shares or in lieu thereof, the July Pre-Funded Warrants, and accompanying July Common Warrants. Each July Share and accompanying July Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-92" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-414">5.00</ix:nonFraction> per July Share and accompanying July Common Warrant, and each July Pre-Funded Warrant and accompanying July Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-93" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-415">4.99</ix:nonFraction> per July Pre-Funded Warrant and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">accompanying July Common Warrant, which represented the combined purchase price per July Pre-Funded Warrant and accompanying July Common Warrant less the $<ix:nonFraction unitRef="usdPerShare" contextRef="c-65" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-416">0.01</ix:nonFraction> per share exercise price for each such July Pre-Funded Warrant. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-398-2"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The July Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-66" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-417">5.00</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-66" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-418">five years</ix:nonNumeric> from the issuance date. Refer to Note 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the &#8220;January Offering&#8221;): (i) an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-94" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-419">1,261,830</ix:nonFraction> shares of the Company&#8217;s common stock (the &#8220;January Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-95" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-420">1,261,830</ix:nonFraction> shares of common stock (the &#8220;January Common Warrants&#8221;). Each January Share and accompanying January Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-96" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-421">7.925</ix:nonFraction>. The January Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-96" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-422">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-97" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-423">five years</ix:nonNumeric> from the initial exercise date. The January Offering resulted in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-424">9.2</ix:nonFraction>&#160;million to the Company after deducting the placement agent&#8217;s fees and related offering expenses.</span></div></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_73"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 7&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-425" continuedAt="f-425-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-425-1" continuedAt="f-425-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March 31, 2025, there is an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-426">1,035,544</ix:nonFraction> shares of common stock available for issuance under the Company&#8217;s equity incentive plans, including <ix:nonFraction unitRef="shares" contextRef="c-99" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-427">471,889</ix:nonFraction> shares available for future grants under the Company&#8217;s 2021 Incentive Award Plan, <ix:nonFraction unitRef="shares" contextRef="c-100" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-428">176,323</ix:nonFraction> shares available for future grants under the Company&#8217;s 2022 Equity Incentive Plan, as amended, and <ix:nonFraction unitRef="shares" contextRef="c-101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-429">387,332</ix:nonFraction> shares available for future grants issuance under the Company&#8217;s 2024 Inducement Incentive Award Plan. Refer to "Note 8 &#8211; Stock-Based Compensation," to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-430" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-431">1,890,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-432">15.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-102" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-433">6.78</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-434">920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-435">378,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-436">8.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-437">1,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-438">4.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-439">2,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-440">6.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-441">2,265,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-442">14.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-443">7.12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-444">2,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-445">1,060,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-446">23.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-447">5.18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-448">1,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock price and the exercise price of the stock options. <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-449">378,375</ix:nonFraction> stock options were granted during the three months ended March 31, 2025. The weighted average grant date fair value per share for the stock option grants during the three months ended March 31, 2025 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-450">8.92</ix:nonFraction>. As of March&#160;31, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-451">5.4</ix:nonFraction> million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-452">2.93</ix:nonNumeric> years. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-based Compensation Expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-453" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-454">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-455">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-456">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-457">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-458">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-459">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="f-425-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#8217;s stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-460" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-107" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-461">4.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-108" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-462">3.8</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected dividend yield</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-107" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-463">0.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-108" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-464">0.0</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected term in years (for employees)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-107" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-465">6.08</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-109" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-466">5.50</ix:nonNumeric> - <ix:nonNumeric contextRef="c-110" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-467">6.08</ix:nonNumeric></span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected volatility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-107" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-468">106.9</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-469">79.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-470">79.7</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the condensed consolidated financial statements for the period ended March&#160;31, 2024.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#8217;s initial public offering. The offering period and purchase period was determined by Angion&#8217;s board of directors. No offering periods or purchasing periods were active as of March&#160;31, 2025. As of March&#160;31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-111" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-471">275,309</ix:nonFraction> shares remained available for purchase under the ESPP and <ix:nonFraction unitRef="shares" contextRef="c-111" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="0" id="f-472">no</ix:nonFraction> offerings have been authorized.</span></div></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_79"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 8&#8212;<ix:nonNumeric contextRef="c-1" name="angn:WarrantsAndRightsOutstandingTextBlock" id="f-473" continuedAt="f-473-1" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="f-473-1" continuedAt="f-473-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with  FASB ASC Topic 815, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, certain of the Company&#8217;s outstanding warrants, as discussed below, are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss at the end of each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-112" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-474">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the fair value of the March Pre-Funded Warrants was $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="angn:FairValueOfCommonStockWarrants" scale="6" id="f-475">6.6</ix:nonFraction> million. The Company recorded the $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="6" id="f-476">0.6</ix:nonFraction> million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024. The fair value of the March Pre-Funded Warrants was measured using the Black-Scholes option pricing model as of the grant date. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-473-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March 31, 2025, these warrants were classified as equity upon receipt of Stockholder Approval, as discussed in Note 3.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 3 and 6, in July 2024, the Company closed its Public Offering consisting of (i) the July Shares, (ii) the July Pre-Funded Warrants, and (iii) the July Common Warrants. Each July Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-67" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-477">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July Pre-Funded Warrants. Each July Common Warrant is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-66" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-478">5.00</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the fair value of the July Pre-Funded Warrants and July Common Warrants was $<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="angn:FairValueOfCommonStockWarrants" scale="6" id="f-479">6.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="angn:FairValueOfCommonStockWarrants" scale="6" id="f-480">6.5</ix:nonFraction> million, respectively. The Company recorded the $<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="6" id="f-481">2.9</ix:nonFraction> million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As of March 31, 2025, the July Pre-Funded Warrants are classified as equity, following Stockholder Approval in November 2024, as discussed in Note 3. The fair value of the July Common Warrants was measured using the Black-Scholes option pricing model as of the grant date. For the three months ended March 31, 2025, the Company recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-482">0.5</ix:nonFraction> million in fair value remeasurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following receipt of Stockholder Approval, the Company remeasured the March Pre-Funded Warrants and the July Pre-Funded Warrants, held by GKCC, at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. As a result of obtaining Stockholder Approval, the March Pre-Funded Warrants and July Pre-Funded Warrants held by GKCC and its affiliates met the equity classification requirements under ASC 815. During the quarter ended December 31, 2024, the Company reclassified the July Common Warrants held by GKCC and its affiliates from a liability to equity. The Company will re-assess the equity classification for the remaining March Pre-Funded Warrants and July Pre-Funded Warrants at each reporting period end. As of the three months ended March 31, 2025, there were no changes to the equity classification.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in January 2025, the Company closed the January Offering pursuant to which the Company agreed to issue and sell: (i) the January Shares and (ii) the January Common Warrants. Each January Share and accompanying January Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-117" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-483">7.925</ix:nonFraction>. The January Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-117" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-484">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-67" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-485">five years</ix:nonNumeric> from the initial exercise date. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="f-486" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information regarding the warrants outstanding at March&#160;31, 2025:</span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"/><td style="width:38.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.274%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Warrants</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted <br/>Average <br/>Exercise <br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-487">5,081,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-488">3.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-4" name="angn:ClassOfWarrantOrRightWeightedAverageLife" format="ixt-sec:duryear" id="f-489">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-490">1,261,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" scale="0" id="f-491">7.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightExercisedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-492">68,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" scale="0" id="f-493">5.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at March&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-494">6,274,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-495">4.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-3" name="angn:ClassOfWarrantOrRightWeightedAverageLife" format="ixt-sec:duryear" id="f-496">4.5</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_82"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 9&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-497" continuedAt="f-497-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-497-1" continuedAt="f-497-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Legal Proceedings </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company may be exposed to litigation in connection with its products under development and operations. The Company&#8217;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-497-2"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2016, Former Elicio entered into a license agreement to license certain intellectual property from a university, which agreement has been amended from time to time to license additional intellectual property and to adjust fees, milestone dates, and diligence requirements. The Company is required to pay certain contractual maintenance and milestone payments related to clinical trials and royalties on product sales over the term of the contract, with minimum annual royalty payments commencing in the calendar year after commercialization. The license term for the license agreement extends until terminated by either party under certain provisions. During the three months ended March 31, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="angn:LicenseExpense" format="ixt:num-dot-decimal" scale="6" id="f-498">0.4</ix:nonFraction>&#160;million. No such expenses were recorded in the three months ended March 31, 2025. No commercialization royalties have been achieved to date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the Company is required to pay a total of up to $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="angn:OperatingLeaseFutureMinimumAnnualMaintenancePayments" format="ixt:num-dot-decimal" scale="6" id="f-499">20.9</ix:nonFraction>&#160;million upon achievement of certain late-stage developmental and commercial milestones. The developmental milestone payment will be recorded when the milestone is achieved, and the commercial milestone payment and royalties will be recorded when the sales occur.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Future minimum annual maintenance payments are $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="angn:OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" format="ixt:num-dot-decimal" scale="6" id="f-500">0.1</ix:nonFraction>&#160;million for the year ended December&#160;31, 2025 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.</span></div></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_85"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 10&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-501" continuedAt="f-501-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-501-1" continuedAt="f-501-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#8220;Boston Lease&#8221;).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="f-502">11.1</ix:nonFraction>&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a ROU lease asset of $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-503">8.0</ix:nonFraction>&#160;million with a corresponding lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-504">8.0</ix:nonFraction>&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the deposit on the Boston Lease and has a deposit in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:ProceedsFromSecuredLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-505">0.7</ix:nonFraction>&#160;million, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of March&#160;31, 2025 and December&#160;31, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately <ix:nonFraction unitRef="sqft" contextRef="c-122" decimals="0" name="us-gaap:AreaOfRealEstateProperty" format="ixt:num-dot-decimal" scale="0" id="f-506">6,157</ix:nonFraction> square feet for approximately $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="angn:LesseeOperatingLeaseAnnualRentExpense" format="ixt:num-dot-decimal" scale="6" id="f-507">0.2</ix:nonFraction>&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease expense for all leases for the three months ended March 31, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-508">0.3</ix:nonFraction> million. Lease expense for all leases for the three months ended March 31, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-509">0.4</ix:nonFraction> million.</span></div><ix:nonNumeric contextRef="c-1" name="angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" id="f-510" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="f-511">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="f-512">379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-513">4.80</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-39" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-514">5.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-515">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-39" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-516">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-517" continuedAt="f-517-1" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-517-1"><ix:continuation id="f-501-2"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2025 (remaining nine months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-518">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-519">1,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-520">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-521">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-522">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" scale="3" id="f-523">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-524">7,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-525">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-526">5,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-527">926</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-528">4,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:continuation></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_88"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 - <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-529" continuedAt="f-529-1" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="f-529-1" continuedAt="f-529-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, pursuant to which the Company issued a <ix:nonFraction unitRef="number" contextRef="c-124" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-530">3</ix:nonFraction>% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-531">20.0</ix:nonFraction> million (the &#8220;Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-532">19.7</ix:nonFraction> million from the Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the three months ended March&#160;31, 2025, the Company recorded other expense of $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="f-533">0.1</ix:nonFraction> million related to the accretion of the discount of Convertible Note debt issuance costs. During the three months ended March&#160;31, 2025, the Company recorded accrued interest expense of $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-534">0.1</ix:nonFraction> million related to the interest due on the Convertible Note but not yet payable.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-529-2">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. In March 2025, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-535">3,500,573</ix:nonFraction> shares of its common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-536">20.0</ix:nonFraction> million plus $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="angn:AccruedInterestPremiumForConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="f-537">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note. As of March 31, 2025, the Company has no outstanding debt</ix:continuation>.</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_91"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 12&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-538" continuedAt="f-538-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-538-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company did <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-539"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-540">no</ix:nonFraction></ix:nonFraction>t record a provision or benefit for income taxes during the three months ended March&#160;31, 2025 or 2024. As of March&#160;31, 2025 and December&#160;31, 2024, the Company continues to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.</span></div></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_94"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 13&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-541" continuedAt="f-541-1" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="f-541-1" continuedAt="f-541-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock and preferred stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be antidilutive. Because the Company has reported net losses since inception, these potential shares of common stock and preferred stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-541-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-542" continuedAt="f-542-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><ix:continuation id="f-542-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-543">11,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-544">11,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average shares used in computing net loss per share, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-545"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-546">12,950,574</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-547"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-548">10,273,925</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-549"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-550">0.87</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-551"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-552">1.15</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-553" continuedAt="f-553-1" escape="true">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</ix:nonNumeric></span></div><ix:continuation id="f-553-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"/><td style="width:72.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.904%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.906%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-128" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-554">2,265,453</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-129" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-555">687,204</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-130" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-556">3,642,099</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-131" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-557">1,181,466</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unvested common stock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-132" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-558">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-133" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-559">1,030</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-560">5,907,552</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-561">1,869,700</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_97"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 14 &#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-562" continuedAt="f-562-1" escape="true">Related Party Transactions</ix:nonNumeric></span><ix:continuation id="f-562-1" continuedAt="f-562-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></ix:continuation></div><ix:continuation id="f-562-2" continuedAt="f-562-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement and Subscription Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-563">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the March Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-564">6.0</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#8217;s board of directors,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Jay Venkatesan, a member of the Company&#8217;s board of directors, and trusts affiliated with Jay Venkatesan, purchased <ix:nonFraction unitRef="shares" contextRef="c-134" decimals="0" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-565">1,600,000</ix:nonFraction> July Pre-Funded Warrants and accompanying July Common Warrants and <ix:nonFraction unitRef="shares" contextRef="c-135" decimals="0" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-566">200,000</ix:nonFraction> July Pre-Funded Warrants and accompanying July Common Warrants, respectively, with such July Pre-Funded Warrants and July Common Warrants subject to the terms and conditions of the July Pre-Funded Warrants and July Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the Public Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="f-567">10.9</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-568">20.0</ix:nonFraction> million pursuant to the Note Financing. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-569">19.7</ix:nonFraction> million from the Note Financing, after deducting debt issuance costs. </span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-562-3">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. The Company issued <ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-570">3,500,573</ix:nonFraction> shares of its common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-571">20.0</ix:nonFraction> million plus $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="angn:AccruedInterestPremiumForConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="f-572">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note. As of March 31, 2025, the Company has no outstanding deb</ix:continuation>t.</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_5497558139394"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 15 - <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-573" continuedAt="f-573-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="f-573-1" continuedAt="f-573-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has <ix:nonFraction unitRef="entity" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-574">one</ix:nonFraction> reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#8217;s Chief Operating Decision Maker </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-573-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;CODM&#8221;), its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Other segment items include interest income, interest expense, and change in the fair value of warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-575" continuedAt="f-575-1" escape="true">The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-575-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:71.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.121%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.124%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-576">4,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-577">2,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-578">2,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-579">2,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-580">646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-581">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-582">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-583">1,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:RecoveryOfDirectCosts" scale="3" id="f-584">489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" sign="-" name="us-gaap:RecoveryOfDirectCosts" scale="3" id="f-585">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-586">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="f-587">919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-588">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-589">1,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" scale="3" id="f-590">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-591">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-592">11,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-593">11,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:71.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.121%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-594">28,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-595">28,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div id="i90e86c78fdd244088832607d0b0ad2ca_100"></div><div style="margin-top:6pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">You should read the following discussion and analysis of our financial condition and results of operations together with our condensed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q and in our audited financial statements and accompanying notes for the years ended December 31, 2024 and 2023 included in our Annual Report on Form 10-K. In addition to the historical financial information, this discussion contains forward-looking statements that involve risks, assumptions and uncertainties, such as statements of our plans, objectives, expectations, intentions, forecasts and projections. Our actual results and the timing of selected events could differ materially from those discussed in these forward-looking statements as a result of several factors, including those set forth under the sections titled &#8220;Risk Factors&#8221; in this Quarterly Report on Form 10-Q and the Form 10-K, which you should read carefully to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section titled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Forward-Looking Statements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">at the beginning of this report.</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a clinical-stage biotechnology company pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. Our proprietary Amphiphile (&#8220;AMP&#8221;) technology is designed to generate robust anti-tumor T lymphocytes (&#8220;T cell&#8221;) responses by preferentially targeting lymph nodes.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Recent advances have identified T cell responses as a key component of effective cancer immunotherapy and we believe our AMP technology can generate a robust T cell response that can potentially provide meaningful clinical benefit. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe the therapeutic utility of currently approved and development stage cancer immunotherapies are limited in many cases due to their inability to sufficiently localize to lymph nodes and adequately engage with the critical immune cells responsible for stimulating adaptive immunity.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP technology is specifically intended to localize payloads to lymph nodes leading to the generation of a robust T cell response that we believe is critical to generate an anticancer immune response.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our lead programs focus on our cancer vaccine product candidates, which target biologically validated driver tumor mutations using common and well characterized neoantigens.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This strategy results in an &#8220;off-the-shelf&#8221; therapeutic option allowing patients to receive treatment without delayed manufacturing timelines and increased costs associated with personalized vaccine approaches.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our clinical pipeline includes the lymph node targeted therapeutic cancer vaccine ELI-002, currently being evaluated in a Phase 2 study, designed to stimulate an immune response against mutant KRAS cancers. This study is progressing toward a disease-free survival event-driven interim analysis expected in the third quarter of 2025. Our preclinical pipeline includes the lymph node targeted therapeutic cancer vaccines ELI-007, currently being evaluated in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers, and ELI-008, currently being evaluated in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe that each of our immunotherapy product candidates, if approved, has the potential to reduce the risk of recurrence of tumors carrying specific oncogenic driver mutations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operations to date have been financed primarily by aggregate net proceeds of $193.3 million from the issuance of common stock, pre-funded warrants, convertible preferred stock, convertible notes, the exercise of stock options and common warrants, the private placement of our securities, at-the-market offerings, and proceeds from the Merger with Angion. Since inception, we have had significant annual operating losses. Our net loss was $11.2 million for the three months ended March 31, 2025, and $11.8 million for the three months ended March 31, 2024. As of March&#160;31, 2025, we had an accumulated deficit of $205.3&#160;million and $18.4&#160;million in cash and cash equivalents.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway. As of the filing date of this Quarterly Report on Form 10-Q, we believe that our cash on hand will enable us to fund our operations into the fourth quarter of 2025 based on our current financial operating plan. This period could be shortened or lengthened if there are any significant increases or decreases in planned or actual spending on development programs or more rapid progress of development programs than anticipated. There is no assurance that financing will be available when needed to allow us to continue as a going concern. Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about our ability to continue as a going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will require additional financing to continue this development. We plan to address this condition through the sale of common stock or other </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we are unable to obtain additional capital when and as needed to continue as a going concern, we might have to further reduce or scale back our operations and/or liquidate our assets, and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q have been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our accounts payable and accrued expenses. We expect to continue to incur net losses for the foreseeable future, and we expect our research and development expenses, general and administrative expenses, and capital expenditures will continue to increase. In particular, we expect our expenses to increase as we continue our development of, and seek regulatory approvals for, our product candidates, as well as hire additional personnel, pay fees to outside consultants, attorneys and accountants, and incur other increased costs associated with being a public company. In addition, if and when we seek and obtain regulatory approval to commercialize any product candidate, we will also incur increased expenses in connection with commercialization and marketing of any such product. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending on the timing of our clinical trials and our expenditures on other research and development activities. We anticipate that our expenses will increase significantly in connection with our ongoing activities, as we:</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; advance our lead product candidate, ELI-002, to late stage clinical trials;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; advance our preclinical programs to clinical trials; </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; expand our pipeline of product candidates;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; seek regulatory approval for our investigational medicines;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; maintain, expand, protect and defend our intellectual property portfolio;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; acquire or in-license technology;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; expand our clinical, scientific, management and administrative teams; and</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; operate as a public company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of the filing date of this Quarterly Report on Form 10-Q, we believe that our cash on hand will enable us to fund our operations into the fourth quarter of 2025 based on our current plan. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. To finance our operations beyond that point we will need to raise additional capital, which cannot be assured. Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about our ability to continue as a going concern.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have not had any products approved for sale. We do not expect to generate any product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our product candidates. If we obtain regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. As a result, until such time, if ever, that we can generate substantial product revenue, we expect to finance our cash needs through equity offerings, debt financings or other capital sources, including collaborations, licenses or similar arrangements. However, we may be unable to raise additional funds or enter into such other arrangements when needed or on favorable terms, if at all. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies, including our research and development activities. If we are unable to raise capital, we will need to delay, reduce or terminate planned activities to reduce costs.</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_109"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Components of Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following discussion summarizes the key factors our management believes are necessary for an understanding of our financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Expenses</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operating expenses since inception have consisted primarily of research and development expenses and general and administrative costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses consist primarily of costs incurred for the development of our product candidates and our drug discovery efforts, which include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">personnel costs, which include salaries, benefits, and equity-based compensation expense;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expenses incurred under agreements with consultants and contract organizations that conduct research and development activities on our behalf;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">costs related to sponsored research service agreements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">costs related to production of preclinical and clinical materials, including fees paid to contract manufacturers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">laboratory and vendor expenses related to the execution of preclinical studies and planned clinical trials; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">laboratory supplies and equipment used for internal research and development activities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We expense all research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and service providers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses are not currently tracked on a program-by-program basis. We use our personnel and infrastructure resources across multiple research and development programs directed toward identifying and developing product candidates. Substantially all our research and development costs are incurred on the development of ELI-002 and our preclinical candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We expect our research and development expenses to increase substantially for the foreseeable future as we continue to invest in research and development activities related to developing our product candidates, including investments in conducting clinical trials, manufacturing and otherwise advancing our programs. The process of conducting the clinical research necessary to obtain regulatory approval is costly and time-consuming, and the successful development of our product candidates is highly uncertain. At this time, we cannot reasonably estimate the nature, timing and costs of the efforts that will be needed to complete the development of, or the period, if any, in which material net cash inflows may commence from ELI-002 or any of our preclinical candidates. This is due to the numerous risks and uncertainties associated with developing drugs, including the uncertainty of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the scope, rate of progress and expense of our research and development activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">clinical trials and early-stage results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the terms and timing of regulatory approvals; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability to market, commercialize and achieve market acceptance for ELI-002, or any of our preclinical candidates that we or our future collaboration partners may develop in the future. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any of these variables with respect to the development of ELI-002, or any other of our preclinical candidates that we may develop could result in a significant change in the costs and timing associated with the development of such candidates. For example, if the FDA or other regulatory authority were to require us to conduct preclinical and clinical studies beyond those which we currently anticipate will be required for the completion of clinical development or if we experience significant delays in enrollment in any clinical trials, we could be required to expend significant additional financial resources and time on the completion of our clinical development programs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our general and administrative expenses consist primarily of personnel costs, including equity-based compensation, and other expenses for outside professional services, including marketing, legal, audit and accounting, facility-related costs not otherwise included in research and development expenses, and recruiting. We expect our general and administrative expenses to increase over the next several years to support our continued research and development activities, manufacturing activities, increased costs of expanding our operations and operating as a public company. These increases will likely include increases related to the hiring of additional personnel and legal, regulatory and other fees and services associated with maintaining compliance with the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nasdaq Marketplace Rules or the Nasdaq Listing Rules and SEC requirements, accounting and audit fees, director and officer insurance costs and investor relations costs associated with being a public company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other (Expense) Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2025 and 2024, other income and expense consisted primarily of interest income, foreign exchange transaction gains and losses, gain on sale of equipment, interest expense, and gains and losses related to the re-measurement of our warrant liabilities. </span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_112"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Comparison of the Three Months Ended March 31, 2025 and 2024</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes our results of operations for the periods indicated (in thousands, except percentages):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">% Change</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></div></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,958&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,682&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:30pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10,241&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Loss from operations</span></div></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10,736)</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10,241)</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(495)</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total other (expense) income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net loss</span></div></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(11,209)</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(11,827)</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses were $7.8&#160;million for the three months ended March 31, 2025, compared to $7.6&#160;million for the three months ended March 31, 2024. The increase of $0.2&#160;million was primarily due to higher clinical trial expenses resulting from the ELI-002 Phase 2 trial being fully enrolled during the fourth quarter of 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">General and administrative expenses were $3.0&#160;million for the three months ended March 31, 2025, compared to $2.7 million for the three months ended March 31, 2024. The increase of $0.3&#160;million was primarily due to higher professional fees incurred in connection with the January Offering.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Other Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other expense for the three months ended March 31, 2025 was $0.5&#160;million compared to $1.6&#160;million for the three months ended March 31, 2024. The decrease of $1.1&#160;million was primarily due to the change in fair value associated with the outstanding Common Warrants and initial loss recognized resulting from the March Offering. </span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_118"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Sources and Uses of Liquidity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operations through March&#160;31, 2025 have been financed primarily by aggregate net proceeds of $193.3&#160;million from the issuance of common stock, pre-funded warrants, convertible preferred stock, convertible notes, the exercise of stock options and common warrants, the private placement of our securities, at-the-market offerings, and proceeds from the Merger with Angion. Since inception, we have had significant operating losses. Our net loss was $11.2 million and $11.8 million for the three months ended March 31, 2025 and three months ended March 31, 2024, respectively. As of March&#160;31, 2025, we had an accumulated deficit of $205.3&#160;million and $18.4&#160;million in cash and cash equivalents. Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, and to a lesser extent, general and administrative expenditures. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable and accrued expenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about our ability to continue as a going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will require additional financing to continue this development. The unaudited condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q have been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. We plan to address this condition through the sale of common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. However, there is no assurance that we will be successful in raising additional capital or that such additional funds will be available on acceptable terms, if at all. Should we be unable to raise this amount of capital our operating plans will be limited to the amount of capital that we can access. We may also consider steps to reduce our operating expenses. There can be no assurances that we will be successful in any of the foregoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Summary Statement of Cash Flows</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth a summary of our net cash flow activity for the three months ended March 31, 2025 and 2024 (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash provided by (used in)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating activities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10,119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(12,122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effect of foreign currency on cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net increase (decrease) in cash</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">240&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,095)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Operating Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2025, net cash used in operating activities was $10.1&#160;million, which consisted of a net loss of $11.2&#160;million, changes in our assets and liabilities of $0.3&#160;million, and non-cash charges of $1.4 million. The non-cash charges were related to $0.5&#160;million of change in the fair value of warrant liability,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$0.5&#160;million of stock-based compensation, $0.2&#160;million amortization of the ROU asset, $0.1 million depreciation and  $0.1 million of non-cash interest expense.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2024, net cash used in operating activities was $12.1&#160;million, which consisted of a net loss of $11.8&#160;million and changes in our assets and liabilities of $2.8&#160;million, partially offset by non-cash charges of $2.5&#160;million. The non-cash charges were primarily related to $1.3 million of change in the fair value of warrant liability, $0.6 million loss on the issuance of the March Pre-Funded Warrants in the March Offering, $0.3 million of stock-based compensation, $0.2 million amortization of the ROU asset, and $0.1&#160;million of depreciation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Investing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2025 and 2024, net cash provided by or used in investing activities was immaterial. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Financing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2025, net cash provided by financing activities was $10.3&#160;million as a result of the issuance of $0.8&#160;million of our common stock under our at-the-market offering program with JonesTrading Institutional Services LLC, as agent, $9.1&#160;million from the January Offering, and $0.4 million from the exercise of common warrants and stock options. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2024, net cash provided by financing activities was $11.0&#160;million, primarily as a result of the issuance of $5.1 million of our common stock under our at-the-market offering program </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents, and $6.0 million of the March Pre-Funded Warrants in the March Offering.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Future Cash Needs and Funding Requirements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based on our current operating plan, as of the filing date of this Quarterly Report on Form 10-Q, we believe our cash and cash equivalents will be sufficient to fund our planned operations into the fourth quarter of 2025. However, we have based our projections of operating capital requirements on assumptions that may prove to be incorrect and we may use all our available capital resources sooner than we expect. We are unable to estimate the exact amount of our operating capital requirements. The amount and timing of our future funding requirements will depend on many factors, including, but not limited to:</span></div><div style="margin-top:8pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the scope, progress, results and costs of researching and developing product candidates, and conducting preclinical studies and clinical trials;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the outcome of any future clinical trials, for any existing or future product candidates;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">whether we are able to take advantage of any FDA expedited development and approval programs for any of our product candidates;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the outcome, costs and timing of seeking and obtaining and maintaining FDA and any foreign regulatory approvals;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the costs associated with any delays we may encounter as a result of evolving regulatory requirements or adverse results with respect to any of our product candidates;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the number and characteristics of product candidates we pursue, including product candidates in preclinical development;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the ability of our product candidates to progress through clinical development successfully;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">our need to expand our research and development activities, including to conduct additional clinical trials;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">market acceptance of our product candidates, including physician adoption, market access, pricing and reimbursement;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the costs of acquiring, licensing or investing in businesses, products, product candidates and technologies;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">our ability to maintain, expand and defend the scope of our intellectual property portfolio, including the amount and timing of any payments potentially required to make, or that we may receive, in connection with the licensing, filing, prosecution, defense and enforcement of any patents or other intellectual property rights;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">our need and ability to hire additional personnel, including management, clinical development, medical and commercial personnel;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the effect of competing technological, market developments and government policy;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the costs associated with being a public company, including our need to implement additional internal systems and infrastructure, including financial and reporting systems;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the costs associated with securing and establishing commercialization and manufacturing capabilities, as well as those associated with packaging, warehousing and distribution;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the economic and other terms, timing of and success of our existing licensing arrangements and any collaboration, licensing or other arrangements into which we may enter in the future and timing and amount of payments thereunder; and</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the timing, receipt and amount of sales and general commercial success of any future approved products, if any.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Until such time as we can generate significant revenue from sales of product candidates, if ever, we expect to finance our operations through the sale of common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. Adequate funding may not be available to us on acceptable terms, or at all. To the extent we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be or could be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we raise funds through additional collaborations, or other similar arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to and/or may reduce the value of our common stock. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_121"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our critical accounting policies are described under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Policies and Significant Judgments and Estimates&#8221; in the Form 10-K. There have been no material changes in our critical accounting policies and estimates in the preparation of our condensed consolidated financial statements during the three months ended March 31, 2025 compared to those disclosed in the Form 10-K. </span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a smaller reporting company and an emerging growth company, as defined under the Jumpstart Our Business Startup (&#8220;JOBS&#8221;) Act. Under the JOBS Act, emerging growth companies can delay the adoption of new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. Other exemptions and reduced reporting requirements under the JOBS Act for emerging growth companies include presentation of only two years of audited financial statements in a registration statement for an initial public offering, an exemption from the requirement to provide an auditor's report on internal controls over financial reporting pursuant to Sarbanes-Oxley Act of 2002, as amended (&#8220;Sarbanes-Oxley&#8221;), an exemption from any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation, and less extensive disclosure about our executive compensation arrangements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that (i) we are no longer an emerging growth company or (ii) we affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our condensed consolidated financial statements may not be comparable to companies that comply with new or revised accounting standards as of public company effective dates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We will remain an emerging growth company until the earliest of (i) December 31, 2026, (ii) the last day of our first fiscal year in which we have total annual gross revenue of $1.235 billion or more, (iii) the date on which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which means the market value of equity securities that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter and (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company&#8221; and/or &#8220;non-accelerated filer&#8221; which may allow us to take advantage of many of the same exemptions from disclosure requirements including not being required to comply for a period of time with the auditor attestation requirements of Section 404 of Sarbanes-Oxley, and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements.</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_127"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_130"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 4. Controls and Procedures</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Definition and Limitations of Disclosure Controls</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluates these controls and procedures on an ongoing basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are inherent limitations to the effectiveness of any system of disclosure controls and procedures. These limitations include the possibility of human error, the circumvention or overriding of the controls and procedures and reasonable resource constraints. In addition, because we have designed our system of controls based on certain assumptions, which we believe are reasonable, about the likelihood of future events, our system of controls may not achieve its desired purpose under all possible future conditions. Accordingly, our disclosure controls and procedures provide reasonable assurance, but not absolute assurance, of achieving their objectives.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our management, with the participation of our President and Chief Executive Officer, our principal executive officer, and our Chief Strategy and Financial Officer, our principal accounting and financial officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March&#160;31, 2025. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based on the evaluation of our disclosure controls and procedures, our President and Chief Executive Officer and our Chief Strategy and Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Quarterly Report on Form 10-Q as a result of our material weaknesses in our internal control over financial reporting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">However, our management, including our Chief Executive Officer and our Chief Strategy and Financial Officer, has concluded that, notwithstanding the identified material weaknesses in our internal control over financial reporting, the financial statements in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)) under the Exchange Act) that occurred during the quarter ended March&#160;31, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, except as follows:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Material Weakness Remediation Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As previously reported, in connection with the preparation of our condensed consolidated financial statements, we identified control deficiencies in the design and operation of our internal control over financial reporting that constituted material weaknesses. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our financial statements will not be prevented or detected on a timely basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The material weaknesses identified in our internal control over financial reporting related to (i) insufficient resources with knowledge and expertise in U.S. GAAP to properly evaluate certain complex transactions, including debt instruments and equity instruments; and (ii) insufficient financial reporting and close controls to ensure that incurred expenses are accrued at period end and deliverables from third party contractors are reviewed for accuracy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We initiated several steps to remediate these material weaknesses, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; engaging SEC compliance and technical accounting consultants to assist in evaluating transactions for conformity with U.S. GAAP;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; hiring additional finance and accounting personnel to augment accounting staff and to provide more resources for complex accounting matters and financial reporting; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; strengthening our financial reporting and close relating to incurred expenses by ensuring our data capture procedures are clearly defined and that responsible personnel, including supervisory personnel, have adequate training regarding the process and expectation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although we have initiated efforts to remediate these material weaknesses, the material weaknesses have not been fully remediated as of March&#160;31, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and continue to be disclosed as material weaknesses in this Quarterly Report on Form 10-Q for the three month period ended March&#160;31, 2025. Our remediation efforts are intended to address the identified material weaknesses. Management is committed to continuous improvement of our internal control over financial reporting and will continue to diligently review our internal control over financial reporting. However, we cannot assure you that we will be successful in remediating the material weaknesses we identified or that our internal control over financial reporting, as modified, will enable us to identify or avoid material weaknesses in the future.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Inherent Limitation on the Effectiveness Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable and not absolute assurances. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but there can be no assurance such improvements will be sufficient to provide us with effective internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_133"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II OTHER INFORMATION</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_136"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 1. Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may be subject to various legal proceedings, claims and administrative proceedings that arise in the ordinary course of our business activities or otherwise. Although the results of the litigation and claims cannot be predicted with certainty, as of the date of this report, we do not believe we are party to any claim, proceeding or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to us, including any costs associated with the indemnification of directors and officers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 1A. Risk Factors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors, described in the section titled &#8220;Risk Factors&#8221; in the Form 10-K as well as the other information in this Quarterly Report on Form 10-Q, before deciding whether to invest in shares of our common stock. There have been no material changes in our risk factors from those described in the Form 10-K, other than as follows.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Significant political, trade, regulatory developments, and other circumstances beyond our control, including as a result of recently announced tariffs, could have a material adverse effect on our financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Changes in United States trade policy, including recently announced or potential future tariffs, could have a material adverse impact on our business, financial condition, and results of operations. The imposition of new tariffs or increases in existing tariffs on goods imported from or expected to be imported from countries where we or our suppliers operate could result in higher costs for materials or components essential to our operations. For example, in April 2025, the United States imposed broad tariffs on imports from virtually all countries, with particularly high tariffs on imports from China.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since this announcement, most tariffs for countries other than China have been suspended temporarily. In response to tariffs, some countries have implemented retaliatory tariffs on U.S. goods, while others seek to negotiate agreements regarding U.S.-imposed tariffs.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Historically, tariffs have led to increased trade and political tensions and, to date, the outcome of the negotiations between the United States and the various countries is not yet clear. Political tensions as a result of trade policies could reduce trade volume, investment, technological exchange and other economic activities between major international economies, resulting in a material adverse effect on global economic conditions and the stability of global financial markets. Any changes in political, trade, regulatory, and economic conditions, including U.S. trade policies, could have a material adverse effect on our financial condition or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_142"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None.</span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_145"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None. </span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_148"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None. </span></div><div id="i90e86c78fdd244088832607d0b0ad2ca_151"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5. Other Information</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal quarter ended March&#160;31, 2025, none of our directors or executive officers <ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-596"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-597">adopted</ix:nonNumeric></ix:nonNumeric>, modified or <ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-598"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-599">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_154"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.    Exhibits </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:57.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.127%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit <br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit <br/>Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Filed Herewith</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/d914999dex41.htm">Form of Common Warrant</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/30/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/d914999dex101.htm">Form of Securities Purchase Agreement, dated as of January 29, 2025, by and among Elicio Therapeutics, Inc. and the purchasers party thereto.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/30/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148525000022/confidential-elicioemplo.htm">Employment Agreement, dated March 21, 2025, by and between Elicio Therapeutics, Inc. and Preetam Shah.</a></span></div><div><span><br/></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/24/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-amendedandrestate.htm">Amended and Restated Non-Employee Director Compensation Policy.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit311.htm">Certification of Principal Executive Officer</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit311.htm"> Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit312.htm">Certification of</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit312.htm"> Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#x5E;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit321.htm">Certification of Principal Executive Officer </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit321.htm">Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit322.htm">Certification of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit322.htm">Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Instance Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________________________</span></div><div style="margin-top:3pt;text-indent:-9pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#x5E;          The certification that accompanies this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, is not deemed &#8220;filed&#8221; by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">+&#160;&#160;&#160;&#160;Indicates management contract or compensatory plan.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i90e86c78fdd244088832607d0b0ad2ca_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i90e86c78fdd244088832607d0b0ad2ca_13">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ ROBERT CONNELLY</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">May&#160;13, 2025</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Robert Connelly</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">President and Chief Executive Officer </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Executive Officer)</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;padding-left:72pt;text-align:right;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ PREETAM SHAH</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">May&#160;13, 2025</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Preetam Shah</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chief Strategy and Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>elicio-amendedandrestate.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-amendedandrestate</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-amendedandrestate001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-amendedandrestate001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    ELICIO THERAPEUTICS, INC.    AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY    Non-employee members of the board of directors (the &#8220;Board&#8221;) of Elicio Therapeutics, Inc. (the  &#8220;Company&#8221;) shall be eligible to receive the compensation as set forth in this Non-Employee Director  Compensation Policy (this &#8220;Policy&#8221;), which was first adopted pursuant to the Board&#8217;s action on June 9,  2022, amended as of December 28, 2023 and further amended as of April 23, 2025 (the &#8220;Effective Date&#8221;).   The compensation described in this Policy shall be paid or be made, as applicable, automatically and  without further action of the Board, to each member of the Board who is not an employee of the Company  or any parent or subsidiary of the Company (each, a &#8220;Non-Employee Director&#8221;) who may be eligible to  receive such compensation, unless such Non-Employee Director declines the receipt of such compensation  by written notice to the Company; provided, however, that Non-Employee Directors shall not be eligible  to receive cash or equity compensation under the Policy (but shall be entitle to receive reimbursement  pursuant to Section 3 below) if and while they are receiving other compensation (including severance  compensation) from the Company resulting from their former employment with the Company.  This Policy  shall remain in effect until it is revised or rescinded by further action of the Board.  This Policy may be  amended, modified or terminated by the Board at any time, without advance notice, in its sole discretion.   The terms and conditions of this Policy shall supersede any prior cash and/or equity compensation  arrangements for service as a member of the Board between the Company and any of its Non-Employee  Directors, including pursuant to this Policy as in effect prior to the Effective Date.    1. Cash Compensation.    (a) Annual Retainers.  Each Non-Employee Director shall be eligible to receive an  annual retainer of $40,000 for service on the Board.    (b) Additional Annual Retainers.  In addition, a Non-Employee Director shall receive  the following annual retainers:  (i) Non-Executive Chairman of the Board.  A Non-Employee Director  serving as the Non-Executive Chairman of the Board shall receive an additional annual retainer of $35,000  for such service.  (ii) Audit Committee.  A Non-Employee Director serving as Chairperson of  the Audit Committee shall receive an additional annual retainer of $15,000 for such service.  A Non- Employee Director serving as a member of the Audit Committee (other than the Chairperson) shall receive  an additional annual retainer of $7,500 for such service.  (iv) Compensation Committee.  A Non-Employee Director serving as  Chairperson of the Compensation Committee shall receive an additional annual retainer of $10,000 for such  service.  A Non-Employee Director serving as a member of the Compensation Committee (other than the  Chairperson) shall receive an additional annual retainer of $5,000 for such service.  (v)  Nominating and Corporate Governance Committee.  A Non-Employee  Director serving as Chairperson of the Nominating and Corporate Governance Committee shall receive an  additional annual retainer of $8,000 for such service.  A Non-Employee Director serving as a member of  the Nominating and Corporate Governance Committee (other than the Chairperson) shall receive an  additional annual retainer of $5,000 for such service.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-amendedandrestate002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-amendedandrestate002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  2      (c) Payment of Retainers.  The annual retainers described in Sections 1(a) and 1(b)  shall be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company in arrears  not later than the fifteenth (15th) day following the end of each calendar quarter.  In the event a Non- Employee Director does not serve as a Non-Employee Director, or in the applicable positions described in  Section 1(b), for an entire calendar quarter, the retainer paid to such Non-Employee Director shall be  prorated for the portion of such calendar quarter actually served as a Non-Employee Director, or in such  position, as applicable.    2. Equity Compensation.  Non-Employee Directors shall be granted the equity awards  described below.  The awards described below shall be granted under and shall be subject to the terms and  provisions of the Company&#8217;s 2021 Equity Incentive Award Plan, as amended from time to time, or any  other applicable Company equity incentive plan then-maintained by the Company (in any case, the &#8220;Equity  Plan&#8221;) and shall be evidenced by the execution and delivery of award agreements in substantially the forms  approved by the Board from time to time.  All applicable terms of the Equity Plan apply to this Policy as if  fully set forth herein, and all grants of stock options hereby are subject in all respects to the terms of the  Equity Plan.     (a) Initial Awards.  Each Non-Employee Director who is initially elected or appointed  to the Board after the Effective Date shall automatically be granted, on the date of such initial election or  appointment, an option (an &#8220;Initial Award&#8221;) to purchase 15,800 shares of the Company&#8217;s common stock  (&#8220;Shares&#8221;).  No Non-Employee Director shall be granted more than one Initial Award.     (b) Subsequent Awards.  A Non-Employee Director who (i) has been serving on the  Board immediately prior to any annual meeting of the Company&#8217;s stockholders on or after the Effective  Date and (ii) will continue to serve as a Non-Employee Director immediately following such meeting, shall  be automatically granted, on the date of such annual meeting, an option (a &#8220;Subsequent Award&#8221;) to  purchase 7,900 Shares.        (c) Termination of Service of Employee Directors.  Members of the Board who are  employees of the Company or any parent or subsidiary of the Company who subsequently terminate their  service with the Company and any parent or subsidiary of the Company and remain on the Board will not  receive an Initial Award pursuant to Section 2(a) above, but to the extent that they are otherwise eligible,  will be eligible to receive, after termination from service with the Company and any parent or subsidiary  of the Company, Subsequent Awards as described in Section 2(b) above.    (d) Terms of Awards Granted to Non-Employee Directors    (i) Purchase Price.  The per Share exercise price of each option granted to a  Non-Employee Director shall equal the Fair Market Value (as defined in the Equity Plan) of a Share on the  date the option is granted.      (ii) Vesting.  Subject to Section 2(d)(iii) below, each Initial Award shall vest  and become exercisable in thirty-six (36) substantially equal installments on each monthly anniversary of  the date of grant, subject to the Non-Employee Director continuing to provide services to the Company  through each such vesting date.  Subject to Section 2(d)(iii) below, each Subsequent Award shall vest and  become exercisable in full on the earlier of the one-year anniversary of the date of grant and the next annual  meeting of the Company&#8217;s stockholders after the grant date, subject to the Non-Employee Director  continuing to provide services to the Company through such vesting date.    (iii) Accelerated Vesting.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-amendedandrestate003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-amendedandrestate003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  3    (A) Termination Due to Death or Disability.  In the event that any Non- Employee Director incurs a Termination of Service (as defined in the Equity Plan) due to such Non- Employee Director&#8217;s death or Disability (as defined the Equity Plan), each of such Non-Employee  Director&#8217;s Initial Award and Subsequent Award(s), along with any other stock options or other equity-based  awards held by such Non-Employee Director, shall vest and, if applicable, become exercisable with respect  to one hundred percent (100%) of the Shares subject thereto upon such Termination of Service.    (B) Change in Control.  In the event that a Change in Control (as defined in  the Equity Plan) occurs, each Initial Award and Subsequent Award, along with any other stock options or  other equity-based awards held by any Non-Employee Director, shall vest and, if applicable, become  exercisable with respect to one hundred percent (100%) of the Shares subject thereto as of immediately  prior to such Change in Control.  (iv) Term.  The term of each stock option granted to a Non-Employee Director  shall be ten (10) years from the date the option is granted.   3. Reimbursements.  The Company shall reimburse each Non-Employee Director for all  reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee  Director in the performance of his or her duties to the Company in accordance with the Company&#8217;s  applicable expense reimbursement policies and procedures as in effect from time to time.   * * * * *  528312098v.2  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>elicio10-qxexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio10-qxexhibit311</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio10-qxexhibit311001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit311001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Exhibit 31.1  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION  302 OF THE SARBANES-OXLEY ACT OF 2002  I, Robert Connelly, certify that:  1. I have reviewed this Quarterly Report on Form 10-Q of Elicio Therapeutics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a  material fact or omit to state a material fact necessary to make the statements made, in light of  the circumstances under which such statements were made, not misleading with respect to the  period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information  included in this report, fairly present in all material respects the financial condition, results of  operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over  financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant  and have:  a. Designed such disclosure controls and procedures, or caused such  disclosure controls and procedures to be designed under my supervision, to ensure that material  information relating to the registrant, including its consolidated subsidiaries, is made known to  me by others within those entities, particularly during the period in which this report is being  prepared;  b. Designed such internal control over financial reporting, or caused such  internal control over financial reporting to be designed under my supervision, to provide  reasonable assurance regarding the reliability of financial reporting and the preparation of  financial statements for external purposes in accordance with generally accepted accounting  principles;  c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures and presented in this report our conclusions about the effectiveness of the disclosure  controls and procedures, as of the end of the period covered by this report based on such  evaluation; and  d. Disclosed in this report any change in the registrant&#8217;s internal control over  financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s  fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably  likely to materially affect, the registrant&#8217;s internal control over financial reporting; and  5. I have disclosed, based on my most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board  of directors (or persons performing the equivalent functions):  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio10-qxexhibit311002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit311002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    a. All significant deficiencies and material weaknesses in the design or  operation of internal control over financial reporting which are reasonably likely to adversely  affect the registrant&#8217;s ability to record, process, summarize and report financial information; and  b. Any fraud, whether or not material, that involves management or other  employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  ELICIO THERAPEUTICS, INC.  By:  /s/ Robert Connelly     Robert Connelly  President and Chief Executive Officer  (Principal Executive Officer)    Date: May 13, 2025    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>elicio10-qxexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio10-qxexhibit312</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio10-qxexhibit312001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit312001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Exhibit 31.2  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION  302 OF THE SARBANES-OXLEY ACT OF 2002  I, Preetam Shah, certify that:  1. I have reviewed this Quarterly Report on Form 10-Q of Elicio Therapeutics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a  material fact or omit to state a material fact necessary to make the statements made, in light of  the circumstances under which such statements were made, not misleading with respect to the  period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information  included in this report, fairly present in all material respects the financial condition, results of  operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over  financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant  and have:  a. Designed such disclosure controls and procedures, or caused such  disclosure controls and procedures to be designed under my supervision, to ensure that material  information relating to the registrant, including its consolidated subsidiaries, is made known to  me by others within those entities, particularly during the period in which this report is being  prepared;  b. Designed such internal control over financial reporting, or caused such  internal control over financial reporting to be designed under my supervision, to provide  reasonable assurance regarding the reliability of financial reporting and the preparation of  financial statements for external purposes in accordance with generally accepted accounting  principles;  c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures and presented in this report our conclusions about the effectiveness of the disclosure  controls and procedures, as of the end of the period covered by this report based on such  evaluation; and  d. Disclosed in this report any change in the registrant&#8217;s internal control over  financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s  fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably  likely to materially affect, the registrant&#8217;s internal control over financial reporting; and  5. I have disclosed, based on my most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board  of directors (or persons performing the equivalent functions):  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio10-qxexhibit312002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit312002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    a. All significant deficiencies and material weaknesses in the design or  operation of internal control over financial reporting which are reasonably likely to adversely  affect the registrant&#8217;s ability to record, process, summarize and report financial information; and  b. Any fraud, whether or not material, that involves management or other  employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  ELICIO THERAPEUTICS, INC.  By:  /s/ Preetam Shah    Preetam Shah  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal  Accounting Officer)    Date:  May 13, 2025    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>elicio10-qxexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio10-qxexhibit321</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio10-qxexhibit321001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit321001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Exhibit 32.1  CERTIFICATIONS PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (18 U.S.C. SECTION 1350)  The undersigned officer of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) certifies to such  officer&#8217;s knowledge, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes- Oxley Act of 2002, that:  1. The Quarterly Report on Form 10-Q of the Company for the period ended March  31, 2025 (the &#8220;Quarterly Report&#8221;), as filed with the Securities and Exchange Commission, fully  complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,  and  2. The information contained in this Quarterly Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.    ELICIO THERAPEUTICS, INC.  By:  /s/ Robert Connelly   Robert Connelly  President and Chief Executive Officer  (Principal Executive Officer)  Date:  May 13, 2025    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>elicio10-qxexhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio10-qxexhibit322</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio10-qxexhibit322001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit322001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Exhibit 32.2  CERTIFICATIONS PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (18 U.S.C. SECTION 1350)  The undersigned officer of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) certifies to such  officer&#8217;s knowledge, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes- Oxley Act of 2002, that:  1. The Quarterly Report on Form 10-Q of the Company for the period ended March  31, 2025 (the &#8220;Quarterly Report&#8221;), as filed with the Securities and Exchange Commission, fully  complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,  and  2. The information contained in this Quarterly Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.    ELICIO THERAPEUTICS, INC.  By: /s/ Preetam Shah    Preetam Shah  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal  Accounting Officer)  Date:  May 13, 2025    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>angn-20250331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b5a770-ce93-4e1a-8551-4667fc149643,g:e550b526-85cb-4940-ae39-7686e99f6d4a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:angn="http://www.angn.com/20250331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.angn.com/20250331">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20250331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20250331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20250331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20250331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.angn.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessandFinancialCondition" roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition">
        <link:definition>9952157 - Disclosure - Description of the Business and Financial Condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952158 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.angn.com/role/FairValueMeasurements">
        <link:definition>9952159 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.angn.com/role/BalanceSheetComponents">
        <link:definition>9952160 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchGrant" roleURI="http://www.angn.com/role/ResearchGrant">
        <link:definition>9952161 - Disclosure - Research Grant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockCommonStockandStockholdersEquity" roleURI="http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquity">
        <link:definition>9952162 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.angn.com/role/StockBasedCompensation">
        <link:definition>9952163 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://www.angn.com/role/Warrants">
        <link:definition>9952164 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.angn.com/role/CommitmentsandContingencies">
        <link:definition>9952165 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.angn.com/role/Leases">
        <link:definition>9952166 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.angn.com/role/Debt">
        <link:definition>9952167 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.angn.com/role/IncomeTaxes">
        <link:definition>9952168 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.angn.com/role/NetLossPerShare">
        <link:definition>9952169 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.angn.com/role/RelatedPartyTransactions">
        <link:definition>9952170 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.angn.com/role/SegmentReporting">
        <link:definition>9952171 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.angn.com/role/FairValueMeasurementsTables">
        <link:definition>9955512 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.angn.com/role/BalanceSheetComponentsTables">
        <link:definition>9955513 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.angn.com/role/StockBasedCompensationTables">
        <link:definition>9955514 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsTables" roleURI="http://www.angn.com/role/WarrantsTables">
        <link:definition>9955515 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.angn.com/role/LeasesTables">
        <link:definition>9955516 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.angn.com/role/NetLossPerShareTables">
        <link:definition>9955517 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.angn.com/role/SegmentReportingTables">
        <link:definition>9955518 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessandFinancialConditionDetails" roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails">
        <link:definition>9955519 - Disclosure - Description of the Business and Financial Condition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9955520 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails">
        <link:definition>9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955523 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails">
        <link:definition>9955524 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails">
        <link:definition>9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>9955527 - Disclosure - Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofAccruedExpensesDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails">
        <link:definition>9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchGrantDetails" roleURI="http://www.angn.com/role/ResearchGrantDetails">
        <link:definition>9955529 - Disclosure - Research Grant (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockCommonStockandStockholdersEquityDetails" roleURI="http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails">
        <link:definition>9955530 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofShareOptionActivityDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails">
        <link:definition>9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails">
        <link:definition>9955533 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails">
        <link:definition>9955534 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsNarrativeDetails" roleURI="http://www.angn.com/role/WarrantsNarrativeDetails">
        <link:definition>9955535 - Disclosure - Warrants - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsScheduleofOutstandingWarrantsDetails" roleURI="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails">
        <link:definition>9955536 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955537 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.angn.com/role/LeasesNarrativeDetails">
        <link:definition>9955538 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" roleURI="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails">
        <link:definition>9955539 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>9955540 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>9955540 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://www.angn.com/role/DebtDetails">
        <link:definition>9955541 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.angn.com/role/IncomeTaxesDetails">
        <link:definition>9955542 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" roleURI="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails">
        <link:definition>9955543 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails">
        <link:definition>9955544 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9955545 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.angn.com/role/SegmentReportingDetails">
        <link:definition>9955546 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="angn_WarrantLiability" abstract="false" name="WarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_GainLossOnIssuanceOfWarrants" abstract="false" name="GainLossOnIssuanceOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_PurchaseAgreementMember" abstract="true" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ConversionOfConvertibleDebtMember" abstract="true" name="ConversionOfConvertibleDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="angn_InterestExpenseNoncash" abstract="false" name="InterestExpenseNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_FairValueOfPreFundedWarrants" abstract="false" name="FairValueOfPreFundedWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_FairValueOfCommonStockWarrants" abstract="false" name="FairValueOfCommonStockWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_SettlementOfPromissoryNotesPayable" abstract="false" name="SettlementOfPromissoryNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_NonCashVestingOfRestrictedCommonStock" abstract="false" name="NonCashVestingOfRestrictedCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantsAndRightsOutstandingAbstract" abstract="true" name="WarrantsAndRightsOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_WarrantsAndRightsOutstandingTextBlock" abstract="false" name="WarrantsAndRightsOutstandingTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" abstract="false" name="ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="angn_AngionCommonStockMember" abstract="true" name="AngionCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="angn_WarrantsFairValueDisclosure" abstract="false" name="WarrantsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantLiabilityMember" abstract="true" name="WarrantLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="angn_PreFundedWarrantMember" abstract="true" name="PreFundedWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" abstract="true" name="JulyPreFundedWarrantsAndJulyCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPreFundedWarrantsMember" abstract="true" name="JulyPreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyCommonWarrantsMember" abstract="true" name="JulyCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_MarchSubscriptionAgreementMember" abstract="true" name="MarchSubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPublicOfferingMember" abstract="true" name="JulyPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulySharesAndJulyCommonWarrantMember" abstract="true" name="JulySharesAndJulyCommonWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_SaleOfStockBeneficialOwnershipLimitationPercentage" abstract="false" name="SaleOfStockBeneficialOwnershipLimitationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="angn_MeasurementInputStrikePriceMember" abstract="true" name="MeasurementInputStrikePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="angn_PrepaidResearchAndDevelopmentExpenses" abstract="false" name="PrepaidResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AdvancedProfessionalFees" abstract="false" name="AdvancedProfessionalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_OtherPrepaidExpensesAndOtherAssetsCurrent" abstract="false" name="OtherPrepaidExpensesAndOtherAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccruedResearchAndDevelopmentCurrent" abstract="false" name="AccruedResearchAndDevelopmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccruedOtherOperatingLiabilitiesCurrent" abstract="false" name="AccruedOtherOperatingLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementGrant" abstract="false" name="ResearchAndDevelopmentArrangementGrant" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementGrantReceived" abstract="false" name="ResearchAndDevelopmentArrangementGrantReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementCredit" abstract="false" name="ResearchAndDevelopmentArrangementCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" abstract="false" name="ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_NumberOfResearchGrantAgreements" abstract="false" name="NumberOfResearchGrantAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="angn_RegistrationStatementMember" abstract="true" name="RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreement2022Member" abstract="true" name="AtTheMarketEquityOfferingSalesAgreement2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_A2024RegistrationStatementMember" abstract="true" name="A2024RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreementMember" abstract="true" name="AtTheMarketEquityOfferingSalesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreement2024Member" abstract="true" name="AtTheMarketEquityOfferingSalesAgreement2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JanuaryPublicOfferingMember" abstract="true" name="JanuaryPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JanuaryCommonWarrantsMember" abstract="true" name="JanuaryCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_SaleOfStockAggregateInitialOfferingPrice" abstract="false" name="SaleOfStockAggregateInitialOfferingPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_The2021PlanMember" abstract="true" name="The2021PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_The2022PlanMember" abstract="true" name="The2022PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_Inducement2024PlanMember" abstract="true" name="Inducement2024PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightRollForward" abstract="true" name="ClassOfWarrantOrRightRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightIssuedInPeriod" abstract="false" name="ClassOfWarrantOrRightIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightExercisedInPeriod" abstract="false" name="ClassOfWarrantOrRightExercisedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" abstract="true" name="ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" abstract="false" name="ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" abstract="false" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" abstract="true" name="ClassOfWarrantOrRightWeightedAverageLifeRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageLife" abstract="false" name="ClassOfWarrantOrRightWeightedAverageLife" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="angn_CommitmentsAndContingenciesDisclosureTable" abstract="true" name="CommitmentsAndContingenciesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="angn_CommitmentsAndContingenciesDisclosureLineItems" abstract="true" name="CommitmentsAndContingenciesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_LicenseExpense" abstract="false" name="LicenseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments" abstract="false" name="OperatingLeaseFutureMinimumAnnualMaintenancePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" abstract="false" name="OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_BostonMassachusettsMember" abstract="true" name="BostonMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="angn_NewtonMassachusettsMember" abstract="true" name="NewtonMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="angn_LesseeOperatingLeaseAnnualRentExpense" abstract="false" name="LesseeOperatingLeaseAnnualRentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_SeniorSecuredConvertiblePromissoryNoteMember" abstract="true" name="SeniorSecuredConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AccruedInterestPremiumForConvertiblePreferredStock" abstract="false" name="AccruedInterestPremiumForConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_PurchaseOfWarrantsMember" abstract="true" name="PurchaseOfWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_YekaterinaChudnovskyMember" abstract="true" name="YekaterinaChudnovskyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" abstract="true" name="JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ClinicalTrailMember" abstract="true" name="ClinicalTrailMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_EmployeeRelatedReasearchAndDevelopmentMember" abstract="true" name="EmployeeRelatedReasearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_TranslationalMedicineAndCMCMember" abstract="true" name="TranslationalMedicineAndCMCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>angn-20250331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b5a770-ce93-4e1a-8551-4667fc149643,g:e550b526-85cb-4940-ae39-7686e99f6d4a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7d534ecc-f8ab-44af-8866-5be82f2b325c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_00226aec-adf7-4c29-afd4-2b56bca6739e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7d534ecc-f8ab-44af-8866-5be82f2b325c" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_00226aec-adf7-4c29-afd4-2b56bca6739e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_17237b06-2601-4512-b862-6f6455748869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7d534ecc-f8ab-44af-8866-5be82f2b325c" xlink:to="loc_us-gaap_LiabilitiesCurrent_17237b06-2601-4512-b862-6f6455748869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability_08759730-8543-47e8-958d-9734f3381c19" xlink:href="angn-20250331.xsd#angn_WarrantLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7d534ecc-f8ab-44af-8866-5be82f2b325c" xlink:to="loc_angn_WarrantLiability_08759730-8543-47e8-958d-9734f3381c19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e105d36e-8e6c-4bd6-9b40-c9fe770096fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7d534ecc-f8ab-44af-8866-5be82f2b325c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e105d36e-8e6c-4bd6-9b40-c9fe770096fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_33214e51-4438-4c7b-b9a5-ea7fcecf18b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b4dd6c0b-9ff9-4b4e-a1a3-c8ea6081fa4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_33214e51-4438-4c7b-b9a5-ea7fcecf18b6" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b4dd6c0b-9ff9-4b4e-a1a3-c8ea6081fa4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f75317b9-092e-477d-b53a-8e8a23efdcec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_33214e51-4438-4c7b-b9a5-ea7fcecf18b6" xlink:to="loc_us-gaap_StockholdersEquity_f75317b9-092e-477d-b53a-8e8a23efdcec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6cc9b518-1399-480d-888c-e263bf89cd71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_33214e51-4438-4c7b-b9a5-ea7fcecf18b6" xlink:to="loc_us-gaap_Liabilities_6cc9b518-1399-480d-888c-e263bf89cd71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3a6bb1ee-cc7d-4dc7-9f90-8e470b85d31e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3402f948-3197-4f1d-93ff-4b43614cf940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a6bb1ee-cc7d-4dc7-9f90-8e470b85d31e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3402f948-3197-4f1d-93ff-4b43614cf940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_961bbb08-4081-4bae-b82c-e877f92a82b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a6bb1ee-cc7d-4dc7-9f90-8e470b85d31e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_961bbb08-4081-4bae-b82c-e877f92a82b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_65a775c3-1765-455b-b5df-06f2cac75b87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a6bb1ee-cc7d-4dc7-9f90-8e470b85d31e" xlink:to="loc_us-gaap_AssetsCurrent_65a775c3-1765-455b-b5df-06f2cac75b87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6d38e721-ed6a-48ba-84c4-2726b75aec66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a6bb1ee-cc7d-4dc7-9f90-8e470b85d31e" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6d38e721-ed6a-48ba-84c4-2726b75aec66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_7f0f87a3-3a63-4690-b42c-0ee3a635bc96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a6bb1ee-cc7d-4dc7-9f90-8e470b85d31e" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_7f0f87a3-3a63-4690-b42c-0ee3a635bc96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3a59e4cc-1d43-43d7-863e-ed49eee58d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0fbf03b4-f426-40e5-a4d1-0f35e23a0288" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3a59e4cc-1d43-43d7-863e-ed49eee58d8a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0fbf03b4-f426-40e5-a4d1-0f35e23a0288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_65b778ac-87a1-42dc-aa44-dda32402af3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3a59e4cc-1d43-43d7-863e-ed49eee58d8a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_65b778ac-87a1-42dc-aa44-dda32402af3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_17cc22ae-356d-4ec1-acc9-6c846eaed439" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3a59e4cc-1d43-43d7-863e-ed49eee58d8a" xlink:to="loc_us-gaap_RestrictedCashCurrent_17cc22ae-356d-4ec1-acc9-6c846eaed439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b49f0877-5dc2-4cf4-a7ba-d5f342ae0a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_125a5319-45d4-4a9f-818d-0cad393032b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b49f0877-5dc2-4cf4-a7ba-d5f342ae0a7d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_125a5319-45d4-4a9f-818d-0cad393032b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_befc4559-fb36-4eef-aa05-36690927e56c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b49f0877-5dc2-4cf4-a7ba-d5f342ae0a7d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_befc4559-fb36-4eef-aa05-36690927e56c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_cd38790e-4a0c-46eb-adfa-e0721df82fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b49f0877-5dc2-4cf4-a7ba-d5f342ae0a7d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_cd38790e-4a0c-46eb-adfa-e0721df82fd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6fdb1114-f21c-47fd-b5f3-e9a5a661d39d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b49f0877-5dc2-4cf4-a7ba-d5f342ae0a7d" xlink:to="loc_us-gaap_AccountsPayableCurrent_6fdb1114-f21c-47fd-b5f3-e9a5a661d39d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_77bd1391-8d14-491d-a7a0-ef399f0e2352" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_58c7bed5-047e-438e-9d10-b2e74d776f91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77bd1391-8d14-491d-a7a0-ef399f0e2352" xlink:to="loc_us-gaap_TreasuryStockCommonValue_58c7bed5-047e-438e-9d10-b2e74d776f91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a985c560-2f9e-4253-84a6-b9b0fa684c68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77bd1391-8d14-491d-a7a0-ef399f0e2352" xlink:to="loc_us-gaap_CommonStockValue_a985c560-2f9e-4253-84a6-b9b0fa684c68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_62476722-ea7d-4d3f-b3bf-6d24a310f98e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77bd1391-8d14-491d-a7a0-ef399f0e2352" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_62476722-ea7d-4d3f-b3bf-6d24a310f98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04036699-8d74-41b0-95fc-3d1d25c6e60b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77bd1391-8d14-491d-a7a0-ef399f0e2352" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04036699-8d74-41b0-95fc-3d1d25c6e60b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_86ca7248-1960-4d4b-ad9c-018586b223d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77bd1391-8d14-491d-a7a0-ef399f0e2352" xlink:to="loc_us-gaap_AdditionalPaidInCapital_86ca7248-1960-4d4b-ad9c-018586b223d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5a8ed3fb-fda7-42db-a77e-2c995f66e72f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ee4e444d-905d-45cc-8da1-a317217e389a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5a8ed3fb-fda7-42db-a77e-2c995f66e72f" xlink:to="loc_us-gaap_CostsAndExpenses_ee4e444d-905d-45cc-8da1-a317217e389a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_334dc814-af7a-4a15-8389-3009620ad9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_61f25237-f03a-4ea8-8d12-d96cee043da2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_334dc814-af7a-4a15-8389-3009620ad9f2" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_61f25237-f03a-4ea8-8d12-d96cee043da2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_85335edf-0b3f-4a09-8eb5-2cfc02770fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_334dc814-af7a-4a15-8389-3009620ad9f2" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_85335edf-0b3f-4a09-8eb5-2cfc02770fa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_ea904476-411a-4d72-9030-d552e4fe257f" xlink:href="angn-20250331.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_334dc814-af7a-4a15-8389-3009620ad9f2" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_ea904476-411a-4d72-9030-d552e4fe257f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating_702fed56-e7cb-4966-b484-15ad4522b22f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_334dc814-af7a-4a15-8389-3009620ad9f2" xlink:to="loc_us-gaap_InterestIncomeOperatingAndNonoperating_702fed56-e7cb-4966-b484-15ad4522b22f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_f67c6682-278a-49dd-9f74-72aaac67a76f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_334dc814-af7a-4a15-8389-3009620ad9f2" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_f67c6682-278a-49dd-9f74-72aaac67a76f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_53ddb41c-776c-488a-a98b-d542710bd43c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_334dc814-af7a-4a15-8389-3009620ad9f2" xlink:to="loc_us-gaap_InterestExpenseNonoperating_53ddb41c-776c-488a-a98b-d542710bd43c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1b0a4c21-1970-4e94-84b8-888832aa9511" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cbe7caae-5f71-47c2-84c9-133dde9992b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_1b0a4c21-1970-4e94-84b8-888832aa9511" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cbe7caae-5f71-47c2-84c9-133dde9992b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_e01f5734-faff-490a-b289-59ce0307eb36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_1b0a4c21-1970-4e94-84b8-888832aa9511" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_e01f5734-faff-490a-b289-59ce0307eb36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c67c7d4b-b601-41cf-b3c6-b56271c282ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_09bb48dc-0a85-4711-aeeb-706d1e19df45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c67c7d4b-b601-41cf-b3c6-b56271c282ac" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_09bb48dc-0a85-4711-aeeb-706d1e19df45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bdcd618c-6f37-48a8-9990-a3f2faa2b538" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c67c7d4b-b601-41cf-b3c6-b56271c282ac" xlink:to="loc_us-gaap_OperatingIncomeLoss_bdcd618c-6f37-48a8-9990-a3f2faa2b538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8aa10767-c928-4ff6-9a3e-5b4952f6e24e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b0ebffd5-80d9-424f-a86d-b1a75d7314f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8aa10767-c928-4ff6-9a3e-5b4952f6e24e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b0ebffd5-80d9-424f-a86d-b1a75d7314f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_19259777-7be4-4f27-bc0a-50838b2a8eda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8aa10767-c928-4ff6-9a3e-5b4952f6e24e" xlink:to="loc_us-gaap_NetIncomeLoss_19259777-7be4-4f27-bc0a-50838b2a8eda" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c8980ca1-c8c3-40ef-837d-d33484096fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_6067fd5a-9799-4614-94a3-835975630391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c8980ca1-c8c3-40ef-837d-d33484096fa4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_6067fd5a-9799-4614-94a3-835975630391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ce6b0e17-6b1b-446d-89aa-d0fb0fe67e00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c8980ca1-c8c3-40ef-837d-d33484096fa4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ce6b0e17-6b1b-446d-89aa-d0fb0fe67e00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_7fc08927-9088-4409-bd2f-076d8b1b152e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c8980ca1-c8c3-40ef-837d-d33484096fa4" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_7fc08927-9088-4409-bd2f-076d8b1b152e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_09c12146-cd50-45ec-9577-416fec3fa613" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c8980ca1-c8c3-40ef-837d-d33484096fa4" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_09c12146-cd50-45ec-9577-416fec3fa613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_38806a9e-e9ce-415e-a13a-049585fe69ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c8980ca1-c8c3-40ef-837d-d33484096fa4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_38806a9e-e9ce-415e-a13a-049585fe69ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d36a145-ddbd-465f-9313-c59bf22158b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c73b98e2-3f6a-4723-b374-795274e46afe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d36a145-ddbd-465f-9313-c59bf22158b6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c73b98e2-3f6a-4723-b374-795274e46afe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e9bba614-becb-4c0f-b506-a023d7ba9ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d36a145-ddbd-465f-9313-c59bf22158b6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e9bba614-becb-4c0f-b506-a023d7ba9ff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7ca8ba41-33fe-458f-861a-04214f2abcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d36a145-ddbd-465f-9313-c59bf22158b6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7ca8ba41-33fe-458f-861a-04214f2abcd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0558bc6-460f-4765-af23-542e9b4c9de3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d36a145-ddbd-465f-9313-c59bf22158b6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0558bc6-460f-4765-af23-542e9b4c9de3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_41974be5-55bd-48a4-8d06-e6a094a77803" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_41974be5-55bd-48a4-8d06-e6a094a77803" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5972cdd4-d5a0-4b6b-80ae-669599d52d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5972cdd4-d5a0-4b6b-80ae-669599d52d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_050ca4e9-a0b0-4125-87a7-677d31c04e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_050ca4e9-a0b0-4125-87a7-677d31c04e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0f993271-7015-4081-a8ba-631500207e53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_ShareBasedCompensation_0f993271-7015-4081-a8ba-631500207e53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_e3af5d4a-95e0-4c14-8421-06bb07de056f" xlink:href="angn-20250331.xsd#angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_e3af5d4a-95e0-4c14-8421-06bb07de056f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash_be7d733f-fa9a-4f73-8f4b-dafc842b206a" xlink:href="angn-20250331.xsd#angn_InterestExpenseNoncash"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_angn_InterestExpenseNoncash_be7d733f-fa9a-4f73-8f4b-dafc842b206a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_11428a65-c5b0-443c-83bd-8a61e9f57844" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_11428a65-c5b0-443c-83bd-8a61e9f57844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_89cd7a3f-380a-4511-a51e-90fbc14a2f46" xlink:href="angn-20250331.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_89cd7a3f-380a-4511-a51e-90fbc14a2f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_24badb19-50fe-453f-9ed4-3816405023b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_24badb19-50fe-453f-9ed4-3816405023b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_a68a8b78-fca7-4774-8af4-9ddf46136769" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_a68a8b78-fca7-4774-8af4-9ddf46136769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_84da2b4a-8679-477a-979e-0544e8307864" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_84da2b4a-8679-477a-979e-0544e8307864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_2466b714-ea69-4604-a0dc-63e56b512252" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_Depreciation_2466b714-ea69-4604-a0dc-63e56b512252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_7e15b66e-ad20-4d0e-ac0d-7875f94ceedc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_7e15b66e-ad20-4d0e-ac0d-7875f94ceedc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8c8096b7-bc46-4de6-abba-9ee866bdd05f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8c8096b7-bc46-4de6-abba-9ee866bdd05f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_960f2876-5758-40fd-a430-f0d749bfcd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77c4016f-3145-49fc-a3a6-f110d562371a" xlink:to="loc_us-gaap_NetIncomeLoss_960f2876-5758-40fd-a430-f0d749bfcd4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_74320ac0-34a4-4533-987d-0470dd088014" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_99a4cbd8-b5ac-4d0c-ac92-f039422c1bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_74320ac0-34a4-4533-987d-0470dd088014" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_99a4cbd8-b5ac-4d0c-ac92-f039422c1bd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ffb30c4-4857-4cb5-8ed2-e872e6208cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_381ae7cb-c26a-43ba-a670-e37596f18f08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ffb30c4-4857-4cb5-8ed2-e872e6208cb1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_381ae7cb-c26a-43ba-a670-e37596f18f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_be5d8b70-b2a2-4c98-9b37-d764978fb87e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ffb30c4-4857-4cb5-8ed2-e872e6208cb1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_be5d8b70-b2a2-4c98-9b37-d764978fb87e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1e50e3a6-5e5b-4c5f-b521-7e8d4aa5fb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_20d88088-d4c6-4974-9e4f-6e7812b40b94" xlink:href="angn-20250331.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_1e50e3a6-5e5b-4c5f-b521-7e8d4aa5fb6f" xlink:to="loc_angn_WarrantsFairValueDisclosure_20d88088-d4c6-4974-9e4f-6e7812b40b94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_84a3a772-190c-4073-8272-79d9910829de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d51c095f-164e-4907-b1b6-90a20e503c44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_84a3a772-190c-4073-8272-79d9910829de" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d51c095f-164e-4907-b1b6-90a20e503c44" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4b77cf7e-eeea-4dfc-a6fd-f8c2eaaf7fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_dad59b7b-f828-44f5-877c-12f5267ac91e" xlink:href="angn-20250331.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4b77cf7e-eeea-4dfc-a6fd-f8c2eaaf7fd2" xlink:to="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_dad59b7b-f828-44f5-877c-12f5267ac91e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses_45fd0453-685c-489e-990e-28a2a9c4d689" xlink:href="angn-20250331.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4b77cf7e-eeea-4dfc-a6fd-f8c2eaaf7fd2" xlink:to="loc_angn_PrepaidResearchAndDevelopmentExpenses_45fd0453-685c-489e-990e-28a2a9c4d689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees_a4eb8bc1-3280-4d18-a9b7-aae9c952f4cd" xlink:href="angn-20250331.xsd#angn_AdvancedProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4b77cf7e-eeea-4dfc-a6fd-f8c2eaaf7fd2" xlink:to="loc_angn_AdvancedProfessionalFees_a4eb8bc1-3280-4d18-a9b7-aae9c952f4cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_b14fb81a-61b0-4fbb-ab50-d24ba88a11e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4b77cf7e-eeea-4dfc-a6fd-f8c2eaaf7fd2" xlink:to="loc_us-gaap_PrepaidInsurance_b14fb81a-61b0-4fbb-ab50-d24ba88a11e7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ef2a03f4-f38b-4813-9779-8ab0ebd84f46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6420bdc6-0bea-4b69-a316-f73dd00cf3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ef2a03f4-f38b-4813-9779-8ab0ebd84f46" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6420bdc6-0bea-4b69-a316-f73dd00cf3c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_37644a72-528d-4760-8501-9e050efe0c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ef2a03f4-f38b-4813-9779-8ab0ebd84f46" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_37644a72-528d-4760-8501-9e050efe0c1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7858cf75-187f-4fd9-979b-cbf47dedffa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent_e7aca1d4-e859-4d8e-83f9-77756caac417" xlink:href="angn-20250331.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7858cf75-187f-4fd9-979b-cbf47dedffa3" xlink:to="loc_angn_AccruedResearchAndDevelopmentCurrent_e7aca1d4-e859-4d8e-83f9-77756caac417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_ea500c57-cabf-4771-bc78-61c17c78554f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7858cf75-187f-4fd9-979b-cbf47dedffa3" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_ea500c57-cabf-4771-bc78-61c17c78554f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_de17ddb8-065b-4686-9321-61a9251aeb02" xlink:href="angn-20250331.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7858cf75-187f-4fd9-979b-cbf47dedffa3" xlink:to="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_de17ddb8-065b-4686-9321-61a9251aeb02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e30f67bb-61ac-47ca-8052-81f19449aca7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7858cf75-187f-4fd9-979b-cbf47dedffa3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e30f67bb-61ac-47ca-8052-81f19449aca7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54dd6ade-7013-4fee-b20d-f24b22edc587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c6bba168-ca17-47d9-b9c6-34901099b98e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54dd6ade-7013-4fee-b20d-f24b22edc587" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c6bba168-ca17-47d9-b9c6-34901099b98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a3d33bec-e62b-4f07-be9a-4e5c55b4d008" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54dd6ade-7013-4fee-b20d-f24b22edc587" xlink:to="loc_us-gaap_OperatingLeaseLiability_a3d33bec-e62b-4f07-be9a-4e5c55b4d008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cbced9c2-7cfb-4914-9b3e-94c2a6a11f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d363d5ec-beb6-4100-a63a-7a3cb3a2b7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_cbced9c2-7cfb-4914-9b3e-94c2a6a11f2b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d363d5ec-beb6-4100-a63a-7a3cb3a2b7e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f08ae1b2-0854-4614-bb11-9e277bbf6192" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_cbced9c2-7cfb-4914-9b3e-94c2a6a11f2b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f08ae1b2-0854-4614-bb11-9e277bbf6192" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="angn-20250331.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_122c793f-4d36-449f-840a-a7d3b4b9e03e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_8793b42c-4def-453f-bded-a00d6239c3bb" xlink:href="angn-20250331.xsd#angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_122c793f-4d36-449f-840a-a7d3b4b9e03e" xlink:to="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_8793b42c-4def-453f-bded-a00d6239c3bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dfa46f32-90a2-4baf-9a2d-4436f8094c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_122c793f-4d36-449f-840a-a7d3b4b9e03e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dfa46f32-90a2-4baf-9a2d-4436f8094c4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0ac64b5e-3118-4e96-a468-0fc0937bbcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_122c793f-4d36-449f-840a-a7d3b4b9e03e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0ac64b5e-3118-4e96-a468-0fc0937bbcd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2776eedc-b53b-4173-8273-584a7369473d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_122c793f-4d36-449f-840a-a7d3b4b9e03e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2776eedc-b53b-4173-8273-584a7369473d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_422c72fb-df25-4c20-bc68-7b343365425f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_122c793f-4d36-449f-840a-a7d3b4b9e03e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_422c72fb-df25-4c20-bc68-7b343365425f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_27fcf20d-25e4-4a94-98a4-44ced7e0a28c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_122c793f-4d36-449f-840a-a7d3b4b9e03e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_27fcf20d-25e4-4a94-98a4-44ced7e0a28c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>angn-20250331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b5a770-ce93-4e1a-8551-4667fc149643,g:e550b526-85cb-4940-ae39-7686e99f6d4a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c498ae38-e62b-4aa0-adca-66d81fbd5fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c498ae38-e62b-4aa0-adca-66d81fbd5fbf" xlink:to="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6b6ae022-2836-43e2-9e9e-8574ce74cc69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6b6ae022-2836-43e2-9e9e-8574ce74cc69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6b6ae022-2836-43e2-9e9e-8574ce74cc69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6b6ae022-2836-43e2-9e9e-8574ce74cc69" xlink:to="loc_us-gaap_EquityComponentDomain_6b6ae022-2836-43e2-9e9e-8574ce74cc69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6b6ae022-2836-43e2-9e9e-8574ce74cc69" xlink:to="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_eef24179-7e9a-41c2-bbf1-a294c079afaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_CommonStockMember_eef24179-7e9a-41c2-bbf1-a294c079afaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_4cbbe047-df2a-4372-a0d9-c307fcd1032b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_TreasuryStockCommonMember_4cbbe047-df2a-4372-a0d9-c307fcd1032b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5df0d401-9d89-455c-bc15-d60605849528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5df0d401-9d89-455c-bc15-d60605849528" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a15c5f0-bebe-4275-9a1a-b9bda326268d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a15c5f0-bebe-4275-9a1a-b9bda326268d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_18743c8c-9a31-4cc9-9fba-90ee7bf76982" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_RetainedEarningsMember_18743c8c-9a31-4cc9-9fba-90ee7bf76982" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_428cd4b1-5b6e-4be6-b807-70dfb9078ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_428cd4b1-5b6e-4be6-b807-70dfb9078ac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember_671cc325-84d3-44a4-9f15-8a5ec9208e22" xlink:href="angn-20250331.xsd#angn_PurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_428cd4b1-5b6e-4be6-b807-70dfb9078ac0" xlink:to="loc_angn_PurchaseAgreementMember_671cc325-84d3-44a4-9f15-8a5ec9208e22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_7eef501f-584c-4f04-810e-a0e8c85a3739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_7eef501f-584c-4f04-810e-a0e8c85a3739" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_7eef501f-584c-4f04-810e-a0e8c85a3739_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_7eef501f-584c-4f04-810e-a0e8c85a3739" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_7eef501f-584c-4f04-810e-a0e8c85a3739_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_ca0f15bc-76d6-4447-ab90-dfdca879f27b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_7eef501f-584c-4f04-810e-a0e8c85a3739" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_ca0f15bc-76d6-4447-ab90-dfdca879f27b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember_072df9ca-8f8b-4466-b6cd-f6d2bb4053c5" xlink:href="angn-20250331.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_ca0f15bc-76d6-4447-ab90-dfdca879f27b" xlink:to="loc_angn_ConversionOfConvertibleDebtMember_072df9ca-8f8b-4466-b6cd-f6d2bb4053c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c498ae38-e62b-4aa0-adca-66d81fbd5fbf" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0f0a2935-1b5e-4447-9c8b-db933c6a7589" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0f0a2935-1b5e-4447-9c8b-db933c6a7589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_da122921-d6f0-4399-a849-bdf41d483021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockholdersEquity_da122921-d6f0-4399-a849-bdf41d483021" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_9b430af5-7581-446a-896b-1842bad4d5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_TreasuryStockCommonShares_9b430af5-7581-446a-896b-1842bad4d5a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2ebfd157-ab1e-42dc-9f11-65edf3c8c60a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2ebfd157-ab1e-42dc-9f11-65edf3c8c60a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1422774f-f1cf-4881-9e4b-55b45b589ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1422774f-f1cf-4881-9e4b-55b45b589ed9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_abba6bca-900d-42e0-8e34-2d829e451963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_abba6bca-900d-42e0-8e34-2d829e451963" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fbdb4a45-2f51-4920-822d-591aa4475856" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fbdb4a45-2f51-4920-822d-591aa4475856" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_9d7fc70d-afc7-48dc-99f8-f6d9b4926f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_9d7fc70d-afc7-48dc-99f8-f6d9b4926f7d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_9c07abd6-62be-4dae-af2a-17da7517f26d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_9c07abd6-62be-4dae-af2a-17da7517f26d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_bb68ebfb-1302-4dbb-aaaa-4870e980b768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_bb68ebfb-1302-4dbb-aaaa-4870e980b768" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_05aaa50d-c1be-4f1d-9624-9e42121b2c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_05aaa50d-c1be-4f1d-9624-9e42121b2c3b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d19dcbe0-8471-4f27-a546-d47e4af31d18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d19dcbe0-8471-4f27-a546-d47e4af31d18" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_424bef79-f5af-4533-9446-f76ac103ff79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_424bef79-f5af-4533-9446-f76ac103ff79" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cd70df17-f912-41a6-94df-2f55816bd739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cd70df17-f912-41a6-94df-2f55816bd739" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7f63ac7e-f775-4fdc-a56b-a2f942c6b6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7f63ac7e-f775-4fdc-a56b-a2f942c6b6f9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_97ba8893-75f2-41ba-97b2-eecb609c4ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_NetIncomeLoss_97ba8893-75f2-41ba-97b2-eecb609c4ffa" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7804e2b8-1e09-4c5c-aa03-0866046d9311" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0df20081-6ba3-4597-88e0-f22273d8e7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_844358e0-7664-49d5-a759-bcf53afad1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_73dfac6d-70ed-40c3-b469-5e8f36cb276f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_81b03d20-75c4-45d6-a53b-beb458a0502b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_73dfac6d-70ed-40c3-b469-5e8f36cb276f" xlink:to="loc_us-gaap_StatementTable_81b03d20-75c4-45d6-a53b-beb458a0502b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_8df467f9-1e53-4934-861d-019482c7dd03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_81b03d20-75c4-45d6-a53b-beb458a0502b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_8df467f9-1e53-4934-861d-019482c7dd03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8df467f9-1e53-4934-861d-019482c7dd03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8df467f9-1e53-4934-861d-019482c7dd03" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8df467f9-1e53-4934-861d-019482c7dd03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d4799b3a-717c-432a-af0f-b6dbd9482ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8df467f9-1e53-4934-861d-019482c7dd03" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d4799b3a-717c-432a-af0f-b6dbd9482ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember_225a1269-1d4e-4c92-8d82-ee58d0479ecd" xlink:href="angn-20250331.xsd#angn_PurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d4799b3a-717c-432a-af0f-b6dbd9482ce6" xlink:to="loc_angn_PurchaseAgreementMember_225a1269-1d4e-4c92-8d82-ee58d0479ecd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_826548fa-7236-4908-b7f4-1a07f0e6db70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_73dfac6d-70ed-40c3-b469-5e8f36cb276f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_826548fa-7236-4908-b7f4-1a07f0e6db70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_9e541b09-78d9-4046-b701-7f7a79b73251" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_73dfac6d-70ed-40c3-b469-5e8f36cb276f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_9e541b09-78d9-4046-b701-7f7a79b73251" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_b3343148-167b-4978-826a-c0d44cd1065a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_84c581f3-0961-4bf6-ac6f-8343a953e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_b3343148-167b-4978-826a-c0d44cd1065a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_84c581f3-0961-4bf6-ac6f-8343a953e78a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0bdeb7cb-670f-484f-b710-cf1b1c066b95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_84c581f3-0961-4bf6-ac6f-8343a953e78a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0bdeb7cb-670f-484f-b710-cf1b1c066b95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0bdeb7cb-670f-484f-b710-cf1b1c066b95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0bdeb7cb-670f-484f-b710-cf1b1c066b95" xlink:to="loc_us-gaap_ClassOfStockDomain_0bdeb7cb-670f-484f-b710-cf1b1c066b95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_150b1aa1-116a-4c5f-b1f3-358e2471eb25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0bdeb7cb-670f-484f-b710-cf1b1c066b95" xlink:to="loc_us-gaap_ClassOfStockDomain_150b1aa1-116a-4c5f-b1f3-358e2471eb25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionCommonStockMember_154f464b-d884-4f26-b795-7b612d2fdf14" xlink:href="angn-20250331.xsd#angn_AngionCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_150b1aa1-116a-4c5f-b1f3-358e2471eb25" xlink:to="loc_angn_AngionCommonStockMember_154f464b-d884-4f26-b795-7b612d2fdf14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f70ff3a2-3adb-436f-8353-ced70f0e786c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b3343148-167b-4978-826a-c0d44cd1065a" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f70ff3a2-3adb-436f-8353-ced70f0e786c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8344ff36-3ef6-4da6-bed6-a1713d96869f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8344ff36-3ef6-4da6-bed6-a1713d96869f" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dd5c79f-d544-466d-923d-e1e135c4fc31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dd5c79f-d544-466d-923d-e1e135c4fc31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3dd5c79f-d544-466d-923d-e1e135c4fc31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dd5c79f-d544-466d-923d-e1e135c4fc31" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3dd5c79f-d544-466d-923d-e1e135c4fc31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dd5c79f-d544-466d-923d-e1e135c4fc31" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_92a19a09-0b11-4db2-af69-23644ab22fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_92a19a09-0b11-4db2-af69-23644ab22fdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a438e10a-3903-4c4b-81f4-f96fec857fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a438e10a-3903-4c4b-81f4-f96fec857fd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_543a9d32-dc97-4324-8120-fa3c337eded6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_543a9d32-dc97-4324-8120-fa3c337eded6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_83211b9e-3b9f-4fee-9dae-29e5b3506579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_83211b9e-3b9f-4fee-9dae-29e5b3506579" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_83211b9e-3b9f-4fee-9dae-29e5b3506579_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_83211b9e-3b9f-4fee-9dae-29e5b3506579" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_83211b9e-3b9f-4fee-9dae-29e5b3506579_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_30563519-0228-4e09-8913-b1f491d101a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_83211b9e-3b9f-4fee-9dae-29e5b3506579" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_30563519-0228-4e09-8913-b1f491d101a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d7b2b658-0b55-4fcf-aac7-7f3716f9c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_30563519-0228-4e09-8913-b1f491d101a4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d7b2b658-0b55-4fcf-aac7-7f3716f9c8b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_d93fb924-a4bc-44a5-86a0-777ef7d7d67e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8344ff36-3ef6-4da6-bed6-a1713d96869f" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_d93fb924-a4bc-44a5-86a0-777ef7d7d67e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_306718cc-d5f2-4930-b81f-68a92dd47bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_d93fb924-a4bc-44a5-86a0-777ef7d7d67e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_306718cc-d5f2-4930-b81f-68a92dd47bf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_621b7386-71cb-4079-8c73-3f3bf0e835ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_d93fb924-a4bc-44a5-86a0-777ef7d7d67e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_621b7386-71cb-4079-8c73-3f3bf0e835ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_825855e6-02fc-46a3-8e92-16b27135383e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8344ff36-3ef6-4da6-bed6-a1713d96869f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_825855e6-02fc-46a3-8e92-16b27135383e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_8108db2c-f3bc-432f-8566-c38ac2efc36e" xlink:href="angn-20250331.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_825855e6-02fc-46a3-8e92-16b27135383e" xlink:to="loc_angn_WarrantsFairValueDisclosure_8108db2c-f3bc-432f-8566-c38ac2efc36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_07216b08-bfd3-4246-9b8b-3ff75f431858" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_825855e6-02fc-46a3-8e92-16b27135383e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_07216b08-bfd3-4246-9b8b-3ff75f431858" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1631ad7c-70ce-43a2-8880-e7ff24a7cecb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a6b258ed-ec96-4b98-ac7e-007452d61d05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1631ad7c-70ce-43a2-8880-e7ff24a7cecb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a6b258ed-ec96-4b98-ac7e-007452d61d05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_beaae2de-d5a9-45ce-bf6c-fe0a255820d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a6b258ed-ec96-4b98-ac7e-007452d61d05" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_beaae2de-d5a9-45ce-bf6c-fe0a255820d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_beaae2de-d5a9-45ce-bf6c-fe0a255820d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_beaae2de-d5a9-45ce-bf6c-fe0a255820d9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_beaae2de-d5a9-45ce-bf6c-fe0a255820d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_00af3e28-a000-4878-a69d-5350f7372bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_beaae2de-d5a9-45ce-bf6c-fe0a255820d9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_00af3e28-a000-4878-a69d-5350f7372bd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember_fb78ff83-e524-4757-807b-44a9c5121d77" xlink:href="angn-20250331.xsd#angn_WarrantLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_00af3e28-a000-4878-a69d-5350f7372bd1" xlink:to="loc_angn_WarrantLiabilityMember_fb78ff83-e524-4757-807b-44a9c5121d77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1631ad7c-70ce-43a2-8880-e7ff24a7cecb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_66a63cb7-6878-473d-975e-a42044c481e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_66a63cb7-6878-473d-975e-a42044c481e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e2fef889-d8f3-4f15-bf02-38c36a6fce0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e2fef889-d8f3-4f15-bf02-38c36a6fce0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_69881960-90a2-4df6-b1fd-9989fa53bac8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_52a576f1-94a9-4550-9c97-ca8464e6558d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_52a576f1-94a9-4550-9c97-ca8464e6558d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_52a576f1-94a9-4550-9c97-ca8464e6558d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_52a576f1-94a9-4550-9c97-ca8464e6558d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_52a576f1-94a9-4550-9c97-ca8464e6558d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2369eb81-bebd-4432-8be7-a43c8abe952d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_52a576f1-94a9-4550-9c97-ca8464e6558d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2369eb81-bebd-4432-8be7-a43c8abe952d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_1dadb234-ee2b-41a3-8158-b66b5e607075" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2369eb81-bebd-4432-8be7-a43c8abe952d" xlink:to="loc_angn_PreFundedWarrantMember_1dadb234-ee2b-41a3-8158-b66b5e607075" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_45e8b08c-00df-4a37-8112-fabb12f98e23" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2369eb81-bebd-4432-8be7-a43c8abe952d" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_45e8b08c-00df-4a37-8112-fabb12f98e23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_627b8506-6658-40a2-a74a-34e8826eabb1" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_45e8b08c-00df-4a37-8112-fabb12f98e23" xlink:to="loc_angn_JulyPreFundedWarrantsMember_627b8506-6658-40a2-a74a-34e8826eabb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_70563cb0-3afd-4a6d-925a-b0f5a1f04703" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_45e8b08c-00df-4a37-8112-fabb12f98e23" xlink:to="loc_angn_JulyCommonWarrantsMember_70563cb0-3afd-4a6d-925a-b0f5a1f04703" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_36a6240f-c546-4855-8fee-7b53bebd3413" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_36a6240f-c546-4855-8fee-7b53bebd3413" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_36a6240f-c546-4855-8fee-7b53bebd3413_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_36a6240f-c546-4855-8fee-7b53bebd3413" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_36a6240f-c546-4855-8fee-7b53bebd3413_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a0520d6-f9e6-4160-834b-ff1afa11a4db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_36a6240f-c546-4855-8fee-7b53bebd3413" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a0520d6-f9e6-4160-834b-ff1afa11a4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_754db79c-f032-4105-a78f-be4c6d5b12fc" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a0520d6-f9e6-4160-834b-ff1afa11a4db" xlink:to="loc_angn_MarchSubscriptionAgreementMember_754db79c-f032-4105-a78f-be4c6d5b12fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_3f67f976-c5a7-4552-b7ba-e4e2854e1a3f" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a0520d6-f9e6-4160-834b-ff1afa11a4db" xlink:to="loc_angn_JulyPublicOfferingMember_3f67f976-c5a7-4552-b7ba-e4e2854e1a3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d" xlink:to="loc_us-gaap_ClassOfStockDomain_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_05d19dc4-b954-4094-ba57-43d25ff5dc52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d" xlink:to="loc_us-gaap_ClassOfStockDomain_05d19dc4-b954-4094-ba57-43d25ff5dc52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_d779aa0f-4159-48bb-96ff-b93b2924794d" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_05d19dc4-b954-4094-ba57-43d25ff5dc52" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_d779aa0f-4159-48bb-96ff-b93b2924794d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_eb8af092-c23f-468d-a5cf-0a8cafaa39c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_eb8af092-c23f-468d-a5cf-0a8cafaa39c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eb8af092-c23f-468d-a5cf-0a8cafaa39c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eb8af092-c23f-468d-a5cf-0a8cafaa39c8" xlink:to="loc_us-gaap_EquityComponentDomain_eb8af092-c23f-468d-a5cf-0a8cafaa39c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_49ddd4c9-b899-4ec3-866b-21153475494b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eb8af092-c23f-468d-a5cf-0a8cafaa39c8" xlink:to="loc_us-gaap_EquityComponentDomain_49ddd4c9-b899-4ec3-866b-21153475494b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e4dc1954-680d-4a69-a4cb-2a6b676aed75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_49ddd4c9-b899-4ec3-866b-21153475494b" xlink:to="loc_us-gaap_CommonStockMember_e4dc1954-680d-4a69-a4cb-2a6b676aed75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f1f605a2-812c-4c46-bb05-0a59fb7a1bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f1f605a2-812c-4c46-bb05-0a59fb7a1bd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e73efb60-7f1b-4c66-92fb-45002c461cec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e73efb60-7f1b-4c66-92fb-45002c461cec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b0fab07d-0407-453b-9572-fa4735543278" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b0fab07d-0407-453b-9572-fa4735543278" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c3513971-251c-460d-adf2-3885ce584a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c3513971-251c-460d-adf2-3885ce584a5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8e872551-6400-4f6d-9799-5bd89d2a24f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8e872551-6400-4f6d-9799-5bd89d2a24f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d274f858-d3fe-47aa-83e5-a1949720bed6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d274f858-d3fe-47aa-83e5-a1949720bed6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_b38bb9c1-1c71-454b-a8be-743a76860dba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_b38bb9c1-1c71-454b-a8be-743a76860dba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_66ecfc32-ac44-4f4a-9426-bdeee54e7922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_66ecfc32-ac44-4f4a-9426-bdeee54e7922" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_a1c31e4c-d5a2-4718-a738-a079d49abdbb" xlink:href="angn-20250331.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_a1c31e4c-d5a2-4718-a738-a079d49abdbb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fcb4ba85-0e45-4734-8bef-151b71107b83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fcb4ba85-0e45-4734-8bef-151b71107b83" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_c0c8a654-ec10-4214-a357-28f7d82f87d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_c0c8a654-ec10-4214-a357-28f7d82f87d3" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4681b522-22fd-4a7a-966f-3ab6c6489e80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4681b522-22fd-4a7a-966f-3ab6c6489e80" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0e9aac5e-31fa-45b1-8611-5d0066fb354d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0e9aac5e-31fa-45b1-8611-5d0066fb354d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0e9aac5e-31fa-45b1-8611-5d0066fb354d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0e9aac5e-31fa-45b1-8611-5d0066fb354d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0e9aac5e-31fa-45b1-8611-5d0066fb354d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e47c16eb-171b-4b8b-8e94-6a3cfd4514c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0e9aac5e-31fa-45b1-8611-5d0066fb354d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e47c16eb-171b-4b8b-8e94-6a3cfd4514c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_39dcb793-c403-4336-bdbf-514b75e1498f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e47c16eb-171b-4b8b-8e94-6a3cfd4514c0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_39dcb793-c403-4336-bdbf-514b75e1498f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_80a282f4-cd01-4844-a741-b7a74bbd1854" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_80a282f4-cd01-4844-a741-b7a74bbd1854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_80a282f4-cd01-4844-a741-b7a74bbd1854_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_80a282f4-cd01-4844-a741-b7a74bbd1854" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_80a282f4-cd01-4844-a741-b7a74bbd1854_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_80a282f4-cd01-4844-a741-b7a74bbd1854" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember_7e965d2c-94fc-4fac-bb49-461eaf7632c6" xlink:href="angn-20250331.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:to="loc_angn_MeasurementInputStrikePriceMember_7e965d2c-94fc-4fac-bb49-461eaf7632c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_b5aaeff4-c48e-4e74-be3c-3896b9aa9b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_b5aaeff4-c48e-4e74-be3c-3896b9aa9b9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_3da0b406-2b68-4865-84a2-6d1e6b5d2ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_3da0b406-2b68-4865-84a2-6d1e6b5d2ca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_598a8b64-9c30-4229-b5f5-0d4298c16924" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_598a8b64-9c30-4229-b5f5-0d4298c16924" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fd4b27b6-1d97-4571-8434-fb4c068f6641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4681b522-22fd-4a7a-966f-3ab6c6489e80" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fd4b27b6-1d97-4571-8434-fb4c068f6641" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_3fa99dd1-eedd-4c02-82fe-68a09849cc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4681b522-22fd-4a7a-966f-3ab6c6489e80" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_3fa99dd1-eedd-4c02-82fe-68a09849cc1c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fc68cf06-50b0-473d-ab9a-9412ee14b7da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fc68cf06-50b0-473d-ab9a-9412ee14b7da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24dcc32c-9949-4d3d-af6d-40e62183f228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fc68cf06-50b0-473d-ab9a-9412ee14b7da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24dcc32c-9949-4d3d-af6d-40e62183f228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24dcc32c-9949-4d3d-af6d-40e62183f228_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24dcc32c-9949-4d3d-af6d-40e62183f228" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24dcc32c-9949-4d3d-af6d-40e62183f228_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24dcc32c-9949-4d3d-af6d-40e62183f228" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_74eb6618-b6a0-4a07-9a87-a0d050dddc17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:to="loc_us-gaap_EquipmentMember_74eb6618-b6a0-4a07-9a87-a0d050dddc17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_01964556-4c1c-4f39-88c7-2631e19ec927" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_01964556-4c1c-4f39-88c7-2631e19ec927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ed4891a4-2c54-463c-a332-b21eccb7144c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ed4891a4-2c54-463c-a332-b21eccb7144c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e3d201ae-1864-42ea-b63b-33b781346b33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e3d201ae-1864-42ea-b63b-33b781346b33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e6224e78-200c-4d75-aded-f81c22c73f05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e6224e78-200c-4d75-aded-f81c22c73f05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9329d84b-3bea-4810-a702-f80996cfeb83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9329d84b-3bea-4810-a702-f80996cfeb83" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrantDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#ResearchGrantDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/ResearchGrantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c27a45f5-79af-4cfa-a6e3-c0c95a9001da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c27a45f5-79af-4cfa-a6e3-c0c95a9001da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_8562e5ac-343c-4932-94c3-8a853f8b76fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c27a45f5-79af-4cfa-a6e3-c0c95a9001da" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_8562e5ac-343c-4932-94c3-8a853f8b76fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_8562e5ac-343c-4932-94c3-8a853f8b76fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_8562e5ac-343c-4932-94c3-8a853f8b76fb" xlink:to="loc_us-gaap_ProjectMember_8562e5ac-343c-4932-94c3-8a853f8b76fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_8562e5ac-343c-4932-94c3-8a853f8b76fb" xlink:to="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_b48e0d77-324a-4ec4-9619-469f58a8f49a" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_b48e0d77-324a-4ec4-9619-469f58a8f49a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_44c06a1f-7f11-4a5a-851e-8efa6c6a844a" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_44c06a1f-7f11-4a5a-851e-8efa6c6a844a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_93adaf60-ac06-49e4-a20f-ea6c15e5a92e" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_93adaf60-ac06-49e4-a20f-ea6c15e5a92e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant_d566c0d2-cecf-4b5b-8bf9-6344aa504b97" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrant_d566c0d2-cecf-4b5b-8bf9-6344aa504b97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_72479190-a88d-452d-aa9e-a60e796efe11" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_72479190-a88d-452d-aa9e-a60e796efe11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b6af4e69-c488-499a-819c-fc5787679f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b6af4e69-c488-499a-819c-fc5787679f7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit_04ab15fa-6e7e-4356-ae8b-5cff240661e8" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_ResearchAndDevelopmentArrangementCredit_04ab15fa-6e7e-4356-ae8b-5cff240661e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_00635e3f-2e19-4216-be6f-b35fdc96f676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_00635e3f-2e19-4216-be6f-b35fdc96f676" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_9b3ab81c-706e-4dd0-8928-79af5f372953" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_us-gaap_RestrictedCashCurrent_9b3ab81c-706e-4dd0-8928-79af5f372953" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_1d9478ff-0fe7-42d5-83ac-ebfea003bf41" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_1d9478ff-0fe7-42d5-83ac-ebfea003bf41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements_455e4e8b-1aaf-4baa-951c-77eecbe607ef" xlink:href="angn-20250331.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_NumberOfResearchGrantAgreements_455e4e8b-1aaf-4baa-951c-77eecbe607ef" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6c6a6360-e950-4090-8d6d-e936d676ba50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6c6a6360-e950-4090-8d6d-e936d676ba50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6c6a6360-e950-4090-8d6d-e936d676ba50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c6a6360-e950-4090-8d6d-e936d676ba50" xlink:to="loc_us-gaap_EquityComponentDomain_6c6a6360-e950-4090-8d6d-e936d676ba50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8c87e7a9-54ed-4f7c-9d43-1ab9b9fc9e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c6a6360-e950-4090-8d6d-e936d676ba50" xlink:to="loc_us-gaap_EquityComponentDomain_8c87e7a9-54ed-4f7c-9d43-1ab9b9fc9e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_61ec01eb-b589-4c4c-acf7-4cd2a35df3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8c87e7a9-54ed-4f7c-9d43-1ab9b9fc9e4a" xlink:to="loc_us-gaap_CommonStockMember_61ec01eb-b589-4c4c-acf7-4cd2a35df3f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870" xlink:to="loc_us-gaap_ClassOfStockDomain_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8a7e2c9b-79fc-4597-ae66-792dbbad9284" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870" xlink:to="loc_us-gaap_ClassOfStockDomain_8a7e2c9b-79fc-4597-ae66-792dbbad9284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_4ffc2b37-d1a2-49d1-9156-c7d6d2050374" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8a7e2c9b-79fc-4597-ae66-792dbbad9284" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_4ffc2b37-d1a2-49d1-9156-c7d6d2050374" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_399aadc2-81f1-4d74-8d1c-3de40e219410" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_399aadc2-81f1-4d74-8d1c-3de40e219410" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_399aadc2-81f1-4d74-8d1c-3de40e219410_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_399aadc2-81f1-4d74-8d1c-3de40e219410" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_399aadc2-81f1-4d74-8d1c-3de40e219410_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_399aadc2-81f1-4d74-8d1c-3de40e219410" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember_b83a9ad9-122a-40c6-910d-75c29fd3ba7a" xlink:href="angn-20250331.xsd#angn_RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_RegistrationStatementMember_b83a9ad9-122a-40c6-910d-75c29fd3ba7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_7038b9f9-0f9d-4f7b-a2ec-b5110932f7ea" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_7038b9f9-0f9d-4f7b-a2ec-b5110932f7ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember_e19d2127-f409-40e0-9eda-fac935703ce7" xlink:href="angn-20250331.xsd#angn_A2024RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_A2024RegistrationStatementMember_e19d2127-f409-40e0-9eda-fac935703ce7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_74eb6854-9b6b-4dc7-844b-106086df9f4a" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_MarchSubscriptionAgreementMember_74eb6854-9b6b-4dc7-844b-106086df9f4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_4852380a-a22b-48c7-9662-27dd9dec3a2f" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_JulyPublicOfferingMember_4852380a-a22b-48c7-9662-27dd9dec3a2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_6388bd73-618b-4a14-a948-abd4016d835a" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_6388bd73-618b-4a14-a948-abd4016d835a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_a96b8386-9197-4f7c-a5f6-f5ce8b1b38c0" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_a96b8386-9197-4f7c-a5f6-f5ce8b1b38c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember_4f2973e6-48ca-4a14-99a8-fbaf40988e14" xlink:href="angn-20250331.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_JanuaryPublicOfferingMember_4f2973e6-48ca-4a14-99a8-fbaf40988e14" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_8594ed2e-49f8-445c-8e59-685ef1448e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_8594ed2e-49f8-445c-8e59-685ef1448e6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_8594ed2e-49f8-445c-8e59-685ef1448e6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8594ed2e-49f8-445c-8e59-685ef1448e6d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_8594ed2e-49f8-445c-8e59-685ef1448e6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8594ed2e-49f8-445c-8e59-685ef1448e6d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_eb822227-21ef-479b-a91c-f300721b2b59" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:to="loc_angn_PreFundedWarrantMember_eb822227-21ef-479b-a91c-f300721b2b59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_e56eaf03-1ead-4e41-a66d-96b646b89f9d" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:to="loc_angn_JulyCommonWarrantsMember_e56eaf03-1ead-4e41-a66d-96b646b89f9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember_047e713e-e37f-418b-ae8f-1f291073fc87" xlink:href="angn-20250331.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:to="loc_angn_JanuaryCommonWarrantsMember_047e713e-e37f-418b-ae8f-1f291073fc87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3bb7f0c9-01dd-4747-ab04-4402e19e08bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3bb7f0c9-01dd-4747-ab04-4402e19e08bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e6827299-a6c7-4178-8130-fb9c3c43af35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e6827299-a6c7-4178-8130-fb9c3c43af35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_26363e51-6483-45ba-b440-8cb83117edb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_26363e51-6483-45ba-b440-8cb83117edb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_792784b4-5e72-45b3-a427-50c8244147df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_792784b4-5e72-45b3-a427-50c8244147df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice_ea16602d-a2ae-4ed8-92ac-e760eaec160f" xlink:href="angn-20250331.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_angn_SaleOfStockAggregateInitialOfferingPrice_ea16602d-a2ae-4ed8-92ac-e760eaec160f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ad8616ea-395e-47b6-a74b-5df248946cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ad8616ea-395e-47b6-a74b-5df248946cdd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a8762370-187b-4067-88fc-5fcc1ad23e02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a8762370-187b-4067-88fc-5fcc1ad23e02" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1bcbde04-ec7d-4b12-99cb-460a7ce72d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1bcbde04-ec7d-4b12-99cb-460a7ce72d1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_e33ef08f-5bb5-4a9a-aa7f-ac170fd435c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_e33ef08f-5bb5-4a9a-aa7f-ac170fd435c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_97626a53-c37c-452f-9579-a872a39fc617" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_97626a53-c37c-452f-9579-a872a39fc617" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_faf44442-6703-4572-94ca-85765678a09d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_faf44442-6703-4572-94ca-85765678a09d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_da8829da-08ae-4f71-b2da-a6c81a1d8470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_da8829da-08ae-4f71-b2da-a6c81a1d8470" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_415fbf2f-a64b-451b-9da6-af1a5f46b125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_415fbf2f-a64b-451b-9da6-af1a5f46b125" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_77ece132-8dd6-4547-90d1-1825201667d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_77ece132-8dd6-4547-90d1-1825201667d8" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c08bb551-cd66-43a0-9bb0-08cdcf93bd37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:to="loc_us-gaap_PlanNameAxis_c08bb551-cd66-43a0-9bb0-08cdcf93bd37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c08bb551-cd66-43a0-9bb0-08cdcf93bd37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_c08bb551-cd66-43a0-9bb0-08cdcf93bd37" xlink:to="loc_us-gaap_PlanNameDomain_c08bb551-cd66-43a0-9bb0-08cdcf93bd37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_c08bb551-cd66-43a0-9bb0-08cdcf93bd37" xlink:to="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2021PlanMember_cf2be1f3-3318-4cf8-bbde-6304a5800c38" xlink:href="angn-20250331.xsd#angn_The2021PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:to="loc_angn_The2021PlanMember_cf2be1f3-3318-4cf8-bbde-6304a5800c38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2022PlanMember_09dbaf19-2153-4a41-9dcf-6c0af2ee520e" xlink:href="angn-20250331.xsd#angn_The2022PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:to="loc_angn_The2022PlanMember_09dbaf19-2153-4a41-9dcf-6c0af2ee520e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_Inducement2024PlanMember_28bc8cf9-960c-47ef-88d1-750c779a4f99" xlink:href="angn-20250331.xsd#angn_Inducement2024PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:to="loc_angn_Inducement2024PlanMember_28bc8cf9-960c-47ef-88d1-750c779a4f99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d08a8e92-22a2-4679-b821-bccd51b523e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:to="loc_us-gaap_AwardTypeAxis_d08a8e92-22a2-4679-b821-bccd51b523e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d08a8e92-22a2-4679-b821-bccd51b523e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d08a8e92-22a2-4679-b821-bccd51b523e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d08a8e92-22a2-4679-b821-bccd51b523e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b395c5b3-25e7-4f59-87ab-dc51fc39fc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d08a8e92-22a2-4679-b821-bccd51b523e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b395c5b3-25e7-4f59-87ab-dc51fc39fc4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_968a1617-efa4-422e-bcb2-aff433c0df14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b395c5b3-25e7-4f59-87ab-dc51fc39fc4e" xlink:to="loc_us-gaap_EmployeeStockMember_968a1617-efa4-422e-bcb2-aff433c0df14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_354f524a-b8b5-40ce-91f6-775bc3e8818d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_354f524a-b8b5-40ce-91f6-775bc3e8818d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_9df1e170-bcbd-458d-922c-e5688a114627" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_9df1e170-bcbd-458d-922c-e5688a114627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5b8bcd01-f24e-485d-90fe-a86339996954" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5b8bcd01-f24e-485d-90fe-a86339996954" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4785b203-b720-40f4-bd70-9a9cb6f66b60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4785b203-b720-40f4-bd70-9a9cb6f66b60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_12bb7910-64a4-4086-a566-8a81e009e289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_12bb7910-64a4-4086-a566-8a81e009e289" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_38aaefd9-aac8-49c4-9079-ced156bf58e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_38aaefd9-aac8-49c4-9079-ced156bf58e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_eb99ca55-6cfb-4e68-8aff-ab38dbcbe62e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_eb99ca55-6cfb-4e68-8aff-ab38dbcbe62e" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_642a8ffa-eb57-4aa8-9b00-5f371de4c023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4a647b3-5c16-45b0-9326-b47fb789e2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_642a8ffa-eb57-4aa8-9b00-5f371de4c023" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4a647b3-5c16-45b0-9326-b47fb789e2b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_96b27077-144d-40fa-95a9-b0e37290785b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4a647b3-5c16-45b0-9326-b47fb789e2b7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_96b27077-144d-40fa-95a9-b0e37290785b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_96b27077-144d-40fa-95a9-b0e37290785b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_96b27077-144d-40fa-95a9-b0e37290785b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_96b27077-144d-40fa-95a9-b0e37290785b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2f7ac9bc-2b5c-4fa1-b916-dfce93d6a9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_96b27077-144d-40fa-95a9-b0e37290785b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2f7ac9bc-2b5c-4fa1-b916-dfce93d6a9c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6be2a36c-21a6-4ac0-822b-f96a318a4776" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f7ac9bc-2b5c-4fa1-b916-dfce93d6a9c5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6be2a36c-21a6-4ac0-822b-f96a318a4776" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c95e1854-899a-4403-b9dd-08b98ae4d440" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f7ac9bc-2b5c-4fa1-b916-dfce93d6a9c5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c95e1854-899a-4403-b9dd-08b98ae4d440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_659f908c-47b5-422c-8e7e-c1ec6704bc03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_642a8ffa-eb57-4aa8-9b00-5f371de4c023" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_659f908c-47b5-422c-8e7e-c1ec6704bc03" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_034c9afc-67b4-4bec-9024-af67e0c9414d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:to="loc_us-gaap_AwardTypeAxis_034c9afc-67b4-4bec-9024-af67e0c9414d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_034c9afc-67b4-4bec-9024-af67e0c9414d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_034c9afc-67b4-4bec-9024-af67e0c9414d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_034c9afc-67b4-4bec-9024-af67e0c9414d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5ebc09f0-a610-4868-b70d-ca0fb43fbf67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_034c9afc-67b4-4bec-9024-af67e0c9414d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5ebc09f0-a610-4868-b70d-ca0fb43fbf67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a92648a9-dc28-4199-86e8-0d6fb34028f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5ebc09f0-a610-4868-b70d-ca0fb43fbf67" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a92648a9-dc28-4199-86e8-0d6fb34028f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:to="loc_srt_RangeAxis_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225" xlink:to="loc_srt_RangeMember_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a06c5de5-6ca0-449a-85e6-a90d4fb48ad7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225" xlink:to="loc_srt_RangeMember_a06c5de5-6ca0-449a-85e6-a90d4fb48ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_47a3177c-e926-4a73-94fa-d9f012ebfdcf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a06c5de5-6ca0-449a-85e6-a90d4fb48ad7" xlink:to="loc_srt_MinimumMember_47a3177c-e926-4a73-94fa-d9f012ebfdcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0cc36f53-2d6e-412e-860b-fc109124932a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a06c5de5-6ca0-449a-85e6-a90d4fb48ad7" xlink:to="loc_srt_MaximumMember_0cc36f53-2d6e-412e-860b-fc109124932a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9d0f59ac-0064-4df1-a4f3-d1a0fae89dff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9d0f59ac-0064-4df1-a4f3-d1a0fae89dff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4831c1d8-64b4-45b1-8f20-5453da40d378" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4831c1d8-64b4-45b1-8f20-5453da40d378" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b71a3ce9-4728-408d-8273-4e252774f583" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b71a3ce9-4728-408d-8273-4e252774f583" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5d60f2e5-27ba-4c4b-b5e6-a68fb592e3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5d60f2e5-27ba-4c4b-b5e6-a68fb592e3a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_6a799027-eae4-48c7-8372-914898f491c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_6a799027-eae4-48c7-8372-914898f491c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_e76478fe-8cc7-4acd-a8b1-b2c9e88fe6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_e76478fe-8cc7-4acd-a8b1-b2c9e88fe6bf" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#WarrantsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f7400a59-e02d-44e3-a94b-0fae708b261b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f7400a59-e02d-44e3-a94b-0fae708b261b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_f7400a59-e02d-44e3-a94b-0fae708b261b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f7400a59-e02d-44e3-a94b-0fae708b261b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_f7400a59-e02d-44e3-a94b-0fae708b261b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f7400a59-e02d-44e3-a94b-0fae708b261b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_12e7f956-dc95-4c79-a3a9-c01e05451256" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:to="loc_angn_PreFundedWarrantMember_12e7f956-dc95-4c79-a3a9-c01e05451256" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_be0995f6-63ab-4870-9bb1-65d19139157f" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:to="loc_angn_JulyCommonWarrantsMember_be0995f6-63ab-4870-9bb1-65d19139157f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_f66e63c2-bbaa-4c9c-a368-dfdefe92c6d4" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_f66e63c2-bbaa-4c9c-a368-dfdefe92c6d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f85928d2-e52e-46c3-b646-e93a07b78dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f85928d2-e52e-46c3-b646-e93a07b78dc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f85928d2-e52e-46c3-b646-e93a07b78dc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f85928d2-e52e-46c3-b646-e93a07b78dc4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f85928d2-e52e-46c3-b646-e93a07b78dc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd3bed5e-a3c0-412b-ac9c-404cb272fc67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f85928d2-e52e-46c3-b646-e93a07b78dc4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd3bed5e-a3c0-412b-ac9c-404cb272fc67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_783ba97a-06fd-49eb-a4f3-fffbdf6ec422" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd3bed5e-a3c0-412b-ac9c-404cb272fc67" xlink:to="loc_angn_MarchSubscriptionAgreementMember_783ba97a-06fd-49eb-a4f3-fffbdf6ec422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_89795c02-2cd6-4c0f-b03e-e561fc3dde12" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd3bed5e-a3c0-412b-ac9c-404cb272fc67" xlink:to="loc_angn_JulyPublicOfferingMember_89795c02-2cd6-4c0f-b03e-e561fc3dde12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_80b81030-71c7-42b0-ba52-bdedc5f9e2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_StatementClassOfStockAxis_80b81030-71c7-42b0-ba52-bdedc5f9e2d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_80b81030-71c7-42b0-ba52-bdedc5f9e2d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_80b81030-71c7-42b0-ba52-bdedc5f9e2d4" xlink:to="loc_us-gaap_ClassOfStockDomain_80b81030-71c7-42b0-ba52-bdedc5f9e2d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_908bb528-8c5d-4c1a-b314-b3d3bf11702f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_80b81030-71c7-42b0-ba52-bdedc5f9e2d4" xlink:to="loc_us-gaap_ClassOfStockDomain_908bb528-8c5d-4c1a-b314-b3d3bf11702f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_7469b660-bea5-4063-a9a7-ecdbb15601f0" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_908bb528-8c5d-4c1a-b314-b3d3bf11702f" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_7469b660-bea5-4063-a9a7-ecdbb15601f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2" xlink:to="loc_us-gaap_EquityComponentDomain_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fd0be2d8-27f8-49e1-b787-69cb22e57358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2" xlink:to="loc_us-gaap_EquityComponentDomain_fd0be2d8-27f8-49e1-b787-69cb22e57358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2463f060-ec86-4435-9776-d3fec966337d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fd0be2d8-27f8-49e1-b787-69cb22e57358" xlink:to="loc_us-gaap_CommonStockMember_2463f060-ec86-4435-9776-d3fec966337d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f14fef64-dcb5-49a1-bcc1-9675d051a357" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f14fef64-dcb5-49a1-bcc1-9675d051a357" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f14fef64-dcb5-49a1-bcc1-9675d051a357_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f14fef64-dcb5-49a1-bcc1-9675d051a357" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f14fef64-dcb5-49a1-bcc1-9675d051a357_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f4b1f661-b844-45f5-98af-9c86a93efcef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f14fef64-dcb5-49a1-bcc1-9675d051a357" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f4b1f661-b844-45f5-98af-9c86a93efcef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_66a8cbf5-30a6-4936-84fa-313f0acb3ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f4b1f661-b844-45f5-98af-9c86a93efcef" xlink:to="loc_us-gaap_SubsequentEventMember_66a8cbf5-30a6-4936-84fa-313f0acb3ab1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_a9f26bd9-8aef-4180-b420-a90363c6249a" xlink:href="angn-20250331.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_a9f26bd9-8aef-4180-b420-a90363c6249a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bf769f82-6171-49fa-aad6-c919d0a4e38d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bf769f82-6171-49fa-aad6-c919d0a4e38d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrants_4ba085ca-af0c-4f42-9a3e-4f6863ea8e00" xlink:href="angn-20250331.xsd#angn_FairValueOfCommonStockWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_angn_FairValueOfCommonStockWarrants_4ba085ca-af0c-4f42-9a3e-4f6863ea8e00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_7667613d-e410-43bd-9db6-0312b518bad1" xlink:href="angn-20250331.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_7667613d-e410-43bd-9db6-0312b518bad1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_694e0ef9-b0c8-426d-834b-0c606195700a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_694e0ef9-b0c8-426d-834b-0c606195700a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0cdd2b67-a2cd-47ea-8179-f208612c55e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0cdd2b67-a2cd-47ea-8179-f208612c55e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_67c3b34f-d481-4fb8-af13-bf91af04f97e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_67c3b34f-d481-4fb8-af13-bf91af04f97e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9cbdb69f-8dd7-4ba6-bb88-2906813e727c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9cbdb69f-8dd7-4ba6-bb88-2906813e727c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_e8d24bf5-9939-482f-9579-0a381bb7e51b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_e8d24bf5-9939-482f-9579-0a381bb7e51b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_ffe671bf-f444-4da0-a658-9b281de3f5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_ffe671bf-f444-4da0-a658-9b281de3f5d3" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:href="angn-20250331.xsd#angn_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureTable_ce42cd13-0c30-4eb3-9bb2-ab2267c28106" xlink:href="angn-20250331.xsd#angn_CommitmentsAndContingenciesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:to="loc_angn_CommitmentsAndContingenciesDisclosureTable_ce42cd13-0c30-4eb3-9bb2-ab2267c28106" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3e8e6d86-5a38-42a4-885e-5c51744a287c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_ce42cd13-0c30-4eb3-9bb2-ab2267c28106" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3e8e6d86-5a38-42a4-885e-5c51744a287c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3e8e6d86-5a38-42a4-885e-5c51744a287c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3e8e6d86-5a38-42a4-885e-5c51744a287c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3e8e6d86-5a38-42a4-885e-5c51744a287c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cca94c1f-8ba7-4bd9-982d-0f8abfc67ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3e8e6d86-5a38-42a4-885e-5c51744a287c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cca94c1f-8ba7-4bd9-982d-0f8abfc67ea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5bd6bb70-c31d-4bdc-ab37-c81833671657" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cca94c1f-8ba7-4bd9-982d-0f8abfc67ea8" xlink:to="loc_us-gaap_SubsequentEventMember_5bd6bb70-c31d-4bdc-ab37-c81833671657" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LicenseExpense_29ff8f8d-c294-48f0-8457-b010c014fcde" xlink:href="angn-20250331.xsd#angn_LicenseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:to="loc_angn_LicenseExpense_29ff8f8d-c294-48f0-8457-b010c014fcde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments_863202db-79cc-4182-9e4d-ff8f4d99e874" xlink:href="angn-20250331.xsd#angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:to="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments_863202db-79cc-4182-9e4d-ff8f4d99e874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter_7ea9aa9c-d435-4156-969f-0ee11d91550d" xlink:href="angn-20250331.xsd#angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:to="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter_7ea9aa9c-d435-4156-969f-0ee11d91550d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_93e626b1-08a3-4e44-8537-9ffe0196d889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_93e626b1-08a3-4e44-8537-9ffe0196d889" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0a0ee695-31df-424f-b335-2e9de3e618e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_93e626b1-08a3-4e44-8537-9ffe0196d889" xlink:to="loc_srt_StatementGeographicalAxis_0a0ee695-31df-424f-b335-2e9de3e618e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0a0ee695-31df-424f-b335-2e9de3e618e9_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0a0ee695-31df-424f-b335-2e9de3e618e9" xlink:to="loc_srt_SegmentGeographicalDomain_0a0ee695-31df-424f-b335-2e9de3e618e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_639f02d8-4e55-4236-a570-e4c977ae5928" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0a0ee695-31df-424f-b335-2e9de3e618e9" xlink:to="loc_srt_SegmentGeographicalDomain_639f02d8-4e55-4236-a570-e4c977ae5928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember_c7dbbb39-fb98-4ca0-baff-e85c05538670" xlink:href="angn-20250331.xsd#angn_BostonMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_639f02d8-4e55-4236-a570-e4c977ae5928" xlink:to="loc_angn_BostonMassachusettsMember_c7dbbb39-fb98-4ca0-baff-e85c05538670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember_1bfa7f78-7e14-4db8-9f32-f295e7941ca4" xlink:href="angn-20250331.xsd#angn_NewtonMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_639f02d8-4e55-4236-a570-e4c977ae5928" xlink:to="loc_angn_NewtonMassachusettsMember_1bfa7f78-7e14-4db8-9f32-f295e7941ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_aed2af02-d1a3-4201-a0dc-36d45c349b32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_OperatingLeaseExpense_aed2af02-d1a3-4201-a0dc-36d45c349b32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8919332e-0768-4a04-9aff-8d1afca9eb62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8919332e-0768-4a04-9aff-8d1afca9eb62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ace68428-ec04-4ec6-a23f-cbd96fbd1c06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ace68428-ec04-4ec6-a23f-cbd96fbd1c06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_201525c0-6013-4dff-b79e-6f17a174d7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_201525c0-6013-4dff-b79e-6f17a174d7a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_663c8199-cdb4-4fce-b50f-baf49f75599d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_663c8199-cdb4-4fce-b50f-baf49f75599d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense_a60895b8-3233-4ac5-accf-d7e6de917e44" xlink:href="angn-20250331.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_angn_LesseeOperatingLeaseAnnualRentExpense_a60895b8-3233-4ac5-accf-d7e6de917e44" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_070e1179-321a-46b5-a133-881822583aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_DebtInstrumentAxis_070e1179-321a-46b5-a133-881822583aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_070e1179-321a-46b5-a133-881822583aaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_070e1179-321a-46b5-a133-881822583aaf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_070e1179-321a-46b5-a133-881822583aaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_70699c13-efe4-4f5f-b0d1-fc63354d3ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_070e1179-321a-46b5-a133-881822583aaf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_70699c13-efe4-4f5f-b0d1-fc63354d3ae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b9e35457-4669-402a-b4ba-ceeadd6e0832" xlink:href="angn-20250331.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_70699c13-efe4-4f5f-b0d1-fc63354d3ae6" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b9e35457-4669-402a-b4ba-ceeadd6e0832" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cd9da6d7-4e18-471f-96c5-65185930d945" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cd9da6d7-4e18-471f-96c5-65185930d945" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cd9da6d7-4e18-471f-96c5-65185930d945_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd9da6d7-4e18-471f-96c5-65185930d945" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cd9da6d7-4e18-471f-96c5-65185930d945_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0e6d814d-2f5a-4a88-b972-36a67a2e9f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd9da6d7-4e18-471f-96c5-65185930d945" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0e6d814d-2f5a-4a88-b972-36a67a2e9f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_42ff513c-ff2b-41a1-adc4-8d8f6141a110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0e6d814d-2f5a-4a88-b972-36a67a2e9f81" xlink:to="loc_us-gaap_ConvertibleDebtMember_42ff513c-ff2b-41a1-adc4-8d8f6141a110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_3ed8731d-9b73-4fdf-b5f1-1337006814b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_3ed8731d-9b73-4fdf-b5f1-1337006814b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3ed8731d-9b73-4fdf-b5f1-1337006814b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3ed8731d-9b73-4fdf-b5f1-1337006814b9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3ed8731d-9b73-4fdf-b5f1-1337006814b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3ed8731d-9b73-4fdf-b5f1-1337006814b9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_06692847-dde0-4793-ba54-31a358b43ec0" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:to="loc_angn_PreFundedWarrantMember_06692847-dde0-4793-ba54-31a358b43ec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_7eb7a766-424e-46af-81bd-d8df758fc89d" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_7eb7a766-424e-46af-81bd-d8df758fc89d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_18de7b61-01ec-48e2-a364-ac3993fc0379" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:to="loc_angn_JulyCommonWarrantsMember_18de7b61-01ec-48e2-a364-ac3993fc0379" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3652fb96-ec43-49dc-8de2-3b175e7e68bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3652fb96-ec43-49dc-8de2-3b175e7e68bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3652fb96-ec43-49dc-8de2-3b175e7e68bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3652fb96-ec43-49dc-8de2-3b175e7e68bd" xlink:to="loc_us-gaap_EquityComponentDomain_3652fb96-ec43-49dc-8de2-3b175e7e68bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_994559dd-c851-45db-a393-9e98cb70aea8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3652fb96-ec43-49dc-8de2-3b175e7e68bd" xlink:to="loc_us-gaap_EquityComponentDomain_994559dd-c851-45db-a393-9e98cb70aea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3025d776-7f80-45c7-ada2-ec38dcfd34bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_994559dd-c851-45db-a393-9e98cb70aea8" xlink:to="loc_us-gaap_CommonStockMember_3025d776-7f80-45c7-ada2-ec38dcfd34bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_acbb5f4e-8024-4126-b27d-0c20b56c3605" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_acbb5f4e-8024-4126-b27d-0c20b56c3605" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_acbb5f4e-8024-4126-b27d-0c20b56c3605_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_acbb5f4e-8024-4126-b27d-0c20b56c3605" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_acbb5f4e-8024-4126-b27d-0c20b56c3605_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_df9e85b6-b78d-4a8a-9aeb-ee53e41e8ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_acbb5f4e-8024-4126-b27d-0c20b56c3605" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_df9e85b6-b78d-4a8a-9aeb-ee53e41e8ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1d0d0461-1fc2-4cf3-8bd4-da9b55087632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_df9e85b6-b78d-4a8a-9aeb-ee53e41e8ed6" xlink:to="loc_us-gaap_SubsequentEventMember_1d0d0461-1fc2-4cf3-8bd4-da9b55087632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ed560d43-4f8b-4dce-8c1c-b1815e7d4804" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ed560d43-4f8b-4dce-8c1c-b1815e7d4804" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ed560d43-4f8b-4dce-8c1c-b1815e7d4804_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ed560d43-4f8b-4dce-8c1c-b1815e7d4804" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ed560d43-4f8b-4dce-8c1c-b1815e7d4804_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8195d3bd-5b96-41bd-9bb8-cb70f3f0b09c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ed560d43-4f8b-4dce-8c1c-b1815e7d4804" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8195d3bd-5b96-41bd-9bb8-cb70f3f0b09c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_5a54da9e-5ce0-4354-848b-c8c08adf7810" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8195d3bd-5b96-41bd-9bb8-cb70f3f0b09c" xlink:to="loc_angn_JulyPublicOfferingMember_5a54da9e-5ce0-4354-848b-c8c08adf7810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ff55eada-1c6e-4943-8bf2-ccb19f651e17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ff55eada-1c6e-4943-8bf2-ccb19f651e17" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ff55eada-1c6e-4943-8bf2-ccb19f651e17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ff55eada-1c6e-4943-8bf2-ccb19f651e17" xlink:to="loc_us-gaap_ClassOfStockDomain_ff55eada-1c6e-4943-8bf2-ccb19f651e17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_86d2c0df-479d-40b3-be03-bcb5f6333c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ff55eada-1c6e-4943-8bf2-ccb19f651e17" xlink:to="loc_us-gaap_ClassOfStockDomain_86d2c0df-479d-40b3-be03-bcb5f6333c7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_27a5beea-9c36-4c47-b468-ff733b8db7ea" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_86d2c0df-479d-40b3-be03-bcb5f6333c7d" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_27a5beea-9c36-4c47-b468-ff733b8db7ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f5d0ff1-0b4e-43ab-905c-f063b33d287d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f5d0ff1-0b4e-43ab-905c-f063b33d287d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5c05b3b8-62a8-4de7-82c1-0a3e991bd895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5c05b3b8-62a8-4de7-82c1-0a3e991bd895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_dd62d17f-a167-4a68-9dae-4c614380515a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_dd62d17f-a167-4a68-9dae-4c614380515a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_add6a810-20b0-4543-aa17-825c7be3dca7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_add6a810-20b0-4543-aa17-825c7be3dca7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_21e7c1b3-d27b-4934-9044-c00a33f845be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_InterestExpenseDebt_21e7c1b3-d27b-4934-9044-c00a33f845be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_36f873f1-ad3f-4e8a-9076-20924cc9356f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_36f873f1-ad3f-4e8a-9076-20924cc9356f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_36365e56-164d-4657-a16e-d8e19f5a8735" xlink:href="angn-20250331.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_36365e56-164d-4657-a16e-d8e19f5a8735" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_e7743ea2-76cf-42b7-a042-2b02e45de5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_e7743ea2-76cf-42b7-a042-2b02e45de5b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c5582dd5-77da-4291-904c-1cc046efc386" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c5582dd5-77da-4291-904c-1cc046efc386" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a8b42794-9e57-4e52-8fd3-d7ddb33bbd05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a8b42794-9e57-4e52-8fd3-d7ddb33bbd05" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9f23b4ca-a8b4-47b6-9f28-ace4b8981712" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1d4e7175-f35b-47b7-88f1-2ca0d27300b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9f23b4ca-a8b4-47b6-9f28-ace4b8981712" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1d4e7175-f35b-47b7-88f1-2ca0d27300b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5973ec9-6a95-4e60-a210-db5d03bfa76e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1d4e7175-f35b-47b7-88f1-2ca0d27300b2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5973ec9-6a95-4e60-a210-db5d03bfa76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d5973ec9-6a95-4e60-a210-db5d03bfa76e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5973ec9-6a95-4e60-a210-db5d03bfa76e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d5973ec9-6a95-4e60-a210-db5d03bfa76e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5973ec9-6a95-4e60-a210-db5d03bfa76e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1a6e508f-8e1c-4fc7-ac62-10e0cd478afc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1a6e508f-8e1c-4fc7-ac62-10e0cd478afc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_37e46980-c201-4397-ac21-6b64f7ab54dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:to="loc_us-gaap_WarrantMember_37e46980-c201-4397-ac21-6b64f7ab54dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d16fa4ec-055a-4729-a6f3-751e52b8bd16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d16fa4ec-055a-4729-a6f3-751e52b8bd16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12c2b1db-730f-45bd-b617-0a25e44eb9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9f23b4ca-a8b4-47b6-9f28-ace4b8981712" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12c2b1db-730f-45bd-b617-0a25e44eb9ce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_aa1ffa68-fb51-4694-b67b-6864b99812c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_aa1ffa68-fb51-4694-b67b-6864b99812c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_aa1ffa68-fb51-4694-b67b-6864b99812c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_aa1ffa68-fb51-4694-b67b-6864b99812c6" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_aa1ffa68-fb51-4694-b67b-6864b99812c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_9a8aab1e-8b80-4d55-bbc9-293ccbd83312" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_aa1ffa68-fb51-4694-b67b-6864b99812c6" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_9a8aab1e-8b80-4d55-bbc9-293ccbd83312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember_fb43baab-ec6c-4ccd-8e88-823086561c6b" xlink:href="angn-20250331.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9a8aab1e-8b80-4d55-bbc9-293ccbd83312" xlink:to="loc_angn_PurchaseOfWarrantsMember_fb43baab-ec6c-4ccd-8e88-823086561c6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4357a30b-2368-4ecd-bae6-da1d62b2e8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4357a30b-2368-4ecd-bae6-da1d62b2e8e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4357a30b-2368-4ecd-bae6-da1d62b2e8e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4357a30b-2368-4ecd-bae6-da1d62b2e8e7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4357a30b-2368-4ecd-bae6-da1d62b2e8e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50a1c466-17bd-4668-bebc-bed88122e377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4357a30b-2368-4ecd-bae6-da1d62b2e8e7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50a1c466-17bd-4668-bebc-bed88122e377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_b6b56d7c-9996-4da4-b8fa-b51e87f029ae" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50a1c466-17bd-4668-bebc-bed88122e377" xlink:to="loc_angn_MarchSubscriptionAgreementMember_b6b56d7c-9996-4da4-b8fa-b51e87f029ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_1114e5dd-563a-4983-b143-29b27484b78a" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50a1c466-17bd-4668-bebc-bed88122e377" xlink:to="loc_angn_JulyPublicOfferingMember_1114e5dd-563a-4983-b143-29b27484b78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_597de904-037e-4efe-9507-aaa7cb14faff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_597de904-037e-4efe-9507-aaa7cb14faff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_597de904-037e-4efe-9507-aaa7cb14faff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_597de904-037e-4efe-9507-aaa7cb14faff" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_597de904-037e-4efe-9507-aaa7cb14faff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e97012e4-456d-4f0a-a0f2-2606d1db28bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_597de904-037e-4efe-9507-aaa7cb14faff" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e97012e4-456d-4f0a-a0f2-2606d1db28bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_e95a12d8-31af-48fb-8522-f591733fb335" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e97012e4-456d-4f0a-a0f2-2606d1db28bc" xlink:to="loc_angn_PreFundedWarrantMember_e95a12d8-31af-48fb-8522-f591733fb335" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_4892533c-774f-4cc9-9296-8b370500c472" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e97012e4-456d-4f0a-a0f2-2606d1db28bc" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_4892533c-774f-4cc9-9296-8b370500c472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a14bf6f6-0b19-4a17-9fd7-f376d327da98" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_srt_CounterpartyNameAxis_a14bf6f6-0b19-4a17-9fd7-f376d327da98" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a14bf6f6-0b19-4a17-9fd7-f376d327da98_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a14bf6f6-0b19-4a17-9fd7-f376d327da98" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a14bf6f6-0b19-4a17-9fd7-f376d327da98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc6461af-a940-49fa-a72a-7c6da312dd5a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a14bf6f6-0b19-4a17-9fd7-f376d327da98" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc6461af-a940-49fa-a72a-7c6da312dd5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember_b784f5e4-6387-4c63-8038-6037d89a80c0" xlink:href="angn-20250331.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc6461af-a940-49fa-a72a-7c6da312dd5a" xlink:to="loc_angn_YekaterinaChudnovskyMember_b784f5e4-6387-4c63-8038-6037d89a80c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_c3969111-dfda-4d2a-8e38-1802457dfed7" xlink:href="angn-20250331.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc6461af-a940-49fa-a72a-7c6da312dd5a" xlink:to="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_c3969111-dfda-4d2a-8e38-1802457dfed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a70f3569-a107-47c6-b3ee-db0e0bae7f33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_DebtInstrumentAxis_a70f3569-a107-47c6-b3ee-db0e0bae7f33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a70f3569-a107-47c6-b3ee-db0e0bae7f33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a70f3569-a107-47c6-b3ee-db0e0bae7f33" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a70f3569-a107-47c6-b3ee-db0e0bae7f33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d2cc165b-856e-4376-9ad1-7446c56a5384" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a70f3569-a107-47c6-b3ee-db0e0bae7f33" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d2cc165b-856e-4376-9ad1-7446c56a5384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_c1f9c295-ab51-4428-9569-1a01326becf1" xlink:href="angn-20250331.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2cc165b-856e-4376-9ad1-7446c56a5384" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_c1f9c295-ab51-4428-9569-1a01326becf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f241038a-14d0-405b-a3cd-b5cbdefd35be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f241038a-14d0-405b-a3cd-b5cbdefd35be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f241038a-14d0-405b-a3cd-b5cbdefd35be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f241038a-14d0-405b-a3cd-b5cbdefd35be" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f241038a-14d0-405b-a3cd-b5cbdefd35be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f3978dca-78f9-468b-8efa-5387d489e89a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f241038a-14d0-405b-a3cd-b5cbdefd35be" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f3978dca-78f9-468b-8efa-5387d489e89a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_3b2ec85b-8112-403f-95ac-761f450e3d84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f3978dca-78f9-468b-8efa-5387d489e89a" xlink:to="loc_us-gaap_ConvertibleDebtMember_3b2ec85b-8112-403f-95ac-761f450e3d84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8ceadf2f-f8ee-4b66-8e7d-992985695d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8ceadf2f-f8ee-4b66-8e7d-992985695d3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_6207104d-1ed2-4670-822e-ebc25496495c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_6207104d-1ed2-4670-822e-ebc25496495c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_a37e9b49-a628-42bd-be11-44d615c3c0f7" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_a37e9b49-a628-42bd-be11-44d615c3c0f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_51bdb2c8-b6c3-4462-93e8-f042cff3870f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_51bdb2c8-b6c3-4462-93e8-f042cff3870f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_69d550ac-36da-44d7-b7ce-2a0d3ef57cca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_69d550ac-36da-44d7-b7ce-2a0d3ef57cca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_999bb826-6d20-49bc-a6bd-799be150b9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_999bb826-6d20-49bc-a6bd-799be150b9e4" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:to="loc_srt_ProductOrServiceAxis_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180" xlink:to="loc_srt_ProductsAndServicesDomain_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180" xlink:to="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember_1c88af88-6400-40e4-8d36-a1ce061f7216" xlink:href="angn-20250331.xsd#angn_ClinicalTrailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:to="loc_angn_ClinicalTrailMember_1c88af88-6400-40e4-8d36-a1ce061f7216" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_cc327284-580c-4344-9a53-273a9fac5aeb" xlink:href="angn-20250331.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:to="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_cc327284-580c-4344-9a53-273a9fac5aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember_32246cd0-e427-436b-a408-c29efc8a95f1" xlink:href="angn-20250331.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:to="loc_angn_TranslationalMedicineAndCMCMember_32246cd0-e427-436b-a408-c29efc8a95f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember_44e06d7d-0a96-4073-8d32-97efa5d05e98" xlink:href="angn-20250331.xsd#angn_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:to="loc_angn_OtherMember_44e06d7d-0a96-4073-8d32-97efa5d05e98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_159ed1e5-319f-4632-bd4b-7770f0b705de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_159ed1e5-319f-4632-bd4b-7770f0b705de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_159ed1e5-319f-4632-bd4b-7770f0b705de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_159ed1e5-319f-4632-bd4b-7770f0b705de" xlink:to="loc_us-gaap_SegmentDomain_159ed1e5-319f-4632-bd4b-7770f0b705de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_95f20ec2-3e64-4a76-85bd-b594e0de946b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_159ed1e5-319f-4632-bd4b-7770f0b705de" xlink:to="loc_us-gaap_SegmentDomain_95f20ec2-3e64-4a76-85bd-b594e0de946b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember_fb254ac9-513a-4fdb-bafe-cec614cc4243" xlink:href="angn-20250331.xsd#angn_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_95f20ec2-3e64-4a76-85bd-b594e0de946b" xlink:to="loc_angn_ReportableSegmentMember_fb254ac9-513a-4fdb-bafe-cec614cc4243" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_da2a1588-3906-4346-bafb-222250824a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_da2a1588-3906-4346-bafb-222250824a7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_3baf1dce-4bc9-484a-97db-42085703dc80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_3baf1dce-4bc9-484a-97db-42085703dc80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_85a58549-b977-49ef-be08-6b2161f3d0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_85a58549-b977-49ef-be08-6b2161f3d0e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_ad5300c0-0cdb-43e7-a227-c2ba7fcb3d04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_ad5300c0-0cdb-43e7-a227-c2ba7fcb3d04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_1ce41a70-04e2-42ba-b5e6-8bc57db4ff8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_1ce41a70-04e2-42ba-b5e6-8bc57db4ff8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d37403d8-0957-41d3-a4ea-c33d2dce3563" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_NetIncomeLoss_d37403d8-0957-41d3-a4ea-c33d2dce3563" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_751ad036-df22-4f6d-bf2e-a75e7c9a354d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_Assets_751ad036-df22-4f6d-bf2e-a75e7c9a354d" xlink:type="arc" order="6"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>angn-20250331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b5a770-ce93-4e1a-8551-4667fc149643,g:e550b526-85cb-4940-ae39-7686e99f6d4a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_62af34e9-6a4b-4839-8e94-ffbda1af8e79_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_0bc4b0f3-d01b-429c-831a-81e3e6717cc1_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant award</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementGrant" xlink:to="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_934afac0-1d88-4ead-ba89-c2b9c04508ae_terseLabel_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other prepaid expenses and other current assets</link:label>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_label_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Prepaid Expenses And Other Assets, Current</link:label>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_documentation_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Prepaid Expenses And Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:href="angn-20250331.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:to="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d60ed4e7-7228-4799-a8cd-d900e45351d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a591dd22-0b52-47bf-97e8-0067670f1b7d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_f2f0f16a-7a95-4a54-8a20-c85b315e5877_terseLabel_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_label_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPreFundedWarrantsMember" xlink:to="lab_angn_JulyPreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8ee02bf9-63a5-430a-8218-0e706b7ac479_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_75dd6087-ba3a-41d3-a47f-90e58b3b424e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_89f687ad-e9d7-482e-ad9d-f84e51af416a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2da323d-0c86-4a20-9f21-7c69eb746ac6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f04e0574-d51f-4c6d-9a87-1d2751e1d852_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_04126981-d5d4-43c1-853f-279b53db5fa4_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightRollForward" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_74ef950b-6843-4b48-b2cb-b127e9864b7f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_634b74c8-5d77-4ff4-87d2-dfe7ca0902f7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_05b754f1-dd92-4682-96ad-df0a96f2acad_periodStartLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_29798678-5eef-4ba6-865f-1007ae8cecae_periodEndLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Weighted Average Life</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Weighted Average Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_31fd7725-188e-4db6-aa35-a6caeae6755b_terseLabel_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of research grant agreements</link:label>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_label_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Research Grant Agreements</link:label>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_documentation_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Research Grant Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements" xlink:href="angn-20250331.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_NumberOfResearchGrantAgreements" xlink:to="lab_angn_NumberOfResearchGrantAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b87b9579-3f03-44a6-87b1-e0b18afa401f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Net Loss Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_329acce9-ec3f-4e8d-9572-c82acabbd9f1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable into common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_3175a28a-4d00-47b3-89cf-4f665c3d3960_terseLabel_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of Warrants</link:label>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_label_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants [Member]</link:label>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_documentation_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember" xlink:href="angn-20250331.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PurchaseOfWarrantsMember" xlink:to="lab_angn_PurchaseOfWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureLineItems_74d74828-5ac0-4439-a8eb-143299b05ca2_terseLabel_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureLineItems_label_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureLineItems_documentation_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:href="angn-20250331.xsd#angn_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="lab_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_d12a7fdf-455e-41ae-81e6-41a9cf5e62c5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3661eaba-7644-4057-abe9-52fc1ab5268d_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the Business and Financial Condition</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4630d256-5069-415c-81b8-efee86001366_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_426b6069-0b12-4426-93df-589902b7c650_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon settlement of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_1954ff64-40e6-4143-a00c-5a242b44522b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_dc10a294-9065-4461-a83e-aefb07117cd5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_21617014-d851-4ac2-bbf0-6c96b580d1dd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7fa0d14a-5a68-4b46-87cb-49cb3c15b051_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_94485740-2f12-4627-90d8-023b4e89716c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_af83b64b-ee86-4d37-a390-bc4430d48917_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_ecadd086-7d11-44f9-98bd-8c1cda9aebbf_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_69a3be3e-d22a-4f43-81f2-065c7fdfd102_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_69b66b99-8c66-4914-aaf0-4ac0309dea77_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_7daa8064-bd10-4319-9546-90d14cbed310_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_05571390-32a4-48d3-9f52-cff040622a80_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, contractual term</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_be11b957-b7b5-482d-8284-ebfcfd740191_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred research obligation</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_a65ab0d0-e55e-44d2-82ce-da55a247de60_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_23cd5f36-cfb3-41b1-ac31-241b86a2881d_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AdvancedProfessionalFees_ea24d4f3-d138-4307-8469-a4ad1c66ad42_terseLabel_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advanced professional fees</link:label>
    <link:label id="lab_angn_AdvancedProfessionalFees_label_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Professional Fees</link:label>
    <link:label id="lab_angn_AdvancedProfessionalFees_documentation_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Advanced Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees" xlink:href="angn-20250331.xsd#angn_AdvancedProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AdvancedProfessionalFees" xlink:to="lab_angn_AdvancedProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b675dde5-98bd-457f-b306-a62dc360064e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_75a57026-a53b-4b64-937d-383522b17eb3_terseLabel_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Share And July Common Warrant</link:label>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_label_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Shares And July Common Warrant [Member]</link:label>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_documentation_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Shares And July Common Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulySharesAndJulyCommonWarrantMember" xlink:to="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_8b677cc1-cff2-44c5-8a82-83013ec88eff_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_ff19401d-2867-4801-9dc8-c5a9efdecd4d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock and common warrants from the January Offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_571857b1-6186-4898-9baa-fcf586b250d3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4ad18ae1-ec3d-480d-a79b-61c211e5d216_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_0b625bbd-ad04-4f3a-9b4a-62b142263b17_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0b0c172f-12c7-49c7-8de4-fb02ac652551_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_faf1d57c-c635-4b81-9338-ecbf0cbd1b73_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProjectMember_c1eab8ba-7697-4400-ba2b-43dc4af7c409_terseLabel_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project [Domain]</link:label>
    <link:label id="lab_us-gaap_ProjectMember_label_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProjectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProjectMember" xlink:to="lab_us-gaap_ProjectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_1a33cf7a-4cb7-4ced-b2f6-97d107ecabfe_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fff42fe0-88e6-4f05-b14e-773d586b338d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_2f46e5be-20a1-4ea6-8676-06f9e351a667_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_3152e398-c41b-4f30-8b67-b72d2da36bcd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_90cb6aa6-fded-4d80-b260-faa5723da3ab_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingAbstract_label_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding [Abstract]</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingAbstract_documentation_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract" xlink:href="angn-20250331.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract" xlink:to="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_e2fd5311-2fb0-477a-aa52-2cb9e9b5ad8c_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1d4ad8e0-7458-4cfb-a6cb-3b5c8fd74f81_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, total intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_NonCashVestingOfRestrictedCommonStock_4cac8bf6-c37c-411e-8290-a4ccebc1452c_terseLabel_en-US" xlink:label="lab_angn_NonCashVestingOfRestrictedCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash vesting of restricted common stock</link:label>
    <link:label id="lab_angn_NonCashVestingOfRestrictedCommonStock_label_en-US" xlink:label="lab_angn_NonCashVestingOfRestrictedCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-cash Vesting of Restricted Common Stock</link:label>
    <link:label id="lab_angn_NonCashVestingOfRestrictedCommonStock_documentation_en-US" xlink:label="lab_angn_NonCashVestingOfRestrictedCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-cash Vesting of Restricted Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NonCashVestingOfRestrictedCommonStock" xlink:href="angn-20250331.xsd#angn_NonCashVestingOfRestrictedCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_NonCashVestingOfRestrictedCommonStock" xlink:to="lab_angn_NonCashVestingOfRestrictedCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_b1be8c2d-0986-4ef5-8ead-d058c3426648_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Sept. 2022</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2022 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d3af1ce2-e0ad-4f38-af8c-e29d31ae1b09_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_63edbd43-498b-418d-bd73-fc3bb65936fc_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_d0a68cae-25a4-4079-84de-c40acae2ab3d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2a2172f3-ec14-4242-8a8c-eacf6d349cb1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_c9f562d4-090e-4e98-8366-6dca20767a28_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_d0e7abff-d125-4071-a8cd-d78641913aec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_5bc0ba2d-b613-4bed-8782-27794ed5a2ae_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant award received</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant Received</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:to="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_61fc7a97-be9a-4c5a-bfea-6a023bae3a04_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_7fc19c23-6bb7-460f-9e93-af81134e7978_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_0e6741d1-afea-417d-b21a-720f6ef8f040_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f8285bdf-37a9-4599-b646-feaf7b8b6b38_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_17c86fcc-1544-4896-80bd-965031b24350_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_1ca8fed0-6f89-48b3-8992-c41f62d23f30_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_1b7aa2df-3222-4396-9b16-8c50816bd4fe_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield (per share)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_81da9c83-1aeb-4f8d-9e95-9bbb78a944e1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f94eb3b0-62c6-403f-b55e-4090be94357e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8d321868-ca9a-445e-b46a-60386667a61b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c630c8a4-2924-4dcc-9c90-e841512c09f8_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyCommonWarrantsMember_d014102b-7916-4e0d-84d9-608193e7894a_terseLabel_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Common Warrants</link:label>
    <link:label id="lab_angn_JulyCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyCommonWarrantsMember" xlink:to="lab_angn_JulyCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_98125554-3009-4ba3-a445-3f670669232c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_358a7f84-b0e6-4f7f-831b-ad8cfdeb031b_terseLabel_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_label_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Other Operating Liabilities, Current</link:label>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_documentation_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Other Operating Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:href="angn-20250331.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:to="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_856d1065-7d40-4d08-b4c7-488146610147_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_5e8c595f-d08c-495d-b8ed-cfbf483eb7e9_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_ddb3a1ed-e6b0-4ebc-9991-78ae41c7771f_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PurchaseAgreementMember_cdb30482-6b94-4851-a4a7-994dcf89e543_terseLabel_en-US" xlink:label="lab_angn_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Agreement</link:label>
    <link:label id="lab_angn_PurchaseAgreementMember_label_en-US" xlink:label="lab_angn_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Agreement [Member]</link:label>
    <link:label id="lab_angn_PurchaseAgreementMember_documentation_en-US" xlink:label="lab_angn_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember" xlink:href="angn-20250331.xsd#angn_PurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PurchaseAgreementMember" xlink:to="lab_angn_PurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SettlementOfPromissoryNotesPayable_37a7b047-6baa-415d-8573-c022ed1de5ce_terseLabel_en-US" xlink:label="lab_angn_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of related-party senior note payable into equity</link:label>
    <link:label id="lab_angn_SettlementOfPromissoryNotesPayable_label_en-US" xlink:label="lab_angn_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Settlement Of Promissory Notes Payable</link:label>
    <link:label id="lab_angn_SettlementOfPromissoryNotesPayable_documentation_en-US" xlink:label="lab_angn_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Settlement Of Promissory Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SettlementOfPromissoryNotesPayable" xlink:href="angn-20250331.xsd#angn_SettlementOfPromissoryNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SettlementOfPromissoryNotesPayable" xlink:to="lab_angn_SettlementOfPromissoryNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_249afd97-8e49-490c-aa86-58ef5126b7bf_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical trial expenses</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_2cf25038-af40-4121-ad20-f59dd5545925_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0b01702a-38e2-4d2c-a2e2-e711549e6f99_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_d094629d-1ea9-4abb-b223-ad724a54679f_terseLabel_en-US" xlink:label="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee&#8203; Operating &#8203;Lease&#8203; Liability&#8203; Payments&#8203; Due&#8203; After&#8203; Year&#8203; Four</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee&#8203; Operating &#8203;Lease&#8203; Liability&#8203; Payments&#8203; Due&#8203; After&#8203; Year&#8203; Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="angn-20250331.xsd#angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_8833768f-c4e1-4691-a29b-73a58d8eea39_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_10a404fb-821b-4174-9d26-f2de173907a0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f4c9ab38-1825-44b5-9e2a-64cd97fc739b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c5cb907e-52f4-400b-afa9-a9835f419bd0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_NewtonMassachusettsMember_b1be0d7b-3b41-4fe6-adff-0c09dc0f0004_terseLabel_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Newton, Massachusettes</link:label>
    <link:label id="lab_angn_NewtonMassachusettsMember_label_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Newton, Massachusetts [Member]</link:label>
    <link:label id="lab_angn_NewtonMassachusettsMember_documentation_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Newton, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember" xlink:href="angn-20250331.xsd#angn_NewtonMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_NewtonMassachusettsMember" xlink:to="lab_angn_NewtonMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_512a9ca7-7818-4da1-92ff-562147e41775_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1b868490-7f9b-423c-9065-06feeb76e255_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_032997f2-00c6-4077-9ca5-4352a9c309ef_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_c26366c0-f865-4c63-a239-cda284cbf678_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_6b0ce092-10dc-46c2-9f37-ecf3307df9be_terseLabel_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average strike price</link:label>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_label_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Strike Price [Member]</link:label>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_documentation_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember" xlink:href="angn-20250331.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_MeasurementInputStrikePriceMember" xlink:to="lab_angn_MeasurementInputStrikePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_dfd60259-f992-4acd-acc9-d7f9a36aa712_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_988ba274-bbd9-4e1b-b075-b4c9246e5603_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_9686b040-a498-4eca-b9d4-6a71f3fbda10_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Sept. 2023</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_64828c34-888c-496f-ae5f-9e29be4cd92c_terseLabel_en-US" xlink:label="lab_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Expenses and Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:href="angn-20250331.xsd#angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_85849c8f-a8c5-41c9-b8bf-642717cfa1a7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_878e8956-9941-436a-bdb1-8b6c7369efe9_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_45882a38-e7f5-4584-b74d-e56954ec2c5d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_aad91cdb-28bc-4603-8dcd-4dca290c1814_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_14deba32-db5f-4121-a6da-0faba839e181_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_f07d4570-c6df-4d9a-8d03-a6c714bad558_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_22fd4ac0-4959-46c4-a2be-46c2cd9a763c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4431ee17-c6e5-4ce9-99cc-7405e13cba2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_418631ce-54e3-4230-8775-6fae76fdcedb_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_daf6fb34-65cc-4937-8666-df014fb631d5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_1474a4cc-986c-476a-bb45-f38185c38008_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: operating lease liability, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_3551d617-faa3-4efe-a302-93ffd1e7d4d0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_9e9e98a0-e148-4c1c-aa54-462f33e3693f_verboseLabel_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of pre-funded warrants at issuance date</link:label>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_label_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_documentation_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value of Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfPreFundedWarrants" xlink:href="angn-20250331.xsd#angn_FairValueOfPreFundedWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_FairValueOfPreFundedWarrants" xlink:to="lab_angn_FairValueOfPreFundedWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_ea63d413-17c1-4dfe-9c2b-cf33a083801d_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2f702b11-9c5f-49bc-b0e4-2f37a30442ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c06cbad4-c023-4c1e-894d-94c3c925ae9e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_85f274bf-6a26-4eae-a160-625fd8617efe_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3a40d4db-83e1-4b38-8421-df3d466fb750_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_97ae8085-fbf0-41d0-aa19-718157f06f64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_16f5c716-4795-4fe4-8fc8-cf24f424e864_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Issued In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_9d4de999-47e4-40d4-87de-83c255a4724a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_35f3caf8-2cc7-428e-9fb5-efbf05a1c2e7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_002f3bc5-aeca-404b-a016-2b3bad36d9ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_e2b8f66d-6a48-437f-a73e-2e57b054cef0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_f1b3501b-49dc-4152-9efc-eebcad3fa419_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_afc1c81d-2463-4bf7-931b-dbc7390b5777_terseLabel_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</link:label>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_label_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member]</link:label>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_documentation_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:href="angn-20250331.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:to="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f4afaf29-56a5-47f9-9f4c-13d77946bc69_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8bf63afd-a77d-4cd6-8c59-d3f091d3b7ea_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2ccdd569-2160-4328-9540-2c72a2c29221_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSecuredLinesOfCredit_f8466e42-0118-431a-9369-75b357b07cb3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Secured Lines of Credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSecuredLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Secured Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_RegistrationStatementMember_5b5c1f4d-92b7-41ed-b696-1307b09ecbc4_terseLabel_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registration Statement</link:label>
    <link:label id="lab_angn_RegistrationStatementMember_label_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Registration Statement [Member]</link:label>
    <link:label id="lab_angn_RegistrationStatementMember_documentation_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember" xlink:href="angn-20250331.xsd#angn_RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_RegistrationStatementMember" xlink:to="lab_angn_RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2c9aa076-6427-441b-9916-77ac29a0335b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c5dd3af5-1ff6-4d20-8cd9-39a74284a58d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f507fa02-4093-49b9-bc41-27d5bf1fd924_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a9dbced6-1426-4a8f-a62f-c9be3ac05255_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PreFundedWarrantMember_9137537e-2464-426a-a329-990a11a30017_terseLabel_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:label id="lab_angn_PreFundedWarrantMember_label_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant [Member]</link:label>
    <link:label id="lab_angn_PreFundedWarrantMember_documentation_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PreFundedWarrantMember" xlink:to="lab_angn_PreFundedWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_f4a8c1f7-c87d-47bd-98b7-78caf8329c20_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_0c08cd68-5643-45d7-bc15-9e48e0096af1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value measurements, recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_815f739f-6abc-45e6-aa84-e4f7e9c09513_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_150f5b2f-7cae-4ae4-9371-b14711a625c7_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Credit</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementCredit" xlink:to="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_7d36a4ca-7431-4d19-96b3-d6d46eda1b9a_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_977428e7-b062-4f4d-9890-7b3fc4c8e2f0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a70b8477-add9-4c62-8b6b-b12b4894d740_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_5cf2921a-39c0-45c1-ae79-1f6dc1b4119e_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b497e9cc-1ee9-481e-a0db-d7ee7e59d1ba_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_cf889f14-4dd9-469e-8c81-f3b22610fddf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f4507c94-c29c-470f-922f-eb2d1a7c486d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_550e0ae1-027c-41aa-9f6c-e391b647a958_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_91f83f02-8045-4af9-bef2-c06064c1c879_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5096e042-95c3-4c0a-a41d-0142981a8841_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_3bc21a9b-b982-4882-bf9a-abcc7d9bb613_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d76c98e1-0b0c-4d7a-bb26-d3e8cf0fd3d0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ef554b6a-6d04-4522-8d2a-552c01fe3ef4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_44beb598-5ede-44ef-a54f-744f73a74557_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_f6a67e8a-1fc4-495c-a8b7-b194cb489345_terseLabel_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_label_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky [Member]</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_documentation_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember" xlink:href="angn-20250331.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_YekaterinaChudnovskyMember" xlink:to="lab_angn_YekaterinaChudnovskyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_f5fa4078-cdd6-4e0a-b76a-2b417078a8f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (expense) income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_8bc116d5-613d-4323-a2c3-40b64f13fc2d_terseLabel_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on issuance of pre-funded warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_2931e633-51d2-4c8a-8449-66c7419f2919_negatedTerseLabel_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on issuance of warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_label_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Issuance Of Warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_documentation_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Issuance Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants" xlink:href="angn-20250331.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_GainLossOnIssuanceOfWarrants" xlink:to="lab_angn_GainLossOnIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7c6df8e5-f4af-443b-8a8e-029c4b02d6e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_c1849002-ed7e-400c-9ccc-75979365c108_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_d29afbc1-c1cb-4904-aae3-4a89185bd1d3_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_816b99e9-81de-46be-8f01-770f18a43623_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c01235da-4977-41e6-b0eb-8ad032c522d9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_06b98fe1-0d9b-4d20-ae4a-d4973e088ee1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b6483205-7a3d-45d2-9bb7-29867dbad384_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_252a070b-7ae9-4b0a-9729-e9dbf3dd10ce_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reimbursement from grant funds</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Reimbursement from Grant Funds</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Reimbursement from Grant Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:to="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_2d54b7aa-f1c7-435a-8e2a-169562445cda_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_4dcac32e-4ffd-4d0c-8262-5bbd960aa78f_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share of shares issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_778f19df-b8bb-4832-9cbd-5ec4627c89d9_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fd7b0a30-05e0-4fbe-adac-9c83a4603b16_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less present value discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_bdeabdbf-1a76-4832-b040-7854b17a92a7_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_d372eb85-f3e4-4ad7-a98e-3528d4ef2349_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-funded warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_ad561819-d6f5-460e-b11c-92f6f161f159_periodStartLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_19f09f1b-66cd-4569-9886-1a1b1a763f17_periodEndLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57da1543-2f78-4d7b-90d8-2340d14ee6cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_608addb5-e60b-4ba8-a007-d7747aed84dc_terseLabel_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Quantitative Information Regarding Operating Leases</link:label>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases [Table Text Block]</link:label>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_documentation_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:href="angn-20250331.xsd#angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:to="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_45694c3c-0734-49fe-9e22-ddbd8d449792_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_7161c189-7e81-420a-9a39-ea2869286a23_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_88d06dfa-fe03-4406-abb9-0a700e566c78_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_a150236e-ebcf-48db-a5c9-a6147e77d983_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_1e1c6d04-9db4-4ec7-a372-627b815eb357_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_d89bc84c-81dd-4389-bd64-dd871628a627_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_646d893d-c611-4b9b-bff0-94063ef78f06_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_3eab501a-e671-49b3-b338-37545eb50912_terseLabel_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional fees and other general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_bfb7be09-d9c9-4154-98a8-5adea8696ab8_terseLabel_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee related research and development expenses</link:label>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_label_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Related Reasearch and Development [Member]</link:label>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Related Reasearch and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:href="angn-20250331.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:to="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_54e63ec2-1904-4ccc-9056-18a804650599_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1144390d-a87f-424e-8da2-f708b3cc5819_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per common share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_92e9af11-1b07-4bb2-a018-fd9311591259_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d610fe26-e352-46f1-8453-2782798976b3_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_66b1b844-ac51-461f-9ede-f375d7b085aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets, operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_InterestExpenseNoncash_7df88b4e-7cc4-44e5-a4cc-b6db15c56fd6_terseLabel_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_angn_InterestExpenseNoncash_label_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Noncash</link:label>
    <link:label id="lab_angn_InterestExpenseNoncash_documentation_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash" xlink:href="angn-20250331.xsd#angn_InterestExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_InterestExpenseNoncash" xlink:to="lab_angn_InterestExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c774e60a-c7ef-4585-81fd-6c0af1b37ff2_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_badae97f-8fa4-4f8d-89f0-be4baabaafd8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred research obligation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_fb765580-4b82-46e3-8666-7b502ec5ead2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Outstanding Warrants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_a71d7054-9169-413d-9705-97ec07d844a1_terseLabel_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_label_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding [Text Block]</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_documentation_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingTextBlock" xlink:href="angn-20250331.xsd#angn_WarrantsAndRightsOutstandingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsAndRightsOutstandingTextBlock" xlink:to="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_3fa5182c-ec6d-4a43-a9c1-9a54ddc08656_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_c68e8a1b-6c66-411b-b365-97f77e44fb47_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_97cd0c34-0a9b-4271-b07c-430ac06dfa15_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on fair value of warrants</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7666ec4f-49e0-42f9-be4c-40ad3670473e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange transaction gain</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0a4991fd-3ef7-4bce-99c1-0215cca05408_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_5860bc52-5e45-440f-866d-40fa8837c1e8_terseLabel_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January Common Warrants</link:label>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember" xlink:href="angn-20250331.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JanuaryCommonWarrantsMember" xlink:to="lab_angn_JanuaryCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0df081ed-8cbc-41a9-a030-c4ad46a6c17f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d49c179b-4e0c-43ad-903f-db0d9439662d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_58183ac4-f753-45d0-bc58-27c18b36f70e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of equipment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_db0ed8a1-04a0-4acf-8265-477c5cc87e4f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d62f7988-0e9b-4b2f-a443-c0e47e591a07_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_d8d91211-c73d-40b2-a6ad-d22a03ce23d5_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_2b876b15-0ce8-42c1-af10-7c9fd8057381_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Exercised In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Exercised In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightExercisedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc3d3c51-9b9c-4b26-88fa-738f4feb268e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_68df3704-4d25-443d-abd6-2fc5bda8473d_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_The2022PlanMember_82aa2efb-3550-4daa-a134-48c908e712c2_terseLabel_en-US" xlink:label="lab_angn_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 2022 Plan</link:label>
    <link:label id="lab_angn_The2022PlanMember_label_en-US" xlink:label="lab_angn_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2022 Plan [Member]</link:label>
    <link:label id="lab_angn_The2022PlanMember_documentation_en-US" xlink:label="lab_angn_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2022 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2022PlanMember" xlink:href="angn-20250331.xsd#angn_The2022PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_The2022PlanMember" xlink:to="lab_angn_The2022PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_851a0633-6195-4a93-bc70-f3024a4e719b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_444ba15d-733b-4bdc-987a-dc4930a21355_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_0cc8e204-8627-41ad-81f7-813c5a2377fd_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a5e9083e-a0d4-4b36-b245-8cdc553f2c68_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_ba37a67e-86d5-4fe3-bae4-f2f7c2d7d4f6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9532bd77-5a6e-4f9b-b7b3-8dd97c26a1a3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_adb7044b-b49b-40ce-a214-d2849ec97d3f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_397634c6-563b-4bbe-bfb1-9b758d81db08_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_d6c72719-27dc-4114-bcf8-f82db7274a36_terseLabel_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note</link:label>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_label_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note [Member]</link:label>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_documentation_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:href="angn-20250331.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:to="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_35d3968d-a50a-4faf-8839-586e640bfa84_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Rollforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_979a5281-7ab9-430a-9d97-a6446b7d3fc3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of common warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_b4742718-4b42-48f9-ba8d-3d464e75f3cc_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_f6705469-15a1-4107-89d3-4f245e3aef42_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d93b72c7-40c5-4843-bab7-4b55fbf65795_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon the exercise of common warrants</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b86a00eb-2364-4944-941c-9a67212422f8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_4162ff68-4c42-4940-86cd-8d1fdcfda8cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (unvested) (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_15a94141-3cd4-4b9b-8d17-abb7b189c123_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term in years (for employees)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_9fee406f-4c3c-4891-bd2a-ab425a5c3995_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_bff454ec-0e72-4744-b2a9-664afeb164df_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_256661d6-1a4d-447a-886c-1c6d32a201f0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2d85898c-0738-4f39-9938-3fd1fd0a19dc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_459ea685-0c5c-400e-bdc1-0381310146f5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_1e36b1fa-c1d4-4cf9-a2d5-5a4e13bd5db8_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantLiability_fe05da77-6849-413b-bca7-fdef93174618_terseLabel_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_angn_WarrantLiability_label_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_angn_WarrantLiability_documentation_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability" xlink:href="angn-20250331.xsd#angn_WarrantLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantLiability" xlink:to="lab_angn_WarrantLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_dc8ed257-0de9-4b04-8497-da150317ecc3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_Inducement2024PlanMember_80e74772-73b7-4b4d-bd76-e14c301fe662_terseLabel_en-US" xlink:label="lab_angn_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan</link:label>
    <link:label id="lab_angn_Inducement2024PlanMember_label_en-US" xlink:label="lab_angn_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan [Member]</link:label>
    <link:label id="lab_angn_Inducement2024PlanMember_documentation_en-US" xlink:label="lab_angn_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_Inducement2024PlanMember" xlink:href="angn-20250331.xsd#angn_Inducement2024PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_Inducement2024PlanMember" xlink:to="lab_angn_Inducement2024PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2a7625c-dc60-4a75-9feb-62d2d8549f24_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPublicOfferingMember_900025a0-b6df-49fb-a856-da86fa55143f_terseLabel_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Public Offering</link:label>
    <link:label id="lab_angn_JulyPublicOfferingMember_label_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Public Offering [Member]</link:label>
    <link:label id="lab_angn_JulyPublicOfferingMember_documentation_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPublicOfferingMember" xlink:to="lab_angn_JulyPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_43a49861-0efa-4719-bdfe-d06b8b307f62_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3edd1a1c-f0e1-40cb-97bb-e2fa9708c21e_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, end of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_74417200-8113-42ab-9dc7-7c0a3dd21e1f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_68e92dd6-2015-4da1-b2ba-cd7fb2c499f7_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantLiabilityMember_ee5d9a15-7c53-4317-8eae-9d668e784ab5_terseLabel_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_angn_WarrantLiabilityMember_label_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability [Member]</link:label>
    <link:label id="lab_angn_WarrantLiabilityMember_documentation_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember" xlink:href="angn-20250331.xsd#angn_WarrantLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantLiabilityMember" xlink:to="lab_angn_WarrantLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_7005d35a-173b-4e4d-b8d4-cf397820b012_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ae68fafb-152d-45c3-9e3c-e0c68ef539db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_37a9e263-0415-4648-9d5b-c04703ec138b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80362e85-ddd0-4880-bf3f-dd7239bc8627_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5908c5fc-01bb-45bc-8674-2368a96bf6c7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_21654590-207f-41a6-8b3a-e9a9af4c252b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ee4f9e37-0fb2-4336-bc3f-f41a033f5ec6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_05652bb3-4194-439b-9c35-6d30f5254ec6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_ff90f448-586f-44f3-87c2-7ceb8f1f2873_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Black-Scholes Option-Pricing Model Following Assumptions</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0827a64b-9bf6-48a4-bfbb-8d4069289d2c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_A2024RegistrationStatementMember_fe92e417-96f1-4f0d-91b7-1028226e3492_terseLabel_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Registration Statement</link:label>
    <link:label id="lab_angn_A2024RegistrationStatementMember_label_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Registration Statement [Member]</link:label>
    <link:label id="lab_angn_A2024RegistrationStatementMember_documentation_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember" xlink:href="angn-20250331.xsd#angn_A2024RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_A2024RegistrationStatementMember" xlink:to="lab_angn_A2024RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_763a05bb-4275-4b1c-a260-54d888b2f58e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_792f96fb-6581-4251-b154-ac47de437e46_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ReportableSegmentMember_8726f4cb-d01e-4997-bc97-2ddc7c810496_terseLabel_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_angn_ReportableSegmentMember_label_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_angn_ReportableSegmentMember_documentation_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember" xlink:href="angn-20250331.xsd#angn_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ReportableSegmentMember" xlink:to="lab_angn_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_1705dee0-f457-4a5d-b8df-6f7bbb951bce_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureTable_64bec474-e84a-4ddb-8ef1-6d5bcc42c933_terseLabel_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureTable_label_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureTable_documentation_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureTable" xlink:href="angn-20250331.xsd#angn_CommitmentsAndContingenciesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable" xlink:to="lab_angn_CommitmentsAndContingenciesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_7e0cc254-59a5-4deb-bdb4-5907702c6676_terseLabel_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chemistry, manufacturing and controls expenses</link:label>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_label_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Translational Medicine and CMC [Member]</link:label>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_documentation_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Translational Medicine and CMC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember" xlink:href="angn-20250331.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_TranslationalMedicineAndCMCMember" xlink:to="lab_angn_TranslationalMedicineAndCMCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_e3a7cc8a-f302-4aa3-8dd6-5de6bcf3b055_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_52ab1529-6df7-4d22-a922-e7191320e80d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fb065e6-8106-4426-a41f-b057739295f4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_abec29e6-68ee-4a96-805e-eaed168938cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other long-term prepaid assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_59dcf02a-7ce7-46c1-868e-7f85aeb36eda_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 14,455 shares outstanding</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_6b03f159-4b9b-47c5-a885-1ac452e488ee_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Life (years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Life [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_a1409f50-6bc1-4d49-8a85-c91c5944999a_terseLabel_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March Subscription Agreement</link:label>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_label_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">March Subscription Agreement [Member]</link:label>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_documentation_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">March Subscription Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_MarchSubscriptionAgreementMember" xlink:to="lab_angn_MarchSubscriptionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_51d47077-fd15-4d5e-8c38-e72afafd9efa_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f8221f44-69e9-4ad0-91ff-711d4959f907_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_0920db83-0f7c-4e95-ac70-5f92304b02c2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility (annual)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9663cc28-c059-4040-8d54-eab57d09e1e1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9ef60d86-9c22-4c42-bd0c-4922082490ce_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_8b1cde86-f89f-4980-8419-336f2237570f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c925f59d-b8de-4fbc-83f2-bb53fbe993a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_103b9f63-0cf5-446a-8dea-c1f5ced3f78f_terseLabel_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, aggregate initial offering price</link:label>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_label_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Initial Offering Price</link:label>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_documentation_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Initial Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:href="angn-20250331.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:to="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2a303ffd-6d2e-4219-8df7-328488323b80_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option Activity, Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2229329b-721a-4404-b226-7b2b8d681fcb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_The2021PlanMember_80e50270-8570-4cbb-bfcd-4f22caa43aef_terseLabel_en-US" xlink:label="lab_angn_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 2021 Plan</link:label>
    <link:label id="lab_angn_The2021PlanMember_label_en-US" xlink:label="lab_angn_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2021 Plan [Member]</link:label>
    <link:label id="lab_angn_The2021PlanMember_documentation_en-US" xlink:label="lab_angn_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2021 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2021PlanMember" xlink:href="angn-20250331.xsd#angn_The2021PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_The2021PlanMember" xlink:to="lab_angn_The2021PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ed0b94f5-0d54-4712-9e41-046f36778c55_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_54456b67-62d0-411d-8866-2b0d46fecec1_terseLabel_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid research and development contract services</link:label>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expenses</link:label>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses" xlink:href="angn-20250331.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PrepaidResearchAndDevelopmentExpenses" xlink:to="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_39e281fe-e7ef-4161-a1d9-2bb8319d1208_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_526e8f46-3865-461a-81c2-e102c40694b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d192c7e1-7589-4815-b5e3-f45e5a7ac0a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_60d637be-27af-4c55-a289-16e14830451b_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_789ab015-36f4-4d2a-b951-0c1fcf01155a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_9004a195-c3c8-4b6b-8020-79d75a5109d4_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Aug. 2024</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_FairValueOfCommonStockWarrants_729f9540-aab1-4996-b0c6-fd28fe045e92_terseLabel_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants upon settlement</link:label>
    <link:label id="lab_angn_FairValueOfCommonStockWarrants_label_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants</link:label>
    <link:label id="lab_angn_FairValueOfCommonStockWarrants_documentation_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrants" xlink:href="angn-20250331.xsd#angn_FairValueOfCommonStockWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_FairValueOfCommonStockWarrants" xlink:to="lab_angn_FairValueOfCommonStockWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_23e934ec-69c3-49e6-a89a-330c36589e44_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_b6b8aa39-1576-433c-84da-a9a5f97bd32c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_36ab8ef1-1dd7-4b3d-bed7-0ab036d988b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock split, conversion ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_93614af2-12fc-4634-8f12-e310d000c30b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_19c00c13-c29f-43ae-846a-9632e808cd90_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AngionCommonStockMember_e1f5da2a-3493-4fd7-8870-b77cfa8c15d9_terseLabel_en-US" xlink:label="lab_angn_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Angion Common Stock</link:label>
    <link:label id="lab_angn_AngionCommonStockMember_label_en-US" xlink:label="lab_angn_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Angion Common Stock [Member]</link:label>
    <link:label id="lab_angn_AngionCommonStockMember_documentation_en-US" xlink:label="lab_angn_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Angion Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionCommonStockMember" xlink:href="angn-20250331.xsd#angn_AngionCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AngionCommonStockMember" xlink:to="lab_angn_AngionCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_67e4b96d-95f6-4cf0-9e7e-584d8b5c17e8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_b955673d-1017-43fb-9c32-af6933b5149c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_772db9b9-85ff-4276-9add-4f0b52198fba_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_e9c0e6c9-77b7-4fec-8210-4bf7ccc6953d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a3493d5d-18e3-4865-a3f6-0e7156e8fb42_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_1ce75a18-5a3f-4157-b6d3-7cff67858f29_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_97d0ca6f-5a31-456c-b659-3431b503b190_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_3d9b7a99-dc70-41c1-aaa0-e091f39d19c4_terseLabel_en-US" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_label_en-US" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_22765ac3-1b54-4c1b-ac6c-a7e70bf6fed3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_7ceb4e04-5727-4cdc-82f7-9b0a7ed6bd28_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_cd0616e1-ead9-4246-a5aa-51da96885379_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_408dea6c-adf8-488c-b3bc-b430dcd37e5b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Common Stock and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecoveryOfDirectCosts_33401973-c4ac-45a9-a570-5052e62d2909_terseLabel_en-US" xlink:label="lab_us-gaap_RecoveryOfDirectCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract and grant reimbursements</link:label>
    <link:label id="lab_us-gaap_RecoveryOfDirectCosts_label_en-US" xlink:label="lab_us-gaap_RecoveryOfDirectCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Direct Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecoveryOfDirectCosts" xlink:to="lab_us-gaap_RecoveryOfDirectCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_c78e1557-321d-4d68-b9a2-02e084dd0a93_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c42edf5e-9e64-439b-8209-f5604027998f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d6798bc4-11c4-497b-85ae-826397ac377d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter_3cda04c3-82b5-4c5a-b8b9-2aacca2df352_terseLabel_en-US" xlink:label="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future minimum annual maintenance payments</link:label>
    <link:label id="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter_label_en-US" xlink:label="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Future Minimum, Annual Maintenance Payments, Due Thereafter</link:label>
    <link:label id="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter_documentation_en-US" xlink:label="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Future Minimum, Annual Maintenance Payments, Due Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" xlink:href="angn-20250331.xsd#angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" xlink:to="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_faa6e168-26ba-4a75-9bef-07face31e37a_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_513450ed-eec9-4710-b600-d8631203350d_terseLabel_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:to="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6d793bb7-8a77-4568-85dd-e6ac6ba928fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_38c26b1c-6a0d-467a-8150-462c5e19c9f0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_c020bf19-72f6-4583-89ea-9e848739406f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_20efc4d9-7442-4b3d-b70d-b699348cbe79_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_facb8565-495d-4835-a53a-bb3707624694_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_1244d24f-d1b1-42bf-a2e3-8d8dc9f308f2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_96500d9d-b524-404d-ab88-2515f1bb722d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_4e0aa5ba-616d-4447-bf73-1c59b261f15d_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_a3c020f7-0d88-4cd9-83fe-14672e70e770_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_2190e14c-349e-4d80-822d-22f7a42f5625_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_2b2fb9d6-d3c7-4f45-b9f3-98e848a19ec2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_caeeb443-996e-49df-871f-88e292a2ed76_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_145bc8fa-e45b-4d90-a4a8-702a7f98917d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_cb72d568-2026-45f9-a4b5-62b3991b0c37_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_e21a6da5-b54c-4295-b523-7f8e00461958_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_72322fdf-9acb-4bad-b902-e2a337be44f4_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued (in dollars per share)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3bb19816-ca66-422e-8dfb-c8e4aebae8c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a1bf65c0-86df-41e7-b87f-103d21dfd57a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_23a5fb4c-e404-4c55-bf03-71d55936a469_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_1f38b5df-251f-4445-bd73-2728a66b3f7d_terseLabel_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liability</link:label>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_label_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants, Fair Value Disclosure</link:label>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_documentation_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure" xlink:href="angn-20250331.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsFairValueDisclosure" xlink:to="lab_angn_WarrantsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_e903387e-b472-4e6d-856a-a4f679d7349b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_73b26f26-a207-4f0a-b556-921de8e08f53_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_bfc9430f-7039-4e21-84f1-bd55ea754ebf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_76e3c338-decb-41eb-b661-3bd964510f37_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperatingAndNonoperating_a3ffd409-7527-441c-8fb4-2f00eb8ede0c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperatingAndNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Operating and Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:to="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_59c5e50f-1812-4ff0-8f6f-72d8bb77d8a5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_6e0f11f9-ad7f-41e2-bd5b-6a7b8b0b8ba2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_8bbce671-1f3e-4ffe-a872-2a77c78f5e74_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_4452ce46-2257-4662-9612-850a43ec36a3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_1fc594fa-1eb1-43c9-8f31-0fa502169cbc_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_c16c4a1d-2c17-440e-a07b-17da7315f6d8_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments_7900e6ca-3b5e-4ae7-b93e-6a5f71b2773f_terseLabel_en-US" xlink:label="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future minimum payments</link:label>
    <link:label id="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments_label_en-US" xlink:label="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Future Minimum, Annual Maintenance Payments</link:label>
    <link:label id="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments_documentation_en-US" xlink:label="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Future Minimum, Annual Maintenance Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments" xlink:href="angn-20250331.xsd#angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments" xlink:to="lab_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e66fe4a7-a6bd-4ad4-9eff-2f3e89bf68c7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate&#8212;operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a09f8f3e-d6bc-4f14-a590-108e00123853_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_56bfe162-9a8d-4515-a264-dc5a3288593a_terseLabel_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, beneficial ownership limitation, percentage</link:label>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_label_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Beneficial Ownership Limitation, Percentage</link:label>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_documentation_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Beneficial Ownership Limitation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:href="angn-20250331.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:to="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_96dc83e0-c17c-4176-bbea-0a9dcf30ecfb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_df776983-398f-48ac-a461-db50db971a62_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0a9acf4d-5921-44f2-b2e3-932d7c07b275_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7270c511-abfe-47c3-a585-e2c25bb79b44_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_556f31dd-79d7-4c06-b377-ef46d99eeed6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on disposal of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_769f9486-fbbc-4e31-86e8-184917b407cf_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c6b5013e-0dc6-467f-b6ba-de42bd89a5a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_570c8aa6-8f52-4230-ac64-bb8ea6b0433f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares sold in offering (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_24a6961d-aed0-457f-90fc-93c098432de3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_97ca0423-32d6-466c-a3b2-abeb1a31e723_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_89142f6b-4874-414e-b483-c20e91fd7e04_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_ee831c13-60cb-4858-8ae9-b2c9f8811bb5_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c11f0448-fa6b-49f7-9cc7-c3942eb64309_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_235b5a42-0a46-42dc-a358-6158ebbcf3e6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c78eb1e2-9bfa-44a7-b917-ae2581665227_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_98956abb-04ac-4687-bfa6-79a2a8b7971c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_418781fd-6e43-40cb-82d2-7746881678ce_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a9345f63-03dc-4f5a-b61f-4a6e5da85806_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.01 par value per share; 300,000,000 shares authorized; 15,983,191 shares and 11,043,837 shares issued at March&#160;31, 2025 and December&#160;31, 2024, respectively; 15,968,736 and 11,029,382 outstanding as of March&#160;31, 2025 and December&#160;31, 2024, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_0a97f228-0b03-454c-8dd2-6d8a1c1621be_terseLabel_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January Public Offering</link:label>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_label_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Public Offering [Member]</link:label>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_documentation_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember" xlink:href="angn-20250331.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JanuaryPublicOfferingMember" xlink:to="lab_angn_JanuaryPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClinicalTrailMember_ad9f5640-3c9d-4165-b658-1d092099615c_terseLabel_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical trial expenses</link:label>
    <link:label id="lab_angn_ClinicalTrailMember_label_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Trail [Member]</link:label>
    <link:label id="lab_angn_ClinicalTrailMember_documentation_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Trail</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember" xlink:href="angn-20250331.xsd#angn_ClinicalTrailMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClinicalTrailMember" xlink:to="lab_angn_ClinicalTrailMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_09a5a848-a49d-4316-a93e-b665ef282322_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_aa2ddb02-9c41-44b8-87b2-3d0a34edc4bd_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_LicenseExpense_f02b83ef-2b72-49a9-aa10-70a43e8a07fc_terseLabel_en-US" xlink:label="lab_angn_LicenseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License expense</link:label>
    <link:label id="lab_angn_LicenseExpense_label_en-US" xlink:label="lab_angn_LicenseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Expense</link:label>
    <link:label id="lab_angn_LicenseExpense_documentation_en-US" xlink:label="lab_angn_LicenseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LicenseExpense" xlink:href="angn-20250331.xsd#angn_LicenseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_LicenseExpense" xlink:to="lab_angn_LicenseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e8aff8ed-eb18-4036-99d4-e0487637f809_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7a915400-4c76-4ffc-9407-ed56c4d28e8f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_78d25fee-fd08-4987-92f9-a256fe0be0b8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term prepaid assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense Other, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ebb3bfce-959b-4f5c-9d77-f9eefb6df39c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_ced0db7f-9dbf-4eb0-b5cb-c8999dd0592a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_a9849bf8-bb1c-4a12-8f60-2a4f801d4d41_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible note - related party</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8f8e4225-2308-417b-890b-aca74fe83c1d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per common share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2ddcac29-484a-4ade-ad95-fc8e9a64dc39_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_91f7b390-4334-415d-a084-461236bd3ba1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_4ee65518-ad2a-4cfb-bdae-3d070ca08280_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_120dc4f5-1bb9-4f42-882b-b81d8605cd38_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_d852d0af-727e-4fcf-b982-51558b79424a_terseLabel_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued research and development</link:label>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_label_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_documentation_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent" xlink:href="angn-20250331.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedResearchAndDevelopmentCurrent" xlink:to="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_c08bde6f-2a0f-4b59-8e7f-4a712a57042b_terseLabel_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_label_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Interest Premium For Convertible Preferred Stock</link:label>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_documentation_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Interest Premium For Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:href="angn-20250331.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:to="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_b0847074-2b5c-4b9b-b497-5d8c62005b43_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_352005b2-8d3b-4852-a538-4675ac146ea4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_868a9585-cc83-4662-9c42-b5e86267ec2e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation related to unvested stock option awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_454177f8-e89b-4b39-8155-d04fd2c8d873_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_2d5bd543-ab83-4c9f-8c47-1e4a90da7e50_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_7ae8e09f-4073-48e5-b836-2563757731b7_terseLabel_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, payment per year</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_label_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Annual Rent Expense</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_documentation_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Annual Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:href="angn-20250331.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:to="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_21b92a7d-fe76-40c6-986b-3d51136f8d73_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ef222a23-092c-4b99-b9f5-805bcabb1f10_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies&#8212;Note 10</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_OtherMember_26ab19ec-ea21-41de-8505-33c33855a50a_terseLabel_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other research and development expenses</link:label>
    <link:label id="lab_angn_OtherMember_label_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_angn_OtherMember_documentation_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember" xlink:href="angn-20250331.xsd#angn_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_OtherMember" xlink:to="lab_angn_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_724aebb2-4d34-41f8-8142-9da3ca6eb9d2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_6250e771-a62e-45f9-bcbd-c866b0c2a941_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8eca79a8-5d32-41a0-926a-d044c866b342_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c6cf14a8-8b54-4f2d-9d3f-007b2ec9d18b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price of equity-classified broker warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_914dbd4a-e018-42af-9b48-997709121a07_periodStartLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8000d58a-af79-4040-acc9-5432be0e76db_periodEndLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b8162e1d-9b9f-40e3-99c9-debc8311c9d4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b03a2355-16d9-4541-9360-3796502b1fcb_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5d6127f5-740c-4893-8f77-a52d55e1d376_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_6c1c8747-7ab7-48c4-8b5b-ed8a4403deb7_terseLabel_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Convertible Debt</link:label>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_label_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Debt [Member]</link:label>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_documentation_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember" xlink:href="angn-20250331.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ConversionOfConvertibleDebtMember" xlink:to="lab_angn_ConversionOfConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0d7a8d2b-7fda-43fa-ac65-e11b809794f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b1d9c4e9-d471-4c99-b5b7-b27ab185f130_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d0604256-8d09-400d-85bd-82c3457a1ac0_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_6453bbf8-ba45-4ce6-a548-c387552dff66_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_1fe952a4-40da-464e-a1a4-ddba947d1632_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b0874055-d989-4a80-aaa1-aafbd9f9de42_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_58240678-84f3-4237-a0f3-450e2b0aa61f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable into common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_da873f14-a643-462e-bf54-2a08fceadafe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_9fe31b24-8a3c-4345-b356-4ae99f922b36_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_83033581-f912-450a-82a4-65a8fbb1a77d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense related to accretion of discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_90511756-4368-4466-99b8-6cdb887d16de_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of office space (in sqft)</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_cb719cf8-9089-4365-ad5c-fd1282943c63_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_fe539c98-48af-4a65-b25f-6328150c5064_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_6cc5fc22-f878-47c0-96b4-2c45c93010c3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2fd9ca12-7c51-462d-b1af-864cdfa47c0f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_de59297d-8863-49f6-8c69-6671a083993a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_abe0bd6b-a638-4976-95b0-dd3416737445_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_612e98e7-6e2c-4438-b83f-53b2e99c6aa8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of foreign currency on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_0a3d3885-d54b-4dab-b816-1d1f3cc1ac4c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d443b588-8979-4410-baaa-53752f5be447_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025 (remaining nine months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7ab8f2fa-1c6c-45ca-adfe-22156d0ab750_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable, total intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f4639038-259e-4fc2-a862-23d322236521_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term&#8212;operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_198b63ea-9757-4aa2-9aee-33ef27135d5b_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022 [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7697e393-f917-43bd-885d-8fe3cb5cef49_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_4d5632dd-99a8-4b4a-9dff-59ce51f1d46e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_001df160-857e-494d-9928-40e7fb2ae720_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_2a04e9ea-6815-46e3-b60b-5d8ea3c4c6d3_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9b19cfb-9e51-47fa-8456-a5f98ddc4281_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_975cd514-66c8-47d4-86ca-c491027e4dfd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c95b1442-eb0c-43d1-985d-44d7a66fec10_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fb48dd85-9ca7-4e1e-bc41-faba1dc882ea_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_97d03c79-ed64-43bc-a5e5-cf241c157e63_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_6dc7356a-208a-4017-84a4-1fcb3844d29f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_49217fbd-feaf-4f19-b0a8-195e10afdaf2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_bf3774dc-251a-4d51-9585-3a964c41ebe7_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f071d3af-6f4c-4048-a09e-ac92e9388196_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_9f3776f1-2282-456a-a8a6-0500aa5320ab_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_BostonMassachusettsMember_d3232bcb-ca98-4a0e-8335-d2a31004fcb8_terseLabel_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts</link:label>
    <link:label id="lab_angn_BostonMassachusettsMember_label_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts [Member]</link:label>
    <link:label id="lab_angn_BostonMassachusettsMember_documentation_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember" xlink:href="angn-20250331.xsd#angn_BostonMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_BostonMassachusettsMember" xlink:to="lab_angn_BostonMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_927e5899-48e2-4424-aa09-2b6b2c19203a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares and pre-funded warrants outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9c6935aa-30b5-4986-8048-2e09d5ba27fb_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_f8920303-caa6-40a9-a2df-1aa2c7262493_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024 [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_2446a4db-938f-4ba3-8e32-b5764b04a723_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested common stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea53a63-779e-4105-8f07-36e681be28f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_c377cf77-a26c-40d8-a1e5-8eba369a36e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9ee61d09-ad7c-4ea2-8300-af727054e666_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (unvested) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f5ebc94c-06ff-4c91-9cc4-57418ab6726e_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_2c619b6f-0376-4574-a962-7ce2c7279273_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_2bc67463-8405-499c-9507-b7a372648d8a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>angn-20250331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b5a770-ce93-4e1a-8551-4667fc149643,g:e550b526-85cb-4940-ae39-7686e99f6d4a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.angn.com/role/Cover" xlink:type="simple" xlink:href="angn-20250331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d5350c8c-5cce-4cae-8f05-084ea66c3deb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_DocumentType_d5350c8c-5cce-4cae-8f05-084ea66c3deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_9f589f31-faf7-4b16-b234-bf124f40e3f6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_DocumentQuarterlyReport_9f589f31-faf7-4b16-b234-bf124f40e3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_28a71127-46f4-4608-9644-206cf99741f6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_DocumentPeriodEndDate_28a71127-46f4-4608-9644-206cf99741f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_092a89e7-6344-49bd-aeb8-091abf8cbbb8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_DocumentTransitionReport_092a89e7-6344-49bd-aeb8-091abf8cbbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_133079e6-aef4-4a51-9052-c9dec324e7de" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityFileNumber_133079e6-aef4-4a51-9052-c9dec324e7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_118ff594-6c8e-4167-b8c5-e8bba974ff3c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityRegistrantName_118ff594-6c8e-4167-b8c5-e8bba974ff3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1886a8f0-cf1b-4820-8449-2867829a1c7d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1886a8f0-cf1b-4820-8449-2867829a1c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_5fff007c-4be7-4ea4-bc25-1b9a818a79aa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityTaxIdentificationNumber_5fff007c-4be7-4ea4-bc25-1b9a818a79aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dd13004c-bae0-41ee-89bf-be0b9b28608b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityAddressAddressLine1_dd13004c-bae0-41ee-89bf-be0b9b28608b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ef0dcdc1-f8d5-4897-9b85-106c25ec7428" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityAddressCityOrTown_ef0dcdc1-f8d5-4897-9b85-106c25ec7428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_16452c87-60ca-44c3-914e-cde2f2826282" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityAddressStateOrProvince_16452c87-60ca-44c3-914e-cde2f2826282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_506ab583-277c-417a-a0ec-b4ad17e04b97" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityAddressPostalZipCode_506ab583-277c-417a-a0ec-b4ad17e04b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1699318d-03d2-47b3-82f7-e008d5fd93aa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_CityAreaCode_1699318d-03d2-47b3-82f7-e008d5fd93aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4b0727ab-f38b-4e06-af10-710c4de5f075" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_LocalPhoneNumber_4b0727ab-f38b-4e06-af10-710c4de5f075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_da9bce08-f8ee-43ff-ba25-0d0f3f8b56f3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_Security12bTitle_da9bce08-f8ee-43ff-ba25-0d0f3f8b56f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_727c7b65-4442-46b1-a7d1-1d4cbf1e27e4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_TradingSymbol_727c7b65-4442-46b1-a7d1-1d4cbf1e27e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f505693e-37fe-4d9a-97da-74785d0c41e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_SecurityExchangeName_f505693e-37fe-4d9a-97da-74785d0c41e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_d9d6e327-0dd8-4e77-a6cb-b8fa546c9089" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityCurrentReportingStatus_d9d6e327-0dd8-4e77-a6cb-b8fa546c9089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a55b1de0-a449-4749-9358-0e1aef35af07" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityInteractiveDataCurrent_a55b1de0-a449-4749-9358-0e1aef35af07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_dfbe7fa2-4920-451f-acb3-3f28644f460e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityFilerCategory_dfbe7fa2-4920-451f-acb3-3f28644f460e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_ff87bf74-5607-4e1a-9983-3ec6150ae6e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntitySmallBusiness_ff87bf74-5607-4e1a-9983-3ec6150ae6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bc1c1812-2203-4c1a-af91-645327f2fbb1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityEmergingGrowthCompany_bc1c1812-2203-4c1a-af91-645327f2fbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_d91f7eb1-b65e-4650-a953-e0ac7713bdbb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityExTransitionPeriod_d91f7eb1-b65e-4650-a953-e0ac7713bdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f88f14fc-c7da-4e36-bb41-ba8fd7878a23" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityShellCompany_f88f14fc-c7da-4e36-bb41-ba8fd7878a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_40dd12f1-2a27-4ae0-85bb-c8e9aca8fde7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_40dd12f1-2a27-4ae0-85bb-c8e9aca8fde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_efb0d4aa-8d2b-4488-85f0-fc9bfc09e17c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_DocumentFiscalYearFocus_efb0d4aa-8d2b-4488-85f0-fc9bfc09e17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_90baa0bc-3ae8-4fa7-9fd2-7197251a5e49" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_90baa0bc-3ae8-4fa7-9fd2-7197251a5e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f9486453-4b61-4cbe-8e05-f66eac55a930" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_CurrentFiscalYearEndDate_f9486453-4b61-4cbe-8e05-f66eac55a930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0ed5200c-8ee5-4061-83f7-5b033689b6f3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_EntityCentralIndexKey_0ed5200c-8ee5-4061-83f7-5b033689b6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_28a33c8f-db61-45f1-b6a6-5818543004fa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1582ed4b-cd84-4e3a-97e9-418617435c0c" xlink:to="loc_dei_AmendmentFlag_28a33c8f-db61-45f1-b6a6-5818543004fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9faed446-8343-483a-a4e3-fbec04e8b8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_246db7fc-83b5-4835-aa87-f5e0937040ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9faed446-8343-483a-a4e3-fbec04e8b8cd" xlink:to="loc_us-gaap_AssetsAbstract_246db7fc-83b5-4835-aa87-f5e0937040ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f5b31439-7aed-4d69-9eca-433cdc7b7f37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_246db7fc-83b5-4835-aa87-f5e0937040ab" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f5b31439-7aed-4d69-9eca-433cdc7b7f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cdb04363-0fac-4e16-90cc-962a6f282e89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f5b31439-7aed-4d69-9eca-433cdc7b7f37" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cdb04363-0fac-4e16-90cc-962a6f282e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_91b15371-f5a4-4a5a-9788-4f573afa23c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f5b31439-7aed-4d69-9eca-433cdc7b7f37" xlink:to="loc_us-gaap_RestrictedCashCurrent_91b15371-f5a4-4a5a-9788-4f573afa23c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6945d1df-d934-4169-84c1-90be31d29ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f5b31439-7aed-4d69-9eca-433cdc7b7f37" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6945d1df-d934-4169-84c1-90be31d29ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e14f930f-9cff-44fc-8dcc-d4c281a56b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f5b31439-7aed-4d69-9eca-433cdc7b7f37" xlink:to="loc_us-gaap_AssetsCurrent_e14f930f-9cff-44fc-8dcc-d4c281a56b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6402d08e-f79c-494a-84c5-94084a50a2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_246db7fc-83b5-4835-aa87-f5e0937040ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6402d08e-f79c-494a-84c5-94084a50a2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3b7dc574-2bf7-4a09-b65b-b18ea2206de2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_246db7fc-83b5-4835-aa87-f5e0937040ab" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3b7dc574-2bf7-4a09-b65b-b18ea2206de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_b967af5d-b041-4aba-a036-95b21c63dd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_246db7fc-83b5-4835-aa87-f5e0937040ab" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_b967af5d-b041-4aba-a036-95b21c63dd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_86cc7641-df15-4d02-92e8-6aac557cf7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_246db7fc-83b5-4835-aa87-f5e0937040ab" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_86cc7641-df15-4d02-92e8-6aac557cf7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_411b54de-3314-4aa6-b313-eb65b11c8eef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_246db7fc-83b5-4835-aa87-f5e0937040ab" xlink:to="loc_us-gaap_Assets_411b54de-3314-4aa6-b313-eb65b11c8eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9faed446-8343-483a-a4e3-fbec04e8b8cd" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7a7e2afc-4300-40d0-b3b0-e2a29f45a500" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7a7e2afc-4300-40d0-b3b0-e2a29f45a500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b3b9ebdd-2cbc-4178-aeac-a0357e176861" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7a7e2afc-4300-40d0-b3b0-e2a29f45a500" xlink:to="loc_us-gaap_AccountsPayableCurrent_b3b9ebdd-2cbc-4178-aeac-a0357e176861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_05f949cc-f559-48b9-997e-304183c2c063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7a7e2afc-4300-40d0-b3b0-e2a29f45a500" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_05f949cc-f559-48b9-997e-304183c2c063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_72fae8d7-2ed5-41ef-8050-098ba4e2b8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7a7e2afc-4300-40d0-b3b0-e2a29f45a500" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_72fae8d7-2ed5-41ef-8050-098ba4e2b8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_811c5630-5d82-437b-9d6a-1689a8e79cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7a7e2afc-4300-40d0-b3b0-e2a29f45a500" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_811c5630-5d82-437b-9d6a-1689a8e79cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_333587df-56c8-4ae0-b63d-c07281b71657" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7a7e2afc-4300-40d0-b3b0-e2a29f45a500" xlink:to="loc_us-gaap_LiabilitiesCurrent_333587df-56c8-4ae0-b63d-c07281b71657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability_c444ac47-98bf-4852-a107-755d9d19604d" xlink:href="angn-20250331.xsd#angn_WarrantLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:to="loc_angn_WarrantLiability_c444ac47-98bf-4852-a107-755d9d19604d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3db65f37-f74a-43c1-a7a2-2947a3783174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3db65f37-f74a-43c1-a7a2-2947a3783174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_3d6e8387-5b0a-4ff6-8f92-af89cba2a51a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_3d6e8387-5b0a-4ff6-8f92-af89cba2a51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5c9c4b96-c8f7-4854-92a9-1aeca7637109" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:to="loc_us-gaap_Liabilities_5c9c4b96-c8f7-4854-92a9-1aeca7637109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3c07fa38-7c16-4c68-92de-760045b8b430" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3c07fa38-7c16-4c68-92de-760045b8b430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_947b8e61-84a7-4910-917c-4a66cde195b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:to="loc_us-gaap_StatementOfStockholdersEquityAbstract_947b8e61-84a7-4910-917c-4a66cde195b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_42258d8c-dae8-43d0-9d2a-0f65afff8387" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_947b8e61-84a7-4910-917c-4a66cde195b0" xlink:to="loc_us-gaap_CommonStockValue_42258d8c-dae8-43d0-9d2a-0f65afff8387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_fe409ef8-e777-4b57-baba-65763cc68be4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_947b8e61-84a7-4910-917c-4a66cde195b0" xlink:to="loc_us-gaap_TreasuryStockCommonValue_fe409ef8-e777-4b57-baba-65763cc68be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1e3a9caa-ada2-4628-964a-c5b70dde607c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_947b8e61-84a7-4910-917c-4a66cde195b0" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1e3a9caa-ada2-4628-964a-c5b70dde607c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_457fe9ad-bd20-4a91-bafc-ec682edc2582" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_947b8e61-84a7-4910-917c-4a66cde195b0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_457fe9ad-bd20-4a91-bafc-ec682edc2582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7dc78c10-8c6a-4e12-af87-07323edc97d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_947b8e61-84a7-4910-917c-4a66cde195b0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7dc78c10-8c6a-4e12-af87-07323edc97d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5a890526-971c-4352-9f17-280809b052b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_947b8e61-84a7-4910-917c-4a66cde195b0" xlink:to="loc_us-gaap_StockholdersEquity_5a890526-971c-4352-9f17-280809b052b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddf475a5-3366-488c-8fb5-27e7540897c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb19a6ff-698d-478a-976f-867d1e5723d0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddf475a5-3366-488c-8fb5-27e7540897c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_be18e83d-d14e-4cc3-a983-2e082631d137" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9faed446-8343-483a-a4e3-fbec04e8b8cd" xlink:to="loc_us-gaap_TreasuryStockCommonShares_be18e83d-d14e-4cc3-a983-2e082631d137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_df85ac83-824b-474a-96bf-f2e2e2318638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_06fd1e82-9ce3-48b8-bb70-9a9ac46f23c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df85ac83-824b-474a-96bf-f2e2e2318638" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_06fd1e82-9ce3-48b8-bb70-9a9ac46f23c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f98e3d72-93a6-482d-b024-fb90f192e901" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df85ac83-824b-474a-96bf-f2e2e2318638" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f98e3d72-93a6-482d-b024-fb90f192e901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b107720c-1733-4c5b-a427-b63cfecbd2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df85ac83-824b-474a-96bf-f2e2e2318638" xlink:to="loc_us-gaap_CommonStockSharesIssued_b107720c-1733-4c5b-a427-b63cfecbd2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_624f5f50-cc6b-42c3-9848-45124edea1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df85ac83-824b-474a-96bf-f2e2e2318638" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_624f5f50-cc6b-42c3-9848-45124edea1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_a33206b7-587e-4c47-af9b-f10c836fabc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df85ac83-824b-474a-96bf-f2e2e2318638" xlink:to="loc_us-gaap_TreasuryStockCommonShares_a33206b7-587e-4c47-af9b-f10c836fabc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_97307c11-577c-4fde-8a20-5382e240149a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_97307c11-577c-4fde-8a20-5382e240149a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_55ac346b-a2de-4cec-9436-f11cb7723a42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_97307c11-577c-4fde-8a20-5382e240149a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_55ac346b-a2de-4cec-9436-f11cb7723a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_128f3aa2-3ca7-46d1-ac46-af79e7d92710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_97307c11-577c-4fde-8a20-5382e240149a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_128f3aa2-3ca7-46d1-ac46-af79e7d92710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5b7e54cb-0b43-4ee3-87be-bd94b0534429" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_97307c11-577c-4fde-8a20-5382e240149a" xlink:to="loc_us-gaap_CostsAndExpenses_5b7e54cb-0b43-4ee3-87be-bd94b0534429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_56d66d58-75aa-49b0-baa1-2cca992f1c22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_OperatingIncomeLoss_56d66d58-75aa-49b0-baa1-2cca992f1c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_14c1b6ad-f34f-4555-b71b-834cb69a1dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_14c1b6ad-f34f-4555-b71b-834cb69a1dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_a0ab2581-71f9-48d0-a243-509732ac63a5" xlink:href="angn-20250331.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_a0ab2581-71f9-48d0-a243-509732ac63a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_0e74de64-a555-4add-bd20-729b17c5dca1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_0e74de64-a555-4add-bd20-729b17c5dca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7c24a53a-321c-4731-82f6-b87b6045a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7c24a53a-321c-4731-82f6-b87b6045a18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating_787d9840-a517-4412-8c26-d700d8ba5c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:to="loc_us-gaap_InterestIncomeOperatingAndNonoperating_787d9840-a517-4412-8c26-d700d8ba5c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_66a63834-39a2-46de-9a65-a52b07467c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:to="loc_us-gaap_InterestExpenseNonoperating_66a63834-39a2-46de-9a65-a52b07467c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3929154d-49a7-49d0-93f6-81b9fdc5a73e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_86974288-1088-494d-bbd1-0fe4ef385c39" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3929154d-49a7-49d0-93f6-81b9fdc5a73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e111f5b5-36c0-4485-a484-acedfa76805c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_NetIncomeLoss_e111f5b5-36c0-4485-a484-acedfa76805c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_32ad7480-8ee2-496d-9c56-f18951dc0bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_32ad7480-8ee2-496d-9c56-f18951dc0bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_244090aa-d9d1-410d-a472-608aeffe5bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_32ad7480-8ee2-496d-9c56-f18951dc0bbf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_244090aa-d9d1-410d-a472-608aeffe5bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_df6166e8-3abb-4bbd-adcc-7cb194887cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_df6166e8-3abb-4bbd-adcc-7cb194887cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_50919331-88cb-4d9e-b426-a3489cbb1d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_EarningsPerShareBasic_50919331-88cb-4d9e-b426-a3489cbb1d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6a32e888-717e-4cf7-9615-c3c7501b96ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6a32e888-717e-4cf7-9615-c3c7501b96ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ab41e0d-87e2-496b-b5f5-b091a81d59b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ab41e0d-87e2-496b-b5f5-b091a81d59b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de2a6eed-fb32-419c-9392-491068dc988b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e678e9d7-f7d3-4ae5-90b4-4e83991c24be" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de2a6eed-fb32-419c-9392-491068dc988b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f060b774-fe4d-42c1-826b-e5d6a3aa4638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f060b774-fe4d-42c1-826b-e5d6a3aa4638" xlink:to="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6b6ae022-2836-43e2-9e9e-8574ce74cc69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6b6ae022-2836-43e2-9e9e-8574ce74cc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6b6ae022-2836-43e2-9e9e-8574ce74cc69" xlink:to="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_eef24179-7e9a-41c2-bbf1-a294c079afaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_CommonStockMember_eef24179-7e9a-41c2-bbf1-a294c079afaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_4cbbe047-df2a-4372-a0d9-c307fcd1032b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_TreasuryStockCommonMember_4cbbe047-df2a-4372-a0d9-c307fcd1032b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5df0d401-9d89-455c-bc15-d60605849528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5df0d401-9d89-455c-bc15-d60605849528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a15c5f0-bebe-4275-9a1a-b9bda326268d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a15c5f0-bebe-4275-9a1a-b9bda326268d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_18743c8c-9a31-4cc9-9fba-90ee7bf76982" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1af64831-f02a-456c-a41c-45c7f73890da" xlink:to="loc_us-gaap_RetainedEarningsMember_18743c8c-9a31-4cc9-9fba-90ee7bf76982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_428cd4b1-5b6e-4be6-b807-70dfb9078ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd97afbc-1ba0-417b-bcfb-95ce9ff4af6d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_428cd4b1-5b6e-4be6-b807-70dfb9078ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember_671cc325-84d3-44a4-9f15-8a5ec9208e22" xlink:href="angn-20250331.xsd#angn_PurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_428cd4b1-5b6e-4be6-b807-70dfb9078ac0" xlink:to="loc_angn_PurchaseAgreementMember_671cc325-84d3-44a4-9f15-8a5ec9208e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_7eef501f-584c-4f04-810e-a0e8c85a3739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_7eef501f-584c-4f04-810e-a0e8c85a3739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_ca0f15bc-76d6-4447-ab90-dfdca879f27b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_7eef501f-584c-4f04-810e-a0e8c85a3739" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_ca0f15bc-76d6-4447-ab90-dfdca879f27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember_072df9ca-8f8b-4466-b6cd-f6d2bb4053c5" xlink:href="angn-20250331.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_ca0f15bc-76d6-4447-ab90-dfdca879f27b" xlink:to="loc_angn_ConversionOfConvertibleDebtMember_072df9ca-8f8b-4466-b6cd-f6d2bb4053c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c498ae38-e62b-4aa0-adca-66d81fbd5fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54418d41-a3f7-4394-8e66-e9b4f93a2ef4" xlink:to="loc_us-gaap_StatementLineItems_c498ae38-e62b-4aa0-adca-66d81fbd5fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c498ae38-e62b-4aa0-adca-66d81fbd5fbf" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0f0a2935-1b5e-4447-9c8b-db933c6a7589" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0f0a2935-1b5e-4447-9c8b-db933c6a7589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_da122921-d6f0-4399-a849-bdf41d483021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockholdersEquity_da122921-d6f0-4399-a849-bdf41d483021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_9b430af5-7581-446a-896b-1842bad4d5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_TreasuryStockCommonShares_9b430af5-7581-446a-896b-1842bad4d5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2ebfd157-ab1e-42dc-9f11-65edf3c8c60a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2ebfd157-ab1e-42dc-9f11-65edf3c8c60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1422774f-f1cf-4881-9e4b-55b45b589ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1422774f-f1cf-4881-9e4b-55b45b589ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_abba6bca-900d-42e0-8e34-2d829e451963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_abba6bca-900d-42e0-8e34-2d829e451963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fbdb4a45-2f51-4920-822d-591aa4475856" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fbdb4a45-2f51-4920-822d-591aa4475856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_9d7fc70d-afc7-48dc-99f8-f6d9b4926f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_9d7fc70d-afc7-48dc-99f8-f6d9b4926f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_9c07abd6-62be-4dae-af2a-17da7517f26d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_9c07abd6-62be-4dae-af2a-17da7517f26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_bb68ebfb-1302-4dbb-aaaa-4870e980b768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_bb68ebfb-1302-4dbb-aaaa-4870e980b768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_05aaa50d-c1be-4f1d-9624-9e42121b2c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_05aaa50d-c1be-4f1d-9624-9e42121b2c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d19dcbe0-8471-4f27-a546-d47e4af31d18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d19dcbe0-8471-4f27-a546-d47e4af31d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_424bef79-f5af-4533-9446-f76ac103ff79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_424bef79-f5af-4533-9446-f76ac103ff79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cd70df17-f912-41a6-94df-2f55816bd739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cd70df17-f912-41a6-94df-2f55816bd739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7f63ac7e-f775-4fdc-a56b-a2f942c6b6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7f63ac7e-f775-4fdc-a56b-a2f942c6b6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_97ba8893-75f2-41ba-97b2-eecb609c4ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_NetIncomeLoss_97ba8893-75f2-41ba-97b2-eecb609c4ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7804e2b8-1e09-4c5c-aa03-0866046d9311" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7804e2b8-1e09-4c5c-aa03-0866046d9311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0df20081-6ba3-4597-88e0-f22273d8e7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_StockholdersEquity_0df20081-6ba3-4597-88e0-f22273d8e7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_844358e0-7664-49d5-a759-bcf53afad1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c4fc5fa8-8e97-461f-9048-c48124869f75" xlink:to="loc_us-gaap_TreasuryStockCommonShares_844358e0-7664-49d5-a759-bcf53afad1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b1db0c9e-6b5a-4b2a-845c-5618e31659e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_81b03d20-75c4-45d6-a53b-beb458a0502b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b1db0c9e-6b5a-4b2a-845c-5618e31659e4" xlink:to="loc_us-gaap_StatementTable_81b03d20-75c4-45d6-a53b-beb458a0502b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_8df467f9-1e53-4934-861d-019482c7dd03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_81b03d20-75c4-45d6-a53b-beb458a0502b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_8df467f9-1e53-4934-861d-019482c7dd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d4799b3a-717c-432a-af0f-b6dbd9482ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_8df467f9-1e53-4934-861d-019482c7dd03" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d4799b3a-717c-432a-af0f-b6dbd9482ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember_225a1269-1d4e-4c92-8d82-ee58d0479ecd" xlink:href="angn-20250331.xsd#angn_PurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d4799b3a-717c-432a-af0f-b6dbd9482ce6" xlink:to="loc_angn_PurchaseAgreementMember_225a1269-1d4e-4c92-8d82-ee58d0479ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_73dfac6d-70ed-40c3-b469-5e8f36cb276f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_81b03d20-75c4-45d6-a53b-beb458a0502b" xlink:to="loc_us-gaap_StatementLineItems_73dfac6d-70ed-40c3-b469-5e8f36cb276f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_826548fa-7236-4908-b7f4-1a07f0e6db70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_73dfac6d-70ed-40c3-b469-5e8f36cb276f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_826548fa-7236-4908-b7f4-1a07f0e6db70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_9e541b09-78d9-4046-b701-7f7a79b73251" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_73dfac6d-70ed-40c3-b469-5e8f36cb276f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_9e541b09-78d9-4046-b701-7f7a79b73251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="angn-20250331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f29e5147-662d-4d01-88fe-0e32172cb502" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f29e5147-662d-4d01-88fe-0e32172cb502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea5c8e3a-8f24-4a4b-b2b9-b34d07f74b42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f29e5147-662d-4d01-88fe-0e32172cb502" xlink:to="loc_us-gaap_NetIncomeLoss_ea5c8e3a-8f24-4a4b-b2b9-b34d07f74b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f29e5147-662d-4d01-88fe-0e32172cb502" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_2605181e-3778-44f7-b074-cab6497116ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_us-gaap_Depreciation_2605181e-3778-44f7-b074-cab6497116ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_11da635f-5629-42c6-b7ce-df46268c9bda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_11da635f-5629-42c6-b7ce-df46268c9bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash_1231d3b7-3e5b-4904-8d40-7bc244d0e86a" xlink:href="angn-20250331.xsd#angn_InterestExpenseNoncash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_angn_InterestExpenseNoncash_1231d3b7-3e5b-4904-8d40-7bc244d0e86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_d844159f-29f6-4e36-a1fb-c09da24a5755" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_d844159f-29f6-4e36-a1fb-c09da24a5755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_91068ad0-f94a-45b9-bf51-74e5edd865bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_91068ad0-f94a-45b9-bf51-74e5edd865bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cdf3f7dc-504d-4e8a-afa2-1a306ce7804c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_us-gaap_ShareBasedCompensation_cdf3f7dc-504d-4e8a-afa2-1a306ce7804c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_7b5c0ee8-a187-4c8a-afe6-7b61d3b2cb48" xlink:href="angn-20250331.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_7b5c0ee8-a187-4c8a-afe6-7b61d3b2cb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_979ae4ab-97a8-4b90-b3a3-a7777f5e4493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_979ae4ab-97a8-4b90-b3a3-a7777f5e4493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d690338-e4f4-4cfe-a8fd-952ee616c274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0017d6c8-b74c-4daa-9305-419fc26bdf11" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d690338-e4f4-4cfe-a8fd-952ee616c274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0068c4b9-cb1b-4c8d-8784-fee50020c66b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d690338-e4f4-4cfe-a8fd-952ee616c274" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0068c4b9-cb1b-4c8d-8784-fee50020c66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_62e6b54a-2157-4572-aab1-66a1680d19aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d690338-e4f4-4cfe-a8fd-952ee616c274" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_62e6b54a-2157-4572-aab1-66a1680d19aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ab952dbc-34ad-4468-9691-3956f3087fce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d690338-e4f4-4cfe-a8fd-952ee616c274" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ab952dbc-34ad-4468-9691-3956f3087fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_4e2e890d-756a-4fb8-ab20-8e06ccbe73e5" xlink:href="angn-20250331.xsd#angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d690338-e4f4-4cfe-a8fd-952ee616c274" xlink:to="loc_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_4e2e890d-756a-4fb8-ab20-8e06ccbe73e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_3cf94d99-bae6-4086-94d6-d43b2ba758e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d690338-e4f4-4cfe-a8fd-952ee616c274" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_3cf94d99-bae6-4086-94d6-d43b2ba758e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_ffaab280-66d4-46e4-9ea4-6aa9afcee2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d690338-e4f4-4cfe-a8fd-952ee616c274" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_ffaab280-66d4-46e4-9ea4-6aa9afcee2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf4e08e-5913-4514-96b2-979be412bded" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f29e5147-662d-4d01-88fe-0e32172cb502" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf4e08e-5913-4514-96b2-979be412bded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_88a76d1c-8da1-4b9f-afe2-b69f07eaefea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_88a76d1c-8da1-4b9f-afe2-b69f07eaefea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b23fe380-56e5-497e-a701-4c344cebf6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_88a76d1c-8da1-4b9f-afe2-b69f07eaefea" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b23fe380-56e5-497e-a701-4c344cebf6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_02f99fb0-7990-4bd7-ae42-afade964f848" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_88a76d1c-8da1-4b9f-afe2-b69f07eaefea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_02f99fb0-7990-4bd7-ae42-afade964f848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_74fee869-cd75-4a31-a8f0-d8ed518120c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_74fee869-cd75-4a31-a8f0-d8ed518120c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_791e2918-e81f-4301-834a-092334d2a620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_74fee869-cd75-4a31-a8f0-d8ed518120c8" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_791e2918-e81f-4301-834a-092334d2a620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_39cd3f21-81ec-4fc5-b0e9-7d6d191b72c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_74fee869-cd75-4a31-a8f0-d8ed518120c8" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_39cd3f21-81ec-4fc5-b0e9-7d6d191b72c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_54ed7bc8-b321-47d6-8c0b-b940cf5b451e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_74fee869-cd75-4a31-a8f0-d8ed518120c8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_54ed7bc8-b321-47d6-8c0b-b940cf5b451e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3d33d45d-cdac-4b26-98f0-dd11f2515169" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_74fee869-cd75-4a31-a8f0-d8ed518120c8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3d33d45d-cdac-4b26-98f0-dd11f2515169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_32d66446-3870-4e19-875b-8db329bb43dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_74fee869-cd75-4a31-a8f0-d8ed518120c8" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_32d66446-3870-4e19-875b-8db329bb43dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_126d6a81-c088-48b6-bd1c-1fa70e5c3c11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_74fee869-cd75-4a31-a8f0-d8ed518120c8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_126d6a81-c088-48b6-bd1c-1fa70e5c3c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ae9376c-7465-4191-bcfb-f94a25cd5c90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ae9376c-7465-4191-bcfb-f94a25cd5c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_60a082f0-738a-45cd-b151-4f5c188cc319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_60a082f0-738a-45cd-b151-4f5c188cc319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_33e64883-358e-4eb7-965c-05a3e11aaa96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_33e64883-358e-4eb7-965c-05a3e11aaa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7cf17928-c79d-492c-8088-cc94eab545e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7cf17928-c79d-492c-8088-cc94eab545e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21a8e6d8-5f20-4542-adad-8e644db93941" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21a8e6d8-5f20-4542-adad-8e644db93941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fa5f832d-1c76-4cb2-bf04-ec4a1176ff55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21a8e6d8-5f20-4542-adad-8e644db93941" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fa5f832d-1c76-4cb2-bf04-ec4a1176ff55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_38101562-fa71-4977-a5f2-6e454b33625b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21a8e6d8-5f20-4542-adad-8e644db93941" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_38101562-fa71-4977-a5f2-6e454b33625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d443e15f-f218-43ee-bea0-d376f38eb805" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21a8e6d8-5f20-4542-adad-8e644db93941" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d443e15f-f218-43ee-bea0-d376f38eb805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_59c5aaf1-8ee6-4451-9f7e-b8249420f6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_66ec4129-19a5-4844-a4ec-5f14b48ef7b4" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_59c5aaf1-8ee6-4451-9f7e-b8249420f6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfPreFundedWarrants_038de9ef-d7b2-4b4e-bf7b-c5c84a7dd854" xlink:href="angn-20250331.xsd#angn_FairValueOfPreFundedWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_59c5aaf1-8ee6-4451-9f7e-b8249420f6b6" xlink:to="loc_angn_FairValueOfPreFundedWarrants_038de9ef-d7b2-4b4e-bf7b-c5c84a7dd854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrants_d007db1e-7919-4a57-88dc-f8b72c053b31" xlink:href="angn-20250331.xsd#angn_FairValueOfCommonStockWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_59c5aaf1-8ee6-4451-9f7e-b8249420f6b6" xlink:to="loc_angn_FairValueOfCommonStockWarrants_d007db1e-7919-4a57-88dc-f8b72c053b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SettlementOfPromissoryNotesPayable_b9bdb879-9b33-423c-bbe9-a8940f780a46" xlink:href="angn-20250331.xsd#angn_SettlementOfPromissoryNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_59c5aaf1-8ee6-4451-9f7e-b8249420f6b6" xlink:to="loc_angn_SettlementOfPromissoryNotesPayable_b9bdb879-9b33-423c-bbe9-a8940f780a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NonCashVestingOfRestrictedCommonStock_428b43af-fe7d-4877-a65e-0bafdc63c423" xlink:href="angn-20250331.xsd#angn_NonCashVestingOfRestrictedCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_59c5aaf1-8ee6-4451-9f7e-b8249420f6b6" xlink:to="loc_angn_NonCashVestingOfRestrictedCommonStock_428b43af-fe7d-4877-a65e-0bafdc63c423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition" xlink:type="simple" xlink:href="angn-20250331.xsd#DescriptionoftheBusinessandFinancialCondition"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb761db8-cf97-4759-8ba1-87b3c780b310" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4302e4aa-0504-464f-9b44-d29008c3cde5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb761db8-cf97-4759-8ba1-87b3c780b310" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4302e4aa-0504-464f-9b44-d29008c3cde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="angn-20250331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_142e04ac-98b2-432d-8c32-0307b5ce512f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_fcc57127-8226-49b7-b16f-40f57ac485e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_142e04ac-98b2-432d-8c32-0307b5ce512f" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_fcc57127-8226-49b7-b16f-40f57ac485e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_05f94d58-fbe2-43bb-8455-f869e855da81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_7213b468-f630-463b-8e14-4fce125cd5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_05f94d58-fbe2-43bb-8455-f869e855da81" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_7213b468-f630-463b-8e14-4fce125cd5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_10c65eb1-bb90-4e54-b82c-b6f9b7e36ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_df05bcb8-2352-44db-8c0a-cdcbad6e1d53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_10c65eb1-bb90-4e54-b82c-b6f9b7e36ea4" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_df05bcb8-2352-44db-8c0a-cdcbad6e1d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrant" xlink:type="simple" xlink:href="angn-20250331.xsd#ResearchGrant"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ResearchGrant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_3e668434-8e23-4d5c-869f-a240db434b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_355a3fd6-5bec-49ab-a970-0a2668d4e5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_3e668434-8e23-4d5c-869f-a240db434b4a" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_355a3fd6-5bec-49ab-a970-0a2668d4e5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquity" xlink:type="simple" xlink:href="angn-20250331.xsd#ConvertiblePreferredStockCommonStockandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_241fb84d-ca06-4d3a-8b56-f1d4c8b9c53a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_bcf0bdbc-21b7-4832-a75b-b9bfd24ea123" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_241fb84d-ca06-4d3a-8b56-f1d4c8b9c53a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_bcf0bdbc-21b7-4832-a75b-b9bfd24ea123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b399750e-8618-4d21-b3f0-81882d611ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_92c20d53-fb22-48d7-bebe-9443c97be334" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b399750e-8618-4d21-b3f0-81882d611ab2" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_92c20d53-fb22-48d7-bebe-9443c97be334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Warrants" xlink:type="simple" xlink:href="angn-20250331.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_efa6548a-c64a-4df7-b7f5-ef577caf974e" xlink:href="angn-20250331.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingTextBlock_3644a9f9-3bc5-4bf8-8aa4-bac09ab14833" xlink:href="angn-20250331.xsd#angn_WarrantsAndRightsOutstandingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_efa6548a-c64a-4df7-b7f5-ef577caf974e" xlink:to="loc_angn_WarrantsAndRightsOutstandingTextBlock_3644a9f9-3bc5-4bf8-8aa4-bac09ab14833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="angn-20250331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ed915c94-77d6-47e9-b0fe-c991ed277bed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d78217cc-b0a8-4283-bffb-8c3dbea1c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ed915c94-77d6-47e9-b0fe-c991ed277bed" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d78217cc-b0a8-4283-bffb-8c3dbea1c4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Leases" xlink:type="simple" xlink:href="angn-20250331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_53c347e7-bb77-43d4-9ec0-2ce864bc0edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_295eccad-b4db-4e19-ac06-91f86643f4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53c347e7-bb77-43d4-9ec0-2ce864bc0edf" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_295eccad-b4db-4e19-ac06-91f86643f4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Debt" xlink:type="simple" xlink:href="angn-20250331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ea1ccb19-bea0-4cec-a8f3-d9503401c04a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e1f26782-0082-45ab-bd0c-064e32759b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea1ccb19-bea0-4cec-a8f3-d9503401c04a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e1f26782-0082-45ab-bd0c-064e32759b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxes" xlink:type="simple" xlink:href="angn-20250331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_17adb377-a0e7-442f-bd16-73fd2fb9e024" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_7cdfb4fe-77eb-4d54-bbcd-79b9cb9fabeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_17adb377-a0e7-442f-bd16-73fd2fb9e024" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_7cdfb4fe-77eb-4d54-bbcd-79b9cb9fabeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShare" xlink:type="simple" xlink:href="angn-20250331.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a300fba0-fbe7-4b62-8b3f-107cc8d3429b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_15a5d38b-dc10-45f2-b0db-6a72b2568b51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a300fba0-fbe7-4b62-8b3f-107cc8d3429b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_15a5d38b-dc10-45f2-b0db-6a72b2568b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="angn-20250331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_d57c43e0-7940-48af-949e-3e6ff99856e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_8cf80abb-0f11-4179-8820-07d0e35c4416" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_d57c43e0-7940-48af-949e-3e6ff99856e1" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_8cf80abb-0f11-4179-8820-07d0e35c4416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReporting" xlink:type="simple" xlink:href="angn-20250331.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_29263c46-a0ed-4e9d-a19f-8c92de97ae31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0ca59ff5-aa1f-4b0a-be70-2111ad4407dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_29263c46-a0ed-4e9d-a19f-8c92de97ae31" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0ca59ff5-aa1f-4b0a-be70-2111ad4407dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="angn-20250331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_83c49f18-074a-40a2-a1bd-7eb190cd24dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d001b23c-a932-4036-855a-c8eba6f6839f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_83c49f18-074a-40a2-a1bd-7eb190cd24dc" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d001b23c-a932-4036-855a-c8eba6f6839f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8f393082-056e-40f3-97a4-fbb4c2be3b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_83c49f18-074a-40a2-a1bd-7eb190cd24dc" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8f393082-056e-40f3-97a4-fbb4c2be3b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4d374f4d-9823-47ab-902e-68c0767bef9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5052c996-5477-41da-987d-217ab41d7b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d374f4d-9823-47ab-902e-68c0767bef9e" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5052c996-5477-41da-987d-217ab41d7b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_673dc8d3-eb19-439e-9ffd-5cfc54144c43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d374f4d-9823-47ab-902e-68c0767bef9e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_673dc8d3-eb19-439e-9ffd-5cfc54144c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_7806df23-ca5d-4620-8269-e45788d80fda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d374f4d-9823-47ab-902e-68c0767bef9e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_7806df23-ca5d-4620-8269-e45788d80fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bef1a7f3-2e3d-4571-a0ea-a38abe4dc0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_951f8f19-e1ed-4ac5-8d58-bb3415944eea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bef1a7f3-2e3d-4571-a0ea-a38abe4dc0ff" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_951f8f19-e1ed-4ac5-8d58-bb3415944eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_219b89fb-97c1-49a8-a9ae-7133f96b64ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bef1a7f3-2e3d-4571-a0ea-a38abe4dc0ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_219b89fb-97c1-49a8-a9ae-7133f96b64ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_79ea6726-46ad-4f2a-a748-061a4a4686ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bef1a7f3-2e3d-4571-a0ea-a38abe4dc0ff" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_79ea6726-46ad-4f2a-a748-061a4a4686ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0ce7c81a-cfea-421d-b533-fb28e51553df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ec9b6d54-6551-4ae0-8013-0074c054a268" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0ce7c81a-cfea-421d-b533-fb28e51553df" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ec9b6d54-6551-4ae0-8013-0074c054a268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4f03c206-58c9-4478-a52c-d8df496de1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0ce7c81a-cfea-421d-b533-fb28e51553df" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4f03c206-58c9-4478-a52c-d8df496de1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_994a3902-d6ff-4701-ae7d-c96efd8b83ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0ce7c81a-cfea-421d-b533-fb28e51553df" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_994a3902-d6ff-4701-ae7d-c96efd8b83ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsTables" xlink:type="simple" xlink:href="angn-20250331.xsd#WarrantsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_7e159778-a6bc-40c0-bcd9-bd59cad9db41" xlink:href="angn-20250331.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_6e66c331-bceb-4bab-a506-7b784bff732f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_7e159778-a6bc-40c0-bcd9-bd59cad9db41" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_6e66c331-bceb-4bab-a506-7b784bff732f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesTables" xlink:type="simple" xlink:href="angn-20250331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bcb11ad3-ba71-4fd1-b768-eb06da855a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_74619107-a8f2-477e-8f7d-67858ff26a07" xlink:href="angn-20250331.xsd#angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bcb11ad3-ba71-4fd1-b768-eb06da855a99" xlink:to="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_74619107-a8f2-477e-8f7d-67858ff26a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_bdb5d5b3-b5cf-4b61-9dca-9cb9939b4e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bcb11ad3-ba71-4fd1-b768-eb06da855a99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_bdb5d5b3-b5cf-4b61-9dca-9cb9939b4e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="angn-20250331.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f2f6e2ef-3182-4e6e-84e2-083fe959e127" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ea7e0731-6916-445a-80ad-737e6ec08b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f2f6e2ef-3182-4e6e-84e2-083fe959e127" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ea7e0731-6916-445a-80ad-737e6ec08b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_bf4641e0-4a84-44ad-9186-d1d802ab5f68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f2f6e2ef-3182-4e6e-84e2-083fe959e127" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_bf4641e0-4a84-44ad-9186-d1d802ab5f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="angn-20250331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5bc5d58d-6166-4a70-a74b-b1e17b97cd31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f9fc5422-4d4a-4759-8db3-b187e156e753" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5bc5d58d-6166-4a70-a74b-b1e17b97cd31" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f9fc5422-4d4a-4759-8db3-b187e156e753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#DescriptionoftheBusinessandFinancialConditionDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d4d1ecf4-71c9-4723-9a8c-f7d1aaed7078" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_72a36aa7-1b93-41bb-b63b-e4161f112823" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d4d1ecf4-71c9-4723-9a8c-f7d1aaed7078" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_72a36aa7-1b93-41bb-b63b-e4161f112823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_10af007f-7ddb-43bb-80ab-093726e6aa98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d4d1ecf4-71c9-4723-9a8c-f7d1aaed7078" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_10af007f-7ddb-43bb-80ab-093726e6aa98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8ff2ff1c-f37e-452d-bd3a-ae05b303385c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_84c581f3-0961-4bf6-ac6f-8343a953e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8ff2ff1c-f37e-452d-bd3a-ae05b303385c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_84c581f3-0961-4bf6-ac6f-8343a953e78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0bdeb7cb-670f-484f-b710-cf1b1c066b95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_84c581f3-0961-4bf6-ac6f-8343a953e78a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0bdeb7cb-670f-484f-b710-cf1b1c066b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_150b1aa1-116a-4c5f-b1f3-358e2471eb25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0bdeb7cb-670f-484f-b710-cf1b1c066b95" xlink:to="loc_us-gaap_ClassOfStockDomain_150b1aa1-116a-4c5f-b1f3-358e2471eb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionCommonStockMember_154f464b-d884-4f26-b795-7b612d2fdf14" xlink:href="angn-20250331.xsd#angn_AngionCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_150b1aa1-116a-4c5f-b1f3-358e2471eb25" xlink:to="loc_angn_AngionCommonStockMember_154f464b-d884-4f26-b795-7b612d2fdf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_b3343148-167b-4978-826a-c0d44cd1065a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_84c581f3-0961-4bf6-ac6f-8343a953e78a" xlink:to="loc_us-gaap_ClassOfStockLineItems_b3343148-167b-4978-826a-c0d44cd1065a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f70ff3a2-3adb-436f-8353-ced70f0e786c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b3343148-167b-4978-826a-c0d44cd1065a" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f70ff3a2-3adb-436f-8353-ced70f0e786c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a30b2697-f048-42a6-bf64-e1b26b990520" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a30b2697-f048-42a6-bf64-e1b26b990520" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dd5c79f-d544-466d-923d-e1e135c4fc31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dd5c79f-d544-466d-923d-e1e135c4fc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dd5c79f-d544-466d-923d-e1e135c4fc31" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_92a19a09-0b11-4db2-af69-23644ab22fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_92a19a09-0b11-4db2-af69-23644ab22fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a438e10a-3903-4c4b-81f4-f96fec857fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a438e10a-3903-4c4b-81f4-f96fec857fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_543a9d32-dc97-4324-8120-fa3c337eded6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d0b6640-fe92-4e22-b2e0-4d9e449601c8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_543a9d32-dc97-4324-8120-fa3c337eded6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_83211b9e-3b9f-4fee-9dae-29e5b3506579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_83211b9e-3b9f-4fee-9dae-29e5b3506579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_30563519-0228-4e09-8913-b1f491d101a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_83211b9e-3b9f-4fee-9dae-29e5b3506579" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_30563519-0228-4e09-8913-b1f491d101a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d7b2b658-0b55-4fcf-aac7-7f3716f9c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_30563519-0228-4e09-8913-b1f491d101a4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d7b2b658-0b55-4fcf-aac7-7f3716f9c8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8344ff36-3ef6-4da6-bed6-a1713d96869f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06f594e0-b692-4445-8ae8-6967be8dcd7f" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8344ff36-3ef6-4da6-bed6-a1713d96869f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_d93fb924-a4bc-44a5-86a0-777ef7d7d67e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8344ff36-3ef6-4da6-bed6-a1713d96869f" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_d93fb924-a4bc-44a5-86a0-777ef7d7d67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_306718cc-d5f2-4930-b81f-68a92dd47bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_d93fb924-a4bc-44a5-86a0-777ef7d7d67e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_306718cc-d5f2-4930-b81f-68a92dd47bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_621b7386-71cb-4079-8c73-3f3bf0e835ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_d93fb924-a4bc-44a5-86a0-777ef7d7d67e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_621b7386-71cb-4079-8c73-3f3bf0e835ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_825855e6-02fc-46a3-8e92-16b27135383e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8344ff36-3ef6-4da6-bed6-a1713d96869f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_825855e6-02fc-46a3-8e92-16b27135383e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_8108db2c-f3bc-432f-8566-c38ac2efc36e" xlink:href="angn-20250331.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_825855e6-02fc-46a3-8e92-16b27135383e" xlink:to="loc_angn_WarrantsFairValueDisclosure_8108db2c-f3bc-432f-8566-c38ac2efc36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_07216b08-bfd3-4246-9b8b-3ff75f431858" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_825855e6-02fc-46a3-8e92-16b27135383e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_07216b08-bfd3-4246-9b8b-3ff75f431858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_43d7d9c7-be66-4b65-81b3-bb856edef62c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a6b258ed-ec96-4b98-ac7e-007452d61d05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_43d7d9c7-be66-4b65-81b3-bb856edef62c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a6b258ed-ec96-4b98-ac7e-007452d61d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_beaae2de-d5a9-45ce-bf6c-fe0a255820d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a6b258ed-ec96-4b98-ac7e-007452d61d05" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_beaae2de-d5a9-45ce-bf6c-fe0a255820d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_00af3e28-a000-4878-a69d-5350f7372bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_beaae2de-d5a9-45ce-bf6c-fe0a255820d9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_00af3e28-a000-4878-a69d-5350f7372bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember_fb78ff83-e524-4757-807b-44a9c5121d77" xlink:href="angn-20250331.xsd#angn_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_00af3e28-a000-4878-a69d-5350f7372bd1" xlink:to="loc_angn_WarrantLiabilityMember_fb78ff83-e524-4757-807b-44a9c5121d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1631ad7c-70ce-43a2-8880-e7ff24a7cecb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a6b258ed-ec96-4b98-ac7e-007452d61d05" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1631ad7c-70ce-43a2-8880-e7ff24a7cecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1631ad7c-70ce-43a2-8880-e7ff24a7cecb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_66a63cb7-6878-473d-975e-a42044c481e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_66a63cb7-6878-473d-975e-a42044c481e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e2fef889-d8f3-4f15-bf02-38c36a6fce0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e2fef889-d8f3-4f15-bf02-38c36a6fce0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_69881960-90a2-4df6-b1fd-9989fa53bac8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f1cea92f-4a60-4885-85c7-aab07e43f9c8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_69881960-90a2-4df6-b1fd-9989fa53bac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8301c7a7-dbdf-45d8-a1a7-6d5205b18047" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8301c7a7-dbdf-45d8-a1a7-6d5205b18047" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_52a576f1-94a9-4550-9c97-ca8464e6558d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_52a576f1-94a9-4550-9c97-ca8464e6558d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2369eb81-bebd-4432-8be7-a43c8abe952d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_52a576f1-94a9-4550-9c97-ca8464e6558d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2369eb81-bebd-4432-8be7-a43c8abe952d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_1dadb234-ee2b-41a3-8158-b66b5e607075" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2369eb81-bebd-4432-8be7-a43c8abe952d" xlink:to="loc_angn_PreFundedWarrantMember_1dadb234-ee2b-41a3-8158-b66b5e607075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_45e8b08c-00df-4a37-8112-fabb12f98e23" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2369eb81-bebd-4432-8be7-a43c8abe952d" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_45e8b08c-00df-4a37-8112-fabb12f98e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_627b8506-6658-40a2-a74a-34e8826eabb1" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_45e8b08c-00df-4a37-8112-fabb12f98e23" xlink:to="loc_angn_JulyPreFundedWarrantsMember_627b8506-6658-40a2-a74a-34e8826eabb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_70563cb0-3afd-4a6d-925a-b0f5a1f04703" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_45e8b08c-00df-4a37-8112-fabb12f98e23" xlink:to="loc_angn_JulyCommonWarrantsMember_70563cb0-3afd-4a6d-925a-b0f5a1f04703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_36a6240f-c546-4855-8fee-7b53bebd3413" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_36a6240f-c546-4855-8fee-7b53bebd3413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a0520d6-f9e6-4160-834b-ff1afa11a4db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_36a6240f-c546-4855-8fee-7b53bebd3413" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a0520d6-f9e6-4160-834b-ff1afa11a4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_754db79c-f032-4105-a78f-be4c6d5b12fc" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a0520d6-f9e6-4160-834b-ff1afa11a4db" xlink:to="loc_angn_MarchSubscriptionAgreementMember_754db79c-f032-4105-a78f-be4c6d5b12fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_3f67f976-c5a7-4552-b7ba-e4e2854e1a3f" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a0520d6-f9e6-4160-834b-ff1afa11a4db" xlink:to="loc_angn_JulyPublicOfferingMember_3f67f976-c5a7-4552-b7ba-e4e2854e1a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_05d19dc4-b954-4094-ba57-43d25ff5dc52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c5508bb7-a45f-4f2d-b7a2-43ab65553c7d" xlink:to="loc_us-gaap_ClassOfStockDomain_05d19dc4-b954-4094-ba57-43d25ff5dc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_d779aa0f-4159-48bb-96ff-b93b2924794d" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_05d19dc4-b954-4094-ba57-43d25ff5dc52" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_d779aa0f-4159-48bb-96ff-b93b2924794d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_eb8af092-c23f-468d-a5cf-0a8cafaa39c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_eb8af092-c23f-468d-a5cf-0a8cafaa39c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_49ddd4c9-b899-4ec3-866b-21153475494b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eb8af092-c23f-468d-a5cf-0a8cafaa39c8" xlink:to="loc_us-gaap_EquityComponentDomain_49ddd4c9-b899-4ec3-866b-21153475494b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e4dc1954-680d-4a69-a4cb-2a6b676aed75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_49ddd4c9-b899-4ec3-866b-21153475494b" xlink:to="loc_us-gaap_CommonStockMember_e4dc1954-680d-4a69-a4cb-2a6b676aed75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_38bbc2b6-36a2-423d-9144-9dc41e64a36e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f1f605a2-812c-4c46-bb05-0a59fb7a1bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f1f605a2-812c-4c46-bb05-0a59fb7a1bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e73efb60-7f1b-4c66-92fb-45002c461cec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e73efb60-7f1b-4c66-92fb-45002c461cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b0fab07d-0407-453b-9572-fa4735543278" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b0fab07d-0407-453b-9572-fa4735543278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c3513971-251c-460d-adf2-3885ce584a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c3513971-251c-460d-adf2-3885ce584a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8e872551-6400-4f6d-9799-5bd89d2a24f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8e872551-6400-4f6d-9799-5bd89d2a24f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d274f858-d3fe-47aa-83e5-a1949720bed6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d274f858-d3fe-47aa-83e5-a1949720bed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_b38bb9c1-1c71-454b-a8be-743a76860dba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_b38bb9c1-1c71-454b-a8be-743a76860dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_66ecfc32-ac44-4f4a-9426-bdeee54e7922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_66ecfc32-ac44-4f4a-9426-bdeee54e7922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_a1c31e4c-d5a2-4718-a738-a079d49abdbb" xlink:href="angn-20250331.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_a1c31e4c-d5a2-4718-a738-a079d49abdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fcb4ba85-0e45-4734-8bef-151b71107b83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fcb4ba85-0e45-4734-8bef-151b71107b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_c0c8a654-ec10-4214-a357-28f7d82f87d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_271a9e8f-fd34-4e11-99ab-b5e569e5509b" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_c0c8a654-ec10-4214-a357-28f7d82f87d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d42cd883-3f07-4589-a121-b636ceee6922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d42cd883-3f07-4589-a121-b636ceee6922" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0e9aac5e-31fa-45b1-8611-5d0066fb354d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0e9aac5e-31fa-45b1-8611-5d0066fb354d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e47c16eb-171b-4b8b-8e94-6a3cfd4514c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0e9aac5e-31fa-45b1-8611-5d0066fb354d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e47c16eb-171b-4b8b-8e94-6a3cfd4514c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_39dcb793-c403-4336-bdbf-514b75e1498f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e47c16eb-171b-4b8b-8e94-6a3cfd4514c0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_39dcb793-c403-4336-bdbf-514b75e1498f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_80a282f4-cd01-4844-a741-b7a74bbd1854" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_80a282f4-cd01-4844-a741-b7a74bbd1854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_80a282f4-cd01-4844-a741-b7a74bbd1854" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember_7e965d2c-94fc-4fac-bb49-461eaf7632c6" xlink:href="angn-20250331.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:to="loc_angn_MeasurementInputStrikePriceMember_7e965d2c-94fc-4fac-bb49-461eaf7632c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_b5aaeff4-c48e-4e74-be3c-3896b9aa9b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_b5aaeff4-c48e-4e74-be3c-3896b9aa9b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_3da0b406-2b68-4865-84a2-6d1e6b5d2ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_3da0b406-2b68-4865-84a2-6d1e6b5d2ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_598a8b64-9c30-4229-b5f5-0d4298c16924" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7871b411-243a-4aaa-9f17-d6865be55f97" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_598a8b64-9c30-4229-b5f5-0d4298c16924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4681b522-22fd-4a7a-966f-3ab6c6489e80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_359ed060-ebf9-4b98-9ce9-e7d962d609cd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4681b522-22fd-4a7a-966f-3ab6c6489e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fd4b27b6-1d97-4571-8434-fb4c068f6641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4681b522-22fd-4a7a-966f-3ab6c6489e80" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fd4b27b6-1d97-4571-8434-fb4c068f6641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_3fa99dd1-eedd-4c02-82fe-68a09849cc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4681b522-22fd-4a7a-966f-3ab6c6489e80" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_3fa99dd1-eedd-4c02-82fe-68a09849cc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59256e14-21c5-4c9b-801c-20a7381175c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses_ff6cfb3e-ba47-4146-bb08-c9d4f09275ac" xlink:href="angn-20250331.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59256e14-21c5-4c9b-801c-20a7381175c8" xlink:to="loc_angn_PrepaidResearchAndDevelopmentExpenses_ff6cfb3e-ba47-4146-bb08-c9d4f09275ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees_e4b4dea1-f1d5-477e-b01d-e9d79d463c79" xlink:href="angn-20250331.xsd#angn_AdvancedProfessionalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59256e14-21c5-4c9b-801c-20a7381175c8" xlink:to="loc_angn_AdvancedProfessionalFees_e4b4dea1-f1d5-477e-b01d-e9d79d463c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_ccd7747e-0abf-43d1-8867-55b8873853b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59256e14-21c5-4c9b-801c-20a7381175c8" xlink:to="loc_us-gaap_PrepaidInsurance_ccd7747e-0abf-43d1-8867-55b8873853b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_c0b6c8b9-c3db-43e9-8b27-6321f261ab30" xlink:href="angn-20250331.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59256e14-21c5-4c9b-801c-20a7381175c8" xlink:to="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_c0b6c8b9-c3db-43e9-8b27-6321f261ab30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4cf3107d-b59d-4132-9707-bff189bdfaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59256e14-21c5-4c9b-801c-20a7381175c8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4cf3107d-b59d-4132-9707-bff189bdfaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ea4b276-721b-45e8-9715-66828a35ee04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fc68cf06-50b0-473d-ab9a-9412ee14b7da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ea4b276-721b-45e8-9715-66828a35ee04" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fc68cf06-50b0-473d-ab9a-9412ee14b7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24dcc32c-9949-4d3d-af6d-40e62183f228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fc68cf06-50b0-473d-ab9a-9412ee14b7da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24dcc32c-9949-4d3d-af6d-40e62183f228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_24dcc32c-9949-4d3d-af6d-40e62183f228" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_74eb6618-b6a0-4a07-9a87-a0d050dddc17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:to="loc_us-gaap_EquipmentMember_74eb6618-b6a0-4a07-9a87-a0d050dddc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_01964556-4c1c-4f39-88c7-2631e19ec927" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_01964556-4c1c-4f39-88c7-2631e19ec927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ed4891a4-2c54-463c-a332-b21eccb7144c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19cfd693-28f1-40a4-881b-77c060c1deea" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ed4891a4-2c54-463c-a332-b21eccb7144c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fc68cf06-50b0-473d-ab9a-9412ee14b7da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e3d201ae-1864-42ea-b63b-33b781346b33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e3d201ae-1864-42ea-b63b-33b781346b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e6224e78-200c-4d75-aded-f81c22c73f05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e6224e78-200c-4d75-aded-f81c22c73f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9329d84b-3bea-4810-a702-f80996cfeb83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f49d977-98e9-4de4-a625-8896ed7202c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9329d84b-3bea-4810-a702-f80996cfeb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23968519-aa02-43da-84ae-033517dd4ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a5ebfd21-9c1c-43c0-8214-f8c3c700fa85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23968519-aa02-43da-84ae-033517dd4ad4" xlink:to="loc_us-gaap_Depreciation_a5ebfd21-9c1c-43c0-8214-f8c3c700fa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_810540e1-a879-41c3-a788-c8a9af3fa220" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23968519-aa02-43da-84ae-033517dd4ad4" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_810540e1-a879-41c3-a788-c8a9af3fa220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12b0623a-970e-433e-b790-06750561a019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_194f5e70-98a9-4b94-b468-7ee137b8aee0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12b0623a-970e-433e-b790-06750561a019" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_194f5e70-98a9-4b94-b468-7ee137b8aee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5b8f01cf-e34c-41d3-be8a-364242f66523" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12b0623a-970e-433e-b790-06750561a019" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5b8f01cf-e34c-41d3-be8a-364242f66523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent_26eb379e-75d1-444d-81e0-c0dc9a18bd5d" xlink:href="angn-20250331.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12b0623a-970e-433e-b790-06750561a019" xlink:to="loc_angn_AccruedResearchAndDevelopmentCurrent_26eb379e-75d1-444d-81e0-c0dc9a18bd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_e69ab24d-7498-4fe1-9e8f-a15b00a0d251" xlink:href="angn-20250331.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12b0623a-970e-433e-b790-06750561a019" xlink:to="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_e69ab24d-7498-4fe1-9e8f-a15b00a0d251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4894e792-8ceb-4c21-ad5c-71a15ad0ad40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12b0623a-970e-433e-b790-06750561a019" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4894e792-8ceb-4c21-ad5c-71a15ad0ad40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrantDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#ResearchGrantDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ResearchGrantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_e123c6c1-f1f0-44f9-9940-f242367595cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c27a45f5-79af-4cfa-a6e3-c0c95a9001da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_e123c6c1-f1f0-44f9-9940-f242367595cf" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c27a45f5-79af-4cfa-a6e3-c0c95a9001da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_8562e5ac-343c-4932-94c3-8a853f8b76fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c27a45f5-79af-4cfa-a6e3-c0c95a9001da" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_8562e5ac-343c-4932-94c3-8a853f8b76fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_8562e5ac-343c-4932-94c3-8a853f8b76fb" xlink:to="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_b48e0d77-324a-4ec4-9619-469f58a8f49a" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_b48e0d77-324a-4ec4-9619-469f58a8f49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_44c06a1f-7f11-4a5a-851e-8efa6c6a844a" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_44c06a1f-7f11-4a5a-851e-8efa6c6a844a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_93adaf60-ac06-49e4-a20f-ea6c15e5a92e" xlink:href="angn-20250331.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_c234eda3-4876-43df-979b-418384594184" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_93adaf60-ac06-49e4-a20f-ea6c15e5a92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c27a45f5-79af-4cfa-a6e3-c0c95a9001da" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant_d566c0d2-cecf-4b5b-8bf9-6344aa504b97" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrant_d566c0d2-cecf-4b5b-8bf9-6344aa504b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_72479190-a88d-452d-aa9e-a60e796efe11" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_72479190-a88d-452d-aa9e-a60e796efe11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b6af4e69-c488-499a-819c-fc5787679f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b6af4e69-c488-499a-819c-fc5787679f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit_04ab15fa-6e7e-4356-ae8b-5cff240661e8" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_ResearchAndDevelopmentArrangementCredit_04ab15fa-6e7e-4356-ae8b-5cff240661e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_00635e3f-2e19-4216-be6f-b35fdc96f676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_00635e3f-2e19-4216-be6f-b35fdc96f676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_9b3ab81c-706e-4dd0-8928-79af5f372953" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_us-gaap_RestrictedCashCurrent_9b3ab81c-706e-4dd0-8928-79af5f372953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_1d9478ff-0fe7-42d5-83ac-ebfea003bf41" xlink:href="angn-20250331.xsd#angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_1d9478ff-0fe7-42d5-83ac-ebfea003bf41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements_455e4e8b-1aaf-4baa-951c-77eecbe607ef" xlink:href="angn-20250331.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b556ad03-92d1-4f1e-89c0-33eafb04216a" xlink:to="loc_angn_NumberOfResearchGrantAgreements_455e4e8b-1aaf-4baa-951c-77eecbe607ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_099abb3a-e6e5-4922-a0fc-f62dd2da7ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_099abb3a-e6e5-4922-a0fc-f62dd2da7ec1" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6c6a6360-e950-4090-8d6d-e936d676ba50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6c6a6360-e950-4090-8d6d-e936d676ba50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8c87e7a9-54ed-4f7c-9d43-1ab9b9fc9e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c6a6360-e950-4090-8d6d-e936d676ba50" xlink:to="loc_us-gaap_EquityComponentDomain_8c87e7a9-54ed-4f7c-9d43-1ab9b9fc9e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_61ec01eb-b589-4c4c-acf7-4cd2a35df3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8c87e7a9-54ed-4f7c-9d43-1ab9b9fc9e4a" xlink:to="loc_us-gaap_CommonStockMember_61ec01eb-b589-4c4c-acf7-4cd2a35df3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8a7e2c9b-79fc-4597-ae66-792dbbad9284" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bfea94c5-fc20-41d4-b6e7-9fa7f6a7a870" xlink:to="loc_us-gaap_ClassOfStockDomain_8a7e2c9b-79fc-4597-ae66-792dbbad9284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_4ffc2b37-d1a2-49d1-9156-c7d6d2050374" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8a7e2c9b-79fc-4597-ae66-792dbbad9284" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_4ffc2b37-d1a2-49d1-9156-c7d6d2050374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_399aadc2-81f1-4d74-8d1c-3de40e219410" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_399aadc2-81f1-4d74-8d1c-3de40e219410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_399aadc2-81f1-4d74-8d1c-3de40e219410" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember_b83a9ad9-122a-40c6-910d-75c29fd3ba7a" xlink:href="angn-20250331.xsd#angn_RegistrationStatementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_RegistrationStatementMember_b83a9ad9-122a-40c6-910d-75c29fd3ba7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_7038b9f9-0f9d-4f7b-a2ec-b5110932f7ea" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_7038b9f9-0f9d-4f7b-a2ec-b5110932f7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember_e19d2127-f409-40e0-9eda-fac935703ce7" xlink:href="angn-20250331.xsd#angn_A2024RegistrationStatementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_A2024RegistrationStatementMember_e19d2127-f409-40e0-9eda-fac935703ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_74eb6854-9b6b-4dc7-844b-106086df9f4a" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_MarchSubscriptionAgreementMember_74eb6854-9b6b-4dc7-844b-106086df9f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_4852380a-a22b-48c7-9662-27dd9dec3a2f" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_JulyPublicOfferingMember_4852380a-a22b-48c7-9662-27dd9dec3a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_6388bd73-618b-4a14-a948-abd4016d835a" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_6388bd73-618b-4a14-a948-abd4016d835a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_a96b8386-9197-4f7c-a5f6-f5ce8b1b38c0" xlink:href="angn-20250331.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_a96b8386-9197-4f7c-a5f6-f5ce8b1b38c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember_4f2973e6-48ca-4a14-99a8-fbaf40988e14" xlink:href="angn-20250331.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f415ddc-8660-44b9-a4c1-06a091de039c" xlink:to="loc_angn_JanuaryPublicOfferingMember_4f2973e6-48ca-4a14-99a8-fbaf40988e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_8594ed2e-49f8-445c-8e59-685ef1448e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_8594ed2e-49f8-445c-8e59-685ef1448e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8594ed2e-49f8-445c-8e59-685ef1448e6d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_eb822227-21ef-479b-a91c-f300721b2b59" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:to="loc_angn_PreFundedWarrantMember_eb822227-21ef-479b-a91c-f300721b2b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_e56eaf03-1ead-4e41-a66d-96b646b89f9d" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:to="loc_angn_JulyCommonWarrantsMember_e56eaf03-1ead-4e41-a66d-96b646b89f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember_047e713e-e37f-418b-ae8f-1f291073fc87" xlink:href="angn-20250331.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_45b63eda-3ccf-4dc7-9f4d-f5235ac6c351" xlink:to="loc_angn_JanuaryCommonWarrantsMember_047e713e-e37f-418b-ae8f-1f291073fc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_928c0288-36c7-4cd2-95a3-95f60e26703d" xlink:to="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3bb7f0c9-01dd-4747-ab04-4402e19e08bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3bb7f0c9-01dd-4747-ab04-4402e19e08bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e6827299-a6c7-4178-8130-fb9c3c43af35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e6827299-a6c7-4178-8130-fb9c3c43af35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_26363e51-6483-45ba-b440-8cb83117edb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_26363e51-6483-45ba-b440-8cb83117edb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_792784b4-5e72-45b3-a427-50c8244147df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_792784b4-5e72-45b3-a427-50c8244147df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice_ea16602d-a2ae-4ed8-92ac-e760eaec160f" xlink:href="angn-20250331.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_angn_SaleOfStockAggregateInitialOfferingPrice_ea16602d-a2ae-4ed8-92ac-e760eaec160f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ad8616ea-395e-47b6-a74b-5df248946cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ad8616ea-395e-47b6-a74b-5df248946cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a8762370-187b-4067-88fc-5fcc1ad23e02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a8762370-187b-4067-88fc-5fcc1ad23e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1bcbde04-ec7d-4b12-99cb-460a7ce72d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1bcbde04-ec7d-4b12-99cb-460a7ce72d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_e33ef08f-5bb5-4a9a-aa7f-ac170fd435c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_e33ef08f-5bb5-4a9a-aa7f-ac170fd435c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_97626a53-c37c-452f-9579-a872a39fc617" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_97626a53-c37c-452f-9579-a872a39fc617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_faf44442-6703-4572-94ca-85765678a09d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_faf44442-6703-4572-94ca-85765678a09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_da8829da-08ae-4f71-b2da-a6c81a1d8470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_da8829da-08ae-4f71-b2da-a6c81a1d8470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_415fbf2f-a64b-451b-9da6-af1a5f46b125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_415fbf2f-a64b-451b-9da6-af1a5f46b125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_77ece132-8dd6-4547-90d1-1825201667d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_acacad5a-98f4-40bf-baa0-d7378a668eea" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_77ece132-8dd6-4547-90d1-1825201667d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_522e6b46-4057-44eb-af4f-3500ce88fff8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_522e6b46-4057-44eb-af4f-3500ce88fff8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c08bb551-cd66-43a0-9bb0-08cdcf93bd37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:to="loc_us-gaap_PlanNameAxis_c08bb551-cd66-43a0-9bb0-08cdcf93bd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_c08bb551-cd66-43a0-9bb0-08cdcf93bd37" xlink:to="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2021PlanMember_cf2be1f3-3318-4cf8-bbde-6304a5800c38" xlink:href="angn-20250331.xsd#angn_The2021PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:to="loc_angn_The2021PlanMember_cf2be1f3-3318-4cf8-bbde-6304a5800c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2022PlanMember_09dbaf19-2153-4a41-9dcf-6c0af2ee520e" xlink:href="angn-20250331.xsd#angn_The2022PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:to="loc_angn_The2022PlanMember_09dbaf19-2153-4a41-9dcf-6c0af2ee520e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_Inducement2024PlanMember_28bc8cf9-960c-47ef-88d1-750c779a4f99" xlink:href="angn-20250331.xsd#angn_Inducement2024PlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6dcadb9a-d2a7-46f9-b027-f784fb3662d2" xlink:to="loc_angn_Inducement2024PlanMember_28bc8cf9-960c-47ef-88d1-750c779a4f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d08a8e92-22a2-4679-b821-bccd51b523e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:to="loc_us-gaap_AwardTypeAxis_d08a8e92-22a2-4679-b821-bccd51b523e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b395c5b3-25e7-4f59-87ab-dc51fc39fc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d08a8e92-22a2-4679-b821-bccd51b523e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b395c5b3-25e7-4f59-87ab-dc51fc39fc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_968a1617-efa4-422e-bcb2-aff433c0df14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b395c5b3-25e7-4f59-87ab-dc51fc39fc4e" xlink:to="loc_us-gaap_EmployeeStockMember_968a1617-efa4-422e-bcb2-aff433c0df14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6a3e052-dca3-4898-a93f-800820d34a52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_354f524a-b8b5-40ce-91f6-775bc3e8818d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_354f524a-b8b5-40ce-91f6-775bc3e8818d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_9df1e170-bcbd-458d-922c-e5688a114627" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_9df1e170-bcbd-458d-922c-e5688a114627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5b8bcd01-f24e-485d-90fe-a86339996954" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5b8bcd01-f24e-485d-90fe-a86339996954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4785b203-b720-40f4-bd70-9a9cb6f66b60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4785b203-b720-40f4-bd70-9a9cb6f66b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_12bb7910-64a4-4086-a566-8a81e009e289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_12bb7910-64a4-4086-a566-8a81e009e289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_38aaefd9-aac8-49c4-9079-ced156bf58e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_38aaefd9-aac8-49c4-9079-ced156bf58e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_eb99ca55-6cfb-4e68-8aff-ab38dbcbe62e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a1a47ae8-bdd0-4f5d-969c-f8cbc4d9cb9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_eb99ca55-6cfb-4e68-8aff-ab38dbcbe62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensationScheduleofShareOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b39b696-ec3e-4af4-93ed-08a31d765f69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3bff53b-3ed8-49a7-b56b-9bac3033fcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b39b696-ec3e-4af4-93ed-08a31d765f69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3bff53b-3ed8-49a7-b56b-9bac3033fcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_47efa679-79bd-43bf-8902-c2513021a6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3bff53b-3ed8-49a7-b56b-9bac3033fcbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_47efa679-79bd-43bf-8902-c2513021a6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0fce83b6-3e22-4218-ba23-1b9c265c4bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3bff53b-3ed8-49a7-b56b-9bac3033fcbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0fce83b6-3e22-4218-ba23-1b9c265c4bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f87b2eaa-52fa-487f-a6d3-d2644e838688" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3bff53b-3ed8-49a7-b56b-9bac3033fcbb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f87b2eaa-52fa-487f-a6d3-d2644e838688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3331c9ec-2211-4a3a-a700-f77a823e80d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3bff53b-3ed8-49a7-b56b-9bac3033fcbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3331c9ec-2211-4a3a-a700-f77a823e80d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4236cb10-2dcc-4dee-8ee1-a8518e49f1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3bff53b-3ed8-49a7-b56b-9bac3033fcbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4236cb10-2dcc-4dee-8ee1-a8518e49f1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_18a23198-7e0a-4d24-ad23-6d1d78315791" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b39b696-ec3e-4af4-93ed-08a31d765f69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_18a23198-7e0a-4d24-ad23-6d1d78315791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0ab40b55-c479-4a1c-8d5c-e3e6843c9e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b39b696-ec3e-4af4-93ed-08a31d765f69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0ab40b55-c479-4a1c-8d5c-e3e6843c9e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_42512965-dbaf-499c-a7de-92b2d049314a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0ab40b55-c479-4a1c-8d5c-e3e6843c9e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_42512965-dbaf-499c-a7de-92b2d049314a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_de7424a2-53bf-49d3-a653-866e0b9f4299" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0ab40b55-c479-4a1c-8d5c-e3e6843c9e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_de7424a2-53bf-49d3-a653-866e0b9f4299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4290234d-9128-4e83-a415-e3387e5ad0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0ab40b55-c479-4a1c-8d5c-e3e6843c9e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4290234d-9128-4e83-a415-e3387e5ad0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a12bb9c6-5732-4084-8073-a8f97bb2123d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0ab40b55-c479-4a1c-8d5c-e3e6843c9e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a12bb9c6-5732-4084-8073-a8f97bb2123d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c308573c-ad89-4a60-961a-9a5d28c4c6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0ab40b55-c479-4a1c-8d5c-e3e6843c9e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c308573c-ad89-4a60-961a-9a5d28c4c6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a7763448-f20d-4ea4-8b9a-f6d2e94a8569" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b39b696-ec3e-4af4-93ed-08a31d765f69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a7763448-f20d-4ea4-8b9a-f6d2e94a8569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_abfb6b94-52a9-487c-bb3f-a9d128dafc00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b39b696-ec3e-4af4-93ed-08a31d765f69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_abfb6b94-52a9-487c-bb3f-a9d128dafc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_15f67973-8e67-4b51-9a82-bdaf6a51196a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_abfb6b94-52a9-487c-bb3f-a9d128dafc00" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_15f67973-8e67-4b51-9a82-bdaf6a51196a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c7f4f137-e400-4e11-b488-b625c1036780" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_abfb6b94-52a9-487c-bb3f-a9d128dafc00" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c7f4f137-e400-4e11-b488-b625c1036780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ac3be060-d604-42ab-a515-fc3263cb6307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_abfb6b94-52a9-487c-bb3f-a9d128dafc00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ac3be060-d604-42ab-a515-fc3263cb6307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_be55aef9-f542-43e9-9680-20745e4d7b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_abfb6b94-52a9-487c-bb3f-a9d128dafc00" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_be55aef9-f542-43e9-9680-20745e4d7b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72140d42-2925-4568-be0e-69d126a4a8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4a647b3-5c16-45b0-9326-b47fb789e2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72140d42-2925-4568-be0e-69d126a4a8e9" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4a647b3-5c16-45b0-9326-b47fb789e2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_96b27077-144d-40fa-95a9-b0e37290785b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4a647b3-5c16-45b0-9326-b47fb789e2b7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_96b27077-144d-40fa-95a9-b0e37290785b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2f7ac9bc-2b5c-4fa1-b916-dfce93d6a9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_96b27077-144d-40fa-95a9-b0e37290785b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2f7ac9bc-2b5c-4fa1-b916-dfce93d6a9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6be2a36c-21a6-4ac0-822b-f96a318a4776" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f7ac9bc-2b5c-4fa1-b916-dfce93d6a9c5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6be2a36c-21a6-4ac0-822b-f96a318a4776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c95e1854-899a-4403-b9dd-08b98ae4d440" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f7ac9bc-2b5c-4fa1-b916-dfce93d6a9c5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c95e1854-899a-4403-b9dd-08b98ae4d440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_642a8ffa-eb57-4aa8-9b00-5f371de4c023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4a647b3-5c16-45b0-9326-b47fb789e2b7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_642a8ffa-eb57-4aa8-9b00-5f371de4c023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_659f908c-47b5-422c-8e7e-c1ec6704bc03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_642a8ffa-eb57-4aa8-9b00-5f371de4c023" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_659f908c-47b5-422c-8e7e-c1ec6704bc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5df374ff-f27f-43c7-89bd-9edeb18378c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5df374ff-f27f-43c7-89bd-9edeb18378c0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_034c9afc-67b4-4bec-9024-af67e0c9414d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:to="loc_us-gaap_AwardTypeAxis_034c9afc-67b4-4bec-9024-af67e0c9414d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5ebc09f0-a610-4868-b70d-ca0fb43fbf67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_034c9afc-67b4-4bec-9024-af67e0c9414d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5ebc09f0-a610-4868-b70d-ca0fb43fbf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a92648a9-dc28-4199-86e8-0d6fb34028f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5ebc09f0-a610-4868-b70d-ca0fb43fbf67" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a92648a9-dc28-4199-86e8-0d6fb34028f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:to="loc_srt_RangeAxis_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a06c5de5-6ca0-449a-85e6-a90d4fb48ad7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c6d23a3a-465b-43a1-b2db-6c6e7cb7e225" xlink:to="loc_srt_RangeMember_a06c5de5-6ca0-449a-85e6-a90d4fb48ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_47a3177c-e926-4a73-94fa-d9f012ebfdcf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a06c5de5-6ca0-449a-85e6-a90d4fb48ad7" xlink:to="loc_srt_MinimumMember_47a3177c-e926-4a73-94fa-d9f012ebfdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0cc36f53-2d6e-412e-860b-fc109124932a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a06c5de5-6ca0-449a-85e6-a90d4fb48ad7" xlink:to="loc_srt_MaximumMember_0cc36f53-2d6e-412e-860b-fc109124932a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a15efd0b-d2c1-4b07-8c08-a40199f3c7d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9d0f59ac-0064-4df1-a4f3-d1a0fae89dff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9d0f59ac-0064-4df1-a4f3-d1a0fae89dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4831c1d8-64b4-45b1-8f20-5453da40d378" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4831c1d8-64b4-45b1-8f20-5453da40d378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b71a3ce9-4728-408d-8273-4e252774f583" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b71a3ce9-4728-408d-8273-4e252774f583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5d60f2e5-27ba-4c4b-b5e6-a68fb592e3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5d60f2e5-27ba-4c4b-b5e6-a68fb592e3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_6a799027-eae4-48c7-8372-914898f491c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_6a799027-eae4-48c7-8372-914898f491c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_e76478fe-8cc7-4acd-a8b1-b2c9e88fe6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94a2fd9e-3c2d-4a15-ac69-3d26075bd829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_e76478fe-8cc7-4acd-a8b1-b2c9e88fe6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#WarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_1f1d3ee9-0a45-4fd6-97da-ec75a7599912" xlink:href="angn-20250331.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_1f1d3ee9-0a45-4fd6-97da-ec75a7599912" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f7400a59-e02d-44e3-a94b-0fae708b261b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f7400a59-e02d-44e3-a94b-0fae708b261b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f7400a59-e02d-44e3-a94b-0fae708b261b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_12e7f956-dc95-4c79-a3a9-c01e05451256" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:to="loc_angn_PreFundedWarrantMember_12e7f956-dc95-4c79-a3a9-c01e05451256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_be0995f6-63ab-4870-9bb1-65d19139157f" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:to="loc_angn_JulyCommonWarrantsMember_be0995f6-63ab-4870-9bb1-65d19139157f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_f66e63c2-bbaa-4c9c-a368-dfdefe92c6d4" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fcb1da90-a2d3-408b-906a-f2d98a1d2f8f" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_f66e63c2-bbaa-4c9c-a368-dfdefe92c6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f85928d2-e52e-46c3-b646-e93a07b78dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f85928d2-e52e-46c3-b646-e93a07b78dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd3bed5e-a3c0-412b-ac9c-404cb272fc67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f85928d2-e52e-46c3-b646-e93a07b78dc4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd3bed5e-a3c0-412b-ac9c-404cb272fc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_783ba97a-06fd-49eb-a4f3-fffbdf6ec422" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd3bed5e-a3c0-412b-ac9c-404cb272fc67" xlink:to="loc_angn_MarchSubscriptionAgreementMember_783ba97a-06fd-49eb-a4f3-fffbdf6ec422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_89795c02-2cd6-4c0f-b03e-e561fc3dde12" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd3bed5e-a3c0-412b-ac9c-404cb272fc67" xlink:to="loc_angn_JulyPublicOfferingMember_89795c02-2cd6-4c0f-b03e-e561fc3dde12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_80b81030-71c7-42b0-ba52-bdedc5f9e2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_StatementClassOfStockAxis_80b81030-71c7-42b0-ba52-bdedc5f9e2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_908bb528-8c5d-4c1a-b314-b3d3bf11702f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_80b81030-71c7-42b0-ba52-bdedc5f9e2d4" xlink:to="loc_us-gaap_ClassOfStockDomain_908bb528-8c5d-4c1a-b314-b3d3bf11702f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_7469b660-bea5-4063-a9a7-ecdbb15601f0" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_908bb528-8c5d-4c1a-b314-b3d3bf11702f" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_7469b660-bea5-4063-a9a7-ecdbb15601f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fd0be2d8-27f8-49e1-b787-69cb22e57358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a79f39b8-7d2b-4bdf-b0fa-54033e1e53e2" xlink:to="loc_us-gaap_EquityComponentDomain_fd0be2d8-27f8-49e1-b787-69cb22e57358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2463f060-ec86-4435-9776-d3fec966337d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fd0be2d8-27f8-49e1-b787-69cb22e57358" xlink:to="loc_us-gaap_CommonStockMember_2463f060-ec86-4435-9776-d3fec966337d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f14fef64-dcb5-49a1-bcc1-9675d051a357" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f14fef64-dcb5-49a1-bcc1-9675d051a357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f4b1f661-b844-45f5-98af-9c86a93efcef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f14fef64-dcb5-49a1-bcc1-9675d051a357" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f4b1f661-b844-45f5-98af-9c86a93efcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_66a8cbf5-30a6-4936-84fa-313f0acb3ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f4b1f661-b844-45f5-98af-9c86a93efcef" xlink:to="loc_us-gaap_SubsequentEventMember_66a8cbf5-30a6-4936-84fa-313f0acb3ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c915050c-9739-4364-befe-0e3644801e10" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_a9f26bd9-8aef-4180-b420-a90363c6249a" xlink:href="angn-20250331.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_a9f26bd9-8aef-4180-b420-a90363c6249a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bf769f82-6171-49fa-aad6-c919d0a4e38d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bf769f82-6171-49fa-aad6-c919d0a4e38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrants_4ba085ca-af0c-4f42-9a3e-4f6863ea8e00" xlink:href="angn-20250331.xsd#angn_FairValueOfCommonStockWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_angn_FairValueOfCommonStockWarrants_4ba085ca-af0c-4f42-9a3e-4f6863ea8e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_7667613d-e410-43bd-9db6-0312b518bad1" xlink:href="angn-20250331.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_7667613d-e410-43bd-9db6-0312b518bad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_694e0ef9-b0c8-426d-834b-0c606195700a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_694e0ef9-b0c8-426d-834b-0c606195700a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0cdd2b67-a2cd-47ea-8179-f208612c55e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0cdd2b67-a2cd-47ea-8179-f208612c55e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_67c3b34f-d481-4fb8-af13-bf91af04f97e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_67c3b34f-d481-4fb8-af13-bf91af04f97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9cbdb69f-8dd7-4ba6-bb88-2906813e727c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9cbdb69f-8dd7-4ba6-bb88-2906813e727c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_e8d24bf5-9939-482f-9579-0a381bb7e51b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_e8d24bf5-9939-482f-9579-0a381bb7e51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_ffe671bf-f444-4da0-a658-9b281de3f5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3b00e736-ff61-4c07-a5ac-8bcdb4445c0c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_ffe671bf-f444-4da0-a658-9b281de3f5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#WarrantsScheduleofOutstandingWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_085355b8-9b8b-4550-a4b6-5159cb7679a2" xlink:href="angn-20250331.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightRollForward_385b72bd-80d5-4f19-a09e-89e5377f4464" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_085355b8-9b8b-4550-a4b6-5159cb7679a2" xlink:to="loc_angn_ClassOfWarrantOrRightRollForward_385b72bd-80d5-4f19-a09e-89e5377f4464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_599095a1-4dbc-45ed-b43f-6c48ed16abce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_385b72bd-80d5-4f19-a09e-89e5377f4464" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_599095a1-4dbc-45ed-b43f-6c48ed16abce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_9e9c5e7c-1676-4abe-bbc5-ba05bc80606b" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_385b72bd-80d5-4f19-a09e-89e5377f4464" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_9e9c5e7c-1676-4abe-bbc5-ba05bc80606b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightExercisedInPeriod_9c331acf-ccde-4814-80ae-1ff54a21ff89" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightExercisedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_385b72bd-80d5-4f19-a09e-89e5377f4464" xlink:to="loc_angn_ClassOfWarrantOrRightExercisedInPeriod_9c331acf-ccde-4814-80ae-1ff54a21ff89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_ebf7c078-5031-4e11-8719-f38cf0081204" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_385b72bd-80d5-4f19-a09e-89e5377f4464" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_ebf7c078-5031-4e11-8719-f38cf0081204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_3bd6699c-ed4d-4ad6-a4bd-5bc9989281f6" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_085355b8-9b8b-4550-a4b6-5159cb7679a2" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_3bd6699c-ed4d-4ad6-a4bd-5bc9989281f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_585f1e10-0911-4522-8fe0-c07e0273e448" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_3bd6699c-ed4d-4ad6-a4bd-5bc9989281f6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_585f1e10-0911-4522-8fe0-c07e0273e448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_05d591e4-b19a-421d-87e7-3bd52a10296b" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_3bd6699c-ed4d-4ad6-a4bd-5bc9989281f6" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_05d591e4-b19a-421d-87e7-3bd52a10296b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_5016ce41-a113-4627-bbb2-73c8b20b45fe" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_3bd6699c-ed4d-4ad6-a4bd-5bc9989281f6" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_5016ce41-a113-4627-bbb2-73c8b20b45fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3b61c2ef-422b-49e8-848a-30bba653ae61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_3bd6699c-ed4d-4ad6-a4bd-5bc9989281f6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3b61c2ef-422b-49e8-848a-30bba653ae61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_f1523843-821b-4edb-bedb-ca7eb4eeb1b9" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_085355b8-9b8b-4550-a4b6-5159cb7679a2" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_f1523843-821b-4edb-bedb-ca7eb4eeb1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_67135bb7-5c88-455f-b60c-e2ecb011d90c" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_f1523843-821b-4edb-bedb-ca7eb4eeb1b9" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_67135bb7-5c88-455f-b60c-e2ecb011d90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_bd3d912a-d4e8-446e-8d78-cef6d98da5f5" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_f1523843-821b-4edb-bedb-ca7eb4eeb1b9" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_bd3d912a-d4e8-446e-8d78-cef6d98da5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_debdd695-290d-44ab-955f-c18cbb20f474" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureTable_ce42cd13-0c30-4eb3-9bb2-ab2267c28106" xlink:href="angn-20250331.xsd#angn_CommitmentsAndContingenciesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_debdd695-290d-44ab-955f-c18cbb20f474" xlink:to="loc_angn_CommitmentsAndContingenciesDisclosureTable_ce42cd13-0c30-4eb3-9bb2-ab2267c28106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3e8e6d86-5a38-42a4-885e-5c51744a287c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_ce42cd13-0c30-4eb3-9bb2-ab2267c28106" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3e8e6d86-5a38-42a4-885e-5c51744a287c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cca94c1f-8ba7-4bd9-982d-0f8abfc67ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3e8e6d86-5a38-42a4-885e-5c51744a287c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cca94c1f-8ba7-4bd9-982d-0f8abfc67ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5bd6bb70-c31d-4bdc-ab37-c81833671657" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cca94c1f-8ba7-4bd9-982d-0f8abfc67ea8" xlink:to="loc_us-gaap_SubsequentEventMember_5bd6bb70-c31d-4bdc-ab37-c81833671657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:href="angn-20250331.xsd#angn_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_ce42cd13-0c30-4eb3-9bb2-ab2267c28106" xlink:to="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LicenseExpense_29ff8f8d-c294-48f0-8457-b010c014fcde" xlink:href="angn-20250331.xsd#angn_LicenseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:to="loc_angn_LicenseExpense_29ff8f8d-c294-48f0-8457-b010c014fcde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments_863202db-79cc-4182-9e4d-ff8f4d99e874" xlink:href="angn-20250331.xsd#angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:to="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments_863202db-79cc-4182-9e4d-ff8f4d99e874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter_7ea9aa9c-d435-4156-969f-0ee11d91550d" xlink:href="angn-20250331.xsd#angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_a62e5eff-c175-45b6-a7d0-ff8f6282b05c" xlink:to="loc_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter_7ea9aa9c-d435-4156-969f-0ee11d91550d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_26b324b7-dd6a-457b-b8f6-748eac0d7fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_93e626b1-08a3-4e44-8537-9ffe0196d889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_26b324b7-dd6a-457b-b8f6-748eac0d7fbb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_93e626b1-08a3-4e44-8537-9ffe0196d889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0a0ee695-31df-424f-b335-2e9de3e618e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_93e626b1-08a3-4e44-8537-9ffe0196d889" xlink:to="loc_srt_StatementGeographicalAxis_0a0ee695-31df-424f-b335-2e9de3e618e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_639f02d8-4e55-4236-a570-e4c977ae5928" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0a0ee695-31df-424f-b335-2e9de3e618e9" xlink:to="loc_srt_SegmentGeographicalDomain_639f02d8-4e55-4236-a570-e4c977ae5928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember_c7dbbb39-fb98-4ca0-baff-e85c05538670" xlink:href="angn-20250331.xsd#angn_BostonMassachusettsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_639f02d8-4e55-4236-a570-e4c977ae5928" xlink:to="loc_angn_BostonMassachusettsMember_c7dbbb39-fb98-4ca0-baff-e85c05538670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember_1bfa7f78-7e14-4db8-9f32-f295e7941ca4" xlink:href="angn-20250331.xsd#angn_NewtonMassachusettsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_639f02d8-4e55-4236-a570-e4c977ae5928" xlink:to="loc_angn_NewtonMassachusettsMember_1bfa7f78-7e14-4db8-9f32-f295e7941ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_93e626b1-08a3-4e44-8537-9ffe0196d889" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_aed2af02-d1a3-4201-a0dc-36d45c349b32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_OperatingLeaseExpense_aed2af02-d1a3-4201-a0dc-36d45c349b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8919332e-0768-4a04-9aff-8d1afca9eb62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8919332e-0768-4a04-9aff-8d1afca9eb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ace68428-ec04-4ec6-a23f-cbd96fbd1c06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ace68428-ec04-4ec6-a23f-cbd96fbd1c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_201525c0-6013-4dff-b79e-6f17a174d7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_201525c0-6013-4dff-b79e-6f17a174d7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_663c8199-cdb4-4fce-b50f-baf49f75599d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_663c8199-cdb4-4fce-b50f-baf49f75599d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense_a60895b8-3233-4ac5-accf-d7e6de917e44" xlink:href="angn-20250331.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09842fbf-da79-4e2a-88d6-3e907c64e32b" xlink:to="loc_angn_LesseeOperatingLeaseAnnualRentExpense_a60895b8-3233-4ac5-accf-d7e6de917e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_50c9f6ba-3ec1-4d73-bf10-d50030f67091" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f5da94f6-a9e7-4947-b4eb-e01faa571d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_50c9f6ba-3ec1-4d73-bf10-d50030f67091" xlink:to="loc_us-gaap_OperatingLeasePayments_f5da94f6-a9e7-4947-b4eb-e01faa571d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_80db5aaf-61af-4096-a792-ec7c6e7e5fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_50c9f6ba-3ec1-4d73-bf10-d50030f67091" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_80db5aaf-61af-4096-a792-ec7c6e7e5fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1a518b09-d1c2-49bc-b3f3-c75e2988fb25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_50c9f6ba-3ec1-4d73-bf10-d50030f67091" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1a518b09-d1c2-49bc-b3f3-c75e2988fb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_00c89a1a-67c5-4bc1-9c95-faba5def1e85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_00c89a1a-67c5-4bc1-9c95-faba5def1e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c0c3f33c-f27b-4223-b5e9-9172cb55a2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c0c3f33c-f27b-4223-b5e9-9172cb55a2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_097d665e-4a1f-4916-9d3a-b6c87e0a67f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_097d665e-4a1f-4916-9d3a-b6c87e0a67f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2fd0ae8b-724e-48a3-a795-1c1c72858340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2fd0ae8b-724e-48a3-a795-1c1c72858340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7b9bd687-054e-4646-a943-76e7c216df2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7b9bd687-054e-4646-a943-76e7c216df2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_cfabe0cb-c79d-4b41-a7cd-0383af3e86af" xlink:href="angn-20250331.xsd#angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_cfabe0cb-c79d-4b41-a7cd-0383af3e86af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f7bedaf1-468d-4bdf-b820-be089fe31a11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f7bedaf1-468d-4bdf-b820-be089fe31a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b6634b12-5c3c-473a-a56a-fa3b2c8d8517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b6634b12-5c3c-473a-a56a-fa3b2c8d8517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_992e4934-71be-4b53-acc0-b0b455ebc625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_OperatingLeaseLiability_992e4934-71be-4b53-acc0-b0b455ebc625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f17053ec-a84a-4c13-a781-2f08cac74c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f17053ec-a84a-4c13-a781-2f08cac74c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ffe1e56b-2154-4fbe-944d-e6cfa8495464" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_74ab5af5-b6be-4ad7-a0e5-0c702c714a44" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ffe1e56b-2154-4fbe-944d-e6cfa8495464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_42d4f5ac-fd69-4fdc-9356-16ec87e41a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_42d4f5ac-fd69-4fdc-9356-16ec87e41a3f" xlink:to="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_070e1179-321a-46b5-a133-881822583aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_DebtInstrumentAxis_070e1179-321a-46b5-a133-881822583aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_70699c13-efe4-4f5f-b0d1-fc63354d3ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_070e1179-321a-46b5-a133-881822583aaf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_70699c13-efe4-4f5f-b0d1-fc63354d3ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b9e35457-4669-402a-b4ba-ceeadd6e0832" xlink:href="angn-20250331.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_70699c13-efe4-4f5f-b0d1-fc63354d3ae6" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b9e35457-4669-402a-b4ba-ceeadd6e0832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cd9da6d7-4e18-471f-96c5-65185930d945" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cd9da6d7-4e18-471f-96c5-65185930d945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0e6d814d-2f5a-4a88-b972-36a67a2e9f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd9da6d7-4e18-471f-96c5-65185930d945" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0e6d814d-2f5a-4a88-b972-36a67a2e9f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_42ff513c-ff2b-41a1-adc4-8d8f6141a110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0e6d814d-2f5a-4a88-b972-36a67a2e9f81" xlink:to="loc_us-gaap_ConvertibleDebtMember_42ff513c-ff2b-41a1-adc4-8d8f6141a110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_3ed8731d-9b73-4fdf-b5f1-1337006814b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_3ed8731d-9b73-4fdf-b5f1-1337006814b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3ed8731d-9b73-4fdf-b5f1-1337006814b9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_06692847-dde0-4793-ba54-31a358b43ec0" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:to="loc_angn_PreFundedWarrantMember_06692847-dde0-4793-ba54-31a358b43ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_7eb7a766-424e-46af-81bd-d8df758fc89d" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_7eb7a766-424e-46af-81bd-d8df758fc89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_18de7b61-01ec-48e2-a364-ac3993fc0379" xlink:href="angn-20250331.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_05c4831e-cd41-428b-b395-e450d03c340e" xlink:to="loc_angn_JulyCommonWarrantsMember_18de7b61-01ec-48e2-a364-ac3993fc0379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3652fb96-ec43-49dc-8de2-3b175e7e68bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3652fb96-ec43-49dc-8de2-3b175e7e68bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_994559dd-c851-45db-a393-9e98cb70aea8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3652fb96-ec43-49dc-8de2-3b175e7e68bd" xlink:to="loc_us-gaap_EquityComponentDomain_994559dd-c851-45db-a393-9e98cb70aea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3025d776-7f80-45c7-ada2-ec38dcfd34bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_994559dd-c851-45db-a393-9e98cb70aea8" xlink:to="loc_us-gaap_CommonStockMember_3025d776-7f80-45c7-ada2-ec38dcfd34bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_acbb5f4e-8024-4126-b27d-0c20b56c3605" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_acbb5f4e-8024-4126-b27d-0c20b56c3605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_df9e85b6-b78d-4a8a-9aeb-ee53e41e8ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_acbb5f4e-8024-4126-b27d-0c20b56c3605" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_df9e85b6-b78d-4a8a-9aeb-ee53e41e8ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1d0d0461-1fc2-4cf3-8bd4-da9b55087632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_df9e85b6-b78d-4a8a-9aeb-ee53e41e8ed6" xlink:to="loc_us-gaap_SubsequentEventMember_1d0d0461-1fc2-4cf3-8bd4-da9b55087632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ed560d43-4f8b-4dce-8c1c-b1815e7d4804" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ed560d43-4f8b-4dce-8c1c-b1815e7d4804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8195d3bd-5b96-41bd-9bb8-cb70f3f0b09c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ed560d43-4f8b-4dce-8c1c-b1815e7d4804" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8195d3bd-5b96-41bd-9bb8-cb70f3f0b09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_5a54da9e-5ce0-4354-848b-c8c08adf7810" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8195d3bd-5b96-41bd-9bb8-cb70f3f0b09c" xlink:to="loc_angn_JulyPublicOfferingMember_5a54da9e-5ce0-4354-848b-c8c08adf7810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ff55eada-1c6e-4943-8bf2-ccb19f651e17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ff55eada-1c6e-4943-8bf2-ccb19f651e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_86d2c0df-479d-40b3-be03-bcb5f6333c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ff55eada-1c6e-4943-8bf2-ccb19f651e17" xlink:to="loc_us-gaap_ClassOfStockDomain_86d2c0df-479d-40b3-be03-bcb5f6333c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_27a5beea-9c36-4c47-b468-ff733b8db7ea" xlink:href="angn-20250331.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_86d2c0df-479d-40b3-be03-bcb5f6333c7d" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_27a5beea-9c36-4c47-b468-ff733b8db7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_acbc56a3-7e1d-4260-b28e-734948ef1d3b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f5d0ff1-0b4e-43ab-905c-f063b33d287d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f5d0ff1-0b4e-43ab-905c-f063b33d287d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5c05b3b8-62a8-4de7-82c1-0a3e991bd895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5c05b3b8-62a8-4de7-82c1-0a3e991bd895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_dd62d17f-a167-4a68-9dae-4c614380515a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_dd62d17f-a167-4a68-9dae-4c614380515a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_add6a810-20b0-4543-aa17-825c7be3dca7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_add6a810-20b0-4543-aa17-825c7be3dca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_21e7c1b3-d27b-4934-9044-c00a33f845be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_InterestExpenseDebt_21e7c1b3-d27b-4934-9044-c00a33f845be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_36f873f1-ad3f-4e8a-9076-20924cc9356f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_36f873f1-ad3f-4e8a-9076-20924cc9356f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_36365e56-164d-4657-a16e-d8e19f5a8735" xlink:href="angn-20250331.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_36365e56-164d-4657-a16e-d8e19f5a8735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_e7743ea2-76cf-42b7-a042-2b02e45de5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_e7743ea2-76cf-42b7-a042-2b02e45de5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c5582dd5-77da-4291-904c-1cc046efc386" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c5582dd5-77da-4291-904c-1cc046efc386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a8b42794-9e57-4e52-8fd3-d7ddb33bbd05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c58572e4-f22f-4950-ac1e-d45d92d833a2" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a8b42794-9e57-4e52-8fd3-d7ddb33bbd05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_444a1a77-3684-4217-a93d-264077860c23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_06aecf53-3ad3-4c3c-bffa-5fe0257fc447" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_444a1a77-3684-4217-a93d-264077860c23" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_06aecf53-3ad3-4c3c-bffa-5fe0257fc447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2a8af9a0-8870-4072-b561-7d55787c227c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_b21e28e6-5531-483a-b732-e0bdfd4e7d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a8af9a0-8870-4072-b561-7d55787c227c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_b21e28e6-5531-483a-b732-e0bdfd4e7d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0b0d0d81-41d7-4216-be26-f4ab23f4c20d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_b21e28e6-5531-483a-b732-e0bdfd4e7d3a" xlink:to="loc_us-gaap_NetIncomeLoss_0b0d0d81-41d7-4216-be26-f4ab23f4c20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0ef098b2-cf81-4ee2-a2bf-69aab3469985" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a8af9a0-8870-4072-b561-7d55787c227c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0ef098b2-cf81-4ee2-a2bf-69aab3469985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f3fdc13-74be-46b9-8099-fb934d945a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0ef098b2-cf81-4ee2-a2bf-69aab3469985" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f3fdc13-74be-46b9-8099-fb934d945a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01a8d122-3254-455b-bd8e-03ab15797bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0ef098b2-cf81-4ee2-a2bf-69aab3469985" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01a8d122-3254-455b-bd8e-03ab15797bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bd019ab6-fd36-4996-ba5e-64c3b0ae156c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a8af9a0-8870-4072-b561-7d55787c227c" xlink:to="loc_us-gaap_EarningsPerShareBasic_bd019ab6-fd36-4996-ba5e-64c3b0ae156c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8fa0554c-ddd7-4991-ba33-ee735e2765b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a8af9a0-8870-4072-b561-7d55787c227c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8fa0554c-ddd7-4991-ba33-ee735e2765b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5f4e254c-9ef5-4ca9-a71a-e40c625fed5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1d4e7175-f35b-47b7-88f1-2ca0d27300b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f4e254c-9ef5-4ca9-a71a-e40c625fed5f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1d4e7175-f35b-47b7-88f1-2ca0d27300b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5973ec9-6a95-4e60-a210-db5d03bfa76e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1d4e7175-f35b-47b7-88f1-2ca0d27300b2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5973ec9-6a95-4e60-a210-db5d03bfa76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d5973ec9-6a95-4e60-a210-db5d03bfa76e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1a6e508f-8e1c-4fc7-ac62-10e0cd478afc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1a6e508f-8e1c-4fc7-ac62-10e0cd478afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_37e46980-c201-4397-ac21-6b64f7ab54dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:to="loc_us-gaap_WarrantMember_37e46980-c201-4397-ac21-6b64f7ab54dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d16fa4ec-055a-4729-a6f3-751e52b8bd16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b57106ea-64dd-4423-a9e9-3c3a67652df7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d16fa4ec-055a-4729-a6f3-751e52b8bd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9f23b4ca-a8b4-47b6-9f28-ace4b8981712" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1d4e7175-f35b-47b7-88f1-2ca0d27300b2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9f23b4ca-a8b4-47b6-9f28-ace4b8981712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12c2b1db-730f-45bd-b617-0a25e44eb9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9f23b4ca-a8b4-47b6-9f28-ace4b8981712" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12c2b1db-730f-45bd-b617-0a25e44eb9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_c1818b37-9978-47dd-b168-45cd9dfe6293" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_c1818b37-9978-47dd-b168-45cd9dfe6293" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_aa1ffa68-fb51-4694-b67b-6864b99812c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_aa1ffa68-fb51-4694-b67b-6864b99812c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_9a8aab1e-8b80-4d55-bbc9-293ccbd83312" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_aa1ffa68-fb51-4694-b67b-6864b99812c6" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_9a8aab1e-8b80-4d55-bbc9-293ccbd83312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember_fb43baab-ec6c-4ccd-8e88-823086561c6b" xlink:href="angn-20250331.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9a8aab1e-8b80-4d55-bbc9-293ccbd83312" xlink:to="loc_angn_PurchaseOfWarrantsMember_fb43baab-ec6c-4ccd-8e88-823086561c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4357a30b-2368-4ecd-bae6-da1d62b2e8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4357a30b-2368-4ecd-bae6-da1d62b2e8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50a1c466-17bd-4668-bebc-bed88122e377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4357a30b-2368-4ecd-bae6-da1d62b2e8e7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50a1c466-17bd-4668-bebc-bed88122e377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_b6b56d7c-9996-4da4-b8fa-b51e87f029ae" xlink:href="angn-20250331.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50a1c466-17bd-4668-bebc-bed88122e377" xlink:to="loc_angn_MarchSubscriptionAgreementMember_b6b56d7c-9996-4da4-b8fa-b51e87f029ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_1114e5dd-563a-4983-b143-29b27484b78a" xlink:href="angn-20250331.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_50a1c466-17bd-4668-bebc-bed88122e377" xlink:to="loc_angn_JulyPublicOfferingMember_1114e5dd-563a-4983-b143-29b27484b78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_597de904-037e-4efe-9507-aaa7cb14faff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_597de904-037e-4efe-9507-aaa7cb14faff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e97012e4-456d-4f0a-a0f2-2606d1db28bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_597de904-037e-4efe-9507-aaa7cb14faff" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e97012e4-456d-4f0a-a0f2-2606d1db28bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_e95a12d8-31af-48fb-8522-f591733fb335" xlink:href="angn-20250331.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e97012e4-456d-4f0a-a0f2-2606d1db28bc" xlink:to="loc_angn_PreFundedWarrantMember_e95a12d8-31af-48fb-8522-f591733fb335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_4892533c-774f-4cc9-9296-8b370500c472" xlink:href="angn-20250331.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e97012e4-456d-4f0a-a0f2-2606d1db28bc" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_4892533c-774f-4cc9-9296-8b370500c472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a14bf6f6-0b19-4a17-9fd7-f376d327da98" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_srt_CounterpartyNameAxis_a14bf6f6-0b19-4a17-9fd7-f376d327da98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc6461af-a940-49fa-a72a-7c6da312dd5a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a14bf6f6-0b19-4a17-9fd7-f376d327da98" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc6461af-a940-49fa-a72a-7c6da312dd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember_b784f5e4-6387-4c63-8038-6037d89a80c0" xlink:href="angn-20250331.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc6461af-a940-49fa-a72a-7c6da312dd5a" xlink:to="loc_angn_YekaterinaChudnovskyMember_b784f5e4-6387-4c63-8038-6037d89a80c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_c3969111-dfda-4d2a-8e38-1802457dfed7" xlink:href="angn-20250331.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc6461af-a940-49fa-a72a-7c6da312dd5a" xlink:to="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_c3969111-dfda-4d2a-8e38-1802457dfed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a70f3569-a107-47c6-b3ee-db0e0bae7f33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_DebtInstrumentAxis_a70f3569-a107-47c6-b3ee-db0e0bae7f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d2cc165b-856e-4376-9ad1-7446c56a5384" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a70f3569-a107-47c6-b3ee-db0e0bae7f33" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d2cc165b-856e-4376-9ad1-7446c56a5384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_c1f9c295-ab51-4428-9569-1a01326becf1" xlink:href="angn-20250331.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2cc165b-856e-4376-9ad1-7446c56a5384" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_c1f9c295-ab51-4428-9569-1a01326becf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f241038a-14d0-405b-a3cd-b5cbdefd35be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f241038a-14d0-405b-a3cd-b5cbdefd35be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f3978dca-78f9-468b-8efa-5387d489e89a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f241038a-14d0-405b-a3cd-b5cbdefd35be" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f3978dca-78f9-468b-8efa-5387d489e89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_3b2ec85b-8112-403f-95ac-761f450e3d84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f3978dca-78f9-468b-8efa-5387d489e89a" xlink:to="loc_us-gaap_ConvertibleDebtMember_3b2ec85b-8112-403f-95ac-761f450e3d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_dbcaaf73-53f9-472f-ac02-82b4f3655dad" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8ceadf2f-f8ee-4b66-8e7d-992985695d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8ceadf2f-f8ee-4b66-8e7d-992985695d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_6207104d-1ed2-4670-822e-ebc25496495c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_6207104d-1ed2-4670-822e-ebc25496495c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_a37e9b49-a628-42bd-be11-44d615c3c0f7" xlink:href="angn-20250331.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_a37e9b49-a628-42bd-be11-44d615c3c0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_51bdb2c8-b6c3-4462-93e8-f042cff3870f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_51bdb2c8-b6c3-4462-93e8-f042cff3870f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_69d550ac-36da-44d7-b7ce-2a0d3ef57cca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_69d550ac-36da-44d7-b7ce-2a0d3ef57cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_999bb826-6d20-49bc-a6bd-799be150b9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_fe7de84b-61e4-46e0-9bc4-c2096aa58c9a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_999bb826-6d20-49bc-a6bd-799be150b9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="angn-20250331.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ee666c5b-cf09-4f2a-9fac-f8fb9934c113" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_4adbee39-6263-4c16-914a-ffa71cf7e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee666c5b-cf09-4f2a-9fac-f8fb9934c113" xlink:to="loc_us-gaap_NumberOfReportableSegments_4adbee39-6263-4c16-914a-ffa71cf7e1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee666c5b-cf09-4f2a-9fac-f8fb9934c113" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:to="loc_srt_ProductOrServiceAxis_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c4f3ad20-9ea6-4f31-ae2a-dc620b8f8180" xlink:to="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember_1c88af88-6400-40e4-8d36-a1ce061f7216" xlink:href="angn-20250331.xsd#angn_ClinicalTrailMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:to="loc_angn_ClinicalTrailMember_1c88af88-6400-40e4-8d36-a1ce061f7216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_cc327284-580c-4344-9a53-273a9fac5aeb" xlink:href="angn-20250331.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:to="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_cc327284-580c-4344-9a53-273a9fac5aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember_32246cd0-e427-436b-a408-c29efc8a95f1" xlink:href="angn-20250331.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:to="loc_angn_TranslationalMedicineAndCMCMember_32246cd0-e427-436b-a408-c29efc8a95f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember_44e06d7d-0a96-4073-8d32-97efa5d05e98" xlink:href="angn-20250331.xsd#angn_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a9d8f0ae-1aee-48c7-9f09-e04122814e59" xlink:to="loc_angn_OtherMember_44e06d7d-0a96-4073-8d32-97efa5d05e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_159ed1e5-319f-4632-bd4b-7770f0b705de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_159ed1e5-319f-4632-bd4b-7770f0b705de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_95f20ec2-3e64-4a76-85bd-b594e0de946b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_159ed1e5-319f-4632-bd4b-7770f0b705de" xlink:to="loc_us-gaap_SegmentDomain_95f20ec2-3e64-4a76-85bd-b594e0de946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember_fb254ac9-513a-4fdb-bafe-cec614cc4243" xlink:href="angn-20250331.xsd#angn_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_95f20ec2-3e64-4a76-85bd-b594e0de946b" xlink:to="loc_angn_ReportableSegmentMember_fb254ac9-513a-4fdb-bafe-cec614cc4243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d8846d55-0f24-4a83-b00c-1dc1062a355b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_da2a1588-3906-4346-bafb-222250824a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_da2a1588-3906-4346-bafb-222250824a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_3baf1dce-4bc9-484a-97db-42085703dc80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_3baf1dce-4bc9-484a-97db-42085703dc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_85a58549-b977-49ef-be08-6b2161f3d0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_85a58549-b977-49ef-be08-6b2161f3d0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_ad5300c0-0cdb-43e7-a227-c2ba7fcb3d04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_ad5300c0-0cdb-43e7-a227-c2ba7fcb3d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_1ce41a70-04e2-42ba-b5e6-8bc57db4ff8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_1ce41a70-04e2-42ba-b5e6-8bc57db4ff8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d37403d8-0957-41d3-a4ea-c33d2dce3563" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_NetIncomeLoss_d37403d8-0957-41d3-a4ea-c33d2dce3563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_751ad036-df22-4f6d-bf2e-a75e7c9a354d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6fb2c34d-a6fe-4c73-a8b9-075b2450ca28" xlink:to="loc_us-gaap_Assets_751ad036-df22-4f6d-bf2e-a75e7c9a354d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>elicio-amendedandrestate001.jpg
<TEXT>
begin 644 elicio-amendedandrestate001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -=$EC:.15=&!5E89
M!!Z@BE551%1%"JHP !@ 4M% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMG93VUJLK1#SV7<S  G@9XY]:L>)O%VG>%Q9QW0EGO;Z40V=G;@&6=R0,#)
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MW6FP3:A%CR[EQF1,<C:W4=3T]:MV6E6.G23R6EN(GN'WS$$_O&_O')Y/ YH
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M*7=W=QZ5;1W%X"+F2-=AF!ZAL=<]\U7C\">%HK1[2/0K-+9SEX53",?=>AH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(]#N=8:2Y^QVUT;.1OLS[A*&"$%<9'S$#)Q71T <+XBTVPU[Q;HR:?J$7VJ
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MT71=4T_Q%XEOY_LHAU.6.6W\N5F9"D2Q_,"H'\.>":Z:D+*I ) +' R>IZT
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M>\A*QRL$95B09#%<Y[]/;WK5U#P/JL[7.MV5U:V_B%]3348E?<T "1>2(F.
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M,DZCH3"X9&/N-[C\:[*L&WTE[KQ?)K]RA18+7[':1MUP6W22'TR0H ZX4^N
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M.UY>YUQ!'=@,GW0FP;?EX^7C_P"OS3&\&VK63V7]HZA]EELTL9H=\966)00
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MH&MMU_<F4QQ$8*+P, \<]3@<\"M'0]'AT'28--MY[F:&!0B-<2;V"@  = ,
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M" "C;E*E2 ."O;/7FEN_!>G7>G)9F>[C O5OY)4=?,EG#!@[$J>X'  & !C
MQ0!JZ5:7EE9>3?ZD^H3;V;SWB6,[2<A<* .!QGO5ZD4$* 220.I[TM !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %9/B/Q!:>&M'?4+M7D^=8HH8QEYI&.%11ZDUK5P?Q3L[E])T75
M889)XM&UBWU"YBC7<QA0G<0!UQG/TS0!LWNH^)+#29=0?3+&=DCWM:0SMO0=
M\,5PY'IA<]JZ!YHHW1))$1G.%#, 6/MZU037]*FL(KVWOH+B&8#R3"X<RD]
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M("%8P[<$X[CN: /:-Z *2ZX;[O/7Z4T3PM"9A*AB&27##;QUYKRB;1-"MY/
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ML@7<C^:-P8CH<#G/I72P?8=0U;QY9>)5A\U&!C,^/EL_*&QD)Z ,'.1T8^M
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M8A_O PK\WUXYK(?QOH46EPZC)<3)!+=_8>8'S'/OV%'X^4AO7BHSX[T?S+V
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MELY>WM8(F(P6CC"DC\*X;6O%4,FK>"]7T_4;EM)OI9]\4*,1,! Y4% -Q;<
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MVM^@&66>([7X'<XW8']Z@#>;3K%U"O9V[ ,6 ,2G!/)/3J:5;&S5I&6U@#2
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MTO1]>U[7+K[3J4+(VG/;LF^9F! CCQN^0 C@<C+$D<T =M)96LLPFDMH7E'
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M<D8).#@< =2TNLZSJ4FN&"3PEK-YI]I('B, AV3R#D.=T@.%/(&.O/85VU%
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MP>!Z7--%;PO--(D<2#+.[ *H]23TIMM=07MK'<VLT<\$JAHY8V#*X/0@CJ*
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M,X"AL(S9_0 * ..C5TG4M;_X1&UO;*6V&BR+=7KOC:TT<91%C/\ $"S%LCC
MYP3BN]JO=7]G8A3=W<%N&^Z9I F?IDT <6=>U>XUDW4W@O69&A=DL0Q@6*,'
M@R,?,SN([X^520.ISH^)B->L=5\/S>';NX+PF.&:6-/(=F7A@^[Y=I/4@'C@
M'BNEMKNVO(_,M;B*>/.-T3AAGZBIJ *.FV<NFZ%:6(E\^:VMDA\Q_P#EHRJ!
MD_4BO.--LO$$VJ^$-2OM!U!;FRFN%O\ +QB.,O$RCRT#X$8)'(&2,?>->C_V
MUI7V6[NO[2M#;V;%;F43+MA( )#'. 0".OK5U65T#*P96&00<@B@#RJYT?5Y
M/ &O6"Z3=F[NM>:[ABV#+1&Z64-G.!\JG@G-:7D:QI.M>+(CI%Y>VVMJ+BSN
M8 IVMY(0QR!B"N-HQ[>_%>B44 8/@JWNK'P/HEG?6LEM<VUE%#+$Y4D,J '[
MI([5RD6BZI>^$_'VFBPGAN=3N[N:S$H"B57C55.>@R5Z'!KTFJ\VH6=O>06<
MUW!'<W&?)A:0!Y, D[5ZG !/'I0!PMJ=5O/%OAG5&T#4+>TM--N()S*$#([>
M5U4-G'RD#')],<U6L=!U:;X(ZCH)L)H=3:"[1;>3 +%Y'=<'..0P[UZ74%W>
M6MA:O<WES#;V\8R\LSA%4>Y/ H XQH]0O/&'A/4FTF]@M[6SN8[@R*I,3.(P
MH;:3UV'IG'&<5SYT+6X]--_'H;W<EEXCN]0.G3A0;FVEWKE<\;@'R ?2O4!J
M=@;J&U%[;_:9T\R*'S!O=>NX#J1[U8=UC1G=@J*,LS'  ]30!YMK&GS:AH<-
MQIGA&33FDU2SN'@6"-)W2*0,SR;3C@<*"<]?6O2@=RA@#R,\C%0V=[:ZA:I=
M65Q%<6[YVRPN'5L$@X(X/((J>@#RBULO$=S=^%[Z^T"_%[9:E*UZ%DC6%%9)
M%'E('QL&Y<M@$]RQIU_H^K7'@/QSI\>EW1NM2U.::TC* &5'V;6SG ^Z>N#^
M=>JT4 <)K>EWNL>,XI(;:YBM9M"NK)KEDP(I)60J#WZ*:K^$K>X":=::EX'C
MLM0TQ LVH-%$T9VKMW0LIWEF^@QDY)Z'T.H);VU@N[>TEN84N;C<88F<!I-H
MRVT=3@'G'2@#S"VT?5X_A_H6GMI5V+RUUY;N:+8,K$+II2V<X/RL. <]JFN+
M'7-/TKQUH9T:\O/[7>[NK&Z@VE'$T>-C9(*LI&,=QTKTB]O[/3H!-?7<%M$6
M"AYI @)/09/>K% 'EL>G:EH^KP7M]X1FU>ROM,MK>2)%ADFM)HE*E2&;;L8-
MG(/&*T5T_4O#WC+3M7AT(MIDVE?8)+33E7_0G$ID&%R 5(;!([C/3%>@T4 <
ME\/[2_LM*U*/4-/FLWDU6[GC64H=R/*S _*3V/\ AFN7\3V'B'5+;7;>31+V
M69-3@FLS;NB0/;K)$=V-PWR$*V=P.,#! KU6J]G?V>H1O)974%RD;F-VAD#A
M6'521W&1Q0!P-]I&HMXB;5M%M=1TS59+V'[3 Q#V=[#E0SOR55E3(R"&RO .
M0:W_ ![H]_K/ADQZ6HDO+:Y@NXX6;:)C%('V$G@9QQGOBNGHH Y#['/K7C;2
M=?%G=6=MIME.CB>/:\DDNS";>I"A22>F2,9YP[P#;7=EIVJ17MG/:R2ZK=W*
M+*N-T<DA93D9'0].M=;10!S5[:2:UXJCAN;>^AL;"$R031NT:R3OE20RD$;4
MR.>#YA]*R-%TN]\-?$?5(K2RO9="U2&.>2X=BXBNQD'ECN(9<$GGD"N\J&[G
MAMK26:XN4MH54EIG8*$'KD\#\: /)M&L9_$OPD'AR"SG\VYU"8>>R8C1!>L[
M2;NG ! 'WLCICFNQT"WN[?QQXMO)[*XCM;M[9K>9DXE$<01L=^H[]>U;'AO2
M=/T;18K?2IGEL7+3Q%I/,!\PER0W<$L3^-:U 'E4FC:NWPBO])&E77]H2ZB\
MJ6^T9*&[\T'.<?<]^O%>F75TT&GR74=M/<,L>]8(U D<XX4 XP?KBK-% '%:
M!JVJW.KK+>>$]4M[R[(6:ZN&A$-O&,D(NUV8@<]OF8Y.!P&ZW9GQG%:0'0KV
MQO+34(IENKN-%,"QR!F9&#'=N4$ #/WAG&*[>B@#)@UMY?$]UHTFG7,(BA$T
M5TVTQSCY=P7!R,%@.>O/I6=XKU34K=H;&RT35+V"92;F>Q\L,B_W%+.N&/J.
M@Z<D$=&D$2323+&HEDP'?') Z#/H.>/<^M24 <)J-A?:WI&C7]KH4VFR:)J4
M4\%A*R!Y(%78R@*2JG:S;1G^$=,U,MM>Q>)]9\8#3+J<K816-C9J LLP#%V8
MAB-H+,!S@X4G'3/:U7^WV?\ :']G_:X/MOEF7[/Y@\S8"!NV]<9(Y]Z .5\.
M:GJ<NHL;KPOJEO=70W75Y=&%4 4':B!78X!. ..I).2<OG2?Q>VD--HE[IS6
M-ZEV[W@0-&4S\J;6.[=G&1QM)YS@5U%I>VM_ 9K.YAN(@[(7B<,-RG!&1W!!
M%3T <C\3=/N-2^'^I1VL;230^7<B-1DN(I%D( [G"FD\8PW.I6WAO4=,M9+^
M*UU6"\=8"NYHMCC<NX@'[X[]*Z>]U"STVW\^^NX+:'(7S)I BY/09/>DM[:V
MTVV9(@L-NI+[2V%0=3C/0>W04 <'/8:E+=?$&0Z9=#^U+...T&T'S7%N8R!S
MQ\QQDX'?I5)-.U+2+_1M3N?#$VL6<NBV]A<VZ)&T]K-%N.0KD J=Y!(/;/IG
MTNSO+74+5+JSN(KBW?.R6%PZM@X.".#R"*GH S]#M5L]&MX$TZWTU1N86ENJ
MJL0+$XPO&>><<9SBM"BB@#RJ[L=7O?C7%XBN]"U!]'TVQ:&R=$4EY".6VE@1
M]]^3_=%2>+-=O=.^&WB>4:')I$,I-K902;?.FDG8[Y,*2!DR' SGY3[ >HUB
M7'A32KO6O[5N8YIYO,CF$<DS-$LD8*HX3. 0"?QYZ\T >;>+]$>U\%^!?A[$
M/WM_<PQW*K_SSC&^9O\ OH[OPK2\1Z-K$OQ8BOYM.U2YT8:6;6T?36C!BD8_
M."6(V9&1N!!P1@\<=OIWA32M,U)M1BCFEN_W@22XF:4Q!VW,$W$XR?QZ#H*V
MZ /+#HFH^'?B/HE[:^&YYM"MM):TMK>P9'%I,SY8G<5Y(X+'KGKUJUK6AZE>
M_$;PBT6A^7HVG1RW3B H(TN'./FZ<C ;@'))QFO2:* /,_!&@ZL+'QG=:SID
MMM>:Q=SG$C*2T>TJBJ 3D#+<G'48S5"P\%>)++X0"T9$_P"$@MM.FM[.&-QF
M(2ON?YNF\KA>.!C@\DUZO<3PVMO+<7$J101(7DD=@JHH&223T %+#-%<01S0
MR+)%(H='0Y5E(R"#W% '!_#[0(K:TTNYN=$O[:\LK!;59=09 8C@;EB1>,$Y
M)<@$\<GG%#XMZ7J_B7^Q-%L=*N[K3EODN-1EB"@",<8&2-QPS'CT%>G57NK^
MSL6A6[NX(&GD$40ED"F1R<!5SU))Z"@#@/$/A74OB!XATI=2LFT[PUIDGGF&
M9U,MY)V&U20J <<G/)X].-UOP_XSN;/QM FB7$EQK&K1H;I60E[-3\BH">@
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M83JD 'B$$$_93^X!B$7]_P";Y1GMS0 RX\4ZW=^(X=(T>PL#]HTH:C%-=3.
MN7"X8*OOT'UR.E5],^(,NHV%E!)9?9=8FN;BTN(A&\Z0O!@2$*@W,.4P./O=
M>.:4$=U9?%/3M/@O[)KJW\-^2_F1D"3$PZ*&RIX!ZGC/U&C<_#^1;*QFTO5V
MM-<M+R>]^W&$.DLDQ)E5H\_=;@ 9R HY- $,WC77K73K1Y]#2.XEUE-,)F\R
M%9D<_++&&7(!'8]".]3GQGJ=A'XHBU&Q@DN=%6"4&TWLKQR@D$@_-\N&)QU
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MUI(R&'W@!P0>1GVI;/P=_9GB#2+ZQNXXK'3=..G1VK0EF9"5.=^X<Y0?P^M
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MK$-G&W;E",=<8.>PWE\/7D?B^_UZ.^@Q=64=HL#6Y.S8S,&+;^>7/&!6/;>
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M5G+%J$GG^9>.8Q$DK*T+0[=H.T#G.[/.>:N>&;?4-3\2Z])=:]J;1:9K!2&
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M\1+&WUB_*Z98Q7EI++())(G:&1F 9@?ER@X[9.,4 >GT5YNLFK:+X@\)7O\
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M%_:RW$8+/$DRLZ@'!) .1SQ4'_"0:+Y+S?VQI_E)((F?[2FU7/12<_>/IUH
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M<,4J[XWDG55=?[P)/(Y'/O0!?HI%974,I#*1D$'((I: "BBB@ HHHH ****
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MXCDQRGE?>)SZ Y[5TM% '!I?G3/B9?7.NXM;._TR!;*6X8"-"C,98BWW0Q+
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MK,C/$,@L@&"<A%/']XU[I10!XYXRG&N_#?P]X9T*VN(K75;V&Q@>:(AOLT1
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M@N1+YCL,;V?: J^@Y/)SV%<VEO?Z-XB^'5E+9^;=6>E75O-%'*N3LC@4E2<
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MEA<ZA+I\ GNDM]N44@D*,GYG(!(4>W(R,UM"TJ_L_&'B;4;F!4M=1>W:W82
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M48IPPV@@=>3SVQR >JT5Q'B#Q+JEM:RW5I-;V\:Z3]N@B$9GEDEP20ZC[L0
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M/S(<$8/(P.:R=(\0>,+[PI<^(!]ANO)%W&MC;VK;Y'CF9%9?G]%/R=3CKD\
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MR1G//M3Y_ [+K]SJ>FZ]J.FI?;3?6T&PK.5&W<"RDHQ  ++S]#S71&:]&KI
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MO6W;7MM>27,=O*LC6TODR[?X7VJV/R858H Y^X\+1C7+?6=-NGL;V.V^R/\
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M0>O:L^?P4L\7B6-M2E"^(!MN,1KF,>6(_D_X".^>>:W[&:]F-U]MLTM@D[)
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M^H[(547CK@S@<!SZY'.>_7O1JGA_1M<:%M5TJSO6A.8C<0JY3Z9%:( 4
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M&$;!@",[2.0,]LU!H3W)\8>'-2?3M7\D:/-;RM)8/%'!)F(^6J8&Q5"D#CG
M +&@#L[7QMX;O9K.*VU:&1KUS';E0VUV!(V[L8!^4X!.3VS3M(\4V>LZYJNF
M017"OI\BQ.[PNH9MH8\D8 Y&,]>HXP:\^LK.\B^'GA2V;2]16XMO$"7$T7V*
M7?'&+EW+D;<@;6!S[UUOAM+BT\<>+(I[.Z1;NYAN(9C"PB=! BDA^F=RD8SG
MVH V/%/B*W\*^'+O6+F.25($RJ1H6+,>@.!P,]SP*GFUW3X(H7DDE#3*S1Q"
MWD,K*OWCY87=@<<X[CU%9'Q(L;K4?AYK5K96\EQ</!E(HUW,V&!( [G /%9I
MN;BW^(<'B"6SOCI%_I0M8W^RN7MY%D+8= -RA@>I'4 ''% '96%_::I8Q7MC
M<1W%M*,I+&V0>W\^*YKQMXE;P_<:+#->'3K"^N6BN=1V!O(PA*K\P*J6/&X@
M@ 'ZB3P)I5QIFGZK)/&\,=_JMS>V\#C:T<3L-H*_PYP6QVW<\U=\0W4"RVUA
MJ&E27^EWD<JW.VV:=8R-NW<H!X.3V/.#T!- "Z8]_:3WTVH:I'=Z4(8Y;:Z=
M40@?.7WLN%. %.0 ,'ZDV;/Q!I=_>36<%SBYAC$SQ2QM$WEGHX#@97_:'%>9
M+X3OX-,\6:=X46]&ARV\4EE:W1=!]H#[I$BWX8(5 &>F6Z\5IS6D/B_1=4?2
M]"UBRU>32YK7[1JIE1HRX_U*F1CNR>I' QUYH [(>+=$+.JW;,ZV[7*JL+YE
MB'5X_E_>#IRN>HK+3Q;8ZSX6TS5%U271A>3P>67ARSEF!$8#+@[@<$CIGK4&
MAZH/$-E;(WAJ[M-1M;1X99+RT\K[.2F"D;L/FW$#[O&!DXX!YP17C_"/PU8?
MV5J8N[.ZL4FA-E)O7RI5+G&,[0 ?FZ'L30!Z-J'B#3-+>1+NYV&*,2R[(V?R
MD.<,^T'8O!Y; X/H:BN_%6A6-Q%!/J< EFA,\2*2Y>/CE=N<YR,8ZYXKG+!Y
MM$\6^*?[4LKN>TU0Q7-I-%;/*)%$01HCM!VL". <9!SZUC>&=$U#0=6\#VM]
M:W3O8Z5=1W$JP/(D+R,C*A< C( *]>U 'I&EZK8ZUIT5_IUPEQ:RYV2+GG!P
M1@\@@@C!J+5[;4;JW$6GZBNG]2]QY2R.!V"AOE^I.>G3G(P?AW%-!I&IQSVM
MS;LVK7DJ+/ \1*/*S*P# 9!!K9US4=/M5AL]2LKFZM[S<C".R>YCXQPX53@'
M/&1VH J>"K[5-1\-1SZN\4UP)942XB7:MQ&KE4E"CIN !_'/>JOCO5;S1K+2
M+JUOOLL;ZM:P7)*KM:)Y '!+#@8[C%+X%T+^P=/U*&&*2WL+C4)+BRM7!!AB
M8*,;3]T%@S!>P89 .13/B#:W%SH^FR06TUPMKJUG<S)#&9&$22@N0HR6P.P!
M- &KI?BK0]:2\:PU*&46?_'R#E#$,9RP8 @8!YZ<4Z#7=/U2XGTZSO7CO5A\
MT(T3(X0\"10Z_,N>X!%</XFT'4/$NHZ]JNC6\D8?1%LHS*C0FZE\WS, -@X"
MKMW''W\=C6KX=NM.U74(]67P]K5K>VUNR33:DLQ:('K$F\DN2>?E&./4@4 6
MO!?B1KGX?Z)JFM7?F7=Y'RPCR\KDMPJ(,DX!. .@/I6J_BS0X]/^W-?J+?S_
M +,S>6^4ESC8RXRK9P,$ \BO._#=EJFE:3\/]2N-/OA;:;%<VM_ ;9_-@:08
M63R\;B!C!(!P&SZUN+X4?7YO'$CI);V6MB!+7S$*'S(XL>=M."/GVXR.=F>F
M* .RBUO3YM4N-,CG9KVV022PB)\JIZ'IWP<>N*R[_P 21V2Z5JT<_G:/?S);
M,60KY9D.(Y!D [2V%.>S C&#GCTT_P 4W=SHGB)[:6#4=3@.E:C #@VT)7(E
M^JNKO_VT [5O?$JR\_P5!H]F@66ZOK.VMD7^'$JMQ[!48_04 =M7,C7[2T3Q
M%?)JSZBEFP+6T<61:D1CY 57)R1DDYQFNFKSRW2XCO/B)(UC?!;HJ;<_9)/W
MV+94^3Y?F^8$<4 :W@VYU+6K+3]=EU>:2&ZL4:XL9+4(BS,%;=&V =H!(_B!
MXYR.>@O]6LM,>&.ZE82S[O*BCC:21]HRQ"J"2 .IQQD5F^"!)'X'T.":&:":
M"P@AECFB:-E=8U!!# 'K5#Q/<W$/BG14_L^Y-J\4ZM?VEJ9I8W.S$08 ^6KX
MY;C[HY'6@#5D\6Z!%9V-V^K6RV]^<6TA;B0\]/3&#G/3%/LO$VC:A87=];ZA
M$;:S8I</(#'Y1 R=P8 C@@UYII5I>Q>$?!-G-I&II-8:^TMPCVDC&- T_P Q
MP#Q\Z<]#GC.#4NOZ?JUQJ7BZXL=-O9E74].O1#]G=1>10JGF*A( 8Y7H.N*
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MLR$   $GDBN2U:"^A\(>#M1M]-U">+2FB:\L;=7BN GD-$Q51M;<I;IWY[4
M=I;^(](NK&XO(KU/)MY/)FWJR-')D#8R, P8DC QDY&.M%OXBTFZBO)([Q5%
MDP6Y656C>$D9 96 89!&..>U<%JMH9--A\1>'_#^I8@U6VOKJ*X607-ZD:LK
M$(Y+$J&4C."=O3@$W?$33Z_X>N=5T30+M)([NTNI$DA-M<WPA<,RXX?Y5 VD
M]^GN =-<>)-)N=,U7R]6^PO9Q$3R2Q&.2UW*=KE) #[C(P<=ZDL=>TT-IFG-
MJ+7-Y=6JRPNT14W"A03)P,#U/IGM7*2"QU7P[XBU+3= UB*YN-*EMFEOHIC/
M,Q4[8U1B68 GKTYX)YP[4=.OU\#>%]9T^RG?5]#C@E6V,9221-@CFBP1D$J3
MVZJ* .BUO7-/%DR#6VTQX[R*W:7R<DON4^6 RX.X$#(Z;LU)?>,O#VFW%W;W
M6IQ+-9JK3QJK.R YP2%!/8Y],<XKG_&6FW4'@2UM$MY[N]:_MKB<6T+RDO\
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M[/4HI9[J'SH%"L!(N W!(P2 02.H[BII/$FD17T=F]ZJRRS_ &9&*-Y;2_\
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M9#B.1TVX"DXSAB1N'7G !V-%<O!XN?[9XBM+ZQCM9=&C$V/M!;SXBI97'R#
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M$)(!4 EL'!Z''6J_A^]N/"USXDO6M+N'0;F_MX-$L9U,3-,_R,$5N41G((R
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M"2)MRGYOF;)SD\<8P.,FQ)H&HZAJZZU?I9I>6]A):6T$,S.@:0@N[.4!_A
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M2B@#SD>"/$?E6<;W^F226>M?VD+F1)#+<KE\>9Z%5?: ,C  R,5I-X5U:/\
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M4-*3D+P<D*#DXY&,'4\(:3=:#X3TW2+QH7FLH%@+PL2KA1@'D#'TK:+JI +
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M)\=^%M/1+26ZM/#LL$@:5E1PKPKD-M)'0'IZCWKI[7QWH-[S!+>LHNOL;/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(6\6V6-1&=DGRY(PQ^[M.23D\ ;]A%=2?%O7!_:=V(TTVU=8OD*#<THQ@KD
M$9X(.>I-:,W@73;C2M8TV6YO6MM7G-Q=C>N6<XS@[> =J\#T^M7AX:M%UX:T
M+B[%Z;9;:0B7"RJI)4LH&"06/MSTH X"_P!3O]6^%R7&HW)N+A/$$</F%%7*
MI?!5X4 = *]7()! .#ZUS'_"":;_ &%_8_VJ^^R?:_MO^L7=YOF>9G.WIO\
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MNS>C8W*^.H)4'MTK.E\":;/H^J:7)=7S6VIW1N[D;U!:0D$D';P"57@>GUH
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MQ1>S:%JRW4<FFW<(>]CF>/80Z HT.U=PPQQ@DY'OS6UXU_Y$/Q#_ -@RY_\
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M1;BV6:X*[ECSNVC:H')P23D\#F@#FOBYD>!&V@%OMUI@$X&?/2H]8T[4-/\
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M#<Z9"[CE/F&3_"PYKHM"2_31;8ZI.\MZZ;Y=ZJ"A/.SY0!\N<9QSBL'4K/\
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M:<LDL<C,MLL6\_. >"V<@L.PQ0!NRPQS)LEC21<YPZ@BF16EM"VZ*WBC;U5
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M-CX0T:SO(&@N;:RAAEC9E8JRH%/*D@\CUK8HHH **** "BBB@ HHHH ****
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MV=QI=O8VIN8I+<L#"$F;: 6(]2<@Y]!79^'=%B\.^'K'2(97ECM(A&'?J?\
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M^+__ "2K7O\ KE'_ .C$H U;KQC9Z8;=M8LK[2X)W")<7,:F(,>@9T9@F?\
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M9Q^8_,5F^'M>A\1Z=)>06\T"QW$MNT<VW<&C8JW0D=0>]<Y>6<<OQHT]VDN
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MJMEXE:>344.F7-I\MDUY)<L958?O49P"%VD @<=#74T %%%% !1110 4444
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M4 5[&R@TZQALK566"! D:L[.0HZ#+$D_G5-O#NDOK$^JM9JUY<1"&9BS%9%
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MH **** "BBB@ HHJ-)X9)9(DEC:2+'F(K E,C(R.V10!)1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 $9&#TJO;6-I9ES:VL$!?[WE1A=WUQU
MJQ10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 445@Z;K#:QKVJ)#)LL-*E%LQ'_+6?:&?)_N
MJ&4?7.>@H WJ*Q;'Q3HVJ7,%I:W3L]W$TMN3$Z+.BX#-&Q #8R.AZ$'IS4>B
MZO)+K6J:%>/ON[#RY$EP 9H) 2K$#C<"&4XXX!XS@ &]1110 4444 %%%<3X
MK\77FA^)-)6)%.CQW$<.JRG_ )9F;<L7/8!AEO9E]: .VHK.U?7M,T&*"74[
MH6\<\RP1LRD@NQP 2!Q]3Q5!?&V@&SU*Z:\DCCTW!NQ+;2H\0(R&VE0Q! )!
M P<4 =!16)9>+=%U'4#8VMT[W'D?:%4P2 2QC&60E</C('RYH3Q;HDFFV.H)
M>,;2^N/LMO+Y$F&EWE-I^7*G<"/FQTH VZ*Q;GQ7HUI=O;S79#1W"6LD@B=H
MXY7QM1G VJ3N7J>XSU%9]I?7W_"T=2TV2\EDLETJ"XC@8*%C=I)%., $\*.N
M: .JHK#\8W5W8>#=9O[&Y>VNK2RFN(I%56^9$+ $,"",BN0/B+7-,?P1(-5?
M4Y=<:)+JRFAB#*CQAFF0QJI 0]<Y&#0!Z7169JGB#3M'$GVN67]U'YTHA@>4
MQ1\_,VP':.#R?0^AK.B\96-QXKM]$MDFF6:Q%XMS'"[1LK,H3:P&"I!)+=!P
M,YS0!TE%8MKXKT6]O;:U@NRSW32);N8G$<S1YWA'(VMC!Z'L<=*SX?%&B:;;
M:WJ5SKD\UI;WOE3^;"V+5]J_NU 7)'(.>>6ZT =51618>)M(U+4;FPMKHFYM
MXQ*Z21/&#&3@.I8 .N0?F7(]Z;#XJT>>^CLUN76::%IX!)!(@G1>2T9*@/@$
M'Y<\$'I0!LT5S5IX^\-7VTVVH-('0NI%O)AL2"/:#MY;>5 7J<CCD5LV&IVV
MI"?[,9<V\ODRK+$T;*^U6QA@#T93GIS0!<HHIKJ7C95=D)& RXR/?G(H =17
MF_A/5[[5_"\]_JOB^YMKA+JX@!6.U& LA1/E,1)/ ^M=;=>(K'18EM]4NF>[
MAM!<7'D0/)M0<-(0BG:N0>OH?0T ;=%9T^NZ=!%;2>>9OM4?FP+;QM*TB8!W
M!5!)7!'/3D>HKE-6\5Q2:[X.U'3M79M%U"2Y$JQKE9=L+E>-N_<&&-OJ,8S0
M!WE%9^C:WI^OV;W6G3-)''*T,@>-HWC=>JLK ,I'H16!X\N_$6FP:==^')C+
M<FZ"-8.J%+E CNRY*[@Q"8!!')H Z^BN0;Q,GB'POIVL:)J$UJLM[;P2H$0N
MA:9$DC<.IPPW'^?2MF_\2:7I33I=7$A-L@>X:.!Y!"IZ,Y12%X!/...>E &M
M16'=^+]#L[R*TDO2]Q-;_:8HX87E,L?'*; =WWAP,GO5_2=6L=<TR'4=.G$]
MK,"4<*5Z$@@@X(((((/I0!=HKB?%6IZC9^.O"^FP:Q-96.I"[%P%2$X\N,,I
M#.AQR>:T[?48=+35-0O/$4E]IMJBB4R1QDV[J"S<Q(,@JR''.,4 ='17.IXY
M\//<10"]D$DT/GP9MI0)UXSY9VXD;D?*N3DXQ3AXW\._V2NIOJ'EVK7/V0M+
M$Z,DV[;L=2,J<D=0* .@HKG;?Q5I6OPZG::3J,BWMI$2X,+1R1Y!VN%D7D>^
M"*J>$O$(;P%X>OM6NGEO+ZV3HA>2:0KN.%49/ ).!P!0!UM%8$OC30(=-.H2
M7K+;K<?99#]GD+139QL=0NY#DC[P'4>HK2FU:RM[U;2:8QS- UQ\T;!5C7&Y
MF;&U<9'4B@"[163:>)=*O=1&GQSR)=-#YZ1S0/%YD><%EW@;@/;I3;;Q1I%U
MJ-O81W+">Z1I+;?"Z+<*O),;$!7P"#P3QSTYH V**HZRTT>B7LEO.\$T<#ND
MB*I*D*2.&!'Z5Q_AX^*-9^'^G:U;>(I7U:XM5G$5S;0&!W(SM(1%8 ],AN/>
M@#OJ*X;2O&ECXD\.^'-3GOKC29[R]6+[/$N[S9E+*T+':?E)!/8X YK:7QIH
M$FJG3$O6:\%R+5HU@D.V0KN )VX (Z$\'UH WZ*QXO%.CS:A;6*W3"6[W?9F
M:%UCGV\G8Y&UN.>"<CD4C^*]&CO(+9KLAIYS;12>4_E22C.8UDQM+<$8SU!'
M48H V:*YK1/&FGZO9:I>R+-9VUA<2PN]S"\8 0[222,9SGY>HXR,U?@\2:7<
M7,]J)I8[F&'SWAF@DCD,?3>%906&>.,\\=: -:BL/1?%^A^(9UATJ\:X9H/M
M"L(752F[;D,5 SGMG-:-[J5KI[0K.S^9,Q6...-I'<@9.%4$X [T 6Z*X;6/
M$XB\5^%;BWU&==)O4O/.@\D_O&C0;?EV[RVXD;>YQQFMZ#Q;HEQI,>IQ7A-O
M)<?95!B<2&;=M\ORR-V[/;&>_2@#;HKC/%OB,7'P\\0:EH6H3075A'(K.L>U
MXI4&2C*ZY'4=NA!!I\NH7\?Q!\/V8O939W6F7$LMN0NTNACPV<9S\QZF@#L*
M*QO%L]S:^#]9NK.Y>VN8+*::*5 I*LJ%A]X$=O2LSPQXTTC48=*TM]1+ZK-9
M1R8DC=1,P0%]CD!7(YSM)QSZ4 =916.WBG1TO[>S>Z97N9C!#(T+B*209RBR
M8VEN#QGJ".HK8) &2< 4 %%8T'B?2+N_@T^*Z=9[J-GMB\+HLZJ,DQLR[7P"
M#P3QSTKE-*UUCX,OIM;U^[MF369K5+V.,&3"7&U%P$( . O3'- 'HE%9FH>(
M=,TN:6*YG?S(8/M$JQ1/(8XLD;VV@X'!Z]<'T-9MWX@TF^.AS0:W/!'=W8^S
M>3&=MV=K?(25/RD<YXZ<&@#I:*\[T?QS9Z/=>(H?$>L3,(-8>"&22$L(HMD>
MW<8UVHN2<%L9Y]ZV)-0O!\4;&R2^D?3I](FN/(&W9O62,!@0,GACU)H ZRBL
M=/%.CR:A;60NF$MT66V=H76.<KU"2$;6..>#SVJ[J>H1:5I=SJ$Z2O%;QM(Z
MQ1EV( SP!UH MT5S^E>++*_\.Z9JDXE@>_CC*0>1(79V0.51=N7 &3N (P"<
M\5I:7K%CK,,LMC/Y@AD,4J,A1XW'565@"I]B* +U%9>K^(M*T*2UCU*Z\E[I
MS'"/+9M[ $X&T'G /'?M5;_A+]%.FQWZ3SR0/";C]W:RLZQ@D%F0+N49!Z@=
M#Z4 ;M%9$WB?2(;6&Y6Z,\<T'VF/[-$\Q,7]_" D+SUIQ\1Z6;*UNX;AKF*Z
MB,T MHGF:1!C+!4!.!D<XZD#J: -6BN:NO$.CZA%H-S;:[+##>W:_9C;H2+H
MX8&)LJ=HZY!P05]JOVOB72KS^TO(GD)TUBMV&MY%,1 SC!49XYXSQ0!K45D7
M?B?2[*U%Q-+.4\@7#!+65V2(_P ;J%)4<'J!T/H:T;6Z@OK2&ZM9DFMYD$D<
MB'*NI&00?2@":BL6\\5Z+87,T%Q=E3!+'#.XB=HX7?&Q7<#:I.Y>I[C/45!?
M>-_#^G7%_;W%Y)Y]@JM=1QVTLC1JP)#$*I^7"DDC@<9QD4 =#14=O<0W=M%<
MV\BR0S()(W4Y#*1D$>Q%24 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM"MKB&6&XM[""&6.5"K*ZH%((/N#6[110 4444 %%%% !1110 4444 %%%%
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M D#2-O;]\!&T?'R\<-G\,54U+P+KMQI/B'1[6^TY++4]0-_%)(CF16:1'9&
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M&YB!(<]5#;0!Q@ 9&* -6V\8ZC<ZMJEO_8L4=EI5WY-[=/>#Y(_*$GF!=O.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC/?'2NKH **XS1_&%Q>^/K[1KF)8[&: RZ7+_P ]O*<QS?CNP1_LC/>MV_\
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MHB _4AO^^3Z5V=5K:PAM9Y[A06GN"#)*_+,!]T>P&3@#U)ZDD@%FBD9@HRQ
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MV4<_F6\T6_*21IAL'?U(ZBNY_P"$5T[_ )[ZM_X-[O\ ^.4?\(KIW_/?5O\
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M:3N9%R06?&!U ZXKT^B@#S>&&?\ M3X;.^GWVVSM)5N&-G)B!C;J@#_+\IW
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M8EE%K)MB+I&%#G;\I)4]<=*E^(L,L^EZ2D5I<W6S5[2:1(+=Y2(TD!9B%!P
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"0!DD#ZT +1110 4444
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MKQEA'5)=0CDC)0JKCR$4LI/7Y@1D5KCPS:DD#4-7XZ_\3*;_ .*I?^$8MO\
MH(:Q_P"#*;_XJ@#9<$HP4X8C@^AKR".SO+WX2IX1D@FC\307*Q;"C;EE%P'^
MT!L?=QE]_3DCKQ7HW_",6W_00UC_ ,&4W_Q5'_",6W_00UC_ ,&4W_Q5 &*9
M /C&'(?R_P"P_)\W8=GF>?NV;L8W8YQUKM*Q?^$8MO\ H(:Q_P"#*;_XJD_X
M1JUSC^T-7SUQ_:4W_P 50!CZH[67Q5TF\E@N#;2Z5/;++'"SJ)#+&P!(!"\
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M',=SA2 =I#8*\=L&@#<A\9B:.\@72[DZK9WL=E/9H=P1I,;)"X'^J*G=NQP
M>,\55N?B#%:>']>U)]->671+CR+F&"965CA2&5SC(PP[9!SQ5/4O"&M3OJ.J
M6CVBW^HZA;3W5F\S+%+;0IL$+.%SSRQ.W'\.".M.]\$>(+G1O%]A&NDQC6WC
M> )*ZK%B-%(/R=!LXQUST7I0!TQ\4W,<T-K<:-+;WMY<M#8P23H?/0)O:5BN
M=B@9R""<X SFLGP+Y@\7>-A+:K:O]N@W1*^]0?(7)!P,@]>@Z\BKWB/0M7O;
M_0-=TT6HU/27DW6LTK"*:.10KJ'"Y!X!!V_A4OAK1]7L?$7B'4M1CLTCU.6&
M6-()F<H4B5"#E1Z=?TH GN/%&-9OM,LK1+J>Q$1N(O/V2X?!W(F#N4 Y)R.X
M&37(P:Q+X8\2^/[VUTB2\@MIK>XG$<JQA$%NK.1GJW4X'OR.,ZWBKPA>>(KV
M:46UG#=121MINK13,EQ:@!=P8!?F&=Y R0=W..M)=>%M:G_X3D*MB!K\(CMB
M9V^3$'E9?Y./7C/I0!J:IXM:RADGM=.DN+>+3_[0>>5_)C*'.$5L$&0X)VG'
M;GFL?4[JVU3QI\/-6MT(6[2YE0L,-L:V+ '\ZCN/"GB.9XXG_LV>V.C+8JLT
MSD6DP4JTB+LPVX$<G:1C\Y[+POKL,G@=YEL#_84#Q7(2=_FS#Y0V?)S_ 'N<
M>GO0!/X B2"\\7QQ*%1=>EPHZ#]U%5O5/%UW9^))M"L?#]U?W<=FMXNV>.-7
M0OL."QXQ@]>3Z=ZE\*Z-J.D7NORWJVVS4-1>\A\F5F(4HBX;*C!^3/&>M(-&
MU(?$=]=VVWV!M,%E_K6\W<)"^[;MQCG'6@"E<?$2P@E@D2*.:QEO/L9DBN%:
M9&W%-YBQGR]PZYSCG&*N7/BR14NKFPTFXU"RM+L6<[P',I<,%<I& =RJ3@G(
MZ-C.*S=!T/Q7H$LFC03Z;)H7VAY8+IF?[3#&[ES'LQM8@D@-GCK@]*--T'Q1
MH6J:G9Z=-I[Z-?WDEXEQ*[">U,ARZA -K\Y*Y(Z\YZ4 6=;\?V>D_;WCACNH
M].E$5TBW*K,3@%O+C/W]H89Y'<#.*>FK6DOC:ZCM-',FIKI"7$=TT@7SX3(=
MJ#KCYMW4"JL6B^*M$\0ZH=%DTR;2=4N/M1-VSB2TE90'( &'4[00,KSW'6M"
M#1-1C^(3ZVY@:Q.EI8Y,I\TLLC/N*[<8.['6@!VE>+!K&@Z3J=K9?-J,QA$#
M2X:(C=NW<=5V-D>U4;_XB6%DWG)''/8K>?8Y'CN%,RL'V%Q%C)0,""<YP,@$
M<U:T+PK)H_B75[[SU:PN)3/:6X'^I>0*9C^+(I'IEO6L_1]#\5Z#>76EV<^F
MR:%-=27$-S(SBXMED<NR!,;6(+'!)[Y.>E '4ZQJ3:58?:([.>[D:6.)(H5)
M)9V"@D]E&<D]@#7.W'CV.TTGQ'=2Z<\D^@L%N8K>=75@4#AE<XXP>1C((/!K
M2\7Z;JFJZ*D&DRQ+,MS%+)%-(R)<1*V7B9E!(##CH?3H:Y:[\%Z_/9>,;>./
M284UV")($CE<+"RQ",@_)T&.H'/HM '26'BJ2Y\20Z/=Z5-9FYM&N[65Y5;S
M%4J&! ^Z1N!^GH>*T-5U:>QN[.TMK%KB6Y$C>8[%(8E0 DNX!VYR ..>?2L@
M:'JS^,-$U9X[1;>RT^6UF43L6W.4.5&S! V=R.M2^(])U>^UW2+NR%G<V%OY
M@N+*[D9$9FQLDX5@Q7!P"._!!Y !'8>.+74]%T>\M+5VNM6EDAMK5G ^:,L)
M"6&1M78QR >V!DXKG]"U>+0?$'CW4-0M?LWEW=H/L\+!R[M$H4(>,EV88SC[
MW..:98^!_$>EZ=H-Q!+ITFIZ'>W<D<1D=8KF&=F+@MMRC888X(&.ISQ)J'@?
M7M9;Q--/)86<^HSVEW9&.5Y!%+ J !\H,J2N,C\J +"R7?\ PN*VEN=-6&<Z
M#.P$,PD\W]]%@9(7##ISQR.:KV_BA[7PEX4E\-Z/%9V6I:E]E\B2;!B&^0D#
M@CYBC9/;/?J-:VTOQ+<>,K'Q!?6>F0"'39;22&*[=R69T;<"8QQE.G;/4]*S
M;3P9KMKX,\.Z>/[/;4-'U07I4SN(I5W2$C=LR#B3^Z>E &PFMZ7:>+M:>[T[
M['=66F17%U?,X8/#ER  .P(;T/M4R^,##/HYU#3GM;36&$=I-YH8B1EW(DBX
M&UF .,%AD8R*HWWA&^U?7]=EOC;)8:II":<6BD8R*P+DMM*XQ\_'/:B'PWK&
MH6/AVPUH6@31;B*X:>"5F-R\2E8\*5&W)(8\GI@9SD $<GQ%>.QO-0;0+I;&
MPU$V%W*TR9C(=4W!03NY89 [=SR!?U[QI_8(U"XFTR4V.GR0QS3N_EF0R8YB
M!&)-H89Y'<=JP[KP;KUQX/\ $6D!=/%QJ>JO>Q,;A]JHTJR88^7G/RXX'>F^
M(_!WB76X_$<!.F2C4!&;.XGF<O;*H7,(4)@*64G<#SG)![ &H\2)\:H)%4!G
MT"7<1WQ/&!70:KJL]C=6=K;6+W$MSYA\QF*0Q*BY)D< [<Y ''/X5EKHVK-X
M_M=>E2S%LFEM9R*DS;@[2*^0"N"!MQU!/7 Z4[Q)I.KW^M:/=60L[FQMC)]I
MLKN1D1V8#9)PK;BN#@$=^QY !23XA0RZ'H>J0:5=3)JUX;)421,QRAG4C)//
M,;8/3U(IEW\0CI^CZ_=7FB7"7>BRQI<6R3(V5=0R.&XX(;D8)%9MEX+\0VNB
M:#I[_P!FN=,UM]09UF==\9>5L ;#AOWO3H-O4YX?KW@S7M4C\9QP#3U&N&V%
MN7N'&P1JJG?A.^W/&: -^+Q7<-KUWH\^D26URED;ZW\R=2)HPVTYVYV,"1QS
MUJ.V\;17-AX9OEL9!!KSK''F0;H6*,XW#'(PIZ&EET34[CQW%K4B6J6?]E/8
MR*LS&0,SJ^0-F"!MQU%<_IWA'Q1;Z9X4T^9-+$>@7BOO6X<FXC$;H&QL^4X8
M?+SGU&.0#?G\:?9KZSCN-,EAM;O4FTV*21]LK2 D!_+(YC)7 8'N#CFJOAN)
M(OB;XT$:A0R6#$#N2DF363-X.\43&!I3I4]S;:VNH"\DF?S+B(.Q5&^3Y-JL
M  "1QVZGI=(T;4;+QKK^K7 MOLFHI;K%Y<C%P8E8'<I7 SN[$]* &ZUXLN=-
M\0)HEGH=S?W<MG)=Q;)DC5]C*"N6/'WNIQVZYJGJGQ$M--AN;C[,DL-G,L-U
M&MROGJW ;9'SO"DX/(Z'&<5>NM&U*3XA6&MQK;&Q@L);1]TK"3+NC9"[<8&S
M'7O6;:Z)XKT36]3ATJ;39='U*Z>[$ERSB:T=^9,*!AQGD D=>: )K/Q1J,GB
MSQ);362OIVEVT$J>0Y>1@R2/D+M^9FP!MSQ@=<U;TWQ8]WKB:1<Z<UO=RZ?_
M &A'&LP=MF0"C@A=C@LO'(]^*HW7AO7DU[Q+=:;=VL*:O8Q117+.WFP31QNJ
MG:%P1E@<YXQT-5M$\,:]8^)-+U66UTF!(-,DLKB*&=V+.71O,W%!N+%.<\C.
M<M0 FF>+]/TSPEI-YIWA^XAM;_5'LEMHY$S%(T[J2<GG+!C@<<]1UK3A\<0Q
M+KBZM8R6$VCF(RQF59 ZRC]V588&2>,'H>_>L2W\&Z_#X6T73"NG&>PUO^TI
M&%R^UH_.>7:#Y>=WSXZ8XJSJO@K5-8O_ !6SS6]K%JT5I]DFCD9GBEMR65F4
MJ!@MCH3TH GG^(D-I)JD4M@)Y;'3VU &RN4FCDB7[PW_ "[7'=?3D9K>T#6;
MS6H6N)](FL;=HXY+>225&\Y77).!RN/0^OX#"N-/\9:WX6U73]632(;BXL9;
M2-;:9RDCNNWS&)7*@=E .<]:Z;1;>XL]#L;6[6-9X($B<1.67*@#@D XX]*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR79$)>>Y6';&2 Y4G^+:3CWQ7)>+]+\.W>@0GPW/H5IK-I<0W%G*+F*,1,C
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MUYJEW D\UTTS*R.X#$1X(\M1G "XZ>M6]9OO#6NZ+>Z5=ZSIYM[N%H7VW29
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MJQ0BY6XG-N89HTV;QA6RI &0.<T 6H_%EY<^-[+2X=/D&GSZ5]N,DA5'^9T
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M0)%W<%3DYZ'OSTH N-\0=.?3]&O;6ROKF+5;DVL81%#13 -E'!8$-E&'IQU
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M7#JO!SP-BG&>>^: /11-I;:N^EB%/M:0"X*_9SMV%BH.[&W.0>,YJW]CM?\
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M&XG$A@)B<)+L.'".1M8CN :T;I))+61(IFAD(^615!*_@>*\O\'ZO=:5\/\
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M9)6X&3@ = !@   "H[[1_MVJZ??->W,8L7:1($">6[%2N6RI.=K$<$=:TJ*
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M$@1%SG  P*PM1\*0ZJUW%=WUS+8W=Q'<26C!"JLFW 4[=R@E 3SZX(S70T4
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M33(05+DJ1C@<  8 '2KVK>';#6KS2KJ\5FETRX^T0L#C+;2,'VS@X]5%:U%
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ML;@$P7,30R!3@[6!!P?H:L5D>)]9D\/>&=0UB*U6Z-G TQB,GE[@HR><'^5
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!  "2  2<GWI:**
M(8[6&*XEN%3][* '<DDD#.!ST R>!QR?6IJ** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3XOU'6O#$&OV6@;[6:(RI']K'FD D$;=N,\'C- '74444 %%%8D^OO!XSLM
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS L.IV%M>Q*VY4N(ED4'UP1UH NT4V.-(HUCC4*BC"J!@ >E*RAE*L,@C!%
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MMVT^_=K^ 26K1VKNDH^RB/"L!@G>,8'/MC)HMH+@:E\.-ME>H+6QFBN&^R2
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M^(M)N-/%[#>+)"93" BL7\P9RFS&[>,'*XSQTK/U'Q'I5WH2W5KXBCL$:Z2
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ME:=97TC6%QI\\\MN]OLR5*;'!90Q!W-R#@XKC]4TW5[^/QU'IUCJDSW:V%Q
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MMRX9(]Q/F$G'"@\#)QP#I_#*WDM/AUHMM/:S6MQ!!Y<L4\+1.K9.<A@#WZT
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M1(,HA8L$0+P!DGI7FFCVFIV7A'P!?/I]]Y>C3M_:%HULXE0.CQB381EMN[/
M)P<T >C_ /"3Z*-.N[]]0BCM[-BMR9<HT+ 9PZL RG'8BI-*U_2M;DN4TV]C
MN6MBHF"9^0L,C\Q7!:_IMS>_\)UJ]E:W36U_HJV4$:V[[[F<))\P3&X@!E4'
M'KZ5WV@!1X>TX")XL6T:E'C,;+A0,%2 1B@!J>(-,DN5MTG9I&+A-L+E9"F=
MP5L88C!S@FF)XFT:2SL;Q+^-K:^F\BVE ;;))N*A<XX.01@^AKC/#]M?Z?XB
MTY=*:^?1[F69[K3=0MF!TYBK'?%(P!VECM"\Y#$COC$M1>0>#_#^C-I.J&\T
MSQ%')=*ME(51!<N^X-C#C:0?ESQUQ0!ZA?>(](TV9HKR]2(HZ)(Q5BD3-C:'
M<#:A.1C<1G(]:YJ+Q='I'C'Q1;ZYJP33[1+1[97C'[L.KE_NC)' R3G'%9^G
M7,NG7_B'P]K/AZ\U W^I27=HWV0RV]S'(05#N050H0 =V, "I)HIO^$A^(,C
M6-X5N=.@B@<6DA$S+%(K*AV_-RP''K0!Z%%+'-$DL3J\;J&5U.0P/((-/K#\
M&+)'X(T**:*6*:+3X(Y(YHRCJZQJ&!! (.0:W* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Q_$
M?B&#P[:VLUQY2BYN5ME>:7RXT9@QR[X.T?*1TZD#OF@#8HKF[CQ2]E!:)>6L
M$%]=SR10QM<_NBJ GS/,VYVD8QA<Y8#U(RI/B)+%I)NVT.5IH]4CTV2-)OD8
MNP59(W*C>IW<<#G(..M '<TUY$B7=(ZHN0,L<#). /SKEO\ A*M5M-6T>QU;
M0HK)=3GE@647PD",H+*#A!DNHR!D=P?>OXDU^--(EFOM"AOK&/5(;6/=,"&;
MS57S,%>-LAQCGE3S0!U\\9F@DC61HBZD;U )7W&016?X<T*'PUH-KH]M<3SV
M]JNR-Y]N_;Z': /TJA?^)KI)M6BTC2O[1?2E7[0GG;&9RN_RXP%;<VT@\X'S
M 9ZX@U/QD+62>"SM(I+NWM4N98+JX\AAO!*QC"ME\*>. ,CGG@ ZJBJ6CZDF
MLZ/::C'#-"MS$LGE3+M=,_PL/4=*NT %'6L3Q3<.NEKI\,_D7.I2"TCD!P8P
MP)=Q[J@<CW '>L?X::G-<>&WT>]E$FH:'.VGSMG[ZI_JW^C)MY[X- '9T5S'
MQ TNTU;P9J$-U$K$(/+DP-T39'S*>QKEAJ]U'X>U_P &>*BDVK6>G326MS(O
MRW\ 1ML@S_&O\0ZY&?6@#U"BN>_M9;34;?P]I%E!)=)9_:FC:3R8HH\[5Y"L
M<ELX '8GTSD_\+$#VFG20:/-)/<:HVDW%N9E5K>X4,2N>C#Y<@\<$?2@#MZ*
MY_0?$LFIW.K6>HV<>GWFF3K%,HN/-C8.@=&#E5Z@],<5SOQ7%I<>'=*G,<=P
M%UBT7*J')4R891ZY'&.] 'H5%<II\&C'7P=.\/-97=K;M*LOV06PD#?+LS@;
MAT)]./6LRV^(MY/I&BZNWAUEL-3NQ9_+>*94E9V1,+M *DJ 26&,]"!D@'?4
M5Q<_CJZL;;Q+]NT4)>:' ET\,-V'66)E9@0Y48/R,",'VS3[7QI=/K^EZ;JF
MA/96VKQ,UE<_:%DWL%W%'4#Y#MR1R<_G@ Z])$DSL=6VG:<'.#Z4ZO-_".K6
MWA[P[?(D 9[CQ)=V5I;H0@9VF8*,_P *@ D\<!3@'I6^_BN]BU'4M(?2%;6+
M6S%];V\=SE+J+.T[7* A@PQ@KU(YP<@ T=&\/1:+?:I=QWES.VI7'VB99MF%
M?:%^7:H.,*!SFMBN<T[Q5_:NF^'[RSM8I#JPWLGGG]P@4LQ)V\[3A2./F8"L
M^+X@13SZ7+;V2W&G:C<"WCE@G+S1[LA9'C"X"''7=P",CJ  =G17&3?$")7M
MY[:R6ZL);S[(7AG+3K\Y3S/*"_<W#^]G&#CM6EX[ABF\ ^(!+&KA=.N'7<,X
M81L01[CUH Z&FM(B,BLZJSG"@G!8XS@>O KS_3_"&EW_ ,,M,EM($T_4O[+A
MFBO[0>3*LOE [BRX+<]0<YYJOX=\7#7=&\!WVJ:3%<WFHR2QK=,0/(E1) SA
M<?Q!#TQUH ]*HKCK+QK>W=YJ6[0_)L-+O);>^NWNU_=(D0DWA<9;K@@=,@\\
MX=9^.1<:KIMO+8H+74(GDCN()_-,!5=V)EV@)D=PS#(Q[T =?17,6?BB_P!0
M32[RUT1Y=,U,GR;A9B7C7:61Y$V_*K8Z@DC(XR<5DZ!XTOO^$4EU76;>!I9=
M2DLK6*WF),DAG:)(^5& ,#YLG@$D#I0!WM%<K<^+Y].U.\TR_P!,5+V.Q:_M
MEAN-\=Q&G#@,57:P..,=#FK7A;7]0\164%_/HWV&RN;2&XMY3<K(7+KDJ5 !
M&.,'N".G( !T%%<UJ'BMH-=N]'LK6"XOK:V2X\B6Y\J296W?ZI=IW8V\].2!
M5?6_&ZZ:^IK96D5ZVF$"XB-QY<KMM#E8EVG>0K#J1DG% '6T5QTOC34)M<;2
M]*\//=R?88;]&ENEAS%(Q7D$':PP>#Z=JGM?%\TJ>(H[C34AO-&D$?V<7)8S
M[E#1D'8,!\X'!YR* .H\Q/-\K>OF8W;<\X]<>E.KE$U1?^$[FLWT.$:JFCK.
M+I9@2Z>81Y0.T'&[)R?RJCI?Q!N=0M_#M]-H9M].UN7R(YOM09XY2K%04"\J
M=A&<@^WJ =S17&:GX^^PZ;K.IV^F_:+'2+T65PQGV2%_E#%5VD$ N!R03@GT
MSUJRR"S$TL++($W-$AW$'&2H]: )J*Y/3?&4MUKNF:5>Z:MG-J-H]U'']HW2
MP[=IV2H5&QL,.YY!';-3^'/%;>)%M[FTM8&L9E<M)'<[Y(&4C"2IM&UCSQDX
MQ]#0!TM%9FL:G<:=]D2VL6N7N)3&7+%(H%"LQ>1@#M'RXZ<D@57\+>(D\2Z9
M-=K"L3P74MK(J2^8A:-MI*M@;E/!!P.M &W17+W?BC45\37VA6&B+<7-O9I=
MH\MV(DD5F9<'Y6(Y4]C^'6J%C\0)KRU\/:B=%:+2]9F2V69KD&2.5@V!L"X*
MY4C=N!]J .WHKC-5\?QV"WD]K9)>V]E<_9ITCG_TAB&"N8X@IW;2>[ G:WME
MMYXXU"*7Q&EIH G_ +#"22F2\$8DC,?F97Y3\VWH.G7D=P#M::DB2+N1U89(
MRISR#@C\ZY2V\7R7FKZ/97.C^5I^N6[R6<S3AV;;&'*R1XPH*DXPQ]P*Y'PG
MXHN?"?@2SGDT,OH45]<13WB7"AH UTZAA%CE 2 >0?;'- 'K=%<AK7CE=..I
M&RLX[T::XCN(A<;)G;:K,(DVG>0&'4C)R*'\9:A/X@FTG3/#[W3QVUO=AY+I
M8<Q2L1G!'!&"<=\'I0!U]%9NO:U;^']'FU&Y5G1"J+&F-TCLP55&>Y8@5G#Q
M+=6_B&'0]0T^&"\N[9Y[%TN2\4Q3&]"VP%2,@]",<^U &^9X1.(#+'YQ&X1[
MANQZXZXJ2O/? 5E_;MF^J:Q86LEU;ZM=RP72S,TBN)73'W1\H4!1R00!P,5K
M7>L:J?B5;:&D%J^FOIDEPX>4AF_>QJ21L(R 2 O?)R10!U22)("4=6 )!VG.
M".HIU>5>$O$$WAGPVFW25;2FUVXM))UG"&+S+ID4K'@[E!(!Y'L#72ZSX[73
MO[1:SLH[U-.E$4\:W&V9VPI81)M._ 8=2N2"* .PI"RJ0"0">F3UJAJ6JI8^
M';O5U1G2"T>Z"$$%@J%L8[=*Y?P'I%KK'A"QUK6K>#4=3U.+[3//<QB0_.<A
M%SG:JC "CCB@#N**YB&:'PN]AX;T]#=75W)<SP1S3%1''O+L6?#' +A1P2<C
MW-9][\0C8Z/JMQ+I+&_TF\BM;RT6<87S&4(ZN1\RD.". >N0* .WHKDCXKUC
M_A(;K0AX?C^W+:K>6V;X>6\18J=[;,HP(Q@!^O7'-5(/B')=V?AR:TT.6636
MS-&L9N%7RI(E<LI..1E",\<<^U '<45Q=G\0$-KJD>JZ<=/U33KJ*UEM#.'5
MFF(\IEDP/E;.<XX /%1W7Q!ELK379)=($LFEVPNE:WN=\,\?.<2%!AACE<>G
M6@#N**Y:T\77+>((=-O](-JEU8O>VLJ3B5G5"NY64 ;6^8$8+9I-)\8R:MI/
M]K6VGI=6+63W2FRN/.DWKM/DLFT8D()XR>010!U5->1(P"[JH)"C<<9)Z"N5
ML_%UU=:S<:,^GVT>HIIPOT079=1SM,<GR HP)'8\&L*R\33WW@?POJFO:/;7
MS:C?VP1A+Q$[R?+)@KP5)X STZT >DT5SMSXDN9+W5;72-.2^DTM5^T![CRM
MSLN_RT^5LMMP><#+ 9ZXSD\?B_GT!=(TMKR/6[66>WD><1;#&!N5Q@XP6P2,
M]#@&@#LZ"0!D\"L7POK[>(=,FGEM/LES;74MI<0>9Y@22-BIPV!N'?.!UKFX
MY1XI^*FLZ5J"B73-"MH-EHXS'+-,-_F,O1MH& #P.3UH [T,& (((/3!I:YK
M4;+1?"LEQXI*+:06EE*L\4"85P2C9VCC=E,9ZG.#T%#>*;FRU?3+#5=,6V&J
M*PM9(KCS )57=Y;Y5=I(S@@D$@CZ@'2T5P/_  L6\&BIK+^'B+!=0-C<$7BF
M1&\[R@RKMPPW8SDKU[]:TE\7WL6I:OIU]HPAN[*Q&H0I'="031$L.3M&U@5.
M1R/0F@#K*;)(D4;22.J(HRS,< #W-<3;^/+^9?#TK>'BMOKL(:U9;Q2ZRF+S
M-K+M "X!^;)/'W1TJ/4?%ZW'@_Q0^K>'XY9-(9H;VP^T!XY5V*X(<J,@JP_A
MS0!WG6BN.&N:L?B!9:/;6MHNG'2#=!#,RGF2-<\(1\O( [Y)R.E5-#\9WPT2
M_P!1UJ*U4C59;&W6*<X+B7RU7E1A1C);DXR<=J .\I%544*H"J!@ #  KCT\
M?10G5$U"R$361A\N6";S(;CS6"(%<JN&W$ @CC.>15[1?%#ZEK]UI$]DD;Q0
M+<1W-M,9H)%)VE=Q5<.#_#CH0: .CI 0P!!!!Y!%<MKFH-=^--%\- _N)H9K
MZ\']^./"HA]B[ D=]N.A-3W'B2X>[U6VT?3DOFTH*+@-<>46<KO\M/E;+;2.
MN!D@9ZX -V.UABN);A5_?2X#N222!G YZ 9/ XY/K4BR(Y8(ZL5.UL'.#Z&N
M&'C*\U?7_"G]C1V\FE:M:SW6992CG8%!5@%(&W?TYR1U&.<31->E\(Z=XHNX
M-'272[?Q%.+AUF$9B1FC7*)M.[&<D';[$]@#U:BN2UOQLNFR:FEE:17CZ9@7
M$1N?+D=BH<K$NT[V"L#R1DG'KB.X\:W\FM#3-)\/27DKZ='J,1ENE@W1NVW!
M!!VD<\'].M '8TTR(KJC.H9L[03R?I6%XVU6^T/P7JVIZ<D37-M;/(OFL0%P
M.O .2/3C/J*Y;5)+U?'/@J]_L^"34Y;&]4JDW#_)%C=(5!QR3]TXR< T >D4
M5R6G^,;K4-)CGCT5Q>C4)=/N81-F*V>,MO=I OW,+P=O4@54?XB;?"]QK,>E
M^>;;4O[.FCAN0R[O,5 Z/@;E.Y2.!^% '<45SVD>([F\\27^AZAIHLKFW@CN
MHBEQYHDB<LH)^4;6!4@CD>YJKXGUK5]/\3^&=/T^&V>&_GF67S9F0MLA=@O"
MM@=#GDY &!UH ZE9$9F574LO# 'D?6G5Y9:ZS<>%-1\>W]CHR7-I:7Z7%P%G
M$.U/L\98H-IW-U.#@>^:ZW4_%\=M<O:6$=M/<I:)=LMS<^0-K[MB@[6RQVMV
MP.,GF@#IJ*SM!U=->T.SU1+>>V%S'O,,Z[7C/0J1[$&M&@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "LK7[&YU&SAMX+>QNH&E_TJVO?]7-%M8%?NM@[BIZ=JU:CGGBMH))YY4BAC
M4L\CL%50.I)/04 >?1_#_5=+TVPET.^MK;4-.OI[FSMYV>2VCAE&&M]V-VW
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MM;)(L+&(S*,F/>!@-P>_4$=1BI-2\1Z;I5U':W$DKW#[3Y5O \K*&) 9@@)
M)!QZX.,X- %'P9HM_H&D365^;9F:[GN%:!V88DD9\'*CINQ[TE_H>HMXXL=?
MLI;7RDLI+.>.;<&VEU<,N.I^7'/3.>>E:-UXATFST+^VY[Z---VJPN.2""0!
M@ 9/)Z4_1M<T[Q#8?;M+N/M%MO*"38RY(Z_> - '&?\ "%:U_P (@VC[]/\
M..K_ -H[_.?;M^T>=M^YG/\ #^OM5Z/P_P"*-)\0:C-HE]IG]F:I,+F:.[5V
MDMI2H5VCV\.#M!PQ'/Z]'J&OZ9I<QAN[DI(L7G.$C9_+CSC>^T'8O!Y; X/H
M:EO-7L;".!YY\_:&VP+$C2-*<9^55!+< G@=.: )WMHYK-K6<&:)XS&X?G>"
M,'/UKE?#NB>(/"=BNC69L-1TJ!B+22YN'AFBC))",!&P?&< Y7CM70?VYIG]
MD?VK]LC^PX_UO/7.W;CKNW?+MQG/&,U)8:I::D)OLLC%X7V2QNC1O&< @,K
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M;W,DH8X9P4V+$!QGY<GC.:NGP39S^'K_ $C4-0U+4!?1B*:ZN9@9MH^Z%(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/D@HX)Z@J>G'N* .QHR 0,]:XQO'-\IUJ >&[AK[2 LEQ"+F/;Y3(75@_<D
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MA-#*C="C@#)!&"" 170T %%%87BMI[C2AI%G,8;S5&-JDJ\F)""9'_! V/\
M:*^M &[17*?#S6+C5?"D4.H'_B::;(VGWP)Y\V([<_\  AM;\:ZB:&*XA:*:
M-9(W&&1QD$?2@!]%>4^&-5O/!=^EGJTS3>&M5O)X[*YD);[%,)740N3_  ,%
MRI/0Y'O72Z=?V/AS3;V;R,RW.L26L$48 :61I"J(">@')]  : .QHKEYO&0L
MKK5+"^TZ1-0L;(WZPPRAUN(!D%D9MO((P00.V,U%IGC=K_4-"@GT>>U@UNV,
MUI.TJMEA&)"I4<@;2<'OCH* .MHK/UV*.;0-021%=?L\AP1WVG!KSGP>-"O/
M ?AZ.ZT^[?4+N**,W8LY5(D/\?G%=O'7.>>G.: /5J*Y2[\87,>KZSIEGH5Q
M<W&F013MF=$617#G@Y./N''<GTZU'9>/$O)=!E_LFYBTW6\+;73R)D2&,N%9
M <@$*1GU'3'- '7T9&<9YKA+KXC306FK7L7AF_FM-(NWM[Z02Q@QJBJ2X&?F
MX;.!T R32?:;-_BQ9:G%(@MYO#<LYFZ IYT1#'\* .\HKE!XWC2VTG4KBPDB
MTC594BMKKS 64O\ ZLR)CY5;C!!.,C(%2VWBX2'Q$ES8_9IM$YEC>7/F*4WJ
MXP/NL.G?((QQ0!TU%<KJ/C1; 2P_98#?6UJMS<6TMXL97<"0BDCYG^4\<#IS
MR*:WCRQGM;9[!8GFGLEO?*N[A;8JC$A5).?G)5ACI\IR1QD ZRBLWP_K=OXC
MT&SU>U26.&Y3<$E7:ZD$@@CU!!%:5 !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9VM:YI_A[3GU
M#5)V@M(\;Y1$[A<D 9V@XY(H T:*Q4\6:*;FWMY;J2UEN3M@6\MI;?S6]%,B
MJ"?8<U?EU&&+5+?3V28S3QO(C+$Q0!<9RV, _,, ]: +=%%% !112!@PRI!&
M<<4 +1110 4444 %%%% !152TU&&]N+R"))E:TE\J0R1,@)VAOE)'S#!'(JW
M0 4444 %%%% !15#4=9L-*>".ZF(FG)$,,:-)))CKM106..YQQWJH_BO2(S<
M))-/'+;V[74L+VLJR+$I +;"N2,GL/7T- &U15;3K^WU73+74+5BUO=0I-$2
M,$JP!'';@U9H IZOIZZMHM_IKMM2[MY(&;T#J5S^M8_@V,R^![#3+^)?/L[9
M;"\A;G#(H1@?8@ CU# ]ZV;+48;Z6[CB296M9O)D,D3("V <J2/F'(Y'%6!%
M&)6E"*)& #,!R0.@)_$_G0!SO@OPW<>&=(:TN[K[5(C&&&0]5MD)$*'Z*<_5
MC4'A"P=M9\2^(&&(]6O$^S_[4,,8C5_HQ#$>HP>]=5)&DT;1R(KHPPRL,@CW
M%. P,#I0 4444 %%%% '.^-+J&+0);9[W3K66X(6,W]T($.""<$@Y_*N9\=I
MX6\8Z$%C\4:/9ZQ C&TN4OX_D9EPR$YR48<'\\5Z14%Y=V^GV4UY=RI#;P(9
M))'. J@9)H X&;5-)T_QHWB'3?$6@W$=U9):7=M+J4<9#(24D5N0>I!!QZ^U
M94D.DP6&F):^)?#DERNOG6KTOJ:(NYF8E$X.<;@ 3C[N>,UZ/INNV>J7MW9Q
M)<17-IL,L4\+1G:X)5AD<@X/3TYQ2ZSKNGZ#8B\OY'6$RI#NCC9\.S!5!P#C
MD@9.!S0!PIU#3QK/BZ\'B#PV8]8MHH;8'54RI2-DR_' .[/&>E5K*XLK9_ V
M_P 0^&BN@6S0W1&JK\Y,'E IQSTSSCTKU6B@#Q^Z6VN/!_B721XB\,"XU357
MO86.K+M5&D5\,=N<_+C@'K1XF:/73XDA_P"$C\*RQ:E;(EE-/JBEK/" -&JX
MQAF!.X$'GD' %>F:KXATO1)[6+4KDVWVJ011.\3^67/12X&T$^Y%3ZEJEII,
M,<UXTBQR2+$I2%Y/F9@JCY0<9) 'N: .&35[*/QK;:Z/$/AEHY-+6RN8_P"U
M%!C99"^4X^<'..=OKCM6)&MLGABQTT^(?"YGM]>&J,?[67:8Q<&;:#MSNYQT
MQWKV!2&4,,X(SR,&EH \KU36-+M]1\7:J^M^')K?4M.BM8(3?+*2Z!U = !E
M29!GG@#GVA\/>(K31]3TXZE+X=E5(191WD'B$7#P1\=$=1\I(&3G/ ZX%>K3
M017,#PSQ)+$X*NCJ&5AZ$'J*Q='T[P]I6KWEEI&BV]C<I&DDLD%D(E=6)P X
M #?=/&>* $N?%WAR2UF2#Q1H\4S(P23[;$=K$<'&[G!KSW29$MM1\,7MSKWA
M+S],6=+R5=6#O=&1 IF+%02Q*YP?7KV'L-% 'C^+;_A##H__  D/A?[2=8_M
M#=_:R[-GVGSL9VYSVZ>]3RW4-C-XHM=.\0>&;C3]>$DX,VJK&]M,\>QQ@ AU
M. 1R*]3N+F.VMIYWW,L"%W$:EFX&< #DG':BSN8[VR@NXE=8YXUD42(48 C(
MRIY!YZ&@#E_#GB/0=,\-:9I]YXCT+[1:VL<#F'4(V0E%"Y!.#SC/2LC7+W1O
M^$JL_%6A^)M _M"&W-I<VUQJ")'<P%MP&X$E6#<@X/H:]%HH XQO%.D:Q:S6
MVI:YH5G:S1/%)%%JD<KN&4J<G@*!DGC))QTP0>:MFT^?POI/A?5/$GAUK/3I
MX2;N/4DW3Q0L&C79_"QVJ#R<<XSFO6** /._#^KZ5I3>)GO/$'A_9J-])>0^
M1J:.P#1HFU@0.?DSQGK7.^&-0TS5_ 'A/3-1UC1;."R:"ZF+Z@GF-Y1W*FPX
M*DG&<G@ XSGCV*>"*Y@>&>-9(G&UD89##T-9.DWFBVNI7'AO2X%MI;*)9GMX
M[<QHBN2 5X .2#TH X&)M/L]"U_PU;^)?#SZ;J<L[073ZD@>W2?.]2G\14EB
MISSD9Q6EHU[HFD^,KF^3Q!X?&EMIMO8P@:HAE'E%L$C&.0WKVKNM2U2QTBW6
M>^N%B1W$:#!9I'/1549+,?0 FJT/B+39;ZWLB\\-U<EA#%<6TD3284L<;E&<
M <^G'J* /+T)/]EO<>(_"4UY8ZP;V6]?509+N,^8!NX^7:' "Y(XX*@<V[V+
M3KR+Q59+XL\/06^J7D>H6=TNH(9(YD$14,G3 :('.3D'I7K5% '#Z!XR\T^9
MXA\0>%K<HFP1V.I+()6XRY+8VCCA>>IR>E7=>U?P;XBT&]T>^\1:2;:[B,;[
M;Z+(]".>H."/I75T4 >;V?B3[%X:;1+G7?#=_*EN;:*]&K)$)%V[0TBD$JV,
M9P6S6;9P:5HMIX1N+'Q5X?N+_0K=[6>-]01$N(G #;6R2"" 1D<]\5ZU10!Y
M_IMUX6:Z\0WNJ:_H;2:[LCGMTU"-E6%(_+5<Y&206)./XL=LFAIT/A__ (5_
M>^'=4\9Z1-<W4#6QNEO8R511LB_B[*%)'J6]:].R-Q7(R!DBEH \\T+Q==^0
ML6N^(O">;>,J'M=34F[?& 6R/W8[G&3GT'!QL67_  IP>$3XD\,_VB(!;^9_
M:B^5C=G=G&>G;'XUZG?W]IIEE)>7UQ';V\8RTDAP!V'XD\8[UG_\)1I:M;K,
MUU;_ &B5(83<6<L0=V.%4%E R2>E '%:OJ-O?>)GU6R\4>';0G1)]/CE_M1&
M>*9V5E<#&" 5]<^U4]&N;>Q\0:1JLFL>$H?LVG2V=Q'%JP9G=F1O,W%1N+%.
M<\C.<MTKUJB@#Q^S6UMO"/A;26\1>&#<:1J:7<S#5EVNBLYPORYR=_<#I5[2
MM3.@ZCJ-A8>*/"[Z+>WDEW'<RZBHGM?,.YT"?=?DG:21UYSTKU*B@#R^/6'T
M3Q%JC:+XF\*SZ5JEQ]J)N]159+24J Y 7(=3M! RO/&1UKM(_%_AE(U5O$VD
MN0 "S7T66]S@UN44 >;2:AI>B^+[[7]"\0^'[B'5$C%_93ZDD1WH,+)&PR,X
M."I SUS4_B+4='\7>&-0TR^\4:'8&XC A6'4(Y=CJP=79CC/*C@=L\G(QZ%1
M0!YU_;&FZMK&B:GJ^N>'8)=)65U2#5$<33NFS.3C:@!8]SDCTYQ(1;1>!]*T
M4^(O#!NK/5EOG;^UEV%!<F; .W.><=/>O8** /*]8N;*_P!5\47,/B#PT(]6
MTA=/AWZLH*N!(-S#;T_>=L]/>IUO]/\ [5\'71\0>&Q'HUO)%<@:JN6+QA/D
MXY VYYQUKT6^OK33;.6\O;B.WMHAEY9&PJCZUG?\)3I2F 3/<VXN)4AA-Q9R
MQ"1W("J"RCDD]/QH \WO5MKGPKXITM?$7A@3ZOJAO8&.K+M1"T9PWRYS^[[9
MZUT#ZQIB_$"+7HO$7ATVLNFK97"OJ:;XRLC/E1T;.[')7'7VKT&B@#QVWBBM
MO!FF:=!XL\,0ZGHE\;JPE_M%6CG&9,B3H5#+(1@9QC.>>-/5=5_X2+0-]UXJ
M\,:?J]O<0W5C'#J"RPQR1DGYV."=V2" .!CKS7I]% '%:1XEU35;*Z\O4?#4
MVL^2?LMA:7_G(6'5W8#=CIP!QZG/'91>884,P42[1O"'(![X]J?5.PU*#4;>
M6:(2HD<SPMYT31G<K;20& R,C@]Z +E<]+HDFJ>)9KK6-/T^YT^* 162R'S6
M4DDR,49, G"#@G 7WKH-PW!<C<1D"EH XW2/#%_H/CS4K_3;;3X-!U"&,2V\
M<A1DF3(\Q4";0"O!&>3S78L6",5 +8X!.,GZTM% '-VGAS[=X3N=#\06MM)%
M</,9$BD+J5>1G!!*@@C<.<<$9K!7P!J<'@^QTY-36XU/2]4_M&TN+@G$VUR5
M60@9Y1B"1GGGFNQU37+'1I;&.]>1&OKE;6#;$S!I&Z D#"_B1TK1H XV_P##
M>I:O?ZAJ\T-M!>2:1)IMK;^>64;SEG=]OKM  !X!]<"&V\,:S#+X'9DLL:#
MT5UB=OG)@\K*?)SZ\X]*Z_4+ZWTS3[B^NF=;>W0R2,D;.0HY)PH)/Y5G'Q3I
M0CT5S+*!K.W[&?);#[DWC)QA3MYP30!23P5H^CVE^_A_1[.VOKFV>#?N* AN
MQ.#QD ].U4M TOQ1H7@NPT2.RTB2YM+=85G>\D*;AT?;Y63CKC(Z=1UKM**
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M1REF;((4-@%B0":IV/@+3=.U:6[M;W4H[66<W+::+G_1?-)SN"8SUYQG&>U
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M;S_M)A5DEQE6B\OJIY!#$XX.>M7)O"=C=:Q=:E=RW%RUW8_8)X9"GEO#DG!
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M9Y=,^SO;7U]$J"-95R0P1<$@@[>,DD YK:F\#Z?-'$#=7B2)J0U1Y4*!I;@
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M/'& 2HN)-H)'8#&*D\?:/I'B"U-O-*T&L64:W-I<1-MEA#-M)7U7(Y'3I[4
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MY(,3QG^'Y@[9'\54F^V:1H7A'QYJL#->VMM'!JY*9D:"0 >81UWH=I/?!84
M>K=!DT9!&<\5YAJ[+HK>'&U3R+&SU:\GGU%YX@T2SNNZ)).0" "5&>,J#[U4
MOC8>'+2QBM]9CF\/7&N-]LD,8:UMR\3%8P <"+S-I(S@'\10!ZT"",@Y%<QK
M?B:_TSQ5I&A6NEV]RVJ),\4TMXT03RE!;<!&W]X8Q^E,\':?IVGS:M_9>J)>
M6T\ZRF*W"BWMW*_,L>TD#/#$9XR#WK/\2LH^+7@;+ ?N=1ZG_IG'0!JP^+&@
M\2V^@:UIYL+N[1GLY4F\V"XV\LJMA2& YP5%;5C)?N;K[?#!$%G80>5(6W1<
M;6;(&&ZY'/UKAO%[)XA\>^%-*TQA-/IE[]OOI(SD6T:CA7(Z%SP!UX]*YO5(
M(5^&/Q$0<+#KDY3YC\O,0_K0![/D8)R,#K2Y&,YXKS;Q%:Z5X;\0Z):?Z-8Z
M/J4EQ)<RW*F2&2[VQB,R;CC)4/C/4\]>:SPVE^']2T&PDU5;OPQ<ZC>%WDVB
MUCF**8X0?N^6"9, D@,/5> #TZ^U*TTV*&2ZF6-9IX[>/)^^[L%4#UY/Y9-6
MB0.IQFO+/$NF>'8-%TD6!BN;!?%%NQ:0K)%%OD!D2,]!'V(' .1VK1T^+3=:
M\8>*=,U>&VDM8+:V_L]' V):&/EXNP&_.67IA?04 >AD@=:*\9TJRDUH_#B/
MQ"'N);JUOXY?-8@SQ!/W>[GG*8/ODYZUZG>6MKI_A>XM(9FL;2WLFC25"28$
M5" P[_*!G\* -($'H10"#G!SBO'YKK5M!TK6K%M,M8]8AT0S6^I:3Q'=6ZLH
M+%>JR '(YYR<'@5M:98^';Z^&IZ5K-K,+G39(Y+2P18TDCQD/*H)(93P"<'G
M% 'H^0>AI#G!Q@GMFO*_#7@72?$'PCLV6!!J=]I4:"\9B6#J,H>O9OTXZ5N^
M%+B+Q?90ZQ?6*Q/:VAL&C9-I2;I.!_L@JJC_ (%ZT =;ILE])IL#ZG#!#>E?
MWL<$A=%;T!(!/Y5;!!Z5XOI-M!=^#OA=YVYC)>&-B'(+*8IB1P>Y JW=0+IN
M@?$;3M,N8=-M;:]A:%-_EQQAHXF=!C[H<Y7CNU 'K@(/0YI2<#)Z5PGAW3[.
M]\=7&N626EM:+81PK:Q3Q.?.RVZ3;&Q4?*53/4X]A5_QM<V*W&@6=X"TES?_
M +B.20);LRQN?WV0<J!R%ZE@O3K0!U>1C.1CUI>M>0:*DFH>'-0T[3M4TU;J
M#Q-/]D@E7-K.!N<1% 3MC/S,,9P5&*[?P)=I=:-=I_97]EW%O?2PW-JKAXUE
M&"QC(ZJ=P/MR.U '3Y (&1D]*6O'/'UY82VOC"YMI8TO;*:V5IKJ0&5)%"%5
MMQP47!SNR<G?QCFO7U:*Y@W(RR12+PRG(8'T(H ?D>HI<@]#7B$&EV*?#;2]
M32/;?0^(?+BNE<B2-#?,A56SD J3D#KUZUK:U&_AS6_&D/AV'[,?[ ANO*MA
MC][OE5I !_'M'7J2!0!ZP"#G!Z49&<9%>;Z;9>'-0O$U32M9M9A<:;)'):6"
M+&LL>,AI@"2"IP,G!R<=ZP--TFP'A?X9WZQ;;RZN(K:>X5R))(F@DW1E@<E>
M!QTH ]*\8Z_/X:\,W&K6UM%<F%D#(\A089PF1@'.-W3CZUO9![]*\6\0VUMI
MNB?$G3+.-+:P@NK!X[>+Y4B+K"7*@?=R>>*V=:TEO#WBYY_"$+1W,^B7DUY%
M$Q97=0/(=@2<N7+ 'J<'WH ]/R"2,C(ZTN1ZUYEX6@T#5[GP_JUCK=NUVUL\
M<MM:HJR7 9/G%QR6.TC.3_%WYYM_"K1--7PQ9:PL ;4 UW!YY<DB/[0_R]<8
M^4'\_4T >A$@#).!6;X@UJ#P[X?OM7N$9XK2(R%%ZL>P'U.!7.Z[.)?B5H6F
MZDBOI4]E<-#'(,QRW0*X!!X)";B,^IKB]?LUB^'WCZU>-)-*L;_&FF0!A#GR
MRZQYZ*K,RC'3D4 >JZ;/K+WMW#J=G;1P($:WN+>4L),YW*5(R"I YZ'/;D5I
MU#:VMM9VZP6D$4$*_=CB0*HSSP!Q4U !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %07EC::A;FWO;6
M"YA)!,<T8=<CH<'BIZP?%?B1/#&G6]R;::=KB[AME$:%@N]PN3CV/ ZDX% &
MHNFV*K<*ME; 7(Q.!$O[T8Q\W'S<<<]JCLM%TK3F5K'3+.U95V*8(%0A<YP,
M#IGFN0E\2MIGQ$OUNKC4)K Z-#=1V:6[NR,9) Q$:KN'"C)/3UKJ$\1Z;-IU
ME?6TS7,5\F^U6%"SRKC.0O48'7.,=Z )(= T:WF,T&D6$4ID\TNELBMOY&[(
M'7D\^]2II.FQK<*FGVBK<@B<"%0)0>N[CYOQIFCZU8Z]8_;-/F,D8D:)PRE&
MC=3AD93@JP/8UE>.1J:>&9I]&U"2RU!'C6%P%*%F=5PX8'(Y[<T ; TG35E@
ME&GV@DMU"PL(5S$!T"G' ^E#:3IS7_V]M/M3><?Z085\SCI\V,UQT7BZ?6_
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M[%<(2W'.* -I=$TI$")IEDJB+R !;J!Y><[.GW<\XZ4#1-) A TRRQ!_JO\
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M(YQG/N.1D5G6_BO0M+TW6-3FU6_FM(=2:"=KF%S]GE(0>6HV J@++C/&2>:
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M4W^GV\MS:WT$ D='B*2(C@[7&X$$<'UP1SB@"[-H^F7,\T\^G6DLTT?ERR/
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MXTBUE@F";E\PR*BY4<XQL'4\Y[4 7O%7B*?PY;Z?+#IXO/M=]#9E?.V%3(V
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M*:6%S+(%DW!)#G^$?*,=@!\M %^?Q(NGZKXRFBT*V^U:19P7$DRS!6O$V2,
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MXOM1FOD\EF.P2$':<@9QCKW]!0!/?ZX\6O6^A6,,<U_+;/=-YLA1(HE8+DD
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M_E0CY&;(!.3@$XSG@ R_B!I]P-7?6==\-V6N>&K6)1M29OM%HO62780%;MD
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? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>elicio-amendedandrestate002.jpg
<TEXT>
begin 644 elicio-amendedandrestate002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N9T75O[;UG6[MY-ECI5TUC"I;"ET4&61O7EMHST"GU-=-7#>&]'
M,(\:>';EC&UY?SW4;CO#<H,,/7#;U^JT ;%MXML[R\TVW^Q7JV^JJ[6=R\8,
M4P"[NQ++E>1N R*CT35)(O%&K>&[B1I#:QQ7=J[G+&"3(VD]]KJPR><%<Y()
M-+P>OBNRT^PT35M+MX(M/C6!K]+E7%RB#:NQ ,J3@9W8QSCKP_2[-[SXGZWK
M0'^CV]C#IJ-V=PS2/C_=W*/KD=C0!U]%%% !1110 V1!+&R,6 88)5BI_ CD
M5X9;ZW?6_P .+?4M.UZ_N/%8U%XK>T>^DG-R!<%?+:%F(QL&<X!XSFO<9YA;
MP/*PR%&< @9_$D#\S7&?#B"30_"JZ?JGD6]S'<32?\?$;AE>1G&"K'H&YS0!
MI:EXUL=+:^,]I=O#I\D,5[<1JI2%I-N.K!F WJ25!QGZXNQ>(K>7Q3-X>-K=
M1W<5N+H2.%$<D9.W*G=D\\'CC\17 ^+=.UO7(/$EF\-G>"62)],F>_18XXUV
M$H$)XDR&RQQD'K@ 5L^-(6OQH>H:?J%M9:U'<?9@5E#_ +J9=LJY[[5'F ^L
M= &LWCBS6;2XCIVI%]4>9+4+&C;S&K,3D-C!"\'W!.!S51_B-8Q:9?7SZ/JZ
MIITS0Z@GE1[K3&"6;Y\,,$'Y"QQSBH]7M4'B7PA+IR0-8:2\WFE;B,;$:!HE
M !8$XR/P%8MWIM]/H'CRS6"+SM:GD>SS=0X(:)(QN^?CE2?I0!V>J>*;33C,
ML=O/>O!;BYF2W*92,YP?G9<D[6P!D\>XS27Q[IMQ=6-O86E_?/?V)OK7[/$N
M)$!48RS  _,/O8 ]<USDMOJ.E^(_[5M=*T_5[6_LX(KBVFNX8Y+66($;@6R"
MI!YQSQ^>FD-Q'XYTK4WCM#;6^ES6TS6\\:HLCNCA54L"5&TC.!VH ?=^/_-L
M/#UYI>F74T>JWYM'#[$>%EW[T(+#YLQL.N.#STSVRDE Q4J2,D'J*\IMM)U*
MWT+1@(+=KG3_ !#+J#P&\B&^%VFZ-N(R!*,@^AKTF2[L[BT>*6[MU,B%7V3#
MC(P<&@#(/C?35@M+QX+I=+NYQ;PZB57R2Q8JI/S;@I(P&*XZ=B"<;4)IO$'Q
M!OO#UY:7XL(]-C9&AG2,QN\CCS@0^>B#'!(P>!GG+@T.\N/ %OX'OOLZI!-%
M&=16YC\M[>.4.&"[MX<JH7!&,\YQ6_;>8GQ+O]5=8A83:=#:I-]HBY='=B=N
M[.,/Z=J -;Q/&]MX&U417-RLMMI\K1SK,RR;EC.&W*0<Y&:\]L-6NI+/P.WA
M[6+W4-9N/LK:M;F\>Y00-'F5Y0S,(R#TZ'.0 :]!\3W$=YX7U2SLY(9[BYM)
M8(T$Z+\S(5&2Q  R:XZ'1KW3]&\-:MIAM8?$.DV<-C=6SW482]@555T+ D<$
M;E)Z'J.: .UU;Q+;Z7+/"MM<7D]O +B:*W* HAS@_.RY)VM@#)X^E9%EXX&K
M>*M,L=-LIKC3;W3&OEN5*#(+HH."P("Y;(ZYZ XK(U!=0M?%LNNV>D6.J6NI
M6T45Q:7%W"DMK)&6PP8DJ5(;D YXJZMO=VWC;2=65=.D@_LV2SN1#<HBV[-*
MDF0#RR@ @8&21SC- &O;^-;"YN[",6MXEO?W,MK:W3HH222/=D8W;AG8V"5&
M<?2LYO%FC:+%XJU7[+JA^P7*"^1OG^;RUP8U+8"[2OIUKFTL-?N;C0;S4+6R
MGU*PU5IKJ[?48_WL96108QSL0!E^7@\="<FI-9TK4+W2_'MM#!"7UJ6,V>;N
M$ @1HA+?-QRA/T(H [:T\6V=QK<VE3VEY92I:F\CDND5$EA!"LRX8D8)&0P4
M\]*AA\;Z=)J6GV;V]U%_:4;O92N$*S[5W8P&+*2O(# 9^O%8FK6+ZQXLCG<)
M#8RZ'<:=+*;B(M&\I4] ^3@*>G?%-\)2:K9PVEAJFCZ/;M8($?48;J)C=!5P
M"B\%6;C)8C'/KP :5K\1=-NK%[\:;JD5B@EWW,L*K&KI)Y?ED[N&)QCMZD8.
M.BL-1:]GN(9+*YM9(-I(FVD.&!P5*L01P:XK0;6:R^'UUI5]86EQ.US,S6<U
MS$4GBDG9R,AL [&/7N*D\.V6I>'+;6!HL$M[99A.G:3=:@A>'G$N),L%3!!
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MC;R?9]QP/,VG;G\<5QGB'0+SQ7<Z-+)H)T_5+*[AG;4C-&1$B-EU1E;>X;H
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M'^OMK5%E&<X<C+#\"2*WZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,,DLD<:HTIW/MXW'ID^_O[#TKSJY\<:W#X<UNZ@%J]QIFL16*M/;/&98I#$
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MAV)8KF!-=O8[>35!JD48CC/E3>8)#R5RPSG /3/>NWK,UC68]*-E"$$MU?7
MM[:,MM#/M9CDX. %5CG!H C\1>'K;Q)H,FE74TT88H\<\1 DCD0AE<'U! -<
MG8V=Q9_%2TBU'5)=2E.ARPO<21+&NXS(0F%  ) )QU/7IBNIT35=7U&>=-1T
M"334B&%D:Y202/N8$*!SMP 02!G=TXJC;>,#<_9;V/3R=#N)981?B89C9'*
MLA'W6884@D\C(&: *%G\.S:VNC6AU^]>VT:Z$]FGE1@JH5E"$X^;AL9/8=!U
MH_X5T!!';)KU\EM!JG]IVT8CC/E2%RY!)4EN6;&?7O7;T4 8F@^'VT2\U6X^
MVM<?VE<_:I%:,+L?:J\'/3"CK6$OPVAB\.V&EPZU?13:9-YVFWB*@>VZ_+C&
M&!#$'/6NXJ&YNX+.-'N)5C5Y$B4MW=F"J/J20* .:OO!L^I:+'97FN7,]S]J
MBNI;QX4W.T;!D4*,*J@CH!Z\Y)-:&J>'WU/6M%U1KSRY-+=Y$18LK(SH4;/.
M<8)QC]:6P\0?;?%.K:&;-XFT^*&7SF<$2B3?C '3&SOZUM4 <7I46G^*/&,/
MBBVL[N%;*U:V$ES \)ED+'^%@"=B[QGI^]([&NBU_1;?Q%H-[I%V\B07<9C=
MHB P'J,@BI+O4X[:^MK!%\V\N S)$#C"+C<['LHR!]2!56[\0Q6?BC3M">UN
M#+?QRR1S_+Y8$8!8=<Y^8=L<]: *Q\+?;95GUB^:\GCM9+6%DC$0C608=@ 3
M\Y  ST'8#)SGZ;X#>PNM G?7KR=M%B>W@4Q1J&B957:<+Z(N3U/M6QKVO2:/
MY$=KI=WJEW-N86UJ4#!%QER6(& 2HZYY^M4=0\27D4%K%_9MQ:7-W87%U^\9
M&:W,87AAD@GYQTS^- #K3PFT=_I=[>W_ -LN=+A>*UF: *YWKM)D(/S\=AM]
M3D\TS2O"5SHNE6EE9:PX^S7,MP&D@!$GF%F9' (R-SDC!!X%+IWBOS=(:>XL
M[GS;2WAGN\A<F-TW>8@4G(X;Y>#P>,X!Z2&6.XACFA=9(I%#HZG(8$9!!]*
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M]G"'&,KEVSW/J*[2B@#D[GP5+_PD5UJNEZ_?:8E_M-_;0*C),P&W<I8'RV(
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MEU:QLHX2BE$QDB-2<E4!^ZN0.!@<"@#F/A59V]KX5E,(*LU_>*07)&%N) ,
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MT3EP@DC9I&VE]P7L,\YX)K,U'6-5\/7/CC[$!;M;:3;7,-M',9E@<^8&<9&
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MQNP=NW.,#Z5+K&C7WV/Q'J]O9W365WKEA>0VZ0,9#'$T0EE$>-W)#'IDA<T
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MSP>F<<XZX[5@ZD'?XCO=):W/V4^')H?/-NXC#F16"EL8!V@G!KGM%M$U_P
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M=<Y&,FKEK;:A9>*(I-#DO39W6IS_ &W2[ZV8K;DE]US#(0-JD_,!DAM_'/%
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MH8@[FY!P<5SVN64?B7PKK-]X<T/5%OY+>))'U 2I+<*DJN8%$A);Y0PR.,G
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M@ HHHH **** "LS6H=5DBM7TAX%GBN [K<,RI)'M8,I(!/.1@X.#@\XK3HH
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MCG(QSP>AKVOA;Q1H=]IFIZ2VES7 TN'3K^UGE=8V\K.R1'"DYY.01T->A44
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M<2P;3(D]M)"P#9P<.HR#@\CTJ]0!SE[;>(=1@OH9+?3;>*6SDB14N7<R2,,
MLQC&U5!/0')/;%9$'A76H;?P1$18$Z H6Y/GO^\Q 8OD^3WSSCT]Z[JJNI:C
M;Z3IMSJ%V76WMXS)(4C9R% R3A030!YEXRT;4]+\*>,;RX%ILU+4K.X@$<K,
M5Q+ F&RHQ]W/&>M=B^BZA?>)8==NX;:*2SLI;>U@28L&>0J69FVC PH X/4G
MVK4,&E^)='MI;FSAO+*XC2>-+F(,,$!E)4]^E:"(L:*B*%51@ #@"@#SW3_
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MBV<6&*.5C9B5/0CD#J/?FMG1_ 6F:'>&2RN]26T60RPZ>UR6MH')SE$QV)R
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M <]2P[@[LMGL:BT_P1IUGIUS8W=UJ&JPW$!MF_M&Y,I6(]47I@<#GKP.>!0
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M  %7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *1F51EB ,XR32UPWQ2AM7T71Y+H(J1ZU99D)VE%
M,H#$-U7CO0!VT<L<H8QR*X4E3M.<'TH2:*5G6.1'9#A@K E3Z'TKR'Q)I5QH
M.K^+/^$,M_LT3>'U>XALUVJMQYA 90.C^4'/'/0]ZW9TL9?$?@B_\,"%%F60
M2_9\ /9^5D[\=0&V8ST8^] 'H"SQ/(T:2HSJ<,H8$CZBLE=:.FV%JVO364=W
M<W7V:-;5R5=F<A0-V#D+@MZ8-<5X4\RQUK1K&ZBL=6T^]M)_[.U:!=LIBP&=
M+A>^>,L#R>HR:P;.+3A\//!TDZ6WV:'Q.Z,\@78D9GGX)/ 7[OMTH ]@$E\=
M9*?Z)_9QMPRD,WG&7=SQTV;<<]<U:6:)Y6B61#(O+(&&1]17G5_F+XC:M)H:
M0B]D\)^9;"( ;Y!(_EG'?^$?3%9T:VUWX0\!WVB[!K O+9'=?]:W&+I9.YZ.
M7SW&: /53/$K!3*@8ML +#);KCZU)7AVHZ;I<7@/QS?QVULMS9:_*;:8 ;K<
MB2(C8?X.?3&:]DBU?3I]5FTN*]@>_AC662W5P75#T8CTZ?F/6@"U+-% F^:5
M(TSC<[ #]:))HHH_,DD1$_O,P _.N,\47NF+XSTFSNVMXKDV5Q(DU\W^CJA*
M*P"$C?(>W(PN[KTKD_#7VG4O G@_^R-3L&U:TCN!'9WPWPW 4[6C;'*NJLN,
M<@$\8S0!["&##*D$>HIBSPM,T*RH95&60,,CZBL/P5>PWW@[3[F#3SI\95E%
MKNW",J[*0I'5<@X/<8KS;3-5TF34_ ]]97%K;VTE_=#RWDW7"AXY<^>^>K-C
MY2.N!DXH ]E,\2N%:5 Q;: 6&2>N/K2R310@F25$ &268#%>*S:#H=WX,\=S
M-;0_VC9ZO>"R>/\ UL$N5,2QXY4LV!@8S6W9Z)I.I?$#6K7Q':6<TC:+9RW$
M<V-I?]X)),=,C^]U&>",T =EK.NW>F^)O#VFQ00O;:G-+%)(S'>FV)G&!T_A
MZY_"M2T>^:\OEN_LGD+(OV;R68OLVC/F \ [LXQVQ7E?A];FWL_AC%>RNSB\
MO!"9C\S0^5+Y6<_[!3\Q3M0DEL-.^)K:2C!X[Z!W2VX81F.(RXQT.WS.?K0!
MZW'-%-N\N1'VG:VU@<'T-4=2U$V^B7U[8F"XDMXG<*9/E)49P2,XKA-:O_ [
MZ'J^M::_VE'TCR+A=+GV 0EAM#[>$;+$9(R%#<8!%4K:[M1XQ\0P07>G/]I\
M-H5CL,"-F4RC Y.\A<#/''84 >B>'-7_ +:\/:7?R^4ES=V4-S)$A^[O4$X'
M7&353PSKMUK-QKL5W!#"=.U%K1/*8L&4(C DGO\ /Z"O/M,T?31HWPXU'1(8
M5UMWM?/F@/[R2W$7[\2$<E0 !ST. ,=*+V^:STOQC<*[_8X_%,1OS$H=EMML
M.\E<'(XY&.1D'C- 'KT4T4Z;X9$D7.-R,",_A3ZX?P^_ABPU'5]>T_Q ES;R
M6Z/>O&\7V:+;]UCL4 .1GWP.>U=K%+'/"DT3J\<BAD=3D,#R"* 'T444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !6-K6DZ'.L^HZU9V]S'%
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MGW;F(('4GH/05<NM!TZ]U*PU"XCE>ZT_=]FD\^0;-PPW ;!R.#G-9R:Y?_\
M"PWT"2*W%E_9GVQ'7)D+>:$P>P'7M^-=$V=IVD!L<$C(H Q3X2T8W-S-]FDV
MW4WGW$'GOY,LG'S-'G:3P,\<X&<U'K/@O0=>U.'4;^S8WD2>6)H9WB9DSG:Q
M0C<OL:R/#NN^(==777DO=)M4TS4Y[$,;&1@RQ@'>3YPQU_2NECU$6.DVTVN7
M-I:W#(JRMO"1F3'(7<>G!(&2<4 5;[PGHU_?VE\]L\-U:Q>3%+:SO PB_P">
M9*$97V/%6M%T/3_#VG+8:9 8;569A&9&?!8Y.-Q.,DDX]Z6/7M'F2!X]5L72
M>3RH66X0B1_[J\\GD<"BYU2T>VU!+;5+*.XM4(E=Y%86[$':9!D8&1G!QG%
M%0^$M&-S<S?9I-MU-Y]Q!Y[^3+)P=S1YVD\#/'.!G-1ZSX+T'7M3AU*_LV-Y
M$GEB:&=XF9,YVL4(W+[&HQXMTRPGT73+_5K.:_OX!()8V"1N N?,')P&.-HS
MSGC.*U8-9TJZAN)K?4[.:*V)$[QSJRQ8Z[B#\OXT 1#P]IBZS!JR6[)>06_V
M:)DE=56+(.P(#MQD#MV%5[?PEHUK,7AM76/[1]J%OYSF%9<YWB/.T'//3KSU
MYK8AFBN8$F@E26*10R.C!E8'H01U%<II7B/49_&OB32[^:PCT_1X[=Q*(F1F
M$J,WS,7(&-OIS[4 ='/IEE<ZC::A-;H]W9AQ;RGK'O #8^H HL-,L],2=+*!
M85GG>XE"_P 4CG+,?<FHK;7M'O+M+2UU6RGN9(A,D,=PK.T9&0P .2""#FGM
MJ^FI?K8-J%JMXQVK 9EWDXSC;G.<<X]* &7VC6FH7D%W*;A+B!'CCDAN'C(5
ML;@=I (.U>OIQ5:+PIHT%W874-J\4NGPM!:E)Y%$:-C<,!L'.!DD$G%7)=8T
MR"^CL9M1M8[N0A4@>90[$C( 7.<XJ&X\2:':%A<ZSI\)200L)+E%VN>BG)Z^
MU &<? ?AXQ1H+2=3'=/>1R)>3*Z2OG>P</N&[)R <&E/@7PX=/O+ 6#+:7EP
M+F>)+B50T@8,#PW W ' P,\XJS/XITBW\3P^'Y;R%;Z2 S;&D Q\RJJ\_P 3
M;N!UP#3;+6[2VLYI]2\0:7+&UW)'%,DBQHHS\L9)8@N!U_E0!:30-.37!K(C
ME_M 6XMO--Q(?W8.=I4M@\\].O-.U71;'6HX$O8G8V\HFADCD:-XG (#*RD$
M'!(_&K/VVT^U+:_:H?M#IYBQ>8-[+_> ZX]ZAL]8TS4)Y(++4+6YEB 9TAF5
MV4'H2 >E %=O#>DR:9>:?-9K/;WN3="9B[3' &68G)( &.>,#&,"F:!X7TGP
MU"\>F02(' !:69Y6VCHH9R2%&3@#BMBN4TWQB+WQ[?\ AYX/+@2W$EG<'I<,
MC%)@/]UL#'LU &9XIT*XU'Q5]KNO#][J-H+9(;>?3-1^S2QG<Q<2 R1Y&2,<
MG&#QS6GIG@ZV>RM1J@O9&M+HW5E'-J$LCVOR@ %PWS'[QYSC<0"0*WWU;38K
MR2SDU"T2ZCC\UX6F4.J?WBN<@>],CUO29;2.[CU2R>VED$4<RW"%'<_P@YP3
M[4 4M1\(:'JNHS7]Y9L\\]O]FFVS2(LT?. ZJP5L9.,@XHM?"&BV<^GSP6TR
M2Z="8+5OM4I\M#C(^]SG ZYZ#TJ^-9TMK_[ NHVAO"Q40"9=^0,D;<YR!SBF
M#7M':[2T&JV)N'E,*Q"X3<9 ,E0,YW $''O0!GGP3H!T]['[)+Y#7?V[_CZE
MW+/G/F*V[<IR3T(ZTS4/ GAS4]3CU&YT\_:DC6(M%,\8D0=%<*0''LV?3I5/
MQ'XL^Q:QH-GIFH6$K7>II:74&0\@4JQ)&&XP5 /!Z]JZV0.8V$;*KX^4LN0#
M[C(S^= &/?>%-'U#58M4EMY([V*/R?-MYY(2\><[&V,-RY['-6M%T6P\/:5%
MIFF0M#:0YV1F1GQGKRQ)KSU/B!XBM? T_BZ\BTN>TM+QX+BTAADB<HLWE;E<
MR,,YP<%?QKJ]*UV]NO&VM:;<20_8;:SMKF#$91E$GF9W$DY^Z/3Z4 .NO /A
MR]:^-Q92.E[,+B>+[3*(S*&#;P@;"L2HR0 3SZFKH\+Z2+R]NQ#.)[Z%8+A_
MM4N7100!][C&3R.>3ZU:M=:TJ]\W[+J5G/Y2AY/+G5MBGHQP>!P>:C@\0:+=
M7<%K;ZO8RW$Z&2&*.X1FD49R5 .2.#R/2@"A)X'T"2TTVW%K-$-,&VRDBNI4
MEA7&"JR!MVW'&,XIK>!/#;Z1>Z7)IWF6=[.;F9'FD8F4G.\$ME6]QBNCJM>:
MA9:=&LE[=P6R,=JF60+N.,X&>O )H QAX'T#^R5TQK69K83+.=UW+O:1<%69
M]VYL8&,GC Q70JH50HS@#')R?SJHVJZ<EE%>M?VPM9L>7-YJ['SR-IS@]#TJ
M>VNK>]MTN+6>*>!_NR1.&5N<<$<&@#GHOA]X9@$"QZ>X2VN#<P)]IE*PN<YV
M#=A5.XY4?*>XJ>3P7H4MCJ5E):S-;:G*9KR,W<N)7.,D_-QT'3'05I7>LZ98
M3K#>:C:6\K8(2695)R<#@GN>![TR\U[1]/:9;W5;*W:!0\HFN%4QJ3@%LG@$
MT 4;KP=HMWJ,>H/!.EVL(@:6*ZEC:6,=%D*L-X_WLUH:/H]CH.EP:;IL316D
M"[8XS(S[1]6)--37M'DO+>S35;)KJYC\V"%;A2\J8SN49R1CG(I\^L:9:WL=
MG<:C:174A"I"\RJ[$]  3G)H IVOA?2K1X&BCG(MRY@62YD<0E@0Q0%CM."1
MD= 3C&:@3P3H":9;::MK,+2UN?M4,8NYODEW;MV=^?O$GZFKMUXCT.Q,HN]8
MT^ PNJ2>;<HNQFS@')X)P>/:K-[J-G80++=7EO;J_"/,X4$XSQDC/'- &)-X
M \-W#7)DL9,7-R+MU%U*JB8,&\Q0&PC$CDK@FKZ^&M+34KK4$AE2ZNH%MY76
MXD&8QG"@!L#&3C &,FLKP?XF?5/#5QJ>K7EF%COKB 3IB.)E20HI&2>H [GK
M6_%JNG3Z>=0AO[62R )-PLJF, =?FSCB@!-(TFRT/3(=-TZ)HK2 ;8XS(S[1
MZ L2<51;PEHS7-S,;:3;=2^?<0"=_)EDX^9H\[2>!GCG SFL_0_$DVK>-];T
MV.[M+G3[2VMY8&MQR&<R!@QR<D;1Z?2KOC'Q+#X4\-7>INT)F1<01RN%$CD@
M >I SDX[ T )K/@O0=>U*'4;^S8WD2>6)H9WB9DSG8Q0C<OL:UI]/M;C3)-.
MDA7[')"8&B7Y1Y9&TJ,=!CCBL*QUZ&RGO)-5\3:-/8,@FM9!(D;J@.U]WS;2
MH; !'K@UKW&MZ5:O&EQJ=G$TH4H))U7<&^Z1D]^WK0!%;^'M.MWD?RI)WD@^
MS,]S,\Q\K^YEB>#W]>,YQ6?9>!/#^GS:?-!:SF33RWV1I+N5S"",;5W,?EQQ
MMZ<GCFM6\US2=/>5+W5+*W:%/,D6:=4*)D#<<G@9(&?>FKK^C/=6MLFK6+3W
M:>9;Q"X0M,O]Y1G+#W% %(>%-)LQ++;6<CCSC=+:&X?R3-G=N"$[ =W/3 //
M7FJ>BZ7=WGB+4=>U/3VLQ>6,%G]BF=)"-AD+Y*DJ0=X ^AR!73RRQP0O--(L
M<2*6=W. H'4D]A7,IXML-=\+2ZEH^MV%EF38EQ=%65,2$?,NX8W!3@$@\B@"
MSH?@G0/#D[RZ99-$6!4*\SR+&"<D(K$A >^ *71O!6@>'[QKG3+(PN2Q1#,[
M1Q;OO>6A)5,_[('ITJ_>:]H^GM,M[JMC;M H:42W"H8P3@%LGC/;-":[I$E[
M!9)JEDUU<1^;#"MPI>1,9W*N<D8YR* &Z1H.FZ$LZZ= T*3R-*Z^:S*&8ECM
M#$A1DDX&!DFFGP[I;:U-JYM<WL\0AE;S&VR* 0-R9VD@,1DC."14\VL:9;7L
M=E/J-K%=2,%2%YE#L3T !.<FK<LL<,3RRNJ1HI9G8X"@=23V% &1IWA72-*:
MW-K!($M2QMHY)W=(,@@[%8D+P2..@) P#BK>KZ/8Z[ISV&HPF6W9E? =D(92
M&4AE((((!R#5/0_%6CZ_I,FIV=[ ;:-G#LT@&Q5=E#-_=!VY&<<5H66I6.I*
M[6-Y;W*QMM<PR!]I]#CH: *,7AC2H-2?48HIUNWMQ:M*+J7)C&2%^]ZDG/7)
M)SFJ<_@+PW<:!:Z))I[?8;-]]L!/)O@;U1]VX?G5W7_$FF>&X;634;F.+[5<
M1V\09@-S,P!//8 Y)[ 4)J4;ZVQ76=/:R%D)3; J9 =V?-+;ON%2!T]\T 7-
M,TRST>Q2SL8O+A3)P6+,2>I9B26)]2<U1/A713<ZE.UBKMJ:XNT=V:.7*A2=
MA.T$@ $@ G%31>(]$FN(K>+6+!YYHS+'&MRA9T'.X#/(X//M4UCK&F:G:27=
MAJ-I=6T9*O-!,KHI'4$@X&* ,G3O OA[2].NK"UM)A;W,1AD#W4K,(_[BL6R
MJ^RD59E\*://IFGZ=)!,;73I$DM4^U2@QLGW#G=DX[9)Q5^QU73M3,HL+ZVN
MC$0)!!*K[">1G!XJW0!D?\(UI?V^_OO*G%S?Q+#<N+J4;T&<#&[ QDXQCJ:B
M@\):1:0V<5HEU;K90F"#RKR4%(SC*YW<C@=<XQQBK]YK&F:?*L5[J%K;2-C:
MLTRH3DX'!/<\4V]UO2=-=DOM3L[5EC\UEFG5"$R!N.3TR0,^XH FM+"TL=/B
ML+:!([2*,1I$!\H7&,5A6O@#PW9&Q,%C*#8R,]KNNI6\G<""JY;A<$_+T]JZ
M1'61%=&#(PRK*<@CU%4[?6M+N[EK:VU*TFG12S1QS*S  X)P#T!X- &:W@G0
M&TN?36M9C9SW/VJ6/[7-\TN[?NSOS]X _6DO?!.A7]_<WLUO,L]U#Y%R8KJ6
M,7" 8 D"L Y XR<FKR>(]#DGMX$UC3VFN698$6Y0M*0<$*,\D$$<>E3P:MIU
MU-<0V^H6LLMM_KTCF5FB_P!X _+^- #M.T^VTK3H+"SC,=M;H(XD+LVU1P!D
MDFK50VMU;WMLES:3Q3P.,I+$X=6^A'!J:@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N&^*2VW]A:
M2]VB-"FM61?>N0%\T;OTKN:P_$^@2^(;:RACO%M?LMY#>9,/F;FC8,H^\,#(
MYH X37K&QDUGQ7JFEK;_ -F/X9DMKAX0/*EN26,8&.&<+QQR-RCO4U[;Q6?@
MWP9JEE:QFQM[BREU0P1C=Y:H1N? R0CD,<]",]J]0&=HR03W(&*6@#A;2QM]
M:^(>KWMH8[G1+O1H[6\>,[HKB8NV.1PQ$?!QT# 4WP+;ZAL&F:K&^WPVSV,4
MT@XN,_<D'TA*C/\ TT:N\HH \CT]+.?0=1C75FTF8>*KJ6SO(U5DB<ERC.IX
M,;+N'H<CFEU*^N;SPCI\FJV]G'=0^)K<?:+4'RKE5F4M.F>BD9SVR#7K=% '
MG%M=6MGJGC?3O$14-?R>=;>8.+JV:$(J1_WBI!&T<Y;IS6=I%C)9:]\.[76Q
M&U_;:3<+/YN"4?;%L#$_Q#! ]P<5ZQ10!Y!IR6LNAS1PZR='N8?$][)872JK
M11D^9M#J>/+9&8#IG(P:[SP1>WE]X=,E_:V\%PMS.C/:Y\FX/F',R9YVN23^
M-='10!PD-Y%I7Q(\1C7GCAM+^UMOL$MQ@1O&BL)(@3QG<Q.WJ0V<5S?V>?1_
MAQX/M-0+Q2)KMM+'%+D/';BX++N!Y 5"N<].AKU^B@!%970.C!E89!!R"*\:
MU:XCC^'OQ"TUPZWAU6Y<1%&R5>1"A''.1R/4 ^AKV:B@#S#Q#'YWC2Z@T)HD
MN)_"=S!;& A092ZF-01QG&2/;)J?PE>>'_$.H:'<P?VD^KZ9"\;6\L;1BQ!3
M:ZO\H!&0 !D]B.AQZ110!ROQ(\/W7BCX?ZMI-E@W4J*\2DXWLCJX7\=N/QJ7
M1_&VC:AI\)DNEMK_ & 2Z?*"MS')CE/*^\3GT!SVKI:* .#2_P#[,^)E]<Z[
MBUL[_3(%LI;A@(T*,QEB+?=#$L#C/('?%<MIFG"PE\%0WL2I!_;5[+;13+S%
M:LLOE @]!DJ0#Z@5[+10!Y#?1V#:1\5 J6Y>5G\K"C+DVR8V^O[P'I_%[U>C
MGTC_ (6'X?N=1>T\N3PVV)9]NTOYD?4GC.-PY]Z]0K"D\/S/XUA\0B]0+'9-
M9_9_(SE6=7)W;NN5';I0!YYI@A\.PZ:);7[-876OWLVF7DB,4LH65@NU!QE\
ML$W<8;.#TJ@&M9/"PM;@,YB\:;F%S"4/EFYW$D%0 -O)&!@'D"O;Z* //K*Q
MT[5/'_C/3)DB>TOM/LXG1<8?"RJV/< K].*G\#)JEU+Y&L1L9/#P?3DF;I</
MQ^]'_;(1<^KO76:O:7E]IDMOI^I/IUTVW9=)$LA3!!/RMP<@$?C3M+T]-,L$
MMEEDF?<SR328W2NQ)9C@ <DG@<#H.!0!F>-(K2?PK<QWMY/91&6#%U"!NA?S
MDV/SQ@-M)SV!JAX'O=2N)-7@U)K.[D@G0+JEDNV.]!0<D9(#J  <''0=JZZB
M@#G/%7BRQ\.1P037 BNKK(B9HGD6,=W8*"<#L.YXXY(Y/4ET[4O#FC7OA[[1
M=6>AZW#>74K0NK2\DS/@@%F'F;R0,=<>@]/HH X+[3;-\0]0\6M.IT;3]&6S
M-RGS+)(TID8)C.[ "CC/+8ZU)X>\5:%K?B%+I;B6;5;F,PP0"WD MH1\Q!8J
M%R< L<]0H&< GN:* .*,\/\ PN<#S4_Y 1CZ_P ?GYV_7'..N*[1F"J68@ #
M))[4M% 'D7AF#PU?1>,H=9O(H?M6MWFPM<F(O$P4!E&0".N#SFM>?Q-:VOC[
M3-7U$30Z-=Z6\%A<21,5$WG9/0?*70(1G&0,5Z-2'.#C /;(H \922.+PDFH
M%&2SM/&SW,S&,CR8A<-EF&,@#(SZ5JM?V=[K'Q&F4E[>XTNW,3O&P23$,@X)
M&#R5QZY&,UVWAG0)?#UM>PR7BW7VJ\FO,B'R]K2,68?>.1D\5N4 >6V%S':W
M?PQNI2P@729K=G5"V)3#" AP/O$JPQZ@U?U73;S3O&=SIEE"QTSQ4FZX9.!;
MRI@3-[;XN ?[P%>AUBZ5H=U9ZC/?:CJ\^I3L72W\R)(Q;Q,P8H H&>BY)Y^4
M=.X!LJJHH50 H&  . *\QM[JT/C;XD&66(Q36-H$+$;9-L,@8#UP2 <=":]/
MHH \CTG[';6/PJ,8ABDC4B8J "I-JRMN],O@'/>K?A/4=,GTVV\-:]932^([
M#4GG:W>%]S2^<SK<!L8VX;.XG';G@'U&B@#R.TFTN[.I>%_$C:G_ &L-4EN(
MK2-6'VG,QDBDC<+P,%1G<-H7G HU**P>'XK'R[<O)#MA^49<_95&%]?W@QQ_
M%[UZY10!YQ87D4/CSPY=3LQANO#AMXY-I8/+YD9*Y'?&2?0 YJ'0-%M_$G@C
MQ7I$;JC3:Q>O;NO'EMYN^)Q[9"D'N*]-HH \X9M<\3?#C6-5^QRP:Q<Z>;6*
MWQALH") !V+/Y@'J E6?"]]X=\2:Y8ZKISZC/J-K;-#()D:,6B'&8W^4*3N
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M;)$^[#*2X_NG@\GL#S7-:1::AJ^B^.=%M;5=M_K%[;BZ:0;(@X56++]XD Y
M .3C)'6KVFK/I'Q,U2TL;)[N*'1+*)0)55AM:4+G=@8X.3U'H: $O-;L_$6M
M?#[6]-EF^S7=W. K,5Z0295ESC(8$?AUK7L=?T6RNO%5ZUK<V;V-PGV]Y6W^
M:_EKM**&8<J5  QDGIFLJS\&ZCI*^$(H8XYQIEW<7=ZZN%&Z99,A >H#2=\<
M#UHO_!NJ:O#XUMGV6G]KSPSV4V\-M:)(PN\#I\T8/?@T ;T_BY;&6^CU'2-0
MMS:V1OLK&)1(@."H*DCS ?X<]\Y(YJM?:^FI0:WHES:7%G>PZ9]KQYHYC8,
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MB1S&3/"&VDKA\ @XX8@\BN:NO"FNW'@CQ-I*VD8NM3U66[@S.NT1O*KC<>Q
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M/63$]O*9@JPLL(C(D!&<9&?EW9]J -"U\965[K.E6$%O.T.JVAN[.\.T12*
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M[G4A<,HXYSDYXQ2CQ!K-EXIT.WUA(+2QU2R8F+ +07:*&:,R!L%=N\@XY*T
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M)FB?3+=(XU*KDM,1O;#9Y4*T?;JQ]*PM+EU*7XJ:_#)?[K2"SM"D!BX4,9>
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MLG7Y2>GM5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\3S006QD9"H$:[%7DC&,]?7BNGJGJUZ^FZ3=WT<(F-O$TIC+[=P4$D X//%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGVMV8'WQ&>%7\MO49'% 'DEA*U]X/\$I+J-PQ;Q!+:.T5RZ[HM]P%7ANF$4
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MRVO+FRMYKJU),$TD2L\6>NTD9'X4 >5BXGN?A1IOBFSD<^)UNHBTP)$DLS7
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M,8QZ5FGPSH)L#8'1=.-FS^8;?[,GEENN[;C&?>@#0M[:&TMT@MXUCB3[J*,
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M7TKSKPW>Z>EEX8M-3_M6UM-(G,UJTNE3*#N#+&))@"F K\L.#P<@=>ET%;F
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M[5)!XX(XQP<&ISK^FB\6U\]C(TK0J1"Y1I%!+(' VE@%;(SG@^E7H)5G@25
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M*^U/1KV34+IKF:'4[JW61E524CE*KPH Z"L]7FF^)>CWWV&^2V_L6:)I'M9
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MYOKDQB-!)(5C=Q$A.-S[0=B\'EL#@^AHO?$&EZ?$LD]T"K1&<>2C2GRAU?"
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M'>QPW=S<"[NI+M_/V<2.<MC:HXSVK8HH **** "BBB@ HHHH **** "BBB@
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MH<5AIQM5=;J&=FN)&48C<-@;5.<XQ71OYQM6PD?GE.$+G;N]-V,X]\?A4M%
M'G>G^#?$6G:)X5L1)IEPFD^8MU:RROY,^1\D@.S[R')"D8YZ@X--M_!/B"#2
M-.L6ETR0V>OG5-PDD3?'YCOC&TX8[\8Z#'4YX]&HH Y*'1M>L=?\4:O9C33+
MJ,, LUEE<A7B0J/, 4<'/8UU4/F^1'Y^SSMHW[,[=V.<9[9I]% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5BV6KMJGB#4+2V8+::8
MRQ3OC)DF9=Q0>@52I/<EL<8.=JN#\()-8#QU;R6QN+E=8N+E8.\J21(T8_$<
M?A0!U-IK^DZC<BUL]0BDF>,R1A3]] <%DSPP![C(J#1]8>YU/4M'NROV[3V0
MEE&!+$XRCX['AE(]5/8BO/\ 0KEY_$?@:[6UODB2SN8)(5L)(H;-RD>(ERN<
M#!&YB>G7M736$,DWQBUB[C!\BWTBWMI3V,K2.X'U"X_,4 =I1110 4444 -=
M6:-E5RC$8#  D?G7%>$/%SW'A:;6/$FI6L(%[-:JQ B3Y)"B@9.2QQ_]:NU=
MUC1G<A549)/:O%XXY'^"FK636ER;E]49Q;M;OO93=AP0N,D;03^!H ]4M_$F
MBWWVU+75[1VLUS<$2C$0.<,>V.#STXK)_P"$NL-&T;0OMNK)J<NHR+#'>1QA
M$FZDR87(48!^M4998D^*4]RJ.+4^'A'YJQ-L+"4L%SC&=ISCKBN<L(Y[7X>_
M#N66TNP-/U&$W:+;NSPCRY5RR ;NK*.G<4 >AVVIVSZYJ7_$^MI8+>WC>2S
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M4[;2;F9=7NS9HBR)^[E!<$$YY&8VP>F.210!VE("",@@]N*YJ'Q%=W\HTO\
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MO$V@2M?ZK8V5DFI6,8+3W"J>&A!/+?-C;D\#O0!V'_",VO\ S_:O_P"#.?\
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M[6[_ .$=?3-/N;R+75E,#AD38R(S%6!/4%2#V'/)Z54E^(=S#H^JW\GAV?\
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MR#[4 4M?M+F_\/ZA96:Q&>YMY(4\YRJ@LI&20">_I6!H^G>*=)\(Z=HL=KI
MGM+6.V%T;R1@I50N\(8>3QD#(^M=A10!S-OHVJ1?$&[UQEM#8S:?'9J/.;S<
MH[-N(V8YWXZ]JR$\%:I=Z!XJTN]FM;8ZO?R7MM/;RM(8F.PIN!5>AC!.#7;W
M5W!96[3W$@2,$#.,DDG   Y))(  Y)-2JVY%;:5R,X/44 <3<Z#XH\4^&+_2
M/$DVFVAEMS$CZ>SOOER"LAW ;0"/NC.<]1BM#3+7Q5>Z?+;>(7TV$_9VAS9,
M[^<Y&/,;<HVCK\HSUZC&*Z>B@#SY/"?B(^$O"VE2#3//T6\M97*W$FUXX!C@
M^7]YO3&!ZFMGQ!X5?5_$6DZI!.L(A#V]^O\ S\6QP_E^_P ZK^#-6X^J6:1S
M2&4E(I!$Q"DY<D#:,#YCD@8&>>.M5/$'B?2/"MBE[K5T;6V9]@E\EW&[L#M!
MQ^- &-JVC>(K/Q<VO>'&L)EN[9+:]M+Z1XP=A8I(K*#R-Y!&.E=191W,=G&M
MY,LMSC,CHNU=QY( ]!T&><#FG6EU%>VL5S#O\J1=R^9&R''NK $?B*KZSK%C
MH&D7&JZG/Y%G;J&EDVEL D < $GDB@#F=*T7Q'I/BCQ)JJ6NES1ZM+#)&AO9
M%,?EQ[.?W)ZXS5>;P3JYT[Q'?QZK$/$^L(J"Y0-'% B8VQ)C+ 8R"W7)SCBN
MVM;J"]M(+JWD#P3HLD3]-RD9!Y]JHZ-XBTOQ ;T:9="<V5PUK<?(R[)%ZCD#
M/U'% ',V'A75T\17=]+!I5E9W>D+8M!:N[&%@SGC*J&!WYSQZ8/6J4'A+Q5I
M^D>&;BRETL:OH4#6?DM(Y@NH"J*V6V@JV45AQ@'UKT*ZN8K.UEN9V*Q1(7<A
M2Q"@9)P.35/0]<T_Q'I,.J:7,9[*8L(Y3&R;MI*D@, >H/:@!^DKJ8L]^K-;
M_:Y&W&.W),<0P %4D MTSD@<D\ 5ROB'PA>:[J_VO[/9V]Y!=126.JP3,D\4
M0VET=0OS9PX )(PW:NXJIINIV>KV8O+"X6>W+O&)$^ZQ1BK8/<94C/>@#CKO
MPGK=Q:>.(5&G@Z^,6Q-P_P"[_<B+Y_W?MGC/I[TE[X6\17-TH)TV:U;2!9*D
MTKD6DV&#21KLP^X$#)VGC\#WM% '":;X6UVVNO!4MP-.VZ'9R6USLG?+;HT0
M%,IS]S/..N.V3K^%-%U'1[C7GOA:[=0U.2]B\B5G*JRHNULJ.?D[9ZUTE% '
M&^(/#VMZEXAGG@:PGT^;3C;1I=.P-I*2V9$4*0Q((&<@C'7L:5OX6\0V-MX,
MN(DTV:]T.U>SG@:X=(W1HT3<K["<CRP<;>Y';-:]M\0_#%WK:Z/#J#F]:X>U
M"-;2J/-7[R;BH (R._>KNF^+=%U>$365V7B^TM:%VC9 LPQ\AW 8)R,9ZY&.
MHH Y/_A"M?&CW,1DTY[L>(AK, \QU21?-WE&.TE#CTW5LVNAZUH_B?5=6L4L
MKF+5XXGN(9)FC\FXC39E3M;*$8ST(Q774@8$D @D'!P>AH X2Q\#WND2^#HK
M*2UEM]$>XDN7ED9&D>9'#%%"D8W.3R?;WJ.Z\(:Y<:%XTL -/$FNW#RV[?:'
MQ&&C1/G_ '?4;,\9ZUZ!10!YUJ_A#Q)J8UB%CI<L-]I2VELTTSDV3^6RN$&S
M!#D@EN#Z@X K3@\/:W!XAT'5A_9[-;::]A>(9' 4%D8-'\OS?<QSMZY]J[*B
M@#SF3P-KDNC:@J7%C;ZFNOMK6GNLCR1[BV0DGR@XP2#C/6M75--\7ZSX8NHY
M9]/LM1D:+9;P3.8BBN"ZM)M#?.,KP.!ZY-=C534]2MM(TRYU&\9UMK:,R2LD
M;.0H&2<*": .(_X1#72_BLI#I$$>M:;':PPQ2N%@=8W3'W.5^?.0!TQ@=:O2
M^&]8?_A#"%L<Z(<W(,[_ #?N3%\GR<]<\X]*ZVRNXK^QM[R DPW$2RH2,':P
MR/T-3T <-/IUCK7Q&M+_ $S4(I84MLZG% ZNDC12 V^XCHP?>?HA':NX(R"/
M6JUEIMAIB2)865O:K*YDD$$2H'8]6.!R?>K5 ' :9X,U4>$](\+ZE]C%CI\\
M<DEQ#*S-<+&^]5"E1MR0N>3@ XSG(GT[0O%>AZGJ%CI]QIKZ)>7<EU'/,SBX
MM/,8LZJH&U_F)*Y(Z\YZ5V[NL:,[L%51DDG  JCI.LZ?KMFUWIMP)X%E>(N%
M(&Y3AAR!T- #=>O;?3?#VHWMTT:P0V[NYE7<N IZCN/;O7 >';;5]#;07O=)
MTFZBB5+2VGMM6>5HEDVAC'&R;<=SM/"@XX&*['_A+_#]SKS^'A=F:_+-$T M
MI&4D#+ MMV],YY]14J:7X;\+Q3ZE!IFG:< ,2306JHQR0 /E&222  .I(H P
MK'PSX@M?"GB73H[NUL]0U&[NKFTN()G;R_-8L 25!!'3(SZBH+'POKUOKZZF
M+31K:-M':P:V@GD(5]^X'=L&<D\DC(_VNM=A9ZQ9WMS+;1O(EQ$BR/#-$T;A
M#D!L,!D<$9'<8J"Q\2:5J-S%!:W)9IE9H&:-E6=5.&,;$ .![$\<]* .4L_"
M&N6VB^"[)O[/+Z#,LEPPN'Q(!&T?R?N^OS9YQTIMQX(UJ:QU^SBN[. W&K?V
MOIUT"S,DP9&59%Q@ %",@G.>@QSUI\2:4+XVAN3O$XMB_EMY8F(XC,F-N[VS
MG)QUXK5H XG4O#_B3Q;X2U'3->ET^PGGB5818L\B"16#AV+ '&Y1\HZ GDY&
M"/2?%-]XH\/:QJ=OI4/]G07$5PL%R[^89 @W+F,8^[G!Z>M==?7L.G6,][<E
MQ! ADD*1LY"CJ<*"3^ INFZA;ZMI=IJ-J6:VNX4GB+#!*,H89';@T 9_A>_U
M74=):76(;2.Z69TW6;LT,BCHREAG';Z@D<8K,@T+5]%\2ZW?Z6MI<VFKE)C'
M/,T9@G5=A/"MN5@ >Q!%=;10!PFF>"+S1-0\)K9/;2V6BVEQ!,\DC))(\NTE
ME4*1C*DXSW]JV/"&BZAHD&JI?BVS=ZG<7L?D2L^%D;=@Y5>171T4 <L=$U:U
M\;ZEK%H+*6TO[*&%EEE9'1XR^  %((.\<YXQT-8MEX-UVU\-^#=-;^SFET.\
M2>=A</B151U^7]WU^?/..E>ATUW6-&=V"HH)9F. !ZF@#B=,T+Q7H>HWUA87
M&FOH=W=R74<\K.+BU\QBSJ$ VO\ ,25)(Z\YZ5T/BG0D\3>%M2T5Y3"+R$QB
M0#.UNH.._('%)IOB;3]4U 6=N+@2/;"[A:2!E2:$D#>K$8/4<<'D<5I7-U%:
M02S2EML2;W"(78+Z[5!)Z'H* .+CT;Q9?:UX8O\ 4XM*C?2?.6=H;EV\[?'L
MWJ#&-OK@D_6J%AX.\40S:!/=-I,EUIM])-<W7G2-)>*Z.GF-\G# ./ER1Q@%
M0,5WFDZI:ZWI-KJ=DS-:W48EB9EVDJ>G':KM 'GC^"-<;1M4L8KNR@F76'U;
M3+D%F_>&7S LJX& ,E3@MG.>V#U6A?\ "0RJTVOK802;0J06+LZ^[%F //8
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M0R3PQES$S0\.%^7($IY ["M"\U+Q+H7BJ33+C6%OK>_TRXNK:1K5$-K+%@D
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M&O2B6\D\WY\@Y 4XX ].:=-\/]%FOM"NBUVK:+&\=L@F^5@PPV_(R>/0C\J
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M6 *DCG!K TGP5"NHP7M[X?\ #NGO 6.-,BR9MRE2&8HORX8G;@Y..>.>UHH
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M=S!<7^F6=U/ <PR3P*[1GK\I(R*OT44 9J^'=$2.*--'T]4A<R1*+9 $8]6
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M'D<<'T-0:OJ]EH6ESZEJ,IAM(%W22!&?:/HH)H O44V-UEC61#E6 8'V-.H
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M']OX[BF5K8R+++IWEKM^SF79@-][S "#G.,@C%&IZ]XG#^-VMM4M8$T%5G@
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M4@ ;%  '10* (_[5OM;\4ZWHMC>FP&DPP9D6)7:265689# C8 !P,$DGD8K
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M'P<$9:;D'L1U![&J?@\S:C)8^'+^'_2?#$KK=N4P)6 VP,/4.C&0_P"TH]:
M/1Z*Y/XG _\ "M=?=7D1X[1W5HW*$$>X/Z5AOHL6E^/O#,NE2W.-4MKE=37[
M0[>=&L8*R'G@ARH!&/O 4 >A7;SQV4[VL*S7*QL8HG?8'?'"EL' )P,XXI;9
MYI+6%[F)8IV13)&K;@C8Y /&0#WKR?P]HMFWP=O-;9KEM2.EWT?VC[5)D*'D
M8#[V."H/KU]36GI$XO\ Q)X;T?5$673G\-1W%O%,,QS3Y4/D'AF5,8ST#$T
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MPDMN)8<Y &>!7.:7!<^(I?AZOB![F22_TN]%TAF=//55CV%@".2IR2,$YYH
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MDR&*5&1D>)QU5E8 J?J*BG\0:=;7;6TDLI=9X[=V2!W1)'V[%9@"%)WKU/\
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MVWBO1KS1)-9@N9'L(W,;2"WD!#!MI&W;N//'3K2ZCXITC2=[7MR\<<159I1
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M[1M,U.6.6^T^UN9(P51YHE8J#U&2.A]*=-I.G7%S;W,]A:RSVPQ!*\*EHO\
M=)&5_"LQ?&F@/JITQ+UFO!<BU:-8)#MD*[@"=N ".A/!]:GB\4Z/-J%M8K=,
M);O=]F9H76.?;R=CD;6XYX/(Y% $I\.Z(8;B$Z/IYBN6WSI]F3$K>K#'S'ZU
MA?\ "(>=X[EU2YT_37TK^S8[*&+.70J[MD+LP 0^, ]JUSXJT87L%J;LAKB9
MK>&0Q/Y4DJYRBR8VEN", ]01U%4M'\:Z?JEOJUS(L]I;:?=/ TEQ Z A-H))
M(QN+$@+][IQDT ;%WHNE7\5O%>:99W$=L0T"2P*PB(X&T$<?A41\.:&RA3HV
MGD"8W !MD_UIZOT^\?7K42>*-(9[N-KB2&6TA$\T4T$D<BQG^,*R@E>,9 //
M'6DT7Q5H_B&0II=TT^(4GW>2ZJ4?[I!8 'H<@<@C!P: #4-,EM(;J]\.6&DQ
MZS.5W2W,919 ",[V0;CQG'O5G1M/?3K$K/(DMW-(T]Q(B[0TC')P/0#"C/.%
M%9O]MZ9:Z[K,DNLW#?8K:)[FT:,^7;+\WSC"Y);!S@G[M)'X\\.2RVL:W[C[
M7!Y]LS6\H69<!L(Q7#-@CY02W;&: -R\LK34;9K:]MH;F!B"T4R!U)!R.#QP
M0#1:6-K81M':6\4",VYA&H&X^I]3P.:QO^$V\/C0KK67O7CLK64PW#26\BO%
M(,95D*[@>1U'<4'QMH*WL]G]JF-U%&)1"+24O*F<;HAMS*,]TS0!I7FBZ7J%
MP)[S3K6XF">7YDL2LVS.=N2/NY/3I4DFF6$U[!>RV5L]U;@K#.T2EXP>H5L9
M'X53MO$VDWFDVVIVUT9K:Z8I!Y<3EY&&<J$QNR-K9&.,'/2FP>*=&N=+DU&.
M\_<1S?9W#1L)%FR%\LQD;M^2!MQDY% %F+1-*@OFOHM-M([MV+M,L*ABQ&"V
M<=2.,]:2?0=(N=5BU2?2[.74(AB.Z>!3(N.F&QD5R6G^(VG\6>+XKC4[R+3K
M*RMG420%&M2PEW%5* GHIR0>W45NV?B'2[31])!U&YOFN;,3P2>0\DUQ&%4F
M4HBY'49X')QUH T'T+2))KF9]+LFENEV7#FW4F9?1SCYA[&FP^'=$MY898='
ML(Y(5V1,EL@,:^BD#@>PK)OO'.FV\V@"U$]W!K+MY,\$#R*$$;/GY023\H&W
M&>I.,5H:AXIT?2Y&6\NFC1)%BDF\ES%$[8VJ[@;4/(ZD=1GJ* )UT#1DL9K%
M=)L5M)VW2P"W0(YZY*XP3[U(NCZ8EA)8KI]K]DESYD'E+L?/7<,8/0=:YJ/6
MI['Q]XABOKZ=],M--M[I8_+W>3N:0,0$7<>%'J:WHO$6ESZ=8:A%/(]KJ#*M
MJZP2'S"P)'&W(! )R0!B@!;GP[HEY8P6-SI%C+:6Y!A@>W4I&?\ 9&,#\*4>
M'M%%E<60TBQ%K<L6GA^SILE.<Y88P3GUK,\>>(9?#7A2ZOK8/]I)2.)EA:0(
M6=5W' (&-V1GJ1CGI3;*_M](N;AIM5U*\CNE$\%G+:2/-;JORN<!=^TG&-PZ
M].M &H/#FAC3(]-_L>P^P1G<EL;9#&I]0N,9]ZENM&TR]:)KK3[69H5*1,\2
MDHIZ@'L#@<5S7BG7FETGP[J>AZH?LMWJ]I$SP[2LT3R ,I)&1Z<8/4&I],U*
M['Q"\2V=U?N]C:V=I-$DFU5AW>;NP0!Q\HY.>G6@#JHXTAB2*)%2- %5%& H
M'0 =A5*;1-*N+[[=-IMI)=_+^^>%2YV\KSCMV]*K6_BC2+J[@MH[B02W$32V
MXD@D03H!DF,E0'XYPN3CGI4"^-= ;3K;4%O)3:W-S]DBD%K+\TV[;LQMR#NX
MY[B@#2?1M+DO)+Q].M&NI4\N28PJ7=?[I;&2/:I;*PL]-MEMK"T@M;=>5B@C
M"*/H!Q65KVMZ=;Z=JL%QJ-Q8&VMO,FN8H')@5@<.IVD$\$X&>E-D\5Z+ITEK
M8W%_+)=2VOGQ*('>29 !\P"KRQR/E SSTH T;W1=+U&=)[W3K6YF12BO+"K,
M%/5<D=/;I3IM)TZXO8;V:PM9+J 8AG>%2\?^ZQ&1^%5(/%&C7.BV^K0WH>SN
M9!%"P1MSR%BNP)C=NR",8SP:?IOB'3-6O+FTLYV:YM3MGB>)T:,\<'<!SR#[
M@YZ4 :A&1@UEV_AG0;-HFMM%TZ$PRF:,QVJ+L<\%A@<'WI;WQ!IUA-+%/++N
MA"F4QP/((]WW=Q4$#/O]>E,;Q-I*'5 UPX;2@&O5\B3,0(W XVY(P"<C/% %
MBWT;2[.6>6VTVSADN,^<T<"J9,_WB!S^-0R>&M"ETD:5)HU@VG*VY;4VR>4#
MZA<8!]Z)/$6F1VUK.)WE6ZA^T0)#"\CO'@'?L4%@/F')'<#J:YC5O%41\1>#
M[^PU=GT34!<F1(E#+,%B)7 "[RV[C:._&,T =4^@:/)#:PR:38M%:8^SHUNA
M6''38,?+^%:-9^CZW8:]9&[TZ9I(ED:)P\;1LCJ<,K*P#*1Z$5F7?COPY9?;
M?.OI/]!D$=ULM97\DX!RVU3A<$?-T]Z -&;P[HEP;HS:/82&[8-<;[9#YQ'0
MOD?,1[U*FCZ9'>I>IIUHMU&GEI.(5#JG]T-C('M5.T\4Z-?:NNEV]V6NGC,L
M68G5)E&-QC<C:^,C.TG%*/%.CG4+>S-TRR7+M%;NT+B*5USE5D(VD\'@'G!Q
MTH GL] T?3[^>_LM*LK>\G_UL\,"J[YY.6 R>:M7EE:ZA;-;7MM#<P-]Z*9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1M06VCT4032VT&V=9P$!A9S@QI\I.00"0.<"O3** /)-#T_5K#P[\/Y9]%U
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M6"GD97!P?7MTJIKOAZXO==TG7M.GCBU#3O,CV3 ^7/%( &1B.5.0"#S@CH:
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MJ3R*MIX2UC[9XDN9=0L6.M64=N42!D$3JC)D'<?E ;..I/I0!L^#/^1%\/\
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MV<EW;I;R1QB(XN#&CN%4$E>O! P,8'.>LO=/OK-+Z<ZX]SI\VF2*;:<*S-,
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M/UVYN=;33-8?4;+6HK-C<V5V T=PVY<S0N."O48&,;NG!-=Y0 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHY);!XQTIMMXPUO5+CPI'90Z?"NNZ;)=L9E=_)=50G !&X?/TX)QU% '2?\
M"'>&/^A<TC_P!B_^)H_X0[PQ_P!"YI'_ ( Q?_$URK^,]?C\'SZP8K RZ7J<
MMGJFV%V4PQR['EC&_(P/FP2>_-==9ZC<7VO7<,#V[Z;;PQY=4)9IG!; ;=C
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MYI'_ ( Q?_$USEEXM\0"/7=-OK?31JND7-NDMR&,=L;>7!$V&;.57<2N[DC
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MR #O:*YG3]>OH_&EQX9U,022&R%_:W,"% \>_8RLI)PP8CD'D'MBF>*_%/\
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M3TR\L["^:-4NBT;I&9,;-^ULKG(&<$#N10!<TSP_/INO:WJHODD;5&C<QF#
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MK6FFSDMWTN:.)F=P?,WH'!&.@P1WK:H Y7PYX4U+0Q#;W'B6YU"QM%VV=O+
MBF,8PN]QS)@' Z?H,4QX!F71XM/&KKB/5_[6$GV7DR>9YFW&_P"[N/UQ^==M
M4<\T5M!)/-(L<4:EW=C@*H&230 \9P,D$]R!BEIL<BRQ)(ARC@,I]0:=0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7.>,HM3ETVT&D^1+<K=*YLYI3$MX@5BT6X=#@;O3Y.>,UT=
M5+_3+/5(XDO(1((9!+$=Q5D< @,I!!!P3R/6@#S:+Q&ERNA:?&USIEO=:E=6
M]Y#J+LQBG5=RP%PPRI+?+AL$!1TXI=>TV]T;0TM5\17,Y_X2&T$?D.Z&UCDD
M3,))=MX .0&S@$<8Q7?77AG1;[2'TJ[TVWGLG<R-%*N[<Y.2Y)YW9)^;.?>H
MQX3T$:5;Z6NEVZV-NXDB@4857!SNQW;/.3S0!R_B+3(_!K:+KMK=WYT^RO2M
M_'/>RR*89B5WMN8YV.RD9[9J'Q0)X_!RZQ'<WD$U[JUK.H2X=0L3SHJIMSC!
M3!*]-Q->@75E;7UC+974*SVTJ&.2.3Y@RD8(.>M0ZEI-AJ]LMOJ%LEQ"KAQ&
M^<!AR#CU!Z4 <=NC\3>(O%VDW^H7%G-8^4EH8IC&UO&T0;SEY SO+?,>P J"
M627Q%XFU'0'U81B+3+>2S:3>KR!U;=.NQT^8';SVP,8R<]9J7A+P_K%];WNH
MZ3:W5U;@+'+*FYL#H"?XA['-+K7A70?$4D$FKZ5:WCP?ZMI4R5'IGT]NE $N
MA12#P[9P7.H_VE(L(C>\"[//QQOZGKZ@\]:\MU&74K'3-4T*WFO;C5=!U!M1
MC+7<FZ>QXE 9LY?(/E8]1[5[&B)%&L<:JB* JJHP !T %1"RM1>2W8@C^T2Q
MK%))MY9%+$*?8%F_.@#SOQ/=#4OAUXF\3V-Y=Q)<6VZR>*XDCQ&@ W  \;FW
M_4;:N-96\GQAT^>3S-YT!I,^:PRRS1@=#T]NAKKYM#TRXT9='ELHFTY8UB%M
MCY-B\!<=QP.*;+X?TFXN+.XFL89)[)2MO*XRT8.. >O8?E0!Y3:PM9>#XM:M
M[J[CO(?$[HFRX=4V/>E&4H#M((8YR"??@5Z3XX@2X\!Z^D@)7^SYVP&(Y$9(
MZ>XJ;_A$]"^P_8O[-B^R^=Y_DY.WS,YWXSUSSGUYK5DABFMW@E19(G4HR.-P
M92,$'/7B@#S&XL839_#6VCDF1)9@79)FW<V;DX;.5S[8QGC%5GU:YT#3]?L8
M[Z:+3X/$<%IY\\SN;:WD6-F&\MN"Y8C.<C<<$5Z'%X4T*".RCATR&-+)B]L$
MR/*8\97!X..,^G%2#PYHXCOHSI\+QWYS=JXW"<^K ]3[T 9GA[29M*UW4"=9
M2XM[J*.5+!$;; 1D%U+.V WIP"02.]8EV39?'BQN;T[;:]T-[6R=ONF990[*
M/]K;S77Z+X>TCPY:M;:/I\%G"[;F6)<;CZD]34^IZ3I^LVGV74K.&ZAW!@DJ
MYVL.A'H1ZCF@!FKWGV*PEECC66[6*1[:(C)=U0G _E^/O7G/VRZ'@/PIXHT^
M]N)M7N;BT%P?-8BZ,K!98V7., DX&/EV\8Q7H]AI%CIA)M8-KD;3([M(^/3<
MQ)Q[9Q4-KX<TBRNOM-M811R"1I5"YV([9W.J_=5CDY( )R?6@#S?4[:272/B
M/<-J.I>9I=P\MD5O91Y++;HXQAN1GL<@=@,FMF**2T\;^&"EY>M_;&FW)O@]
MTY$C*L3*P&<(06;&T#&>*ZUO#.C-'?1M81E+\YNU).)ST^?GGCCGM3FT'3(Y
MK6[2Q#W%C&4M2&.Z-2.54D\ X ].E 'E%O;WT?PQTOQ5;:MJDFMV]^$B\R\D
M=9E:[,9B9"<-D'J06]\#%:FM7\@F;4M.O;F7R_$T%JUU).4*_O$C>!$'!C R
M#G&3DX/6ND\">$AH_AZSAU6Q1;^WFEEXE\R/<SLP=1G&[:P&< UK3^#/#=S-
M=2SZ)92/=2"68M$#O<$'=]<@$^N.: .,U&R-_KGQ!CEO]1\JTL[>>V2.]E41
M.89&W+AN.1G'W?:I;F]N=.TOP=XVNKNX:V^RP1:LIF;R]LT:@3E<XRKD9..C
M'TKMO^$;TCS+V06,8>^01W)!(\Y0,!6YY ' '8<=*S-0T:^F\GP]9V%C%X:,
M*),[2L9%4-S$L>,;2H"YR, GT H O>&89/[-:_F,HEU"5KK9(['RT8Y1 "?E
MPNW('?-<%XPOY!:^(M3TV]N9)K#4K6+[2\YC%LX:(-#$@^\"&);. =Y^]BO5
MZQ+OP?X=O[B[N+K1K.:6\ %PSQ@F3&,$^_ YZT <Q=Z>NJ_$/Q!87%[J'V/^
MR8)EACO)$57+2C<,,,?=' X]0:S?#6N76M/X(TO5;F5H+O1GNY&9R#=SIM4*
MQZMA2S$=S@GI7H*^'=)CNI;F.R2.:6$0.Z$J3&.B<'[H[#H*@E\(Z!/IMKI\
MFEP&UM'WVT>"/)/^P0<K^% &'\-[=+5/%,$;.R1^(+E5WN7(&R/@D\G\:QO'
M=VSQ^+Y;*[N9+K3=/B<L9S"E@^UG4Q;>6=N"<X& !GM7?Z9H>EZ+Y_\ 9MA;
MVOGOYDIB0*7;U-5[[PKH.I7L]Y>Z3:SW$\/DRR/&"73&,'UX)&>M '*RP'5_
MB+I]K<WE[]EN?#[S3017<D:.XEC&<*1MZ\[<9[]ZQ;5M1_X5II/B)+N^N9]#
MO)FFC^T/FYM8YW1E89^8A ""<\K[UZ/#X;T>VN8;F"PCAFA@^SQ/&2I2/^X,
M'@9YQZ\]:S;W2+_3K6+2?#.GV%OI]R)5N99)6!MRW\:)@AB<L<9&3C/4T 6/
M#<B:F][KT4LCV]](!:@NQ7R4&T,%/ W,&;(Z@K6!JFGC5OBHVEW%[J"V,NAF
M9[>&\DC5F$P7(VD%>,?=QG'.><]Q:6L-C906EM&(X((UBC0=%51@#\A7*WGA
MVXO_ (D1ZO/:,=/33#:+*D^QUD,F_(VD';C(Z_AB@#E_#UU=7$6FZ+?7]W?S
M0:EJ%O:Q22[5O8(6V"2:3J0F<# .3CCC(K6UU>WG@7PH9-3O1,?$?V-Y(KI\
MO%Y\JA2<_,,*H!.3Q7I=SX8T.\ALH;C2K22.Q)^S*8QB+(P0/8]QT/>HAX0\
M/+"L*Z3;)&EP;I51=H$V<[QC^(=CV[4 <H]FB^+9/!ZW\D=I'IJW%I'=SRR/
M*SRR>8P?S Q*X0#)) Z8JN;&Z77O!.F77B&]U%9(+Z&ZN(9GA%SY8 4D!CR,
MD;@<GKGFNXUKPQH?B-(5UC3+>]\@YB,JY*>N#UY[CO4K:#I;W5E<_8HEFL4V
M6K)E?)7&"$ Z @ ''4"@#RFX@%QH5K9W$UQ-%8>-TL[<R3N62+SAA=V<G .
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MQ9#2+06]Q,9Y4$0^>0G.\_[6>A[=JE&@:4+&XLC91O!<X\\2$N9<=-S$DMT
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MA<Y(!ZDDU?JM8:?::791V=C;QV]M$,)'&, 59H **** "BBB@ HHHH ****
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MS MO'4=1CUK1U?28] \+Z'KN@:7-;/H<A:.Q=R9)+61L21'<2=Q!# $\$ 4
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MH **** "BBB@ HHHH ***Q?$VOGPW807KVAGMVN(X)G\S:(0[!0[<'Y02,T
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M55'85+573+J:^TRVNI[9K66:-9&@9MQCR,X)]?7WJU0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5
M#6]*@UW0[[2KD?N;N!H6/ID8R/<=?PJ_10!P,/@.^:7P_?75^CZC"&36)5'_
M !]QD*VSW :.->?X<UM:AHVHW'CS2-9B6V^Q6=K/!(&E82$R%#D#:1@;/7O7
M25D0^)M(GU6'38[LFYG$AAS$X278<.$<C:Q7N 30!R-UX,UVX\$>)]%_XEZW
M.K:C-=0M]H<HB22!\,?+SD8QP#FO0XRYC4R*JN1\RJVX ^QP,_E4=U=0V5K+
M<W#[(8E+NV"< =\#FF:=J%KJNFVVH64OFVMS&LL4FTC<I&0<'D4 <1#X,U5_
M"MWX3NOL@T^XO)99+M)6+M"\QE*A"O#<[>I Z\]*M1Z+XJT3Q%J;Z))IDVE:
MI/\ :6%VSK):RE0KE0HPZG:#C(Y[CK7;4A(4$D@ <DF@"&6U6XL'M)G9UDB,
M3L< L",$\=ZY/PII?B_2+>TT74)],DTRP CBO(F?SYHEX160C:IP "<G@<<G
M(V3XNT)8'N6U!1:)G-V480<>DN-A_.ME&5T5U.589!]10!YY<^#-=N/!GBO1
M\:>MQK%_-<P-]H<HB2,#ACLSD8[ ]:9K::EJ/C9QI4.F2WEGIJ07<37\EM(/
M,8MMW*I+K@ C@8))')X]'K,U+P[HFL3)-J>CV%[+&,(]S;)(5'H"0: .2&FZ
MCKFC>'8K#3-/L$T754DDA6[+Q%(E9<1,$^;[W<#!4@U='A_6[34?$XM!9/!K
M<@DCGDE8-;GREC.Y-OS8VY&&&>AQUKL8XTAB6*)%2- %55& H'8"G4 <;9>$
M;G2_$N@S68MVTK2]*?3OWDK"5LE,-@+C^#U[U%X6T3Q9X?A@T&2?39-$M'Q!
M>!G^T&$'*QE,;<X^7=GIVS7;T4 8?C+1)_$?@_5='MI(XY[N QQO)G:&ZC..
M<<5ES:'K:^)M-\411V1OELFL;ZS$[;&C+;U*.5Y96'=1D$]*["B@#"\-:$^C
M_P!IW-PT9N]3O7NYA&253("J@) SA5'.!DD\5!'HVHK\1I]=*VOV"334LP!*
MWFAED9]VW;C'S8Z]JO7?B;1[&XFAN;U4:#'GOL8I!D9'F.!M3C!^8C@UI6\\
M5U;17$#AX94#HXZ,I&0?RH XO1=#\5Z!<W&DVL^FR:$]S)/!<NS_ &BW21R[
M)LQM8@L<$GC.2#THTW0/%&A:KJEGITVGOHVH7DEXD\K,)[4R'+JJ ;7YR5R1
MC/.>E=3J&LZ?I4]E#>W'E27LPM[<;&.^0]!P..AZ^E7Z .)BT7Q5HOB'5&T6
M33)M)U2X^U-]K9Q):2E0'("C#J=H(&5Y[CK6A8Z)J-OX]OM9E-N]E/80VBGS
M292T;.VXKM YW]CVKIJ* .7T7PJ^D^*M6U 3JUA<R&XMK8#_ %4L@'G-^)12
M/3<WK6?HVA^*]!NKG2;2?39-"DN9)X+F1G^T6Z2.79 F-K$%C@D]\D'I7<44
M 8ND:AJMSK>L6M]!:"TMW3[)-;.S%E.[*R9& XP"0.S"LG7] UO4?$C7,!L9
M].DT]K9([J1@;68DYE50I#$@@=5(QUZY["B@#@%\*>(!X9\&Z<5TXS:'<V\L
MY^T.%98HVCPIV<D[L\@8Z<]:MZAX2O\ 4/$'B!W>V&F:YIL=G.V]O-A95D7Y
M5VX8'S,Y)'3H:[2B@#E/#EOXRMX8;76VTMX[./8LUM(^^[(7"[@5PG8G&>1Z
M58\#:+?^'O"5II.H_9S/;F3YK>1G5@SLPZJI_BQT[5N0WMM<7-S;0SH\ULRK
M,@/,9*A@#]00:GH YK7=%U*Z\5Z!K.GFU9;!;B*9)W9?EE"#<N <D;.AQG/4
M5F:'H?BO0+B?2+:?39-":YDF@NG9_M,$;N7:/9C:Q!8X8GCJ0>E=Q10!S.@Z
M/JFF:]XEOKB.T,6I7"3VXCG8L-L:IALH,9VYR,]:P+7P9KUOX,\-Z.1IS7.E
MZG'>2L+A]CHDC/A3Y><G=CD=J]%JA>:SI]AJ-CI]S<;+J^9DMX]C'>0I8\@8
M' /6@#F+SPSK,^J>+[F-;'R]9T^.TM]UPP*LJ2+E_DX'[S/&>GO1:^&M9AU+
MP=<.MCY>BV,EM<XG8EF=$3*?)R/DSSCK7;44 ><CPCXEALITC_LYUEU^74I;
M1KEQ'<P29/ENWEY!!(.,$''--E\$:[+X<\3:=OTU)-0U./4;78[A05:%MC?+
M\H_=8R,YSG QBO2** .3N-"U6^\8Z;JUS'9"VBT^>UN(TG<MF4J?E^3D#;C)
M(SG.!TK*M_!6JMX,A\%WKVLFF0S(!>K(?,>W242*NS;@/\H4G.,<^U=GJ^KV
M.A:9-J6I3^1:0C,DFTM@?0 FKJL'4,O((R* .$N_">MW%IXXA5; '7P1;$W#
M_)^Y$7S_ ">V>,^GO78Z7#-;:3:6]P$$T4*(XC8LN0 ."0,C\*MT4 <*_AC7
M'7QLOEV _MY2MM_I+_N_W B^?]W[9XSZ5/J'A74KOPUX<2*2VBUC0Y8)HP9&
M,,I1-C(6VY 92>=N1Q79UD7?B?2+&#4YKFZ,<6F$+=L8GQ&2H8=OFX(/&: ,
M'5/"VHZQ-KFIR1VL-_>Z.VE6T/G$HBL6+,[[>NYAP!T7KSPJ>'-8&H^#;@I9
M;-%@DBN0)VRQ:(1_)\G/3/.*[&*5)H4EC.4=0RG'4'D4^@#F_">C:AH]QKSW
MPMMNH:G)>Q>3*SD*RHNULJ.?D[9ZU0\9>%;GQ,T\36-E)M@']GWWGM%<6<_.
M6!5<[?NG /4'BNDU;6=/T.U6YU&X\B%I%B#;&;+,0%' /4D"K=Q/':VTMQ,Q
M6*)"[D G  R>!R: .+_L+Q7HGB2ZO]%GTZ^MM2CA^UI?N\;1S1H(_-7:#D%5
M&5XY'6K]OH>K1>/8=:E>VFM5TH6+R>85E9_,WE]FW ';&ZNBL[N&_L8+RV8O
M!/&LL;%2I*L,@X/(X/0U/0!R^I>%7N_&UCK<,ZQV_D>5?PX_U^QP\)^JODY]
M.*CU'PU>:CXUGU"46_\ 9<^C2:8^)6\W+ON+!=N,8XZUM7VO:;IUS]FN+@^>
M$\QHXXWD*)TW-M!VKP>3@<'TJU8W]IJ=G'>6-Q'<6TF=DL;;E;!QD'N,@T <
MOX5TOQ7IME::-JTNFOI]B@A2Z@9S+<QJ-J!D(PG&,G)SC'?-0>%=%\6:!#;Z
M#+<:;+HMFV(+P,_VAH0<K&4QMSCY2V>G;-=O1TH 9+%'/"\,J!XY%*LI'!!X
M(KSI/AM>IH.GVXU/&I6%V%@NQG<ED-T?E ^OE.Q_WCZ<UWIU.T&KC2O,;[88
M#<!-C8\L,%SNQCJ>F<U;H YG7-"O;SQ!X9N[".U6TTJ>2217D*':T31@* I'
M&[/)'2LB?PGKG]D>--+A.GM#K<L\UM*\SJRF6-4(<!#@+M)R"<Y[5WM% '(+
MX?U<^(_"^H.EFL.EV4UM< 3L6+.L8RHV<@>7W(ZU>\9Z+>:[H"VVGM"+J&Z@
MNHQ.Q5&,<BOM) )&0,9P:ET[QEX=U;57TNPU>UGO5!/E(W+ =2IZ-CVS6C=Z
MG9V)87$P4K&96 4L50?Q$ <#^= &!!H^M)XYGU^6*Q,4FEI9^6EP^X2*[/W3
M[OS8SUXSCM7/6'@KQ-HN@^&)=.FTXZSHD<MO)#)(Y@N89""PW;05.54CCJ*]
M!T[4;75M-M]0L9?-M;F,212;2-RGH<'FI+:[@O(V>"0.%8HPQ@JPZ@@\@^QH
M KZ2NI"SWZLUO]KD;<8[<DQQ#  4,0"W3.2!R3QBN?NO#NI:7XQN?$F@BVF_
MM"%(M0LKB0QB0IPDB. V& XP1@CN*ZZJ%YK.GV&HV.GW-QLNKYF2WCV,=Y"E
MCR!@< ]: ,O6=$O?%7A[4=+U,Q645W;M"L<#^:58\AV8A>A ^4>_)R,4ET'6
M=5DT!M;2S1M'D^T,T$S-]IF$912,J-J_,6/4YP/>NPHH \Y_X0S7O^$&&B8T
M[[2-6^W;OM#[-GVGS\9\O.?X>GO5GQ)HVI)?^)M=E6U6RF\.O9A5F8R!E$CY
MQM Q\^.O:N]J&ZM+>^MI+:[@CG@D&UXI%#*P]"#U% '#Z+HU_KWA_P &->);
MV]KID4%XK1R%VED$.V/ VC:/GW'GJ .>M5-.\'^)X+CP[<W?]E276F7<LEU<
M^=(TEX'C=/,8E.& 8?+DCME17H=K:6]C:QVUI!'!!&-J11*%51Z #I4U 'G5
MWX,UZY\(>)]) TY;C5M3>\A8W#[41G1L-^[SD;.P[U;\86-MK^HZ-;6NH10:
MU#<&&9() [K;R1GSU;N 4P02!\VSU%=U56'3+"WOY[^&RMX[RX $UPD2B20#
MH&;&3C'>@"PB+&BHBA548"@8 %><:CX.\37C7FXZ7/+_ &S%J%O=S3.)'A25
M76 C8=@4#'!(/IDDUZ310!Q3^&]:;4?&%P5L"NLVL4%O^_<;66)D)8;. =V>
M">E4]+\*^(= U/2M3LET^YD728=,O[:2X=%S%]V6-]A/<Y!6O0:* .;\$:+J
M.@:#)8ZE]F,INYYU-N[,"LDC/SD#!^;'>N<\2^#?$>LCQ) K:;,FH&-K*YN)
M7\R!%V$PA0I"J2I.X'G/(/;T>B@#E8-'UE/'%SKTD5B8I=+CM!&MP^[S%=WS
M]S[OSXSUXSCM7/S:''I'PDA\+ZS>VD6JV]MFT^SS;G:9&W1-&&"DG?M&,=\9
MYKTJJLVF6%S?07T]E;RW=N"(9WB5GCSUVL1D?A0!#HFGOIFCV]K-();@ O<2
M@8\R5B6=OQ8DURM])=Q?&2!K2WCG;^P'W(\NSC[0O(.#WQQ_^H]U5,Z3IQU,
M:F;&W-^$V"Y\L>9M]-W7'M0!Q;>#=9M+>R:U>RNFDU2XU'4[*:5HX)VES@!@
MK$A"5P"N#MR0#BJJ>"O$<=JL'_$J<)XE_M@$32(#'YA<KC8<'G&.>G6O2J*
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MJ""": ,:VU;4X_&-]X6N;KS"U@M_9WHB4.J[]C(X'RD@X(( X/M5?X412_\
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MTJXD #ER022<9SD<Y-5I_ -K<:%K>D2:G>F#6+IKJX8"/<K-C(7Y< ?*.H-
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M5]8326TIB&8IXL,P)/4;,L/HU:/BGPS!XKTI+"XN[BU6.=)TEMMHD5T.5(+
MXYI^K^&[/7;73X=1>29K*X2Y23A2[*""&P,88$@CH0: .>\*>)=4U_2M*CGG
M\K51=31ZE&80OEK%PP /3):+'?#U#:>*=777] M[BY@N%U*YN;>Y2"+,$11'
M9!%)@%B-F&Y89STKJK'P[8:?KFJZO C"YU+R_/YX^1=N1Z9&,^N!6#8_#FVL
M(]'BCUO5&BT>=I;-&,?[M&5E*'Y,D88C)Y'8B@#.M?$VOQVGB'6K^^M#I^A7
MMW%+;16A#7"1Q@J Q8[#DCU[_@S4O[3F\0_#^]OKU)?M%U)(\*1!5C<VTAPA
MZ[<$CYLD\'CI73Z?X1L[.RUJRGN)[VVUB>6>YCG"@9D&'"[0,# %9]KX!^SG
M1A)X@U2>/1Y=]FKB+*KL*!6.S+?*<9/./2@"#P[XJN-3\0+IE]=M9ZG&TOVG
M2KF (2@SL>%\?.O R<G/7CI6YXBOKNS?3D@NHK:&>X*3OMWS%=C$+"F#N8D#
M/!P,G'I%:^%(XKS2[B[OY[UM*W_9#,J!EW*4.Y@ 6PI('YG) -3:YX<36K[3
M+Y+^ZL;S3I'>&6WV'AUVNI#JP((]N* .6M_&6KGPA_:,]O/)]FU::RO9K6W#
M2QP1LZ^:(^1G(0-@'&20.*ZOPOJ::QH<=[%J4&HQ22/Y=S"NT,FX[01V8# (
MXY!X%4-/\%C2H72QUG4$)U"34 7*.-SAPR$;>5.\GGG('(Q6KHFB6VA6UQ%;
MDLUS<274SD ;I'.20!P!T&/;N>: //O%^K7WB7X:>+=1@NE@L[=I[6*W\L-Y
MB1MM9F)YW$AB,8 &,@\UOWFM:S?7^IZ7H:2K/IMM"59$B8/*Z%@'WL/DQ@?+
MSUYXI;SX<VUQ!K5E;ZO?VFFZPS2W-G$(R@D;[S*64E<]2 <9_*K%[X&6?5H=
M5L==U/3KX0+;7,UN8_\ 2HUZ;U*%=PR<, ,9H RM:\7:KI/V)-:SH8N+!6%V
M(A/;)>$D-'*_.U1\I!XSD\\5I-JVK:Y?Z[8:->6]M/I<<2Q,Z!UGG>/S!O/.
M(\%1\O/4Y[5>O?"J744UM'J%Q%9W%DME-;LJR*R O\X+ G>=YR3G/&0:I2^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRL3I]WIDNH1_/&=A#)(?E#!DS]#7HO\ 8^F?] ZS_P"_"_X4?V/IG_0.L_\
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M!>"2"<]!CF*PA@B^&NDZ#J-MIM\8(HK:\LY+N(AT48+(V[&00".G([=:[?\
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M5OIF[[=)92K $.&+%3@#W/:N2T#5_"VLWUAK,=S?->:;:R),DZ&-;&,K\Z2
M*H/( "\\\C@&@#NX=9TNX^S^1J5G+]ISY&R=6\W'7;@_-COBEDU?38K]+"34
M+5+QSA+=IE$C'&<!<YZ<UYUX4>W\,>*H;:X18]+UB)Y]%R^X689MSPGLN_*L
M.V?ER<"J>G3Z7>I<^&?$<NI?VW#JLMPEDB$&=C,TD4L;A?NX(Y+< '.!0!Z<
M=<TD72VIU2R^T-+Y*Q>>N\R8SMQG.['..M/@U?3;F[>T@U"UEN8P2\*3*SJ
M<$D YX/%>=6-A!?W_P 15TV&V;5/.+6+A5W))]F559#VP^1D=\UH^$-7\-Z[
M;Z D5D_]K:5:F&2)X70V'[L+('R .2H&#UZCH2 #J=-U)$TV>ZOM8T^XB%S(
MJW$)"1HN["H3N(W#@'GKVJVNJZ<UB;Y;^U-H#M,XF78#G&-V<=>*\NTI;.;P
MD\::Q_9,Z>)KI[.[159(G+2E-ZG@HRY';.11/K>H6]IHNL:Q!]GL++5;J*^O
M-,0O$Y9-J72J0?D)+ GG!)]: /5K.]M-0MEN;*YAN8&SMEA<.IQUY'%5KS7M
M'TXRB]U6QMC#M\SSKA$V;ONYR>,X./7%9/@V'2!;ZA>Z*]S+;7UR;A[B;(6>
M0@;G0$#C@#(&"0:YZ0:#%\6-?&L+8K')I-L1]I5=K?-*&Z\$D8]\4 =U<:QI
M=HL37&I6D*RH9(S).JAT W%AD\@ $Y]*K6NH+>:W_HVKV$]D]FLB6T1#2DEO
M];N#?<(( X_&O+M$TN*PD^'%EJL2 I)?L(KE?F2%U<PJX/3@J #WXZBMW4K<
M1_$'6++1!#;W;>%3!:K" @642/L48X! *G'88H [Z#5M-N;Q[.#4+66Z0$M"
MDRLX .#E0<\'BA-7TV34#IZ:A:M>C)-NLRF3CK\N<\5PWA35="U[3M"@L[-Q
MKVE6C0"-X71M/?R]C[\@#!( YSG(/KC+\(7&CZM:>'M+U"34SXCT:1-]BZ%&
M@E4;7D9@HRA&XY+'=G')- 'J\DB11M)(ZHB LS,<  =235.#6=+N8)YH-2LY
M8H/]<Z3J5CXS\Q!XX]:Y[XD)>'PM'+;0R3PV]];3WD,:EFDMTD#. !UX&2/0
M&JJRVVI?$JRUO2;J&2PBTJ5+^YB<&-@74Q*6'&X?.?4#ZT 3^&/$5_XJ:VU2
MPU#3C8^=.ES8D;I8XU=UC8,#PQV D$8P3CIST]_JNGZ6BOJ%];6B-G#3RJ@.
M.O4URWPJFBD\ V:(ZETFN=ZYY7,\A&1VR"#67X@U.TTCQ]?IXBNKJSTS4M/A
MAM+A(]T3%3)YD1.UL,=X..,_E0!WEWJVFZ?$DMYJ%K;QR LC33*@8#DD$GD<
MT^?4;*UM5NKB\MXK=\;97D"JV1D8)X->;R/IFDZCIVCVUM<V"G0Y([:YN$>6
M:6(OQ;HIR W"L006 (&!SC+\.:]#HEKX&U75#*NBIHSV1N&B8I;7.8SEN.,J
MI4'ZCUH [K7?$DUGJ?AEK"[LY-,U*Z:*:7&[*")W#*X; 'R^A^M=%8:C8ZI:
MBYT^\M[NW)*B6WE$BY'49!Q7G.K1Z(MUX*BL;1+?36UB6=(Y5(#*T<A,FUN0
MI=N,^H]16SX(D@'B7QG% R",ZHLBJA&#F&,,P_X$#D^H- '67NI6&FHKW][;
MVJ-G#3RJ@..O4T2ZG80) \M[;1I/_J6:50).,_+SSQSQ7(RWJZ3\4[R;694@
ML;O3(H[&XF(6(%78R1[CP&.5;'< >E<<=/AT[0_"O]J1(FGMXIF:U2X3 CM&
M$QC!!Z*1AL'C!&: /3+_ ,8Z#8>'+K7O[3M;BPMP<R6\RR!G'\ (/+'TJ4ZF
MEWJ.E&RUC3_LTXD+P;@[W.%X\LAOX2"3P>G:O-?$6E+)8_$:]T6$-IEUI\"C
M[.N8Y9T#&1DQP<*5R1WSW!KH=4U"POO'G@2\MIHW1UO,2XQE3%A>O8G@>O:@
M#M6U?34OEL6U"U6[8[1 9E#DXSC;G.<<U%=:_HUB9A=ZM8VY@*K+YMPB^66S
MM#9/&<'&>N#7E@\R\^$U[X<N>/%L5XX\@G$[7)N"Z3+W*D$-O'&,\X!K4>+3
MSXK^(!NA:NYTNV3>RK\S>7*'Q^)7/U% 'IZL'4,I!4C((/!%4[C6-,M)_(N=
M1M(9L@>7),JMR,C@GN*R_ <@E\ >'COW,NG0*_/(81@$'W!&*\YUB]T?=XJ\
M,ZCK=G:17NL+<M/>;TEB_P!4S!5V[6 V85MPX[8'(!ZM/K^C6IQ<:M81$!6P
M]PB\-PIY/?MZU(-8TPW_ -@&HVAO,E?($R^9D#)&W.<XYKB;>WT6_P#BY=(8
M;&X@?0X!&-BNC$2NW'8G;M/TQ7-7&K6<XT:6)'LEMO%1>>P2%W: EY07E8@G
M<Y.0!@8; !QF@#U:;Q#HENVV?6+"-O-\C#W* ^9P=G)^]R..O-0?\)1I/_"3
MGP_]LA^WK")6C+@$9.%7W8\G'H/>O,]3BTY_#WQ2*QVQEDG;R<*-S?N(\;?7
MYP>G<>M;R71_X6 7AF(FOO#,4=G* 2))1(Y."/3<"?0<T =W%J^FSW[6$6H6
MLEXH):W693(,<'Y<YXKG?&?BO^Q;6!=.U"P^VF^MX);>0AY-CR*K8 8$$!L\
M@URWA&YT;6;;P]932:D?$>C *;&2,H;64)M=F(4?(>>I.[('6L8ZM:-\+]/T
MJ^)77['5K=KZVD0F99?M09Y",9(8$G=T.[&>U 'M-[>VVG64UY>3I!;0J7DD
M<X"@=S6?I?B72M5T"WUF*]@2TE1&+/*H\LL 0K'/#<CBK.K*UQH-\L2LS26T
M@50.22IP,5YCI6I+%I?PVU!V;^Q["W:VOI&4A+>X,"HC/D< '>N[H"W- 'JM
MI>VM_;BXL[F&XA8D"2%PZDCKR*BOM5T[3 IO[^UM=P)7SYE3('4\GH,BN9\)
MV['QCXLU&T8'2+R6W,#(?W<DRQXE=>QS\@)'4@^E9OBZ_ME\57M@T9M;J;1'
M5+D1M(]TI9OW,:\KP>6."<,.F,T >AJRN@96#*PR"#D$4M<W\/ITN/AYX>*%
MCLT^"-MRD?,L:@CGT((KI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YCQ[9W-UX7E^PZA=6%Z
M)84@N+>9TV,TJ+DA2 PYZ'- '3T5YTGB>ZU?P3XAT[5#+I_B;1[24W*6\K1$
ML$)2:-E()1N#^A[5UMQK,-A>C2;6VNKZ\CM_/:&)U+)'D@%FD8<D@@<Y.#V&
M: -BBN5;Q_I!LM)NX(;V>/4YVMHA%#EHY0&RC@G(8;6'?IZ<UI:#XB@UXWT:
MVEU9W5C/Y%Q;704.C;0P/RLRD$,""#0!L45PGQ,N9+*/PU,E]=VL<NN6UO<&
MWN9(@\+;]RG81D<#WXK3TN;2GUJYDTN^U&YDL[4>=;M=33(XD8[2!(Q&X>4W
M([,: .HHKC;?XD:=<6>DWPTS55L-4D\F"Y,*E?-.[:A4,6R=IP0",\9ZXFD\
M?6-OI^MW-YINI6TNC!6N[9T1I C+N5EVN5((!_B['- '645S-EXUL;W7X-%F
ML=1LIKN%I;.6YB")=*HRVPAB00.<$ XYK'\'ZS%I/A_5)+V:XG/]OW5I;HSF
M221C,51 6/)^IP ,D@ F@#OJ*YUO&%M%+J5M+I]^E_I]N+I[+:ADEA.?GCPV
MUAD$=<Y&,=,SVWB:UO-/T6\M[>XDCU<KY 79E 4+[G^;  4'.,^G6@#;HKF!
MXZTO[9IL;1SK:ZE-Y%I>90QR.<E1@-N ;!P2H!_$477CK2[2:W,D<_V*>[^Q
M+>J4,8EW%>1NW[=P*[MN,^W- '3T5S'Q$DFM_A]KES;W%Q;W%O:22Q2P3-&R
ML!D'*D&LJ^TB]A\"QZMH^KZE;ZK;V*W2M->2SQS,$W%721F&&Y&1@C- '>45
MPVC^*M.\07/A*^GM;U-0O[*:>W\MR(5(5?-5AN^8@XQD'KVJ[9_$#3[P3S?V
M=J<-G;/<1W-W+"HBA:'[P8AB<G'& <].M '645S<7C;31JKZ=?1S6$JVC7BM
M<-&4>)?OG*,V"O4@X.*?#XLCFO+>U&E:BCW=L]S:%T0+.J@$KG=\C8(.'V]?
M7B@#H:*X[P[XW_M+POINJ7UC/%<ZE*8[6W0HQF)+$!/FZ*JG);;T)JS<^.].
MLK#69[JTO8Y]'4/>6FQ3*J$95UPVUE(!Y!['.#0!U%4M.TV+2UEAMB5M7<R)
M#CB(L26"_P"R2<X[9.., 0Z/K/\ ;"SN-/OK2.-EV/=1A!,I4$,F">.>^#[5
M6M_$D%]="&WL[J6!KN6R-RA38DD>[<&^;<!E",XZX[$$@%^738KC4X+V<^8;
M;)MT(^6-B,%_=L$C/8$^IJ[7F?A;Q4F@Z=J"WUOJ=Q:CQ!<VC7I/F) #/LC#
ML[;B.@R V.]=/J/C6QTR6],MI>/;6-Q%;75RB+LB>3;MX+!F WID@'&>_. #
MI:*XU Y^+UW;F>X\B304<Q^<^U6,S*2HS\IP!TQ3_AA++-\/[!YII9I/.N09
M)7+L<7$@&2>3P* .OHKF-6\=:7HZ3SSQSO8VTXM[F[CV%(7) .06#$ D D*<
M?@<6=0\5VUD-0:&SN[V+35W7DEL$Q#\N\CYF&Y@I#$+G@CN0* -*_L7OE14O
M[JTVDDFW*@M]=RFJ/]@7'_0P:O\ ]]Q?_&ZBLO%EG?:CI]E':W:RW^G_ -HP
M,P3:T?RY!^;(;YU[8]ZAM?&MC>V=E-;6=Z\M[=S6D-N54/OBW;\G=M &QN<\
M]J +?]@3_P#0P:O_ -]Q?_&Z/[ N/^A@U?\ [[B_^-URWC'78M;^'$^IV#WE
MK)!J$,#H7,;HZW*1NC;6PPZCJ179Z[J3Z/H-_J4=L]RUK \WDHP4MM&>IX'^
M>O2@"K_8$_\ T,&K_P#?<7_QNC^P+C_H8-7_ .^XO_C=<;<ZY>76K_#W59[>
M^26ZCG:6VB?(G)M2P(17*_>/!;!'? KJ;+QGI]WI,UZ\%S;RPWAL'M)@HE%P
M"/DX8J>H.=V,<D@ T 6?[ N/^A@U?_ON+_XW1_8$_P#T,&K_ /?<7_QNC1/$
MUGK=]J%@D4UO?:>R">"7:2 XRK J2I!&>_;G%<KXDNXK7XIZ5;WFIWUOI]QI
MLTDD4=[-&C2*ZA3A&&#@GI0!U7]@3_\ 0P:O_P!]Q?\ QNC^P+C_ *&#5_\
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M+!9/N*VT '&!P!B@#UVBN6OO'%M9ZAJ]C'I.J75QI<4<TZP1)@QL&.Y2S@'
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M%4;TQM;/7[R*:R;/1/%=AX>\5Q6-H;:_O]8DO[;_ $A 7A=DW(&!.QRJL,]
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M:VKR)NYWDNY#%1RX'!/"GUQ7H%% '%KI.JMXG\)7IT]U@TZQG@N6,L>4=UC
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M@ EU_6[C3M8T+3+=40ZI<21&YE4LL02-GQC(RS8P.?7KTKE;CQKXD@\/ZIJ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6LL%[% P5S%)&XN4CD1MIYZL.I!K12:=/B]+;?:9S;-H8F\AI6,8?S]NX+G
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M"SU6PBOK"XCN+689CEC.589QQ^5 %FBBJESJMA9WEK9W-Y#%=73%8(6<!Y"
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MR5'(!/ )"GK72U5;4;--3CTUKF,7LD33) 3\S(" 6QZ9(H Y2*TU?3_',WB
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MI-'+#.\D0>W=8UC99-_.W" Y7..>":]'HH X>YT#4;CQK%(UD8]/.@2::]U
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MB68 #.< =!R:I>'_  =?:+'%8W7B.YU#2+92EK9RP(I5<8"O(.7 !X'';T%
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MMMRW )^5#O/R;0&R0<Y&.^+VG:!KUK8SK>>*9+V],)AM[EK-$6$'&6* _._
MY)QQTY.60>#EL?$5MJVGW:6RBT%K>6XA++=@'(9B6^\,G#<GDY)H S]/\5:]
MJ?\ 8FHV>FBXTW464RQ"W='MHG&5D\PMM;'&X!>_'2JEOXSUZ/3];UJ^BTP:
M7HMW>6]Q'$LGG3"(8382< EL Y]>V.=/0/!5[H$B6D/B*YET*"3S+;3WA7='
MSD(9?O,@/(''0 G'!L6'@V.+1]=TK4+H7EKK%Q//*%B\LH9?O '<>!V[CWH
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MRUW*T;;B-K#'!S]:YOQ/K=[K/@?6Q<QVYFT_Q%!9Q^4&17"7$)!.2V"=W-=
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MB\(RO</JYD@N1)!!)&( 'R91)@JN%##&[.2!WKLXHHX(4AB0)'&H5548"@<
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MYBW2(A^4,"0<9[9!K"NO%NMW,5W>:%IPO([2^:U^R?9WWSK')LD(EW!5.0Q
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M8?LW,(,8C./GY^4#KW_*K'_"*SG5O#U\^HQDZ-!) $%O@3!U522=_'"C'XT
M8L_CK4(_!D7C5(K5]&,H9[7RV\X6YDV!P^[&[HVW;TR,\9+]0\3^)1?^++>Q
M72D31(8[B-YHY',JM&TA4@,,$XQN[>ASQ;MO 26^BOX>_M#?X>-QYRV;0?O%
M3?YGE>9NQLW?[.<$C/>K,OA*=[WQ+<C4D']N0)"RFWSY(5"@(^?DX)_'\J ,
MJTUK5M6\>>'WANH8+"\T)KXVS0EL%GAR"0PRV#@'&!SP<UAZ+K6K^'O#]WJ-
MNMDVG+XDN()XI$8RNLEV4RK @*06'!#9]JZZT\&S65[H5W!JQ2;2[ Z>Y%N"
M)XOD(X).TY09//?I55O ,S^&KG1CJZ;9]2_M$R_9>0WG";;C?TW#\OSH CQ>
M?\+.\1G3C +W^Q;4P^>I*%O,FP&P0<=NM6M#\57VN:3H$D(MDO[MW%_"T3?N
M!%D2@#=D$/M3DG[P.*M3Z>FA:[J?BZ^OP;=K)(9HH[5B52,LP88)).6/:H/"
M.EV1U36?$=G%-'!JLRO LJLF5"J&D", 5WL"3QSM4]Z -O7[R\T_1+BZL(H)
M+A-N/M$@2-06 9V)(X526QD9QCO7(R^-]3CL/&+1+9W$NA6Z7,$Q@DB29&C9
M\%2Q/\!P0<$$&NG\4:#_ ,))HC:>MX]I)YL<T<RH'VO&X=<J>&&0,BL.X\!W
M5TWB%Y=>=FUVS2UN,VJX7:K+N4 ^C' SQW)H =9>(M='B/2;"^33S#J^GRW,
M'DHX:&2,(2&);Y@0_8#'OUK*T_QMXBFT;0-:NH=,%I?ZG_9\\$22;_FF>,.K
M%L#!4?*0<\G(Z#HCX6N3J^AZC_:46_2;62V1/LQQ)O"@D_/Q]Q?UK/A\!30^
M&]+T9=74KI^HB_24VO+L)3*%(W]-S'\,?6@"6/6]<NM4\7V%E;Z?]LTL0FTW
M1L1,7B+A7^8<]%R.GO4VC^*9M9TO0[Z"2W"7-JUU?9B;]VJ@!E7YOE8.=O.?
MNMZ5?TK0)=-\1ZSJ[WJS?VH8BT0AV^7Y:[!@[CGCKQUI-"\+66@S:L\#,Z:C
M<M,8W^[&K<E%']W<TC?\#- &+IWBG7]2.B:A:::)]-U+:TL8MW1[:-UW(YD+
M;7 XW *.O'2JUAXI\67>E:KJJV6G30:=/>V[6T"2&:9HB50ISCDCD=3VK0\/
M^"[[0&2SB\1W,VB6[[[6P>!=T?.54R_>9 >@XZ 9QQ5K2O"UWI6BZG8Q:OB6
M\NY;M+A(-IA>1]YXW'(!Z?KF@"C9>++O4]!U+4]'O-*U1(8XS"1FW\MR2)!,
MKN2NT8;G;GD>]4+GQSJD%EXN,(LKF31;2*[@F,$D:3*ZN2"I8D\H<,#@@BKV
MI_#Y-5&JSS7Z6^H:@ENK36EMY: PR>8K,A8[R3P<GH ..M-O/ -W?/KKS:^[
M/K5BEI<_Z(H VAAN4 \<.<#)]R: (]4\0>*]&T2/7+L:0=/\^!IUBAE9X+9\
M!W)W@$J3GI@CGC%=-97]S>:[?PQM VGVJ1H&"'>9F&YANSC 4H>G\7M5#6-0
MTW0]!MM*UHRWANX6M%C@M';[0=F"N%W;21QR<5:\(Z'_ ,(YX6T_3&9GEAB'
MFNS;BSGEN>_/ ]@* (M3UR=?$]CX>L#"EU<6TEW)-,A=8XT*J,*",DLWKP :
MXGQ=XAU+5/AUXQL9S;V]_I3FUNC'&Q2>-@I5D^;*;E89!W8Y'.<UV^L>'#J&
MM:=K=E=_8]2L5>-9&C\Q)8GQN1UR"1D @@C!%9^I>!EU'PYK.F?;_+N=9F\Z
M]N_(R2?E "KN^4 (H&2?Q)S0!TEG:M%F:X%L]ZZA9)X8/+WJ"=HY+' R>YZG
MUJU4<*RK"BS.CR ?,R)M!_#)Q^=24 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#<W4%G#YUQ*L<>
MY5W-ZL0H'XD@?C4U<1\3[:*XT'3#+N^76+(#:[+C,R@]#Z'KVH W8/$ F\7W
M7A\V<D;V]FEV)V<$.K,RC 'NIZ_E6U7GEQH]KJ7Q1O[&66Z6W7P] N(;ET8X
MGE RX.XX^OUS65HFO7VI:/X#L;^_"IJ5A,TDMPS?Z1-'L"*Q5@22I<X)Y('6
M@#UBD8E49@I8@9"CJ?;FL+PGI]QI6G75C<:N=3,-W)Y;$-F!#AA$2S,6VYZD
MYP0.U9<UV-5^)EQH-Z[K:6VEI<P0+(R"9W=E9S@C.T!0/0DGK0!M>&-?7Q+H
M::FMJ]L&FEB\IV#$&.1D.2./X<UI7%U!:(CW$JQJ\B1*6[LS!5'U)(%>4^$F
MB7P]X<TL7-S--+?ZD4L_-VI<A)9 6E?KA=P/<DD<'&157?JG@_PH;^>:>6'Q
M5]F5S<.2$$\J@;LY. H )YP* /9J*\UDCN/$]_XGTU=:73KG39TCMG+R>9;1
M")&248< @DL23G/0G&*]#L6=]/MFDF$[F)2TH3:'.!\VWMGKB@">L?5=<:SU
M"'2[*U%WJ4UO)<I TOEKY:%0<M@X)+J!QZ],5Y\^H7FI?#'6?%'VRYM]?LKF
MY=2LK#R&BE(6'9G&TH%!4CG=D\\UL-9)=?%O29[E)HYY-"EFD19W 5Q+#Q@'
MI[=#WH [C3[J2]TZWN9K66TDEC#M;S8WQDC[IQQD59JCK;72:#J+6,T<-V+6
M4P2RD!$?:=K,3Q@'!-</H>GW^I:CX7O(?[4M[5-/9M5\VXEC$LVU/+S\P\QM
MV\D\@CKVH ]&HKR;2X88?!6MZ]J&O:Q;RVESJ%LEPMT\AC3SF1<(3AF'&"><
MGKP,78FN[;Q/X@TTO/9VYT!+E8([UW:.3=(-^[C:Y &=IP<=30!Z94,%U!<M
M,L,JR&&0Q2;?X6 !(^O(KR_1!/:GX;7XO[^2?4[;RKSS;IW65?LI<94G:"&4
M$$ 'U))-;7PYM[/3[3Q#)YAC5=<O8\R3,5"B7 X8XSTYZF@#O***\WL[N[L/
M%=G;ZY!/)#>7\XL=6M+EFBGWB3;!,F?E*J<#@C*#&.: /2*Q=)\0#5-<UK2S
M9R0/I<D4;,[@^9O3>" .@P17GB7]VGPYL9VU"[%S'XD^SK(;E]Y3[:5V$YRP
MV<8.>*OMH5OK7B[Q\+B_OK/R6M7CEMKIX?*86RD.=I&[&.C9'M0!Z'-<W<>I
MVMO'8M+:RHYFNA*H$)&-H*GEMV3TZ8JW7F.@ZEJM[J_P]NM0N+D3WVE7+W49
MD8)(RI'M<IG&[#$YQWINB?;?$NDV6O\ _"0)8WMOJ+?:0!(S B4J;9DW[<$8
M &W/0CDY(!ZA4,=U!-/-!'*K2P$"51U0D9 /X$'\:X'P[)'XET*/6[S5[JSU
M.VU63[08IB-A69E%L4Z;2NT;<9)(/)-6O!-E;P>+?&<B>8'&IJH!F8@Y@C8\
M$X)SGGK0!VEQ=06D:O<2K&KR)$I;NS,%4?4D@5-7#_$FTAN4\,&7?QKUJ@VR
M,N Q.>A'/OU':H+ #Q%K/BW3[VZN8#IKQ6]F([AT,$9B#+*"#RQ8L=QST H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MME^WF/R3/D[BG7;UZ9YQTSS4-EX<T?3IUFM+".)E9G15SLC9OO%%SM0G)R5
MSDUI@A@"""#R"*\_TOQ+K/B71M4OM'U&S35+26:/^R)(-QBV,RJK\AM[  Y^
M[DXP<&@#H--L]6OM:&I:Y:65N;,2Q6:6\IE+!R,R,2HVG:J@ >K9[ 6-9\)Z
M!X@N8+G5M)M;R:#B-Y4R0/3W'L>*MZCK.FZ0FZ_O(K<;2_SGHHZL?11W/047
M6LZ;96\4\]["L4J;XV#;MZ@9++CJ,$'(XYH J:QX2\/Z_);R:KI%K=O;C$32
M)RH]..WMTK71%C1410J*,*JC  ]!6#=^,]&M=4TFP%W%*VIJTD,B-E/+"YW;
MAP<G 'U]JL:5J$,\NK3?VY;7UO#<$8C"J+,!!F-F!Y(Y8DXQG':@ E\+:+/J
M,NH26"M>2C;)/O;>R]@3GI[=*NV>EV&GV;6EC:0VMNV24@41@D]3QCGWZU#;
M:]I-X\J0:A;LT,?FR*7P5C[/S_#_ +73WJO;>+?#UY=6MM;:S8S37>3 B3 F
M3&<[?7H?KB@!$\(Z#';6ELFG1K!9RF:VC5F"PO\ WE&>#R>1ZGUIVM>%="\1
MO ^L:7;7CP?ZMI5Y7U&?3VZ5>U%KU;&3^SDB:[.%C\[.Q22!N;') &3@=<8X
MKE]&U7Q!8>,I_#^NW5I?P-8&^AO8(# 4 <(R.NYAWR#GL?P -O5O"VA:[;VT
M&IZ7;7$=M_J R8\KMA2.@X''3BI;CP_H]U]@\[3;9Q8?\>@\L8AXQA1V& ..
MG ]*JZ%K:ZKH[:]+*D&FRAI(-^%"PJ3B1B?[P&[T ([Y-9$'B.XU+XBR:-9:
ME&;$Z0UR%6$;XY?-103NY((/'0$'\: -^7PYH\]_+>R6$9GF*M*1D+*5^Z74
M':Y'&"0<8J9=&T]=8;5A;*+]H_*,^X[BG]WKTSSCIGFL0>,X(/#6HZC=Q#[7
MIUPUG/;QG[]P&"JJY[/N0C/0,,]#5RZNIK:?1[>ZUZUM;R:?,D'EJ3=#:<QQ
M@G( .#NY/R\]: -QE#*58 @C!![UD:/X4T'P_/-/I.E6MG+-]]HDP2,YP/09
M[#BJK:I"'\0/_P )19+% JJ,JF-.;81EVS\Q+?-AL>E-N];DT;2])U.XO8[W
M3IA!!<W(0(,R85)UQT4LRY'8,".AR :%GX<T?3[@3VMA'$RNTB*N=D;-G<R+
MG:I.3D@#.3ZU&_A71'MKVV?3XV@OG\RZC+,5F;U89Y/ Z^@J;Q#<7-GX<U*Z
MLY%CN8+:26-W3< 54GIWZ5E>%?%^F:QI^EVDNKVDVM2V$,\]NLBA]S1AF.T?
M7.!TH U3X?TEK^&_-C$;R"'R(YSDNJ>@;KW./3)JN/">A"PCL!IT8M(YOM"0
MAFVK)G.\#/7/.?7FK+:]I2:BE@VH0+=2.8TC+_><#)4'H6Q_#UK'\/:S>W&M
M^*K?4KJ)K?3;M$B;8(U2,PJYR?;<>2: -A="TQ;VYO?LB-<7,?DSR,2QE3^Z
MV3R.3P?6J=GX-\.6#VKVND6T;VF[[.^W+1[L X)Y' &/3MBK=OK^DW1G$-_
MS01^;(N[!6/L^#SM_P!KI3%\3:&\5G*FJVC1WK;;5A(")SZ(?XC]* (O^$2T
M+[&;3^SH_LYG^TF/<VWS<YWXS][/.?7FJ^N>&DN;#5)=+@MDU>\MC;F:Y+,K
MITVOUR,$XX.,YP:VH;VUN+F>VAG1Y[<@31J>4)&1GTR*L=* //M!\$PVVI6M
MW'X8L]!EMW#F:UU!Y6<#J@4  J>AW=NV>1WMQ!#=6TMO<1I+#*A22-QE64C!
M!'<$52M->TF^NVM+74();A8_-\M7Y9,XW#^\N>XR*++7M*U&Y%O9W\$TQC\U
M55OOIG&]?[RYXR,B@"'_ (1?1/[/M;%=.A2"T;?;B/*-$W3*L#N!QQD&M"SL
MK:PMQ!:PK%$"6VKW).22>Y)Y)/)JI'KNEW%Z+"#4+=KMP_EINSO*_>V_WMO<
M \=\5S?A'QE!<V2V^N:M:#4Y=0N;:%#MC,@25D0!??;@>OO0!8US0+G5/'>A
MZBUHSV-E;W$<DJS;'5Y-F"N"&XVG/3KWK9G\-Z/<V,%E+81-;02>=''R ),Y
MW]>6SDY/.234NNZB^D>']1U**W:XDM+:2=85ZN54D#\<5SVB:KJVKZ=I.K:=
MK-EJ=G<R)]L6.WQY0(Y"$-E<' (?)QGD8H Z*_T;3]4^SF\MQ(]LVZ"4,5DC
M.,$JX(89'7!YJQ:6=O8VRV]K"D4*YPB# R3DGW))))[DU3;Q%HZ6EU=-J=JM
MO:2>7<R&0 0M@'#G^$\CKZUSU[XN31O'EQ:ZKJMK;Z*-*CNXS( F)&E9?O=6
MX7H/?B@#IO['T[^Q_P"R!:1KI_E^5]G7A=G=>.Q[^M5;KPKH=[9V5K<:=$\5
MC_QZ@DAH>V%8'(&., XP!5DZWIGV.WNUO89+>Y&8'C;>)1C.5QG(QSQTILFO
M:5%8PWK7T)MIU+Q2*VX2*.25QU&.<B@"K_PAWAPZ9=:;_8ME]CNY#+/%Y0P[
MYSN/OZ>G:KNDZ/IVA6"V.EV<5I;*21'&,#)ZD^I]S0=9TT:?#?\ VZ!K2?'D
MRJX99<] N/O$^@JLGBC0I+5KE=6M# LPMVD\P864XPA/9N1P>>: +-[H]AJ%
MS%<W$),\2,B2I(R.JMC*Y4@X.!D>U4M3\'^'=9M;2VU#1[2>&S&+=#'CRATP
MN,8' XZ<5H)J=B]_-8K=PF[@022P[QN1#T8CT]ZK0^)-$G>=$U2US!%YTFZ0
M+B/^_P ]5_VNGO0 YM TIKRRN_L4:SV*>7:LN5\E<8*J!P 0 "!U JW<65M=
MO UQ DK6\HFB+#.QP" P]\$_G6?:>*=!O[V"SM-7LYKFXC\V*))06=<9R/PY
M^G/2H]!\4Z;XCGU"*PE#&SN&@.>K[0N6 ],L1[XSWH NW>CV%]?VM]<VZR75
MH2;>0DYB)X.WGC(X/J.*J1^$] BUY]<CTFU74W.YK@)\Q;IN]-WOUJ_J-]%I
MFFW-]/DQP1F0A>2V!T'J3T ]36'X'\1W'B+09)-1A6WU2SN);2^@7I'(A[>H
M*E3GWH N3^$?#USKJ:W-I%H^IH01<&/YLCH3V)'&">1@5./#VE"\:Z%HOF--
M]H8;FV&7LY3.TL..<9&!4?\ PE.@_8OMG]KV?V7SO(\[S1M\S^YG^][5:FU?
M3K>26.>]@B>&'[1()'"[(_[YST'O0!=(!!!&0>U8R>$] BTK^S(]*MDLO,$H
MB1,!7!R&!'(([$=.U31^(='EANIAJ-NJ6@#7!D?9Y((R"V[& 1T)ZU';>*=!
MO$N'M]8LI$MHTEF99AB-'&5)],T 7K+3[73HW2UA"!VWNQ)9G;&,LQR6. !D
MGL*CU/1].UF&*'4K.&ZCBD$J+*N=KCH1[\G\ZY[1?$<^I^/]8TU+R.>PMK."
M6.-8MC1NS.&#9YSA5/..O2NCO=4LM.VB[N4B+ L >NT8W-@=AD9/09% %0^&
M=&8WY-BG_$P7;=_,W[\8P W/(QQ]..E0:AX+\.:K;6=O?Z1;7$5F-MN) 28U
M_N@]<>W2LFY\6"R\=QPW6J6T>@R:*;Y&8 #?YJ*#OZG(8X ]>]=&==TK[!;7
MPOX'MKK'V=T;=YV03A .6. 3@>AH NQ11P1)%$BQQHH5$08"@<  =A5'4]!T
MO66A>_LXYI8"3#+RLD>>NUQAA^!K"\6^(Y;?PE!K.@W\#QO>6\?FJHD#H\RQ
ML >@/)_$58M]5U _$J]T>6=&L$TN.ZCC$8!5VD93D]3POZT ;5OI5C;6LMM'
M;(8I@1*)/G,@(P=Q;);CCG-06/A[2M-7%G:"+$9A4AV)CC_N(2?D7IPN!P/2
MIKW5].TZ>W@O;R&"6Y?9 DC@&5O1?4^U.?4[&.>XADNX4DMHQ+,K.!Y:'.&;
M/0<'GV/I0!17PGH2V%O8KIT:VEM+Y\$(9@L<F<[E&>#GG/J2>]4_$/AN"XT?
M77TZR#:KJ5C):F0R8+Y0JNXD]!G\.<5IP>(=(N8[IXM0@(M,?: 6P8L]-P/(
MSV]>U4-8\::-I&C7&HO<B18)5@:-00PE;&U6&,K]X'D< YH =X9\/VVEZ5IQ
MDLQ%>V]JL!W2&3R^ &"<D*I(SA<9XR*6'P3X9MS$8M#LD,4WGQXC'R/SR/3J
M>.G-;4$\5S DT+K)&XRK+T(JC;>(-(N[L6L&H6\DS!F10_WPIPQ4]&P>N,X[
MT 5V\)Z$]C<V3:=&UK=2^?/$68K+)G.YAGDYP<^H'I5:2PU74=<C@O;2SCT6
MQF2>VD$S22SLJ_+N4CY=K'=G))*CWJP/&'AQIH8EURP9YYC!$%G4[WSC:/?/
M'UXJ/Q3X@M]'T?4"FH06]]%:O-'YB[]G!VEAV!(P"<#- &_165X8O9]2\)Z-
M?W3A[BYL8)I6  R[1@DX' Y)K5H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD/B1'(WAJVFCAEE6
MWU.SGE$2%V6-9E+-@9)P.>*Z^@D#J<4 <'#/;S?%2^OI(G6W;08HUDEA91GS
M9&9>1P=I4E>O/2N8T)-NA?#"*YMY0]I/)]H5X6S#^ZD4%QCY?F*X)]J]CHH
MX6UD&@?$37VU.,Q:?J%K;?8)A&3&%C5E>'@8#;F+!>^XXKG-,T^Z\,6?@*ZU
M."XCM;2[O?, B9S;),LGDJP4$C@J/8\5Z[10!X[<'=X=\47$L-_;-'XHBO;<
MM9R,&PT.TLH&67(.0,L,=,\5H1ZII&IQ>,[^"_+ZEJ.F;/L2V\R%5CC9 1YB
M*78M)C@<94>Y[S7M#&MP6RK?W5C<6LXN()[<KE7"E>58%6&&/!%+IVD36LPN
M;_4[C4;E5*(\J(@0'&=JHH'.!R<GCC% '#6(6/4/ACLA=!!92I-B(CRBUNJX
M?CY27&.>XK=^(8NH=/TG4(;:ZNK:PU%)[R&T+>:8=CJ67;R=I96P/3VKL:*
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M.T'C.<5D^'KPZ=X?\)0S6,\.+R_5KT6;R26>7<JJIM.#(K  D$8'3D8]?HH
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M6W>1+F$P!%12H(^4@Y!]<UZC10!@^"2W_""Z"CQ2Q21Z?!&Z2QLC*RQJ""&
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M%Z&;[080V1&4QMSCY=V>G;-:7BC0+S4=0T36-,>(:AI%PTB13,52:-U*2(2
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M131R>8#A]F00)/[IZ4 ="GC O%JX32[B6XTZ_2Q,4)W^8[A"K9 X7]X"21P
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M!CPZM<QK/J%@A54CX5IAQG;DC.#SUQSD<5UUYJ^OZA=:YI^B/.;O2?+AB?9
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MNJMD ]P#WH R=6\.6^IZG8ZHEQ/::C9!EBN(-N2C?>1@P(93@'IP1D$53O\
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MUBN)#,BR+)+Y86,GYF!P<D#G'>K= &=HNC6NA6+6MKN(>:2>1VQEY'8LQX
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MI1>H( ;))[CKVW:K7M_;:>D3W4JQB69((\]6=V"J!^)_G35EOCJSQ-:Q"P$
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M;>386%TT5\FYG AG.#)R2?D<@CT!:NS/A_16L8+%M(L&M+<YA@-LA2,^JKC
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MIEK8HS.EM"D*LYR6"@#)]^*I0>%O#]K,)K?0]-BD$GFATM4!#_WL@=>3S[T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 445B:[XA?2'2"UTF^U6[=3(8+
M-5RB=-S,Q &>0!G)P<#@T ;=%8_AGQ+8^*M(&H6*S1A9&AFAG39)#(OWD<=B
M/ZUL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !56_O8-.MGN95
M+,<(J(,O*W\**.Y)/%6JY[7O"-OX@O[>\FU75[22W4K$+*[,(7/4\#.3TSZ4
M 2>%-$?1--N#<;/MM_=RWUT$.5620Y*CU"@!<]\9[UNUDZ%X?@T"&=([R_O)
M)G#/-?7+32<# 7<>BCGCW/K6M0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>elicio-amendedandrestate003.jpg
<TEXT>
begin 644 elicio-amendedandrestate003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC4_<(4?-G&<9RU;#P7MOXB\57"16LUOJ]I"(I$O(QM=(F0I@D=R#G@8SWXH
MD\$^+(QHGA+2KRUOUFO]-C\F\E4>7/(D(9USNW9P"<D '!P37>5YG96%[!;?
M#Z-X8LZ(FR]/VJ'"_P"CF+*_/SR<_3WXKT/^T++_ )_+?_OZ/\: ,6^\9V%C
M!?79MKN>PL)C#=W<*JR0L,;N-VY@N?F*@XY]#B*_\<6=GJ[Z9!INIW]RMJEX
MHLX5<21,VT,IW#(SG\N,USD.FWVGZ#XG\-1BWN;?5)KE[.]^TQA(UN <B4%M
MV5+$_*#D8Z5?TC3_ .RO',$R-&VEV^A0Z8EPUQ'DO&Y;)7=G!!'..OYT =Y7
MG]I;-?\ Q5\06%Q?ZF;2&RMI8H8]1GC5&<MN("N.N!7;_P!H67_/Y;_]_1_C
M7$VSW=C\1M:UK[#YUE=VD$$1CNX Q:/=DD%Q@'=QW]J ':;JVHZ!\0;KPM>7
M5QJ-C/8'4+"23#31X;:T1;C?Z@GGL2:O^'O$>D)X:T)=*AOI8]0$@LX)Y TS
M!22Q9G?M_O$\C\*NEZ?(_BV\\7:Q<68NS:_8[*QM[A7\F$-N.YC@%V/X#IDU
MAZ;H*-X$T'0=<TJ*Y%J)?-:"]B6:WDW922-]X[$@\@^WJ =JWBJ'?:01:;?R
M7ES%+,+4*BNBQL%;<68*#D@  G.?3FN8UKQ%!?ZKX$U[3FOY;2\EG(MXBV91
M]GD(4QYVE@W<]/7'-0V=OXAM_P"Q;74[F#6+&.VFCG26^12)#)F)IC_RT CP
MIP&^;)P>#531M(U/3-"\%F:"U>?0IY?/MHKV,NZ/&Z!E)(7JV<$]/?B@#?U#
MQIHNI^$=?EOK/5K==/!BU"S"^7<Q C((*MC!'((;!J2YD9/BCH"Q37 @FTJY
M9HFF8J2K1;3M)QG!//6L?7-%GU'1O&5U$;<:AKT,=O!:_:8\QI&A52[;MN26
M8G!.!@<UJ.LTOCC0=4\N-;2UTZ:WG8W,64=S&1QNY V'./44 5;KQ=;Z1X:U
MO4]&T^_EE36#:SK=2 ^7,S(C, SG"9884<9[ 9-=/!XFBE\2)H,VGWMM>/:F
M[4S"/8R A3@JYR02,@?RKA;G1]0N?"?BBS6.W2ZN];&HVL;W<6)8Q+$^,AB%
M;$9Z\<CFMGQF'O\ 3](U.PO+6QUZUNT%OF59 !*?+D0XZC:=Q[93VS0!U^EZ
MDFJVKW$4$T4:S21#S=OS[&*EA@GY<@X/>KM8T4CZ?;Z78:-:1WEFC+;S2"Y4
M&WB"G#]]YR ,=><ULT %<-J,DZ_&#2[87=Z+5]+FN'MDN9!&SJZ@'8#CH3VK
MN:XZ^TS4W^*&G:S'I\CZ?;Z?+:O*)(P=[LK A2V<?+^M  GQ&TYX([G^S=42
MS-\;"6Y>%0D$OF>6-WS9P6XRH..^*[&O,9?#6O/X%O\ 2QI;_:Y]<-\B^=%C
MRC=";KNZ[1C'K^=>FJ2R@E2I(S@]10!S'_"07-UX[N_#;:=<+:QV*3&X255)
MWLR[LA@P VD<?-GL.#7.^ /%J6?A+PW::A!J,AOI7MEU"0!HS,7<JK,6WDD#
MK@C/&>M;\FG:I:_$>?68;(7%C<:9';,ZS*K(Z2.V-IZY#C';/7'6N<LO#.O6
M_@OPEICZ8_VK2]62ZN5$T>!&KNQ(.[DX<<>QH ZC5_'&F:-'<7$\5P]E:3B"
MZNH]A2%B0#D%@Q + $JIQ^!QTP((!!R#T(KSRTT77]'UO5K.+0-/U*PO[R2[
MM]1FE13;>8<LLB$;F"L21MZ]..WH0&% ]!0!@ZSXML]&%Z3;7-T+",2W?V?9
M^Y4C=R&8$G:-V%R<8]1E;3Q;87NN6>EP17#?;;+[=;7.%$,L7R\J=V<_,.,9
MYSTKG[W2=<TKQIJ=_9Z!9ZWI^K>5(?-G2)[65$$9SN!RA"J>,D<\5H>)_#NI
MWUAHMUI4D$.M:9.ACD"[8]CCRY@!_=VDMC_8% &B?%%MLCVVMR9YI9HX8"8P
MTHB.UW!+[0@/<D9R..16<OQ%TA[*SN5MK]C<:@VFM$L(9X;A<Y1P">>#]W.:
MJ^)?#VH6M[H.IZ%IUOJ2Z7#):2Z?<2*AEA<)RK-P&!C4\]>:;JNE:S?P>'I4
MT6&W:VUB.^FMK>6/$,2QLN"V0'?+9X&.V3@$@#]7^('V;PMXAO[72KN/4='^
M2:TN?+5HRRAD<D,05P0>"3[5V%G/)<VD<LMO);NPYCE*EA_WR2/?K7G^L>%M
M9U1/'\4=GY8UF*$63R2IAS'$$(."2N2.,_CBN]TZ2YEL(7N[7[+.5^:'S ^S
MV)'!/TH Q-?\27>D^)= TJWTV:Y349)=\B,@X2-FV@,PYSM.3@8'&2:YG3?%
M">&;WQE/>0:I>6=KJH,DB'S1;1&*+DEV!V@D\+D@=L5T7B?3-3G\1^&M5T^U
M2Z73YY_.C,HC(62(H&R>P.,]_0&N?OO#FMW.A>/+---?S=:G9[/,T>"#$B?-
M\W'*D_0B@#J-7\7V>DR7R_9+NZ%A:+>W36ZKB*([L'YF&XX1C@9X'TS7D\5S
M-XTTW1[73YIK.[T][S[0K(,C=& 0"P( #'/?D8!K!U_1/$NKQZM8R:8MS9W.
MD""Q62Z54M9_+8/O7G<Q)7:W(&.JY)J[9:/KEMXA\-:FVG1E8-)?3[I!<+^X
M8M&0V<?,,(>!GGVYH [JN;7QK8-=6T?V6\%M<W[Z=%=E%\MIUW KC=N RC '
M;C(],&NDKR^XT#Q7>R:=/>Z5%<ZA8ZX+I[I[Q<26X9]HC7G8H5ER.#E<X8F@
M#H;WXAV%FNKN=+U65-(E$=Z\<*XB7:&W\L,K@@X&3[8K53Q-:R>)HM"%O<B:
M:U-W#.0OE21@@':=V202.,>_3FN4O/#^M3Z=X_@737WZT2+/]]'ALP+%S\W'
M*Y^GOQ5OQ3I=[)X?T"ZL76RU^PGACMO,PW,F(Y$."<KM);C^YGM0!UNEZDFJ
MV\D\4$T4:320@R[?G*,5+#!/&0<>M87Q L[VY\.!M+U&YT_41=6T=O/%,ZJK
M/.B?.H.&7#'@@UT5A90Z=I]O90 B*"-8TR<G &.?>L[Q+#=W.G016=H]RXO+
M:9@KHNU8YTD;[Q'.%./>@#ED\3R^(/!NJ6U[YVF^(=,*QWUO!,T3(^1AU*D$
MHPY!Z5U-SKD-G>2:;:6EWJ%U;0+--% 59HT.0NXNPR6VM@9)XK!\;>"YM=FM
MM8TB3[)K$(6*7D 7-N6!:)^W'4'L1^(LKIFIZ+X[U36;6S>_L=6MX5E2*1%D
M@EB!4<.R@J5;L<@CI0!)_P )_I,HT8VD-[>+K"R&U,$.?FC4ED;)&UA@CGH>
MI !-:GA_Q!;^(;.XFA@N+:2VN'M;BWN% >*1<9!VD@\$'()&#7':9X/U31]0
M\)LMMYZV=S>W5\\<BA8VN%;"J&()"EL=.@S[5?T?PI)>)X@M];M;JW@N]8>_
MMS!>&)F4HJC+1.#_  G@\<C\ #N**JZ;IT&E:?%96IE,,6=OG3-*W))Y9B6/
M7N:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 54U+5+#1[0W6HW<-K;KPTLS;5'U)X%6ZXGXN_\
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M"[WMDZDX '')K$TOQ'XFU9=#U6RTSSM-U!U:XB947R('&5D5_,RQ7C(V\Y.
M*PO%VL7_ (F^%NI:S!-!%ITETL<5N8B6:)+E4W%L\,67=TP!QUYH ]%_X1[1
M/^@/I_\ X#)_A52.P\,3:I/IL>G::UY;QI++%]E7*JQ(4],<[3^5;M<7>^(]
M7@UWQ391M9;=-TR*\M2T+'EO,)#_ #\_<[8ZT =%_P (]HG_ $!]/_\  9/\
M*/\ A'M$_P"@/I__ (#)_A7*:3XFU]]0\(-?R6,EKX@M&9HH865H76 2[MQ8
M[@>1C QQUZGO'#%&"$!L<$C(!^E &#JEKX4T6V6XU&QTNWB=UC5GMD^9F.
M,<G)J[_PCVB?] ?3_P#P&3_"O+;FXU.[^$-_<WUXEW*VM*JEH]ARNH <D$\<
M#  X'K73WOC#5/#FIZ_;:N;6\2STV/4;8P1&'[SO'Y;99LC<H^;W/% '5_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRVHL_+^SJR",,6'4YSDGG]*LZ9X8M],U"\U4W,UYJ]V@C>]NL,50<A%50 J
M\X&,]R3S4?B#Q0="U/2K'^S9KN34Y6A@,4B* X7<=VXC P#0GBVWAUVVT;5+
M&ZTV[NP?LK3[&BN".JJZL1N]C@T 9MOX!^S:'HFEQZM)Y>D7OVV%V@&YVRQ
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M]HUN(+AX/F<-N*G!(QV]._M0!B_\(/$D&JZ?!?RQ:/JLKS7-F$!(+_ZP1O\
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MV^]>]?,878[@ @<_=X&,\^YK:HH **** "BBB@ HHHH **** "BBB@ HHHH
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M/E1V^\RKT5CDY( )R:HZ;9:O>:S_ &EKEM90&T$L5E';2&0E7(S(Q(&#M50
M/5O7  .:NH'USQ/K_ALZFME]BM8%L@YD,B(T>3,A$BY8/D%CG[H]3F..2XUC
MQ OAR^UN*?9HUO+;3/&Z?:V8N))U"R+\WRICDXSD8R:[+6/"F@>(+B"XU?2+
M2\F@_P!6\T88@=<>X]CQ2ZSX7T+Q"D"ZOI5K>" YB\V,$I[ ^G XZ4 +X9AF
MMO#EE;W&JG5984,;7I3:9MI(R1D^F,Y.<9[UK4R**."%(88UCBC4*B(,!0.
M .PI] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<K\1M7U#P_X&U'6-,N!#=6BJR;D5U;+JI!!'H3
MTQ755Q?Q7AGN_AMJ]G:6UQ<W,Z(L<5O"TC,?,4]%![ T +XDO?$?A;0Y-<@O
M(]5M[1/-N[6>!8W:(?>,;I@ @<X(/2M&'7K#4-6TJ6WUU4CN+%KI; JN9HV"
ML)&/5=H]^<^U9?BW4+O7?"UUH>A:=>S7FI0&U,D]K)!% CC:SNTBCHI/ R<X
MXJK'I1T3QIX0LX8;J6TTW1Y[1[E;=R@.(@N6 P"=C<9H Z.S\9>'-0N%@M=8
MM99&CDD&UN-L9PYSTP#_ (]*MV?B#2[^[EM+>['VB*,3-%(C1MY9Z. P&5_V
MAD>]>?Z=I.HWOPDUS3K.RGAU*2ZNY$BGA:%I0T[.!\P'WDP,^]/N+>W\8Z)J
M;Z3HFL6FLMID]MY^IF9#$77_ %(,APV3W' QDD< @';Q^*-&FE:*.]#2" W"
MJ(WS+$.KQ\?O![KGJ*K:)XQTS6?#L&LAW@@G;:BR(VYB20H Q\S$#HN:S_#>
ML0:_]@9O#MW::A:6YBFDO+,Q?925 9$=A\V2!]WC R<< \AH<&IV7AWP'=R:
M;J AT*>2+4;=K5PZ%T>,2!<9<)NSE0>&XZ' !Z/)XKT*'3+C49M3ABM;:3RI
MVERC1/\ W64C<&]B,UGZMK%QK6C7#>#]6@-]:70B?_1_.5V SY9Z;0<K\_0"
MN-\7:5=W]IXXU2QL[N2WU&SM;:"*.W<O<RH26<)C. "!G&#@^E>K6S1O;QO$
MI5&4$ H4(&.X."* *>H:[INELXO+@H8X_-DVQLXC3G#,5!V@X/)QG!]*9XEN
M+BS\,ZG>6DYAN+:UEFC<*&^95) ((.1Q7'>-+6Z76+[4-%GOK;5X[-%\AK5I
M[34T^8B%AC&[)(R"" _ITZCQ*\\G@?5 ]O(;F;3Y4\B%#(WF-&1M 4$GDXH
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M6>Z.50J_*-P)()?)'))*YQ4NH:;JU[I?C06-C=M+_;D-]'"\+)]KAC$)8(6
M#9V-TZX]Z /1H?$>D3-<I]M2)[:,33).K1,D9Z/AP#M]^E067C#P_J-Y:VEG
MJL$T]W&9(%7/[P 9.#C&<<XZXYQ7.ZBO]N>+=+URPANEM;'3;M;IWMI$:3S
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MB X0D=<Y&1D"BU\>27#ZA/+H<]OINF7-Q!?7DD\>(?*3=NV@Y;/3 SC(Z\X
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M< ]001S1+X>UVT\42ZA926=U%>:9%97$MS(R.CQE_P!X%"D-G>>,KSWKLZ*
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MX&,+EE8HH7() /./2N)M/!OBB-M$DN7TF6ZT[4GN9[LRR&2[5ED7>WR<, X
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M\K=?2@#-CG\7Q:)>7FH?V);W\<)%O"DLAMR_=Y'(# >@'3G).>-BS:ZU/PY
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M3;-C%M2,2K'@L <G;O8\GG&.*U+O5=7TCQ?;:(]\;JWU.QGEMIYH4WP2Q8+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8+R%9D5Q\R@C.#[CI7*/K.H:Q>>--*O;*);*PA$2%9<GYH2X)XZG</ICOUH
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MJQ*N<@Y(Y.!CGI6BNNI<ZS/X;U6R%O=RVAN(@)/,BGBSM;#8!W D9!'<$9H
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M^''3O4?]LZ</B VO?V[X>^R'2A9A/[53?Y@D+YQC&WG&<Y[XKT# ]!1@>@H
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M9BUVKYS7'E)(SALX SE?3OGD]+8^!8;*]TR\.MZM-<:=;/:Q/(\?,3;<*0$
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MSBSQH!%/L+JK.!W1)#MZ@KZ'%>A5RW_"O]"_L,:1Y#_91J']H ;N0_F;MO\
MNX^3']WCWH I7>KZ[I[^$A+=*1JE]Y5S') H=4:-W5<C ! 4 \<G/3I7-7?V
MV3P?\4'NM2GN5CFNH5214  %O'@C !&!QCI^/->B:SX>AUJ]TNZFN[J%M.N/
MM,*PE,,^TK\VY22,,1QCK6;=>!;*ZCUZ'^T=1BMM;+-<P1O'M5F559ERA()"
MCJ3CMB@"CI6I:Q8>*]&TN[O(KFRU'2WF2)8 GD/'Y?1LY8$/SGN,\=*W?$M[
M=6-E:M;7<%J)+J..61P6?RSG(B7!W2'  &#W]*C7PM NLZ7JC:A>O-IML]M$
MI\O:Z-MW;L)G/RKT(Z5-X@\.P^($L2]W=6=Q8W*W-O<6Q7<C@%>C*RD$,1@B
M@#B)O&'B!/#FISQ3QK<6/B"/3E>XMQODA=HL;@I #8EY(';H#6W:7OB!_$VO
M>'I-5BDF2QAN[.Z%LJ^2SLZE2O.Y<H.O.">>]/D^'5A)!?0G5M5$=Y?QZA(/
M,C/[Y-IR,H>I121[8&!Q5^YTJ#1=5U#Q69=3O+@V:PO:PQH^]$)8!$"ABV6/
M?O0!E>'O$>H:[IVAP?:&BU02RKJJ;%S&8?EE7&.,NT8'?:V>:V/%VO2Z%IUF
M;<)]IO[^"PA=QE8VD;&XCO@9..YQ4'A;2X1?ZOXA&GRV4VKRH_E3+MD"(@4%
ME_A9CN)'IMSSFM/7M"LO$>DR:=?!Q&S*Z21-M>)U.5=3V8$9H YG4]7U;3/$
M%WH$E_)+'=:5->6=YY:":"2,@,IPNTCD$';QR.:YR-+U_"'PR?[:9;B:\MW2
M2= VS-K)V&"V.3R<GUKT*W\.0B[EO+ZZFO[N2V-IYTP5=L1.64!  ,G!)]AV
M&*S;?P%:V]AHEG_:^J/'HTRS6NYHB1M4HJG]WR I(['GDF@#&3Q=JVFG5],N
MYEO;RWUBWT^VN!$J$K.B.,KD+N4,P'(!.,U)K.K>+]$T'Q->,0MO:6GVFPN;
MM(FEW '>C+&VTCIAL=^0:UKSP!I>H+K:W=U?2C5Y8YY?G13#)& $>,JH*D!5
MZD]/K2MX(CN/#]]I6H:WJUZ;V+R);J:2,RK'_=7Y-HSW.,GN>!@ U-!BU9;>
M2?5-0BN_/V21)';B,0@J,KG)W<\Y.*YNX\4W,'C!](U"[ETN5[R-;%9H ;:]
M@^7<%DP3YA^;C([#'>NTL[?[)9PV_G23>4@3S),;FQW. !GZ 5BW7A2"]=DN
M[ZZGLS>+>BU<)M216#@*=NX+N&<9]><$B@#C;;7[_P .:9XYUF>^DO7MM8-M
M#%.JA-S) B$[0" -PX!' ]>:V]9\1:AX1UZPAOKEM1T^^M;ER3&J212P1F0X
MV@ JR@C!!((')K1E\#:7<?VY%<2W4UEK+&2YLV=?+60JH+K@;@WR*>20".,5
M8MO"\"SV\VHWESJDEM ]O";H)\J. &)VJ-S$  D]L],G(!4T6;Q!?Q:%K'V^
MUDL;VW\Z]MF0 1[T#1^20,G!.#N)R.1CI7*_#_5Y+P-X?L[PV<\%[>7=PS1@
MF:(W,JA8PPP<'[S=N!@YXZK0?!%OX?*1V^K:I-90;OLEG/*K1VV<_=^7+8!(
M&XD#]:KQ?#K3X(+%8=3U..>QO9;R"Z5HA*K2$F1,^7@HQ8Y4CTH V?%6N#PS
MX5U+66C\XV<#2*G3>W0 ^V2*Q+W5]8T+5_#RW%ZE[;:Q(;64&%5\F8H75H]N
M"4^4@AB3C'-=3?:?;:GID^GWT8GMKB(Q2JW\:D8/3^E9%CX6@L#I\EU?WE^F
MEJPLUN I\OY=NX[5!9@N5!.>">_- '$2>*O%\'@F7Q:=0LY8M/O9H[BR6TV_
M:(DG,9^;.5('3'ISG-;WA_\ M*;QUXR']J2N('MTA26-650T.\#  . 6/ (S
MWS5+P3X=;4O"\UIJCZA':MJ<\\EC/!Y0<>>SI]Y0Q0_*Q&>>F<9%=9%X:AM_
M$&I:Q;WUY%+J"()H59/+WHNQ7 *DY"\8SCOB@#E= \8ZEK&F^#[2:=8[[6X9
MY[BY2,?(D74(IR,DE>H. #QFJ^M>,-?TO3/%EFEQ U_H<UJ8KMX!^^AG(P&
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M$1;@6)4;02.!@>^*NT 8 &<^YHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKCOB%>R6=MH2R$K
MID^KP0Z@W\/E'. _^P7V YXQP>#0!UL\\-M;R7$\B1PQJ7>1SA54#))/I7/W
M7BAX];\,VMM;1RV6MB1A.TA#H%B,@^3'< =_PKC_ !%IJ6NK^,-/LK:/^QY/
M#3W4]LJ Q1W0+A&"]%8JI/']T&FI9Z7<R_#2U@CMS;R++YR0$*&8V>3NV]<\
M9SU!YZT >K49KQPW8T'PUK]O;L+;2+3Q6()@JEDM[5A$S#:.B;FY XP2.]'B
MS2]'M_!_BJ[TO5X+F.>*WE>"QVK;PN) H<!20&89SZXR: /8Z*S]*T73M$CG
M33K80K<2F>7#%M\A !8Y)Y.!7*^--0BM_%N@6>IW%M;Z3=0W"[KN,/ UP-FP
M/D@9V^9C/<^M '=45Y23I^A2^'-).K"[\-7.J7(EED(%N&\O=' #T,8<M@9(
MRN#TK+UV"P_LGXHIIT<!M84M7A$ !2-A$"Q7' Y+$X[DT >U5E1:K+9Z=:2:
MZ+:UO+BX%NL4,I=6=G(0*2 22,$\<<^E<JUSI]S\7+!8KBWD$^@S+)Y;CYR9
M8MH)'4[<X]JY*TM;&;X=> Y+N&"5%\0F,O,H;"&:?()/8X&?7 H ]LHKSG7?
M)\'^++;Q#IUE'-9ZQ;?8&CA48^T8W0$8Z!_N'''W36XMEX@\/Z;8Z=X?T_2K
MJ*.+]_)=7+P%I?XF 6-AR<G\: +FC:]<:EXBU_2Y[6.$:7)"BNDA?S!(F_)R
M!C@CC]:WJ\MET+1-<\5>/AKT:&. 6LFXR$"#_1AF1>1@C'#>WUK/@G6^TG3;
M/7BK:PGAGS9_[38&*-&) 8(>6F.T G(Q[GB@#V*C->269U#5/"OA:_L&T_6K
MFVT5?M6E7[\SJ53<Z/R%D!7&2/XN<9Y6'5=*U?5=-L=0EM[/2+K0+>338M4B
M#J>6$@RQ \P+Y?/7 R.O(!ZR3@$C&?>L/PMKT^OVNH27%K';26FH3V12.0N#
MY;;<Y('7Z5Q>F&TA\4^'?#^H7[:EHPTB9[&:]P5NYQ+MSSPY6/[IYX.1UK8^
M%XM(],UZWLVC,,6NWBHL; A4\SY?PQTH [FBN3\:W%B+G0+*[!>2YOCY$4D@
M2W=EC<_OL@Y4#D+U+!>G6N+T[3%U[X?^);*RDMKB]TS6;FXT]8@-B%'#HJ+D
MX1L,N,XPQH ]@HKR*'5F?Q)#XBT^Q1;+Q79_8K;,62MRH!5WST!S(#ZB(&KG
MB:UT2VN[W18D@5[#P^0!>L##%&2V&C3@F5B.6R,?+U/% 'J-9^NZA+I.@W^H
MP0)/):V[SB)Y"@?:I8C.#C@>E>8:=8Z?XEU?P5%J)^VQW?AEQ=*TQ(E8+!D-
M@]<DGZ\]JEN#INH:=\0K75T@^V:<LD-I%.1N@ME@'DE,\C+;CD=2?I0!Z9HU
M^VIZ'I^H.@C:ZMHYB@.0I90V!^=7J\BNH[B7P]I6HV<.GZU:V_AVW%[I=PVV
M18BK?O87Y"O\K _[@[XKU+2[B*\TBRN8%D6&:!)$6088*5! (]<&@#,L=?N+
MKQEJNA2VL<<=E;0SQS+(6,@D+CD8&W&SW^M;W2O-]0TC3]9^(/BJ#4;=+B)=
M&MB(Y.5SF;G'3(['MVK&TO5UN+7P3:Z]>6R6%WH68Y+^,20RW V AMQ W;.A
M/J?6@#T/Q)KUQH<^BK%:QS1ZAJ,=D[M(5,>\$[@,<_=/<?C5OQ'JDVB>'-2U
M2"W2XDL[:2X\IY"@8(I8C(![#TK@+VRM=,T#PA9V6I2:A:1^)H5AG<@C;^\^
M5#W53E1],=JJZE-8ZQH7Q*_MI8&U2R>YC@6?&^&!81Y!3/0,<GCJ2: /4=+N
MVO\ 2;.\90C7$"2E1T!90<?K68->N/\ A.SX>>UC6 Z<;U;@2$L2)%3:5Q@=
M3W/X59\,2)+X5TAXW5U-G#AE.1]P5RNL:3IVM?%N*RU.!+BW?0')A=B%?]^O
M49Y]<'Z]J ._HKR"UT&YD\!2WUG&UU)H&KSW.C>:=YFM(Y/]7D\LK*&"_12.
MU=WX5>WU@W7BB*+:-2VBW9DVM]G087/^\=S?0KZ4 =)17,>/;JRMO#86_,WE
M3W=O"JQRB,.QD7"NQ! C.,-Q]W->?7K6ZZ1\4;!9[39%;I/%#9MLC1_L_P Q
M50?[P&3W/4#I0![117FUMI=A8>/?#BV\"*-3T:X6]!^;[2%\HKOS]XC<>3V.
M.E0Z)IXMM0G^'LUKOM;6]&HQR,F1)9%O,0$GJPEQ&<]5!H ]//3BN4TWQM'/
MXSO?"VI6BV5_$ ULZS&2.Z7:&(4E5^8!E)7T.:ZOI7#:GX9M_%4OB*V\XVU_
M;:A%/97D?W[:86T.UA[>H[B@#I;;4[J;Q#>Z;):1)#;112B83EF<.7 &W:,8
MV'N>HK4KR:/Q!XCN= \:3263VOB/3M-AMY1&.&D7SCYL?J"K!A[\5HW%M9Q:
MCX'O_#:HAOG\N<P\?:+4PEG:3'WMI"G)Y#-ZF@#TBD;<%.T MC@$X!->)#3;
M*W\"RZO'&!?V?B<K;W!<EHE^W!"JDG@%201W[UZF+CQ-_;OE'3M,_LC?CS_M
M;^=MQUV>7C.>VZ@#-T/Q3K.OKJ;6NC6*?V??S6#^;J+C<\9 )&(3P<UTMC/-
M<Z?;3W%N;:>6)7D@+;C&Q&2N>,X/&:\V\(:,VL:?XVB35KRS$FOZA'^X=0HR
M1R<C/?UJ]J<>F:[\2?#LF%N;2YTZ]# L2DP5XP..C+U]B* /0\T5XA/IEE:_
M#C6KZ*(+<Z1K\D6GR[B3:HMXH"QG/RC!(P.N:Z:;P_H^N?$WQ+8ZM")[9M-M
M)##)*P7.907QGJ.,'MF@#J]<UZXTG6]!L4M8Y(=3NFMWE,A#1D1L_"XY^[Z_
MA6]7D.BO>-H?PT^WS22R#4YECDE/S/$(YQ&Q]<IL_2I7$.K>#/&]YJ8":[I]
MY=F.;I-;%!FW\L]5& F,?>R>N30!ZS1TKS*_>Y\)ZKHWBVYL3)/J5BECJ4,:
M?,+HJ&C8 ="S@QGZKZ4V^@M="U_0M!U6>QM]/GL)GWW4 :WGO"ZE\@D*&P3M
MST!('6@#T^BO)I7LM#/AC2I-:CN?#LLMW&MW>()+<RC:8XR<X*C,H7)(R/85
MVO@K3[+3-+N[?3M2-]:?;)'C*X\J'=@F.+&1L4D\9.#D=J '>,/$MQX7TZVO
M(;".\$UU%:[6N#%M:1MJG[C9&3S4&I^+;GP[-:MX@TM+:PN)5A^W6MSYT<+M
MPOF91"H)XW $>N*SOBLP7PUIV2!_Q.++K_UU%1?%J>.^\'S>&K4+<:OJSQPV
MMJIRQQ(K%R.RJ 26/ XH [027_\ :YC,$']G>0&$WF'S/-W'*[<8V[<'.>O:
MK=<!#8Q1_%.YM)6,@;PU&)<L?G(F92?;( KD],MK31_A#H?B*)"DTRVT&I7F
M6<_9?/!<,,\KV(]"10![7UIDTT5O!)/-(L<4:EG=C@*!R23V%>4:V++1-$U_
M5M UA+B.>.V>\@TM56*&+S5#R*$)VNT9?D'D#/;-:^J6'A2YT?Q%<Z,]M.;G
M19#);VK*UOA58I(4' ?)X)Y(7VH [RSNX;^PM[VW8M!<1++&Q&,JPR/T-3UY
M3H\MB;[P+IC16IT>YTMF:-%7RI;T11D!P."VS<0#W.>U9NN6C0:#XILD9UTF
MSU^R6P*N0(B[PF5$]%5F( Z#D4 >T45D6-OH7AIXM+M&MK)[V626*W,N&F?J
MY4$Y/J<5KT -D+B-C&JM( =JLVT$]LG!Q^1K%\(:])XF\+V>KS6Z6TEP9,Q*
M^X+MD9>N!G[OI7'>&_.TSQ+H\%[:6E_!?&=].URT^620%6=DN%/).,_,#U ]
MZP-%L;2V\&>!=8AC"Z@VO+!]I#'?Y;SRJR _W2/X>G?K0![97,KXFO&U_P 1
M:8+"#.E6L-Q"WGD>=O#G#';\OW/0UP&J7VG/>6FIV4\,3+XMCCDGN9 ;IOWN
MR1<\;(@,@*<_+C.*ZBW=6\?>-65@0=*LR"#VVS4 =1X9U=]?\+Z9J\D2PO>V
MR3F-3D*6&<9K5KF/AS_R3;PY_P!@^'_T$52^(EB(+*Q\40VXEN="N%NG 7)D
MM^DJ_@I+#T*T =I17FWB2Z6Q\-Q^("%@M=5U6![V8Q9"V9^5"XX.T@(6!_OL
M#4<NC:?]CUI=#\262M?26CB**-39)*)!M4JI(_>XVL >0<D<\@'H=_J-IIEL
MMQ=S+'&TB1*2?O.[!5 ]R2*M5XSJYM[CP_<6VIZ!::=?67B*P^V)'MDMR7:(
M;XS@85D R#Z\]:]AM1;K:Q+:"(6X4",18V!>V,<8H EHKR3X@W&G7'_":"-X
MA?6.GQ;Y+QP3$VUG06Z\%2<@EL]0.#BM+[%IVN_$K31=K'>07'AQVE1GW)*1
M-&/F&<'OP>X]10!Z36#HFO7&J:]KVFSVL</]ES11JR2%_,#QAP3D#'!''ZFO
M.-"U$1:+X%T[4)/^))-J%_!,96RC-')(+>-R>HXX!ZE5]*Z#PM=Z)H/BSQT3
M=65C917=J26E5(TS"@/? ^8X^O% 'HM5/,O_ .U_+\B#^SO(W>=YA\SS=WW=
MN,;=O.<]>U6@00"""#T(KBC!"WQFE1E#+-X>/F(W(;]^!R#QTXH T;/Q#J6J
MWK2:9I\$^G0ZA)8W#/-LE78=K2 8P0&!&WJ1S[5TM<+\,K&Q@T_6IK:UMXY/
M[9OHM\<:@[!,V%R.PXP*U?'MU96GA&Y-^TX@EEAB(AD$98M(H"LQ!"H3PQ(^
MZ30!TM%>+:BT"6GQ.LDFLU5-.AGC@LFV1I)Y4FXJ >2-JY/&<#(%;2Z#9V'B
M[P=>:.K+-J-O*NHE)6;[3!Y.=[G/.'*8/JP'I0!Z?7.Z=X@O=0UWQ'I0LH$E
MTKRA ?.)$QDC+C<=OR]AT/?K7EUGHMM_PJS1]>T_?_PD4&I".SG65BY8WA0Q
M=?NE2Q*].I/>NMV1S:_\3(WY7[-;$X.,?Z,3VH [ZR>Y>PMWOHXHKHQJ9DB<
MLBOCD D#(SWJQ7D^DZE:0_\ " V.N/$NCW'A\&(7&/)>Z"Q8#9X)";L9[D]Z
MO31^';.7PYH]G<-=6YEO'M/MDX:TVJ/G+9'SA-^$48Z'D 9H ZSQ'KUQH=SH
MJ16L<T6H:A'9.[2%3'N#'(&.?NGN/QJUXCU2;1/#>I:K!;I</9VTEQY3R% P
M12Q&0#V'I7E%E)!>^ _"-I+<I+''XI,)\N0KM3S+@*!@Y48P!STQBM'4=*AT
M-OB%8Z.GDZ+_ &"TLL"D^7%=,DN0H[$H%) ]1ZB@#U#3;LWVE6=XZA&G@24J
M#P"R@X_6K5>6S7MJ^M:!I6LW-E#IMQH$;6OVZ(/#)-G$@^8@;MNS'?!..O/6
M>%I=+T70M+TE==6\\PR1V4ES*H>X56/"<_.%' (SP!0!TK9VG: 6QP"<"L/P
MGKTWB+2IKNXMH[:6*\GMC&DA<?NY"F<D#.<>@K=KQ&71+&X^'NN:O"KC7K76
M;O\ L^XCD/FI-]I.Q$&>-Q(!'?.: /;J*\HOFL-<UKQ1I'B75;/3[N%XS;O.
MBB2*#RD*R0.S#&'WG([]?2K"SZ/J/B/Q!HOBR[0*MA;"REOF6)O):+]Y*F[A
M7\S=DCD$+Z4 >GT5YY8+:ZEX[ET?58VN[!-%MWTV.^7?YJY82N0W63[@)ZX]
M,USFG6TMU_PAL5_)+/ NMWUM:R/*VZ6U5)@F3GD8&,]QCM0![-FCI7C5[H.E
M)H?Q*@6TC$.F.\UC$"=MJ_V9)-T8Z(=W.1BM*XO;75/$0TOQ'>V<,%QHEM+9
MF_C#)(6W^<REB 'SL]\ >E 'J=%9'A>".U\,Z?;Q7\VH111;([N;[TR@X5L]
MP1C![C!K7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J.>"&Z@>"XB26&0;7CD4,K#T(/6I*KWE[;
MV$'G7,FQ"P0 *69F)P  .23Z"@!+73K&QMS;V=G;V\#=8X8E13QCH!BH4T/2
M(Q $TNR7[/\ ZG;;H/*YS\O''/I6>_C308M.OK^6[ECAL)/+NPUM+O@.,_.F
MW<!CG.,>]7[76]/O+B2&"9F:*%)W8Q.J*C#*DL1MR1SC.: )(M*TZ!)TAT^U
MC6XSYRI"H$F>N[ Y_&HH] T:*P^P1Z18)9[M_P!G6V01[O7;C&?>JT/BO1YK
MU+1;B19I(6GA$EO(@FC7JT9*@/C(^[G@@]*K6/COPWJ2-):ZCNB6W-R96AD5
M/+#;2=Q4#.2!MZ\CB@#H8XXX8UCB14C4855& !Z 5!?:?9:G;-;7]I;W=NQR
M8IXQ(I/T(Q63/XGTBXM-5A^WSVDMG;[[@M Z2P(P.) K+DCJ<X(XYI]IKFGV
MVDZ9_IMS>^=9K/'*('DEFC"K^]947(SN!/ Y/2@#0FTK3KC3AIT^GVLMB %%
ML\*M& .@VD8XK#T3PY<:?XB\0W4\%B-.U(0+%!$2=BQQ^7M92H&".PZ=*N77
MB_1;2%99+IV4V@O3Y4$DA2 ])&"J2HZ]?0^AK"UGQ,-,\=:+(^IRMI%WIMQ-
MY,4?F"1E,>QD"*78D,>.: .JM]#TBT5%MM*L85C1HT$=NBA5;JHP. >XI1HN
ME"R-D-,LOLA;>8/(7RRW7.W&,UR7BCQ3'?\ @>'6_#>K.(_M]M$7B4 D-.B.
MC!EW*<,>.#72ZIXETK1A,;V>15@4-.\<#R+"IZ%RH(4?7MSTH KMINKWFO\
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M,6BA$\JQV\DC11G.&<*I*]#UQT/H:T;:Y@O+6*ZMI4F@F0/'(ARKJ1D$'N*
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M_EVK7/V0L\3@I-NVE&!&5(/'(%/A\6:1<VHN();B4,TBB)+24RDQG#GR]N[
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M3%E24:=9B1(_*5Q N53&-H..!CC%9EIXJM[SQA?>'TM[D/:0Q2&4P/L8OO\
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MS*CQNK+N4C)R.#736FOZ=?:I?Z;;S2->6&TW,1@D79NSMY*@'.#C&<T :(
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M*=X\M;N:#0;FUM)[H66LV]S,D";G$8# D#OC<*ZVHXYX903'*C@'!VL#@^E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO=6%G?A!>6D
M%P$.5$T8?:?;(XJQ10 @ 50   . !VI:** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ JK/IMA=7"7%Q96TLR?<DDB5F7Z$C(JU10 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF;4\QVT@CG9+>1A$2 <MA?E7!'S'CGK5ZT\4:/?:N=+MKP/=^6947RW"R("
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MT8CN1V]#SU ( *WA^RETWPWI=A.<RVUI%"YSU94 /ZBM&BD#*V=I!P<'![T
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M#P.) X3! 7&3^%<YIME?0Z%\-H7TV^673YE^UK]EDS"! Z'=QQ\S#^=>IT4
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M\0+:ZGTO2I[:UGN?L>KVEU+' A=_+20%B%')P.PKK** .%TY[O1?&GB&[O\
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M&*$G&XG)QZ>]2:GX2\0W-SXJGLKFRMVU::UD@'G/RL2JK1R$(" X4@E<]<4
M7Y=>BUZS\5:+=6D(GTZVQ,(YA-$XDC8K@E0<@J001P17,V$,?]G_  DF\M?-
M"(F_'.W[&YQGTK=LO"^MVVI^(;K9I,46JV$,$=O"[@0O&KKMSM^[\^=V.WW1
M3;?PGK,%CX)@/V MH&/M!\]\2 0F+Y?D]\\X]/>@";XLQ12_#75FDC5S&(G3
M(R5/F+R/?K5E/&K6NOOIFNZ3+I2O;27=K</,LJRQQC+@[?NLH(..>.]:'C'0
MYO$GA/4-(MYDAFN$4(\@)4$,&YQVXQ6??>&+GQ+?QW6NI;VZ0V-Q:1P6LQEY
MG4+(Y8JO11@#'<D^E "6/CB.[UG3+)K1/)U.-F@F@N!,T1"[MLR@?(2.F"PR
M,5)XOUO5=)O/#]OIT%NZW^HK;RM+*4.-K/@84X!V<G].<B/PMIWB_3XK73M9
MN],EL;)1&EQ;;_.N5487>K#"=B<$Y(JWXLT2_P!6.C7&FM;?:--U%+O9<LRI
M(H1T(RH)!^?(X[4 4=8\>PZ8M_)#:PW2Z=(L5U$ET%F+84L(DV_/M##J5R00
M.E.N/&EVVKZAING:%+=RVMG%>*[W"Q+(C[L=B0?E../KCK5:'0?%FC:_J+Z/
M=:5)IFIS?:91=B026TQ4*[(!D.IV@[21]>YN1Z!JL/BW5M54VDD%UIT5I%OF
M8.60N=S83 SO[9Z4 ;>A:O#K^@V&KVZLD-Y DRJ_50PS@^XK%\#WY\0Z7-XD
MEY-[<3+;@_\ +*!'*(H],[=Q]2WL,7O!VD7>@>$-,TB],+3V<"PLT+%E;'<9
M /Z5G_#^Q;0M"E\.3<2Z;<RJF?XX7D9XW'L0V/JK#M0!7\%H+?Q'XTC#RLD>
MI)M\R1G(!@C.,L2>I-<?_:4P^#W_  GY_P"0Y]I^W>?_ !;/M&SR<_W/+^7;
MT[]>:] \.Z-J.F:[X@O;P6ODZE=+<1"&5F9<1JF&!4?W<\'O60/ MS_PC@\)
ME[?^P1>^>'WMYOD>;YWD[=N/O?+NW?=[9H T+J_.B_$#2K).+3789\Q]DN(@
M'WCTW*6!]2H/KF]XE\0R>'4L)VLA-:W%U';2SF;8+<N=JLW!^7)QGU(JAJ5@
MVK_$71)XQ^XT2&>:9^WFRJ$1/KMWL?0;?45?\6OHDGA^[T_7;R"WMKR"2/$D
M@5FP,DH#R6'!&.^* &ZEXHBTN;4C<0#[)8I"#,)1EYI6PL6"  >5)). '7WQ
MGQ^.L76IVLFF/<3V=G]LC_LV7[4MPN<;%.U<.#CY2.A!JO'X0OM0^&J:5=W[
MQZW.(KN2\9<LMTK*ZDCO@HJ_1:DN=,\;:QX9U"TOK[3-/U"2W,5NU@TA0MD$
MNS$!ER 0 O3<3DG& "RGC)UO]7T^XTY?MNG62WICMKD2!U.X;22%VL"IR".A
M!JE;_$"9],TW4;O1A86>IB 6=Q<WBB-GD1G(<@$H %P#CYBR],\01>%->36+
MN_6'1K>*YT8:?]E@DD"Q.&<C!V<K\^<X![8[U?MO#VI0^"-%T&YM-*OEM8H[
M:]@G=C%/$L97*DH2&W!6Y';&>] '1Z;=7-W:&2[M/LLPD=#&)-X(#$!@V!D$
M $<=ZX6>WG\0^/O$FF:KI5M?V$-A;(D+7!RBL93N3Y1AV(7/(QM')Q73>#O#
M\GAK1'T]Y<Q?:))((1(TBV\3'Y8E9N2![^M066CZM:>-M;UKR[)[:^MX(8D\
M]PX,6_!;Y,#._L3C'>@#,TKX@-<>'+?6IM!N+;2YH4%M(;E'>69I!&L07KDD
MCYCQU^IU_P#A*)K;73HNH:<(KZ2U:ZM!#/YB7 4X90S*N&&0<$8P<YK#M_ F
MH/\ "^R\-7-U;0ZE8.DMM<PLSQB1)-Z$@@''8BM9M$U/4==L];U&&SBN;"TF
MAMH(9V=6DEV[F9R@(&%  P>I/M0!G6OQ$GN-/T#4CX?G6QUEQ#"ZW*%UE96*
MKMX&T[2-Q(QZ8Y.YX?\ $,NKW^JZ=>6'V*^TV1%EC682JRNNY&#8'49XQQBN
M;M?!NMVWA7PCI6=/:;1+V.XF?SW"R*@<87]WU._OZ5OZ-HNH6/C#Q#JMQ]F^
MRZEY'DB.5F=?+3;\P*@<]>": *\VLZJ_Q)705MK5M._LPW+%IB&;,BJ21L(R
M,$!<\Y))[5RWA+Q#)X9\/$?V27TMM>N+22X655\G?<LBE4Q\R@D ],=LUU]W
MHFI#Q[;Z_9M:-;'3S93I,S!U_>!PRX!!SR.2,=>>E<^?!>NGP=+H^=.^T/K'
M]H!_M#[=GVCSMO\ J\Y_A_7VH UM:\>0:7_:#6]M%>)IT@CN8Q<A)F.%+"*/
M!WD!AU*Y.0.E=%=:K9V6BRZO<2^7910&X=R#P@7=G'7..U<M'H7BK1_$.I3:
M+<:6^EZI,+F5+PR>9:S%0KE-HPX.T'!*\^E=!K^AIK_A:^T2:=U%U;- 9L98
M$CAL=^><4 <=JES=7_C[P'>W.E1VHFDN6CD\X/(%-NYV.-HP>0< L,YY]=NW
M\:.^K:19W6EO:+JTDT=NLLN)D\L,09(BHVA@AP03V]:SXM \6W5_X7N-1_LA
M6T623S9(9Y&-P&B,>X*4&T\YQD_6J>G^#/$\$GA^6YFTF2YTR^DGN+G?(TEX
M'1T\QLJ/G 8?+DCC[P Q0!>T?QG>K8:[J&MPVT<-KJKV,*PSD_.&2-4^90,$
MG)8GN> !6QHGBH:KKEYI$MM&D]O$LZ36T_GP2H3CA]JX8'JI'<'FL&;P/J\V
MFZ_8+>VMO]IU0ZKI]RFYGCFWJZAU(P "N."<@]L<]+H*^)'!E\0MIT<BKL6'
M3R[(Q[N2X![< #C)R3G@ S]0UK54^(FGZ'#;VK6$UA-<2%YB&;#QJ>-AZ!C@
M9YSR1BN6\,>('\+:+J#KI!?2E\17-O+.DJIY(>YV+M3'S $C/3';-=AJ>B:E
M)XUTO7;![0QP6DUI/'.S A79&#+@')^3&#CKUKGY?!>NR^#M3T?.G"XN]8.H
M*_VA]JH;A9MI_=YS\NW\<^U &KK7CR#2_P"T'M[:*\33I1%<QBY"SL<*6\J/
M!WX##J5Y! Z5T5WJMI9:--JUQ)LLX8#<.Y!X0+NSCZ=JY:+0O%>C^(-2ET:X
MTMM+U2;[3*EV9#):S%0KE-HPX.T'!*\^E='K6BQ:YX;O=&N97\NZMF@:7^(9
M&-WU[T 97_"726UWI":EIAM;?5SLM)5F#E9"NY8Y!@!6(!Q@L,@C/>L>;XEW
M$&E7&KOX:NO[+LKR2UO9Q<(6AV2;"P0<N >N.GJ><7H?#>KZA!X>M=<-GY>C
M3I<&6WD9FN9(T9$.TJ-@^;<>3R,=.:Y_0-)U#Q#X2\1Z*HMH[*\UJ^CDN#*=
MZ1F<[\)MP6QD [N^>V" ='IGB#5[[QGXAL#:6TMC8Q6YA$<_S-O5V!Y4 EN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9E=-V/D!PQ!Z$ ]<'CO56#QSX7N;JTMH=<LWEO&*VX5^)""1@'IDD' []LT
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M;D.,\KC.,<YQC'>@#H:*XS7O$YTGQ?X>9]5BCT2]M;F67(4JQ0(48-C)SOZ
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M6][!%=V5K':7IMI%02(&)PQ&U@#MR,X(R*]5K&/ABP9B3<ZMDG/&K70_]J4
M<5?WFN:KX#%I)HEW%K.CW<$ES9P0O%'=)#*K$P.  0P&X '((QZ5<1M+U32-
M=U;3-%U=+B73)+9Y[V.?S9#@[8E1\EL$GD#&3@$\XZC_ (1>P_Y^=7_\&]U_
M\<H_X1>P_P"?G5__  ;W7_QR@#C-/AG%[\,M]A>C['82)<%K20"!C;J@#G;\
MIW CFL[4+2YE\!_$2WCTV^-Q>ZI,]O&+*3=,K+&%91MRPRK<CTKT3_A%[#_G
MYU?_ ,&]U_\ '*/^$7L/^?G5_P#P;W7_ ,<H YV"9+#XA:IJ%[:7?V6]TJU2
M"06<CB0J9-Z<*<-\R_*<$UAV6CWGA73_  )/>V=SY%C=W;7"6\+3-;+.LAC4
MJ@)P-RJ<9 -=]_PB]A_S\ZO_ .#>Z_\ CE'_  B]A_S\ZO\ ^#>Z_P#CE 'F
MVI175SX2\9P'2=2,EWX@BN(8C92,9(MUN2P !R,(V?3'-=3XNM3/JMO?:;?:
MAI6JPVC-;W<=JTL$RDY,,J;3SD @<-R<=*Z >&-/(R+K5B/;5[K_ ..4?\(O
M8?\ /SJ__@WNO_CE '"_:KW2]<M-1\0Z+J:6FI:/:PLNEB9EM)TWEHF2(YP?
M,XSGICUJ_!I\5AXO\&1V6C75G86MG>J(_*>1;?S"A16?!"L<'C/'(KJ_^$7L
M/^?G5_\ P;W7_P <H_X1>P_Y^=7_ /!O=?\ QR@#SF]M;E_AQXSMXM,OS<7.
MNRS0Q"REWRH9T964;<D8!.?:M.^DBL_%NO6^N:3K5YINM"*2TDLTG:.1?)6-
MX75"-IRI^\.C'.*[/_A%[#_GYU?_ ,&]U_\ '*/^$7L/^?G5_P#P;W7_ ,<H
M YNPM?L'Q)M&&FW%O:6_AQ+92L,DD<3"3/EB3!!(4>O-<[H,%Y8:)X N9],U
M%4L+^\6YC%G(9(O,68(2FW=@[EYQCFO1O^$7L/\ GYU?_P &]U_\<I%\,Z<P
MRMWJQ'J-8NO_ (Y0!R @O[+Q2MQHCWI@NM6(U#2+VV9HU&\[KF*0CY1@;^"5
M)..O%=[IVIQZD;L1V]U#]EN'MV^T0F/>5Q\R9^\ISPPZU3'A>P!!^TZO_P"#
M>Z_^.5LT %!.!FBD) ZD"@#A_ 0E37O&!EM;N%;C56GA:>W>-9$V*NY2P (R
M#6!J5M<2Z#\38TTZ^:6]F;[,HLY,SCR$4;/E^8;@>E>L44 >7W$_]F>)YI]8
MTS6KG2]5T^VCAELHYSY;HK!HI$3##.[(R.Y]Z] T*SAL-#L[6VLC901Q@1VQ
M?<8E[*3D\@=>3]36A10!PFOV-WHOQ'L/&$5I/=V#V#:;?+;QF22 ;]ZR!!RP
MSP< D#G%=&-575X'ATL3YDC8&Y>%XUB)4X(W ;CG' Z=\<9V** /)H;"]U+X
M9Z/X5-C=6VNV5S;1ONA8"$Q2@M,'QM*E 2"#SNQUJ:\MYY-'^)T:Z?>F2]9Q
M;#[')F?-LJ#9\OS?,".*]3H) !). .] 'G^R0^+? <D=G=B*WT^YCF?[+(%B
M+1Q!5<[<+DJW!]*YC2K1-?\ A!9:'96\AU*34BT;"!@(BMVS&7?C& @(SG_9
MZ\5[*X+1L%<J2.& SCWK*\-:!%X9T6+2H+J>XAB=V1I]NX;F+G[H ZL>U 'G
M'B9[R\M==@&D:C!+!K=O,MO:6#F.>)98O](9PO[QB > > !\O!-;8#MXN\:7
M+V%X([G2K:.%VM),2,$EW*IV\D;ER!FO0Z0D $D@ =2: /,7L;NV^%?AC6H+
M>6/5_#MK#/Y,R&-V58PL\)# $;EW#ZA:[S0;*6RTF,70 O)V:XN<'/[USN89
M]!G:/9146H>'TU+6+>^GU"^$$*J#8)*!;R,K;E9EQDD''?' S6Q0!RWC6RAO
M8M-1[C4+&XCN#);:A9(7-K($89< $;""5.>.0.]<O,VL7=AX0.JV,DMS;Z^\
MLLMM9.%>)1,HG9 #LW%E;G'7->H$@#)( ]Z6@#RK4)+NTO/&T\>B7%W%-J5C
M(GF6+NNQ4B5YD7'[PH5)P.Z@]*BFCN6'Q&"6>L3C4=+B^RRS6<@:X/D.G "C
M!W$#;@$>@%>M44 >>,LS:[\.Y!9WFRWMYA.WV63$): ( _R_+\PQSBO0^@I,
M@D@$9'6EH \UTG2[S4/"'CNPMK:>VO;Z_OVMFG@:'S!(,(P+ 9!Z9JUX8N=.
MUB^TV\D\/ZS;ZKIT3B5[\3A;0E-KJA<D/N(  7/'/&!7H%(2 0"0,\#WH \?
ML;:Y7P3X3MY--U 2V_B5KB:,V4NZ./SYFWL-O"X=3GWK>\MU\4>/YFLKO9<V
M%ND+_9)")BL4BL%.WYCDJ,#->AT4 >6Z;%-9?\*WOKNRO$@L=+FMKEFM9";>
M4Q1* XQE>589(Q5?4=&N[6VO]<CL+E;*7Q/::D+>.!C((8]BO+Y8&[+$,V,9
MQSBO6J* /*=2DGO;GXBS0Z;J1CU'1H([,FRE_?,(IEP!MR#EUX.#STK:U.QM
MKSPCX;B<ZGITT?E&"\M(&$EG*L+#+IMX3&Y"&&/F[5WE% 'DKSZ]:'0M:UO3
M[R[M+66]M+F73(I(I'5W4QW/E(0P#;#D?[6>XKO?"EM80:=<3Z=IMQ8V]W<O
M<8N=XDE9@-TC*YW*20>#SQGO6[10!Q7CP75I?Z!K"V=]>:?93RB\BL2_G*KI
MM$@"$$[3UQV8UE7CVEIIUKJ&D^'KZ.UO-7CFGNIK66>XC.P@W(B8,P/102.^
M<$8SZ510!XV+;5H-/UF>UTK5)S9^*(M5>"6!A)=6X2/[N0 S9&[:.FT<#@5M
M>+KF#Q#X!\276DZ%>B:\MDB\PV#I/=.#PNS;O(4=R,<\=#7I5% '%#<_Q5TV
MYBM;H6O]B2PF;[,ZQJQEC95+8P#@$X-=F[B-&=LX49. 2?R%.H)P,GI0!P/_
M  C*^*?!-F(S<:=J]C+)-8W4D+1R6\N]B,A@"5(QD="*RFMO$3>#]!U*^TZ4
M7EAK[WNI6<"%B4\Z4,R*.6 W!P!G(Y&:]3!!&1R** /+_$]C-JE]XHUK3[>Z
MDM)O#3Z>JI;ONN;ABY7:N,MM! SC'S8['%V..4^*/ ;QV=VD<&FW$4S_ &20
M+"S1Q!58[<+RK<'TKT.B@#D+S2]9T[P_K+:AX@N]866RECB@%C&K!RIQ@1+N
M)[8]ZP?"\.B:9X,T&6;PY=C6[*VB.(](E6;SPFT@OY?<D@DG'.2:]-HH \]5
M)5\5>/)I+*ZV7%A;1Q.+60K*RQR!E0[?FP64<5GV,%Q%I7PP0V%ZKV1470^R
M2 P?Z,R'?\OR_,0.:]2I"<A@&P>G':@#QZ*&'5O OC30H+.2>_O-:O8X8Q V
M&D,WRONQC"G!)SQCZ5NZGINH3^-KNTMQ<B63PL]E'?&%Q&)RYQ\^,9[]:ZSP
M]H$7AZ*]BAO)[D75W)=OYVW*O(=S8V@<9/>MF@#S".VN-<\*>#M(BL;JTU32
M[RT:Y22!D%L(!B1MQ&T@@$+@G=N'OB_JNCWEOXZ>RLT!TKQ)$)+]<_ZIH2H=
ML>DB%8S[X->@5CZ1X?32KJXNI-0OK^XF+;9+R4.84+;MB8  7./<X'/ P <=
MJSKIGC;6H];TO6+O3-7AA^S2V"S2(=J;'A=8SQD\C(Q\QJO+$GAGQ(OV_1=7
M&BWNF6UM;KI[32_96CW@PN(SDY#\'D9S[UZC10!F^'[*WT_0;.UM;%K"WC3]
MW:LQ8Q*22 22>>>1DX/&:Y;QNTB^,/!TZ6E[-#:7DLMP\%K)*(U,14$E%/<B
MNZR,XR,^E+0!P/B:UNO&^K:)IUI974.EV-_'?WEY<P-"&\O.V-%<!F))Y(&
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MSR>#CK6W8>%[_P ,^([F^T5+>YLKVSM[>:WN)C&T;P+L1@P5L@KP1C/&>>E
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M#.^0NCH2G##<P/(ZY!J6#P?K5K:>$8/M-O=?V-=R3S//<.6*,LBJBG8=VU7
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M^4%MP)X/W6P!VDOM1\9:;#H]M=ZA#%+=:Z+)9/*C=Y+9D=E+@#:'&W'RX!H
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M^'[*[34$U%98PPNT4*)??  P?48X/%:= !1110 4444 %%%% !1110 4444
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M05!\Q#E2<@\ ]JJ/X2M7N]:N?MMZ)-8B6&YPR8"JI4;?DXX)'XUO@Y /K2T
M4])TV+1])M--@DEDAM8EAC:4@MM48 ) &<  54U3P[::MJFFZE+-<PW.GF01
M/!)LW*X =6XZ':.F#QUK7HH Y6;P'I\^C:KI4E]?FVU2Z-W<_/&&,A()P=G
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M!W 8VYSGG.<UMT44 <G>_#[3+N35_+O=1M+;6 WVVUMYE$4KL,%\%258]\$
MXY!JU+X-LGO["]BO=1M[BSMOL>^*?!FAR#L<D$]1G(P1ZUT59^NZA+I.@W^I
M0P+</:6[S^4TFP.%4DC.#C@>E &)#X TJVT73-,AN;^---N3=6TRS_O$<[LC
M.,8.]N,=ZN?\(?IKWNL7%P]Q<IJ\*07<$S HR*I50.,C )YSGG/6M+1[YM4T
M2PU!D$;75M'.4!R%+*&QG\:NT <OIG@6QTVPN++^T]7NXI+=[:+[5=[S;QL,
M$1\#'&,$Y(QUQ6E8Z!!::G_:<MS<WEZ+<6JS7&S<L>[<1\JJ#DX))R>*UJ*
M*NI:?;ZMI=WIUVI:VNX7@E4'!*L"#@]N#6,W@RQ:VTM1>7XN]+)-K?>:IF0%
M=I4Y4J5*@ C;CC/7FNCHH H:9I-OI2W!B+R37,IFN)Y2"\KX R< #@
M"F:]HEKXBT>;3+UI5AE*-OA;:ZLK!E8'U!4&I-:OY=+T2^U"&!9WM8'F$32;
M ^T$D;L''3TI-$U!M6T'3M2:,1M=VL4Y0'(4NH;&?QH I)X8@CUV'61?WQNX
MK,V8+.C H6#'.5Z[@#^&.G%9;_#C2'T6STY;O48VLKB2YM+R*8)/ [DL^U@O
M0ECD$']!7844 4=*TN+2++[/'-<3L6WR3W,ADDE;IN9NYP /0  #@4FLZ-8:
M_I<NG:E;B:VEQE<D$$'(8$<@@\@BK]% &-:>'W@1(KK6=2OX$QMBNFC(XZ;B
MJ*S?\")SWS5>?P?8R7VHW$%U>6B:FH%]! ZB.<XV[CE258KP2I4GZ\UT-% &
M(GA>SAUZ+5[>>X@EALOL$44>P1I#D$  KZ@'KV].*H+X#T]=!M]&%]J M8+S
M[:GSQ[A)YGF==G3>2<?TXK?O);Z.:T%G;131/-MN6DEV&./!^91@[CG QQUJ
MW0!Y_I.B3W_B[QEY\NJVEI?2PJI$7EI<((%1B&9.#D,,J0>_H1NW'@K2YM2A
MO(9+NS\NR%@T-K-Y<<D )*H1C/&3@@@\UT=% '+V'@;3].?0V@OM0/\ 8L;Q
MVHDE5AM90I#97GY0!QC&/7)IAMD\&PW'V+3]7UEM5O7FECB6-PDCCEF)VA4.
M .X%/'B>]N[FXET[3HKC3K*_:RO)'GV2($ WR*",$*3C&<G!QZ5-H.NZGK7V
M&]72XDT>_M/M,5P+C,D><%5="!]Y3G*DX((]"0"UX6T*'PWX:LM*AC1! GSB
M/.W>3N;&><9)Q[8J_J%FFHZ=<64DDD:7$;1LT>-P!&#C((Z>U6:K7^H6NF6;
MW=Y*L4*8!8^I(  ]R2 /K0!BQ>#;*'^P-E[>_P#$C4I9_,G0IY?S?+S\AQ_]
M?FKNCZ!!HMQJ,T%Q<RMJ%P;F83%2/,("DC"C'"@8]JUJYK3O$6H:Q<0W&G:;
M%-I#7<UK),9]LL?ELRF3:1@J64C .<$'U  +^O\ A^U\16<%O<RW$#6]PES!
M-;N%DBD3.&!(([D<@]:S&^'^BS0ZS#=->746K[#=)/<%AN4* Z^C?*ISVQQ@
M<5U-% '-VW@K3DTB[TW4+J_U:*ZA\B1]1N/,?R_[H( QZY R2 23@8=I/@VQ
MTRSFM9[O4-4BD@-MC49_-VPGJ@X P<#/<X&3P*Z*B@#G]/\ "-G8+81F\O;J
M'3L_88KAU86YVE000H+$*2H+%L T6?@[3+70M0T:5I[RQOY)9)X[AE.3(27P
M5 QDG/MVQ6D-22[@U ::8[FYLW:$H7VKYP0,$+8./O+D\XY]*L6C7#V<#W42
M17+1J98T;<J/CD X&0#GG% '-VO@.RM[K2[B;5-6O&TM9$MA<3J0J.H4J=J@
ML,#'//J3Q45E\.M+L1I0BO\ 52NE2L]FK77$2LI4H,#[N&(]>V<5U]% '*R>
M M/ET34-)>^U VU_>&]G^>/<9"X<X.S@;@#CVIUUX%T^YUR75DOM3M9KE%2]
M2UN?*2[VC ,@ ZXXRNVNG) !). .I-5["_MM3L8KVSE$MO*-T<B]&&>H]J ,
M+5/ ^G:CK2:M!>:CIEX(A!*^G7'DB>,=%<8.<=B,$>O2NBMX(K6VBMX$"11(
M$11V & *DJL;^U&IIIWFK]K:%IQ&.H0$+D^G+#Z\^E %;6]"L/$-@MEJ,7F0
M+-',!G'S(P8?@<8/L31!H5A;^(+O7(XL7UU!'!*_8JA)'XG(!_W5]*GL);Z4
M7'VZVB@*SNL/ER[]\0^ZQX&">XYQZU;H YO_ (0G37TO7-.FGNYK?6I7FN@[
MJ"'8 $J0HQPJ^HXJ6/PI FJV&IMJ.H275C \$;R2(VY7(+%LKR25'IC'&*WZ
M* ,K0=!M_#UI/;6T]Q*DUQ)<MYY4D.[%FQ@#@DDTNO:%:^(;".TNI)XO*GCN
M(I8'VO'(C;E8$@CJ.XK4HH Y]/"5M'J&HWJW]_YU_;):S%G1OD0$+C*DY&YN
M3GK5&?X=Z7+I^D6T5[J5K/I,?DVE[;3B.=(\ ;"0N&7 '45UU% %73K"'3+&
M.UA:1U7)+RN7=V)R69CR23S5?7-"T_Q#I_V+4(F=%=98W1BCQ2+]UT8<JP]1
M6E10!DV>AO 8_M>K:AJ*Q$,B71C !'0G8B[B/]K///49JB_@K3F?442>[BLM
M3D,M[8QNODS.?O$Y7<N['S!6 -=)10!BKX:MX]=NM8BN[J.YN;9;5E79L6-2
M2H4%>,%C^=4(O FGP:/H^F1WM^+;2+A;FU^9"P=<[<G9R!N;\_I74T4 >>>&
M_#[ZE-XM@U!M4MK._P!6ED-NT7E1W,#(@SEDW8;# [2#@5LZCX TG4;C59&G
MOH(M5@6"[M[>;9&^U-BMC'!"X'7!P,@UU5% &!;^%+:UUBWU2.^OS<P61L5+
MNK QDACG*\G< <^V.G%9DU@OA;08_#>G:5J6KPWPG12X1HHBY+$3-\NU"78]
M">N.PKLJ* *&B:3;Z%H=EI5J/W-I"L2GNV!R3[DY)^M)?Z5]MO;:[COKNTFM
MT=%,!3#*^W(8,K _<&/2M"B@"EI&E6FB:7!IUDA6WA!V@G)))+$GW))/XU=H
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KEO&]Q9QVVDVUV9&:ZU**.&$2!(IG 9@LI(/[O@DC!
M)( KJ:K7VG6.J6WV;4+.WNX"0WE7$0D7(Z'!&* /&KZ:,?#_ ,:0+>1J+37X
M_)%K(42)"]ON"#)PN6?CIDFM_4]"@T7QO-#HYGCM;[1+J748EG<@LI7RY22<
M[R2PSGG!]ZZ/QAX3_M?PS?:=H]GIUO<7LD#S22#RPXC=&&XJI+<)M&>F:U9=
M'BAT6\M]-L+*VN;F H50;$+%2!E@N2!GTH \RT[2(K7P_P##G7=+>8:S<36<
M$\@F9C/ T9\U&!."JJI/MMJSJ:J_A7XJ'<P*7DKJ5<J01;18Z>]=QX/\,Q>'
MO#^FVT]E8KJ-K;);R7%NN=^  3N*@\XR?ZUIG0=&*7"'2; I<G=.OV9,2GU;
MCYOQH XIKS3[KQG#HWB%H?L,FAQ264=R0(G<LPE(SP7 "8[@9QU-,ECT1K[1
M-&CNWOTATN=XGU28/;F$.J^:V1^\?C"D$#:2<C(SV]WH&C7]M!;7FDV-Q;VY
MS#%+;HRQ_P"Z",#\*EN-*TZ\FMIKFPM9I;4YMWDA5FB/JI(^7H.E 'DFCM'K
M>@_"^*]N&N \L\4Q\X[CBWD 4D'/3 QW!]Z37+ :/X6^).FV!<:) L!M8RY9
M(964&5$)Z#)0X[$UZPV@Z.U@M@VE6)LU?>MO]G3RPV<Y"XQG/>GOI&F2Z>+"
M33K1[('/V=H5,?7/W<8ZT <+K4]KJ7CC4M#UJ[L;>!M.A>Q6^BW*P)<2/&2R
M@.#MYZX QT-=;HJ26GA"VCMKV74WAMB(;F8?-<8!VL?7/'/?KWJS>Z!H^I10
M17VDV-S';\PI-;HXC_W01Q^%:  4    < "@#RKPHFG:Y9^&M9_MRV35D8+<
MQPPXN;B0KB6*;+$L,Y)R. ,C I8+6QT;QTL,J%O"]_?E[5V \N/4 NTQY_YY
MGYMHZ;U([#/HT.AZ3;:A-J$&EV45[.");A(%$D@/7<P&32/H6CRV4=E)I5B]
MK&V](&MT*(WJ%Q@'DT >?MX>TC7?&'CNUU9Y#;PI:R+NN' @)A),@YX(.2#V
MYQU-9FB:G<WY\.:;XKN;2-+K0$EA_M.'>DTN\ALY91YGE^6><GD^IKM+#PC_
M ,5?KNJ:I8:9/:WWD"W4_O'C$:;2"&0  X!X/:NBU+1],UB!8-3TZTO8D;<J
M7,*R*I]0&!Q0!YK;Z+9+XD\%Z:VI7&K6AM-0C,TLC8G1"FT'!PRC) ]0.XHT
MNSNYO"EQIFF75JCV?B:[ALK2^RT$\<;2$6[=]NW+#K@H*]+;2-,>X@N'TZT:
M:!=D,A@4M&OHIQD#Z5#_ ,(]HGD-!_8]@(FE\XH+9-ID_OXQ][D\]>: /-3K
MT*P:):W-G'HE@VK75KJ,%T!+;QW(3<J9!4&,EB1VR!Z5VW@W3K73(-1@L=46
M]MFNFD5(EQ#;%@"8X^3A1UQGC-;,FCZ9-IK:=+IUH]BW6V:%3&><_=QCKS4U
MG96NGVD=K96T-M;QC"10H$11[ <"@#S_ $O1+*^^('C"6:%[B:PNK2XM$:=\
M1R_9PV<9[DGKQ6=X4%AKMCX;UA]=MX=9BE47201;;J>4@B6&7+DE<Y/W>  1
M@"O3;?2]/M+N:[MK&VAN9O\ 6S1PJKR?[S 9/XU'#H>DV^I2ZE!IEG'?3#$E
MRD"B1QWRP&30!Y1J,2CX7>-0))1Y'B"<1MYK94">-0,YY&#CFNBD\/Z7_P +
M6;3C;9L[S1&GNK<R,4GD6=5#2#/SG#'DY_2NR_X1[1#;2VW]CZ?Y$K^9)%]F
M3:[?WB,8)]ZE_L;2_M0NO[-L_M"IY8E\A=X3&-N<9QCM0!Y+81I>^%O EI<R
M2/"NOW-N,RL&\M?M*JNX'/0 =>E1^(M,CT73O'-GIH=-'M38SPIO)6VN&D!E
M"$_=^7:2.V[WKUK_ (1_1OL+6/\ 9%A]D9MY@%LFPMZ[<8S[U.NFV"6#V"65
MNMFX*M;B)?+8'J"N,'/>@#B+R2SN/BG?0).A67PXQD6*3!+>;U.#UVX]\8K&
MT#P[%-\,M"O[">"'6KVWMD\V]=WBNMIWB&09QM.".!GH.>E>CP^'=$MT5(='
MT^-5B,*JEL@ 0DDJ..F23CWJ3^Q-)^P"P_LNR^QJVX6_V=?+#>NW&,T >8S:
M\+:QM8+O3X]"@&O?9M8B?][;(QM\I@@J/*9O+)SC!Z\<$\2:59:?X/ULV&KK
M<POJ-E*L-I\D%JS31JRIM8@;@<E<\9S@9KU$Z3IIT^2P-A:FSDSOMS"OEMGD
MY7&#42^']%73DTX:18"QC;<EM]F3RU/J%QC- '%#PYI+?%*^TIK7-A=:-'<W
M%L9&*32^<Z[W&?F;'<_7KS7/:%JY.B^";+5;RW33+FWO(@]^GFPO,DH6)'RP
M'"!L9/7MG&/6O[&TO[4;K^S;/[08_*,OD+O*8QMSC.,=JB?P[HDFFG37T?3V
ML"V\VQMD\O=Z[<8S[T ><:CI%I9:=X;L[;5IKZV_X2=8T>*1D2-&5V,2$,<J
MIX')(QC/%4?$.GVEIH/Q0TJ"!!8VJ6]Q!;XRL3M"&9E!Z$D9KUA]$TF2"V@D
MTNR>&UQ]GC:W0K%C^Z,?+^%.71M+62YD73;,/=*5N&$"YF![.<?,/K0 FGP6
M0TJ."S2%+4I@+;X51GKC;T/->-VFD1#X6Z-X@L))SXA@U$):3"=F9B;LH8L9
MY4J22/J3WKVN&VBL;);>QMH8HXEQ%"@$:+Z 8' ^@KFO!'A%?#NA6L&H6>G-
MJ,#RM]IMQN)W.QSN*@@X;;^% '.!8-;T[QZ^LD)J6GW<X@E8[9+2%8PT#QGJ
M@."V1U.:GL)KZZ\5^ 9=5!6_ET.Y:X!^4[RL&[(['.:[JXT;2[N\6\N=.M)K
ME  LTD*LX .0,D9X/-22Z9I\]['>S6-M)=1C"3O$I=1Z!B,B@#RB/46TCPA?
M,TLB::/%\MO?2;R=EKYY!RW7;PJGV)%:GB_3]"MO!?C*;1KLGSK)9Y(+:8>1
M"P4A2H7A2V,D=\ _7T"+1M+M[:>VATVSCM[C/G1) H63/7< ,'\:CB\/Z-!I
MATV+2;%+ G<;9;=!$3Z[<8S0!Q.KWEO<>,K31M7N+&*PFT=)+5;^+?%++O82
M8RRC>%\O'4@$XQDU5ETR]MM,TE=)N[;Q1'86DRR66H':US"9,"2)^1N7;M!.
M05(YYY]!O-!T?4;2*TO=*LKFVA(,4,UNCHG^Z",#\*=<Z+I5X8C<Z;9S&)-D
M9D@5MB_W1D<#VH S]'U.QD\!6>IP&YAL!IRRJ7YE2,1Y_%@!^-<%H$MI!XJ\
M&-:RPPV^H:5<AQYP:>=<1%&G<8#2$DGIP=V":]9$:+&(U10@&T*!P!Z8K/@\
M.Z):^5]GT?3X?)9GB\NV1=C,,,1@<$C@^M 'DMM86]OX'L-8C\S[?;>)?+AN
M#*Q9$-Z4*C)Z%201W[UKWLMGK=E\1EUI8GO[ S1VZ2D;H+<0 Q,F?N[FW-D=
M3]!7H?\ PCNB?9OLW]C:?Y ?S/*^RIMW?WL8QGWHN_#VBW]RMS>:187$ZH8U
MEEMT9@G3:"1G'M0!6\*".X\#Z*N[<CZ= I*MC_EFO<5Y19Z1$/A;HOB&PDG/
MB*#4%CM9A.S,Y-V4,6,X*E2Q(]B3WKVR.!+2T$-G!%&D:XCB4;$'H.!P/PKF
M? _A%?#NA6MOJ%GIS:E \C?:;<;B=SL<[BH(.&Q^% '-Z;H\,NK^-K^&"2YU
M'3+]IM/5IG.R7[*A&!GG).,'-5TV/X+\%:]H[9UJ>[M$FG4_O+DOQ<)*>K#[
MY.>FW(QBO3;72]/LIYI[2QMK>:8YEDBA5&D/^T0.?QIEOHVEVMX]Y;Z=:0W+
MDL\T<*J[$]22!GGO0!Y]I,NC:];:H^NWAM]=LM:DRR2!+F/9+^Y2//.QDVJ
M.&R>Y)JO=&R\0WWBBQUG6;33;^SO_P!S))'BYMX0%,3PL7& >>@Y).<YKTEM
M%TI]575'TVS;45&U;LP*90.F-^,_K27.B:3>:A#J%UIEG/>P?ZJXD@5I(_\
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MC3V%XTMJYF8F!Q!&P9>>#GO^%>NW6FV%]+#+=V5M<20G=$TT2N4/JI(X/TJ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-&26)R#(2V3G)R3R3R:V: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ***R=;UJ;2T5;32;W5+AE+>3:[!M4=RSL /
M89R>PX. #6HK*\.>(+/Q/H=OJUBLJPS;@8YEVNC*2K*P[$$$5JT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !5748[Z6PF33KB&WNRI$<LT1D53
MZE0PS^=6JR=1T1[[48;V+6-3LGB0H8K:5?*<$YRR.K#/OP: ,3X:7%T?#,VG
M7MI#;W>EWLUE,8,[)G4AC(,\_-OR??/3I78U5T_3[;3+06UJA5-S.Q+%F=F.
M69B>22222:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>elicio10-qxexhibit311001.jpg
<TEXT>
begin 644 elicio10-qxexhibit311001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQA<D@<UE6.C7PT#XIZX;>=+76GE2PC,9#3C,F'"XSAMXQQSS0!T=Y\15\+^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9U_KNG:;IL>HW$[&SDV[)88GF!W$!3\@/!)&#[U?1Q)&KJ& 8 C<I!_$'D4
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MK5TUK;NP02^3(Z[CG )53@\'K5_3[^WU2QBO;1G:WF4/&SQLFY2,@X8 XP:
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M;Z=)<2VUY<C,$-W;R0&7U";U&X^PYK:H **P'\9Z&BW$AN93;6[M'-=K;2-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+:*T6!+>22'3B)9(P I7)E(&0,$@=Z -;QD<^!?$!'3^S;C_ -%-7EGP8O\
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MPMKYA9CCJ=XXX]*TY]!UR^U"QEO->MA9V\ZSRVUK8&+[0R\J&8R,< @'CT%
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M9TUP]K>1H&P,YVNI^\O7C(ZGGDT <9^T,JIX$L+M6*7,&I1F&13AE.Q^A[=
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MO/!O]I?V9X@#?VA()9?/L@VUAGE<./7OFNIT#1KC1K">*YU*34+N>=YY;F5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_:;83#$<5F7DV$YX"'J,\88>M;/B339]6\4^(K_PR%=CX;EM9YK8\2W#-F-
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M=0L[B]GLXKB-[FW ,T2MEDSTR.V:LUR.GZYINB:9!JNN7*V4^O78>,2@YRX
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M<Z5:^0KG!DVO)NV^N.I]!R: %\#>-+>X\.:='K^MVS:O=W-Q%&)61'EQ.Z*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,WWB!R?K3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2,!45>,M@ \G&2Q/'2M;Q/X?U'7M)TD036L&H:??P7P#[FB=H\Y7(P<')[4
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MA+1,2K;5 SR!C..GZUSK>'M<B^(5UXFMVTYHY;!;%8))'! 5]VXD+U]L?C0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% #(H8H$*0Q)&I.2$4 9]>*?110 4444 %%%% !55=-L4U%]06RMU
MO70(]R(E$C*.@+8R1[5:HH **** "BBB@"E9:1IFG3336.GVMM+,<RO#"J%S
MZL0.?QJ[110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4:011
MR/)'$B/(<NRJ 6^OK4E% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MV2-)HVCE171AAE89!'N*=10!5L-,L-*M_L^G65M9PYSY=O$L:Y]< 8JU110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%86NS^)&F6V\/6^GAPGF27&HE_+Y) 10G)/!).1@8ZYX
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M<1AW +GVSUH FHJ.6X@@!,TT<8"ESO8#"CJ>>W-*LL;Q"5)%:,C<'!R"/7-
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MD4-Q%))&<.B."5/N!TJEIFO:=J]W?VUE<)*]C/\ 9Y=K C>%5B!ZXW 'W!%
M&G13)9HH(FEFD2.-1EG=@ /J30DT4D(F25&B(W!U8%2/7- #Z*BM[F"ZB\VW
MGCFCSC=&X89^HI%O+5Y(XUN82\@)10XRP'4@=Z )J*S+77M.O-;OM(@N$>ZL
MEC,RAA\I?=A?J N2/<5=CO+::=X(KF%YH_OQJX++]1VH FHK/LGOEOM1^VW5
MF]NLBFW2)2'B3:,B0D]<Y/;BK275O)*(H[B)I"@D"*X)*GHV/3WH FHI"0H)
M)  Y)-16]W;7<9DMKB*9 <%HW# 'TR* )J*A6\MGDCC2YA9Y%+(H<$L!U('<
M4Y+B"1F5)HV9>2 P)% $E%,CECE7=&ZNOJIR*:+JW,9D$\6P'!;>, _6@"6B
MHVGB3;NE0;P2N6'( R<?A6?J_B'3-%T"XUJZNHOL4*%]ZN"'/95]23P!ZT :
ME%0FZMPBN;B(*V2&+C!QR?RQ1'=VTJ%X[B)U W$JX( ]: )J*C\^+R3-YJ>4
M 27W#: />B">&YB66"6.6-NCQL&!_$4 245#-=6]L4$\\41D.$$CA=Q]!GK5
M*7Q!IL.N6VCM<QF\N(&N%0,.$4J,GZEACUP?2@#3HJ'[9;?:OLOVF'[1C/E;
MQOQZXZU2@U[3KG7KO1HKA&O+6..29 P^7?NPOUPI./0CUH TZ*A6[MGN6MEN
M(C.HRT0<;@/4CK227EK%GS+F%,.(SN<#YCR%^O(XH GHJ,7$!N#;B:,SA=QC
MW#<!ZXZXILEW;13QP27$232?<C9P&;Z#O0!-144MU;P;O.GBCV+O;>X&U>F3
MGM5'5=?T[1X[-KNYC7[;<1V]N-PS(SD#CV .2?04 :=%(K!E#*05(R".]1+=
MVS7+6RW$1G49:(.-P'J1UH FHKE]6\03MXHB\-Z==6UM=/8R7;7$R^8%(=45
M-N1R2Q)YZ#WR-O3&U :3;MK M4OA'FX^S,3$&[E2W./K0!=HJ*WNK>[C,EM/
M%,@.-T;AAGTR*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ K(US7;?2$B@\ZW%]<Y%O'-($7CJ[$]%&>3] .2!6O67J/AG0=8N!<:GHF
MG7LX78)+FU21@OIE@3CDT 4M"ET/1=$ECAU:TEBMW,M[>-,H4S2-N9G;. 68
MYQGC('I70@@C(Y%9:^&M"CTF;2H]&L(].F;=+:I;(L3MQR5 P3\HY]A6F %
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M6MN^R:YAB;89,.X4[1U;GL/6O*M,-OJGPC\6+K(7^U(9[UKXO]]+A69HSZY
M\O;] !4]AI_VKQ[X2.MVL4FH2^&V:\$J EY5,7WQW(.>O0T >D'5]-$$$YU"
MT$-PVV&3SEVR'T4YY/TJ*\:[&LZ:(K^UAM3YHGMI$S).=OR[#GC;R3P>*\F.
MCZ8?AU\26-C;DVNHWZ6Y* ^2%"LH3^Z QS@8YKH[M8W\>_#BZ94-Q-97>^7
MW./(0\GJ>I_,T =AI'B;2M<O+^UL+N*:2RG,$FUP=S!58D>H&[&?4&C5/$NE
M:/J>G:?>7<45S?NRQ(S@8"HS%CGH/EQGU(KF?A^;2+6_&$(\E+C^W9MJ<!]G
ME1=!UQ2^,_LL?Q \#S77DK%Y]V'>7 '_ ![G )/O0!V5SJ5C9-&MU>VT#2\1
MB655+_3)YJU7GOAAK;5-;\=V.N)%)*;O:RS8P;$QCRL9_@QO/IDD]:T_A<;\
M_#;1?[1>1YO*;8TGWC%O;RR?^ ;: .E;4K!+O[(][;+<\?N3*H?GI\N<U2TW
MQ-I6K:K?Z=9W<4LUDXCE"N#EL9('KCC/OQVKA)Y;[0M4^T%;76_#5WKN=P^6
MZL+II]O'9U#\>N#CI4<%WI&F3?$Q]17$2S'?% 0LS1FV7(3N,C//XT >EV^J
M:?=F46U_:S&$9D$<RML^N#Q5/0_$NE^(K::XTZ[BFBBE>,LK@YVL5+?[I(.#
MW%<!IUS;I\1?"H:YTY8I-$EA2"W<,$C)CV1LY/SGTX&>PK(M[V'3_A7<NCJB
M1:\YU$0JK2+:B\._*X.1@C((Q@\\&@#V2SU"RU!7:RO+>Y5#M8PRJX4^AP>*
M?=7=M90F:[N(K>('!>5PBY^IKDM#M-!N/&/]MZ=KSZC?3V'E2+ \1B,08%6<
M1J/FR< GG&1V.'>*KVRA\7>&;9PBZDQN9+6:XD*P1 ( [,N1O;#8 R.I.1W
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MKD:A:F"9Q''*)EVNY. H.<$YXQZU$-?T9H;J8:M8&*T.VX<7*8A/HYS\OXT
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M$T 53H6CMIK::=*L38,<M:_9T\HGUVXQ5FSLK73K6.ULK:&VMXQA(H8PB+]
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M&G6@NMNSSQ N_;C&-V,XQ6>/%>E7'B.Z\/6]_;#48(E9@S@@.Q("XR"6&,D
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M''6PZ;8VTTDT%E;Q2R##ND2JS?4@<T66F6&FK(MA8VUJLC;G$$2H&/J<#DT
M>8^&9?#'B'1O";OKUR^I:?+$8=/1H5FBG4;9%90@<K]XMD\@9)J:QFOM#U/2
M-LEKK?AN^U9Q:2XVW5C<2&0L#CAU!,@)ZCG/2O1X=+T^WOI;Z&PM8[N7B2=(
M561_JP&320:1IMM=&Z@TZTBN#G,L<*JYSUY S0!S/Q80R?"W7PJEL6X; &>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?'&A
M7_B+18;&P-JK+=PW#-<2,HQ&X? PISG&/:NFHH K65G;V4.VWM+>VW?,Z0*
MN[OT S]<4Y+&TCNI+I+6!;B08>58P'8>YZFIZ* (([&TA#"*U@CWC:VV,#</
M0TL5I;0(Z16\4:OPRH@ ;Z^M344 06ME:6,9CM+6&WC)R5AC" GUP*9_9M@9
MI)OL5MYLA#._E+N8@Y!)QS@U:HH *@ALK6WFEF@MH8I93F1TC"LY]R.M3T4
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M76,/(V 68X4?B35J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPLD[+/#,LID25?DP""?7\\XH NZ[XDU[P]I6CW%SIUC-<WU_!9S113,!%YC
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M!Y%\IA#Y9S\IX'KW]%K0F\-:U+J'@VY"V &B*XN!]H?YRT7E?)^[_'G'I[T
M9'C#7;[Q%\-/$]_IT5K_ &6D=Q;IYN[S)E0E'D!'"@,&P,'.WJ,\=]I!"Z%8
M$G %M&23_NBN _X0CQ+8^%=>\)V$FF3:3>^>;.XGE=)8!(22C($(;DGYLCKG
M!Z5Z!IEK-!HUK:7GE-+'"L<GEYVG QQGG% ')3>.+\^$7\86EE!-HJ,SF#)$
M[VZN5,H/W0>"VPCI_%FB'6M6OOBG#:6UQ;-I+:,MY$N&!97E +'U;"\=@#]:
MKV?@K6;+P9>>"DFM'TF7S(8+UI&\Z.W=B2ICVX9P"P!W =#VP=1O#.H6/C>R
MUC2C9_88]*739(IV8.BK)O4K@$'(XY(QUYZ4 <=HWB'5?"_A/7]6M;"UFTZS
MUZ[:Y$DI61D,^T^6 ,#&<\GUX]>VU7Q1.NK7FEZ6L1N;.!)9'FAED4L^2J8C
M''"Y+'ID8!YQS\W@?7IO 'B'P^6TU;G5+Z:YCD^T.419) ^#^[SD8Q[^U:%_
MH'BFQ\4OX@\/2Z87OK>.'4+*]=_+W)D*Z.JYR 2,$#_  A_X3O6IQX66#P\+
M>?6_/1X+V5XG@DC1B01M^[E<[NI';I79:<^I2:1"^I0VT.HE/WL<+EXP_L2
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MF_:A>_:/-^T2;-OVCS\?ZO.?X?U]JTKKP]XGTWQA>:]X>DTQX]5BB6_M+YW
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M4C,TACEC&P-#+\@.TA.<9SG&*T+/PMK9\2:U?WDFFQ6VJZ=':M';[V:%D5U
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M)(P55'J2:;8WUMJ=A!?64RS6TZ"2*1>C*>A%8$MQKICUVRU6TMVM([,O;7T
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M!WB;4[NZ?3-,O[VTF-O<R- K,L@ .UB1S@$=<UTD<:0QK'&BI&@"JJC  '0
M5P+>-=5A\->,=3&G6 N=$O)8A&)&VR*D:-N)QDGGT%7+;Q1K4?B70++4;2Q6
MSUN"1X?(9C)"Z1A_F)X(()Z#@]SU(!V9 .,@<=*9<7$-I;R7%Q*D,,:[GDD8
M*JCU)-4=>O;^PTF2?3;,7=UO1%1F"JH9@"[<CA02Q'M6%H?BB76-7\0:/-)9
MW*V$,4D=W: JDJR*W&"S<@J1D$@^U &PWBG0ETVSU!M4MQ:7KK':R%L><Q.
M%'4\UKUXS%_R0OP=_P!?UC_Z4"O8YC*(7,*HTN#M#L54GW(!Q^5 #Z*\RA^(
M'B)_!FD^*GT[3OL=Q<K!<6ZN_F$-,8@4/08..#G//3I706/B'68_&D_A_5+6
MR8OIQU"V:S9L@*X0QMNZG+### ]J .MHKA;+QGJ8\0>']-U&&Q675A*)K2(G
MS;%UC,@5VW$-D#!X7UJCHGB?5-.M?&FKZS<PW5OIVIRPK%%$RL2L<015.X@
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M<9*@YX/.,#@UT6H_\(WX7%UXAO8K*Q9@!/>>4 [^@) RWTYK;5@RA@<@C(H
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MR7X/(SC Z]<]JVKOP_JMYXL\/:NPLEATV":*:/S6)?S54$K\G;;WZY[5UE%
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MWD84@8VCC//M7544 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<+*P59"K_,H7/S#/88/-:WBKPUJ6M-I.J:7?0V&N:6[/"[J9(7#@!XV'!*G
MYZ\5C^*_[2M?!SV^O:OIJ:AJUS#:*3 19QC=DH0S9P5#Y8D'D 8P* -2'7=<
M3Q\_AN5;":$:>+\7"QO&<%BFPC<PSN&<^GN*RX/'M[%X+N-:OX+>)H=6>QFE
MBB=XH(UEV&5E!W$#'/(ZT[P[+K6FZ]#;SKX9NUO 5D?3I)?/541BK,7+9C!
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M[226TC_?,1! .3SAN!Z'N -O_&UT-;GTB&6STW4#:1SV5MJ<3 W;LI)4/O4
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ME+JB(E\\0,P12HW>NT\C/7!Z=* -&BBB@ HHHH **** "BBB@ HHHH ****
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M7K[4MQ>VEHR+<W4,+2'""20+N^F>M $]%9MR]Z=8L?L][9I9-')YL,B9DE;
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MNKG5UTJR&I$8-V(%\WIC[V,].*6\T+2=1NEN;W3+.XG5=@DEA5FV]<9(Z>U
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M?6L+$_/(["./<>R[CT^O-2MJ%DMD+UKRW%H0")S*NP@]#NSBN5\3:A8P>-]
MMV,,.I"WN98+JZD(AA3"A_ER-[GC R,#)SV/'>&8CJ/@RQM=*URUM-5M->NI
M+'S%#Q2/NFPCJ#PK(7(QZ9% 'KUM=VU[#YUK<13Q9QOB<,,_45#J&H6MA"/M
M%_:6;R9$37+@*6^A(S] :P? NI3ZA8:FM[I<6GZA;7\D-XD#[HI)=JDNA]""
M#ZYSFLK2-1MS\3_%]IK,D23""W%HMP0 UKL)?;GJN\G=[]>E &MX%\0W&L^
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M/QQ6A\6X89?A;KIEC1]D&]"P!VMN&"/0T =9)?6MMM2YO+=)/+,GS.%RHZL
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MY4%VP ) QPKC?Y?/0G ^:KUGJ6C2>)O'.C>*[FW@DN'4*+J41B2R,0"A&)'
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MKQ]4@>>T=XHS&LIB!8R*%W./NKG&3Z9Z]*Y2">VN/B/XC@O+W3[LW.A1;TA
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M]2GAGOM-L[J6 YBDG@5VC/\ LDCC\*74-)TW5DC34=/M;Q(VW(MQ"L@4^HW
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MD@''RD@G)&![T ;5S;07EO);W4$<\$@VO'*@96'H0>#58:)I*@!=,L@!#Y
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M",]3@X'?!H GL=-L-,B,6GV5M:1DY*01+&"?H!4XAB$[3B-!*RA&D"C<5!)
M)] 2?S-5/[:TK[>+#^TK/[86*"W\]?,+8SC;G.<<XIEUX@T:Q$YN]6L(!;E5
MF\VX1?++9VALG@G!QGK@T 27FC:7J-Q#<7NFV=S/ <Q230*[1_[I(R/PISZ7
MI\M\M[)8VKW:XVSM"ID&/1L9K-UCQ?HNB7FF6MY?6Z2:B^(MTJ@!-I;>2> O
M&,]R16XK*ZAE(92,@@Y!% "T444 %%%% !1110 4444 %%%% !1110 4444
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M9;:[L[>>!<%8I8E91CI@$8I9K"SN8DBGM()8X^$1XPP7Z CB@#C?%ZPK\0_
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M-%%'!$L4,:1QH,*B*  /0 4 <GX4EA/PBTF1641KHL>3V&(AG]0:9\/I(?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HILDB11M)(ZHBC+,QP /
M<UC)XR\+R$A/$FCL0<';?1'GT^]0!MT4U)$EC62-U=&&593D$>H-.H ***J:
M;JECJ]I]JT^YCN8-[1[XSD;E)##\"#0!;HHHH ***"0 23@#J30 452TW5]/
MUB*:73;R&ZCAE,,CPMN4. "5R..,BKM !1110 454U+5+#1[&2]U*[AM;6/[
MTLSA5'_U_:K,<B31)+&VY'4,I'<'I0 ZBBJ3:QIR:O'I)O8?[0DC,BVP?+[1
MU..P^M %VBJEAJECJ@N#8W,<XMIWMYMASLD7[RGW%6Z "BF3316T+S3RI%$@
MW.[L%51ZDGI4&G:C9ZM817VGW"7%K+DQRQG*M@D''X@T 6J*** "BBB@ HHH
MH **** "BBB@ HHHH **I7FL:=I]W:VEW>PPW-V_EV\3/\\C>PZFKM !1110
M 444V21(8VDE=4C0%F9C@ #N30 ZBJFFZI8ZS8I?:==1W5JY8)-$<JQ4E3@]
M^0:MT %%%% !1110 4452U+6-.T>*.34;V&V6601Q^:^"[$X  [GZ4 7:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BD)"J68@ #))[53TW5M/UB"2?3
M;R&ZBCE:%I(6W*''49Z'K0!=HHHH ***J:EJ=CH]C)>ZC=PVMK&,M+,X51^=
M %NBF12I/"DL;!HW4,K#N#R#3Z "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N$\2^-=3
M\/6^H7\]M9PV]I=)%%:3-^_O(B4#2H0WRC+G *G[O)&:[NO--7\">(]0TWQ3
MIL=]IC1:M>"ZAN9A(9@ RLL38& J[< C/';F@#TNBLNW771K"&YDT\Z9]D&\
M1JXE^T;N<9.-FW\<UJ4 %%%% !1110 5Y]\*88IO"^L12QH\;ZS>*R,H((W]
M"*[^0N(V,:JSX^4,VT$^YP<?E7#^%/#_ (H\,:5>V2)H\KW-Y-=K,;B7$9D.
M<%/+^;'^\,T <[H6LQ^!/$OCG2(U>31].^SW5G;*3B)Y@/W2]< NXP.WI74Q
M>*M9M];^R7.DS7EF]I).MS;6,\(BD09\IO,&#N'1@1D\8YJ ?#:"7PUKMC=Z
MC)/JNMN)KK40FTB12#'M7/"H0,#/KS5S2['QN]G)'K6HZ4LL4#I!)8JX,TA4
MJKR;A@ 9SM4=>>V" +X6\47/B6&"\L[G3+RTEM6DD6 LCVT^5VQ/DD]"W.!]
MWIS6;9^/)D\ IKDVGV\=U+J+6*01,1$KF<Q!F/7'\1..?;-7+'PE<IXNM_$D
MEIIUC>I:R17(L96VWKMMP7R@P 03_$>1SQS@7VCWGA[X=KX<OKG21=:EJ92
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MVNGM%)I::A;W4\KX*L^T%E ![=!Z]1TK"U+Q?K>K>"_#VHVIM[&XN=;AL;Q
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MXK4\":!J'AGPQ'I>H3VTTD<TL@:W# 8>1G[_ .]6%I3ZFGQ3\:_V?!:39AL
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M -G2)[RYTV.6_6!;@LX/D'*,H8A67V*A3^-&M:M;:%HE[JMV3]GM(6F?;U(
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M=ZQJ5KI>GVHLKQM/2_NQ?1,3;!SA8R@*DMD-GD8"]\U0^%IG.F>(3<K&D_\
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MKHRK@G)!!W>E<JGCWQ*/!\?B>:TTI;2&_-M=0+YA=T^T>3E#G"D<=<YYZ=*
M/39)$AB:21U1$!9F8X  [FJFE:M8:YIT>H:;<I<VDA8)*F<,58J<9]P160=<
MOM3\2ZGHVD/:PG2XXC<37,32;I) 65%567 "@$G/\0&*X[P)X@?2?A[X=LEC
M'V[4+N]1<0O,L82:5G;8GS-C   QUSD 4 >JT5YQJGC?Q+I/AGQ'?2Z3$9=+
M>,V]U-;RP0W<;D#(1OF#*3@C./>NST=M<9KIM82P1"X-JMH7+*F.0Y;@L#W'
M!]!0!J45Q?\ ;_B6^\5>(=#T^+2H3I\4$L$TXD<-Y@<X8 C/W0.,8YZUDV_C
MW7I_#/A_Q,UGIT>G7]Q#;7%O\[2@N_EEU;.  W\)!X[T >E45RUMXAU"'Q[>
M:#JGV2*U-H+NPE1&5I4!PX8EB 5XZ#D'/'2M3P[>WNI:+!?7HA#7&9(A%&4_
M=$_(2"2=Q7!/IG':@#5JC;:+IEIJ$]_;V-O%>3X\Z=$ >3'3<>I_&N8A\87%
M]XFO='MKFP@O+2]2(Z?=1LLTMOE=TJ-N /REF "GISUJ2'Q/JDEQXQM2MGYN
MA[#!((VVR!H?-PPW>^.#[^U '8T5Y\/&NNW(\%K9V.GF3Q#9O,YD=P(G$(DX
MQ_""?<G&.,YIMOX_U+35U^P\0V5M_:NE26ZQ&SW^5<K.P6,@'+#YC@]?;- '
MH=%<9!XB\0C6YK)K!;JU:S::&]^PSVJ12K_RSD#YR".01],=ZSM)\2>-]9\'
M)XCMK31?+DT]KB*VQ*TCR@_=ZX (!QR2#CUX /1*IV.K6.I37D-G<++)93>1
M<* 1Y<F =IS[$=*Q-,\1W&M6'ARXL);5_P"T8C<7!,386(*-VWYN"'95YSU/
MI64GC;4(='\6WMS8P&31K[[.JVZLX*;8R7;NVT.6.,<+^- ';W-S#9VDUU<.
M(X(4:21ST50,D_D*;97MOJ-A;WUI*);:XC66*0 @,K#(//L:Y>'Q)>W'AW5]
M7L;O2=4M8+3S[2>WW(KL%8NCC<Q!&%]/O5'9^+[J]M/"=I!';)J>MV(O'9D)
MB@01JS$+D$Y+!0,CN<\<@'9T5P-YXWU73H/%5E/;6;ZMH=K]MC<;EAN8"I8-
MMR2I&"",]>]36GBG7H]=\,PZC!I_V'787V+ '\R&18O,R23@@C/ ''J>I .X
MHHKB-5N]9_X6OI%A;W\$=DVGSSB%[<MR&0$DAQDX/![<\'- ';T5Q)\5ZOJ.
MA:OKVBQ63V>GS3)';S(Q>Z6$X<APP"$D-M^5N@SUXZ?1=6M]=T.QU:UW""\@
M29 W4!AG!]QTH OT5Y\?'.KW>GVFL:1ISWUE-<!39I83F4P;BOF+-]PG W;<
M8YQGC-/G\3^*)]3\5V-C;Z3&=$$;QO-YCB0-$9-I (Y/3/&/0YX .^HK@Y?B
M"@L?#%S/+;:5#K5F9_M5W&TD,<F$(BR&4 G<QR2.$]^+LGB+6+/7/"MA=QV+
M#5_/2X,08[&CC+AD;<05.!U'2@#KZ*X&^\::O:6'C61+>QEF\/E3$2'59%,0
MD^89//.."*G/BC7K"UM)]3@T\?VK)!%IZ6J2RO&6C9Y#*HY; 7("]>F1UH [
M>BN9\.:UK%]K&I6&I6#BW@"/:WZVDMNDZGJI23)#*?<@^U9WB&[UE?B7X:L+
M2_@BLYX+J7RGMRWS(JC+$.,\.<=,<]>P!U&G:UINKR7<>GWD=RUI+Y,_E\A'
MQG&>AX/:K]>4V^H:WI5Y\1-1T=+ _8KXW,@NP[>8$MT8HH4C!(!^8D_3TZN?
MQ'J-Q#I5S:K:6-A>V(N6O+O]X%D8*4A5 RDL0Q.1_=QCF@#JZ*\LO_%>M:]X
M/\&:M:36]@VI:Q!;W,7E,X)$K#@[@0N8\E>I!QD<Y]-Q<K9X!BDN@G7!1&;'
M7') SVR: )J*\P@\?>)7\%:1XJ>STO[+<72P7%JOF>80TQB#(V<+@XX(.>3D
M=*Z&Q\0:W#XVG\/ZI!8R[]..H6S6@92-L@0QL6/S'YAAOE^@H ZZBN#LO&6J
MKXA\/Z;J*6'FZJ)EN+6 $R6,B1F0*SABK' P1A3W]JHZ)XDU32[3QKK&KW<-
MW#I^J2PK#' R,S!(E15.XA5Y Q@G))S0!Z537=8XVD<[54$DGL!7(VOB#Q ?
M$EK8/8?:K*Z@D/VI+">V6UE49"N9,[E;H",'/;FJ7ACQ)XM\0:-'K!M=&CM
M+I)(]T@<O'(RH5/(V_+@@\\9XS@ '9:9J5GK&FP:CI\XGM+A=\4B@@,/7GFF
MZKJUAH>G2W^IW4=K:Q#+R2'@?XGV%<MIGBK5M1\&^'M72WL;<7XWWES(<06:
M;6.=I8$Y("CGOFL36_$<_B/X2>-&NDA\VPDN+(R0JRI*$"D.%8DKD,.,GZT
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M I&Y3WP<&K5 'G2> ]8C^&]AX6%S8F:UNDG-QN?:P6;S0-NW@YXZ^_M6O?\
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M.\0>;:K':V<ELT'S$MO*DL&[8*CC% &7IGBG7[SPWJ3FWL'U/3M6?3IY\^7
MJ*R[IRK-G 1L[=W4=:K?\);JM[9>-+2WN[;S]'M4GM;Z.V8!U>)G^X6P2"I
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M(!;M97VGR3$F-O,1HPG?=@@[O3M6;%X\O8-)UB2[AM9;VWUTZ-9+&K1I*[%
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M2U\C*I\W>)53!.<8Y/:I_",VMRZ5-_;EQ;W,ZW#+%<V\1C2:/ (8*?<L >X
M/?-12>'[U_B OB)9X!;KIS6'DX._EP^_/3J,8_6@#,\(^,+CQ/-;E+RQ$B[Q
MJ.FM$T=S9L <#YFRP!X)V\]1CH-'QWKVH^'/#ZZCIT=M(XN8876<,1M>14XP
M1S\U4[7PA>3Z[HFL:J]D=0TN-E>\M599+S*%,/GH.<XRW/3%:'C30+KQ+H0T
MVUGA@8W$4S22J6_U;JX  ]2N* ,IM:\4Q^-7\.-)I)-S8->V]P(),6^UPC*R
M[_WGWA@Y3OTZ4S3/%6NWWA:[G^SV)U*QU633KN<ML@C2.3:\^&8' 7G;NSFM
M230=0D\=VWB+S;41PZ>UD8/FR=S*Y;=CL5QC'2L%_ .L?V5<P1ZG9I<-KYUN
M/,3-$Q+%C%(N<E0<'([@<#% #XOB&UA;>+IM0\JZAT(0O#-!&T7V@2IE%PQ.
M/FXW#@@@U#KZ:ROC7P&VI3V<@>\F+)!"R&-_(?@$L=R]>P/'O@6+KX>7>K3>
M)UU75('M]>@@6006Y1HI8EPI7+'Y0<'!R3CJ.\I\+>*;Z\\.W.IZOIC2:-.T
MGF1VSDS@H4RP+#!(/;@'GGI0!#=>,];N],FU70++[8D5V\4=A]AF+7$:2F-B
M)A\BM\K,."!C!YKM=0;?H]TVTC-NYP1R/E-<?8>#_$6B:A>VND:];0Z!>7#W
M!AEMRT]L7.76)L@8))P6!QGH>_8WT$LVFSV]N4$CQ&-#(3@9&,GN: //OAGK
M-SJ7A+0=-T:XLPEA9QC49)HRY5F7*(@#+SCDD\?4Y MS^)/%5QJ7BVSLCI,/
M]B"-XGEAD?S T7F;2 PY/3=GC'0YX9H_P_U/0&T&ZTV_M(KVPM_L=ZVQME]
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M?(^">.1D=* .Y=UCC9VSM4$G SQ]*HZ-K5AX@TU=0TR8S6K.Z!RC+DJQ4\,
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M%MV[CE1QCI6(_P .;B?1-3LIM8$=U<:NVL6=W;P%6M9R<C@L=P'([<$UW]%
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M&-W0CBHKCP?K=EXGOM5\.:_%8V^I,KWMK<6OG*)  OF1_,,,0!D'CZ]!VM%
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M&1UZ?C7>56N=.L;R19+JRMYW3A6EB5B/H2* .<N_!,.MOK,^MRK+/J=FMCB
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "HIK:"XQY\$<NWIO0-C\ZEHH 155%"JH50,  8
M %+110 UXTE0I(BNAZJPR#388(;=2L,4<:DY(10!G\*DHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3M)M32!))[=)5,BY R2H.1U].] &M16=KTQ@T.[==5ATE_+(2^F"E86[,0Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\0QZEH\Q.G):K:6]W'</\K,S2/MZ?>"CVZXZ5Q5A'90_!#PQ<QK DHUB!_-
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MDM5M4L[=;=>5B$0"#Z#&*!I]D&1A9VX*?=/E+\O?CCB@#F_B@L1^&7B'S0A
MLW*[NS8XQ[UA7T=E<?$'X?\ F)!(6T^Z;Y@#G$<14^_?%>C300W";)XDE3.=
MKJ&&?QJ(:?9!D86=N&3[I\I<K]..* /&]7\L?#SXH0P;=B:T[;$Z*/W))P/<
M']:Z/7_$=C:_$#2+^YUHVFB76G2P6VH0F-H1/Y@+*796494#GC[N,]:]"2PL
MXE=8[2!!(-KA8P-P]#ZT36-I<6HM9K6"2W  $3Q@H,=.#Q0!Y-K>G>';;1-
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MC- 'K6C3R7.A:?<3/NEDMHW=CQDE02:JQ^*_#TUU%:Q:U823RS-;QHEPI+R
M E1@\D C\Q4GAN2.7POI4D;JZ&SBPRG(/R"N&\(0V]]%X]^P"VDU$:U=-;N-
MI96\I0C ]OF+8/U]Z .[3Q#H\FHKIZZE:F[;<%B\P98K]X#U([@=.]5)O&GA
MBWV>;X@TQ!)*85)N4P7&,C.>V1GTS7 >%K[POX@T;PU875[>R:UIDL.W2RVR
M6WN(QM8E0 =@^8G/&.O/%1:?'H<OA/XCV]ZMJTK:M?J4(!D)/^K"CJ3N^[CO
MTYH ]6O=3L=.5&O+J*'S,[ S<OCDX'4X'/%02>(=%BTV'49-5LELIB!%.9UV
M2$G&%.>3GL*\]\-->^'_ !IHD'B.3RO-\-06MO+,V%$Z$&6/)_C/!]PH]*PM
M?@BM_ WC2<O&NDWFOPR608C:X\Z+S63U4L&Z<<$T >CZA\0_#=G+:0QZI:W$
MEQ>?9#Y4H(C8<L6(X&!^9Q5Z/4;5_$LS+XBMWACL0[Z<#'^[^;/GLWW@""!@
M\=ZYOQVVGZ;=^$+X&VM;,:XDDLXVI&,PR ,S=/09/M3H;RS?XVRNL\0#>&T/
M+ '_ %['D'V.: .DC\7^')9K.&/7-/>2\8K;*MPI\TABOR\\_,"/<CBKE]K.
MFZ8VV]O88&V&0AVY5!U<^BCN3Q7C$$NGQ? 6PD22V20:PK[@5!W"^//UV?I[
M5T^LZWIV@_$76))=4TU?[1TJ!6CU&X\E5(,@78V"&4@DL!TXZYX /1;+4++4
MH3-87EO=1!MI>"4.H/ID'KR*R=/\7Z5J7B?4-"M[B,W-D(PV6QO=@Q95'?:%
M!)'K[4SP)8V6F>"=*L;#4H-2@@A"?:X&#)(PZX()[\?A7*?:)$\;_$2PM+A8
MM7O+*V.GQEL/(XMG 9?4!L9/:@#NX_$&D2WRV2:E;-<NS*D8D&79?O*OJ1W
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M'A#1I[2.#+Z? K21 9;"#@D=>2?Q)K":2S_X7K\[P>:GAWC)&5/GG\C@_D:
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M%?0/82@&.=6RKY. !ZG/&.N>.M+INL:?K"3-8723>2_ERJ,AHV_NLIY4^Q%
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MROF@D2-T7CO_ "[UFVGC;2-?T/69HM4&F16[S6XNY<(8]OR^9AQ@?,3@'T%
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M4 %%%% !1110 4444 %<)\7I;9/ ;I<O$%>\M?E<CY@)T+<'KQDGVKNZ,9H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M()&0H/8$G'3OBO.-'G\/S:3=>#_%5KJ4VMQW4N;#SKD+>$RF1)$VMMP20=W
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M?3.'>3P>)?AIX>T732$UV":RC%KC$UG)$RB1F7J@55;DXZCU% 'I"^(=+?\
MM +=9;3L?:T\MMT.1D97&>G/TYJ"3Q?X>A2P:35[5%U",RVI+8\Q I;</08!
MY-<5)J5KI/C7Q]:WKM'<:A;6\MG'L8M.HMRC%,#G!!!].]96E7-LUC\)ED8*
M8%;S!*NW81;E03GMNP ?7I0!W]SXZT*/PSJ.NV]RUW;6&Y9DBB;>K@9VE2,K
MVY( QSTJ*?7M/U&S\/S2ZU+IDUS=1-'"BE3<L1S$0RY*$GJ/3K7&Z@5NS\6H
M+7$LDULAB2/DR8M=K;0.O(P<=ZM:]JUC>^'_ (?S03JT::Q9L6(*X58F#-SV
M!(!/0'B@#M+SQKX;L)KV&XU: 2V6W[0BY=H]V2.%!)X4DXZ8YQ5Y]<TQ-.MK
M_P"V1M;7>T6[IEO.+#*A ,EB1S@5QNF75DGQ-\;R2S0*IL[-0[,,':DF\9]L
MKG\*Y2PO+33?AQ\/=4GNO(FT^Y*_O$=HAE) ZR%02AV]#@\D<8R0 >LZ=XBT
MC5KN:TL;^&6ZASYMODK+'@X.Y#AEY(ZCO6I7#> [[1=2U?Q!J.GZS:7E[J$\
M<\UO;L<0(J!%X8 G.,EL#DUW- !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M9^KZ[IF@P1SZI>1VT<LBQ(7R=S$X P/K0!H45@:;XU\.ZO=W=I9:G')/:)YD
MJ,C(0G]Y=P&Y?=<CD>M5$\>^%M2@:.WUL 2VTLPECC==J*=K,&*X!![=>AQ@
MB@#JJ*YBR\3Z!I.A:(L^NO/%>1*+6ZN\F2X&W.YC@8) SD@5H:7XGT?68KR2
MRO05LFVW(FC:%H>,Y8. 0,<YZ4 :]%8]KXJT:[OELH[MEN'A-Q&LT+Q>9&.K
M(74!A[C/K67IGB7P]IF@/?OXBFN[*2]DC6YNB682%\>6OR@[5)P./QH ZRBL
M+2_%^@Z]J-SI>FZFLE["F]HPC*=O3>NX8=?<9'2L;P)K$H\-:I=:OJ,DPMM5
MNH//N&R=JR[5''X  #J>!0!VU%8UOXJT:X:^07AADL(_-N8[F)X7C3&0Q5P#
MMXZ@8J:#Q!IT[W*"2:-[:$3S+-;21%8SG#891D?*W3TH TZ*J:7J=GK.F6^I
M:?-YUI<H)(I-I7<I[X(!'XU;H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ Z4444 %%%% !7.>(/#UYK&N:%J$%Y!"FE7#3^7)$7,I9"A&0PQP
M3V-='10 =*,444 ,E\PQ-Y)428^4N,C/OBL+P7X>G\*^%[71I[J*Z-L7VS)$
M8]P9RW()/][UKH** "CK110 4444 '2BBB@ HHHH **** "CK110 4444 &*
M*** "BBB@ HHHH **** "BBB@ KG]>T/4[[4['4])U=;*YM$D3RI[?SX9 ^,
MDJ&4AOE&&!Z$CN:Z"B@#(TS2KN*[^WZK=P75^(C"K6]OY,:(2"0%+,3DJN26
M/08 YSKT44 %%%% !1110 52U:WOKK2KB#3+Y;&]=<17+0B41G/7:>#Z5=HH
M S=$TN32[1Q<W;7E[/)YMS<E GF/@+PHX4 *H ]!W/-:5%% !1110 4444 <
MY-X=NY/'L'B,7< ABL6LOLQA)8JSARV[=URHXQ71T44 %%%% !1110 4444
M%%%% !1110 4444 %8&OZ'J=_J-AJ.E:NME<V:R*(Y[?SX9 ^,[EW*0PQP0>
MA([FM^B@#(TW2KN*[&H:K=P75^(C"C6]OY,:(2"P +,Q)*KDECT& .<Z]%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI:+.MD]S87@_TY&A2-;8,N5>-MV6 /!!R2.>*V_%.N/H6FV[P1^9<W=W%9P
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M!B<#'//M745@WOB_2[&[$,GVAXQ=+9R7$4)>.*9L;48CH?F7G& 2 2* ,?\
MX06].@>*-*;5X"->N9KAI!9G]SYBA6 'F<X"C'2K4GA&]_M;0=2@U:.*YTVT
M>SF/V7<)HVV\J"WR-\HY.X>U=66 (!(!)P,]ZS-+\06&L:AJ5E:&8S:=(L=P
M)(FCPS#<,;@">._2@#.T#PO-I,FNB\O(;R#5[M[IXEMS'L+J%*YWG(PH].]9
MMMX"GC\-+X5N-42?0$D&U&@(G,(?>(2^[!&1C=MSMXXZUV]% '-R^&;E_&TO
MB%-0C1'TW^SQ;BW.57>7#;]_7)].E06WA*XDUS1]7U6\MKF]TJ)XTN(+8Q23
M[EVYD.X\8R<#N<\=*ZB:58(7E<.509(1"[?@ "3]!6):>+M,OM"T_6;5;N:S
MOYU@A,=NS-DN4W,HY5<@\GI0 SQ5X=N=?73);+4%LKO3KQ;N)I(?-C<@%<,F
MY<\,><@BL6;X?W\\'BF)M?1E\0(HDW60_=-Y81B,,,\#@=NY;K7=T4 <I-X3
MO9M5\,7S:G #H:2+L%J?W^^/RS_'\O'UYK'?X<:C#H&L>&[#7H8="U R-%#+
M9EY;;><LJOO *YR>1GGKWKK[WQ!86&N:;H\YF%YJ)<6X$3%#L4LV6Q@<#IG/
M(K4H KV%O)::?;V\TPFDBC"-($V[L#&<9.*L444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN(!)X"\\^U4;3P'>:;J5\NF^([BUT2^G:XGTX6ZLRLWWQ'*3E%;T R.Q!YH
M9?ZYK^KW&OPZ EPDNER_9H/+6!DEF$:N1)YC A<N%^7'0G)Z":RU[5]9U^WT
M&4?V3=P:;'>:CY6R1UE<[1&A.Y<##$G!_A''-+>>"=0B\376L>'_ !%+I OP
MGVVW^RI.DC*-H=0Q^1L<9P?I4EWX*FBU^SUS1-6:QOH;46=Q]HA^T)=1 Y&\
M;E._/.X&@#BM+U75?#W@[7[ZWNT-Y'XLEAF;RALEWSHC'!Z=21@\5W$NK:FO
MQ*.AQ7*?9)='>\021!O+E$JH.F"5P>F?QJA_PKEG\-:WI$VMRN^I:@VHI/\
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M2/9^8R%W(VD%N>%Z\8].]97@'1Y?$OPV.G2:I"=+N+RY$\,<69=GVAR4W[L
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M:Z@6)XC@X,1P"R ]\MD$'([[OBW7Y=$ATNWM=@N]4OXK&)W&5CW9+.1WPJG
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M//;O;^8T4KC#M$VX!<]<$, ?RH PY_B();'0=3O);G1]'U.R\TWT< E2.Y)
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MPQYX'.??CN+-EJ^M>)=-U^^TW4S9R:==S6EI$(49)6A R9-P+?,V>%*X&.]
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MW<9X 49.:Z,NBLJLRAF^Z">3]*J6FH_:[^^M?L=W#]D=4\V:+;'-N7=F,_Q
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M((Y/+V$HJA1D9//'7CZ50_X1B2'Q;>Z_9ZG) UY!'%/;F)61VCW;&SU &XY
M(SZUT-% '#I\/'C\&6/AI=7/D6=TMRDQMAO8K)YH!^;'WC^7YU/?>"+L^))]
M;T;Q%=:1/>JBW\<,"2QSE1@,%?(1L<9Y_GGL:* (;2UCL[2*VB+%(U"@NVYF
M]R>Y/4GO7'Z5\/YM&N9+:S\17J>'GE:4:3Y:$+DY*"0C<$)_A&.._)SVU% '
M*Q^$)X[CQ+,-34MKH D!M_\ 583RQM^;GY?7OS[53/P_>&#0);'69+75-$MQ
M:0W:P!A+!@#9(A//0<@CGFNVHH YWP[X7DT+5-7OY-5FO)-3E6:1'B1%5@H7
M(P,]O7IZGFG:KX8^U^(K3Q#I]Y]BU2WA:V9VB\R.:$G.QUR"<'D$$8/K7044
M <V?":C0]9L4O"+K6#(UY=M$"6+KL.U<\ * %&3C'.3DG3T+39-&T.STQ[@7
M"VD*0))Y>PE54*,C)YXZ\?2M&B@#G5\,2V_BR_UZSU.2%KZ&*.>W:)71FC#!
M&SP< ,<@$9]>U9,?P\>+P=IGAM-7/D:?=)<QS&V&]BLGF*#\V,;B?PQ]:[BB
M@#CKSP/=_P#"27&M:+XCNM(EOE07\4,"2).5& RA\[&QQGG_ !ZF"&'3K%(@
M^V&!,;Y&R< =6)ZGN2:L44 >4^ =*/B3P'>:<VK1-IEQ?W(N((HP9-AF8[ X
M;A6'^R3AC@],=/JO@B:;Q"-<T'7+C1+QX5M[D10I+'/&OW<HW 8#@'TKKZ*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1X_. $;,PC[N5 )"CN2,"@#3HK%N?%WAZT%J9]9LE%W$TT'[T'S(PI8L,=L
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MHH \VU33K[3/&UWH]E"YTOQ6OF2LG MI4P)S[;XNA_O8KT5XR+9HX,1D(53
MX7CBL30]$U2UO'OM<U=-3NU5HH&CMA"L4;,"1@$Y8[5R?]D>Y._0!Y5X)UW1
M9_#&E^%M7LC+XATV<*^G30LSB=7)$V<8QSN+^Y_%L5U8--\56,]N3(N 2P^8
M?9@OXC=D?7BO5L#.<#/K2T >3:3KUC!_PA-K+)'922>'T"ZGL\R1F C#6\>0
M0'R,G()XP!DU@Z?>67_"M_!MI-(H>W\4KYR3+MV@7,I.<CL""?3(SC->[T4
M><&2RNOB?XIMFN0$GT**-S <N2#)NV@=6 (XZ]*Y[PUKF@ZK;^"["Z\1:7 ^
MC,K1*'9)IF$9C1&5E 0X(W ,V2,#UKUK6=/;5M%O=/2ZFM&N86B$\/WX\C&1
M6%!X?UVZM1I^MZGI=QIX4(PMM.,4DJCL29&5<]]J_0CK0!QD=_H%MJ?B;PWX
MQ:^CN+O4)IH80\^R]@D(V; APQ PN!SP/3CU2PCCL]*MHA&;>*&!5\N1]QC
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MGKCB!M88ZE\--9U2S&F(8;N.2-4;9&[1 (H'7YL?*.O..:]5*AA@@'ZTM '
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M('KAN#COQ6?HFLP6FF> [6X3[*&TIH_[26W\V6.0*@-NG!VL<<Y!/RX R<T
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M1BLYU'3M7MUO+=8'+0%;DD[N/3D#J>W0T >JWWCGPSIMW<VMWJ\$<]LT:3(
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M=0L$N$DC8;?+<>8"".0HZ]A79>*=7M[/Q=H$4J"VBGAG*:JEOYKJ3M_=1G!
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M\_VJ(SP+;Q/,7C&/G 0$[?F7GW'K5JPOK?4K""]M',EO.@>-BI7(/3@\C\:
M+%%<Q/\ $'PS;PWDKZ@[)92F&Y,5M*_E, "2VU3A1D?-T]ZM0^,=!N-7MM,B
MOM]Q= FW81/Y4V!DA),;&('4 YH W:*PYO%^AV]RT,EXPV70LWE$+F))CC$9
MD V@Y(')X)QUJO#XNMYO&]SX<6VN@UO;I(TIMI-I9F(&"!@+@'YCP3T/% '2
M45B-XMT5;ZVM7NF5KJ4P02M"XAED&?D63&PG@X&><'%5CX]\-?;_ +$-2W7
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MLGK@]L$\Y+K*>$_B/X@.N6UT=.UF.W>RN(K9YT)2/8T)" G.<D#'<^M>CT4
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MLG$FHYB?EWVY 0G;MR,<YSG ]3HH \I2Y61/A<^R95MU_?>9"R^7_HQ3+9'
MW< G@]J[3QX?^* \01@%GET^>.-5&2[-&P  [DDUT5% 'FFOK<GX<^%=0L;6
MYNH=,EM;B[MK4LDIB6(HX4##;E+9QQTJIK4V@:MX*\5ZQHEE>,SZ/+%-?W8F
M#-QD1CS>6QR21P.!SDX]6K)\3:/)XA\-W^D1W2VPO(6A>4Q>9M5A@X&1S^-
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M Z\# KG-#;3!I<W@_P 2Z1JUUK$5Q(JVI-P8+S,A=) 0?+5>023C!!->QT4
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M'B&]M-0L-&U6?5K&*5F6^-P#9DH0R;I"5+,<+@9]>U>B44 >*VNHB[;P+?\
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M!BR\C:3T]QG?LK[0]9M[W5-.T/48YXK"6*2ZO;>59(]PXA7=DL2>2%R!CW%
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M[[V>_3VH SOBWG_A6NI;<9\ZUQG_ *^(JDM-3UNQ^(O]B7M_%>VUWICWD2B
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M'J"1+$89(R3&40<  D^I.X\], &:UK=VOQFT@7&H2WB-H]R4,L:*RGS(\_<
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MMM*X)W#C#&J?B'P=<:GKUMKVCZW-H^K10_9GE6%9DFASNVNC$ X.2#[_ $H
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MW&3<S3(%\TD;2-HX5< # _4Y)R]/\$V6G^!)_"JW,[P3P20/<$_O"&!4'/\
MLKA1[*!0!BZ1XEU/_A*_#^GRZB;^#4[&9[A_(58EFC"$F!PJ[T^8C/S#&.>M
M8J:K?:'X,^(FK:=/Y-U::]<R(2BL#Q$,$$=.:Z>T\#7T.H^'[ZY\1S3S:/%)
M H6T1%DC957&.<'Y1D\Y[8IZ> E?0O$NDW>HF:'7;B6YD9(=C0NX ^7YCD#:
M, _G0!-?ZQJ%KX]\.:<DX-GJ-M<O-$47AHU0J0<9'WCFL&^\4ZUIUYILDFH1
MS2SZZEA<6MO$'MHH7<JH\S:#YH&TD;CSG( K9@\&Z@VN:)J^H>(I+FYTN.6/
M"6J1K*KA1TR<?=YZYSQC%9Z?#2XCTBUTM/$EP+6QU%;^R4VJ$QL)#)AR>7Y8
M\\=>0: '>'X]0E^)WC)3JT[K EFL<<B(R -'(P7  .%+$\$$]R:IZ9XWU5_!
M6BSW,T4FJZMK#Z:L_E )&/.D7=M'7")P/7&<\UT]MX7FLO%>H:Y;:K(!?PQ+
M/;O"K!GC4JK;N#C!R0,9(ZCI67#\.HE\(1:%-J4C26UZ;^SO(X@DD$WF&0-@
MD@X+$8]#CWH D?5]6TGQS;>'9[W[7;ZI9RS6=S-"OF0RQXW*P0*&7!!' .>.
M:YFP\5^*6\%>'/%%SJD#BYOX[:YM%M5"R(\YC)W=0PXQC XYSUKNH/#]RVK)
MK&H7L-SJ4-LUM;,EL8XH@Q!9MA<DL2%S\W08&.<XL?P\EB\%Z;X:76!Y5C=)
M<I.;7YF*R>8 1OQ]X_E^= '3^(-7CT#P[J.KRH9$L[=YB@."VT9 _'I7(ZGX
M@UO0-#T+Q'<7JW=O=RVZ7]IY2JD:S8&Z(@;OE)'#%LCTKM[VQ@U/3+BPOD66
M"YB:&9<8#*PP?IUKFK/P5,FFZ;I.H:K]NTO398Y+>)K?;(_E_P"K61]Q#!>.
MBKG:,]\@&9!:W1^-M\?[2G"C1H9-NR/!3SY/W?W>GOU]ZVOB%JNHZ'X%U35-
M*GCAN[6+S%:2+>.H' )QGGOGZ5-%X<N(_&\_B3^T$/G6BV9MOL_ C5RP.[=]
M[)/.,>U6/%>@GQ/X:O-%^U?94NUV/*(]Y"YR<#(YXH PM6U37CXZT?1K/4(+
M>TOM/FF8FV#LC)LYR3R?FXZ =\]*Y77]9UJ_^%GB1;K4W^UZ7JYTY[B&-8S<
MQB:-?F&,#*R<[<=/3(/>2>&;J7Q/I>MOJ4?F6%J]MY0MB!('QN.=_!^48_K6
M;)\/C<>'?$.D3ZJ2NL7QOS+';[3#*61N 6.5!1>#SUYH FO]6U)?$2>&[6:^
MEEBL?MDUU EOYS;I&1!B3" #:V<*3]WISG%O-<\;V&E^'8[_ .RV=_=ZRNGS
M%HE?SHB&*R?*Q"G"\J.^>16SJ_@J^O[W3]7LO$4]CKUI$T#WJVZ.D\;'<4:(
MX& >G/'N>:DO_!MS?P:0'UIWN+"_74)+B6W#-/,H*C(!4*N#C '0#GU ,N>Z
M\6Z?XKT'0)=?MK@7UO=R27/V!48;"I4[=V,@.!V&1DYZ4FF^(=?E\,Z\DVHV
M7VW2M7:P;4+E5B4P@QDN5 V[PKD 8P2!P>AZ._\ #LU[XMTK7A?)&=/BEB6#
MR,AQ)C<2V[C[HQQ^=8D_P[EGLM1B&MF.>ZU==8BE2V'[F==N!M+$,ORC@_G0
M NB:]>WVL^*](N)Y[BULK:&6VEN8!#+B1'W!@%7C*<?*#SWJY\,/^28^'?\
MKR2BU\'7EMK>JZL==DEGU*UC@F5[9 NY P#  @X 8X7/U)K5\+Z&WAOPW9:,
M;K[2EI'Y:2^7L)4=,C)YH PUU+7/$J^(6T._CLI=,NWLK6-XU9)9452QE)4G
M:2V!MP0!GG/$T>L:CJWBR?P\MT+!["PBN+N6V579II,X5-ZD;  3R,G(Z8.8
MY?!%Y;^)+[5-$\17.EP:DP>^M4MTE#N!C>A;[C$=3@U<G\(^1X@MM;T:\%E=
MQV@LI5EB,T<\(Y4,-RG<#T;/US0!R-WXV\1)X9O-LUM'JFEZY'I=Q+Y&5N$:
M1 ' S\F589'/MBMZTOM<B\=WWAR\U83Q3Z5]N@GCMDC:W?S/+*J.01R"-V3]
M:EO_  $EUH3Z=%J!BEGU$:E=7+0[C-,'#],@*ORJ,<\ #WK17PY/_P )JOB1
M[]"PL/L)MQ!@%=^\MG=P=WZ?G0!Y[I.L:_I'P6TK6;/5/-NI[B,.+F)7_P!9
M<E6PV,\ELDG=[8KJY=1UO3_$>F^&KK6$N+G4Y+BY^UQVBQF"WC5<1JI+ L6/
MWCGC/!/-0K\.)T\&IX937G-I#<)+ SVJEHU23S%7@C)W=2>H X%;NN^&#K%U
MI6I17GV35],=G@N5BW(0PPZ,A/*L.VX$=C0!@G6]0%WXN\,:E*+EK33C=6MU
ML"M)$Z,-KA0!N5@1D 9'85M?#[_DG/AO_L&6_P#Z+%*/"S,FLW$UXCZGJL M
MY;D082.,*5543=D ;F/+')/I@5H>'=);0?#UAI+7 N%LX5@27R]A95&!D9/.
M!0!SEIJ^K^)XO$5QI.H?8CIE[+8VL7E(ZRR1 ;C+N!."Q(PI7 '<UF+XVU*\
MT7PAXI2;[-I&H3K;ZE (U/E,Q**P8C(7S!@^Q'2N@C\(W&GZGJUQHVJBSM]6
M<S7,#V_F;)B,-)&=PVL1C.0PR,X[5:NO"&F3^")/"D:&*P-K]F3N4P.']V!P
MWUH SM8\1WFDZ9K>LI(9K>*XCL[.%E7;YA=8V8G@D"1B,$C[AYYX;;R^,(]>
M:+9.^DRVK$W%\EOOMYQTPL3#<A'8\@]ZU;WPII^H^#F\,W1E>T> 1-)N_>%A
M@B3/][<-V3WJGHWAG6K"+&I^*)M5>*,I:F:U5%CR,;G"G,C8XR2.I[G- %'X
M>7OB/7M$TS7]4U:"2WNK1MUG':A<2;^'WYST!&,8Y'ID]O6)X2T!O"WAJTT7
M[7]JCM%*1RF/82N2>1D\\^U;= !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17
M-S#9VLUU<R+%!"C222,<!5 R2?8"I:Y/XFQ22?#?7S'<RP[+*5F\L+\XV'Y3
MN!X/M@^] $@\<6QU.TL?[&UK?>"-X)%M-\;1N<>865CM49&=V",CBNHKS_5+
M[5M!T/P?]DU65TO-3L[6?SH8R6BD'*@A0 ..N,\GFG_:?$6J>-_$NBP:\;.V
MM;:VEMVBM8V>,N'XRP((^49R#TXQ0!WM%>>:1XFU76?"'A/4Y]0BM/MRM]M,
M,>ZXF8*P40IM8$EAEN. #TK+N/%WB,?#S4]0COO+OM/ULZ>)98$+R1^>B#>!
M\H;#\D#M0!ZO17!G6]6T#QO>6.HZDVHV!T674PA@2,Q/&X!5-HSM(/\ $2>.
MM6M'?Q)JVF>'M>M]6A\N\6.XOK.6-1$(9%W;8R%W;UR "6P><^E '2V>I"\O
M;ZU%I=PFTD5#)-%M27*ALQG^(#."?6KC,$0L02 ,\#)_*N#M=<UUY?'4']HV
M?G:9(BV4MVHBAA#0A\N0,X!/4YZ4_0=>U!_'XT9[VZO-/FTC[8DEU;K&WF+(
M$)3"J=A#=QVXXH Z7P_X@L_$FGR7MDDZQ1SR6Y$R;&W(VUN/K6K7%?##_D7]
M3_[#-]_Z.:H-7NO$=Y\19?#VG:X-/M9-&-VCBT21HI/-"9&[K^/8GO@@ [RB
MO/9M7\2:W%KD>BRWBW6FW#6=NT26WE22HBDF42'=AF8CY<87&,FD;4/%FH>-
MH-";4XM+\[0EO9EBMTE,$WF!&"%L@\\9.1@GC." #T.BO+-/\;ZY%9+HFH3Q
MR:R/$']BF_6( ,F-_F[?NAMO '3)!P>E;S:IJ^E^.XO#DNH/=6VI6,D]I<2Q
M)YEO+&0&!VA0RD$$9&<T =K5"^U6.R2R=;:ZNDNYT@5K6/S F[.'8CH@QRWN
M*\OBN_%&M_!^Z\2WGB:5/,T>Y=K:WMHTRZEL-OQD<*00,<'C!&3N7E]JVA>'
M_!/V75)'CO;^SM;@2Q1DM$Z9*@A1@#;CIGD\T >AT5P'VKQ'JGC+Q5H\&O&S
MM[*"VEMFBM8V>,NKG&6!!&5&<@GCC%5[/QGJM[X3\$WDTBVW]LS+#?7J(,1G
M:V, @JI=E Y'&3CG% 'H]%<?X3U#6+SQ'XBMKN_-WINGW"P6TIA0>82BNP+*
M "4)VG _6NPH :KHS,JL"5.& /0XSS^!IU>3Z9K-UX7TGX@Z_/?W=\;#5)D2
M&?9MD;RX@A8A01C(& 0,#I6]K&JZSX8F\.7TVI/J%KJ%Y#8WD#Q1J%:4?+)&
M54$ ,.A+9!]>: .Z) &2< 5CWWB2QT_6-)TR59WFU1F6W>./,?RJ6.6Z=!VR
M:S?B49U^'&O26]U-;21V<CAX2 2 /NY(/![XP?<5SFLVUU'J7PZACOY'G:>7
M;//&A* VS=E"@X'3/XYH ]-HKS4>+M6T"T\7VU[=G4IM)N[:&UN)8D1B+@)M
MWA=JG:7]LXZBM[3/^$IB\4QB874VB2VY$IOC;B2&8="GE=5(X(/0T =917(>
M/-4U?2UT Z5>);F\U>WLY0\(<,CDYZ].G;!]Q5,WVN6NNQ^&)=3OK^X6T>^D
MO+6"WBE*M*41<.=F%P<D#)^7ISD [ND9MJEL$X&< 9)KSV?7?%>D:!I,>MA+
M>XN-86RGOE$9*V[9*R,!E%9N%/8$^XJYHU]KMWXF\46']JF6PT\1K:SM;H3O
M=-S*64 $IQQCHPS0!U>E:@-5TNWOEM;JU$R[O)NXO+E3GHR]C5IW2,9=@H)
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M;DK&7 81C!W2$<*"#DF@#;HKS,^)]<2P\?117LP?1+9+JRFN[9!* T#2;64
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M5#;=DF =H XZ9Q0!WU%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !65XDT8^(O#]YI!N3;
M1W<9BDD5-S!",'&> ?>M6B@#F-3\)3:GINBVDNI[#I5U#=1R+ ,R/$,*&&>G
M7..OM4UOX:GM?$NJZW'J(\[488X6C:#*QB,':1\V<_,<YZ^U=#7/77BZVM[I
MXX;"_O((;M;*XN+6-72&4XX8;MQ W+D@$#/L< &-9?#@Z=9>'HK/7+F&?0_.
M2WG$*$O%+C<K*<C/'![>AHD^&ROHVIZ6-<NS;W^H_P!H,7B1F1]ZR8! &<LH
MSGMT KNJP+/Q7;7XUP6UC?/+H[F.6'RAOE;9O C&><@C&<=: &3>%S<^*X]=
MN+Q7*V+6#V_D?(\;,&;/.<DC\N/>J'A_P)+H#1VB>(+^XT2WD\RUTV14Q&<[
M@#)C>R@\@9'09S75VDYNK."X,,L)EC5_*E7#ID9VL.Q'0U-0!QEW\/XM0@\3
M076I2F/7V1Y?+C"F%D "E3D\849!ZU8M?!US#XDM=>N-?N[F^ALVLY-T,:I*
MI8,. .!D9XY/KCBNKILDB1+ND=47(7+' R3@#\20* ,7POX=/AJRN;47C723
MW4EUN:,*5:1BS#@],GC^M-;PXY\;+XE%\0XL_L7V?RAM,>_?G.<[MW?ICM6]
M10!QUWX%F'B2[U?1O$-]I ORIOK>".-TF8#&Y=X.QL=Q6/(BP_&>VM--U""V
M:#P\(%64>:&Q/]PC<"6Q@]<\9Y%>DT4 <G<^ =/NM#:Q>XG6\-]_:8OTP)5N
M\Y$@&,<?=VXQMX]ZOP>'YAJ;:O>7R7&J+;&U@E$&R.%"<L0FX\D@9.>PQCG.
MDVH0#4ET]-TEQL\QU3_EDAR S'MD@@#J<' P#BW0!R^E^"X-/\!2>$9;V6XL
MWMY;82[ L@1\Y]B1N../2H;CP5/<Z3H=E-K<TC:3=Q7<<KP+EVC&U%(& %QU
M[GUKKJ* .=M_#,UKXBUG68]1'FZI%'$\;096,1@A2/FSGYCG/7VKC-=TN'PK
MH?AKPY+KEY8V5J\CKJAM%DB&%(6.52&4D[R03@?+ZX->JT4 >>Z*-6N]/OK6
MU\527^G/:,(K^VTQ8FMY<C;Y>T;9,@L3@<8'(S78Z#%?P:#91:I,9KY(@)I&
MQN8^^.,^N.,YK1HH Y5/ UF9M?CGNYY]-UIVEGL650JR,H5F# ;NBC'/!I]G
MX1D6+2K?4M4DU"UTF19;1'B",752J-(P/SE0>,!>>3DUT]% %#7-)@U[0K[2
M;EG2&\@>%V3[RAAC(]ZPCX-N'G\/SS:W+-+HS,\;/ O[PE-AR!C V]AWYR:Z
MRB@#D9O 5K?2^)!J-TUQ;Z^(_M$2QA/+,:A4*')Y  /.>0#[59\/>&+_ $AX
MVU/Q'>ZP(%V6RW$:((AC&3M&7;'&YCT)]372T4 87B7PXWB(::!?&U^P7L=\
MFV(-ND3.T')^[R<_SJIXD\'-K>I6.KV.K7&DZQ9H8DN[=%</&>2CHW##/(!Z
M&NHJ"]O+?3K&XO;N58K:WC:661NBJHR3^0H X#QE NDZ7I%A=ZUJ-N)[PW%U
MK+0+*F]4X$J;2F"2H48"C8/3FUX4;4YYI(+3Q-%K&EM;N//&FI"L$F1MVLF%
M?(+9'; R1G!Z+3/$0U'5&L6TO4;1C;K<Q2SQKY<J$XX96(#<_=.#[5M4 <KI
M'A"ZT+1M(T_3]9=1I@=$:2 ,)D;^%U!&<'G((Z#WS!-\/K5]&6S@O9+:Y751
MJXN(HUP+C=GA#QM[8_4]^QHH YVW\,2P^+U\0MJ<DLOV%;!HGB'S(&+[B1CY
MMQ/08[8K&O\ X:K>V.NZ>NO7L5AJUT;QH%C0^7,65B=Q&2N5'R\5UVK:@VE:
M7/>K97=Z8@#]GM$WROD@?*,C/7/T!JZ.10!SEOX8GM_%+Z__ &JTMP]BMB5E
M@&"H8L&."/FW$],#'&!69'\/$C\+6^BC5I@UIJ U&VN1$NY)1(9.0>&&6/%=
MM10!'!&T,$<;RO*RJ 9'QECZG  _(8KFX?"#O)H_]I:D;U-(E\ZU8P!)2VTJ
M-[YY !Z #.!DG'/322)$NZ1U1<A<L<#). /Q) K)3Q%:OXM?PYY%PMVEG]L\
MQD C:/>$X.<DY/IVH 9XH\.+XETZWM_MDMG/:W45W;SQ*&*2QG*DJ>"/8UG6
M_@=$U36;VZU:\NAK%HEM=Q,J*'VJR[AA>.&. /QS7644 <1;_#Z=(]!2Y\27
MLW]B2AK4K#&F$"% IX.3@X+'/3C&3E9?AZR#7;;3M<N;+3-:$K7%F(4<))(I
M#,C'E0>X_(BNVHH Y0>"V27PTZZM,W]@*5A\R%29<IY9W8Q_#P,#ZYJ1/!5K
M_:>NS2W<TMAK0S<V#*NPL8Q&3NQNY Z9X/-=/10!RMEX,:*STS3[_5)+[3]+
ME26UBDB"N2G^K\QP?GV\8P%Y SFKFC>''TC7=8U,WQG.J2)++$8@H1E4*-IS
MTV@9SFM&UU!KG4KZS-E=PBT* 3RQ@1S[ES^[.><=#TP:NT <O:^$'\_17U+4
MC??V,2UJY@"2EBA3YW!.X8/0 9(!.<5<\4>'!XDLK2);V6RN+.[CO+>>-0VV
M1,XRIX88)XK<K';Q%:KXM3PX8+@7;VC7:R%!Y91652,YSG+>E &'+X >63Q#
M(VNW;MKMJMM=;XHST0QEA@#!VD@#H/>K3^#Y))/#;G4R#H0_<X@'[WY/+^;G
M^[Z8YY]JZJB@#AI?AR5M-;TVPUVYM-(U?S7DLQ"CB)Y!ABC'D*?[OY$5UVF6
M/]FZ7:V/VB2X^SQ+&)90H9@!@9V@#]*LM(B,BNZJ7;:@)QN."<#UX!/X4Z@#
MC9/ (.G>(M/BUBX2SUN6:5XC$A$32X\PJ>ISCC/ R>#5N3PE++J/AV];4OGT
M-'6(" 8EW)Y9W<_W?3OS[5-'XOMI[VUCM["_GL[FY>U2_AC5X1(A((.&W!<J
MPW%<9'7'-=#0!Q5I\/FT[4;H6'B"_MM$NYFGGTE50H68Y8*Y&Y%)ZA<=3S72
MZ[H\&OZ#?:1<NZ07D+0NT9PR@C&16A10!R%IX)N(=9T?5;GQ#>7-SIT#V_,,
M:++&VWC ''W1D]3ZBJ,_PS\[1+[1%\07D>ESW7VJ&!(DS QE$I&[&6&0<9Z9
MYS@5W;2(C(KNJLYVH"<%C@G ]> 3^%5+;4&N-4O;(V5W$+41D7$D8$4VX$_N
MSGG&,'@8- &%-X.EC\3/KVEZU<6-U<PI#?#RDD6Z"#"L01A7 XR!CVJ@GPY$
M?A"'PZNM7+01W@O!*\*%MPE\T 8QQNY.<_A7<T4 8$WADR>+[?Q$FHS0SK:+
M:3Q1HNR9 Y<=<E>2>AZ<5+XH\-6GBO16TZ[DEA(D6:&>%L20RJ<JZGU']:VJ
MIW&I06E];VMQNC-R=L,C#Y'?D[,]FP"0#U[9H PX?!QN](O+'Q'JMQK;7<!M
MWDEC2()&>RJ@ !R 2W)R!Z"G6GA.0#2H]4U1]1ATEQ):*\(1BX4JKR$$[V4$
MXP%&3D@G%=-10!R4?@J2/3O$EG_:A*Z]))).WD#,9= C;.>FT#&<_C3I?!LD
ML7AN,ZH1_83*T)\@?O2J%!NY_NGMCGGVKJZ* .3B\&21VGB2W_M0D:\[O,?(
M'[HN@0[>?[H[YYHD\%R26GANW_M0@:"Z/ ?(&92B%!NY_NGMCFNLHH YRV\)
MK%K/B"_FO6E76XTCGA$84($0HNTY_NDYSGGTK/\ ^$!)\*:9HK:W=L^EW$,]
MG<F),Q>5]P;<8(QUSR?TKLZ* ..U+P-/-KJ:WI/B*^TO47@6"[E2..072KT+
M(PV[AS@@<>E.UCP''?'3+K3M7O=-U;3@RQ7Z;9'D#G+B16X?)Y^IKKZ* *&D
M::^F61BFO)KVYD;S)[F8 -(^ ,X4 *,   #@#\:RF\*R6OB&^UG2-1-C+J**
MMY$T(E1V48611D;7QQGD'N#7244 <GJ'@2VN/"]AX?LKR2SM+2=+C?L#O(ZO
MOR2>.6R3QSGM751AQ&HD96?'+*NT'\,G^=.HH XJ7X>J^AZYHZ:S<K8ZM/+*
M8S$A\GS&W.%/4\]"<X&?K6C-X6EN-=T+59-1_>:1')&B+  )1(H5BW/!PHQC
MH?7I7244 <5IWP^;2;R:&R\07\6@33-,VD!$* L<E0Y&Y4)ZJ,=3SR:Z;6M.
M.L:)>Z:)_(%W"\#2!=Q56!!P/7!J_10!R]YX*MM2\$VWAJ]NYF6U2);>[B'E
MRQM'C8XZC<,?SK/U'2]2\/\ A'5KR_UG5=;OOLC012PQ+')"C8!**@ZCABW)
M^7VKN** /*O#DMQ%<VB>'_&L>K@21K+9C28TS'D!M[H%*87)RW<8P2<'K(_!
M\T=YK]U'J\L<VL/%(SQQ &!XP I3D]E'7/\ 2NIHH YH^$(KN^U"_P!2N%GN
M[W3SISO!%Y0$)R3QELL2>I..!@#G-$^ YVT;0M.?79Y!HUS%<P2/ F28EVHI
M Q\N"<]R>]=G10!SFH>%9+OQ5;Z_:ZM<V5RMI]CG6*-&66+=O&-P.TY)YYK(
MM/AQ]BTC1=-BUNX:'2+_ .W6_F0J3NRQ"G&/E^=L]SGJ.E=U10!S0\(J^N:W
MJ,]\SIJ]JMK/"L84*BA@-ISG.&.<_I5[PUHDGA[0[;3'U":]6VC6*-Y452J*
M %7"CL!U.2:UZ* .;U?PO/JZ:M:RZG_Q+M44)-;O;AS&-@0F-L_*2 #R& /(
M%;\%O';6L=M$,11H(U&<X4# J6B@#C]/\!)::';>'Y]2DNM#MI!)';/"JNX5
M]ZI(X^\H;!P%!.!DD9!NOX6>V\17NM:1J!LIM01%O(FA$L<C*,+(!D;7 XSR
M#W%='10!R$G@"V@_L)])U&YT^;1_.$<@5)#*)?\ 6;PPQN8\YQP2>*IR_#82
M:'JNDC7;O[/J.H?;W+Q(S(^]9.#@9RRC.>W0"N[HH YSQ%X4_M\Z9=KJ$EEJ
M^F2&2VO8(P=I88=2AR"K#J,_C1HOA672O$6I:W/J]Q=W&H1Q),AB1$_=@@$
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MD%UP!N!Z$8QG&,<56O/ =G<Z1:Z?%>W, AOQJ3SJ$:2:X#[][DC'+<X '8<
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MLX!/J0* .)\6^(M9TBQUS4;;57FN+&_A$45K&IMX(2T:F.8LO+G<V0I)&5/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
3 **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>elicio10-qxexhibit311002.jpg
<TEXT>
begin 644 elicio10-qxexhibit311002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(R0V1C'6J4%Y/X?M?A]K]Q:W4VEVFD?8+[RH6=[21HX_F9 ,]4VGCC\1D ]
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M=T;6;#7],BU'3)_/M9"0&VE2"#@@@@$$$$8(KE)9XF^,EI=!LV_]@R1^?@[
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MD7SB.&Y:VD$.\D@*SE<*QQT)SC!.* .OHK'U7Q/IVCBX-P;B1;5!)<F"!I1
MAYW/M!QQSCKCG&*I7WCSP]830PO=2RR3VIO(1!;R2>;$ #N0JN&X.>,X&2<
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M7\EA#KT\,<L\<LKQ)A JL,%E )Q@@8)KOI=4MH;VSLW$WGW:LT2B)CPH&=Q
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MQ&"1N'?O6)NO(O!G@;5%T?4[FWT-%@U&T6"2.89@\MF53AFV'TX.>O7'L%%
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M<@UZ+6%H?AV;2[J:[OM7N]5NF#)%+<A%\F,MN**% ZD#)/7:.F* -T    8
MZ"O,+ 2KHOQ)5K2[#75U<O;J;:0&96@5%*#'S98$<5Z?10!X_JVGW&I^&_AW
MIR?VE:21P".XG@MY ]H?LICW-Q\I#''./ZU>GEUK7/AKJGATZ6\&NZ84C")
MT4%V(9%8-$V ,.$Q@="?3%>I44 <)X;U'1=<U*VU"U\.ZC;7EI&_G3ZA;R(U
MKE<%%+?>8GLO8$G' -3P7H<>M_"V\T'4K>X@%Q/=JZS0M&Z;YG9' 8#U5A7H
MU96NZ5>:M;P166M7>E-'*'>2V5&:1<$%3N!'?K[4 8'P_&K7]D^J:\BB_A7^
MS5(;<&$+%7D!]7<'/LJTOQ(BF.G:'=16\\\=EK=I=3B")I&6-6.YMJ@DXSV%
M=78V4&G6,%G;*5A@0(@)R<#U/<^_>K% ' 6=Q-HOQ)U?4]0@N5TS6K.V:VN#
M"Q$3Q @Q. "4)W;@#CN.O%:/P_TFXTS3M7GGB>%-1U>YOH()%*M'$[#:"I^Z
M2%W8[;O6NNHH \G\83WFH'QOIDFF:A'*;/%E'96CA;P>5_K))5'S$'Y=I;&!
MC#&IK&^N-%\9:3K=_8ZA_9-[H45BDHM9&:WF1]VUT +*&[$CTKU*B@#SKPAI
MD>MZ/XTTO4+*[AM]1U>[8>?;O'NCD"@,NX#G(/N"*M^#;'6[WP],=;5H-1M[
M9])AD;/S!"5:8?[Y"GWV ]Z[JB@#R?PD]E/IFD^'=6\*Z@=<TUHHV6>&0VZ-
M'@"=9#\F,#(QSG@5N^"RT>H^-&DL[@";5))XA+ Z":/RD7*DCD$J1Q7=T4 >
M5>']/OK/4K&Q\/WM_)H5[:S>;8ZA"V_26\L[-KL R_,0NP]LD9ZB/PD]E-I>
ME>'-6\*Z@=<TTQ1,L\,AMU,> )Q(?DQ@9&.<\"O6:* .(\+H7\?>-VEMIU@N
MIK8Q-+ RI*JP!&VDC# $$52\&Z1?V.O7.A7"[M)\/3N^GR%LEA,N44^\:-(O
M/9U]*[?5K*XU#2KBTM;^:PGD7"7,*@O&<YR >/;\:9HVE+I%D83<374\CF6>
MYFQOFD( +'  '    P  .U &A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4-6U
MBST6UCGO'8"69+>)$7<TDCG"HH]2:OURWCN\O[+2["2QLYKB,W\*W4EO;^?+
M;P\[I(TP<L#@9P<9SB@"];>*+.[AU+R8+K[5IKB.YM#%^]1B R\ D$$'.02,
M5Y9<:W>/\+H?&D<^LPZXMN[/.A;R)3*Q7YE.5*KD%< 8(%=/X8$MAXK\9SOI
MFKQVETEM-;RW$$DC2*L.T\G+%L_P]1W Q@8LUI?G]G1-'&EZD=3%LD/V3[%+
MYFX2@GC;TP,YZ4 =K9)I^C:@;VW.L&>_CV+IDCL^XQ_>E"N?E." 6+ '([D9
MO6OC'1KS2C?Q3R8%R;,P-&1,+@'!BV==WMZ<].:YGQ>TMKXGT;Q*=%O-5TC[
M++9W,,-NS30%F5ED\L@,1E<'T'X52U>UG@M=(\3:#X7G@MK+5#=SV"6X2YN(
MWB,;RF/KO&XX!YQR<4 ;^M?$&RT_0->O+>UN9+_1U N+)TP\;,N4+<XV$<Y!
M/&>_%=/IMX;_ $^&Y:&6)G4$K*FTY^GI7%^)9[GQ;\/O$ATW1;R$SV96(7%N
M8I[AQDD!#\V , 9ZDG'OU^B78OM'M9Q;W, ,:@)<Q&-^ .JGD?B!0!R,GBN3
MQ%H_C*V2UO[+^SA/##,I:)@4A#9+*<@[CD#TQGN*E\'>,+#^P_"NEW37GVN\
MT^%8[F6%_*FE6(,RB0\%N#^(/.:S+9+NQC^(=A+IFH&2\GGN+=X[5W25'@55
MVL!ACN&,#)'?O4!ANQH/PSB_L[4?,L)K<W:BRES %MV1MWR\88@?_6H [35/
M&.EZ0D\]R+@V=M*(;F[CB+10.2!ACUX)&2 0.^*V9KF*"T>Y8LT2KO)C0N2/
M8*"3^%>6Z?&FDWVL>']>\'WNJ27%_//:7$=IYL%U'*Y<!W/RJ06P=W KTX[;
M/3,-'M$40!C@0MC Z*H&3[#% &!I?Q T'5HA<6[W2VAM6NOM4ELZP[%;!&\C
M&[VZ_CQ5ZU\46%SK0TB6.YM+YX3/#'=1;/.C!P64^W<'!'<5PNF:)JM]\ (=
M&M[*>'5H8%/V:ZB:(L\<PDV88#[P7&>G-;7ARZTO7KV"XB\&W>GW,$;B>:_L
M_*,.Y2"D;'EB2>W&,YQP* -63QYHD-O:73F[-E>S&"TNH[9Y$GD!(VJ$!;G!
MQD ''&:6WU+1G\:WZK<WJZA#IZ//'-YB0)%N)#!6P,YSR/3ZUYQHFHZ;'H.@
MV.KQ:Y;:7I5V+V 2:1*0@4L8P\ZY5D7=G<%&<#MG/72B7_A9VLWG]G75Q:/H
M*0HQMG\J9U=V*!\8.0P_.@#H[;Q/:W31".TOL3VS7=NQAXGC7;RO/!.]< X/
M/2L+2?B38S>"E\2ZK;75G;/*R@^0S* 961!N&1T"@DX&36?X2T^\TCQ)8P:)
M/J<GAR:VD:>QU.!P=.88V*CN >2<;,G@$\\&N?\ LVHK\"WT!M&U7^T;:Y1&
MA%E(2Q%WYAVX'S#8,[AQ[YXH ]%C\;:7+(L*0WWVF6Y:U@MY+5HWG94WDH'P
M-NWG<2!^E,F\>Z%;Z#)K$TMPEM%<FTF!MVW13!MI1\#"\D<DXYZU4\6ZC=Q:
MEX>,5C>OID\DOVJZM+1Y+B#Y/D4 *70,206 R,8R,YKA+BRU%? ?BK35T35Q
M/-XB^TPQM;22,\1GB?.1NW?*K$G)Z=<F@#TVS\7Z;?:I=:9%%>K>06_VE8I;
M5XS/%G&Z,,!N&>/QK+T76Y?'O@6ZG$6IZ>]QYRH]JPCE"B5U4(Y.-V% )Z9)
MIDOFR?%^PO5M+PVG]BR0&<VL@C#M*C!2VW . >M+\+DN;+P?%I5Y8W=K<V4T
MZR^?"44EIG8;2?O#!!R,CGK0!IV.H2:)IUAI-\]UJ6JPV:R7!B =]HX+L3C/
M/''+8/'6MNQO(M0L+:]@W>3<1++'N&#M8 C([<&N*\9Z9!?Z['-%-JVE:K;6
MFZTU6QADD1LLV89%52&&0IVGKNXKI_#,FIS>&-,DUF!(-2:W0W$2# 5\<C Z
M?3M0!17QMH[SVX!G-M<WAL(;OR_W+S@D; >O52,XP2.M<M9^)X/#?C7QJMZV
MJWD$,MJ\<4*2W1A0P[G/?8F23V'I6)>2ZKJ6FZ3<7>B:PFH67B**>ZMH;1U@
M@B69CF-0 ),C!+C<<DY(!%=5IMQ)HGCSQ9=7VGWXBU 6LMJ8K5Y1+LA"LH*
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MM&ZD"7$10E7E9@1GJ,'J*+59A\8[^Y-I=BV?2(K=;@VSB(R+*[%=^-O1AWH
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M?;HA9O%%;$Q.H2./A0@) W@8Q]YLT =M<?$?08(=0FVZA(FG3&&[,=E(?)P
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M-_VAKT6H7&JWYM(U3_B6AP(&=&W*Y&,D@X.,]A]*W** "BBB@ HHHH ****
M"BBB@ HHHH @N;.&\$:SJ71'#A,D*6!R"1WP1GGO4.KV!U32+O3Q,81<Q-"T
M@7<55@0< ]\&KM% &?H6E_V)H5EI8G:=+.%((Y&4*2J@ 9QWP*T*** "BBB@
M HHHH *@NK.&]C6.X4O&&#%,D!B.F1W'L>*GHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *PK3PX;7Q?>^(/MS.]W D#P&,!51"2N#U
MS\QSZUNT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% $%O9PVSS21J?,F;?([$DL>@Y/8#H.@J>BB@ HHHH
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M)TD>!TAE$4A&%<KNVGUQWJAH6E/HNC0Z>;HW)BW?OG0!G)))9L=2222>,YH
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M#[<1+J]Q;0WJ^4FV420L['[N5.5[$5M6W@H1Z]=:M=ZQ>7<EY9"SNHW2-5D
MW<_*HVC#'@?B36?!\.9$L-$LIO$E_)#HMTDUGB*)2JHK*JGY<,<,!N.>!P!D
MT 5;K4K_ ,5>'_&-S!J,MG;V$EU8P0QQHP<Q)\[/N4D[B2, C QWYKH_ ?\
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MDS%MP*GAE.X\=1ZFJNN^'7\.Z5XHU9-2U>ZDU:*..80(I>)MHC,PV+GY5^;
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M4-%,9%DX'(*[E'!]^:ZZTADM[6.*:X>XD4?-+( "Y]<  #Z"@#SK_A)=<O\
MX:2^.K+4#'(BR7:6#1H83 CD>6QV[]VU<E@WWO;BIIM4\0:]XS33-,UPZ;9W
MF@IJ,1^R1R/"[2 #[W7CKGWQC@C5@\ PVVEWFA0:C*GA^ZD9VL?+&Y%8[GC2
M3/"$YXP3@G!%:*>&?+\9+XACO-A6Q%@+41#8(@V\<YSG/?ICM0 >+]??PGX*
MU'6647$UG "H(P'<D*,@=!N(S[5BZSJ>L>%KWPY<RZG)J-IJ-[%I]W#)%& K
MR [9(RJ@@ CD$G(/KS76ZMI=IK>DW6F7\7FVMU&8Y%SC(/H>Q[YK%L_"3JNE
M1:GJ<FH0:2XDM%>((Q=5*JTC#[[*"<8"\\D$XH Y#3(;K^Q_B9)/JEY<B.YN
MXMDWED-BV3!)"@@@<  @8'2I-%OM9T:U^'K?VH9K'4X(K26R,"!$'V?<C*V-
MVX;><D@^@KIF\$A7\0BWU:YBM];+M+ 8T98W= CL#C).T< G /8TC>"F-KX;
M@_M-@N@,C0'R!F7:FP;^?[I[8YH QGUGQ3XATN]U'P[]H2YAOI8;:%OL_P!F
M=8I2A$FX^9E@I.1C&1CIDR7=SXGU/Q[>Z%::Z-,A_LF&\0I:QRF&1I&4@9^\
M/EZG\,=:O#P ]KK5[=:9XAU'3].U"8SWFGPA"CN?O%&(W1[N^WGT(XQJ0>&?
ML_C"3Q EX07LULOLPB 01JQ9<'.<Y)]L=J -Y00H!.3CD^M+110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%<YXPUJXTBWTN"UW"?4K^.S5UVY0$,Q(W?+DA"!GC
M)[]* .CHKSO4Y/%VD:1XINC>RQ6,&G/=V$DS123Q2HA+*<*0R' Y/(J"6]\0
MVUYX,F7Q!.XUM/(N8G@C,:9@WAT&,A@1U)()/3'% 'I=%>87&LZ[IEE\0;%=
M:N)Y=$MX[JSNYHHC(-\+.5;"A2,KZ=Z=<:AXET.?PCK,VMR7]IJ]Q;V5W9/
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M)@$9 ?&5QTZUT=O-J]G\1WT*?6KFZM+[27NP7CC5K>59%3]WA>%PW1MW3J:
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M"F0*?OK@G*'L:NUY-?>(_$,/PS\7:BFL2B_TS5I[>&?RH\^6DBH%(VXZ$\@
MYKI%NM7TKXE:=IT^KS7MIJ=E/*\,D:*L,D93!CV@$##$8);ZF@#LY)$AC:25
MU1%&69C@ 5DOXCMH_%D/AUH+@74MJ]TLI4>644@$9SG.6':N>^+"2MX-1HKN
M>#%]:JPB8 .&F08.0<CG..F>N:JZM8W,GQ5T6TBU.XBD_L:Y#76Q#+CS8^GR
M[0>G.T_3O0!Z'17F-AXMU>W\/?8Y[I[J]_X2270X[LJBR,BLQ#$$!-Y5=HXQ
MD@X/?I] A\1VVOWR7[O)HTD2O:_:9$:>.0'#+E!RAZC/(Z4 =/17%>++O6$\
M:>%],T_5I;.VU(W23JD2-C9"6# LI.?KD9QP<8-6.ZUFZU:_\-IJ-]/+I5I
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MT!) R?2N+\&>)9-3UF&PU"_U"TUF&T;[=I5_$JEY,K^]B(7!08?[IQ@@X[T
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M68D_*"2 5( H ]-HKAM0NM8N_B5;Z-!K4]I87.C273)%%&61Q(BY1F4\X/\
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MM( (^4#OVS2V/A!8$TR&^U*YU"WTIP]G'.J@JRJ55G( WE02 >/4Y.#72T4
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MX'H1TS7K.H^+M/\ $GA_3;.QO$M9M;/E.+A3FW0*6D$BY&,XV#D9+@@T 5/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EJ.FPZI%'#
M<LYMU=9'A&-LI4@J&[XR <#&>AR,@W:** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8_\ 09T/_P %4O\ \D5T-% '/?9?&/\ T&=#_P#!5+_\D4?9?&/_ $&=#_\
M!5+_ /)%=#10!SWV7QC_ -!G0_\ P52__)%'V7QC_P!!G0__  52_P#R170T
M4 <]]E\8_P#09T/_ ,%4O_R11]E\8_\ 09T/_P %4O\ \D5T-% '/?9?&/\
MT&=#_P#!5+_\D4?9?&/_ $&=#_\ !5+_ /)%=#10!SWV7QC_ -!G0_\ P52_
M_)%'V7QC_P!!G0__  52_P#R170T4 <]]E\8_P#09T/_ ,%4O_R11]E\8_\
M09T/_P %4O\ \D5T-% '/?9?&/\ T&=#_P#!5+_\D4?9?&/_ $&=#_\ !5+_
M /)%=#10!SWV7QC_ -!G0_\ P52__)%'V7QC_P!!G0__  52_P#R170T4 <]
M]E\8_P#09T/_ ,%4O_R11]E\8_\ 09T/_P %4O\ \D5T-% '/?9?&/\ T&=#
M_P#!5+_\D4?9?&/_ $&=#_\ !5+_ /)%=#10!SWV7QC_ -!G0_\ P52__)%'
MV7QC_P!!G0__  52_P#R170T4 <]]E\8_P#09T/_ ,%4O_R11]E\8_\ 09T/
M_P %4O\ \D5T-% '/?9?&/\ T&=#_P#!5+_\D4?9?&/_ $&=#_\ !5+_ /)%
M=#10!SWV7QC_ -!G0_\ P52__)%'V7QC_P!!G0__  52_P#R170T4 4M,CU.
M.W8:K<VEQ/ORK6MNT*A<#@AG<DYSSG\*NT44 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[<:8LJK*]W=O!,IYBF6X=HW!]C@_0^];W@?4;OQ1C7M1M7MI[6'^S_*<8VS
MC[0P]BZJH_ZYF@#M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.^>E0Q^(]%E@N9UU2T\JUQ]H8R@>4",@MG[H(YR: (=7LM7BMH5\,'2K24S
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ML=NM &C161-XJ\/V]PUO-K5@DRRI R&X7(D;.U#S]XX/'M6O0 4444 %%%%
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MPB7'5R#QGH.Y^@)%R6*.>)HIHTDC;@JZ@@_@:;#:V]O#Y,$$447]Q$"K^0H
M\0>6Q7X%:E.DEN)?[99]X(SN%Z"#GUV_I7;74\3?&NW$$T(G?PY*$.X<DSH5
M_J:[G[+;XQY$6.N-@I1;PAPPAC##H0HR* /'O#%WX>UGPSI&B:UJ-]_;FGW*
M!M*+A9ENT8_, %R1G+%LXP22>M=5IUU;M\:M;B$\9D_LBV7:&&<B1\C'KR/S
M%=L+: 7!N!#&)R-IDVC<1Z9ZTHMX0^\0Q[\YW;1G- '(?%B6.+X7:_YDBINM
MMJ[CC)+#@53M'\'6&G:-J_VZV^U6<:O$D5WO>1VB,>P)NY)WX QUQ7>/%'*
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MX@LK>6&^U'3&ALX<$.H5#D#_ &C(9,'N E>A)&D2[8T5!UPHQ2JJHH55"J.
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M7H51K!$CEUB16/\ $% -24 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M** "BBB@#.O])2ZO[7487$-]:AD23&0\;8W1L.ZG /L0#Z@Z&T9S@4M% "$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M45N4,),#I)9R*XS(VX I@ ]<9Z#).* /0**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P;G0;^
M]\0_:[K6I)-(1HY8M+%NB@2IR&,GWF&X!L>H'88K>HH **** "FR*7C95=HR
M1@.N,K[C((_2G44 06=I#8VJ6\"E8UR>3DDDY))[DDDD]R:GHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>elicio10-qxexhibit312001.jpg
<TEXT>
begin 644 elicio10-qxexhibit312001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQA<D@<UE6.C7PT#XIZX;>=+76GE2PC,9#3C,F'"XSAMXQQSS0!T=Y\15\+^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?VN?/@%I,#'@X.[*8'/%0P?$#PW=:G=:;;7=U/>VI(GMXM/N'>/!P<@1\<T
M=/17-2>/_#46D7.JRWTJ65K/]FN)7LYAY4GR_*P*97[Z]1WK4T[7--U72%U:
MTN,V#)Y@GE1HE*]=WS@<>_2@#1HKFK;Q[X?O(I+BUN+J:SC)#7D=E,UN,=?W
M@3;@=SG ]:W-/U"TU6PBOK&=9[68$QRIT89QD>W% %FBJMGJ-GJ#W2VEPDQM
M9C;S!3]R0 $J??!%8%Y\1O"VGV\US=:A-%;0SM;/.;*?RQ(I(*[]FTG(/0]J
M .IHK"L_&&BW]V+6WFNC.UN;I(WL9T+Q @;EW(-PRR],]:3P]XRT'Q4TXT2]
M:[\@@2L+>150^A+*!GCI0!O45AOXOT4:A<V,-Q+=W-K_ ,?"6=M+<>4?1BBD
M \'CKQTJSI_B'2M5TIM3TZ[6[M4R&:!6=@1U4H!NW>V,T :=%87AWQEX?\5_
M:!HFI1W;6Y E4(R,F>G# 'L:NZ=K5EJLUU%:-,SVLGE3"2WDCVO@'&649."#
MQV(H T**HZMK&G:%I[W^J7D-I:IP9)6P,]@/4^PYJ@OC#1!=6EO/<36DEX<6
M_P!LM9;<2GT4NH!/MUH W:*PO$/C'0O"@A;6[UK1)CMC<P2,K'TRJD9]J5/%
M^CMJ-I8/)=PW-VQ2!+BPGA$C $D!G0#H">M &Y161X@\3Z1X6LUN]9NFM;9F
M""7R9'7)Z E5..G>H-/\:>']2U&+3K?4 M[-&)8H)X7A>5",AE#J-PQSQF@#
M>HKFO^$^\.'6;C1TNKF34K==TMK'87#R(O') 3IR.?<5?T?Q-HVOVL]QI5_'
M=I Q698P=\9]&3&X'@\8H UJ*Y[2?''A[7+V[LM-O);FYL\_:(UM)@8B,C!R
MG!R",=>*=H7C7P[XEO;FRTG4EGNK7_70M&\;IS@\. >#P?3O0!OT5GV>M65_
MJ%U8V[3&XM"!,KV\B!21D?,R@'(.>#6?)XUT(:I-IL%Q/>7=O_KX[&UEN/)]
MG,:D*?8\T =!16 ?&F@#3;S4!?EK6R.VZ=(9&\DXR0X"Y4COD<=Z2W\;:!=^
M'I-?@O)9-*C!+7*VDVT 9R?NY(&#D]!B@#H**Y:U^(WA.\6S>/5@D5ZQ2VFG
M@EBCF8'!"NZA2<\=:W]1U&TTG3YK^_G2"UA7=)(YX44 6J*:[A(V<Y*@9^4%
MC^ ')K!T;QKH'B#4;G3]+O9+BZM3MGC^S2KY1R1ABR@ Y!'/I0!T%%%<Y=^.
M_#UEKPT.>[G&J,-RVJ64[NPP3E0J'(P#R/0T ='17/IXUT)S?+]HN5>PB$US
M')8SH\<9S\Q4H#C@\@=J99>.O#NI:)<:U9WLL^G6^?-N$M)BJX&3_!DX'7'2
M@#HZ*R-#\4:+XETR34-&OEO+:-BCM&C;@P&<;2-V?PYJSI6KV>M6ANK%Y7A#
MLFZ2!XOF4D$8< \$$?44 7J*JQZC9RZG/IR7"->01)+)$#RJ.6"G\=I_R16;
MXB\7Z'X3CBEUN\:TBE.U)#!(Z$^FY5(!X/% &Y16;>:_IECHZ:O+<%K!U5UG
MAB>4%6Z'Y 3@Y'-.U+7-,T?2CJ>IWD=G9@ F2XRG7H,'G/MC- &A17-GQUH*
M6BW=Q-=VEL_^KEN[&:%),] I= "3V'4]JDO_ !OX?TS7H-$O+R6/4I\>3;_9
M96,F20"I"D$9!Y'I0!T%%,>5(XFE=@D:KN9FX 'J?2HK&^MM2L+>^LY5FMKB
M-98I%Z,I&0: +%%<]#XX\/S^(GT".\E;5DY>U^R3!E& <GY, 8(.>G(KH: "
MBL[6-=TOP_:+=:K>1VT3,$3=DL['HJJ,EC[ $U6B\6:/)J4&G27$MM>7 W00
MW=O) 9?79O4;C[#F@#:HK USQIH'AN]MK/5KV2WGNCM@7[-*_FGCA2JD$_,.
M!ZBGQ>+]'EU*/3O,O([R5&DCAFL)XF=5&6*[D&<>U &Y17+V/Q#\-:I)<QZ?
M=W=V]JVV=8-.N7,1YX8"/CH?R-%S\0_"UGHL6L7&I/'I\LK0K.UK-CS 2"I^
M3(.5/!QTH ZBBJ"ZUIYT?^UWN1#8>7YIGN%,0"8R"=X! K)@\>^'[BT-ZMQ=
M+8=1>R64R6Y'KYA0+CWSB@#I:*YO4_'OAO1H[!]0OW@74$#VK?9I6$P(!&TJ
MIR?F''7FK-OXLT>XU>WTH2W45[<*S0Q7%E/#O"C+8+H <"@#;HKFO^$^\.'6
M;C1TN[F34K==TMK'87#R(O') 3IR.?<5HZ)XCT?Q'#++I%_%=+"^R55R&C;T
M93@J>O44 :E%9NMZ]IWAS3GU#59V@M$QOE$+N%R0!G:#CD@<UFV7C[PS?W-G
M;PZF$DOEW6@GADA$X_V"Z@-^&: .DHKGI_&_A^V\1)X?EO)5U9^4M1:S%F&"
M<C"X(P"<CCBM"XUNQM=6@TN5IQ=SJSQ(MM(P95QN.X*5XW#//&10!HT5S,?Q
M \-S:G=:;#=W,M]: FXMXK"X=XP#@D@)P.1S[UIZ+XATCQ%9M=Z1?PW<*-L=
MHSRC>C \@_6@#3HKG7\<^'TLWO6NY18(2/MOV:7R"0<'$FW:>>,YP3P,T_6_
M&F@>'+VVL]6O7MI[HX@7[-*WFG@84JI!/(X]Z -^BLV_UVPTQ;4W;7"?:I!%
M#MM97+.>BD*IP?KBM!Y$CB:5V"1JNYF;@ >I]* '457L;ZVU*PM[ZSE6:VN(
MUEBD7HRD9!K&M/''AR]\1/X?AU$#5DSFUEADB?@9XW* >.>.W- '0T5EW/B+
M3;34);&>69)XH&N7'V:4J(UZMN"[<?C6/-\2O"MO]B\Z_N(OMV/LF_3[A?/S
M@#9F/YNHZ>HH ZRBLS2M?T[6IKN"REE,UHRK/'-;R0M&6&1D.H/(%9U_X\\.
MZ6;[[7>3HE@XCNI19SO'"QQ@,ZH5S\P[]Q0!TE%<_IWC70=5N;&WM+J=GOU9
MK0O9S1I,%4L2K,@4\ GK4LOBS1H]4GTR.XEN;VW7=/#:6\DYB]-^Q3M/L>:
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M9+-OLLQ$ZL 1MPG)^9>.O-:FJ:_I>B::-0U.\2TMF("M,"K,3T4+C<6]@,T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% ".ZQHSNP5%&69C@ >IKD])^)?A36_$']AV.I[[X@F-6B=%
MEP,G8Q !XY]^V:ZJ6*.>)XI462-P59&&0P/4$5X_XNN[O3_CAX7O]:T2,Z<S
M&RL+FWFW$R.<!G^4<C=]WH,D@G% 'HFJ>,M$T>[N+:[N7\RUC66Z,<3.+9&.
M%:0@?*#^>.>G-'B/QKX?\*:9!J&K:@D4%Q_J-@,AEXSE0N<C!'/3D>M>-6TL
MMQ+\;9+C)D *#/\ =4S!?T"UWWP^NK*U^#VDZQK,2/Y-@T3,Z;F:(.P5 #UR
M H [G ]* .R\/^(M*\4Z2FIZ/=K<VK$KN (*L.JD'D'ZU)K.N:9X>T]K_5KR
M.UME(7>_5B>@ '+'V )KDOA+X2G\)>$GCO$$-Y?7#7DEN#GR P 5/J O/OD=
MJX[XERS7/QS\$:?=$G3E,4L:-]TRF5L_C\J"@#TX^,M'AN;2"]>YL'O#MMC>
MVSPK(W]T,PP&_P!DD'VH\2^-="\(B!M;NI;9)VVQN+>216/IE5/-<I\>8HI/
MA7>O(!OBN(6B)[-O X_ M7G_ ,4+J\O?@]X$N;XLUU(8V=GZM^[X)]R,'\:
M/;E\7:4=3M-/D%_!<7CE(!<:?/$KL 6(W,@7. 3UJ?4?$>G:9J4.G3_:GNYH
MC*D5O:2S'8#@D[%.!DCK6?H\^JZEK^J1:YIT-LEH8)+)(YO-4@A\R!L#DG(Q
M@=/SZ(01"X-P$'G% A?OM!) _,F@#DK7XI>$[[3I]1M;R[FLK=@DT\>GW!2,
M_P"T=G'4=:O7WCK0-.\1P>'[JYG359P##;BTE8R YY!"X(^4\Y[5YK^SO!%=
M>#=>MYXUDAEO2CHW1E,8!!IOCIKE/VC?"C6<,4UP+$;(Y93&K',_5@K$?D:
M/3-0\=:!I?B&WT&\N+B/4[D PP"TE8R D@$$+C&0>_:FZCX]\/Z5KT.AWEQ<
MIJ<Z[HK=;*9VD'/*[5(/W3^5>8>*)-1E_:&\''4K6VMI1 H5;>Y:92NZ7DDH
MF#UXQ^-2^/WN(_VA_"3VD,<UP+(%(Y)#&K'=-P6 ./R- 'J^G>)],U359M,@
M-TE[#$)GBN+.6 ["<!AO49&?2K6K:O8Z)8F\U"?RH=RH,*69W8X5549+,3T
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M<5>*-IL-A<?,"#@\C /0U[M?:'IFIZ)?:-+"AL[H2+-&IZ-(2['V.6W?4@T
M.T_7;#5-#CUFRDDEL9$\Q'$+@LOJ%(S^E3:7J=KK.FP:A9&1K:=0\;21-&64
M]#A@#@_2O%?AG+JMKJ6L?"R]??#93-*UP&_Y=<C>@_WRR?0._<"O=54(H50
MH&  . * *E[JEEI\]E#=W"127LWD6ZM_&^TMC\E/Z>M7*\)^,ET-3C?6M/UB
M&.[\.WJ+;6HF7>Q!'FR!<Y)#[!](V]:ZGQGXNEU;X#7?B+2&*27=K&&V'F+<
MZI*/PRPS^- '4P^.M$O+RXMM.:[U$VS;)Y;&TDFCC;T+J,$^PR:4>.O#[Q1R
M0W,\XEN6M$6"TED<RJ@=EVJI88!YR.,'TK*^#]O;6_PKT/[,J@21-(Y'\3EV
MW9_'C\*ZR#2[*WNYKJ*W19I93*S ?QE54G\0B_Y- '/6_P 2O#-W<WUM;SWT
MT]AG[5''IMPS0X)!W )QR#^5=+8WMOJ6GVU]:OYEM<Q+-$^"-R, 0<'D<'O7
MCWPJ_P"2P?$/_K[?_P!'/7K.H!].\.W0TZ(*]M:.+:-1P"J': /P% %.7Q=I
M"ZO/I5O+->7]NNZ>&TA:4PCMO*C"GV)S[5/I'B/2M>MKB;3;KS_L[F.>+8RR
MQ..JLA 93P>"*\S_ &=0LO@W5KR1B]W-J;^=(QRS8C0C)[\LQ_$U3TV6:S_:
MFU2WLB1;W-J#=HOW?]0C9/ONV\_[1]: /0['XB>'-3O;RRL9KZYN;)BES%#I
MUPS1,"1@@)Z@C\*V=%URPU^S>ZT^21XXY6A<2PO$RNO4%7 ((^E>#>%[_6]-
M\5?%2YT*QBNKI)YF^>;88\2R_,HP=Q')QD=*^A8;>*!I7C0*TS^9(1_$V ,_
MDH_*@#D[_P"*7@[3?$7]A76L(EZ'\M_D8QQO_=9P, ^O/'?%;VJ:_I^D7%I;
M7,CM=WC,MM;0H7DEVC+84=@.2>E<+\3?#-KXGM]&\(Z=:Q)<O="YDE1!_HMN
M-P=R?5B0 /XCGT-9^H.Y_:4T"W)/V>'2&\D9R,%9<G_/I0!Z+#XIT2?PVWB%
M-1B_LI4+M<-D!0#@@@\@YXQC.>,4NE>)=,UB[FL[:61+N&-)7MYXVCD$;#*O
M@CD'U[=#@U\Q7=Y>)\(?$%LA;[*WB95/I@HS$?FJ5ZE=%_\ AI+3K= 3#/HA
MBG4="FUS@_B%H [&R^*7@[4/$8T&VUA'O6?RD^1A&[_W5?&"?3GGMFNQKS'Q
M=X:M?%'C_P -65C;Q10Z"WVN^N(U"B) 5,<(([MM)QV'/<9].H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'W@!? %I=VEOJ;7D%S)YK"2$*RMC'!!Z8'I4>K_#Y]5^(%AXO.K>5<V"".&
M6V4*@M][YLD_.>1BNWHH XC6OA\^L^/--\5MJWE7.G*$AA6VRA4%C\WS9)^8
M],4S7/AY+K7CG3_%?]L_9[RP01P1+:ADP"Q^;+9/WSZ5W5% '/VF@ZB/$,6J
MZAK9NHX87CBM([811HS$9?J23@$<GN:F\0:#+K3Z=+!J4]A/87/VF.2%58L=
MC)M(/!4ACD=_;K6U10!S3^%9=0\0Z?K6L7L%U<Z8D@LDAMC%&C. &=@78L<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBJU]J%GI=G)=W]U#:VT8R\LSA%
M'XF@"S134=9(U="&5@"".XIU !1110 4444 %%%9J>(-(DU5M+34K9M049:V
M$@\P#U*]<>] &E15#5M:TW0K/[5JEY%:P%@@9SU8G   Y)J_0 4444 %%%%
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M]BO-7LK>ZQN\F68*^/7!YQ[T :U%5K'4++5+5;K3[N"[MV.!+!('4GZCBK-
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M%%4YM5L;?5;72Y;A5O;I'DAA(.75,;CZ<9% %RBBF331V\$D\TBQQ1J7=V.
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M -B?V-]EC_L[R/L_D;?E\O&,8^E0^(] L?%&@7>CZ@K&WN5P2IPR$'(8'U!
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M*1 0S-C@.Q^\!G!'6IH?&FM7<.C:G9:8]W8:A*GF6R6$XE@A?I+YI^1L#!(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'#&4IAB201@$\ =: .GHJ(75NR;Q/$5W!<AQC)X ^II8KB&<N(9HY#&VUPC
M[3Z''0T 245"EW;27#VZ7$33H,O&K@LOU'44?:[;#'[1%A?O?../K0!-147V
MF#:A\Z/#G"G</F/MZUSWA'7-0UBZ\0P:A]G+:=J;6D1@C* H$1@2"3S\Q[T
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M9 <%HW# 'TR* )J*A6\MGDCC2YA9Y%+(H<$L!U('<4Y+B"1F5)HV9>2 P)%
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M+;VVGVT<,P D18QAP!@!O48XYIUIH^F6%@]A9Z=:6]FX(:WBA5(V!ZY4#'-
M%7PNMJGAG3EM%A5?LT181  ;BBGG'?!!KS^SFM-8\.?$?^UTADU&&YNXI4F
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MSIUOX-NAJBS/;3211;(I/++LTBA5+'A5)QN)_AS7+VB1/\1?%%E>MI[BXT6
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M=@('"Y.<5H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<^<IC/F QQ[AALXQD^G;K7%>-+W3[BT^(<=LT$$T=HD=X]T^YYG$.8UB0D;
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M/U'QG\2/MEI!<;+>U"B5 P7-L<XST/'6LO3Y(&T_X27%XT93RG1Y)<8P+5@
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M[#TG?;/_ &79;[90L#?9TS$!T"\?*/I3KG6-,LI8HKK4;2"27'EI+.JE\\#
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MEZ'K0 PZ)I36MM:G3+(V]LP>"(P+LB8="HQA3]*2ZT/2;Z^AOKS2[*XNX/\
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MV=&WK%]E38K>H&, ^]6+[4[#2XA+J%[;6D9. ]Q*L8/XDTKZE8Q^1OO;=?M
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MEE!61_)7<X/4$XYS1!I>GVQ@-O86L1@!6'RX57RP>H7 XSWQ0!XQ=ZGI5W\
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M^\L5QWY%>L#2=-$T4HT^T$D0 C<0KE,=,''%!TK3CJ'V\Z?:F]_Y^#"OF?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0P11JW4(@ /Y51U#0[/4+6WM)(85M8I!)Y:Q#L<X7^[GO@9P3TK3HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-=(@E,2/EBA.-P]5SW'%:5 !1110 4444 %%5=0U*RTJV%Q?W45M"76,/(V
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M&P8#;B.#D>]+8>&?$4'B;1M8>+1;>.STZ2RDM;=Y-J@LK H=HSG;W VY_BH
MHP?$/7'\*V7B6;2+&/3VO?LMT@N&,@!G,.Y/EQP<=>O/ XSTUUKVH7>JZKIN
MAPV[SZ7$C3-<9Q)*ZEEB4 C'RX)8GC<.#SCF1X&U_P#X5FOAC=IOVH7OVCS?
MM$FS;]H\_'^KSG^']?:M*Z\/>)]-\87FO>'I-,>/58HEO[2^=P$DC7:KHRKS
M\O!! SC\@">Y\37\>I^$(;S0XK=]6=Q*)I=TMI((F8J !@],9ST[56U_QMJ&
M@Q75[<V=M!;07Z6T=K,^)[J(LBF9"#C&7X&#PO)%7-6\.ZQ>:QX7O$GM9_[*
MGDGN9)7:-I&=&4A%"L !N) )Z #WK U7P-XGOM)\1Z<MSI4G]HZ@MY!=S/)Y
MK(LB.L3@+\H4+@$%N.,#.: ->Y _X79IYQS_ &!/_P"CXZTO'FM3>'?!FH:K
M%8V][]G0%X;AR%() ]#GKTX^M0G0]7?X@66OR?83;1::]G*JRN'+,ZN64;2,
M#;CD\^W2K'CK0[WQ+X-U#1M/:W2>[0('N'954;@2>%)/3I0!5U3Q+J]OXQLM
M L=.M)/M=E)<QSRSLNTJ5!W +P/F[9)XZ=:Q=1\2ZKK/PM\4SF&WM=1T\7ME
M=>6[%,QH06C/7D$$9K;FT/5YO'.E:Z4L5M[2QDMI8_M#EBSE22OR8(&WOC.>
MU9<?A#75\)^+M*/]G>?K=W=3PL+A]L:S#&&_=YR/;K[4 26&HG3[7PI:-9V$
MFN:A;>19S!#^YMTB5W+'[V.%^4$ DCIUJ:;QI?V,WB'3;JQMGU72;+[?%MD9
M(KJ#!^8<,5((((YYQSZ-O?"FJRP^%]1MWLX]9T$;!&96,,\;1A)%+;<KD#(.
MTX]*?>^%=0U*;7M5F6T34]0TS^S+>(3,8X8_F)+/LR26?/"_P@>] &=>^-_$
M]AX'D\4RZ+IIM&LK>XA073[\R8#;AMQ_$"!GIWS6E<^)O$-IXMM=$DTNP;^T
M;>66R=;AOW9C*[A+\OHP/RCKQ[U#JWA36-1^$\7A5#8I?K:P6K2&9_*Q'M^8
M'9GG;TQWZU?OM$U>\\;:#K82R2WL+>>*9//<N3*%Y7Y,'&WOC.>U %73O%VL
M7FAZLW]D1SZQINH_V>\-O(?*<Y3]X">0H5\D=?E-1P^,+Z[?Q1I]L^GS7>DV
MJ7$%W#DPR!U8X*Y)!4H1C<<^U9]SX)\1RZ;X@AAGTZ.34-8344C,TACEC&P-
M#+\@.TA.<9SG&*T+/PMK9\2:U?WDFFQ6VJZ=':M';[V:%D5U &0 1\^=W'3&
MT=: ,VW\2ZMIWPN\/:K>VMGJ#77V-7:5V!'F% '(P=S9.>HKJ)-=N[_Q%J&B
M:.ML)M.ABDN9KD,5#R E(P%(/1<EL\9'![<Y+X/\23_#K2_#DC:5]IL9;;#K
M-($9(64@YV9RVWIC ]36O_PC^JZ7XTO?$.E+:31ZI;Q1WUK/,T>V2,81T8(V
M1@D$$#U]J ,M_B/=R:%IU];:3&;F365T>^MI)\&";?M8*<8;V)(ZCBMO1/$.
MIW'BO4O#^KVEI%/;V\5W#):R,ZM&Y9<'< <@KU[^U8EUX#U%-(L8;.2S>[_M
M]=<OGED9%9]^\HF%)QC"@G'3/>MNUT/4X_B)>:_*+064^GQV@59F,@*.S9QL
M P=V.O:@#IZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *J:GJ=EHVG3:AJ-PEO:0@&25^B@D ?
MJ15NN;\>ZY=>&_!M_J]I:VUR]NJDQW!(4@L!T YZ]./K0!T8((!!R#T-+7):
MIXBUJ'QK:>'["TL62ZL)+E)YY&RK*RCD =/FZ#KQR*I:?X[NY-"S>6EN-8_M
MEM%5(F(A>8,1OYR0NT%L=>,=Z .TNKJWL;62ZNYXX+>)=SR2,%51ZDFFV-];
M:G807UE,LUM.@DBD7HRGH16!+<:Z8]=LM5M+=K2.S+VU] -BRY5MR&,LQ!!'
M7.#FN<\,Z]=Z-X-^'EO%'#);ZFD-I)O!W)^Z9MP.<?PXQB@#TJJ-WK&G6%]:
M65U>0Q75XVRWA9OGD.,\#\.M<U/XX.EW_B]=4CB^R:##!.CP@AI1(K$*021G
M( 'U[5D^(VUF3Q)X$EU(602742YC@5@T+F%_E+$G>,$\X7ITYX /2:9+-';P
MO--(L<2#<SN<!1ZDUPM_XXU5[*[U'1-->^AM;IX%M%L9WDN5238[)*HV*<AL
M#!X')!.!K1>(+[6=9U+3]&6WB_LV./SWO(V8M+(N\1@!AMPN,L<\G&.#0!N:
M;J=EK&GQ7^G7*7-I+GRY8SE6P2#C\0:2/5+&;59]+CN4:^@C666$?>5&R 3]
M<&N5^$6?^%6Z+D8.)L@=OWSU<@\0:A+XSUS1ULK,&SLH;B"3S&S+N+@!SC@#
M;T /7K0!U5%>;6'C[7Y]"\,Z_<V&G)I^K7<5I+$CN95,CE5<'H #CCDGU'0=
MOX@GN[7P[J-S8211W4-N\D;RIO4$*3R,C/3UH DU#6=-TJ6UBOKV&"2[F6"W
M1V^:5V. %'4U>)P,GI7D5]/J4_PY^']W=R175S+JFF2I@%"Q*Y^8DG))ZD?E
M78Z1X@UJ;Q)K&@ZA;V!N[6WBNK9X&=4='+#:^<D$%>H'/H* .ATS5++6=.AU
M#3KE+FTF!,<J=&P2#^H(JW7GEG\0F'@7P]K=Y'::<FJ7#0RSLC-!:#,F"P!!
MY*!<Y RV>V*[+1;F[N[ S7C6KL9&\N6U.8Y8\_*XY/4>YH T:*XFX\1^)[GQ
M?J^@Z58:5FRAMYTEN9I,,CEL@[1PV%XP,#'4U7OO'.JR6%QJFB::]_;P730+
M9I8SO)<(DAC=DE4;%.0Q P>!R03@ '?45PS^)O%&H>)-<T71].TQ)+"&WFBE
MO)9,$2!CA@ #N^4#'0<Y)X%1Z1\0Y-;T_0H8;-+;6=4GGMWAE)9+=H 3*QQ@
ML.!@9&=PY&#0!WM%<1/XRU+3[KQ#I5U:VDFJ:98'4;=U+1Q7,&#SCYBI# @C
M)SZU@^)/$?C&?X9SZ[C3+&VNK*UDC,.]YAYK*KCD@+PX(/) XZ\@ ]5HJ&V%
MPMN@NWB>?G<T2%5//& 23T]ZQ_&SW<?@G6Y+.5(I4L9V+.I/ C;.,$8/H?TH
M M6GB31[_4O[/MK^*2Z,?G+'R/,3.-R$C#KGNN15R_OK73+">^O9EAM;=#)+
M(W15'4UQ.CS:C8>$O"LWV?3F+6D2-J,L6U+&#R0<MEP26*JO! Y'I2)XYOKC
MP'XDU=;2RN+G1[BXMV&66&=8P#O Y(RK#Y<_C0!WD,T=Q!'/"X>*10Z,.C C
M(-8VWPTWC+ CL&\1K;%MP13.L((&2>H'S >^:Q=2\5:Y#JOAO3M/L;!VUFTE
ME#S2.!&Z1JW( X7YAZD]..M5(O[0;XKZ4;X6T>HGPW-YOD[FB63SH\XS@E<T
M >@T5Q&G>,-2G\/Z[)>06D>MZ9=&T%HBMM>0D"'J<D2;EP>.OM789NELLXAD
MN@G(R40MC\2!GZT 3T5Y8OQ%\3)X*L?&4VD:=_8Q;_3(HY7,ZH9"F].V!QP<
MD]>.VY-XE\37?BW5=#TBQTH_8X;>XCEN9I,.DA;(.T=<+QQ@=R: .WHK@;[Q
MSJKV%QJFB::]_!!=- +-+&=Y+A$D\MV251L4Y#$#!X')!.!9F\97$WB+4-&L
MY;&WO[7RC#97J,LMVC(K%D.X#C++C!Y0YQG@ [6BN,U;Q;J!N=8M]$MQ++I9
M$91[*><7$NP.4#1\)PRC)SR>@ R8?^$PUZZUW1M-MM'@M6U/3GNREZSK) Z[
M05=<#@%NG4\?=H [FBO*]>\7:]>?#/6KI6M;/4=/U/\ LR[:%699!YR1DQY.
M5R''7)Z]^1Z?;"X6W073Q//_ !-$A53] 22/SH YYM$\'>)M3N[I],TR_O;2
M8V]S(T"LRR  [6)'. 1US721QI#&L<:*D: *JJ,  = !7 MXUU6'PUXQU,:=
M8"YT2\EB$8D;;(J1HVXG&2>?05<MO%&M1^)= LM1M+%;/6X)'A\AF,D+I&'^
M8G@@@GH.#W/4@'9D XR!QTIEQ<0VEO)<7$J0PQKN>21@JJ/4DU1UZ]O[#29)
M]-LQ=W6]$5&8*JAF +MR.%!+$>U86A^*)=8U?Q!H\TEG<K80Q21W=H"J2K(K
M<8+-R"I&02#[4 ;#>*="73;/4&U2W%I>NL=K(6QYS$X 4=3S6O7C,7_)"_!W
M_7]8_P#I0*]CF,HA<PJC2X.T.Q52?<@''Y4 /HKS*'X@>(G\&:3XJ?3M.^QW
M%RL%Q;J[^80TQB!0]!@XX.<\].E=!8^(=9C\:3^']4M;)B^G'4+9K-FR KA#
M&V[J<L,,,#VH ZVBN%LO&>ICQ!X?TW48;%9=6$HFM(B?-L76,R!7;<0V0,'A
M?6J.B>)]4TZU\::OK-S#=6^G:G+"L443*Q*QQ!%4[B #D#H3DDYH ](IDLL<
M$+S2L$CC4LS'H .2:Y&V\1Z]_P )';:>^F&ZM;N"1A=)97%NEM*HR$D9P05;
MH&&.>U4?#OBKQ5KOAQ->.G:0EF8+@M&9I YDC=E7'!&W"G/?(SQG  .VT^_M
M=4T^"_L9UGM9T#Q2+T93T-,U/5;#1;"2^U*[BM;6/[TLK8 _Q/M7,:?XGU.]
M\*>'-2AM;.VCU"$2W=S(<062;-P^4L"<G"CGC-8>M^(Y?$OP?\737$<(FLS<
MV;/#D))Y9&'4'D @@X)/UH ]-CD66-9$.48!E/J#3JJZ?G^RK7 !/D)@$X_A
M%<7I7C#Q!>KJ=_<V6EP:5I%_=6]\PE=I#'"N=T?&"<COC.>@QD@'?45P]KXN
MUJ6_T60:5)<6&I,%F6&QG1K+<,JS2,-KKV) 7'7D5)X?\87/B&_5+2;3R8KF
M:&]T]PR7-JJAPK-EN<LJ _+CYN^* .THKS1_''BZ;0=8UFST?2F@T>\N(;F%
MIY"\J0G#>6<8! !.3U]..=@^-6U26.'11M9K"&^,LME-< "8$QH5BZ'"DDD\
M<8!YP =G17%Z9XQU+58M%L7TMM-UJ_BFEFAO(VVVZ1$*6V_*6W%EVC(X).>.
M<OQ7K/BR#PJ#<16VG7(UF&S,B#>MS TJA9$ ;*!LX*DDX!'&<T >D45QNI^+
M+JP\0#0'N]-M;]K-9[=KN-ECO9"S QH=XVXVKG)8_/TXYZR)IY+)&95CN&C!
M((RJOCZ],^] $&JZOI^AV$E]JEY#:6J?>EE; SZ>Y]A5Q6#*&4Y!&0:\;O+[
M5]3^"/BN[U6Z@N&:6Z4%(BI!6<KW8C;@# [#N:[6U\0ZO9^+M,T;4[:R6TU*
MTEEMF@9C)$T04D.3P<ANH P?7K0!V%%>?_\ "=:K<V=AJ^F:7+>Z?=3JIM8K
M"<RK 20)1+C8>,,5QWQNXS7=78N#:R?97C2?'RM*A91]0""?SH QM1\:^&M(
ME=+_ %:WMB-WS/D*Q0X8*V,,P/! )(]*WE970,I!5AD$=Q7D&A:G?Z-\"K;7
MY+33=1>SA:>!+B-@4)D<,Q.3DG=VV\$\UV6J>)-:@\7Z;H5C9V++?64MPLTT
MC?*R;<Y '3YN@SGU'6@#KJ*XK2_%FMW_ (:U&9=,MYM7L-3?3I5B<B'*NH,O
MS'.T*VXC.>#S45MXVO96\56\0T^^ET:VCN8;B$M'%.K(S8(RV""A&02#[4 =
MU17 67C/72?"5Y?V6GKI^OK'&5A9S+%(\1D#<\;3@C'4<<FKTGB37=2T_4=1
M\.V-K=Q65VUM':RDB2[\MPLA5]P5.=V,AL[>V: .E.J6(U@:2;E/[0,'VD0?
MQ>5NV[OIGBKE<RFO79^(_P#8$EG;K;G23>I,&)E)\U4VGL!R?7MS63#XUU2'
M5]!M=1M[**35+AX)K!"3/9':S(78,0V0O(PO7CI0!UUGK&G:A>WEG9WD,]Q9
M%1<I&V3$6S@'WX/%7JXGPS_R5#QU]-/_ /1+5M:MK<MOK>G:)9"+[=?)++YD
MH+)%%'C<Q4$%B2R@#(ZDYXY -RBN.G\4ZQI=BD.K:;!'J5SJHTVQ*/\ NK@-
MRLV,DHNW<2I)/RXSS4Z>(]1LO%R^&]1BM99KJT:YL+F$-$DA0X>-U)8J1D'(
M)R.PH ZJF3316\+S32)'$@W,[G 4>I)KS:U\?^(9?"FD^)9]/TU+"XO1:W,2
MNYDPTYB#(>@QQP<YYZ5T_P#;M_JNNZKIFC?9$&EA%FEN49Q),Z[@BA2-H"XR
MW/+=.* +Z^)]$;2[34UU&$V-Y,L%O."=LCLQ4 ?4@BM:O)/">NW>@_";P;)!
M:6TR76H1VDOG,<QB2X894 <D?48]ZZ2TOM;F^*VJV)N[9K*VT^"2.$Q,,!V?
M/.[[Q*C)QTQQZ@'5Z?JECJJ3O8W*3K;SO;RE/X)$.&4^XJY7!6GCR:+PYJ5]
M=V-NMY%K<FDV]O"Y"RR^8$4EB.Y))..@Z5I2^(M2TGQ7I^B:I':3KJL4ILKF
M!6B EC7<T;@EN".0P/MB@#JZ*\R'Q \1+X1;Q-)IVF+9VM^UM=1!W,CH)_*R
MAZ C(//7G@=_3: "BN9\9>(M0\.Q:2]A9V]S]MU*"R<2R%2/,;'&!^I/'H:I
MMXDUJUO(-&OX[)-5DCEN6EM+:>YB2$.%3Y%PQ9B?4 ;3ST% '945Y_\ \)_?
M6FCVD^MV(T:234GL);N[MY!;J%4LLH5MK;7P ,D8).3QS>U#Q/JVEV>B7$J:
M?.NH:O'8%H=Q5HI&.V5#N/\ " <<]>O'(!U\TT5O"\TTB1Q(-S.YP%'J35?3
M=3LM8T^*_P!.N4N;27/ERI]UL$@X_$&LBQUZ[F\=:GH$T<)@MK2*ZCE0$,=[
M,-IR2.-O4>M><Z1?:I8?"#P6-,N8H!<:M%;R[XRQ96NFP 01@9'/J..* /:*
M*XO5/%MW9Z_)H(NM-MM26S2>W%W&RI?2'<"D9WC;@J!U8_-TXYZ\S"&T,]P1
M&$3?(>RX&30!+52_U*STR$2W<WEAB0JA2S,0,G"@$G !/ Z UQMSXWU.#P=#
MXS6TMGT=BLCV@5O/6W+[1('SM+8(8KMZ9&[C)CUB74;CXL>'3:W5KY#:==2P
M;X68!3Y62<,,D]CQ@>M ';Z=J5EJ^GPW^GW,=S:3#,<L395AG'\P15JHK>V@
MM(1#;0QPQ DA(U"J"3DG ]22?QJ6@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YWQS
MH5YXF\'W^BV3P1RW:JGF3,0J ,"3P#GI^M=%10!RLVAZM-XYTW7R+)8;:PDM
M7B$S%B796)!V8P-N/?/:L*3X>ZK<:)J4!OK6UU%M<?6]/N(BSK%*3D*X*C(Q
MD9'KTXP?1Z* .:M;'Q/=:5>_VS/IIO9;=H(8+/S%@4D<LS-EB>G;@#W)K$/@
MO68O"/A:RMI[#^T_#\\4J&1G\F=51D()"Y7(;/0XQ7H%% 'GUQX U'6+CQ7_
M &O?6@@U^V@BQ;QMNA>)3M(R>0"?QQVS@.D\->+]1?PVVI7>CB31KH2O+'YC
M&X 1DW%2!M;GIDC/.1TKOZ* .#L?"_BO0=4O[;1=4TT:%>W+W(%S$[7%HTAR
MXCQ\K#))&[IZ'G-F'PSK>B>+]1U71+FREL=56,W4%ZSAXI47:)$*@[LCJ#C)
M[BNFL]6L;^\O;2UN!)/8R".Y0*1Y;%0P'(YX(Z5=H YOP)H%]X7\(V>CW\]O
M/+;E_G@5@N&=F[]?O>@J&+0=5@\;:OKJ?8FAO+*.VBC,K!@4+$%OEQ@[NW3'
M>NJHH \ZA\#:U#X%\.: )=/:;2+Z&Y:4RN%D6)]X &S()SCVQWKN[^T-_I=S
M9LWEFXA>(L.=NY2,^_6K5% 'GO\ PAOB%O"OAG299],:31;RVGW*TBAT@& /
MNGYF[GH/>MFWT/58/'6H^( +)H;FQCM4B\Y@P*,S D[,8.['MCO74T4 <-H'
MA;6]#\':3H;#2[Q+4R)=0S,WE7,3%B.J'!!(Z@CCWXU_!OAD>%M+NK12B1SW
MDES';Q,6CME;&(T)P2!C/0<D\5IV&MZ;JEY>VEC=I//9,J7"IG]VQ&0,].@[
M5?H YFPT+4;7Q]JNN2&U-G>VT,"HLC&1?+W8)&W'.X\9X]ZR=.\+>*]!U"]L
MM'U73AH%W<R7"_:(G-Q:&0[G6/'RL,DD;NA/0]^\HH \\TTZC%\5_%@T^*VF
M LK$,+F9D.=LFTY"MGOG^=2_\*]GL+70KO3+R(ZUI5U-=-),I6*Y,Y/G*<9*
M@YX/.,#@UT6H_P#"-^%Q=>(;V*RL68 3WGE ._H"0,M].:VU8,H8'((R* ./
MO/"M_J$VN:I/]D35-0TW^S((UE8Q01?,22^T%B6<G[HZ >],O_"&H:C\*D\*
MR3VT5[%:00+,I9HRT10@G@$ [.?3/>NS9@JEF("@9)/05SK>//#,>H6]A)JB
MQW5RT:V\;Q2+Y_F'"%"5PZD_Q#(]Z (YKOQ-!X@T6!GTN2VF5Q?0Q*_F(<$A
MT)XV# &3U)]QC3\26%UJOAO4M-L_)$UY;26X:9B%7>I7/ ).,]*U** .%F\*
MZ_\ 8?"0@GTXS:$ DMO,SM!<8B$8DX7(9<$@8.,]:@7P3KJ^&_%VE/>:=*=<
MN9YHY KIL,JA6)Z],< 9^M>@T4 <;)X;UB37?">H9L0FBV\L,R><^9#(BH2O
MR<8VYYZYQQUJY<:)?GXAV_B(/:BRATY[-E:1@_S.KEONXXVXQG\:Z:D90RE6
M ((P0>] '"0Z=IFN_$J+6]*U".XMHK-6O1;2*\4LH)$!)'!909#[83VKNST-
M9L<6C^&=/6.WMK>PM3)A(;:';O=NRH@RS'T )XI=.U32_$FFR2V4R75J7:&1
M2I!5A]Y&5@"".X(H \W\$Z)J'B;X.Z7HL_V6/3+DGSIUD8RF(3LQ0)MP"<;=
MV[@'..U=GI^@ZC:>/=4UM_LGV*]MH;=461O,3R]V#C;CG=TSQ[U=:?P]X0M[
M2S46FF0W4ZP6\$4>T/(YP %4=R?\:VJ .#T[POXKT'4+VRT?5=.&@7=R]POV
MB)S<6AD)9UCQ\K#))&[H3T/>3Q1X.OO$\%Y8W<>GO"94>POV=Q<V0 7)'R\G
M(8CYAG/-=Q10!P]QX:\3Z5XJO]4\,W^F_9-4V/=VVHHY\N55"^8A3J2 ,@XZ
M=?2X_AS5?^$RTC6/M%O/#8V4MM*TKLLDK2%27P%('*],]^V*ZRB@#SN;P'JU
MUX3\3Z1)<64<^JZH=1@D5G94/F(X1OE!_P"6>,CUZ<5WMF+L6D?VTPFYQF3R
M00@/H,\\=,]_0=*GJEIFK6.L6\D^GW GBCF>!V"D8=#AAR.QH XQ_!FM2:!X
MQTXR6 ?7[F6:-_-<B$.BH0?DYP%SQUS6A/X<U>?6O"5]_H2KHL<JS+YKDR%X
M_+^7Y.V,\]>GO7844 <]XTT.^\0:"+/3KF&&=+B*?9< F*<(P8QR8YVG'-9M
MAX<U^U\4ZOK4T^F.-1LH83 @==CQAP #S\OS?>QDXZ"NSHH \['@?64^'>B>
M&UEL#<:=<PRM*9'V.L<F\8^7()Z>WO7H#&7R"51#-MX4N0N[TSCI[X_"I**
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MTA;!K538ZE!?L9W9=WE'.T84]?7M[U5\3>'-;N==T_Q%X<O+2WU6VA:VFAO
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M6>T1-,@FBDB#,3)YH4$@XXQM!QWSVH =\13=+\/-?>UFCB9;"<N7C+$KY;9
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MUC*(\> 0,'K@DC/L?3- %+Q-KVKZ5<7GD?8;6UALC-!+<J96NIAN)C5%<,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;R6R%59#&K@GYCD_-US74T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5R6MQ^*/\ A)8KO3])T^_LK>+_ $<3WS0E
M)&R'<@1MDXPH.> 6_O5UM% 'F_PFU*:S^'"7&L+9V&GPS3F.Y:ZX;-Q)NWY
M"X8X')S[=*](!! (.0>]47T72Y-+;2WTZT;3VSNM3"OE'+;C\N,?>Y^O-70
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M,;?VA>%8V(!RT";<#W/2KDFEZ7JGC3P.MS:VUS%<:).)0RAEE"I%@-_> R<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^>80DA@0%#$'D8& >H%7_%<>F:;H7B'5-%U>YU)+ZXLSK#Q/&\2P[PK8\M0
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MXPNX-DDX]><^]8FGW>F:=X;NK6Y@5HE\:2P6,9E,4,,@E+H7(Z(N"=O<X'N
M#UJ'4["YM'NX+ZVEMDR'F2561<=<L#@4D.IZ?<77V6&^MI+CRQ+Y23*7V'HV
M <X.1S7D5S+:7"?%B">[LKMS9QS+Y:@*SBU.65<GD$ 9R3D=:U1965CJ_P ,
M)[6WAAEE217D10&D#6I)W'J<G!Y[T >DS:G86]RMM/?6T4[8VQ/*JL<], G/
M8T7>I6-A;BXO+VVMX"<"2:544GZDXKR:^BM]1TWQMX8;4-.EFU#5G=+J>[C3
MR<^6=KJQWYCVX& 0< <5L7MU8Z-\1K?3K[4QI5A)HZ)I\JI"D+L)&\U074J"
M1L.!C( ]J /28Y(YHEEB=7C<!E=3D,#W!KE_'WBR7PCH2WMM:F[N#*K&(#.(
M5(:5S[!,C/JRU8\$Z;I>D^'$L]&O)[O3DFD,,TK*P.6R=A4 ;-V<8'KCBL\6
MUYXEU?5+ZVGL6T]4?2XUN(&E#J#^^(VNN,O\A_ZY"@#K;:XAO+6&YMY!)#,B
MR1N.C*1D'\JACU73I;N2TCO[5[F($R0K,I= .I*YR*\T\+7VIV'@'Q3X1CF,
MFO>'8IX+9D^_)&4+0.H]>< =L"M7PU>>#]<TCPE<6\L$U_9Q!;6"*7][$YCV
MRAU!S@<EMW''?(R =3H7B?2O$?VHZ9=Q3K;S-"2C@[MN 6 _NY) /?%8_BW7
M]:TGQ%X=T[39+!8M6N'@=KFV>1H]J;LC;(N>A&*J?#*6V%IKMNKQ"Y76[XF,
M$;POF^G7'(_.J_Q#C6;QAX$A,SQ%]0E :-MK#]UV- &GI'BC4?\ A/KSPEJT
M5K)-'9"^@N[1&16C+;2K(S,5;)_O'(]*Z4:IIQMWN!?VIAC;:\@F7:I]"<X!
MK@O!8C\-^,M5T'6SYNLW9,]IJL[$R:A;YX0D]&3H5&!C! [UF2W=I::7\5K:
MXGABF>6<K$[ ,V^U7:0.^30!V.O:Y?V7BOPK:6<]N=/U.>6.8>7N9@L3.I5L
MXQP.WXUOW&J:?:745K<W]K#<2\1Q23*KO] 3DUYR)XI9/A0T<J.N",JP(S]D
M(_G5*&31-:@\6Z'XHU^33[C^TYC/;NT*,\6X&%T+H6/R! ,$G@>HH ]3N]4T
M^PD6.\O[6W=AE5FF5"1Z@$U;KROQ''J&F+K6J:=+!JVG)8Q1ZUI.HG9.(UBS
MO1QT8JQ)!&,AL<UZ?:SBZM(;A4=!+&KA7&&&1G!'K0!SMIKVHR?$6]\/W$5L
MMG%IR7D31[B[;I"GS$\?PG@#OU-0^,;_ ,4Z9IU_JND/ID=KI\+3F&ZB=WN0
MJ[F 96 3C('!R1VJM;D?\+MOAD9_X1^'C_MO)5_Q=8Z1XCT2_LKC67M'LU\R
M22VO#&UNX&Y6<*>V <,/I0!LQ:I"FD6U_J#)8"6)'=;B0+Y;, =I)QR.E6;:
MY@O+=+BUGCGA<962)PRM]".#7G(U25;;P FNJJ>(9X9)4GNW*10L(0'9U!&Y
MRK !>.2>1BF> [K4)-"\10Z!<Z7<7R:_=,OVEF$7EE@=P"9(!ZCM0!Z-?/<1
MV,SVBQ-.J$H)20N?? S6/X,UZ?7_  3INMWXABEN8#++L^5%Y/3)/&!ZU;TX
MZQ_8\QUT6 N_F_X\BYCVXX^_SGK7._#.XMK;X1:)<7<L45M'9%I9)6 15!;)
M)/ % $?AKQ-KGBK4_MNFZEX;ET$2G=#'YCWB1\[=V&VJQP#R.,]\5T4&L-J/
MB.[TVS*B'3@GVN7&29'&Y8U^BX+'_: '<CF=0T32!XR\.:QX:%K%?R3,+HV1
M4)/9F-BS.%X(W!,-ZD>V'?#L3)/XV20?Z4/$-RPW?W2J&/\ #&* .R_M33_[
M0^P?;[7[:1G[/YR^9CK]W.:H6VL/%XDET*]*^>T/VJTE QYT0;:P(_O*2,XX
M(8'U \V\.'0O$7@_28-6\0W<6KV-XLDEBC0)<K>JYS@%-Y+,2<YY!.3P<=1X
MG5V^*_@3R<[E34#+C_GGY2CGVW;?QH [>:>*VA>:>5(HD&6>1@JJ/4D]*A@U
M.PN;1[JWOK:6V0D/-'*K(N.N2#@5SOC^]L+/3-+%_#YIFU6V2WWRF.-)MVY&
MD(_@&W)'? 'N.%N);6X/Q8@N+NRNW:PCE7RU 1G6U?+*N3R" ,Y)R.M 'K<.
MJ:?<70M8;ZVDN#&)1$DRE]AZ-@'..1S6)XV\1#0?#6ISV>H6,&IP6KSPPW!#
M%]JDX";@3G!YY^AKD5LK*QU#X77%K;PPS2AE>1% :0-:$G)ZG)QUK-CO[2^^
M%'CN/57A_MA9KTWD<Q <2 GRN#S@ (%^G% 'K6DW$EWHUC<S$&6:WCD<@8R2
MH)K$GU[48?B-8Z"T5L+"YL9KD.-QD+(RC![ ?-[_ %K3\-RQS^%]*DBD61#:
M1893D'Y!7.ZB1_PN70AD9_LBZ_\ 0XZ +/C'Q5)H]U8:5IVH:/::I>;G1M6<
MK$$7 (^4@EB2 !GLWI6YI;ZE!HZR:_/8?:U#--):*R0JN3C&\D],9)-4];MO
M"^M&XTS65TRYD2'?+#.R>9'&<X;GE1UYXKSNY>YT/P;X1M]2GD?0UUSRY9I^
M]H)'^SF3/\/$9YXX7- '8Z=XFGO_ (DSZ1;WUE=:4-*%W&;< D2>;L(9@QSP
M/;KTKKSG!P 3VS7G9G@_X73?'39;(WLWAQ=FYQM>43';NV\GC;TYQ75Z$?%!
MDF_X2!='$>!Y7]GM*3GONWCITZ4 4_"6O:AK-YX@@U".VC;3M1-K&(,X*!%8
M$D]3\WM65?>*=9U3Q5=:-X7U/PTDED1'/#J)D>=WQN8HJ,/E ('U!J7P&0==
M\;8(_P"0VW_HF.J7CG2_#VO^';C4-*>R;7()?^)?=V3)YWVI6X3<O)RW!!Z<
MGMF@#JM2UAX=6L-$M2C:A=H\K,1D0PI@-(1[EE4#U/?!J]=ZGI^G&)+Z_MK9
MI#A!/,J%S[9(S^%<=:"9?CA=_:>6;P]'Y1'3 F._'_ B/TK(DNM+O/%/C/0_
M$NMG36N&0(DK0HDMH85 V-(AZ-O/!X))ZYH [G5=8?1=1L6NBITZ^F6UWXP8
M9F^YGU5B-OJ"1U!X'UA[#Q-;Z3>E3'J".]E*!@ED&7B;WP=P/< @\C)XSQ]:
MQVWP6BM-.EN9BALH[*2X_P!:Y$T80G@<X]@:TOB$LC:UX'6#/VC^W8SQU\L1
MOYGX8H [EW2*-I)'5$4$LS'  ]2:KVNIZ??Q226=];7$<?#M#*KA>_)!XK ^
M(EWIUGX*O'U2!Y[1WBC,:RF(%C(H7<X^ZN<9/IGKTKE()[:X^(_B."\O=/NS
M<Z%%O2$ 1NRM)\N"3N('?^5 'I$>KZ;-/#!%J%H\TZ>9%&LREI%]5&<D<=14
M&MZK!IUC*#J%G:W;1L8/M+##,/\ 9W MSZ&O*+&RLK;X>_#2]AMX8[I]6L0T
MZJ [;@P8%NI!'&/8>E=!H]_:3ZU\0;37'A6]$Q41W! S9>4!'C/\/+$^[>]
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MZZMI+FWU"UEMXCB26.965/J0<"E&J:>;0W8OK8VP.TS"9=F?3=G%<C<VK?\
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MJQ@FE8 #<[("3@<#DUF^.M<U/P_HUO>Z<+;YKR""7SE+';)(J';@CGGOGZ4
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MYIEK>7UNDFHOB+=*H 3:6WDG@+QC/<D5N*RNH92&4C((.010 M%%% !1110
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MS$DX')Y7U%;[Z-I<CL[Z;9L[')9H%))_*GC2M.$!@%A:B$MN,?DKM)]<8ZT
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M"23P:]8^P6?VK[5]D@^T?\]?+&_TZ]:1-.L8[Y[Y+.W6[<8:=8E$C#T+8R:
M/-I)K[0]4^TVLUMK?AR[UXI);N-MU8W33D'81]Y0^3@\X/IDUZE51-+T^.\-
MXEA:K=$DF985#DGK\V,]ZM]: .(\"NK>(_&X5@2-8YP?^F,?^!JE\0(;#7=#
M75="UEFUNQG"Z<UG>E@T^[:8R@;:202#QG&<\9KN[?3K*TD,EM9V\+L,%HXE
M4D?4"FP:5IUK=275O86L-Q)DO+'"JNV>N2!DT <1KVIZ>OC>]LWDMK'4!HH$
MUU<.3YL3.V(XD)"D[LDMSU P>T'@B?7[OX9^&O\ A&KO1R8K7R[K[<LDFU@!
MA1L88(&<@^U>AR6=K+<QW,EM"\\0(CE9 63/7!ZBG06\-K"L-O#'#$OW4C4*
MH^@% '#_ !.-TOP=UG^T&@-W]D03&$$1E]RYV@G.,],UUM_J.F:?81S:G=6T
M%M*RQA[APJ,S=!D\<U9N;2VO$"75O%.H.0LJ!@#^-,DT^RFL_L<EG;O:]/(:
M)2GK]W&* .'M=#MK;QIK%UX7\J*UN=*=+N.V($7VO</*( X#[=^<>H)^]S?^
M%;(/A;H)&%"VQ#9XP0S!L_B#7706\-K"L-O#'#$@PJ1J%5?H!69I^AQ::UY;
M1+&^F7,CS_9W7/E.QRX Z%6)+8[$GJ"  #G_ (0NK_"[12C!AB49!_Z:O3/A
M&KCP/O.?(DO[M[?_ *YF9L8]LYKJ+G2U6QEM=,2"Q,XV/+%&%9%P<E0!@MZ9
MX&<\XP;.GV%KI6G6]A91"*VMXUBB0?PJ!@4 >/>.-4TZY\/>/X+66WLI$N%2
MXAE??<7<JK'AU!/R( !C .=I.1720IIFH_&:TG5;6Y5_#AE5P%8,?M &[/<X
MR,UWLFG6,LLTLEE;O),GERNT2DNO]UCCD>QI#IFGF7S38VWF8V[_ "ESC&,9
MQZ<4 >+VUZFG>$]):0A="M_%TRWF/]7'&)7*;NP0/M/ITKL+6^TV7XYR-;75
MJ[3>'E7,<BG>PG)QQU.W!^E=PFF6$<$L"6-LL,HQ)&L2A7'N,<T6NFV%D5-I
M96T!5/+7RHE7"Y)VC Z9)./>@"6Z(6TF)( $;$D_2N-^&EW;6?PBT6[NIHXK
M:&R+RR.<*J@MDD^U=I-#%<1-%-&DD;?>1U!!^H-1PV-I;PO##:P1Q/G<B1@*
MV?4#K0!Q&H:9H][XQ\.:SX;>T_M#SF-U+9,I66T,;;C)MX(W; ">YX]L2QU6
MS;0OB/8ZU/!'JINKSS(KA@&>$QX@VYZKM  _^O7J-G86>GQ&*RM(+:,G)2&,
M("?7 %,GTO3[JX%Q<6%K-.$*"62%68*>HR1G')XH XOPY+XEN? OAA_#5UH9
MMETNW27[8DCL) @! *, ,="#SFI?B<SIX(MC<M&)?[0LMY7A=WG)G&>W6NXC
MC2*-8XT5$4855& !Z 5%<V-I>A1=6L$^W[OFQAL?3- $&J:AI=A#$-5N;6"*
MXD$,?VEE57<@D+SP3@&N ?0HK.Y\:MX7")I]WH[ Q6_^J^V[9!\@' .W;D#N
M17HD^GV5U:"TN+.WFMAC$,D2L@QTX(Q4T44<$2Q0QI'&@PJ(H  ] !0!R?A2
M6$_"+29%91&NBQY/88B&?U!IGP^DA_X5+HKR,IB731O/; 4Y_K6UIF@PZ9;3
M::J12Z4SM)#!(N?*W-N*8Z%<DD>G3H!3M1T2*ZTR73+5(K.UN04N3"H1BAX8
M+CH2,C/;/'- 'F^GH\'[,#B]R&.DS%=WHS,8_P!"M>FZ!'/%X<TN.ZS]H2TB
M67/7<$&?UJ'4="AU&WM-.=8X]*@:-VMT'^LV$%$(Z! 0IQWP!TSG7(!!!&0:
M /)X&OI?#/Q031V+7_\ :=SY8B/S_P"IC!QCO@-CW%6=9>UU;PKX#N= :/[4
MM_:&S\K&Y(PN)5..BA 0P]N:]&M].L;20R6UG;PN1@M'$JD_B!26^F6%I<RW
M-M8VT,\O^LECB56?ZD#)H X7PAI>E7'C?QH9+*TED@U.!X]T:MY1$*D,O]T[
ML\CN/:KOQ5=8_"$,LC!8X]3LW=R<!5$Z9)/85U\&GV5K*TMO:6\4C##/'&%)
M^I J2:"*YA:&>))8G&&1U#*P]P: .#N6L-3^,NDOF"YB_L.=XSPRD^<@!'Z\
MUR$=Z-+\)O<+))#I-EXSG%VUNH800;WVG:01M5RC=#VKV4Z98-,)C8VQE  #
MF)=P & ,X].*6+3K&"*2*&SMXXY1B14B4!Q[@#GK0!S'AF'0+CQ-J&KZ1K$F
MJW=S;QK=S1RQO" OW ?+4#?C/OCKCC-#QA:65Q\3? RW,,#[VO@1(H.[$((!
M]>:[BTLK33X!!96L-M"#GRX8PBY^@I)M/LKB=9I[2WEE7&UWC#,,>A(H \YG
MO=,T/XB:GI6IZBFAV$^GVZZ=\D,=NT2[Q)&"Z%5^9LX&,Y^E5;A-&\,#P)<6
M&I_\2VSFNU@CU"X5//B=&'F+(V%^7(VYQE7XKT^\T^RU!$2]L[>Y5&W*)HE<
M*?49'!KG_$NAZO?ZI9WE@-*O+6&%XWT_4T;RRQ(/F*RAL, -O*G@GU- '+Q:
M9IH\#>/=22YTRZ.HB[NRMK*DP@!B.U2P_BRNX]LGC/4R1VM_<:3X.N?#^K6U
MMKEOHBF*UNUW0W<)2+>IQR""J'(KJ-%\+06LUQ=WNFZ3!-<1K$]O8P 184D@
ML2!O.3U(&.PZYV)=&TN>%(9=-LY(H\[$>!2JY]!CB@#S(:S;7,GPWU:XM8M)
MM_M=XLD;R#RXF$4B\,>-I()7V(K5T+3=)O\ XJ>,Q/96D^(M/D59(E;!V,=V
M".N0IS]*[^2SMIHHXI;>%XXR&1&0$*1T(';%-CT^RAN&N(K2W2=LYD6,!CGK
MSC- 'B]]K.EW.AZ+<V=S:V-HGBJ*7[$TFZ>,BX;S))68Y7.2<8  8<FNDTZS
MTNZ\=?$-VM[61?LMH02BD - Q8_CQFO0?[+T\^;FQMOWKB23]ROSL.0QXY(]
M:#I6G%Y'-A:EI,[V\E<OGUXYH \ETR[A@\/?":[NKA(X(W97FE<!5_T=P 2>
M!Z5[(CK(BNIRK#(/J*K#3; 0+ +*V$*N)%C\I=H8?Q8QU]ZM4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %0W=Y;6%LUQ=W$4$*XW22L%49.!R??BIJY'X@ZC8Z;IVDR7T$+
MA]5MUAGN'98K67)*RO@C(7!X) )QDCK0!NIX@T>2QGO5U2S^RV[%)I3,H6)A
MV8D_*?8TEMXAT6]U'^S[75;.:]\L2_9XYU+[" 0=N<XP0?QKR>XO[*2/XL1M
MJ,-V\MA'+&_R@2?Z(1N4#C&[ !^G))R=ES96^K?"QH3!'E)0"A R&M3G\VQ^
M- '1^/?$\>B>%]6>RU>VM=5MK=I(U;:S!L$J-IXR<<9ZUT6FRRW.C6DSOF:6
MW1F<C^(J#G'UKR!=8LO^%3>,]+U>XACUY);TW<$[ 2/(S%D8 \D;=N"/[OM7
MK'AZXAN/#6F30RI)$UK&0Z,"#\H[T <QX/\ &,3Z?-'XBUNT%\VJW-I;B5DB
M:14D*J%7C/\ ]>NKU#7-*TI]M_J-M;-LWXEE"D+G&XYZ#/?I7C=V;(_!?QG.
MA@\PZS<-Y@QDD7(*G/TZ5T?B76-,DUWQ39)-;V-T='023.VZ6^4I(52)2=NT
M9() ));'&,T >A2ZUI4-Y;V<NI6:75R-T$+3J'E'JHSD_A4@U*Q-Q/;B\M_.
MMT#S1^8-T:GNP[#CJ:\RD7S_ (1>%/$NELMQ?>'K6VNAY9R718E6>+/NF[/N
MN*T/%37<GPYOM=AAG9KNY@OIXHU_>?9%D0A<'_IDH)!XR7H [BQUO2]3DFCL
M=0MKB2$ R)'*&* ]"1Z'L:FL-0L]4LH[VPNH;JUDSLFA<.K8.#@CW!'X5QV@
MW'A;6_$\.N:7K,VJWZ631/*LB[8H"=VV0*HP=W0'GKZ&NHT"ZT>\T2VGT$VQ
MTQPWD_9D"1\,0<  8^;/XT :5%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,EABGB,<T:21GJK
MJ"#^!I]% $+6MN^[=;Q-NP&R@.<=,_2D^PVGR_Z+#\OW?W8X[\5/10!7DL;2
M:9I9;6!Y&787:,$E?3/I[5.5!7:0"N,8QQBEHH K_8+/:5^R0;2<D>6*>+6W
M#JX@B#HNQ6V#*KZ#VJ6B@!BPQ)"(5C01 ;0@4;<>F/2G  # ''I2T4 0V]K;
MVBLMM;Q0JQW,(T"@GU.*?%%'!$L4,:1QKT5%  _ 4^B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HILDB11M)(ZHBC+,QP /<UC)XR\+R$A/$FCL0<';?1'GT^]0!MT
M4U)$EC62-U=&&593D$>H-.H ***J:;JECJ]I]JT^YCN8-[1[XSD;E)##\"#0
M!;HHHH ***"0 23@#J30 452TW5]/UB*:73;R&ZCAE,,CPMN4. "5R..,BKM
M !1110 454U+5+#1[&2]U*[AM;6/[TLSA5'_ -?VJS'(DT22QMN1U#*1W!Z4
M .HHJDVL:<FKQZ2;V'^T)(S(ML'R^T=3CL/K0!=HJI8:I8ZH+@V-S'.+:=[>
M;8<[)%^\I]Q5N@ HIDTT5M"\T\J11(-SN[!54>I)Z5!IVHV>K6$5]I]PEQ:R
MY,<L9RK8)!Q^(- %JBBB@ HHHH **** "BBB@ HHHH **** "BJ5YK&G:?=V
MMI=WL,-S=OY=O$S_ #R-[#J:NT %%%% !1139)$AC:25U2- 69F.  .Y- #J
M*J:;JECK-BE]IUU'=6KE@DT1RK%25.#WY!JW0 4444 %%%% !115+4M8T[1X
MHY-1O8;999!''YKX+L3@ #N?I0!=HHHH **** "BBB@ HHHH **** "BBB@
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MI&!>)ODX.,C.#UZ<<YLWPQ\[3==BM9(-(DOKF"[LX;0EXK2>+D.,A>6/4 #
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M:S-(Q6&23(B@/4[ WWF'0$G'2NMU[1[?Q!H-]I%T6$-Y"T3,O5<CJ/<'G\*
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M/!R/3H>YZGN*XZ?PYJ\^N>$K_P#T%4T6.5)U\YR9"\8C^7Y.V,\]>G'6NQH
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MN.V<@ ]!JM?:?9:I:/:7]I!=6[_>BGC#J?P/%<U8:[KFIZI>:)$^FP:CI=M
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M+<AD!)(<9.#P>W/!S0!V]%<2?%>KZCH6KZ]HL5D]GI\TR1V\R,7NEA.'(<,
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M#00PV:ND"Y'+,6RS$\=A@# ZDU=L/$^CZGJ1TZUNRUWY(N%C>)T\R(G ="P
M=?=<BM>@#@(/ >H6VA^%O)N[9-9\.96"7YC%/&R[71N,KN&.1G!'>M5O#FIR
MZEJ6O>?;6^M7%K':6P0L\5O&C%\$X!?<Q)/ X 'N>JHH XJ'P,)=6UC49HK3
M3VU33FL9X;%BR2,Q.9FRJ_-S@<>N2<U1M_!GB9[7PM#=:CI:_P!@3(4\J%V\
MU%C,8)R1\Q!' P!R<G@#T.B@#F/#_AZ]T[5O$5Q?-:R6^KW/GA(V8E/D";3D
M#.0,YXK,\.>%?%.@)%H@UNSE\.V[_N',+B\$6<B+=G:!VW8)QTQQCK=3U:QT
M>&&:_F\I)ITMXSL9LR.<*. >I[]*NT 8OBSP]%XJ\,WNC2S/!YZ@I,@R8W5@
MRM^# 5FV&A^(=2TZ>Q\6ZA8W%N]L]L8["-T\X,NTO(6/7!.   "<\\8ZRB@#
MAH?!NJ7'ABQ\+:K=6D^E6<D6;A-PEN(8F#)&R$84_*H+!CD \#.1=MO#NJ6W
MB/Q/J@:S9-7BACBC,C QF-"@+';SG=GCIC'/6NLHH \_M_ VKVF@>$[:"\LA
M?>'YLAG5VCF0HR'@8(.&Z>W6MG1]!U*P\9ZUK-Q+:O;ZE%;Q[4+;T,2L >F/
MFW$X[>]:^HZYINDW%E;WUTL,U[,(+="I)D<]!P./QK0H X:S\&ZII6CZQX>T
M^ZM/['U!YFADDW>;9K+G>H4##@9)4DKC/.:MR^$IX?$/A:ZTXVZ:?H5O+;+%
M(S;W5T5."!@8"@^_M7752LM6L=0N[ZUM9O,GL9!%<+L8;&*A@,D8/!'3- '+
M7/@^^U74])O-3%@+K3+T7$>HP%A/)$"2(B-HX((!.X@X/'/&OXRT*[\1^&IM
M.LKI+>=I(Y%,JEHWVN&V.!R5.,&M^B@#B8O#&OKXFO\ 6I;S36-YIJVCP)$Z
MA64MC!R?E^;.<9.,8%55\$ZO'X3\+:,L]B9-$O8+EI2[XF$6< #;P3GKSC'>
MO0** .%C\(ZYI>I:^ND7MA_9FMN]Q+%=*Y>WG=<.4V\,#QP<8_GT'A'1[KP_
MX4TW2+NXAGELX%A\R)"JD*,#J3^?'TK:H/(P: /-/#$.KW5YX[MM/:S6.?69
MH_-F9MT+&*,%@H!#\$<97D=>>-=?!<]AJ_A.33'MQ8:!;RP;)6;S)A(BJ3P,
M C;GWSVK7@E\-:-KZ:7:P65GJE^K2^7!;A&E"\L6*C'YFMV@#E7\.:AIWC.]
M\0Z-);2#4H(X[VUN79 SQC"2*ZAN0IP01SZUDWGPZN$TJTFTO4HX/$%KJ4NJ
M"[>,^5)-*3YBLN<A""%ZYP!7H%% '&ZGX4UGQ)X;N+?6=5@@U1I(IK:6QC81
M6LD3;D90Q)8YZDXXP !C-'_"-:_X@T*_TWQ;J-DZ7%LULJZ;$Z+DX_>-N/+#
M P  !SUSQV5% 'GS^$O%M[9^';:^U+22=%OHK@3K%(6G5$9067( ;#<@''?(
MQ@S7G@_7/MOBF.POK!+#7HRS&9',L4AB\L@8XVG .>H]#7;7-Q%9VLUU.VR&
M%&DD;!.% R3@<]!3+"^M]3T^WOK23S+:XC66)]I&Y6&0<'D<'O0!Q]MX1UBW
MOO!TS7-C*OA^V>WDP'0S!XUCR!SC 7/O[5+JWAGQ!;>+9?$/A?4;&%[V%(;Z
MUOXW:*39G8ZE2"& )&.E=G10!S%YHFJ7$$=K=?V?K%E) R7<%\"BO*6+;EPK
M;0,D!>>,<\<W_"NAGPUX8L-'-PUQ]ECV>8<]R3@9[#.![ 5L44 <,W@.>Z3Q
M5IUY>0-I&NS-< )&?.CD9%'7., H"..:LIX9U;4K?1+37Y[.2'2;B.Y\VW+%
MKJ2,$1EE( 3D[B 6R1V%=A10!D>*=$_X23PMJ6C"?[.;R!HA+MW;">^,C-9R
M:!J.IWFC3:X;-8])?SHHK5F<2S;2BNQ8#: "V%YY/7CG;U+5K+2$MWOIO*6X
MN$MHCL9MTCG"KP#C)[GBKM '!:/X1\3Z!+/I.G:U9#PW),\D8DA<W5LKL6:.
M-@0O4G#'.,]*ZKQ#HD'B/P]?Z/<LR0WD+1%UZKGH1]#@_A6G5'5]8L-!TV74
M=3N5M[2(9>1@3C\ "30!QC^%/%M];^'8;_4M)+:+>QSB=(I"TZHC*"RY #8/
M(!QWR,8,]MX5\4:)K6HKH6L6$>BZC<O=21W4#/-:R.<OY6" <GD!N!Z'G/<1
MR++$DB'*. RGU!IU '%^)?"%[XCL=0TJZ6PN;*8*+.XN"QGLF"*I=>#N.06^
M\O4Y)!JT= O+7QQ;^(6GA:RM=*:P8.S&5AO5S(>,9^7&/QSVK:?7--CUR+16
MNE_M&6)ID@VDDH,9.<8'4=33]-U:RU9;EK&;S1;7#VTWR,NV1#AEY SCU'%
M'E6D'5);$Z_97GA"[LY[E[]&O&EC<,S$J656*+*%(&=N1CN:[6QTG59O&/\
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M'&>#@C@\^];](S!%+,0% R2>PH YKPIX23PQ/JC).9(;BY9[6+M;PDE_+'_
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M;VWOK _8-*&F2QS([JN"/WL8&/F(4 @XX&,FNZJ&ZNH+*UENKF01PQ*6=ST
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M^P1\XPW[_P#=&+C^[QSWYKDH9;C5-0U;6;#6/"4D$M\[&/5H666/RCM4.%<
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MG+$$MUR<'.,@UI6?AW5K'0M%THOIUY:V5B;*ZMKA6$=R $"-T." C<$$?,:
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M<30(R9=+E-O$AM#*MQ,J*Y5FW#:#N"\<C&<]J .YHJEIUY/<:-;7E]:M9SO
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MRRE2589&0>1P>AJQ7%:?XJOM2M_"MC&T,>H:OIHO[B<IE8U"(6VKGJ6< 9.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5S_C+P]<>*- .EP7D=KNFBE:1XC)]QU<
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M)WG<2?0#''-'_A#?$ET/#ZZAX@L93HMTLT<BV+!I@$9!O_>8R0>V.YYKO**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS+;^8BRL6C#,VP=!R3P* .GHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=N&3[I\I<K]..* /&]7\L?#SXH0P;=B:T[;$Z*/W))P/<']:Z/7_ !'8VOQ
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MXHM5B\)_$R:/9_9$M] UITV>=^[\XK_P,X..X/I7M5S:6U["8;JWBGB/)25
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M9V\=NQR8DB4*3ZXQBD.FV!50;*VPOW1Y2\?I0!:HHHH **** "BBB@ HHHH
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M@9YZCDDUU?PSD27X:>'3&ZL%L8U.TYP0O(^M &U?Z_I.ER^7?:C;6[X!(DD
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M3^T;6WBN'V1I-,JL26(08/\ $0 <>]:$'B71+FR>]@U6SEMDF,!ECE##S!_
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MC3PP&1?[?TW+AV7%ROS!/O$<]!@Y/L?2KHUW26TV/4AJ5J;&1@J7 E'EL2<
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M271!98ED!9@.I7^]COCI6E7EOAG4/"GB5/#92^N[C5]/*F*PW;9+1U4+)N4
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M4NP0=7(4$A1GECQ7,>)_$3V6N^$;NUUA(]'O9I?M!!3RI(Q"SA]^,XX!X.*
M.S>"&25)7B1I$^XY4$K]#VHFMX;E D\,<J YVNH89_&L)O$>GZ]X:U.[\/ZQ
M%*T$3_OK<JQB<*2,JP/IW%1>$];\SX?Z'JFK78,UQ9PM)*_621E'0#J2>P%
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MECA]+38?+^<?OCQD'D#!X]JYC0];GG\$Z_-K7B,V3PZE=VB:E((U,2H^U<#
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M,%G;27-U-'!!&-SR2,%51ZDG@4 +]G@QCR8\>FT55ATN&+59M1.#<2((@0H
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MU..N:P8=2BTWP9\.=8N9)_[%LX##?S6K$FW=H0JNVWD '<#Z;O?%>S!0%"@
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MW/L0_*2#=*1@'V&?PKM;J\T^3XUZ7)]IMGQH<VQMZG!,J$8/J5W?AFN_"@#
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MSJL5ZD3R?888K<1"%6[L<G<P7Y0>."W7/ !M6EK#8V4%I;H$@@C6*-!_"JC
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M$6+5;6,(MZ"@Y('&Y>%...W:JVNW$"?%WPL&E0%+*\5LG[I;R]H/IG!QZXH
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MC"C6]OY,:(2"P +,Q)*KDECT& .<Z]%% !1110 4444 %%%% !1110 4444
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M6,L#Y2^9RS#EOES@CWJ?PO?W^DZKJ5O=:L->T.TT_P"TQ:H(PT\6"?W#LO\
MK&V@M_>]1R*]$IKJ7C95=D)! 9<97W&>* *&AZQ8Z_HUOJ>G,S6LP.S<A0C!
M*D%3T(((_"M&H+.SAL;9;>!2$!9B2<EF8EF8GN222?<U/0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME7C;=E@#P0<DCGBMOQ3KCZ%IMN\$?F7-W=Q6< (R [MC.,C. "<9&2 ,C.:
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MR[LGN;%_+VG>A_>(S9YPI#=!Q]*KR>)-3ACT6S8L]YK#3SQLD WQ6Z#<!M)
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M$@+!BSY8DGY0 .PSR>W0NZQHSNP5%&68G  ]:YL^/-$2:-)GN8(YK<7-M-)
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M7-J5O-#;B%T,7WX\ G(QT).>E/U'Q+K>B^$]'\6SW27%M<-;M?60B4)''-@
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MP1XSU#[8OVO1+^ZAMI/)7YDB52H<8P>IR1BK>O>+Y-)N]*&IW<^EZ9=V0?\
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M@(&%R3DY)))YX]*K7_A2YN/%K:[9ZQ):>=9BSN8?(63<@8L"C$_(?F/8CVH
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M5UEMX+>UE>QO&$/F7$1B8LKJA(4@C&0!G(Q6+K=I?+\+_").J2E'N=, 3RD
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M,MAON@]>O-=7H^GSZ=9E+R_DOKN1M\UPZ!-S8 X4<*    /QR230!AP:M?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7=QI:2HNRUCC$HD"@[NO/R\_AC'?KZ* .!O/AJ]WI&LZ,NOW$6E:C<M=+;K
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MRQM^;GY?7OS[53/P_>&#0);'69+75-$MQ:0W:P!A+!@#9(A//0<@CGFNVHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV4MY?W,5M;1#+RRL%51]36=:>+O#]\;D6VK6TGV:-)9L-]Q7^Z3]>F.N>.M
M&U16,OBW03;WD[ZG!"EEC[2+C,30Y&1N5P",]N.>U,L_&/AS4-772K36+66^
M9-ZPJ_+#&>/4XZCJ* -RBLJ]\2Z/I\SQ7=_'%Y;*DKD$I$S8P'<#:A.1PQ'4
M4S4_%>@Z-.T&HZM:V\RQ&<QN_P P08^8@?4?7M0!L45S&F^.M(U;Q*^D64IE
M"VT4ZSA&V/YF2H4XZ8&<].<=C6[?ZC::9;B>\G6)&=8USDEW)P%4#EB>P'-
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MI^)]#T:X%OJ.J6UM,8VE\MW^;8HR3CT_GVILOBK1(;"&^:_1K::$7"/&C/\
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M%='N;B0R3364,DCMU9B@))_&DO?$NCZ=.T-W?QQ%'6.1B#LC9L;5=P-J$Y&
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MZU:Z5_PG^C:[,MOJES=W5S;I-UNK=XPL7E_W\*N,#.,5ZQ2%03D@$_2@#BO
MVOZ;:>"_!NGSW!2ZO;%(;>,QM\[QQ N,XP,>]=M1@<<=.E% !1110 4444 -
MDD2*-I)'5$499F. ![FO+_ACXDT73O#FJB[U2TA<ZM=RK&THWLI?(*KU.>V!
MS7J5% 'E>G6-S/)X[\::C;R6%MJ=IY%G#<KL?R8XBH=E/*[CC //YBH+1+6[
M\'>!#;>(AHNLP:6?L=TVUHB52(20R*W!S\O'4;3Z5ZW2%0PP0"/0T >0_P#"
M1WEE-X/\3Z]9);:=%)?6]Y-:HS0QR.V$N .NQ\,0?1SZ\WO'-[HMW\*_$][H
M\$<=O>LK?:%CV"\E++EE! += ,]\'TS7J! (P0"/2EZ4 >>R:C'IGQ5AU+4+
MB--)U#1UM[*\9QY(D60LR;N@+ @CUQCM6(FF6CVFO7%SJ4VE:=J/B$3Z5?1$
M 12A/]=SP49U8>AZ]#FO7"H888 CT-+C- 'CFH:CKK^'+B?48DU&/1]=MYKN
M_P!+4I]N@5!N<!3]],IG:< I[58UQ-&\2^&/$>I^"OME_J<VEFWDO!+,VY-R
MMY(#GEBN_@#(Z'[PSZT  ,   =A0 %&  !Z"@#RK5?%.@ZU?^ ;G3+F)UBU
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M  48  'H*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPJ@^F6&![C%8FAS:'+I$G@_Q/8ZI/KL-S(#8&2YV79\TNDB;3L"G()8X Y-
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M!FN)U^WGTN2YNM.UX6OB"STZ&*\LKM1);ZLJQ\ *>2Q)9?EYY QS6NMZ]O\
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MU6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXYX)(Y(@1D$HRAB".A P: .@HKG;+QSX<U'68M(MM25KV9"\2-$ZK* ,G8Q
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MZ=P&>G6L"VN7/C*;PG+J_B&73WLGNH9#'<)/$\D@15\P*&*( V&8D?,02<<
M'8>)_#MUK]SHTL%]#;#3;Y+W:\!D\QE##;D,N!ACZUT-<U;^(]+T:ULM/U#5
MI[F176S-_+;L(Y)AQAI NP-D$=>O'6KNJ>*-(T<SB\N' ME#W#1P/((%/0N5
M!"^O/;GI0!L45S#^,[/_ (3*TT"*&XE6>R-W]HCMY'0@LBIM*@@J=Q);[HXY
MJY=^+=%L;A(KFZ:-6G^S>>87,(ESC89<; <\<GKQUH VZ*PM=UZPM+>]M&N[
MB.XCMS)(UK"\C0*0<,Q56"]#U]">U5/AS>7.H_#S0[R\GDN+F:V#R2R,69CD
M\DF@#J*.M1SS16T$D\\B10QJ7=W.%50,DD]A67:^*-)N[^"R2XDCN+B,RVZS
MP21><HY)0NH#8'/';GI0!9TK2X]'@:TMGQ9AB8(2/]2"22H/]W/0=NG3 %^N
M<M_'?ANZU!+&#4?,N'NFLPJP2<2@9*D[<#CN>#@XZ&I?%EYIUII<0U'5KO3(
MY+F)4FM20[-O&$R >&/!]C0!O45DZEXDTS2FN!=2R_Z-$)IS%;R2B)#G!8JI
MQT)Y[#/2M.65(86ED;"*-Q..@H ?17-Z?X]\,ZK+&EGJ:N)(9)U<Q.J!(SAR
M6( &.N"<XP>A%7;3Q/I5[JBZ;'/+'>/$9HXI[>2$R(.K)O4;@.^.E %;7=!U
M*^U6RU32M9^P75K&\7ES6XGAD5RI.5W*0WRCD'IQWJWINEW4-S]MU.]CO+[R
MS$KQ0>2B(2"0JY8\D#.6/08Q4%IXOT2^N[2VM[MF:]+BU<PNL<Y3.[8Y&UL8
M)X/..,U,?$FF"Z6W$LI+W!M5D6WD,9E!(*;PNW(((//4$=10!K45C7_BO1]-
M:X%S<N$M6"W,J02/' 2 <.ZJ57@@G)X!!. :2_\ %NAZ;?6]E=7ZK<7$1EA1
M$9_,4#.5V@Y/(P!R<C% &U16';>+]"NM#EUF.^ LH93!(SQ.CI("%V%"-V[)
M VXR<CUJCK7B"VU'PSXCCTR^N+;4-.M'>0>6T4L+>660X=<X.."/?F@#JJ*X
MGPEXZT6XTSP_I5SJI?5KFPA.94?$TGEJ6 D(VL^<Y&<Y]ZCTK69-/\:>.#J6
MH74NG6"6<B*P:00*T;,^U5'3N<#H.>E '=45DCQ+I3:+:ZNL\C6-TR+!(MO(
M2Y<@)A0N[DD8X[BM:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEOB.?^+=:]$ S236<D4:
M*"6=RI   Y)KJ:* /-M2EEMM6\"^(0LDND6<,MO=LBEOL[21*JNP'( (P2?N
MYJ'5-)N-:U+QSJNEHTMI>:#]AA*#BZG"/RO][ *KGIDD=C7I]% 'DL>L6^HW
M?PWDM8+V1+-FCN6%I)B)_LQ0J?EZANN,@=ZZ'X?/&=5\8<$-+K4DT9*D>9&4
M0!E)ZC(;D5W-% 'B D8? ==&>VNEO[:\CCE@:W<$,+S>0,CYL*-QQG ZUVTD
MT;_&:QGC;="VA2Q>:H)3<9D95W=,D G%=S10!Q?Q7R_PTUF"-7DFFB5(XT4L
MSG>O  Y-5?&=U!<:CX*FA?S(TU9)G9 2$3RW4LWH,D#FN^HH \JU43Z?KMYJ
M7AF^E^UR:DBWOA^ZCWQW;;U4RQ9&5. &+#(&WG&*GTW6+?P[KWBC0?$>G7<P
MU+4)+NSVV;SI>12*H\L8!&1MVD-@5Z=10!YIK-\Q\0:AI<^FS:>7T9!!]AM2
M[WC8;,7FJO"(3C QU)SCBLFVN WA'X8J8IT:UO+?SP\+*8PL+JS'(X4,0,]*
M]AHH YKX@V%_JGP_URRTQ6:\FM66-%ZOZJ/<C(_&N0U/Q/8>)+[P-)8P741C
MU=!+'-;/%Y+>3)F,E@ 2/;/3Z9]4KG_$7AVXUS4-&NHK^.V&F78NE1K<R>8V
MTK@G>,##&@#@[R[&G6_Q,TF>"Z^VWOGW%M&EN["6-K8 ,& Q@$$'GMCKQ5RR
MU;R;WPO9W%G=V4+Z$B_;8[%S<22#:#; [2R#Y=QZ9XP1W]0HH \/L'V?"_P=
M9S6URDMIX@B:>*2!P45;AV8D$<@ C)Z<]<UV_B^7[+XX\%:H\4[V<,EVDDD,
M+2;6DA 084$\D8%=S10!Y)#<Z=INL^(= \5Z?J\C7U_-<6BP"XDAO89>0@$9
MV[A]TYP.!S6SIB16WQ<B1;?[/''X;BM5499(W68DQ!^A(7'OCFO0J* ,_776
M/0-19S@?9I!]<J0!7E]NP7PE\,(G1P]K>0-<*4.80L+J2XQ\H#$#)KV"B@#B
M/#KK_P +3\9-@A)H;$1L5(5RB2!\'H<9 ..E)XT<V?C'P9J4D,[6EO=7*RR1
M0M)L+P%5R%!/)XKN** /-[*>(>*_B+-("B3V]MY;,I DVVY5@I_BPQP<9YKG
M[:672/#_ (!UB]M=0DTJST^2ROQ:&19;5V$>&94(; *8/_ZJ]HHH YOPC'I$
MD-[?Z-83P6UY*)&N+@2![IL<OB3YL=LGK@]L$\Y+K*>$_B/X@.N6UT=.UF.W
M>RN(K9YT)2/8T)" G.<D#'<^M>CT4 >>7>HQV?B?1K)](DT>SETY_*FM++=+
MDR#%L"BGR_E 8@=\ $8R>;\/6EG=?#_P]87USJ>B7]I=71M]05&C^RR^8YPY
M88*LK8.>#TSFO9Z* /'[N[UU-*T'7-9M)[RUTO4[J*[FTU'B:XA92BW2JA!Q
MDDG'4$GH:[?PB=$NY]0U;1+*Y2*[\L27MR)0]TR@@<2_,0H(&>AR0.E=310!
MP=S-)H/Q8FU+4]R:7J&F);P7;#]W#)&Y)C8]%W!B03@'I6,^GS6G@3XAW9CD
MC@UB:[DL8"A#2;HMH8+UR[ D<<C![UZK10!D^&)4E\+:44;.VTB5AT*L$&01
MV(]*\L\:7DFI:#XWL/L-W:W<5T#'9VMFP6X0&/\ TB1POSD@'O@!0,$\U[31
M0!P%M>P3_&#[< Z6[>'E02RQL@#>>6VG<!AMO.#SBK/PM.WPG-$RLCKJ%TVQ
MU*D*TS,IP>Q!!%=M10!Y7XNOGNKSQMI365S;2MIF+86EHQ;4<PM\SR!3E5)V
MA<COG.<!VGW,<_B?X=2B.94ATF>.1I(638S1Q!0<CC)5@,]<<=:]2HH \3U@
M^;X#^(UO''(\MUK1DMXUC):928?F08^8?*W(]#79:C/#+\6?#<\+;X1IUTAD
M4$J"Q0H">@)P<"NZHH \-NKHP?";5O#QM;QM4MM5)E@2V<E5-Z'#9Q@@@C&,
MYSQWK?\ $^I&]U'Q;IQLKNU:72E^R_9K)Q)J.8GY=]N0$)V[<C'.<YP/4Z*
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M@IY&X8;';-;E% 'EEM(G]D?$Y2&S<SW!A!0YF!MU0;?[V6!''>DN)4&C_#
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M410GR@;A4Q\^TJ2".X%30![CQ#XYBMH]3NCJ.B1"VFGMW!G(CE!(^4 <D #
MSG@5ZU10!Y7Y,?B/P7X+T:P5GU&RGL9;@>65:R\E1YA?(^4\%0#R2>.,FMSP
MVR/\3?&NY3Y<ZV0C+*=LFV)@X!Z'!.#CI7<54U2VNKS3+BWLKYK&YD0K'<K&
M',3>NT\&@#A/"FDWUCXCG\,S1DZ-H=PUY92$YW+,#Y4?OLS-^25Z-69HFDOI
M-HZW%Y)?7D[^9<W<JJK2O@+G:HPH 4  >G<Y-:= !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI.0O4$C(ZC/-9VB:EH6LW*ZI::#J4-U:V[B:XOX)5:WR,&-2V=S$]ER, Y[
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MI=U(^[:L3<*I8GCL!R:\GN(IV_9TM=-%G=F_6&WC:U%L_FAEG4D;<9Z GZ4
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M1IYK*A5U4_-A1DC(!.#70WOBW1M*U"#2[FXG^V2P&:*);>21I%&/NX4[FY'
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MXYZ9YK;HH KVEG%9K)Y>XO*_F2R,<L[8 R3] !Z   <"K%%% !1110 4444
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M^,CC)QCJ>< X-.EU^S3PV->BCN;FS:!9T6"!FE=3C&$ZYYZ4 :E%(K!T5@"
M1G!&#0S*BEF8*H&22< "@!:*** "BBB@ HJ&[NH[*SFNI@_EQ*7;RT+M@>B@
M$G\*KZ-JUKKVC6FJV1<VUU&)(RZX.T^HH O4444 %%%% !12*RL,JP(R1D'N
M.#2T %%5M0OH-,T^XOKGS/(@0R/Y<;.V!UP%!)IFE:E;ZSI%GJ=KN^SW<*3Q
M;Q@[6&1D?0T 7**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *YOQ7X<U+738SZ7KTNDW=B[R1,L"2HSE=N65O8L
M./[QKI*Q]3T_6;C4H+G3M<6SMT0I+:R6BS+(<_>!RK*>W4CVH I^"M:U'6-)
MN8]8@CAU33[M[*Z\G_5NZ@$.N>Q5E/XUTE8D^@SQ^'[FPTK4Y;&]G<RMJ!C6
M20R%@68J< D@8QP ,8Q@5M*"% )W$#D^M "T444 %%%% !7 V?\ R7?4_P#L
M P_^CC7?5S4'A>XA\=7'B<ZDC-/:K:-;?9\ 1AMPPV[[V>_3VH SOBWG_A6N
MI;<9\ZUQG_KXBJ2TU/6['XB_V)>W\5[;7>F/>1*(!%Y,B2*NT$9)4AN^3QUK
M5\7>'F\4^'Y=(^V?98Y7C=Y!%O/R.K@#D=U'X56O?"DM_P")XM9GU%1MT^2P
M>&. KN1R"S!MQP<@8]/?K0!SMEXHUF+6_#$%QJ*79U.::"^2&%3;1N$9@(9
MH+;2N#RW?.#5VS\1:E8:MXITG5KQY[JS1)].VQHC30R#:F.,%_,^0D\9(XI+
M3X=7=M;>'X7\2SN-#ES:E;2-?W>PIM/7+8.-W3CIWK?U/PM9ZGXGTK796=;C
M3U=-B])E;!4-ZA6 8>] &1<:MJYUN/PY'/=RW5OIR75U=VD< =W=F48$I"A1
ML8]">5Y'.=GPI-KTV@Q_\)):I;ZDCLC[&4B10?E?"D@$C&1GKFJ'B/P?<:IK
MEKKND:U-H^K00FW:9(5F2:$G=L=&(!P<D'MGZ8W=+L'TZR6&6ZENYV)>:XE
M#2.>IP. .@ '0 "@#CY]5U#Q1IWBV2SOS96VF23V$4:Q(WFO'&"[2;@3@EL
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M:P.EN8XHE)W,0A<DDD#)W=  ,<YQ(_AY+'X*T_PTNL#RK*Z6Y2<VOS,5D\P
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M=3M3S %8<8&<''8S:OX%?4;;3)X-;NK;7-.E>:+5#&KLS.,.&3A2I  VC
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M'59-HBEG=2R9;&0 NTG'9U]\WM.T@VVERVNH7;ZC+<9-S-,@7S21M(VCA5P
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MSS[5MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEBMTE,$WF!&"%L@\\9.1@GC." #T.BO+-/\ &^N162Z)J$\<FLCQ!_8IOUB
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MDXYQ0!Z/17'^$]0UB\\1^(K:[OS=Z;I]PL%M*84'F$HKL"R@ E"=IP/UKL*
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M!69'\/$C\+6^BC5I@UIJ U&VN1$NY)1(9.0>&&6/%=M10!'!&T,$<;RO*RJ
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M];EFE>(Q(1$TN/,*GJ<XXSP,G@U;D\)2RZCX=O6U+Y]#1UB @&)=R>6=W/\
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M=J@*.@ ]23DGGI@ YO5)]=O/B8V@6FN2V5C+HQNSY<$;/&_G!,J6!YQZYZG
MS@C%TWQCKUO9MH=_.;K4X]?.D"^C1$:2/RS*'P?D#D#;SQR#SWT;XM-\;8?L
MNH+;2)H31[BH=6<S@^60>^/FP"#QGIG.Q>_#_2K_ ,/3:7--=":6[-^;Y'"S
MBZSGS00, CH !@#B@#"UBX\8:+H7BJ[:]EALX+(W6G33F&2>-U4ET. 5*D\@
MGD57\6V&KM\*==U"^\0W5R+G3DF%N(8E2,[/F4';DJ<COGCKR:Z1O!,ESX?O
M]-U+7]0OIKZ$V\EW,$#)$>JHH7:N>YP2>,G@8N:GX775?!K>&Y]0G6!X!;R3
MHJ^8R 8], X YQ0!C'4KR#7?#WA:/4;G_2[22[GN66,2;$"A8UPH R3DG&<#
MKSD9&J^(]>TNV\;Z2-2D:XT>S6_L;XQ(7*,C'8XV[205(!QDCWKK;_PC'??V
M3<_;YHM3THG[->HB[MI7:RNN,,K#J./;%1W?@RWOM+UJVGO9C<ZR@CO+M54,
M4"[0BC&% !..O4G))H YG79_$^C>$[?6D\3322WD]BODM:Q;(@[*K@'&2#N]
M<\=>:O$Z['\1)/#W_"27;6=WI9O3(8(?,@=90A$1V8 (8?>#=/4YK;U7PBNK
M^&K+19]2N%CM7B?SD1-[F(@IG(QU S@<U,WAHMXMB\1'4)OM,=F;(1;%\LH6
M#$],YW 'K0!PMWXF\00_";7[Y=6?^TM(U&:S6[\J/=,B3! 6&W .T]0!TKH=
M6NM9F^)5GHMMK,UI87.E2SNL<,99&5T7*EE///?(Z\>CY?AW;S>&-7T%]5NS
M;:I=O=SR!$WJS.'8+Q@ D#L:U7\,F3Q3:Z^VHS&YM[1K01^6NQE8@L3QG.0.
MAH X^/Q5KUG\/M7G:Y:YN],UF73GOFB4LL"3!6F90-I*H3VQQDCK6SI=[J4W
MQ%N+"UU>6\T.&P2Y8XC<+,S%?++A<\J ^,Y_ BLWQ#H2>&O#%Y;"]U5[?5-7
M%W=7=M"'>T+/YCOM53E,J!@@_>YXJQX5EOWU>V.G^*KO6M-);[2D^G)$D:[3
M@K(J+\V[:-O/!/'>@";XG1S/9>'_ "KVXMPVNV<;"$J V9!@G(.<$ @'C/4'
MBJMY8W5Q\7TM(=4N+=_^$;P]TB1F4C[1U&5V@D]]OK@#J.K\2^'H?$NFQ6LE
MS-:R07,5U!/#M+1R1MN4X8$'Z$57B\+&+Q0FO_VI<R72V/V';(J%63=OW' '
MS;N>,#MB@#DM)\8:O+X;T2TGG>?4;S5;C3GND6-79(3(=P!^0,0BCGU)ZUU'
MAN/Q';ZKJ<6JLTFF-L>P:=XVG3CYU;9P1GD'KZU0;X;6$GAI]&EU"].V];4+
M>[0JDUO.6+;E(&.K'MWK=T'0YM(1WO-5N]5O) %:YN=H(4=%55  '.3W)ZG@
M8 ,G5]7O;KQ@WAZT^U(D6GK=R-:O&LC%W9!S)T VD\=21V&#F6FK^)H)O#_A
MK6;B.'4[^6Y,MY#L+F"%0PXQM#MN4'@@ $@<C&UXC\&QZYJEGJ]IJ=YI.K6J
M&)+NUVDO&3DHZL"&&>1[U#J?@.WU"ST[R]4OX-5T^9IX-4#*TQ=AARV1M(8
M K@#  ' Q0!AS:KK5E>^/K)=9N732=-ANK%WCB+Q,T<KG)V8894=0>!5J37M
M7"?#V<7[C^UMBWJ>7'MFS;ER?NY4[A_"0*J^'K&WG\>^-=+O;Z2]%W96D$DL
MK*&F^259,;0%&-P!"CC-:EO\/#''H:S^(M2G_L60-9DK$NU A0*0$P>#@DY/
M'&.: &Z9=:UJ7B3QMHXUB6,VAMUL9A%'F O$7Z;<,,GN"<"H/#.O:GKWA_1;
M62_FBUI;F2'5&"1[D,!Q*"-NT L8P, $"0'M71:7X<72_$.L:PM[-+)JAC::
M)U4*AC7:NW ST]<U)IOAJPTK7M6U>V5A<:FR-,"?E4JN/E';. 3ZD"@#B?%O
MB+6=(L=<U&VU5YKBQOX1%%:QJ;>"$M&ICF++RYW-D*21E3P*U[U@GQGTYCT&
M@W!/_?Z.DOOAK;7MGK=A_;6HQ6&JW1O'MD\O;',6#%@2NXC*CY2<5L#PN/\
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M /7G2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
-HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>elicio10-qxexhibit312002.jpg
<TEXT>
begin 644 elicio10-qxexhibit312002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(R0V1C'6J4%Y/X?M?A]K]Q:W4VEVFD?8+[RH6=[21HX_F9 ,]4VGCC\1D ]
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M=T;6;#7],BU'3)_/M9"0&VE2"#@@@@$$$$8(KE)9XF^,EI=!LV_]@R1^?@[
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MD7SB.&Y:VD$.\D@*SE<*QQT)SC!.* .OHK'U7Q/IVCBX-P;B1;5!)<F"!I1
MAYW/M!QQSCKCG&*I7WCSP]830PO=2RR3VIO(1!;R2>;$ #N0JN&X.>,X&2<
M4 =+17-W'CK0K>":X::X:"WBBFN9$MW(MTD&Y#)QD'!R1C('4"F7GC"*W\:6
M/A]+6YD6XM'N6G2!G4@%0H7 Y'S$D]!QSZ '3T5S>C:IH[7_ (BN(-2NW^SS
M WHO&=8[8B,<(' VK@9...]6;?Q7I=Q?VED6G@EO4+VGVB!XQ< #)V$CKCG!
MP<<XH VZ*Y2?XC>'((;V4SW;I8SF"Z*64S>00 27&W*J,]3P<'&<5U,<B2Q)
M)&P=' 96!R"#T- #J*P;OQCHUD)99YI1:0S?9YKP0L8(I,XVLX&!@\$] >"0
M:QO%WB$V_BGP[HFV]^R7LDSW1MHI=TBI$6559!D_,03M.>.>,T =O16-86,7
MA[P_-%-J&H75M'OD$MPS2S1H>=H(&X[1TSDUDZ=XJ\.Z-X8T)SJ=Y-97Q6&S
MNKM9)'E)SC>Y'!X)YQP* .OHKFX_&^DSV.KW$"7K2Z4@>YM7M)(Y@""5(1@#
M@@'!Z<<XHT/Q;;ZCX5TS5[J.:&6\BB(A$#Y>1TW;8QC+CKR., G. : .DHKF
M9O'N@6VEZA?W%Q/"FG2"*\B>VD\R!C]T,H&0#D8;H<]:9)\0O#L+[9KFXB!N
MDM%>2TE5&D<97#%<;2.0<X(&10!U-%8>G>+M'U)]11)IH'TY1)=)=P/ T:$$
MA\. =I )S[4:?XKTK4[ZVLX7GCFN[<W-KYT+()XN,LA(]P<'!P<XH W**XSX
M>SW,O_"41W%W<7(M]?N(8FGE+E4"QX4$]AZ5T=_K-KI]Q';/YLUU*C2);P1F
M1RJXRV!T R!DXY('6@#0HK$M_%NBW>CV>J6UWYUM>/Y5N(XV+R/SE F-VX;6
MR,<8). *:GB_1S9ZE</-+$=,YO87@?S8!C.2@&<$<@C(([T ;M%<Y8^.="U"
M^TZT@FGW:C'YEI(]M(L4OR[BJN1M+ =1GC!'7BJNE^.[6^N]?$]K>6]MI4YB
M,C6LA)545F8X!QRW ZX&<4 =;17,V/C[P]J$,D\-U*MNEHMX9Y;=TC,9..&(
MP3DXP,G/'4$5?M/$FGWFJ?V63/;7SQ>='#<PM$TD?0LN1SCN.H[@4 ,\0Z#-
MK0LI;35)].N[&8S02QHLBDE2I#HW###'T(SP:73M'O8[B*YU;5#J$\.?)VVZ
MPQQDC!8*"26QD9)Z$X R:QOAY/<RKXGCN+NXN?L^OW,,33RERJ*J84$]AZ5T
M5_K-II]S%:OYLMW,K/';P1EW95QEL#H!D#)P,D#J: -"BN<G\<Z!;>'VUR2[
ME^P)+Y$KK;R,T,@.TK(H7<A!('('4>M:TNJ6T-]:6;B;S[M6>)1$Q&%QDL0,
M+C(ZXZB@"[16"?&&CK>6<#S2HE[+Y-K<M"PAFDY^57Q@DX..S=LU!;^/-!N]
M1^P6\UU).+PV3@6<N(Y< X<E?E'/!.,X..AH Z6BN7^(7B"?PUX(U34;02?:
MT@80NL1<(YX#' P,9SSQ6.(-'M/$>C7<FM^)+>2\E"06,LDXAFF56RSAQQD9
MR,@' .* /0**YB[\?Z!:2ZE"TEY)+II NHXK*5VB!&[<0%^Z!SNZ<CFK\WB;
M2XUT\Q3/<OJ,1FM([="[2QA0Q8#L,$<G'4#K0!L45SDGCKP]#HEEK#WK"QO)
MA;Q2&%^)-VW:W'R$$$'=CH:M:5XITO6-0N["V>>.ZM5622*YMWA8HV<.H<#*
MG!YH V:*P8O&.C2WMC;">11?LRV<SPL(K@@9(1R,'CD=CVS5/3=>T"TC\1ZF
M-5O#!:7)-\;SS-MNX1<JBL 0,8X Y)XH ZJBLBRU^PU34+C2E-Q;WT<"S-#-
M&T;^6Q(#KGMD$<<@]<5B_#&YN;KP:)+NZGN91>W2>;/(7<A9G R3[ 4 =C17
M-ZKXZT+1M0N+"[FN?M=O")Y(HK25VV$XW#"_,.O(R!@YJ;4O%^D:5'--<R3_
M &>W95N)X[=VC@+8(WD#CJ,^F1G% &]17-7_ (\T#3[VXLGGN);N")9FAM[6
M21F1LX*A5^8<$Y&0.YJU;>+=$O-!MM:MKT365TXC@*(Q>1R<; F-V[(/&.Q]
M* -NBL:V\4:7<&_CWS17%@H:YMY('$L:D9#;0,L#V*Y%<_??%+0XM!NM2T]+
MR]\JR:\CV6D@1U!Q]\C:,$C//'UXH [FBN2O-;TR\7PX]]=:E97%Q=(;>.*.
M6)9I=I^1^,%.2<$\XJ>[\>Z#9W.I6S27<EQINTW44-E*[H""=V OW<#);IR.
M>10!TU%93^(]+6RTZZCN/.34MOV)8E+-/E=PVC_=!))P .N*;I'B73-;NKFU
MLI)C<6K%+B.2W=/*<'E22,9Y' /0YZ4 :]%9=SXAT^TUZUT29YEOKJ-I(4$#
ME751EL-C;QZ9[BJUKXOTB\T[4[^&2X-OIDCQW9:VD4QL@RPVD9) ] : -VBO
M/)=>_LSXIW1FN-2ELY="BN8[)4DE;S#,P.V$ D':HSQQCFM75_$GA[4_"5EJ
M;ZI?0:=>3Q>3<68D1RXD "$@97+#:0<=Q0!UU%96I>(+'2Y9(9?.EFCA,\D5
MO$TC)'S\S =!P<=S@XS@UR.M^(K9O&/@C5++5+A]*OH[MF2%G*3@0Y3]V.6;
M)X&,YXQF@#T.BLO0O$&G^(K6:>P>7]Q,T$T4T31212#&596 (."#^-)J/B*P
MTR]%E)YTUV8&N3!;Q&1Q$IP7('09./4]LT :M%<[<>./#]O9Z7=O>NUOJF/L
M<B02,),@G'"\'@_*>>V*DM_%VF7=A!=6R7DQG5W2W6U?SMJ-M8E",@ C'.,]
MLT ;U%4='UBPU[2X=2TVX$]K,#M< CD'!!!Y!!!!!K(F\>Z##JD^FF:Z:[MY
MXH)HTLY24:3[I/R\+T^;IR.>: .EHK!NO&&CV4T2SS2I!)<?91=^2WD>;G&P
MOC'4$9Z9&,YINH>,]%TR2\%Q-+Y5BZ1WDZ0LT=NSXVAV XZC.,XR,XH Z"BL
MG4/$5AILL\<OGRM;0BXN!!"TGE1G.&;:.^UN!D\'BGW6O65K+# /.GN9H?/2
M""(N_E_WB!T'..>IX&: -.BN=F\<^'H-$M]8>^/V&>80+((7.V0MMVN,?(0>
M#NQBI].\6:1J6H7EC%+-%<6D0GD2YMWAS$<CS%W@97(/(H VZ*P+'Q=I&IW5
ME:PRSJVHQ/+92/"R+<(HRQ0D=@0><''/2N.\,^.=/\/VFMQZYJ%_*L.NW<'G
MO'+.((P^U/,< A!Q@9- 'J%%<5K%W,OQ-\)_9[V<VEW;7CO$DI,4FU$*MM'!
M/S'GWK;TSQ5I6KVFH75G).T>GR/%<[[=T*.HRRX8 D@>E &U15>QO(=1L8+R
MWW^3.@D3S$*,5/3*D C\:X30+]8+'QY_:VI7YLK74YHO/#R2201>2F=A&2-N
M21@<=: /0Z*\]U&ZVZC\.Y--U*_>QNI-G[R9LW$?V=F5I!_$W0\]ZZV#Q%IL
M\5],LLB6]DSK//)$R1@H<-AB,-CGIGI0!JT5BVWB33=0U1M&W7-M?/ 9HXIX
M7A:2/H60D#./3J.XKD_!OBNWT;X?VM]KU[>2B34+BW%PZ23L6\]U0,0"1V S
MQVH ]&HJE+JMM#J=KIS^;]INHWDC41,1M7&XD@87&Y>OJ*R?%OBE?#$6F?Z+
M/.]]?PV@,<3,$#. Q..^W. .2>W6@#HZ*RKGQ#96\D<.RYFN7A^T?9X;=FE6
M/IN9<97GC!Y)! !P:LZ5JMCK>FPZAIUPMQ:R@['7(Z'!!!Y!!!!!Y% %RBL'
M4_&&D:3->QW$LS?8$1[UXH6=;96Y4N0/3GC) Y/%7+W6[*T>VAWR33W2%X(;
M="[N@ RPQT49')P.0.I% &3)X9U:WUF^OM*\1R6T5]*)I[>>U6<!PH7*,2"H
MPHX.16[IU@FGP.@E>:65S)--)C=(Y &3@ = !@#@ 5Y_X1\86>E>'_$>JZO?
M7\EA#KT\,<L\<LKQ)A JL,%E )Q@@8)KOI=4MH;VSLW$WGW:LT2B)CPH&=Q
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MQ&"1N'?O6)NO(O!G@;5%T?4[FWT-%@U&T6"2.89@\MF53AFV'TX.>O7'L%%
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M<@UZ+6%H?AV;2[J:[OM7N]5NF#)%+<A%\F,MN**% ZD#)/7:.F* -T    8
MZ"O,+ 2KHOQ)5K2[#75U<O;J;:0&96@5%*#'S98$<5Z?10!X_JVGW&I^&_AW
MIR?VE:21P".XG@MY ]H?LICW-Q\I#''./ZU>GEUK7/AKJGATZ6\&NZ84C")
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M@B69CF-0 ),C!+C<<DY(!%=5IMQ)HGCSQ9=7VGWXBU 6LMJ8K5Y1+LA"LH*
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MM&ZD"7$10E7E9@1GJ,'J*+59A\8[^Y-I=BV?2(K=;@VSB(R+*[%=^-O1AWH
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M?;HA9O%%;$Q.H2./A0@) W@8Q]YLT =M<?$?08(=0FVZA(FG3&&[,=E(?)P
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M-_VAKT6H7&JWYM(U3_B6AP(&=&W*Y&,D@X.,]A]*W** "BBB@ HHHH ****
M"BBB@ HHHH @N;.&\$:SJ71'#A,D*6!R"1WP1GGO4.KV!U32+O3Q,81<Q-"T
M@7<55@0< ]\&KM% &?H6E_V)H5EI8G:=+.%((Y&4*2J@ 9QWP*T*** "BBB@
M HHHH *@NK.&]C6.X4O&&#%,D!B.F1W'L>*GHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *PK3PX;7Q?>^(/MS.]W D#P&,!51"2N#U
MS\QSZUNT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% $%O9PVSS21J?,F;?([$DL>@Y/8#H.@J>BB@ HHHH
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M)TD>!TAE$4A&%<KNVGUQWJAH6E/HNC0Z>;HW)BW?OG0!G)))9L=2222>,YH
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M#[<1+J]Q;0WJ^4FV420L['[N5.5[$5M6W@H1Z]=:M=ZQ>7<EY9"SNHW2-5D
MW<_*HVC#'@?B36?!\.9$L-$LIO$E_)#HMTDUGB*)2JHK*JGY<,<,!N.>!P!D
MT 5;K4K_ ,5>'_&-S!J,MG;V$EU8P0QQHP<Q)\[/N4D[B2, C QWYKH_ ?\
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MDS%MP*GAE.X\=1ZFJNN^'7\.Z5XHU9-2U>ZDU:*..80(I>)MHC,PV+GY5^;
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M4-%,9%DX'(*[E'!]^:ZZTADM[6.*:X>XD4?-+( "Y]<  #Z"@#SK_A)=<O\
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M:N)Y=$MX[JSNYHHC(-\+.5;"A2,KZ=Z=<:AXET.?PCK,VMR7]IJ]Q;V5W9/
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M)@$9 ?&5QTZUT=O-J]G\1WT*?6KFZM+[27NP7CC5K>59%3]WA>%PW1MW3J:
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M"F0*?OK@G*'L:NUY-?>(_$,/PS\7:BFL2B_TS5I[>&?RH\^6DBH%(VXZ$\@
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M:>%],T_5I;.VU(W23JD2-C9"6# LI.?KD9QP<8-6.ZUFZU:_\-IJ-]/+I5I
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MT!) R?2N+\&>)9-3UF&PU"_U"TUF&T;[=I5_$JEY,K^]B(7!08?[IQ@@X[T
M=IJNH-IEC]I2QN[T[T3R;5 S_,P&<$C@9R?85=KDOB-J.HZ1X7%]IMZ]M,EW
M;QMM16WJ\JH0=P..&/3!JG>S:S>?$^;0HM<N;73WT87>V&*/?&YFV':Q4]@.
MH;J<8Z@ [>21(DWR.J+D#+' R3@#\R!3J\<OM1U36OA_X>FO=4N/M47B2*SE
MEB"IYX2Z**S#&,C:#CIGD@UUMSJ&I:AXDU+P_:W%\%TVT@+30/"DKR2;SO;<
M,8 48  &2<]J .VHKS.>\\917?@O3=2U9+2^OWN8+_[+'&ZMLC9E=<KPV,''
MW<]B.*L1IXAC\>6_AF7Q3>26YT-KB2<6\*R&03*NY?EP#C Y#=^YR #T2J.L
M:I%HNCW>ISQ32PVL332+"H9MJC)P"1V%<+I.O:O=>#(&NM:CBG@UF2PN+IH\
MS7,22,NV-54YE8!1P.F3UYJ--7U"]\-?$73KV2X>/3X94M_M(7S51[;?M8KP
M<$G'?!YH ]"TR_CU32K/4(598KJ!)T5_O ,H8 X[\U:K%\'_ /(DZ#_V#K?_
M -%K7.V5UKOB[1M2U+2=7^P7D.H2P6D3(K0JD4FTB08)8L 2>>-PQC'(!WE%
M<;:ZE=^)?%?B'2HM0GLK?25@B0VVW<\DB%RY+ \#@ =.#G/&.8'BWQ%?:#H+
MB_%M?KXC&C7K) ICG"LP+X(R,[1P".] 'K--CDCFC62)U>-AE64Y!'L:\Z-U
MJ\.H^,]!GUN]N(K?38[RVN6$:31%UDW*"J@8R@QQD=O6LRWN=8TGX<^ 7T[6
M9XVOKFPMI%DCC=1'(@RH^4' QZYZY- 'K59VO:S!X?T.[U:YAGE@M8S+(L"A
MFV@9)P2!^M<M!<ZG#XQM?!T^N75QBQFU*:\:.-)9%,H1(AA< #))(&3@=!6-
MJNL:A-X6^)'A[4IC=/I%HWDW3*%:2*6%G4-@ %EY!( SQ0!Z99W*7MC;W<:L
MJ3QK(H;J PSS^=3UG:!_R+FE_P#7I%_Z *XJWUK6/$/@K6/$]AJ<MI<6\MRU
MG;A$,02%B D@(R2P7DYXW<8Q0!Z-17G;>)M2:\\&>('NYH=$UI$ANK3:FV&>
M1-T1W;=V"V5Z^E7-3U^_T_2#J$5S+(-5U6*SL58)B")F";ER "6VLRELCYE]
M#D [BBN"NO\ A+=.&NS_ &R:+3!ICSVTEPT4D\-R@)P %P4(]<X/3%:/@:/5
M[K1=.UK4M;FO/MVFV[FV:%%2-RH)8$#.3GG/?/;  !N:IK$&EO:PNCS75Y(8
MK:WCQNE8*6.,D  *I))(_,@51\/^)CKUQ<PG1-6T\VXP[WT 16;<054@D-C&
M<CC!'-<[XPLYIOB3X*V:A=0"22\"B,1_N\0'E<J>3T.<^V*MVM]JLGCWQ'I#
M:I,;:#3H)K;,<>868ODCY>?NCKF@#M:*\CT[7?$8\(^#/$EQKL\TM_?V]K<V
MQAC$4D<KE23A=V[H<@@<=*O^-=?UC2K'Q+?VFJN]QIS1O;0VB*8K=,*2)RPP
M68D_*"2 5( H ]-HKAM0NM8N_B5;Z-!K4]I87.C273)%%&61Q(BY1F4\X/\
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MM( (^4#OVS2V/A!8$TR&^U*YU"WTIP]G'.J@JRJ55G( WE02 >/4Y.#72T4
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MX'H1TS7K.H^+M/\ $GA_3;.QO$M9M;/E.+A3FW0*6D$BY&,XV#D9+@@T 5/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EJ.FPZI%'#
M<LYMU=9'A&-LI4@J&[XR <#&>AR,@W:** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/F)=I -JAB 6_NYQD9]:YK3+3PUJGB33]:L->;4;MK)X4A@,.QH",_O%1 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD6?_ !\D7"?N/]_GY?QH SOLOC'_ *#.A_\ @JE_^2*/LOC'_H,Z'_X*I?\
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MV4%GI]Q;Q6TDFV!1YD6_!+'D\^O;M0!I?9?&/_09T/\ \%4O_P D4?9?&/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4?@*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!6:9I$#01!&;=AL@9*A02,<FN5DU+24\2^,=#\5:V^F?;)@Z)*T:1W-JT*H
MK.I)(PPP#U)P,YJ]JB6FGZU\-+2!I4@CFE2%;IOWNP6S*N[/.>0/QH ZRTEU
M+1_#=]=ZE>KJ[P++/!)%$$:6(+N13M^4MVR  >.*Y_2=8U[7/"5IXATG6;*\
MEG"//:+; I$"1O1"#N#J"?O9R1T&:[/4[T:;I5Y?,AD6V@>8H#C=M4G'Z5Y-
MXGT?2=)T[_A.? &JK97TKQL+2U<-!J!9@/+,7]XYZ#WX!Y !Z++XOT>+Q8OA
MU[R!;W[.9G#2!=IW*JISU8Y)QUP/>K</B+1+BYBMH=7L))YF=8XTN$+.5^\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112,RHI9B H&22> *
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M-1O]8\46M_=_:%L=1$$!\M4VIY:-C@<\L>3764 %%%% !1110 4444 %%%%
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M'PK?-< KD8&">3C ^E>X&V@*JIAC(1MRC:.#ZCWI3;PD$&&,@MN(VCD^OUH
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MO5&1&38RJ4_ND<4WR(1&8_*CV$YV[1C/TH \ODDL9]<^%/F/;R VLQ&X@_\
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M)$BD]2J@4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU2TO2HM-%S)N\VZNY3-<SD8,CX ''8  *!V '4Y)OT4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRJC=C^).">.N*N:/?P3?$_1KV*YO+R"XT26%+@VC1QE_,C.U % 50 ?IW)-
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M>"!GCKUKNJY#2[&UO_'TWB72UQ:2:=]FGF5"JW4F\,I'][:H(W?[0&>#CKZ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>elicio10-qxexhibit321001.jpg
<TEXT>
begin 644 elicio10-qxexhibit321001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQA<D@<UE6.C7PT#XIZX;>=+76GE2PC,9#3C,F'"XSAMXQQSS0!T=Y\15\+^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MER70LI_*1N.&?9@=1U/<5N2:[I46B'6GU"W_ +,$?F?:@X*%>Q!'7GC [\4
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M16US!>6T=S;31S02J'CDC8,K ]"".HJ6@ HHHH **** "BBB@ HHHH ****
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M) 5-Q.,DDY;)XY&!ANB:-=Z9I$UG=WL-[/+)+(TYMM@=G8L=R[CGKC&1P *
M*/P^\4+XO\$Z=JVX&X9/+N0.TJ\-],]1[$5X_J6@ZC\.(]"^(?AF,O92V< U
M6S'W3N1=S?[K'_OEL'H>/2? _P .[WP)%J4%AKT<UO>-YB0RV1VPOTR/WF2,
M8!!ZX'-=3I&CM9>&K?1M0EAOXXK=;9F\C8LD84+AE+-U'7M[4 8_@G4=.\4:
M0^LVJ^9;RW\EQ 7&"C;0IR/4985P?AO_ ).@\4?]>'_LL%>F>$O"UKX/T9]*
ML9&:U^T22Q!^J*YSMSWQTS6%IGP]N=.^)%]XR.LQR3WL?E2VWV,JH3"#@^82
M#\@YY[\4 =DMC;)9R6BPJL$F_<@X!WDEOS)/YUX[\;T6/Q+\/D10J+?,%4#@
M#?#7M5<-XX^'TWC35M'OCJZ68TJ4RPQBU\S<Q*'YCO''R#H!UH Q/CU+-8?#
MVXGLU*27MQ!:W4B<$PC>P4^VXX_X$:Z_PM86?_"M=)LMB?9)-*B5QCAE:(;B
M?KDG\:T]8T2S\0Z%<:3J\:W%O<)LE"C;SU!7DX((!'/:N<M?!VN6'A4^&K7Q
M)&+ 1&WCGDLBUS'">-H82!20. VWCTH X_\ 9ROKRX\':E:S,S6UM>8@+=%W
M*"RCVS@_\"->RUC^&/#.F^$="@TC2HBEO%DEG.6D8]68]R?_ *W2MB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#X2TNWB9EM)[P^>1T)525!_4X]O:@#T$^/M!738]4DENXM+D("7TEG*L)R<
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M]-N&>(#KD!,TNI?$?POI-CIU]>WTT=MJ2![206DK"4$ \84X/(X/-<#\/?\
MDOOCG_<;_P!&)47Q^@2ULO"<-M$BHE\P1!P!]WCV% 'I?B#QUH'A:.VDUJXG
MM$N3B(M:2MN/I\JG!]C1KWCK0/#*6KZS<7%HMT<0EK24[CZ<*<'GH:\I^/$V
ML2Z=X?&I6%E;(+X[#;WC3$G Z@Q)C\S5_P#:'S]@\,[0"?M[8!..PH ]-B\7
M:5)J]II;"^AN[PL(%N+">)9"JEB S(%R ">M:U[>VVG64UY>3I!;0(7DE<X5
M5'4FN?T":_U"[U23Q!9PVTUGJ8%HBS&1$4P(H*L0,Y\Q^PY8C%3^-]"3Q-X.
MU'17NA:F[18TE;H'W@H#[%@!^- "Q^,-*9K02B\MQ>R)':M<6DB+,S'Y0"1P
M3G.#@XR<<5M75S#9VDUU<2"."%&DD=NBJ!DD_@*\/TSQGXH\(:CIOAGXBZ5]
MHL&GB2UU./G#(P*,6'# $ ]FQUSTKT+X@RVFH:</#-QJD.G#4HI#-/)*$VQJ
M. ">Y<H,=U#^E '66=Y!?V,%[:R"2WGC66)UZ,K#(/Y&N>C^(7AZ76KK1HIK
MV74K12T]M'I\[N@&.<!.GS#\Q7&_ ;Q(][X:NO#=Y(#>Z-*47YL[HB3C![X;
M</IMKG+?6)] ^/7C?5(=-FU#[/IY=X86 ;:! 21GKCTZT >RZ+XIT7Q%9SW.
MD7JW26[;)D1&$D;>C(0&!X/4=JQH?BCX3N(;Z:*\NWBL&VW;KIUP1 >?OX3C
MH>OI7*?!*Q34'U_QG]LA:76;IRUG"3BV.]FVL2!EOF'X?7CCO!7]O/;?$Z'0
MK*TN9)9W23SYBK*"9A\BA2&.">"R\XZT ?0.E:K8:WIL.H:9=1W5I,,I+&<@
M]C]#[4)JED^KRZ4MPAOHH%N'A[B-B5!_-3^GK7GGP6O?#]K\,V;3KRX:&TDD
MDO7ND"&-]H9C@$@+MQCD_GFN&U;7U\,_%'0O&W]IQ7$&KH8M1A297-LA. A
M/&U"A]VC;UH ]M\2>+=&\(VD=UK5Q+;V\C;!*MO)(N[T)53@\'K4LOB32HO#
MJZ^+AI=,:+SA/!$TOR8SNPH)P._''>J/C#3++7;33--OX5GL[J\V2(>A!AEY
M!]>X/K7C*7FI_">[UCP3J[27&@ZI;3?V7<XSM=E( ]LD@,.QP>AY /9M<\=Z
M!X;^Q_VO<7-J;SB -9RG>>..%.#R.#S5B'Q;I4VL6NE'[=#>708P)<6$T0?:
M"S89D X ]:\Q_:!+"7P@4 +?;GP"< GY.]>B>'IK_4)]2F\06D5M<6>J$6J+
M,9%C4P1JI5L#.X2-V'+$8S0!;E\5:8E[=6L0NKEK,A;I[:V>586QG:Q4')QR
M0,D=\5H:;J5IJ^GPW]C,)K68$QR <, 2,C\J\8U:W\;_  V\0ZOX@\.QQZUX
M;U"ZDO+FW'S&)R3OR!\PQR-PR, 9'%=?IOQ2\(67A#2]5E::PMK]IO+@$+R%
M)%;,B_*#QEN.G!_"@#M=7UG3M TZ34-5O(K2TC^])(<#/8 =2?8<UF/XVT6!
MK3[;)<V$=XP6WEO+62%'8\@;F "D]@V#7D7Q#\06WBOQU\/'M9GET"ZND=-Z
M,@D<7 1\JP!XV@<^OO7>_&V**3X2ZRTH!,9A9">S>:@X_ D?C0!T'B;QMH/@
M\0-KEU+:I/D1R"VDD4D=MRJ0#[58O?%&EV%A8WL[W'D7[K';F.UDD+LPRHVJ
MI(R/45QFC:5!XR^!&GVOB278'L=_VF7K%LSLER?10#[@GUKFO@[K<\6M_P#"
M(^)FE&I:7$?[+2=2H\LC+8! .[:1C/(3(&.<@'IVL>.M T#4;+3]3N+B"ZO2
M!;1_9)6\TD@8&U2,Y(&/>NA5P\8<!@",X((/Y5XQ\8?^2F?#K_K_ %_]'15[
M-)+'$ 9'506"@DXR2< ?G0!S,7Q"\.W&MW6C037LNI6H)GMH]/G9T (&2 G3
MD<^XJS%XTT2;2M0U)9;H6^G2&.[W64RO"0H8Y0KNP 0<XKQR"[U>Q^-OC^XT
M.SBNKY--D*))*8\?ZKD<'<1QQQGU%>ZV-O;&W+%$:6YB1Y\\F3Y0N2/H,?A0
M!4\.^*=(\6:<^H:+<M<VJ.8S(873YAR0 P!/4?G5G2M9L]:CGDLC,5@F:!S+
M \?SJ2& W 9P01D<9KQ30UU+X<?%34O!6FD&RUU1/I[,<BV)S\^#UVA7&/XM
MBU[G864&G6,-G;*5AA0*N3DGW)[D]2>Y- $>IZI9:/9_:]0N$@@\Q(][]-SL
M%4?F15RO)/C&MOXCTC4=(75(+>72X%NU@>95,\YY"8)R<1AN.YD7TK3\+>-K
MG7O@M=:U;.7U:QL)HY.Y\^.,D-]2-K?C0!T]QXUT:+6)=(MY+B^U"$9GAL;=
MYC#_ +Y487Z$YIK^.O#Z173M<S[K5XHYXOLDOFH\I(13'MW9)'3'IZUQ7[/D
M<)^']S=@[[JXOY#<2$Y9F 7&3]#G\3ZUZ8=+LFOY+YK=#<2",,Y'7RRQ0_4;
MV_.@#!7XB^'&UI]&66_.IHF]K0:;<>8%P#G;LST(-;FD:O9:[ID>HZ?(\EM(
MSJI>-HVRK%6!5@""&4CD=J\DL_\ DZG4/^O ?^B8Z]EA@BMT*0QJBEV<A?[S
M,68_B23^- &5?^*=)T_5HM)>=YM3E3>MI;1-+(%_O,%!VCW; IVE>)M*UB]N
M;&UN2+ZUQY]I-&T4L8/0E6 ..1R,CGK7E'P4EFO_ !YXZO\ 426U'ST1B_WE
M!>3*_0;5&/84OCN6:Q_:)\(3:>2MQ/#%'.$_BC,CJV?7Y<_D/2@#T4_$'P]_
M;\^@K->/JL"[I+5+"=G48!SPG3!!S[UIZ1XBT[7)KN"R:X$UFRK/'<6TD#(6
M&1PZ@\@5X]YVH6_[3/B&72[.*\NUT]=D,L_E!OW,/\6T_P">]>N^%S-=>']-
MU*]B"ZE=6,'VHXP=P7.#]"S?G0!E^(_B7X4\*:I'INK:F(KM@"T:1-)Y8/0M
MM!Q_.MG4/$6E:;IMMJ%Q=J;>Z=([8Q@N9V?[BH!RQ/;'UKEOB=IEM?>$;C0K
M*QAFU369U6W3:,F3<"TK'J JCENW [@5Q_C+3VT+Q-\)]!CE:2UL[E8]_9W1
MHES_ #^F: /6=-\0Z7JMI=W%O<@+9R/%=+*"C0.OW@X/3'7/3'-5=+\9:)K%
MY!:VER_FW,1GM?-B:,7$8."T98#</UQSTYKPO6;R\MM1^,$=L6$3K%OQ[RA3
M_P".L]:-U++;ZE\%7MR0YMXU./[K"(-^A- 'J&H_%+P=I7B'^P[S6$CO0XC?
M]VQ2-O[K.!@'UYX[XKL:\S^)WAJV\2V>D^$=-M8ENYKH7+R*@_T6 9\R4GU8
MG _O$GT->D01I%;QQQG*(H5><\ <4 24444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMK*(DQV\2Q*3UPH '\JL44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSJ7@!)?&@\6Z1JDNF:J\7DW!\I98YUP!\RG'. O(/84 :\/_ "/%[[:;;_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!117/:Y:ZP7O;VWUN>RM8+3=%!!#$VZ0;BS,71CC&T8&.AH Z&BN#\&/XCU[
MPKH6N3>(KAWNDWW4#6\ 0J0P^0B,$$'!Y)Z8J+P1XUM?[!M8O$&N1OJ5Q?7$
M$9FPK/B9T0': %SC Z9QQ0!Z#16=J>O:9HX)OKH1;4\Q\*SE$_OMM!VK_M'
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M34X9M4%LLDD0;YCP-Q]"0>N.G>K4_B71[6]2SGOXXY7E$"E@=GF_W-^-N_\
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MJ<$UXL9E\E"22HZX]<=P.14EEXBTG4;&YO;.]CGMK8LLTJ D(5Y8'CJ.X[4
M:E%<NS:S>^)H+S3=7W:'<6+'R39C;&W.R59#RQ)Q\O3 )[BLY+_Q!X<\&KK.
MLWK7[V,C&Z+6XA:>UWX\S8/N.%^8#N!@C)R #N:*9%*DT22Q,'C=0RL#P0>A
MJK?ZM8Z9L%W/M=P66-$9W8#J0J@D@9&3C S0!=HK/77=+?3(-2CO8I;2XQY,
MD1W^:3GA0,ECP>!SP?2JA\7^'AIO]H-J]JEMYWD;G?:1+G&PJ>0W/3&: -NB
MN0O?B1X>@FLX;2]2\>XOOL1,(9EC8#<Q) ].GKGC@&M&'4;*;Q7,(M>,CQV
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4\0P&SMX[3I/;7$3H'8KU4 *[$GL?>NDDO;5?CE$C7,0;^P&BP7'WS<*0O\
MO8YQUKO-H#%L#)ZG%+0 5Y+HTWA:Y^)WCJ769=)>-Y+,6[W;QX;$.'VENN"
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MC%<2"0C>AQPKDA@3UW5VQ4,,, 1Z&JM[817_ )*3LWE1R+*8QC#LI#+GO@$
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M1EOA]K5]HV][?4;ZT>2YFD=A=.LR;BH<\@*.2.#SZ&O8R 1@C(/:@  8 P*
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M1]>*]4VC=NP,],TM '.^ 95F^'OATJX?;IMNC$'.&$:@@^X(Q71444 %%%%
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M;GYU,DVV3YMOJ3P<9Z$$@'8:MJ<GBCPG<7'A'6I8;F.8QI-!;[R9%/,95P,
MG&2> .>E:MUXAT_2T9-0N2)8(E>Y:*"1TCR.K%00N><9Q6JA5E#(05;D%>AS
MWKR_Q@S6.M:YJ>@ZNL&JQI&MYHUX@DAU-1&-H1>NX@[/E[@ XSF@#U"1#)$R
M+(T;," ZXRON,@C\Q7#^ _$I'@#2;S7+Z:>[N[F>!96C9WE<32 #"C^ZOIT%
M=HD^+-+BY M_W8>0.PQ'QD@GVKQ3P%J<OAFUT74]0?[1I-X\]EAE_>:;*9Y&
M#8Z[)!@L<9X7G&!0!ZE=^-?#MC<75O/J<8GM%5IXE1G= <X^4 DG@Y Y&.:O
M?V]I9TJVU-;V-[.YV^1(F6\TMT"@<L3Z 9KD=+O++_A;7B*Y-Q!Y1TRU"REA
MM."Y8!NG *D_A7'^&Y)M/\.?#G5Y0YTO3)[N*_ 4_P"CM+O6-W'\(&3R>@;W
MH ]6'BK1387M[]LVPV!Q=AHG5X.,_.A&Y1CG)'3GI2GQ3HXETV(W;;]37?9#
MR9/WPQG*_+Z<_3GI7.:=8PZQ\2]7U>T*3Z--I$5E/(AS%<S;V)P1PVU, D=-
MV/6N1?3->B\*RQ+'+Y_@>Z9[-V_Y? C!P/7'V<[<=R_M0!W7CK6VC\'>)#I5
M_/;:AIML9&>./!1MNX#++CD>G-;,>L6UEI-@]Y+(TTT"L$CB>61\*"Q"("QQ
MGDX[CUKE?%,;K\(]?N;E#'>:E;2SO&WW@\@PD>.[*H1./[M96J:K::+XCT+6
M=6:[&@7.C):"\M))0L$X;=\_EG(## ^J^QP >@1>)-'GT>/5HK^*2QE8)'(F
M27<G&P*!DMGC;C.>,5S?AW79=0^(_B2V_M&YFL;:TMG2&XC\K[.S%]PVE5(X
M /(SC'-<[J']G:'=>%_$&FZ?=0>&(=4N;B[=Q*Y+2Q;%N&5\L%W%N3]?XJMV
M]WIVL^.O&'EO/-97NB0IYUM"S;U"RABAQ@G!&/4\"@#LSXS\/*]LKZG'&+H$
MVSRHR).!WC8@!^H^Z3P<]*FU+Q/H^D.XOKSREB*K+)Y3M'"6QCS' *IG(^\1
MU%>8^&]?T#4SX+M;_P 06<,NCJHA3RY(WG<Q^6BMO4*G!Y +9/3BK,=[HMCK
M'B3P[XOAU(37U_-/;1QM<-'?028VJHC."P^Z1[#T. #UL$,H92"",@CO5#5=
M<TO1%MVU.]AM1<2K#%YAQO<G  _/\*H:=KNDVVJ6OA5-]MJ$5BDJVK!F"1@8
MVB0\,1CUSQFL/XJO#'H&D27 !A76[)I 5W#;YG/'?B@#=T[QIX>U=KU-/U)+
MB2R7=/&D;EU7^\%QEA[C(J;_ (2G139:=>B^4VNHR+%:3!&*RNQPJYQP2>F<
M5S,MM#K?Q1M=6TEXYH+729H+NYA8,CL[#RX]PX)&&;'88]17%6>K6O\ PK;P
M7I@$[7NFZS9K>PB!RUN4E;<&XX/MU- 'J5WXY\,V5Y/9W&KP+<02QPRH S%'
M<D*#@>WX<9QD5<7Q'I;WD5JMPYDEE>&-A!)L=U#%E5]NTD;6X!_A/I7+^&YK
M:7XK>,6#(6EAL1&2.6VHVX#Z'&1V.,UC:3+-IFO:9_PC^IC4-)O=083Z+=*&
MFT]FWEY(V^\J YZ\8;@G=0!WO_"5Z+_9E[J7VW_1+&9H+J3RG_<NH!8,,9&,
MC/'%27GB/2K$Q":Y9GEA-PJ0Q/*_E#&7*H"0O(Y(Q7EM]J$%AX8^)FB7'FKJ
M4]Y=W,5N(F+-$\2;7'&-O!Y_^M6T-:M_^$@TNSDBEL?.T./R[Q+1C/=?-@P*
M2IV@8W$8R<@C'4@'9S^+O#]M!833:M:K%J W6K[^)!C.1Z# /)JN?&^A-HFI
MZK;W,EQ#IH/VF.*!_,0@9QL(!Y'?&.^<5YEHEU;GP=\,H9<J]KJ8\Y94*[,+
M("3D= 2HSTS6[<8NO$/Q1@M_WDMSI<*1(G)E86\JD+ZD$J#CID4 =]X=UE-?
MT&SU)(WC,\*.Z-&R[690Q W 9'/4<&J.G^+[/4?%VJ:!'%<"2P6+,C0. SN'
M)&<8  5<$X!R<9H\"WT%]X(T9K=F816<,3ED*X=8U##D<X/'U!]*YAQ./'?C
MS3H6DAO]4TZV%@VQL,PAE4L&Q@!6(R30!V*>*=%>Z@MQ? &XD,4$C1N(I7&?
ME20C8QX/ )/!K8KQ^YDCU_X/:9X9LQY7B*'[):BS(Q-;31.@:1EZJH"LV[I@
M]>:]@H Y'1=3U.7XC>(M+N[P36=M:VLMO&(@HCW[]WN?NCJ:SM0\3A/%>OZ5
MJ6K3Z4]I!'+IL<:J/M"%,EURI\QM^5V>PX)S4NB7,#?%[Q,%E0^996B)AOO,
MOF;@/4C(R.V:S=?TRP\1:[KEMXGNFT^:T,3:+<"3RVB38&,L1XW-YF0PY/RJ
M/3(!WF@SZA<^'].GU6!8-0DMXVN8EZ)(5&X>W-<OI.H:K-\5M;TF;5;B33K2
MS@GBMS'& &?.<L$W$<>O>M_PE+JD_A+2I-;4KJ36ZFX!7:=V.I'8D8)'8YKE
MIIXO#7Q<O]2U5Q:Z;JFG11PWDG$2RQL<HS=%)!R,XS0!T=\UZ/&FE6\>HW$5
MI+:W$LMNJQE79&B"\E2P^^V<'TJ+Q[K=YX=\&WVIV*$S0[ 7";S$A=5:3;WV
MJ2<=..>*2UOK?7?%MK>Z;*MS965G/%)<Q\Q-)(\155;HQ C8G&<9'K1>>,-/
M_L:[O[:.:Z@M+];"Z06[E@?,5'PN,L &SP#G!H K:49[^;2-3T/Q--JFD22,
M+M9#&X9?+?!#!05(?;E?T&.=?Q1X@M_"WAF_UNZ4O':1;]@."[$X5<]LL0/Q
MKSMM'T?3O'FBZAX O$6:[N@NJV-E+OM_L^"6D=1Q&1P ..3P,YKI/&EM!X^\
M(>)?#>F2L;^V*1LKHR+YJE9%7)&"#@#(]: -#1M.UG4-(M[_ %36KJ&_N(Q*
M8K58UBM]PSL52IW8S@EB<^U:N@QZG%I$<>KS+-?+)*'E50H<>8VT@#IE=O':
ML/P]XXTBZTFVAU"Z33]5CC6.XL+K]W,L@&"%0\L,]"N<\5L3^(+2S.G+>I-;
MR:C/Y%M&8F8EL$C=@?+D#//3OWH UJX7P=K]WK]]&3J<8NK431:OITH&^.7<
M/+:, ?< #8;)!!&<FNOU2UEOM)O+2"<P33P/$DR]8V92 P^A.:\^T9QJWBO1
M[>^TS^R?%&BH1=%,".YM-A3]V?XXRY0@?P$'H>H!Z8<XXZUR7@[4]3O=:\4V
MNHW@N18Z@L,!$80(AC5L8'NW?)KK:X7P-<P2^*O&GERHWF:DLD>#]]1$BEAZ
MC((R* #Q1'XETZ\L-1T_7G>XFOXX5THQ1^1+$S?, <;]P3+%MW\)X XJ3XA^
M*1H,%C:?VI/I NG)EU*.R-PMNB]B,$ L2!SV#5E>-AX;\;Z/<PZ5)%<>);63
MR[)HE*7,$RL.3D!E0$<D_+CGTKK]1\3:)IE]%H^K7B1W,\&\++$VR5<E2 <;
M2<@_+G/M0!S^HZ[?>'? UG-#KJZW?ZI>16ME?O#&J%IFPI"I@$*,GW(J\FJ7
M6B>.]/T"YO)KRUU2TDD@DG"[TFBP7&5 &UE;.,<$<<' Y6^\)W-EX'MIK*TF
M$.F^(5UFVL0AWI;+*3L"]0=I9MO7G'7BMRY\G7_B3H^L6<JS:9HEC<22W,7S
M(9)0%" CJP4%B!TX]10!WE8^H^*=&TF6>.\O-C6ZJ]P5B=U@5ONF1E!" _[1
M%2Z!X@T[Q-I,>IZ7,TMLY*@LA1@0>00>17FOC+4H[EO'FF>3)97(LODBM[8F
M34!Y)Q([[3E%^[QC&#D\X !Z9>:YI]@RK-,Q8Q^=B&)Y2(_[YV X7W/%7+:X
MBN[6&Y@</#,@DC8?Q*1D'\J\MOI89TTS4](\0MHNMP:-"4-VF+>\BRW[ME<#
M)#*>1SA\C->A^&KFXO/#&EW%W8BQN)+6-I+4# B.T?*!VQZ=J (O^$KT3[9'
M:_;AODN#:H_EOY33#K&),;"W!&,YR".M,U_7;&QM;RV:^E@NDMS*SV\)E:!3
MG#MA6"#@\MQP?2O*[[6(+[1]+G\J6Q>T\3PR7&EP6K!+11<'+2$+DNWWLYP=
MW XKH=)UJ#1?$7C'3]=,D%UJ-P;NR:6)O])@,2JJ)QR5VXV]>>G6@#?\%^(
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M!AN3YL!OQ!.GX=/B?7/#EU$=6MK&^@U!XQJEM9K)'?1*H'F!&.!DG!(XRG%
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M>#].N%U*32G)ECOY;,+YIEC;9A"P(5206S@GH/6@#3M]!UVXA%IK>N6EY8C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %4-8UK3M TZ34-5NX[6UC&6D<_R
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M+$@;<8 SSG% ':T5YK'XVUK7I/!DFD2VEG!K\%R95F@,C0R1QY)!W#< V<#
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MT3LI4D9(S@\CI5^O*/ ^N7%GX#\%Z-9I)]HO[6>1I(E5F2.-N=H8@9)=>N>
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M\0>')]=N=&G%_';MIEVMV!]G+"1PI7'WA@88\=?>@#+BU^]T?QMJVFZ[J&;
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M^Z(.$.2<#G!/)],8P;VE^ +O1KF6UL?$MU'X=DE:7^RO(0E=QRR+*?F5"2>
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ML"MM1S&A5<8_O=2":W=0X^,NBG_J#W7_ *,CJ6[\#SW?@6Q\+MJR+':>0JW
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M;E<@XXR/7L?084>.%$DD,K@8+D %CZX'% 'G&BR:E'\7O'?]GVEK<$QZ?O\
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MISW6UK<2><4@C8J<]%(&..>>O'/67>LZC=R:6Z7RV-K>:=]H5+6,37,DYVD
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M?W)9!&<?/S\H[]_RILG@JYDT_P ,6@U6,#0)(Y(V^RG]Z40H-WS\?*3G'?\
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MH(]Z^8[;1N/0#/\ *K.M+*VAWPAN);:40.5FBQN0@$Y&01^E>4-'=?\ "I?
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M0"[C SGN!SS55/%FMZ9IOBF]N;L7MOI]^MA8NT**)"[(H9B-H8H7P>@.WL:
M/2Z*Y/3#XIB\4QK,MU-HDMN?-:^-N)(9AT*>4>5(X((X/>M+Q3JDFE:#-);[
M_MDY%O;!(VD;S'X#!5!+;1ER .BF@"WI6L6&M0W$MA<+,EO<26TA7^&1#AA_
MGUJ_7E?A.2R\*?$F;0[*.[ATC6[59K47-M+#BYB7;(!YBC)9 &)]:ZA]2O\
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M.,8H ])HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'.7$BD;6#')QP 3QZ5-J7@S^TM BLI=6NCJ$5W'?+J+(I?[0A&UMF N, #:
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ML<;+&[CYBC$9"GKM_E77:=9_V=IMM9>?+.((UC$DNW<P P,[0!^E %JBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI&D*V]N8HXI)L*HS$6)"$<DGF@#T:BN!\9Q>(-!\(Z]J%OXFO95BLO,A:2&
M21R*><%8P""#Z9&.#S71:1XHTC4+J/2XM1BEU%8!(\0SD@8#$'HV#P<$X[T
M;E%9,WB;1K>^CM)KY4DDF^SHS(WEF7_GGYF-N_\ V<Y]JU7=8T9W8*BC+,QP
M /4T +17+Z9XBT33M :^N/$RWMI)=R(EW.PY8N?W:X R >!C-:-CXHT34[RZ
ML[+48I[BU3S)8TR2$_O#CYA[C(H UZ*\\TO6+CQ?>ZO);ZW=:9)IVJ-% $A/
ME&",)N$@8 $MENIR.,=.>NM/$ND7MY%:07BF:=#) KHR"=1U:,L ''?*YXH
MU:*YYO'7A9;D6YURS\PW!M0 ^1YH )7/3H1STI$\=^%Y%M&36K9DNY#% X)V
MLVXKC.,#)! SC..,T =%163IWB;1=6U&?3[#489[J!/,>-<YVYQN&>&7/&1D
M4EKXHT6\O(+2"^5Y;C>+<[&"3[/O>6Y&U\8.=I- &O17+Z;XVTO5KS6K99GM
MH]-D,33RHR#A 6;+#  +8&>N,]#5K1]3T^T\*6-V^M/J%LRA8[Z;[]P2<#
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ME-,8?,!)4,#CD@8 SQD\>]7;3Q/HM]K$FDVVHPR7R*7,0SR <$@]&P>#@G%
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M:ZQ"9!)4WBMG'IMR?I7:SWEG_P +HT]TN(=IT&5-P<8R9491GZ D#TYKO:*
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MQ(Q*GY%'R\8Q@Y/.*O65_I]WX^\%2"6-A_8DR*7&"'/E@#GN0&QZC.*]2HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %9^L:[IF@6J7.J7:6T+N(U9@3EB< 8'/4UH5P_Q9*'P.\3#>SWEJ1&%
MW%@LR,W'? !)]J -VU\7Z'?6TMQ:7WGI'<&U*QPNSM*!N*JH7<W'/ (QSTI]
MOXIT:[T\WL%YOB6?[,5$3^8)N\9CQO#?[.,XYZ5ROCN[73=?\.:_<)=S:%$E
MQ#=36+R9A\P(4D/ED$K\A!^OTJE>6?A6_P!'^U61U'3+:^U*.6+6 \JO]H6-
MR)CYF3LP-A)P#N/89H [.;QAH-M:&YN;\01BY%H?.B=&\TX^7:0#GYAV[TNC
M^+] U_4+BPTS48Y[JW7=)%M93M_O#<!N7IR,CD>M>::[?:E-X!O%UM[>^6UU
MZT1-1MX=JW\8>/Y]HX)'W3CCY<#I70:]8_\ "3^.+.]T":-VM=(O(9[R)LIN
ME4+#'N'!(;<V.W7N* .MC\5:+)J%M9"\(ENBRV[-$ZQSD=0DA&QS]":+SQ7H
MMA.8KF]\L+,MN\OE.8DD/1&D V*>1P2.H]:X#PG>>']7L=#TB^TO56\0:6\.
M^QN'N=MK+%A3+DGRPH&2/7(&.:?X7UFRL-)N_!OB'2YKK6(KV=DM9;1I%O=\
MS2)*&VE<98?,3QC- '8V7C"TO/%VJ:"(;E#81Q%IGMY I9MY/.,!0%&&. <G
M&<5H67B'3=0NXK:VFE:2:$SQ;[>1%DC!4%E9E 8?,O0]Q7'I<16'Q'\8)?6T
M[I>Z=:O"BQL1,B)*'PP&!C..2.M5?"<ESI&OZ?8Z=JYUOPZ]G*Z>?'FYTQ5"
MD(S 9P>%"L ?E_V: /3JYJ#Q9;W_ (NU'PW%'>126L,9,XMGQO?=T)4J  HP
MQX)/&<5H^'_$.G>)])34M,D=[=F*?O(RC*1U!!Y'8_C7,6=U'IOQ<U_[6)(U
MO-/M&@<QML8)YF\[L8 &1G)H J^ _&UDGA72H==UAY=2NKJ> 2S*S;F\^145
MF VJ2   2/:NQU3Q%I>C>9]MGD7RH_-E\J"27RDY^9]BG:.#R<#@^AKR5'C7
MX%VT&,7(U8.8MIWC_3B^=O7[G/TK:O-2TS1O'&OP>)EU%;#5_*FL+FV:X:*=
M/*5&BQ$>N5Z8Y!]QD ]0M[B&[MHKFWE26"5 \<B'*LI&00>XKSZ367\4>)O$
M6DKJ6J:6NGI MG/!#+&(W*&1WDRH!'08?@@<=<UV>@6EO8Z#9VUI9-8VT<>(
MK9V):->H!SDYQU';I7*^%[RW_P"%C^-W,R*DCVAC=CA7"088J>AP0<XZ4 7M
M(\2:#I/A6"]G\2S7]I)<O$E]=Y+22&0@J %' / XQCVK6TWQ3HNKWUS965\L
MEQ;())$9&3Y#T=2P 9?]I<CWKRCS(V^#7V<C,IUW=Y14[MOVS?G;UQLY^E=7
MJ=Y&GQ6DNH8EO /#$JK&G(F?S0ZQ9Z989P/0YH ZJS\6:)?W=M;6]Z3)=(\E
ML7B=$G5?O&-V 5P!SP3QSTJG+\0O"L,4LKZO'Y<,YMY76-V$;C&=Q"_*,D#<
M>,]^*\^T[5(+G6/AYJ*_:?+B:>.:"&R=(+)FMV40HH7L>.23QG(%2/)"_P /
M?B7&I!EN-3O6A7'S2AE4(5'\0)!P1UQ0!ZI?ZS8Z<T:3RN99%+I%#$\SLHQE
M@J G R.<8Y'K6-J&OZ'J-KH-U%XBDMX;R]B-HUHW_'VV2/*;@_*3P1QTZC%<
MM'KT7ACQG:ZMJHF_L?4M%M[>"]CB:1(I8RQ,;;02,[L_4>W$WBJ2R32?!_V.
MP73[4>(;>=+<0^64B!<F1DP-@.<G/3<,X/% '8ZCXLT32IKB.\O"AM=GVEEA
M=T@W_=\QE!"9Z_,1P<]*R-<O;VW^)7A*VAOIA97D=X9K<$>6Y2-2IX&3]X]3
MZ5QWC/4!?6?CS3OLTUI<K$#';VMJ2UZHC&)I) IRHQ@ $ !><YQ6W=WT%QXW
M^'LZ,PC%K=[BZ%=NZ) N[(XW$'&>O:@#T.XN(;2VDN+F5(8(E+R22,%55'))
M)Z"LZQ\1Z7J&HOI\%PZWBQ"?R)H7A<QDXWJ' W+GC(R*Q_B5:7]YX%O5TV!K
MFXBDAG^SIUF6.5791ZY"GCOTK.N-8T[QWHVI'PW:N^IR:9/;B\EMFB:W++Q%
MO8#DMC@' P2>V0#I8O%>BS75M;I>\W3%+:1HG6*=AV20C8YX/0G/:J]YXX\.
M6-Q?6\^IKYUCM^TQQQ/(R;@2.%4D\ DXSCOBN'O)$\3?#/0= L5:+78);*)K
M4J5ELWA91([+U50JM@GKD8ZBMC3;BVC^(WCF661%1K2T57;@-MC<. >^"0#C
MI0!V#Z]I::;:ZC]K1[6[V_9FC!<S%AE0BJ"6)'. .Q]*XW0O$(NO$?CK[7K-
MVNF6:VPC>=3&UKNC??A2H*D'U&>!UKE=!NY-%TKX<:Q>I+_9-E;W%K>,$)^R
M2N %9U'('49[9]ZW;#4;6?Q+\1KJ/S/L]Q9VQBF,+A),6[ X8C!Y(QZY&,T
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M#A3M5>I Y^;.0!SRVD7*V_A3X97LT5RMO8W317+FW?\ =L874<8R1D@9'&:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH[CRS<6;6[1D!B1\CASSQW!Z^U>H:5J$>K:/9:E$C)'=V\<ZJ_50ZA@#[\T
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M1K<,$5W%<O&/(!$;(,;67//(Y]LX[5KT %%%% !1110 4444 %%%% !1110
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MUQ5>30M(FO/MDNE6+W0.?/:W0OGUW8S0!YQ\;[ZWO_A%)=0,3%+=1>664KO
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%<E)XIU4^/)_"]OI5F[1V(OEN)+UE#(7V8V
MB,X.?>K6A>*CJ>NZEH-]9&RU73U21XUE\V.2-_NNCX!(]00"* .CHHHH ***
MH7]_);7FGVL**TMU,5.[^"-5+,WZ!?JPH OT450M[^2XUJ]M$1?(M8XPS]S*
MV25_!=A_X&* +]%<KK_BC4=*\6Z)H5KIEK<'5A,8II;MHPGE(';<!&W4'C%2
M:%XM;4O$FI^'=0L/L6JV")*52;S8Y8FZ.K;5/< @@4 =-117.GQ!=K\0X_#C
M6L(M7TU[U9PY+DK(J8(P !\Q]>W2@#HJ*** "BJFI:E::382WM[*(H(\98]R
M3@ >Y) 'UJW0 45S-GXFNM>U"^@T"U@DM+&8V\U[<R%4>4?>2-5!+8S@L2!G
MIFKVE:I?W6J7]A?Z<MJ]JD3K)'+YB3!]_*G (QLQ@C.<^Q(!L4444 %%%% !
M16?KM_/I>@W^H6T,<TMM;O,L<CE%;:I.,@'T]*YN;QE?Q:)X-U 65LPUV:UA
MGR[#RC*F\[1CGH>I].M ':4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:@"IK$\'@+Q[)J[0%].URV:+:HSLO(P65%]/-&1@=645V?AW21HNAVUF0GG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5S7BO.F_&'PAK%X=FG20SV2RM]V.9@2H)[%LX'TKT.XN(K:+S)G"ID+SW).
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3K^0SZX%97@GQ#=>(?#J7VHBVBNFNIX-D.0I\N1E&,DD\+6NQU+^W(PKV?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%<[XYUJ_\.>#]1UG3A;--9Q^9LN(V97&0,<,"
M.M '145QUWJ?BZP\.IK4<>EZH%@%Q-9PP26\A3;N(1C(X) [$#-;.D^)]*U?
MPW::]%=1PV%R@97G<)M.<%22<9!!'U% &Q16/K'B?2=$T8:K<WD)MG94A99
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M !!>#]WGKP =S17,7^H>(=7MK:?PJ=-CMI;9+E;K4$=Q)O&5554C'&"23W&
M><5-'\<B;P%=^(=9MDLYK!IH;N)7^3S8V*D*Q[%L 9[G\: .RHKE?"5_XEU0
MF\U.\\-W6FO&?)?2&D<E\CJS'& ,].]=50 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3"BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>elicio10-qxexhibit322001.jpg
<TEXT>
begin 644 elicio10-qxexhibit322001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQA<D@<UE6.C7PT#XIZX;>=+76GE2PC,9#3C,F'"XSAMXQQSS0!T=Y\15\+^
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MB.\N;5))0!@$D=<=LC!Q[UN5D>&-6EUSP]:ZE+82:?Y^XI;2C#QH&(7<.Q(
M./>M>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTD>9[N>+SDMH;>227R^FYE4$J,\9..>.M3:5K6GZTD[Z?<>:()/*F!1E:-\
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M3Y@7;@'OG'O0!TE%16US!>6T=S;31S02J'CDC8,K ]"".HJ6@ HHHH ****
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M]""/3'L]SHER;_29+"[MK2STX$+;?92VX%"@ (<;0 >.*@\3^#]/\42Z7<W
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M]R?_ *W2MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA=Z?;S7TMY9J6N((]-N&>(#KD!,TNI?$?POI-CIU]>WTT=MJ2![206DK"4$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M X'_ ->O1;&T33]/MK*(DQV\2Q*3UPH '\JL44 %%%% !1110 4444 %%%%
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M=K:QB*-<Y( ]3W-<SJ7@!)?&@\6Z1JDNF:J\7DW!\I98YUP!\RG'. O(/84
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M<<ECT XZUW% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M51RA8D(1R3UJWXNC\0Z%X6US4+?Q)=2K#8/+$TD$ >.5>>"L8!!&>V1C@\T
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M8MI;^-',OD;B#Y8E_P">9?&T/_LYS[4V\\4Z%87DUG<ZI;1W,$7G20[\NJY
M!('.22,#J: ->BN?_P"$Y\,""SG_ +;M/*O"! X?ALG:,_W>01SCD$5-J/B[
MP]I,\\%]K%I!-;QB26-I,LBDX&0.<DGIUH VJ*RX_$FC3:1!JT6HP26,[!(9
M8VW"1B<!5 Y+9XV@9SVJ,^*M"73+G4I-3MXK2UD,4[RG88G'56#8(;IP1F@#
M8HK'M/%6A7VIMIUKJ<$UXL9E\E"22HZX]<=P.14EEXBTG4;&YO;.]CGMK8LL
MTJ D(5Y8'CJ.X[4 :E%<NS:S>^)H+S3=7W:'<6+'R39C;&W.R59#RQ)Q\O3
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MRLIR&!Z$&G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9OB">&V\/:C
M+/*D<8MI,L[8'W36E10!Q7PJN8#\+M$_?1_N;;;+\P^0@G(;T_&N >YLQ\"=
M1"30B8ZP7P&&XG[:&!]?N#/T]J]THH \KO\ 6=(TCQ]KL7B>[NK6PU6*"33[
MF.600SQB((\>4XSNR<=]WN,]]X9LK+3_  Y96NG6LUK91H?(AF+%U0DD9W<C
M(.<'D9QVK5*AL9 ..1FEH X+Q?>VVD?$;PAJ6H3I;6*Q7L#7$IPBNRQE5)Z
MG:<?2N)U>_MIOA]\34#E7FU=GC21"K,"(<8!&<_*>.O%>Y$ ]0#WYI0 .@H
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M&^RS2S V#!<2%\G:%&,<\'@5Z<%"C   ]J H!)  )ZGUH X+X8/93V_B)H3
M\G_"07LN5P3AG^5OH1T/I77:]!=W7AW4[?3WV7LMI*ENV<8D*$*<]N<5H44
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M? FH:K=?VQ:ZJUI=RVERJ#4[--L=[F-?F('&Y1A3CCC':NOP ,8&/2@ *
M .PH XWXL([_  QUG8C,56)R%&3M65"3^ !/X5G7.L6\'Q0TO79[E?[!O=(D
MM+6\;B)9_-#G+'@;E48/\6WC->B4A4,,$ CT- '%^";1QXE\7ZG;G_B4WU]&
M]H5^[(RQ 2R+Z@OQD==M:/CF+3[CPV8=2OIK")KB'R[R%@K6\H<&-\GC 8#.
M>WYUTE% 'C>MSZWJ/P\\;Z=?M:ZI+9QP^7JEE'M%VO#'<HR-Z <XXY%;-WX@
MTW6?B;X6N=+O4GA>PO4CGC4LF]O+P,XQD=QV[UZ4%"C   ]!0%48P ,<# H
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M;]@."[$X5<]LL0/QKSMM'T?3O'FBZAX O$6:[N@NJV-E+OM_L^"6D=1Q&1P
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MPI"I@$*,GW(J\FJ76B>.]/T"YO)KRUU2TDD@DG"[TFBP7&5 &UE;.,<$<<'
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M4 %%%% !1110 445S'CSQ1+X5\/I<6D23:A>7,=E9QR?=,KG@MCL "??&.]
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M>49<(Y4DNQ)+'Y%&>!UX]-ZB@ HHHH **** "D8$J0"02.H[4M% %:RLHK"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUX:TK5'0(]Y:17#(O12Z!B!^=:5 !1110 4444 %%%% !1110 4444 %%%%
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M89!H \J^'^B3^)/A38Z;<:A =)GFE,T4<)\UD%P[&/?NP 2.3MS@X]ZZ34/
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M\T,L+QN@8D+D,!UVFM.@#CM1^'UKK&EZU%J%VQU#5I8YI+R!-GE-$ (MBY.
MN.Y).6YYX(_">MW&OZ%K&J>(+>XGTI)H]L-AY8F$@4$G+G!^7J..F ._8T4
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MJ03GH;<NI^-=,L?$#OIUQ>00)'+ITKK";A@2!(I2,[6*C)7@9Q@YIR_#9/\
MA#+;0'U>59[*[:\LK^&+9)!*79\XR0>788XX/XUJ0>&]9&F3)>^)YKK5',?E
MWGV5(UB5'#X$2G'S8PV3S]!B@!O@[7[?Q!]LN++7#J5HHC41S1+'/;R?-O61
M0JX_AQQV/UJYXGO;VSBL#;7D%G!)=!+F9L-*$VDA8E(.YRP48P>">*-*\."Q
MU^_URXFADO[V&.&0P0>2FU,D$J68ECNZD] !VY9XD\-3:W>:1?VFI-87NF3M
M-"_E"5&#(48,I(Z@GG/% '%W?C/7XO /BV_@NE%YHVH-;PSW%J [Q?NR-R<
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MQDAN5VX&.O?!\.RS68M3X?\ &^CZQ<[45K*/2XQ-,,C(=T8.OJ68<=375_\
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M1E.[D\Y.1R?2B7P?-=:E=:K<:E&FJRZ<UA'<VEKY6P,0V\@LVY@0,<@#GUH
MJ>$_$@\1RSBQUUY9([?;/9WULL=Q:3Y'WD4*2O4?4=3GC*T7QOJE[X0\)&>:
M/^UM>NI(&G$8"QHC.68+TSM4 9[G)SC!Z>V\,S)XA.OW5W;2:F+(V:216IC4
MJ6#$N-Y+'*C'( Y]:RK;X<QP>$=+T7^U'^TZ3<_:K"_2$*T;[BWS+DA@=Q!'
M&1^= !+KFL:9XMO/#DMXMR)M,:_L+R:%=T;*VUD=4VAAT(( ]#FL73_$_B8:
M#X+U^ZU*"6+5KNWM+FT6V501+N&_=UW @' P.V.Y[!?#<\M_=:I>7T,NJ2V?
MV**5+8I'#&3N.$+DDDX));L.G?+7P%.GAKP]HJZNFS1+J*YBE-KS(8R=H8;^
MG)SC]* .VKA_B['*WPQUIH[AX@D.750#Y@W 8.1Q^&*V-*M]9B\4ZM)<ZC)=
M:7(J&"*2W$8@?H50]7&.23QR ,X-2>+O#[^*?#5WHHO!:1W2A9)?*WD*"#P,
MCGCWH R;S4-4TCQ=X4TS^T7N;;4C<K<"6*,$^7%O7!51CFLZXU:_OM'^(UA>
M3^=%IT4L4#%%5@K6V_!P!GEJW=:\+WFJR:+>PZJEKJNE2,\5P+7?&X="CJ8R
MW<?[7%5(? T\,/B9#K<LK:\NV1I+=3Y9,8C+#!&3C..@'H<4 <_??\BO\+/^
MOZQ_])GK=CU^]T?QQJFFZ[J'_$O>Q-]ITAC50$3/G*Q Y9?E(_V3S4UQX+N)
M]+\,V7]JQK_8,T4T;_9<^<8T*+N&_CY2<X[^E4-;.A>./$6GZ5;2/<7>C7YD
MO&1'40*JD-&Q(P0Y*KM!Y&3V- '5>'_[0;0[675)&>\E3S)%9%4Q[N0F  ,@
M8!/J#6G110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !117/>+-;FTF+2K:V98[C5-0CL4F89$08,S
M-@\$X4@9XR1G/2@#H:*X?Q#JVN^"=%\0:Q=WL.HV$441L%F4+*DK$(0^Q54I
MN93ZXR*=K&I:OX5UGPZTVI2:C9:G=KI]Q'+%&ICE=24D0HH(&5((.>/?F@#M
MJ*\LDUGQ3/X:\::@FO\ DRZ%?W*V^RTCQ(D4:.$;(/R\GI@Y/7M6F-9UZVU_
MPE<3:FLUIKP=)K+[.JQPGR3(I1OOY!&#DG/M0!Z!63>>(K*Q\0Z9HDR3_:]1
M$A@81GR_D7<V6Z=.PSU%<''?^--5TCQ3=6GB&*";1M2N8K=!91D3+&JL$;/0
M'U'.2>>@$_\ :[:_XE^&&KM$(GO+>\F9!T5FMP2![9H [ZUU);O4;ZS%K=Q&
MS9%,LL16.7<N[,;?Q8Z'T-7:\[F\8:GH]QX^FO)DNHM%$!LX_+" &2+=@XY(
MW,,DGH*T[1O%L7B.Q8+<W&E2Q.MX+W[,AC<#*-%Y1S@G@@YP,&@#L:*\^\(^
M*KC5]7MK#4-3N;36HHW.H:/>6Z1Y./O0D+ED!Z?,<CD^^QX_O=6TGPQ)J^DW
M4D36+K-<QI&CF6 ,/, W X(7)!]J .IJEJ&I+IS6:M:W=Q]JN%MP;>(N(R0?
MG?\ NH,<GW%<<?%KVGQ%^RSZJ[Z%<Z>T\#^6@1)E42,FX+D_NF5QSW[T:IJG
MB'2K+PC))J#>;J.K0P7<<D$>X1R!FV9  &T*%R!D\\T =S+<1Q+(3EFC7>R(
M"S8YQ\HYYP?RJCX>UVS\2Z';:O8"46MQN,?FKM;Y6*\CMR#7+>'8KM_BOXO\
MS5+N2*".QVQ-Y94JR2D+]W( ))&"#SR37)>&+_6M"^&?A75;74]MJ=02VDL?
M(0I)')<,C$L1NW<Y!! ]CUH ]IK'UGQ+8:&E@UR)I%OKN.TB:"/>OF.VT;CT
M S_*K.M+*VAWPAN);:40.5FBQN0@$Y&01^E>4-'=?\*E\#2&]DFEFU/370SJ
MI$9+]/E )&?4D^] 'LU%>>OXEU3PSKWB:UU*^;5+:QT<:K#OB2-E.7!C^0#(
M)48SDCU-6[&X\72:GHMW$MQ/I]PO_$P2Y^S+&@9<J\.PE^#V8G(]^: .WHKE
M/B1JNI:'X$U'5-)NEM[NW"%7,8?(+JI&#QW]#5+4+_7=&U6PTN?4Y;^?6+F1
MXC!;0QO;11Q[F1-YVMDXP6R0,]3S0!W%%>>2Z]XIT&VN+?4H]WVW4[:RTFZN
MO*,F)CAC*L1VG9@D8QNXJ\UUJ]C\1-/T1M9N;BRO-/GG;S8H0Z2(R $%4''S
M="#S^5 ':U2.I*-;33/LMV6:W,_V@1'R!A@NPO\ W^<X]*\Z_P"$LU[_ (5'
M#X@_M _VBE_Y#2>3'B1/M?DX*[<#Y?3'-=+)JFJ#XIC11>+_ &?)HLETD7E#
MY91*B!B>IX)XR!S0!U@ &< #/6EKS#1?$'B,>$[WQ9J.LK/;Z8U^)+%;1%%R
M(V<)EQRI! Z=NOK6S9S>+WU72+F(7$VGW"'[>MT+943*Y5X?+;=P>S$Y'?/-
M ';45Y-/K_BK_A"O$VMKKP2XT74KJ*)%M(]LR1.!M?(S@C^[@\]3VZ ZIK>G
M^./#EO<:G]IL];AN#):F!$6!HXPZE"!N[D'<30!W--6-%.510?4"O.;?7?%F
MOZ):Z]H$5PSRW!9;63[,+9X!(5*EB?,#;1G/][/&*E:]\2ZCXF\8Z9#KWV2'
M38K>2U:.TC9E+QL^/F!!&1SG)X&".<@'H+.J8W,%W' R<9/I3J\HFU/4?$2?
M#349-1N+62_=FF2W";/,$#G> RGGKP<@ ],\UJ:EXINK'Q3<:1J>IW.CR/<1
M+IDTL"&UNX\)N4R%#B0G>.JX^7'N >AT5E>)=97P[X9U+6&C\T6=N\PCSC<0
M.!^)Q7*:KK>M^'M)T#7I=1-[!=SV\-_:M$BH!-@;HBH##:Q& 2V1UYYH ZC5
MO$5MI4SP"VNKVZCMS<O;VB*TBQ XW8)&>> !DG!P#@U++K^G0:!'K<TS16,D
M22JSQL&(?&T;,;MQ) "XSDXKD;.SN#\:M4/]IW6%TJWDV[8L%3-)^[^Y]T?]
M]>]=%XQ\/KXF\/2::+YK&X,B2VUPO6.9&W(<=^1TH D@\464NIVNFS6]]:7E
MUN,$=Q;,H<*I8D-RO '3.>1Q6W7F^D>*=9LO$FF>'O'>E1I?/(W]G:K:G,%P
MX1E((_A8JQX]^@XIQUOQ5K^D3ZMX=2X\]+V2.WMV^SBVDCCE,9$A8^8"0I.1
MC!(QQR0#T:FEU5E5F 9ON@GD_2N.34M7\2ZAXBL]-U Z9+I>RW@"HC[IVC#[
MI-RM\@+!<+CHQSR,9MS%J\GQ-\,Q7VJRQW!TF=YX[7881*IC#[ Z$X))Y/.,
M8Q0!W%IJ2W=_?6@M;N(V;JAEFB*QR[EW9C;^(#H?0U=KSF?QIJ.B#Q]=7TJW
MD>B-#]DC$80#?$&"G')&YADDG@5<U?5M9\,/X<OYM2;4+74+R&QO('B10K2C
MY9(BJ@@!NQ+9!]>: .ZHKRZ?5_%4^G>.+B/7Q VA3RM;^79QG>$A638VX'Y>
MOOSU[5Z'HMZ^IZ%I]_(H5[FVCF95Z LH) _.@"&?Q#IMMX@M-#DF;^T+M7>*
M,1M@A1ECNQCICC.>146N^);'P^@-S%>7#[2YCL[5YV5!U9@H.U?<X[XZ5A^(
MO^2J>"?^N.H?^BXZZ;6#J2:9</HT%K+J!3$0NI"B9YQD@$GZ<?44 +INKV&K
MZ/!JUC<I+8SQ^8DW0;>^<],8.<],5-97D=_:K<P!_)?F-F&-Z]F ZX/;->12
M:HA^$>C:-;V4FGF?6(M$O8&?<4;SCYWS#KNPV?\ >(KT3Q)=W=I<:5'!?QV5
MI+,RW'EION) $)5(4VMDYY/'"@T :]_J$&F6WVFZ++;J?WDH&5C']YO1?4]N
MIP,D6@01D'(-<CX'U6\\0:+JL.K$SM:ZE<V!:6-5:2-3@;POR[L'!QQQ4/PK
MOY[WP%:QW#M))9336>]CDLL;E5_\= 'X4 =I17&6.I:IXKN_$:Z?J;Z<-,O&
ML+8)%&^Z1$4L\FY22"S8P,< ]SQS]KXSU_Q!9^"+JSNHM/.L2W%O>1B . \:
M."RDYXRF0/IG/- 'J=9:>(=-D\2'P^DS'45MC=-'Y; ",,%SNQ@\MC@]C5C2
MK:]L]+@M]0O_ +?=HN)+HPB+S#GKM' XP./2N6E_Y+=:_P#8NR_^E$= &]K_
M (ETWPS:Q3ZE)*%E?8B0PO*['&3\J@G ]>G(]:FL=<L;[0UUA9'AL2C2%[F-
MHBJJ3DD, 0.#UK$\4^%]8U/48M8T+Q%/INHVT!BBB:))('!.XA@1GYB%!.?X
M1QQ7,ZCXEN_$>C>!X;NW%M)J>KB._A!RI-NS;D_W2\8/T% 'IMM.+FW281R1
MJXR%D7:V.Q([9ZX//K@UBVOB_3;O^U62.Z1-+G$%V\D)78=H;=CKM (R<>_3
MFJVJZS<S^-K#PO9W#6IDLY+^YG15+[%8(J+N! )8DDX/"\=<C*^'\$L/B#QM
M#<W!NG&J*#*ZJ"X\E,9  &<8!P!]* .\1UD171@RL,A@<@CUI:XGX77<DOAF
M\T^0EETK4[G3XB?^><;_ "#\ 0/H*GM]4OO$?B;Q!IEIJ,NG0Z28H%>&.-F>
M5TWEFWJ?E'  &,X//3 !TNI:C:Z3IT]_>RB*WA7<[$9]@ !U). !W)JGI>O1
MZEJ%[8-8WMG=6@1G2YC #*V=K*RDJPX/0Y&.17FGB'6[_P 3_!^2\O)FMKVU
MU&.SNT@5?+ED2ZC7=\P) Z$ $<\'(KUNW@DAM5BDNI;AP#F:0(&/X*H7CZ=J
M *>M:Y9Z#H]YJ=WYKP6BEIA F]E &>@Z<<\XJY:7*7EG!=1AA'-&LBANN",C
M/YUY)#'='X;_ !(EN-3N[K9=:E#MFV'.T !B0H.< #&=N.@%;VGW^M:3XA\&
MVDNI_:;'6+22-[4P(JPF. .I1@-QZ$').<]N@ /0Z:[K&C.[!44$LS'  ]37
MG,6N^+-?T.+7/#\5PTC73&*UD^S"UDA64H59B?,#;5)SQ\W;%=]J-M!>Z7=V
MMVVRWF@>.5MVW"%2#SVX)YH Q3XXTE;2*]>*_6PF95@NS:/Y4I8X7!QD DC!
M8 '(P>:Z2O(VU#Q!\.-/CTGQ3:+K7A% L$>J6XQ+;1Y 42IZ#CD?F3@5U%]K
M6I:MXAU72-*>]B6PMX6$UD+=B9)59@6\XXV@ 8 '/.3TH [2BN$TW6_$-[J6
MC>'-7*:;JKZ?+>W\EML<G;((U"9#*-V=QX..@Q4>K7WBGP_8Z(+W589IY]?A
MLV>*)?WUK(YQO!4;9,==N!0!W]0W=P+2SGN3%+*(8VD\N)=SO@9PH[D]A7*I
MJFJOX_UO1DOL6T6F174 >)#Y4C.ZGH 2/E'!)K"T#4O%=_\ #K_A*Y_$*>8V
MDS2K;?8DVB522K[N#G"D8QCGVY /1+2]2[L+6[,<MN+A%=8KA=DBEAG:RGHP
M[CVJ./4EDUF;3?LMVK10K-]H:(B%MQ(VJ_=ACD>XKSJ^N-2U:3X874NK7<4M
M\@DG\H1@-(;5F+X*D9Y(]!G@#K6U+XCU#2_&?B*WN[G[1IVG:,E_'"(U4@Y?
M=R.22$^G/2@#N**X/3[WQ?>2Z!J=LEQ-:7>Q]0AG^S+"L3KG?"5)?*D\!B<C
MKS4.D^*KFY\4QZ1JFI7&F:LMY+NT^Y@18;JW&_88'VY;C8?O9R&X] #MM4U*
M#1]-N-0NA)]GMT:25HT+E5 ))P.> .U9">-=,DTI-42WU)K%XA,LXL92OED9
M#=.F.<U8\9_\B-X@_P"P;<_^BFKF_",GB!O 'A:.&QL#9M:V:2O]H9Y#"54-
M\AC SCK\W SUH [X*JDD* 3UP.M+7">.==U;PAJ%AK0O#-H<C&WNK0B-3'(R
MG8ZN5SMR/FYX'/3(JYJ6J:EHUEX>TN34A<ZCJMVMN]\8T 0;&=V10-O1<+D'
MJ"<XP0#=U[6[7PYHMSJUZLS6ULF]Q#&7;'T_J>*O6\RW-M%.@(25 ZYZX(S7
M ^,[36[/P-XT34=0CO=/:R+6+,H$Z?(=ZOM55(SC!'.#S3[._P!:TGQ7X5LI
M]3^U6.L6DP>V,"(L#11*ZE& W'.2#N)_#L =_17FEWXFUNPN](D;4Q<R7&NK
M8745O$K6B1.[*J+(5#&10%)PQP=P/:II+[Q-?Z_XST^'7OLD6EI!):M':1LR
MEXB^T[@01GKG)/&".<@'HM%>?0>+]2O=)\"R2.+2/7!_IMXBC$;B$LJ+N! +
MN,#.>X'/-54\6:WIFF^*;VYNQ>V^GWZV%B[0HHD+LBAF(VABA?!Z [>QH ]+
MHKD],/BF+Q3&LRW4VB2VY\UKXVXDAF'0IY1Y4C@@C@]ZTO%.J2:5H,TEOO\
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MBB)(#$$C.=K<#)^4\5A:SJFL>%KSPY<S:D^HVFHWL6GW<,D4:A'D!VR1E5!
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MZTU.6%KZ&))[<QJR.T88(V?O  ,> 1GU[5DQ_#SRO!VG^&UU9_L]C=+<QS&
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MI \80XE)+KP>F6..XJIX>\%7FA&&WF\2W^H:;:?\>=G<1H!'C[NYP-S[>P)
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M1D*>NW^5==IUG_9VFVUEY\LX@C6,22[=S # SM 'Z4 6J*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,EC3)(3^\./F'N,B@#7HKSS2]8N/%][J\EOK=UIDFG:HT4 2$^48(PFX2!@
M2V6ZG(XQTYZZT\2Z1>WD5I!>*9IT,D"NC()U'5HRP <=\KGB@#5HKGF\=>%E
MN1;G7+/S#<&U #Y'F@ E<].A'/2D3QWX7D6T9-:MF2[D,4#@G:S;BN,XP,D$
M#.,XXS0!T5%9.G>)M%U;49]/L-1AGNH$\QXUSG;G&X9X9<\9&126OBC1;R\@
MM(+Y7EN-XMSL8)/L^]Y;D;7Q@YVDT :]%<OIOC;2]6O-:MEF>VCTV0Q-/*C(
M.$!9LL,  M@9ZXST-6M'U/3[3PI8W;ZT^H6S*%COIOOW!)P,  ;B3P !D^]
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M#.E7%Q;WNLVL4ML469"V3&6)"@X[\'Z=Z -^BN=T#Q?8^(=3U6SM5E!L;@P
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M(-,T?=]NN3'L3S)-L;2>6G]]]H.U>#R<#@^E07/BSP_:3013:O:*\\/GQ 2
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MR#TX(Z&@#IJ*R?"US->>$=%NKB1I)YK""21VZLQC4DGZDUK4 %%%% !1110
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M[Z4>H;;'^*MZUN>,IXK?P5K;32(@:QG1=QQEC&V /4GTK1TS3X]+TZ&SC=Y
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MN*D)D9R5P:]:Q1B@#RF\U;3-'\<Z[!XO-]96VK)!+92K+,(I%$01X3Y9QN#
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MGM7L%% &#X)ECE\"Z 8W5@NGP*<'."(U!!]P>,5O444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MGZQKNF:!:I<ZI=I;0NXC5F!.6)P!@<]36A7#_%DH? [Q,-[/>6I$87<6"S(S
M<=\ $GVH W;7Q?H=];2W%I?>>D=P;4K'"[.TH&XJJA=S<<\ C'/2GV_BG1KO
M3S>P7F^)9_LQ41/Y@F[QF/&\-_LXSCGI7*^.[M=-U_PYK]PEW-H427$-U-8O
M)F'S A20^602OR$'Z_2J5Y9^%;_1_M5D=1TRVOM2CEBU@/*K_:%C<B8^9D[,
M#82< [CV&: .SF\8:#;6AN;F_$$8N1:'SHG1O-./EVD Y^8=N]+H_B_0-?U"
MXL-,U&.>ZMUW21;64[?[PW ;EZ<C(Y'K7FFNWVI3> ;Q=;>WOEM=>M$34;>'
M:M_&'C^?:."1]TXX^7 Z5T&O6/\ PD_CBSO= FC=K72+R&>\B;*;I5"PQ[AP
M2&W-CMU[B@#K8_%6BR:A;60O");HLMNS1.L<Y'4)(1L<_0FB\\5Z+83F*YO?
M+"S+;O+Y3F))#T1I -BGD<$CJ/6N \)WGA_5['0](OM+U5O$&EO#OL;A[G;:
MRQ84RY)\L*!DCUR!CFG^%]9LK#2;OP;XATN:ZUB*]G9+66T:1;W?,TB2AMI7
M&6'S$\8S0!V-EXPM+SQ=JF@B&Y0V$<1:9[>0*6;>3SC 4!1AC@')QG%:%EXA
MTW4+N*VMII6DFA,\6^WD19(P5!9690&'S+T/<5QZ7$5A\1_&"7UM.Z7NG6KP
MHL;$3(B2A\,!@8SCDCK57PG)<Z1K^GV.G:N=;\.O9RNGGQYN=,50I",P&<'A
M0K 'Y?\ 9H ].KFH/%EO?^+M1\-Q1WD4EK#&3.+9\;WW="5*@ *,,>"3QG%:
M/A_Q#IWB?24U+3)'>W9BG[R,HRD=00>1V/XUS%G=1Z;\7-?^UB2-;S3[1H',
M;;&">9O.[& !D9R: *O@/QM9)X5TJ'7=8>74KJZG@$LRLVYO/D5%9@-JD@
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M66S>%E$CLO55"JV">N1CJ*V--N+:/XC>.999$5&M+15=N VV-PX![X) ..E
M'8/KVEIIMKJ/VM'M;O;]F:,%S,6&5"*H)8D<X ['TKC="\0BZ\1^.OM>LW:Z
M99K;"-YU,;6NZ-]^%*@J0?49X'6N5T&[DT72OAQK%ZDO]DV5O<6MXP0G[)*X
M 5G4<@=1GMGWK=L-1M9_$OQ&NH_,^SW%G;&*8PN$DQ;L#AB,'DC'KD8S0!NR
M>,-/T+2?#$,5Q?ZHFIF.*&\>!Y&D3;N+L0O+$#IC/.<8!K4M[_3[GQG)%#K%
MR]XM@"^F'(C1-_\ K2"O#\[>3T[5P"2BV\$_#*[D63R+&Z@6Z98V8PGR'7Y@
M!D?,0/QK;N7:\^+-X+64PRS>&/(BD8%=DIE9@I]& (..N* .J/BO1%N(H6O=
MHFF-O',8G$+RY(V"7&PMD$8SU!'6HKWQIX>L+R[L[C45^TVBAYH8XWD=0<XP
M%!)Z'@9QCFO.CC5/@HGA 0M'XBB2.R^P,,2I*DB_O,?W,#?OZ8[UTNF30V_Q
M:UMYYTPNDVT9F?@,RLY<9Z9&02* .UT_4+35M/@O["=)[6X0/%*G1E-9U_XM
MT339IXKN]V?9F1+B01.T<#/C:'< JF<CJ1U'K6'\)"%^&NEPD%9(C,KQL,,G
M[UR 1VX(/T-<9XVOQJ&B^/-/%K/9W4<GR6=M:MFZ4*G^D2.%Y!P0.0 %&<DT
M >GWWBS0M-U)]-NM01+U(#.8%1G<ID#@*#DY(X')]*DMO$VC7F@C7(+^-M..
M?WQ!'.[;MP1G=NXVXSGC%<G'?6MS\7=-O V(3X?D0/(A3#&9& .X#!*@G!YQ
MS7)))<0>'4U&&&6>RT[QC+?7D,2%F^SF1BL@4<E1D,,>F>U '::?KLM]\7I;
M"&^O&LET4S-:3Q-$(Y/.4;@K*I^[W.>IYKJ=7\0:5H/V;^U+V.V^TRK##OS\
MSGH..GU/%<;8ZO8ZK\8X+VP>2>UET Q+.D+["WGAL;L8Z _D1UJW\3'B$'AE
M9,$+K]I*XQG$:L=S$?W1W/04 ;MMXOT.]L4O+2[DN(W>2-$BMY'D9D.'Q&%W
M<'&3C'(]14L'B?1[K3K:_MKP3P7+F.'R8V=W89RH0#=D8.1CC'-<?XNOH="\
M>Z?K.K+??V#<:<;3[59O*!;S>9O!?RCG:PP._(%5[O3?#LNFV#:;/?>'?/O9
MKNPU/+@^:4 9Y!+T5\D8;&<#^]0!VP\5:,8[*0W;*E[<FT@+P2+NF#%2AROR
MME6&#CH:F&JV6H7E]I%M>21W]L@,JK&5>,-G:PW+@YP<'D<5YKJ-]JDOA+0=
M2UJ*,KIGB:.2XO+6$B.:!6=?M.T=%8MG(X/4<&MK0]5M9_BCXAO5\Y;273+4
MQSO"ZHP4R$G)' YXSC/;- %;PYXZDTWX:^%;_5#=WU[JEPEN9?*>3):4@EBH
M/(7.!U)  'IVMYXGTJPCDDN9IE6*$7$N+65C#&<X+@*=G0_>QT/I7E=@3!\'
MO \LD<@73]8M9;L!"6A597R64#(QD?F*V?%DB_VGJ6L:%J[Z?JZ6J>;I]Y%N
M@U2/82J>6P!W\E?E^89 (&: /4@<C(K&/BO1%N(H6O<":8V\4QB<0O+DC8)<
M;"V01C/4$=:L.+R_\., GV.^N+3[N?\ 4R,G3/L3^E>6G&J_!6/P@(6C\11)
M%9?8&&)4E21?WF/[F!OW],=Z .L\0>(1)XXT_P -M)J$-K):333O:PS*[."B
MH%=%SM&XDD<9P">QZ73X7T/04CU/56N_LL;&6]N=J$J"3EB..!P3[9KE+V>*
M'XP:*))@?+TB>)Y#T#LZ$ GH"0I.*O\ Q-T_4-3\ :E;Z9$TUR/+E\A.LJI(
MK,@]<@'COT[T ;%KXETF[OELDN6CN6B,R1SPO"9$'5EW@;@.Y&<5ES_$CPA;
MJK2ZW"$,QA+A'*JP./F(&%&>,G X//!K(U:XMO%_B#P?=:)+YKV=VUU<2*.;
M>'RR&23^ZS$JNT\]>.#7/Z9=:;+X'\>:3($EO;G5=2CBM N9)W9B$VKU;YL<
MCICMB@#U#4-<L-, ^T2R,Q0RA((7F?8.K;4!.WWQBJ4OC3PY#;V$[ZO;^5J
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MSV%UH'PU\!Z;J>Y;N#6+2:2)N6BC\UG^;T"J0">@Q7L*.LB*Z,&1AD,IR"*
M/,?$?C:;6_A5JVMZ//?:;/;S%8V$31DH)_+^\RXR0,D*<@\&NYL/%&C:GJTV
MEV=ZLE[%'YICV,NY,XW*2 '7/&5)%>3SSJOP+UO1WBG6_AO)4D@:%@=QNRX
MX^8[>>,\<UU^KS17'Q2T)K2= &TFZB65#E59BA09''."0/:@#IV\5:*E]!9O
M>%7N)3!#(T3B*209RBR8V%L@C .<@CM2^*O$$'A7PQJ&MW*%X[2+>$!QO8D!
M5SVRQ _&O-_"D^AWFC:7X9UK2]5?Q%IKQHUA*]R4$D9P)@<^6$Q\V?R!XSW7
MQ"\.3>+/ FJZ-;,!<3QAH=QP"Z,'4$]LE<?C0 FC:9J]_I%O?ZKK-Y%J-Q&)
M6CM=B16Y89V*I4[L9QEMV?TJW87L^C:);KXAO!+?-/)$'2,EISO8IL10224
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M "BBB@#G_%_AVX\3:7!90WT=F([F*X+O 9<F-PP&-RXY'-;Z;@BAR"^/F*C
M)]A2T4 %%%% !2$9! )!/<=J6B@"O9645C"T<6YB[F21W.6=SU8_YP!@# %6
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&W;3M(#8X)&1FL
M#PGX=N/#=OJ$4]]%=B\OIKW*6YBV-(VXKRS9&>E=!10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 9?B/2I==\.:AI,5REL;V!X&
ME:(R;592I(&X<X/K4VCV4NFZ-9V,TZ3O;0I#YB1E VT  [<G'3UJ]10 4444
M 8NO:1JFK26J6.O2Z9:KO6[CBMT=IU8 8#MRA'/(]?:M:""*UMXK>!!'#$@1
M$7HJ@8 'X5)10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 45YCKWC+Q#8_%_2_"%I<6:V>H6_G^;);%GCXDX
MX8 _ZO\ 6NJTB77Y=5N$N;ZTN]->$FWN8+4QLDJN596!9@?4'C//I0!TE%>:
M?#7QIKOBSQ#XDLM3EM!!I%P(4$$!4R9:1<DECC[@Z>M=3XYU6^T'P;J>KZ=)
M$MQ9PF51+'O5L=B,C^= '145YUHGQ#DM_A)'XU\1/&SR*Q$%O'L!82,BHN2>
M3@<]N?2K_A>Y\7^(]#M]=NK^QTX7B":VL4M#*J1GE3(Q8%B1@\;>M ';45YE
MXP\7^*O#/PY;798[*'5(;UH)(#$S1,GFLJLO(/*A2#[U8UWXCMX3^&^E:[?H
MEYJFIP1-!;QKY:EW0,?4A5S]>@[T >BT5PVN:AXO\/>#9-?EN;"ZO+6(7%W8
M_9RD93JZHV[<"HSR<YQTYKH/"OB2S\6^&[/6K$,L-PIRC?>C8'#*?H0?KUH
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MPZ%F'3/(/8<<\9G@WQQXD\3:GXHM;S4=.LXM%N!"LJV3-OR[KDCS/]@<#UH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJVML[ZE=#$UY<2O+*XXXW,3@<#@8' ]*\/\ A_I%AKGB3QU'<:@;:2+4XKF
MBZ,:.4GD;YE!PXX'4'&<C%?1'D0^1Y'E)Y.W;Y>T;<>F.F*J?V'I'_0+L?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ .AHKGOM7C+_H#Z#_X-9O\ Y'H^U>,O^@/H/_@UF_\ D>@#H:*Y[[5XR_Z
M^@_^#6;_ .1Z/M7C+_H#Z#_X-9O_ )'H Z&BN>^U>,O^@/H/_@UF_P#D>C[5
MXR_Z ^@_^#6;_P"1Z .AHJEIDFIR6['5;:TMY]^%6UN&F4K@<DLB$'.>,?C5
MV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 45@^)?$R:!]@MH;<W>IZC/Y%
ME:A]N]NK,S8.U%').#]*AU"]\3:58&\:'3K\*R^;%"KQ-$A(#,"2V_:,G&%S
MC\* .DHKF-(\0WEUXQ\2:1?"UCM=,6V:&1,@D2JQ.XDX[ <8K9U(ZD/L9TY[
M-1]I3[3]I#<P\[@F/X^F,\4 7J*8\L<94/(JECA0QQD^@K%\0:\VEWFD:=;^
M6+O5+DP1O("RQA49V8@$9X7 &1R?:@#=HK$M+[5-.T&^O/$2VIDL_-DWV(;;
M+"HR&VL258@'Y<GZUC6_B+Q%=>&K3Q#;6VF7-K=)'+]EC=P\,;D<^9DARH.2
M-J]#S0!VE%4#K%D-=71A,IOC;M<F,$?*@95R?3);CZ&KOF1[@N]=Q)&,\\4
M.HIB2QR,RI(C,APP# D?6J>EZQ9:REQ)8S+-'!.UNSJ0077&['J 3C\#0!$G
MAW2H]9;6$M -19=C7.]MY7.=I.?N^W2I=5T73M<MEMM3M5N8%8.(W)V[AT.
M>2.U7$ECESY<BOM.#M.<'TH66-I&C612Z_>4'D?44 4-6\/Z3KVFC3M5L8KR
MU!!"398@CH0>H/OG-1Q^&-#BT Z$FE6HTLC!M?+!0\YR1W.><]<UJAE)P"#^
M- ((R"#]* ,C3/"F@Z/I,^EZ?I5M!8W (FA"9$H(P=V>3QQS4+^"O#3V]E;M
MHMH8K$DVZE/]7GK]0<#(/7%;9EC$HB,B"0C(3<,D?2E>6.,$NZJ ,G)Q@>M
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M,]L\<'W!K-N_%'B'3!I=S<KI<UGJ[6]O;E%=7MYY6'##<=Z!=QR-I)7'&<T
M=W17.Z6WBT:V\>JR:,^EKO\ +DMUD6:7[I4[22%Q\P/)SQTK?,L8D$9=1(1D
M+GDCZ4 /HICRQQLJO(JLYPH)QD^U*\B1_?=5P,\G''K0 ZBBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \W\;
M_P#$K^)_@K7[L[=+B:XLY)F^[#)(A"$GL"3C/M7H=Q<PVD!FF<*@(&>I))P
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M"D=!'OVY'3''>NUU73/#<EKXHN++RI[B]TPM=QQN'B 1&$;%1P&/.#U.WVH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN+J>ZGT:PDN+B+R9I7MT+2)C&TG&2,<5(GA_1H[F&YCTFR2>&,112+ H9$'
M53C@>PJQ!J-C<W,MM!>6\L\7^LBCE5F3Z@'(H.HV(OA8F\MQ=D9$'FKYA'^[
MG- %:+P_HT%I<VD6DV,=M=$FXA6W4)*3U+#&#^-):>'=%L-+DTRTTFRAL)<^
M9;I H1\]=PQ@_C5L7UF7F074&Z$9E'F#*#_:]/QH%]:&&.874!BD8(CB0;78
MG  /<YXQ0!2F\,:!<6MM:S:+I\EO:MNMXFMD*Q'U48P/PI7\-:%);W-N^C6#
M0W4OG3QM;H5ED_O,,<GW-6#JVFBUN;G[?:F"USY\@E4K%CKN.>/QK(&O+K_A
M>'4]#U2SM?.,;B:Y =50L,JPR,,5X&?6@#H(H8X(4BAC6.-!A448 'H!5.]T
M/2]2G6>\L+>:95V"5D&\+Z;NN/;I5B>^M+9F$]U!$40R,)) N$!P6.>V2.:<
MMU;O:BZ6>(VY7>)0XV;?7/3'O0 R"PL[6R%G;VL,-J%*B&- J 'J,#BJ<7AO
M0X+*6RBT>PCM)N9($MT"/]5Q@U=MKVUO$WVMS#.F2-T4@89].*QO%?B=/#=K
M:+%!]JU'4+E;2RMMVT22-W8]E'4F@"Z_AS1);&*QDTBP>TB;=' UNA1#ZA<8
M%)J7AO1-9:W;4](LKQK?_4F>!7V>PR.GM61KFI>(O#6C2ZU<26.HV]JOFW=M
M!;-$XC'WFC8NW*C)P1SCJ*37?&ME9Z?H<ME=VY_MFXACAED88CB<%C(02/X5
M(&>,D9]* -W5-#TK6[1;75-.M;RW4[ECGB#A3ZC/2F3>'M%N+:UMIM)L9(+3
M'V>-[=2L..FT8^7\*Y%/$FJQ>(4\-7.N:7YL\<UU#J$2C(B&P1JR$[=Y+GIP
M548&3QT7AHZ\!=)K^HZ9=7*E (K!"HAXYW9.?FZ]!CF@#=    & .@K(;PGX
M<8W!;0M-/VF02SYM4_>.#D,W')SS5^WU&QNYY8+:\MYI8CB2..569/J >*%U
M&Q>^:R2]MVNU&6@$JF0#U*YS0!7&@:.)KF8:59"6Z&VX<0+F8>C''S?C4<WA
MG0I]*72Y='L6T]6W+;&W7RU;U"XP#[BK3ZA9E_LXOK=)V<Q*OF+NWXS@#N0"
M#BJ6BZR;^ZU#3;I434=.D5)U3[KJPW)(N>@8=NQ##)QD@%BPT+2=+FDFT_3+
M.UED4*[PPJC,   "0.@ '%+?:'I.ISQ3W^F6=U+"<Q//"KLA]02./PJ_10!%
M-:V]S:M;3PQRP.NUHG4%2/0@]JJ)H6D)I;:6FF6:Z>W6U$"B(_\  <8K0HH
MS1X>T4/:.-)L=UF-MLWV=<PCT3CY?PJ2WT72K26YDMM-M(7NN+AHX54R_P"]
M@?-^-7J* ,S3/#FB:-%/%IFDV5G'<?ZU8(50/]<#GK7-^+_"*W.A6&EZ%HUF
MMO'J4%W/"BI%&41]S#'0DCCI]:[>B@"C9Z5I]G%(+>QAA\\#S0$&6&,88]\
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MP]HNAS0JRA-,.YI=PQAV$:#;WVX/.#D8P>P95=2K %2,$$<$4 <UX\U&WM?
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MOKZ9EDO[^027$B] %&U$7_94?F23QG% &I1110 4444 %%%% !1110 4444
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MEI.H^$K+PY';6NJ6$NF0RBV,\DRM'),WS$%_NL[%LG'<T 1^#K_Q!JP:^O\
M5_#U_IKH1$VDHY._(ZLS$<#/&,UUE</H>B6.F_$>_N= 6*+39[ ?;X;? A%S
MO&P@#@-LWY [8)^]SW% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMIUH;-CEK<P+Y9/J5QBKM% $5M;6]G D%K!%!"@PL<2!57Z <5+110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
0 !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>May 09, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Entity Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Elicio Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-3430072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">451 D Street, 5th Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">209-0050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,996,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 18,351<span></span>
</td>
<td class="nump">$ 17,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash, current</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">1,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,901<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">20,935<span></span>
</td>
<td class="nump">20,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">430<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">5,481<span></span>
</td>
<td class="nump">5,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, noncurrent</a></td>
<td class="nump">698<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other long-term prepaid assets</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">28,144<span></span>
</td>
<td class="nump">28,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">4,037<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">5,770<span></span>
</td>
<td class="nump">8,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred research obligation</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,413<span></span>
</td>
<td class="nump">11,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantLiability', window );">Warrant liabilities</a></td>
<td class="nump">2,962<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">4,865<span></span>
</td>
<td class="nump">5,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible note - related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,034<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">19,240<span></span>
</td>
<td class="nump">39,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies&#8212;Note 10</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value per share; 300,000,000 shares authorized; 15,983,191 shares and 11,043,837 shares issued at March&#160;31, 2025 and December&#160;31, 2024, respectively; 15,968,736 and 11,029,382 outstanding as of March&#160;31, 2025 and December&#160;31, 2024, respectively</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 14,455 shares outstanding</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">214,348<span></span>
</td>
<td class="nump">183,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(205,310)<span></span>
</td>
<td class="num">(194,101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">8,904<span></span>
</td>
<td class="num">(11,312)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 28,144<span></span>
</td>
<td class="nump">$ 28,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares outstanding (in shares)</a></td>
<td class="nump">14,455<span></span>
</td>
<td class="nump">14,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">15,983,191<span></span>
</td>
<td class="nump">11,043,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">15,968,736<span></span>
</td>
<td class="nump">11,029,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares outstanding (in shares)</a></td>
<td class="nump">14,455<span></span>
</td>
<td class="nump">14,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 7,778<span></span>
</td>
<td class="nump">$ 7,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">2,958<span></span>
</td>
<td class="nump">2,682<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">10,736<span></span>
</td>
<td class="nump">10,241<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(10,736)<span></span>
</td>
<td class="num">(10,241)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other (expense) income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(507)<span></span>
</td>
<td class="num">(1,278)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of pre-funded warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(578)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale of equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange transaction gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperatingAndNonoperating', window );">Interest income</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(473)<span></span>
</td>
<td class="num">(1,586)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,209)<span></span>
</td>
<td class="num">(11,827)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (11,178)<span></span>
</td>
<td class="num">$ (11,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="num">$ (0.87)<span></span>
</td>
<td class="num">$ (1.15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.87)<span></span>
</td>
<td class="num">$ (1.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares and pre-funded warrants outstanding, basic (in shares)</a></td>
<td class="nump">12,950,574<span></span>
</td>
<td class="nump">10,273,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)</a></td>
<td class="nump">12,950,574<span></span>
</td>
<td class="nump">10,273,925<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperatingAndNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income classified as operating and nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperatingAndNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Conversion of Convertible Debt</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Conversion of Convertible Debt</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Conversion of Convertible Debt</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,603,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 11,373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">$ 153,827,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (197,000)<span></span>
</td>
<td class="num">$ (142,203,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">5,062,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,056,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon the exercise of common warrants</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(73,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,827,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,827,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,219,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="nump">$ 4,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">159,218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(270,000)<span></span>
</td>
<td class="num">(154,030,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2024</a></td>
<td class="nump">11,029,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,043,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="num">$ (11,312,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">183,004,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
<td class="num">(194,101,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">$ 835,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">834,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">1,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of senior note payable into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of senior note payable into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,176,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</a></td>
<td class="nump">9,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon the exercise of common warrants</a></td>
<td class="nump">716,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">715,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,209,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,209,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2025</a></td>
<td class="nump">15,968,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,983,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 8,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">$ 214,348,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (144,000)<span></span>
</td>
<td class="num">$ (205,310,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Conversion of senior note payable</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_PurchaseAgreementMember', window );">Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-51<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,209)<span></span>
</td>
<td class="num">$ (11,827)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets, operating leases</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_InterestExpenseNoncash', window );">Non-cash interest expense</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on disposal of property and equipment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term prepaid assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,999<span></span>
</td>
<td class="num">(3,264)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(2,645)<span></span>
</td>
<td class="num">(432)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred research obligation</a></td>
<td class="num">(489)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(215)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(10,119)<span></span>
</td>
<td class="num">(12,122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from exercise of common warrants</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January Offering</a></td>
<td class="nump">9,143<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">835<span></span>
</td>
<td class="nump">5,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">10,328<span></span>
</td>
<td class="nump">11,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency on cash</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">240<span></span>
</td>
<td class="num">(1,095)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">19,492<span></span>
</td>
<td class="nump">14,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">19,732<span></span>
</td>
<td class="nump">13,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Components of cash, cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">18,351<span></span>
</td>
<td class="nump">11,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">1,381<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">19,732<span></span>
</td>
<td class="nump">13,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfPreFundedWarrants', window );">Fair value of pre-funded warrants at issuance date</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfCommonStockWarrants', window );">Fair value of common warrants upon settlement</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SettlementOfPromissoryNotesPayable', window );">Conversion of related-party senior note payable into equity</a></td>
<td class="nump">20,034<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_NonCashVestingOfRestrictedCommonStock', window );">Non-cash vesting of restricted common stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_FairValueOfCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Common Stock Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_FairValueOfCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_FairValueOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value of Pre-Funded Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_FairValueOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Expenses and Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_InterestExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_InterestExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_NonCashVestingOfRestrictedCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash Vesting of Restricted Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_NonCashVestingOfRestrictedCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SettlementOfPromissoryNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement Of Promissory Notes Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SettlementOfPromissoryNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business and Financial Condition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of the Business and Financial Condition</a></td>
<td class="text">Description of the Business and Financial Condition<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#8220;ESC&#8221;), an investment company, Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;), and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#8220;Elicio&#8221; throughout these condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Liquidity and Going Concern</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has experienced net losses and negative cash flows from operating activities since inception. As of March&#160;31, 2025, the Company had an accumulated deficit of $205.3 million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2025, the Company had $18.4 million in cash and cash equivalents. The Company&#8217;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it might have to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Please refer to "Note 2 &#8211; Summary of Basis of Significant Accounting Policies," to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's significant accounting policies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated interim financial statements include the accounts of the Company and its wholly owned subsidiaries, Elicio Pty, ESC, and Former Elicio.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#8217;s consolidated financial statements, once adopted.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes of the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amount that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact of this adoption on the consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,715&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,715&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,962&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash equivalents at March&#160;31, 2025 and December&#160;31, 2024 were held in U.S. Treasury securities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There were no transfers made among the three levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The fair value of the warrants assumed in the merger (the &#8220;Merger&#8221;) with Angion Biomedica Corp. (&#8220;Angion&#8221; and the warrants, the &#8220;Angion warrants&#8221;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion warrants issued by the Company has been estimated using Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion warrant liability was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:59.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">79.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed an underwritten public offering (the &#8220;Public Offering&#8221;), consisting of (i) 500,000 shares of the Company&#8217;s common stock (the &#8220;July Shares&#8221;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#8220;July Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock (the &#8220;July Common Warrants&#8221;). Each July Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July Pre-Funded Warrants. As of reporting period end, the outstanding July Pre-Funded Warrants are equity classified. Refer to Note 6 and 8 for further discussion. Each July Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July Common Warrants. At the Company&#8217;s annual stockholder&#8217;s meeting in November 2024, the Company obtained stockholder approval for GKCC, LLC (&#8220;GKCC&#8221;), together with its affiliates, to exceed the 19.99% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) (&#8220;Stockholder Approval&#8221;). As a result of obtaining Stockholder Approval, certain July Common Warrants are equity classified while the remainder of the outstanding July Common Warrants are liability classified and are subsequently remeasured at each reporting period end. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company identified the July Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. For the three months ended March 31, 2025, the Company recognized a loss of $0.5 million in fair value remeasurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company records the change in the fair value of the outstanding warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prepaid and Other Current Assets</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,901&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment, Net</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">430&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense for each of the three months ended March 31, 2025 and 2024 was $0.1 million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other long-term prepaid assets </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $0.6 million for both March&#160;31, 2025 and December&#160;31, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Expenses</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,770&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Grant<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research Grant</a></td>
<td class="text">Research Grant<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $2.8 million award, $2.3 million was received in September 2022 and the remaining $0.5 million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $0.5 million payment was applied as a credit to the second grant agreement described below. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $3.1 million, with such amount received net of the $0.5 million credit, described above.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> For the three months ended March 31, 2024, the Company incurred </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$1.4&#160;million in research and development expenses related to this project, of which $0.1&#160;million was reimbursed from available grant funds. As of March 31, 2024, the grant funds available for the second grant agreement were</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$0.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the deferred research obligation was </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$0.6 million. The second grant agreement activities were completed in the third quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $1.5 million. The grant funds available as of March&#160;31, 2025 were $0.7 million which are reflected in restricted cash in the </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">accompanying condensed consolidated balance sheets. The deferred research obligation as of March&#160;31, 2025 was $0.7 million, which was reflected in the deferred research obligation in the accompanying condensed consolidated balance sheets. For the three months ended March 31, 2025, the Company incurred $0.5 million in research and development expenses related to this project, of which $0.5 million was reimbursed from available grant funds. </span></div>The award money for the three agreements was earned and recognized as a contra research and development expense as the expenses were incurred.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock, Common Stock and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Convertible Preferred Stock, Common Stock and Stockholders' Equity</a></td>
<td class="text">Convertible Preferred Stock, Common Stock and Stockholders' Equity<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes 300,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a registration statement on Form S-3 (the &#8220;Prior Shelf Registration St</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">atement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $100&#160;million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $21 million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#8220;2022 ATM Program"). During the three months ended March 31, 2024, the Company issued and sold a total of 615,363 shares of common stock under the 2022 ATM Program for aggregate net sale proceeds of approximately $5.1 million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, the Company filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, the Company entered into the Capital on Demand</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services LLC, as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221;). During the three months ended March 31, 2025, the Company issued and sold 106,823 shares of common stock under the 2024 ATM Program for aggregate net sale proceeds of approximately $0.8 million after deducting sales commissions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the Company entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, providing for the issuance and sale by the Company to GKCC of pre-funded warrants (the &#8220;March Pre-Funded Warrants&#8221;) (the &#8220;March Offering&#8221;). Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. The net proceeds to the Company from the March Offering were approximately $6.0 million. Refer to Note 8 for additional information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offerings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed the Public Offering, which resulted in net proceeds of $10.9&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Public Offering consisted of the July Shares or in lieu thereof, the July Pre-Funded Warrants, and accompanying July Common Warrants. Each July Share and accompanying July Common Warrant were sold together at a combined offering price of $5.00 per July Share and accompanying July Common Warrant, and each July Pre-Funded Warrant and accompanying July Common Warrant were sold together at a combined offering price of $4.99 per July Pre-Funded Warrant and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">accompanying July Common Warrant, which represented the combined purchase price per July Pre-Funded Warrant and accompanying July Common Warrant less the $0.01 per share exercise price for each such July Pre-Funded Warrant. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The July Common Warrants have an exercise price of $5.00 per share, are immediately exercisable and will expire five years from the issuance date. Refer to Note 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the &#8220;January Offering&#8221;): (i) an aggregate of 1,261,830 shares of the Company&#8217;s common stock (the &#8220;January Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#8220;January Common Warrants&#8221;). Each January Share and accompanying January Common Warrant were sold together at a combined offering price of $7.925. The January Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the initial exercise date. The January Offering resulted in net proceeds of $9.2&#160;million to the Company after deducting the placement agent&#8217;s fees and related offering expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March 31, 2025, there is an aggregate of 1,035,544 shares of common stock available for issuance under the Company&#8217;s equity incentive plans, including 471,889 shares available for future grants under the Company&#8217;s 2021 Incentive Award Plan, 176,323 shares available for future grants under the Company&#8217;s 2022 Equity Incentive Plan, as amended, and 387,332 shares available for future grants issuance under the Company&#8217;s 2024 Inducement Incentive Award Plan. Refer to "Note 8 &#8211; Stock-Based Compensation," to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Options</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,890,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.78</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">378,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2,226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,265,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,060,694&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock price and the exercise price of the stock options. 378,375 stock options were granted during the three months ended March 31, 2025. The weighted average grant date fair value per share for the stock option grants during the three months ended March 31, 2025 was $8.92. As of March&#160;31, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $5.4 million, which the Company expects to recognize over a weighted-average period of approximately 2.93 years. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-based Compensation Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">324&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#8217;s stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected dividend yield</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected term in years (for employees)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.50 - 6.08</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected volatility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">106.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">79.5% - 79.7%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the condensed consolidated financial statements for the period ended March&#160;31, 2024.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#8217;s initial public offering. The offering period and purchase period was determined by Angion&#8217;s board of directors. No offering periods or purchasing periods were active as of March&#160;31, 2025. As of March&#160;31, 2025, 275,309 shares remained available for purchase under the ESPP and no offerings have been authorized.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingAbstract', window );"><strong>Warrants And Rights Outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with  FASB ASC Topic 815, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, certain of the Company&#8217;s outstanding warrants, as discussed below, are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss at the end of each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the fair value of the March Pre-Funded Warrants was $6.6 million. The Company recorded the $0.6 million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024. The fair value of the March Pre-Funded Warrants was measured using the Black-Scholes option pricing model as of the grant date. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March 31, 2025, these warrants were classified as equity upon receipt of Stockholder Approval, as discussed in Note 3.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 3 and 6, in July 2024, the Company closed its Public Offering consisting of (i) the July Shares, (ii) the July Pre-Funded Warrants, and (iii) the July Common Warrants. Each July Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July Pre-Funded Warrants. Each July Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the fair value of the July Pre-Funded Warrants and July Common Warrants was $6.8 million and $6.5 million, respectively. The Company recorded the $2.9 million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As of March 31, 2025, the July Pre-Funded Warrants are classified as equity, following Stockholder Approval in November 2024, as discussed in Note 3. The fair value of the July Common Warrants was measured using the Black-Scholes option pricing model as of the grant date. For the three months ended March 31, 2025, the Company recognized a loss of $0.5 million in fair value remeasurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following receipt of Stockholder Approval, the Company remeasured the March Pre-Funded Warrants and the July Pre-Funded Warrants, held by GKCC, at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. As a result of obtaining Stockholder Approval, the March Pre-Funded Warrants and July Pre-Funded Warrants held by GKCC and its affiliates met the equity classification requirements under ASC 815. During the quarter ended December 31, 2024, the Company reclassified the July Common Warrants held by GKCC and its affiliates from a liability to equity. The Company will re-assess the equity classification for the remaining March Pre-Funded Warrants and July Pre-Funded Warrants at each reporting period end. As of the three months ended March 31, 2025, there were no changes to the equity classification.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in January 2025, the Company closed the January Offering pursuant to which the Company agreed to issue and sell: (i) the January Shares and (ii) the January Common Warrants. Each January Share and accompanying January Common Warrant were sold together at a combined offering price of $7.925. The January Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the initial exercise date. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information regarding the warrants outstanding at March&#160;31, 2025:</span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:38.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Warrants</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted <br/>Average <br/>Exercise <br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,081,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,261,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">68,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at March&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,274,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.5</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Legal Proceedings </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company may be exposed to litigation in connection with its products under development and operations. The Company&#8217;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2016, Former Elicio entered into a license agreement to license certain intellectual property from a university, which agreement has been amended from time to time to license additional intellectual property and to adjust fees, milestone dates, and diligence requirements. The Company is required to pay certain contractual maintenance and milestone payments related to clinical trials and royalties on product sales over the term of the contract, with minimum annual royalty payments commencing in the calendar year after commercialization. The license term for the license agreement extends until terminated by either party under certain provisions. During the three months ended March 31, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $0.4&#160;million. No such expenses were recorded in the three months ended March 31, 2025. No commercialization royalties have been achieved to date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the Company is required to pay a total of up to $20.9&#160;million upon achievement of certain late-stage developmental and commercial milestones. The developmental milestone payment will be recorded when the milestone is achieved, and the commercial milestone payment and royalties will be recorded when the sales occur.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Future minimum annual maintenance payments are $0.1&#160;million for the year ended December&#160;31, 2025 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#8220;Boston Lease&#8221;).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $11.1&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a ROU lease asset of $8.0&#160;million with a corresponding lease liability of $8.0&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the deposit on the Boston Lease and has a deposit in the amount of $0.7&#160;million, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of March&#160;31, 2025 and December&#160;31, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately 6,157 square feet for approximately $0.2&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease expense for all leases for the three months ended March 31, 2025 was $0.3 million. Lease expense for all leases for the three months ended March 31, 2024 was $0.4 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.80</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2025 (remaining nine months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(926)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, pursuant to which the Company issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $20.0 million (the &#8220;Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of approximately $19.7 million from the Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the three months ended March&#160;31, 2025, the Company recorded other expense of $0.1 million related to the accretion of the discount of Convertible Note debt issuance costs. During the three months ended March&#160;31, 2025, the Company recorded accrued interest expense of $0.1 million related to the interest due on the Convertible Note but not yet payable.</span></div>In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. In March 2025, the Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. As of March 31, 2025, the Company has no outstanding debt<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company did not record a provision or benefit for income taxes during the three months ended March&#160;31, 2025 or 2024. As of March&#160;31, 2025 and December&#160;31, 2024, the Company continues to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock and preferred stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be antidilutive. Because the Company has reported net losses since inception, these potential shares of common stock and preferred stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(11,209)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(11,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average shares used in computing net loss per share, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,950,574</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,273,925</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(0.87)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1.15)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:72.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.904%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.906%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,453</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,204</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642,099</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181,466</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unvested common stock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,030</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,907,552</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,869,700</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement and Subscription Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the March Offering were approximately $6.0 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#8217;s board of directors,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Jay Venkatesan, a member of the Company&#8217;s board of directors, and trusts affiliated with Jay Venkatesan, purchased 1,600,000 July Pre-Funded Warrants and accompanying July Common Warrants and 200,000 July Pre-Funded Warrants and accompanying July Common Warrants, respectively, with such July Pre-Funded Warrants and July Common Warrants subject to the terms and conditions of the July Pre-Funded Warrants and July Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the Public Offering were approximately $10.9 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million pursuant to the Note Financing. The Company received net proceeds of approximately $19.7 million from the Note Financing, after deducting debt issuance costs. </span></div>In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. The Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. As of March 31, 2025, the Company has no outstanding deb<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has one reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#8217;s Chief Operating Decision Maker </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;CODM&#8221;), its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Other segment items include interest income, interest expense, and change in the fair value of warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:71.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:71.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,209)<span></span>
</td>
<td class="num">$ (11,827)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated interim financial statements include the accounts of the Company and its wholly owned subsidiaries, Elicio Pty, ESC, and Former Elicio.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#8217;s consolidated financial statements, once adopted.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes of the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amount that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments</span>. This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact of this adoption on the consolidated financial statements and related disclosures<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,715&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,715&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,962&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion warrant liability was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:59.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">79.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,901&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">430&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,770&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,890,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.78</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">378,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2,226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,265,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,060,694&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Components of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">324&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Black-Scholes Option-Pricing Model Following Assumptions</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected dividend yield</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected term in years (for employees)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.08</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.50 - 6.08</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected volatility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">106.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">79.5% - 79.7%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingAbstract', window );"><strong>Warrants And Rights Outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Outstanding Warrants</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information regarding the warrants outstanding at March&#160;31, 2025:</span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:38.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Warrants</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted <br/>Average <br/>Exercise <br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,081,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,261,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">68,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at March&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,274,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.5</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock', window );">Schedule of Quantitative Information Regarding Operating Leases</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.80</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2025 (remaining nine months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(926)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Quantitative Information On Operating Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Net Loss Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(11,209)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(11,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average shares used in computing net loss per share, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,950,574</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,273,925</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(0.87)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1.15)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share</a></td>
<td class="text">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:72.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.904%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.906%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,453</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,204</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642,099</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181,466</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unvested common stock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,030</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,907,552</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,869,700</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:71.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:71.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of the Business and Financial Condition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 205,310<span></span>
</td>
<td class="nump">$ 194,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 18,351<span></span>
</td>
<td class="nump">$ 17,618<span></span>
</td>
<td class="nump">$ 11,853<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=angn_AngionCommonStockMember', window );">Angion Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split, conversion ratio</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_AngionCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_AngionCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair value measurements, recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">$ 11,715<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">11,715<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liability</a></td>
<td class="nump">2,962<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">2,962<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">11,715<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">11,715<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liability</a></td>
<td class="nump">2,960<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">2,960<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liability</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Warrant Liability - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, beginning of the period</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, end of the period</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=angn_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=angn_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,274,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,081,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockBeneficialOwnershipLimitationPercentage', window );">Sale of stock, beneficial ownership limitation, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (507)<span></span>
</td>
<td class="num">$ (1,278)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="nump">615,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares) | shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction | $</a></td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Share And July Common Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | March Subscription Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember', window );">July Pre-Funded Warrants and July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember', window );">July Pre-Funded Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SaleOfStockBeneficialOwnershipLimitationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Beneficial Ownership Limitation, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SaleOfStockBeneficialOwnershipLimitationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Weighted average strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">76.00<span></span>
</td>
<td class="nump">76.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Volatility (annual)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.791<span></span>
</td>
<td class="nump">0.749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.040<span></span>
</td>
<td class="nump">0.044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Dividend yield (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=angn_MeasurementInputStrikePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=angn_MeasurementInputStrikePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_PrepaidResearchAndDevelopmentExpenses', window );">Prepaid research and development contract services</a></td>
<td class="nump">$ 1,331<span></span>
</td>
<td class="nump">$ 1,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AdvancedProfessionalFees', window );">Advanced professional fees</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_OtherPrepaidExpensesAndOtherAssetsCurrent', window );">Other prepaid expenses and other current assets</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 1,901<span></span>
</td>
<td class="nump">$ 1,897<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AdvancedProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advanced Professional Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AdvancedProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_OtherPrepaidExpensesAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Prepaid Expenses And Other Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_OtherPrepaidExpensesAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_PrepaidResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Research And Development Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_PrepaidResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 2,035<span></span>
</td>
<td class="nump">$ 2,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(1,605)<span></span>
</td>
<td class="num">(1,552)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">430<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other long-term prepaid assets</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">$ 740<span></span>
</td>
<td class="nump">$ 1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">698<span></span>
</td>
<td class="nump">2,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedResearchAndDevelopmentCurrent', window );">Accrued research and development</a></td>
<td class="nump">4,302<span></span>
</td>
<td class="nump">4,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedOtherOperatingLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 5,770<span></span>
</td>
<td class="nump">$ 8,415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedOtherOperatingLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Other Operating Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedOtherOperatingLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Grant (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 7,778,000<span></span>
</td>
<td class="nump">$ 7,559,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred research obligation</a></td>
<td class="nump">680,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,169,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash, current</a></td>
<td class="nump">$ 683,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,178,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_NumberOfResearchGrantAgreements', window );">Number of research grant agreements | agreement</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member', window );">Research Grant Agreement with GIRF Sept. 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrantReceived', window );">Grant award received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member', window );">Research Grant Agreement with GIRF Sept. 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrantReceived', window );">Grant award received</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementCredit', window );">Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred research obligation</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds', window );">Reimbursement from grant funds</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member', window );">Research Grant Agreement with GIRF Aug. 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred research obligation</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash, current</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds', window );">Reimbursement from grant funds</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_NumberOfResearchGrantAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Research Grant Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_NumberOfResearchGrantAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementGrantReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Grant Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementGrantReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Reimbursement from Grant Funds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock, Common Stock and Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 835<span></span>
</td>
<td class="nump">$ 5,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember', window );">Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member', window );">At-The-Market Equity Offering Sales Agreement 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember', window );">2024 Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember', window );">March Subscription Agreement | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember', window );">At-The-Market Equity Offering Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember', window );">January Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember', window );">January Public Offering | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember', window );">July Share And July Common Warrant | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="nump">615,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Equity Offering Sales Agreement 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Equity Offering Sales Agreement 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SaleOfStockAggregateInitialOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Initial Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SaleOfStockAggregateInitialOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">1,035,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">378,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation related to unvested stock option awards | $</a></td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</a></td>
<td class="text">2 years 11 months 4 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">275,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized for issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_The2021PlanMember', window );">The 2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">471,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_The2022PlanMember', window );">The 2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">176,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_Inducement2024PlanMember', window );">Inducement 2024 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Shares available for future grants (in shares)</a></td>
<td class="nump">387,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_The2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_The2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_The2022PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_The2022PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_Inducement2024PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_Inducement2024PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Share Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">1,890,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">378,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(1,628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (unvested) (in shares)</a></td>
<td class="num">(2,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">2,265,453<span></span>
</td>
<td class="nump">1,890,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options vested and exercisable (in shares)</a></td>
<td class="nump">1,060,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 15.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="nump">8.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">4.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (unvested) (in dollars per share)</a></td>
<td class="nump">6.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share)</a></td>
<td class="nump">14.58<span></span>
</td>
<td class="nump">$ 15.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 23.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Option Activity, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, weighted average remaining contractual life (in years)</a></td>
<td class="text">7 years 1 month 13 days<span></span>
</td>
<td class="text">6 years 9 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and exercisable, weighted average remaining contractual life (in years)</a></td>
<td class="text">5 years 2 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, total intrinsic value</a></td>
<td class="nump">$ 2,248<span></span>
</td>
<td class="nump">$ 920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options vested and exercisable, total intrinsic value</a></td>
<td class="nump">$ 1,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 517<span></span>
</td>
<td class="nump">$ 324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years (for employees)</a></td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">106.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years (for employees)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years (for employees)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockBeneficialOwnershipLimitationPercentage', window );">Sale of stock, beneficial ownership limitation, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfCommonStockWarrants', window );">Fair value of common warrants upon settlement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 373<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Gain (loss) on fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (507)<span></span>
</td>
<td class="num">$ (1,278)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Share And July Common Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | March Subscription Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfCommonStockWarrants', window );">Fair value of common warrants upon settlement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfCommonStockWarrants', window );">Fair value of common warrants upon settlement | $</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfCommonStockWarrants', window );">Fair value of common warrants upon settlement | $</a></td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Gain (loss) on fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember', window );">July Pre-Funded Warrants and July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_FairValueOfCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Common Stock Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_FairValueOfCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SaleOfStockBeneficialOwnershipLimitationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Beneficial Ownership Limitation, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SaleOfStockBeneficialOwnershipLimitationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Outstanding Warrants (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightRollForward', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding beginning balance (in shares) | shares</a></td>
<td class="nump">5,081,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares) | shares</a></td>
<td class="nump">1,261,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightExercisedInPeriod', window );">Exercised (in shares) | shares</a></td>
<td class="nump">68,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding ending balance (in shares) | shares</a></td>
<td class="nump">6,274,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Outstanding beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod', window );">Issued (in dollars per share) | $ / shares</a></td>
<td class="nump">7.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Outstanding ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward', window );"><strong>Weighted Average Life (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLife', window );">Outstanding beginning balance (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLife', window );">Outstanding ending balance (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightExercisedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercised In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightExercisedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Rollforward</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant Or Right, Weighted Average Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Weighted Average Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_LicenseExpense', window );">License expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments', window );">Future minimum payments</a></td>
<td class="nump">$ 20.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter', window );">Future minimum annual maintenance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CommitmentsAndContingenciesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CommitmentsAndContingenciesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_LicenseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_LicenseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Future Minimum, Annual Maintenance Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Future Minimum, Annual Maintenance Payments, Due Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 01, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSecuredLinesOfCredit', window );">Proceeds from Secured Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=angn_BostonMassachusettsMember', window );">Boston, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember', window );">Newton, Massachusettes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in sqft) | ft&#178;</a></td>
<td class="nump">6,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_LesseeOperatingLeaseAnnualRentExpense', window );">Operating lease, payment per year</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_LesseeOperatingLeaseAnnualRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Annual Rent Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_LesseeOperatingLeaseAnnualRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSecuredLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSecuredLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=angn_BostonMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=angn_BostonMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Quantitative Information about Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 334<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term&#8212;operating leases (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate&#8212;operating leases</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2025 (remaining nine months)</a></td>
<td class="nump">$ 1,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2026</a></td>
<td class="nump">1,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2027</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2028</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2029</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">7,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less present value discount</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">5,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: operating lease liability, current portion</a></td>
<td class="num">(926)<span></span>
</td>
<td class="num">$ (901)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">$ 4,865<span></span>
</td>
<td class="nump">$ 5,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee&#8203; Operating &#8203;Lease&#8203; Liability&#8203; Payments&#8203; Due&#8203; After&#8203; Year&#8203; Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 05, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700<span></span>
</td>
<td class="nump">$ 9,143<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Other expense related to accretion of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Share And July Common Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember', window );">July Pre-Funded Warrants and July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Other expense related to accretion of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,209)<span></span>
</td>
<td class="num">$ (11,827)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">12,950,574<span></span>
</td>
<td class="nump">10,273,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">12,950,574<span></span>
</td>
<td class="nump">10,273,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.87)<span></span>
</td>
<td class="num">$ (1.15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.87)<span></span>
</td>
<td class="num">$ (1.15)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">5,907,552<span></span>
</td>
<td class="nump">1,869,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">2,265,453<span></span>
</td>
<td class="nump">687,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">3,642,099<span></span>
</td>
<td class="nump">1,181,466<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 02, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,143<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember', window );">March Subscription Agreement | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of Stock, Consideration Received on Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common warrants</a></td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of Stock, Consideration Received on Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember', window );">Purchase of Warrants | July Public Offering | July Pre-Funded Warrants and July Common Warrants | Yekaterina Chudnovsky</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember', window );">Purchase of Warrants | July Public Offering | July Pre-Funded Warrants and July Common Warrants | Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>entity</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | entity</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 7,778<span></span>
</td>
<td class="nump">$ 7,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">2,958<span></span>
</td>
<td class="nump">2,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,209)<span></span>
</td>
<td class="num">(11,827)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total segment assets</a></td>
<td class="nump">28,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecoveryOfDirectCosts', window );">Contract and grant reimbursements</a></td>
<td class="num">(489)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Professional fees and other general and administrative expenses</a></td>
<td class="nump">1,866<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">473<span></span>
</td>
<td class="nump">1,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">11,209<span></span>
</td>
<td class="nump">11,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total segment assets</a></td>
<td class="nump">28,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_ClinicalTrailMember', window );">Clinical trial expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,192<span></span>
</td>
<td class="nump">2,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember', window );">Employee related research and development expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,298<span></span>
</td>
<td class="nump">2,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember', window );">Chemistry, manufacturing and controls expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">646<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_OtherMember', window );">Other research and development expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="nump">$ 1,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecoveryOfDirectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecoveryOfDirectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_ClinicalTrailMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_ClinicalTrailMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>82
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /"#K5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( /"#K5J_8K'Y\0   "L"   1
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M8<(3^8YP?B+Y*MM4G7$I>90=+AGUF5 /P/TYYW)_HOY!L2\_^A=02P,$%
M  @ \(.M6J,]W6I-!@  ^!D  !@   !X;"]W;W)K<VAE971S+W-H965T,BYX
M;6RM66USTS@0_BN:P' PDS26_!*[+YF!=F[N/G#'4#@^J[;2:+"M(,DMO5]_
M*SNU$TM6R\$'J%]V5\^NM/OL.N?W0GY56\8T^EZ5M;J8;;7>G2Z7*M^RBJH3
ML6,UO-D(65$-M_)VJ7:2T:)5JLHE"8)D65%>S];G[;,/<GTN&EWRFGV02#55
M1>7#.U:*^XL9GCT^^,AOM]H\6*[/=_2673/]>?=!PMVRMU+PBM6*BQI)MKF8
MO<6GEV&KT$K\P]F].KA&QI4;(;Z:FS^+BUE@$+&2Y=J8H/#GCEVRLC26 ,>W
MO=%9OZ91/+Q^M/Y[ZSPX<T,5NQ3E%U[H[<4LG:&";6A3ZH_B_@^V=R@V]G)1
MJO9_=+^7#68H;Y06U5X9$%2\[O[2[_M '"C@:$*![!7(<Q7"O4+8.MHA:]VZ
MHIJNSZ6X1])(@S5ST<:FU09O>&VV\5I+>,M!3Z\O15W IK "P942)2^HAIMW
MM*1USM"U,:S0 GV^OD*O7[Y!+Q&OT:>M:!2M"W6^U(#!6%KF^_7>=>N1B?7>
M4WF"0CQ')""Q0_W2KW[%\EX].E9?@N>]^Z1WG[3VPBGW&RE9K1%5"OQTN=/I
M1VY]DV2G:D=S=C&#+%),WK'9^M4+G 1G+N=^D;$C5\/>U=!G?7U)U1;!IJ'<
M7+!O#;^C)?CN]+HSE;2F3"6X6^,TC/'Y\N[0'8?4*L%I+W6$,^IQ1EZ<'YG2
MDN?F%!JD<\B"=H]<,#M+\0& ) U'(&T9C%<3&.,>8^S%^$&R'>4%8M]W)GE4
M&U>AMTP^HO6<J-@&E 7CT#J$TFSE1IWTJ!,OZD]"T_(9 !-K;1)D83Q"Z))*
MLM -<=5#7#T16" HJ1_:@)HSN@/*T'-4,^?^KRP,41B,<#IDT@F4:8\R]:+\
M&S!2S>M;5#*@D#F2ABP68K-H%/,$-K6@Q%$ZWGF'T"I(W("S'G#V8SE5B]J3
M5IF=5EDZ@NF2F4")@X&, G]@VQ0J17V[T$Q6:+?/L^F0[@T>X0C&1^ )H6.P
M!\R)GY%.'FC8SI 41]$8G%-LJD+A@=GP\ZBMY/2&EUQSYD;Y2PGN5UD[]GF@
M..SGN+=Y+AJ@-+2C#_2F9$Z'0[L@!.%JO"NV% ["J4T9N W[R0T RH8-Q.$$
M:#-6O%I99]J62B,<3P <B W[F>V*;1B<FP*9[:$RWR)Q4_);:GIN)UB;J)+4
MPNI@,YQD$U@'.L-^/AN5X?ZD/WA[!FP35T:2,6*'T %''P,>R W[V>V8@)]*
M3)NX,([PN+UQBL5D@N'P0''8SW%?J)3T&2AMNB)90L8@'5(IF<JF@=6PG]8\
M!\!/<-AFKRA-QAV.0RK&P42*D8'DB)_D8-"Z@QZ'0WT"F)K!="59V8Y=.PJ]
MCW,*L1ELG&0.$9CEPV@"[D!SY#DT]\0Q(#:)X8Q$%D9;+,RB;(**R<$4Y^45
M"&E5<6U:Q:X5ST5MC@6K<\#[ZD5*,#G[RX0:!T[T_X.UD'.^^WE#QQ$8F(^$
M7K:_UB+_NA5EP:3ZK>V<H8E^7; -S[E^<^KTVLNE/SS:_B)KQ_X/Q$K\Q&I.
M@*B1,F&8HY?!28!--B&8<1N&H$X@M:62G:$P".9!]Z][!">FT5LA^;^L.$,X
MGF=I.,<9[M_"><)X'D3A/ U7CT^Y4H;'J4;O#4MVGCQ^UVAUKEC.JALFCUY%
M<T.L.]9^O"H?NO62=+X*DWXADLW#E"#1:*7AF2EO5"&Q^:F5G ? ,1HG5LJZ
MYN>IA!W:#.)O,SY)*-B-?'C<,(AC+A0,>CB:1W'\&.6#&#@=L/N*!8XM#YZ0
M.G9AZ#Z(O_MX6Q3<=$50',V,LN US%8[#L72"=4Q+N,HC,9CE4,.IW!FI\KX
MT'L0?^\!G6=3-1W-[+]4B I2<6L^R=X!=PKEKNQV?[&PAQBGU&J**H<FA/B;
MD$/0^UKFQ&BW%PL2Q"&VCH)#$&<1GFKMR-"*$'\KTK&D\E9A)W2[QTBSP JO
M+;7 .,3$#3L<>I'0WXM8Y-X6E$,W6O9<G3W+F?UBAQ\$71.O6VQJX@V'3B5\
MHE,9%16[B*#7D*7=8[<#CC8F@GHT=N IL<Z!Y<%G>?.;"-3O6UXK:%8WH!><
MK," ['YFZ&ZTV+5?ZF^$UJ)J+[>,PBX8 7B_$=##[&_,Q__^QY[U?U!+ P04
M    " #P@ZU:6R;!Z,\"   M"   &    'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;*U676^;,!3]*Q:;IE;JPC>D78+4IIJVATE1LX^':0\.W 2K!C/;).U^
M_:Z!HB2E33LM#\$V]QR?<[GX,MD*>:MR $WN"EZJJ95K75W8MDIS**@:B0I*
MO+,2LJ :IW)MJTH"S1I0P6W/<2*[H*RTDDFS-I?)1-2:LQ+FDJBZ**B\OP(N
MME/+M1X6;M@ZUV;!3B857<,"]+=J+G%F]RP9*Z!43)1$PFIJ7;H7L]C$-P'?
M&6S5SI@8)TLA;LWD<S:U'",(.*3:,%"\;& &G!LBE/&[X[3Z+0UP=_S _K'Q
MCEZ65,%,\!\LT_G4&ELD@Q6MN;X1VT_0^0D-7RJX:O[)MHV-8HNDM=*BZ,"H
MH&!E>Z5W71YV &[P!,#K -Y+ 7X'\!NCK;+&UC75-)E(L2721".;&32Y:=#H
MAI7F*2ZTQ+L,<3J9B3+#9P(9P9$2G&54X^2*<EJF0!:&6)&3.950ZAPT2RD_
M)>_)6V(3E>.JFM@:=1@V.^WVO&KW])[8\PN5(^*[9\1SO'  /GL>?@UI#P_V
MX3:Z[U/@]2GP&C[_";Z%1LM8F)J(%?G(2C3.*"=SH5A3:3\OETI+K+=?0U9;
M[F"8V[R#%ZJB*4PM?,D4R U8R;LW;N1\&#+^G\CVTN#W:?"?8\=** ITBQ67
MWIZ1BDJRH;P&<L)*D@G.J52D MD^]=.A5+3\<<-O3H]-XHP<=V)O=BT>"=J3
M'O32@U=(;\N2T%KG0K(_6,W&0KLZJ+LE#W<D^4[W.Q#_DL@]!V'O('R] Z94
M?5Q]^$B3&YZ/???\,/,#@:X3^&,_'M8>]=JCUVO'AJ$T+3-6KH\9B(8,1./8
MCPX,# 2ZCG?NC[UA W%O('[6P%=L?ZJ6]_]N(7ZL+ C"\$#_L:A6O+USF)M&
MBJ?EFI6*<%@ASAG%2"#;YM1.M*B:\WTI-':+9IAC/P=I O#^2@C],#$MH_]"
M2/X"4$L#!!0    ( /"#K5J<IM>\ P4  +L3   8    >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&ULK9A=<YLX%(;_BL;;V4EFZH!D8VROXYG$W>YV9K.;2=KM
MM0*R80O(E82=_OL] @P8A)+.Y"8Q<'1X7GV<5VAUY.*;C!A3Z#E-,GD]BI3:
M+QU'!A%+J;SB>Y;!DRT7*55P*7:.W M&PZ)1FCC$=6=.2N-LM%X5]^[%>L5S
ME<09NQ=(YFE*Q8];EO#C]0B/3C<>XEVD] UGO=K3'7MDZLO^7L"54V<)XY1E
M,N89$FQ[/;K!RPV9Z 9%Q+\Q.\K6;Z2E/''^35]\"J]'KB9B"0N43D'AWX%M
M6)+H3,#QO4HZJM^I&[9_G[)_+,2#F"<JV88G7^-01=>C^0B%;$OS1#WPXY^L
M$N3I? %/9/$7':M8=X2"7"J>5HV!((VS\C]]KCJBU0#RF!N0J@'I-I@.-)A4
M#8J><TJR0M8'JNAZ)?@1"1T-V?2/HF^*UJ FSO0P/BH!3V-HI]8;GH4P*"Q$
M\$OR) ZI@HM'!?]@M)1$?(O^V3-!=:]+1#,=F<*4B?18'ACZBTN)QNC+XP=T
M\>X2O4-QACY'/)<0*E>. DC]*B>H@&Y+(#( -$%W/%.11+\#6'C>W@%QM4)R
M4GA+K GOJ+A"$_P>$9=X!I[-ZYM/+3B3NL,G1;[)0+ZJ+[,=8L][W?-R:>JD
M,LG4G$2O[:7<TX!=CV D)!,'-EK_^@N>N;^9%+Y1LC.]TUKOU)9]_0 9J0BB
M8N:$[ "%8Z\GEDETF6E69-+UY[#V?7^^<@YM,88@SUO406>07@WI62'_8!F,
M2E(PTA"662R5'J4#,V&6N;P6 5EX74Q#T&Q.S)BS&G-FQ?S,%4#RW@PR0<YZ
M[\>N/YEU*$U19(K-F'Z-Z5LQBXJP%3P]H4+A,"'ZO9>/38S&L$'(>0TYMZ]#
M%3&!+JHNO(2J%?#4.-SSMUR*;Y3L3/*BEKRPCLLFHMF.Z?J\I;% !YKD3)?W
M(Q6"9@HE,7V*DUC%YAFUZ(^#Y_J=P3($8=):PV?@V&U<RGUY2H'KQU+F- L*
M;.BA\3;7+G%28+8;MX?D=J -(6-O$+IEK=A>56 7I:$E30I@]CV/!VM?E<N*
MV0^9##"2AI%8&6$O!#N=#$I)4,X.J'N9I.4>:P<"C*SD9=9^"/:&:!OOQ%:K
M6G_*%(-UH2RKM<IP5GAQCZX?A#UW@*YQ.FRWNIJN*BI&O*EA@?C=DF>*:M7%
M<[[&Y+#=Y2K[* I?A?@>9<P\'?O^-9[ZDRZG(0I[\R'2QN>PW>C^AN^7!):\
MD:SO66.,B;OHLAGCYL0?@&O<#?NO<([@;!.L88W[.&RURI]UC[?*=JZ\L4QL
MM:>Z6 2Y$"P+?I3%(J'E!UGX'WRN#):W>;]VX>Z(]6/&_E#-:$P/O^!ZO8$R
M\BUZVTJ8+;BW^S3'+=R!XD$:AR-VASM->;0O)U>JC2.B I8H?*;& ;H ,PEY
MDE!1QA0/+TU:JC?Y;4;W:MZU:E,8OL+>@)+&]HC=]BQ*PCC)]>?E3VC!K]-B
M"+-H:>R1V.WQ:W$, ,3T #M9L,>VGO)KV+ -03Q74L%#V*2WAZ]L9=9I\$OX
MJG ]?]J5:HATB3]9D"&UC;T2N[V^A=KV$-OT&AQX0*\ATJS7:1V#I$SLBM,A
M"2+R3)7G!?7=\@3J%B\WQ4%-Y_X-7MX4YS%.DZ8\UKJC8A=G$B5L"RG=*Q^P
M1'E25%XHOB\.6YZX4CPM?D:,ADSH 'B^Y5R=+O0+ZO.Z]?]02P,$%     @
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MRJ!WB8E0=6FO!T:6KCHNI<%:Z[HYOH:@; #^7TD\[,W +M"^K\E?4$L#!!0
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MGGLM<_D9SM,YZMOF$4MQ @.VM52.XROBM]M&S6KIK%6>=?!\BAVK/&(8)9.
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M4^U&41]]J6\4K^SID157BN_LY9:2G HCH/^_YCJBS8UYP?$ TN+_4$L#!!0
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M@N 2HD0FWA>(K)\$/"QS9>AH6F4B-8P:?TRY- R* :N*X:S8/7,P'@EK3L8
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M>0/6UP'7A>&%#4S_'+G^'5!+ P04    " #P@ZU:^O)^/I0(  #P%@  &
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M2/GQLE)#VDH?QRAN?_E^==,9E+:K2,JRY62N?.9TY$A*=O24!A3Z0!/!?C+
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MCA;@^=HB!^F"#N@^<M_^%U!+ P04    " #P@ZU:9E#AGT$)  ")&0  &0
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M-UP:]I%GI6!W@MO2"'C<V8N! W-:,D@J1C>!T7@/HR-VIY5;6/:S2D7:I1]
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M8C/W@.?283IC;S#V(Z  2B>+_:0R83YH'I/J^PQ>V8+<P.8)QAR8TC"5XZC
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MR<%UXW)[C-:&W6<_1&O[E=Q*;7L-Q<^F-X'''J863VIW-GI*:Z64(_%MX9<
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M'AM+?"RP(K(- OB^-$"^/80+NJ5S]@]02P,$%     @ \(.M6M*SWUJ= @
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MA6_:W',>U9O;(I;60J#[).4PC;L79Q$SS0VL.3A=A5M/HAWN4.&QP*65C%>
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M'7OX6F6 .HZH]5KQ4D;=JB;BW3<B?3I*A:,FP,HX?J(&C[1Z5 F)]$;C1<:
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M%=(,:XFUR_-6RT0)ILPTU1(E[<R43IFE3SUOF:5&%GNE5+3"=KO72AF7M='
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MKP 9CG=>RW6&9$;J(.[K(/X?=8!M7.K/EL##IX;9F$W(;Z"'2F 4^%()G%F
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M,Y!& /=S(?1I8@STU[W5OU!+ P04    " #P@ZU:9]N<)),$  "1"@  &0
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M>./$ =%WCWZB^-HZ=LF5]K\=UKKAHC !>K_B7.TFYH"AA>?_ %!+ P04
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MKSE>Z2"- :YG0NCMP-P:W9^$^!]02P,$%     @ \(.M6D?[L5-5 P  @@X
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M((T!?L^$T)N)Z?S=11__!5!+ P04    " #P@ZU:9R'?GF8&  #[/P  &0
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MI;_[SH,6S;A1+48UB6H*U32J&4IS"Z#)N$?^C'MW?7#P;FU^L_,+.YIIHYI
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MZ!S]W2JX+C@S2=B"&PVN<#=:6*.%O6A/.8.(KO+D+\D5M>N104H4K*"HS#?
M59NKK8]H84Y'58U<47?!FFE'+=A@<& M1S7KZ+2L%RK;"8UU55:^]&NU(#N0
MR]%9%/U4V%@BUT69.91\%)-=WUEQ50=\U>OZ?5:D= > ])';A=9K?^1>=YU&
M")PW/LLJ@/\YP);2N2<ZSBK'[9,$AX'G7'5O 1<W2/A?(95B39G>"8HIX;PD
M>02O8N$]+.< 42-H;J^B3']9@Y)-%\U3DG=.>@I%<AM)<OVWKM)>43PVP$;B
MW'Z-^X8JW=<[/W1'HT-5V@B>VZ]X54W@PS71:W]LRAK5<\.WKHE>W3TVP$8J
MW7Y5^H::&.U_B85##WL':J(1,[=?S>[SN(Q,9F5I^(=+XQ2BAAM1PV\M:O@4
MHH8;4<-'B-JR%"4#4R'\M1+!^^+FC4+/^^>WJ-VZ9&; 5OHJS>6G6YD+<]^L
M>^OK^HVYI#;#S5U?7M!6B?R$3F$I39U!*"=GYOIL'@0M])5U086\ .OF&D@,
M3 V0[Y>4BI<'-4']3XSI%U!+ P04    " #P@ZU:H!!1&L$$  "_%0  &0
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MM/*^L!(=L-(%3RR52P&^I1&).N0?S/(0&138RF65W]#6;_?(J/$)\QYPX35
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MN,[3C9C+RYXZ,Z4R>9"]Z3__88^L?[6)$0GSD# ?":-(&$/". BF:7"PT^#
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M1S*9CZW80AG,\**0-VSU#1J'#&#*"F&>:%7OC2(+I0LA6=D(*X*2T/J-'YI
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MZ@R&BH[7/6$]D:PR?=B42=75F6&N^FC@>H/Z/F-,KB?:0-N9)W\!4$L#!!0
M   ( /"#K5JCRDME P,   T,   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q
M+GAM;+U7:VO;,!3]*\(KHX,M3ISGLL30QBTKM% :NGT8^Z#8-XFH'JXD)^V_
MGR0[7M(Y9AEF7ZR'=<[5/9(OQY.MD$]J#:#1"Z-<3;VUUNG8]U6\!H952Z3
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M9%IV;Y$A:0Z4YD)I'I3F0VD!BM;6H]7HT8(VOS4.)4$DS8'27"C-@])\*"U
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M#^L[A3._\I*P#(1F4A %R[%W'5[=#*V],_C%8*MK8V*5/$GY;"??DK$76$+
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M@Z^[&Z;8?X&R!KB_E-+L)O8#54<W^0M02P,$%     @ \(.M6E.##M>- P
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M-(_EI^S)9_4%C0I>F,6B_)<\U6V-'@ES(;.D#E8]2**T^I]^KS^(K0!S^$J
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MR.H[9ZMHD2VTIK#US@#9>^^,NEN H=?> &J"(!QY[0E\B6T"JK<)R+Q-*#:
M%M=>F_N$T"I:9 NM*76].4'!)6>NU:V)5;3(%EI3V'IK@LQOV4^:N=WWWA#V
M.U-7$Q5T7F68TSJ5MGMP%B$E;)6?Z>!R$=UFHOA/?W6W.#=R"Z_#_'A%Z_X-
MO+[)3U&X-4QQ&.4>LU6<<9"0I83L7?FR-K'B?$=Q(>@F/_$PHT+0-/^Z)GA!
MF J0OR\I%?L+U4%URF;Z/U!+ P04    " #P@ZU:*VM9XUD#  "0%@  #0
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MK)Z#!\\C;_><\MK_04]_ U!+ P04    " #P@ZU:EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( /"#K5KD&49:LP0
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M4YJ4&1)F,YP:R[UPQIB4,A)F99P:E?1@4C9)F&UR&)P<:OF7&(Q22L*LE/T
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MZEVFST,NUYZO-5[_)ZF>SN?FZ^4ORZ^=>+]H+S@G^'?G\2]02P,$%     @
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M3UE?K%W]]=\>W3UO3-4>\UG_2\WL#5!+ 0(4 Q0    ( /"#K5I&QTU(E0
M ,T    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ \(.M6K]BL?GQ    *P(  !$              ( !PP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ \(.M6IE<G",0!@  G"<  !,
M         ( !XP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #P
M@ZU: =8V8-P%  "C'P  &               @($D"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ \(.M6J,]W6I-!@  ^!D  !@
M         ("!-@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( /"#K5I;)L'HSP(  "T(   8              " @;D4  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #P@ZU:G*;7O ,%  "[$P
M&               @(&^%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ \(.M6M3+S#8]"@  SV@  !@              ("!]QP  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( /"#K5J75XX'MP(
M &L'   8              " @6HG  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " #P@ZU:K,%!F. '  ",)   &               @(%7
M*@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ \(.M6D+!
MT+/H!@  *!$  !@              ("!;3(  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( /"#K5KZ\GX^E @  / 6   8
M  " @8LY  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #P
M@ZU:9E#AGT$)  ")&0  &0              @(%50@  >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( /"#K5K3K^A3%P0  !$*   9
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M970Q-2YX;6Q02P$"% ,4    " #P@ZU:&D1Z-DT&   D#P  &0
M    @('F;@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M /"#K5I5&0HJ:@4  +X,   9              " @6IU  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ \(.M6KN-W0ES!   @ H  !D
M             ("!"WL  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " #P@ZU:TK/?6IT"  #-!0  &0              @(&U?P  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( /"#K5KG\*H$N00
M *X+   9              " @8F"  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ \(.M6A159!%(!   $@L  !D              ("!
M>8<  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #P@ZU:
MO*:CY0<%  #<"P  &0              @('XBP  >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( /"#K5KM\I1U0@(  )H%   9
M      " @3:1  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ \(.M6A.MA^M$ @  B@8  !D              ("!KY,  'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #P@ZU:([9$5PH(  #H%
M&0              @($JE@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( /"#K5K\D=_%M 0  $H,   9              " @6N>  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ \(.M6C0%F5;;
M P  ^@D  !D              ("!5J,  'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " #P@ZU:9]N<)),$  "1"@  &0
M@(%HIP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( /"#
MK5HIN5=$HP(  ,X%   9              " @3*L  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ \(.M6A(.9O*& P  50@  !D
M         ("!#*\  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " #P@ZU:N9D4<=T#  #7"   &0              @(')L@  >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( /"#K5I_A]K^8@,  &8'
M   9              " @=VV  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ \(.M6IUDX&F@ @  *P<  !D              ("!=KH
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #P@ZU:"5]]
M5"@"  #/!   &0              @(%-O0  >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    ( /"#K5I(YP!G500  #<9   9
M  " @:R_  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
M\(.M6BOGHK[F @  XP<  !D              ("!.,0  'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " #P@ZU:\]U3-/T)  "9<@  &0
M            @(%5QP  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( /"#K5J_/1Z0? ,  ,80   9              " @8G1  !X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ \(.M6A=@?\,$ P
M, @  !D              ("!/-4  'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " #P@ZU:1_NQ4U4#  ""#@  &0              @(%W
MV   >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( /"#K5J=
MRJ.%PP(  -D'   9              " @0/<  !X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ \(.M6EU*>:SJ @  ] <  !D
M     ("!_=X  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /"#K5H-&B]&+ ,  +P+   9              "
M@68  0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ \(.M
M6AG:"9O? P  >A(  !D              ("!R0,! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " #P@ZU:$*E8OP4)  #K8@  &0
M        @('?!P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( /"#K5HHWLE**0,  *4+   9              " @1L1 0!X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ \(.M6J/*2V4# P  #0P
M !D              ("!>Q0! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    " #P@ZU:Q/A',-@$  !:(P  &0              @(&U%P$
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( /"#K5I1SIK%
MX@(  ,$'   9              " @<0< 0!X;"]W;W)K<VAE971S+W-H965T
M-3,N>&UL4$L! A0#%     @ \(.M6NT2.(); P  P P  !D
M ("!W1\! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " #P
M@ZU:$'W^=AP(  !+4P  &0              @(%O(P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( /"#K5JD07P52 (  ),%   9
M          " @<(K 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#
M%     @ \(.M6I7RB6DA P  W0D  !D              ("!02X! 'AL+W=O
M<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " #P@ZU:4X,.UXT#   6
M#P  &0              @(&9,0$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM
M;%!+ 0(4 Q0    ( /"#K5IUT\'UD@<  ,9,   9              " @5TU
M 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ \(.M6IP%
M=V&<!0  <2,  !D              ("!)CT! 'AL+W=O<FMS:&5E=',O<VAE
M970V,"YX;6Q02P$"% ,4    " #P@ZU:*VM9XUD#  "0%@  #0
M    @ 'Y0@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( /"#K5J7BKL<P
M !,"   +              "  7U& 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M /"#K5KD&49:LP0  ),G   /              "  69' 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " #P@ZU:F!M:GOL!  #+(P  &@
M@ %&3 $ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #P
M@ZU:=-+&8MX!  !:(P  $P              @ %Y3@$ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     1 !$ ),2  "(4 $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>148</ContextCount>
  <ElementCount>251</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>62</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of the Business and Financial Condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition</Role>
      <ShortName>Description of the Business and Financial Condition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Research Grant</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ResearchGrant</Role>
      <ShortName>Research Grant</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquity</Role>
      <ShortName>Convertible Preferred Stock, Common Stock and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.angn.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/BalanceSheetComponents</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/StockBasedCompensation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/Warrants</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/NetLossPerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/SegmentReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Description of the Business and Financial Condition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails</Role>
      <ShortName>Description of the Business and Financial Condition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Balance Sheet Components - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Balance Sheet Components - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Research Grant (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ResearchGrantDetails</Role>
      <ShortName>Research Grant (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/ResearchGrant</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails</Role>
      <ShortName>Convertible Preferred Stock, Common Stock and Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquity</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Share Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Warrants - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsNarrativeDetails</Role>
      <ShortName>Warrants - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails</Role>
      <ShortName>Warrants - Schedule of Outstanding Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/CommitmentsandContingencies</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Quantitative Information about Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/Debt</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/IncomeTaxes</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/RelatedPartyTransactions</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="angn-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/SegmentReportingTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="angn-20250331.htm">angn-20250331.htm</File>
    <File>angn-20250331.xsd</File>
    <File>angn-20250331_cal.xml</File>
    <File>angn-20250331_def.xml</File>
    <File>angn-20250331_lab.xml</File>
    <File>angn-20250331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="490">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>89
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "angn-20250331.htm": {
   "nsprefix": "angn",
   "nsuri": "http://www.angn.com/20250331",
   "dts": {
    "inline": {
     "local": [
      "angn-20250331.htm"
     ]
    },
    "schema": {
     "local": [
      "angn-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "angn-20250331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "angn-20250331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "angn-20250331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "angn-20250331_pre.xml"
     ]
    }
   },
   "keyStandard": 217,
   "keyCustom": 34,
   "axisStandard": 24,
   "axisCustom": 0,
   "memberStandard": 25,
   "memberCustom": 36,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://fasb.org/us-gaap/2024": 1
   },
   "contextCount": 148,
   "entityCount": 1,
   "segmentCount": 62,
   "elementCount": 538,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 490,
    "http://xbrl.sec.gov/dei/2024": 30,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.angn.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-24",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-24",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit) (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition",
     "longName": "9952157 - Disclosure - Description of the Business and Financial Condition",
     "shortName": "Description of the Business and Financial Condition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952158 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.angn.com/role/FairValueMeasurements",
     "longName": "9952159 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.angn.com/role/BalanceSheetComponents",
     "longName": "9952160 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.angn.com/role/ResearchGrant",
     "longName": "9952161 - Disclosure - Research Grant",
     "shortName": "Research Grant",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquity",
     "longName": "9952162 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Equity",
     "shortName": "Convertible Preferred Stock, Common Stock and Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.angn.com/role/StockBasedCompensation",
     "longName": "9952163 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.angn.com/role/Warrants",
     "longName": "9952164 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "angn:WarrantsAndRightsOutstandingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:WarrantsAndRightsOutstandingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.angn.com/role/CommitmentsandContingencies",
     "longName": "9952165 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.angn.com/role/Leases",
     "longName": "9952166 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.angn.com/role/Debt",
     "longName": "9952167 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.angn.com/role/IncomeTaxes",
     "longName": "9952168 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.angn.com/role/NetLossPerShare",
     "longName": "9952169 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.angn.com/role/RelatedPartyTransactions",
     "longName": "9952170 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.angn.com/role/SegmentReporting",
     "longName": "9952171 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.angn.com/role/FairValueMeasurementsTables",
     "longName": "9955512 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsTables",
     "longName": "9955513 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.angn.com/role/StockBasedCompensationTables",
     "longName": "9955514 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.angn.com/role/WarrantsTables",
     "longName": "9955515 - Disclosure - Warrants (Tables)",
     "shortName": "Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.angn.com/role/LeasesTables",
     "longName": "9955516 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.angn.com/role/NetLossPerShareTables",
     "longName": "9955517 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.angn.com/role/SegmentReportingTables",
     "longName": "9955518 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
     "longName": "9955519 - Disclosure - Description of the Business and Financial Condition (Details)",
     "shortName": "Description of the Business and Financial Condition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R34": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9955520 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R35": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "longName": "9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-44",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-44",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails",
     "longName": "9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-49",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955523 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-65",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails",
     "longName": "9955524 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-56",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-56",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails",
     "longName": "9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "shortName": "Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "angn:PrepaidResearchAndDevelopmentExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "angn:PrepaidResearchAndDevelopmentExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
     "longName": "9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "shortName": "Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
     "longName": "9955527 - Disclosure - Balance Sheet Components - Narrative (Details)",
     "shortName": "Balance Sheet Components - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R42": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails",
     "longName": "9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.angn.com/role/ResearchGrantDetails",
     "longName": "9955529 - Disclosure - Research Grant (Details)",
     "shortName": "Research Grant (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "angn:NumberOfResearchGrantAgreements",
      "unitRef": "agreement",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
     "longName": "9955530 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Equity (Details)",
     "shortName": "Convertible Preferred Stock, Common Stock and Stockholders' Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails",
     "longName": "9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Share Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails",
     "longName": "9955533 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
     "longName": "9955534 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.angn.com/role/WarrantsNarrativeDetails",
     "longName": "9955535 - Disclosure - Warrants - Narrative (Details)",
     "shortName": "Warrants - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "angn:SaleOfStockBeneficialOwnershipLimitationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-91",
      "name": "angn:FairValueOfCommonStockWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails",
     "longName": "9955536 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)",
     "shortName": "Warrants - Schedule of Outstanding Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:ClassOfWarrantOrRightExercisedInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.angn.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955537 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "angn:LicenseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "angn:LicenseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.angn.com/role/LeasesNarrativeDetails",
     "longName": "9955538 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails",
     "longName": "9955539 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)",
     "shortName": "Leases - Schedule of Quantitative Information about Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails",
     "longName": "9955540 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.angn.com/role/DebtDetails",
     "longName": "9955541 - Disclosure - Debt (Details)",
     "shortName": "Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-125",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-127",
      "name": "angn:AccruedInterestPremiumForConvertiblePreferredStock",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.angn.com/role/IncomeTaxesDetails",
     "longName": "9955542 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails",
     "longName": "9955543 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)",
     "shortName": "Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R58": {
     "role": "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails",
     "longName": "9955544 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.angn.com/role/RelatedPartyTransactionsDetails",
     "longName": "9955545 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-136",
      "name": "us-gaap:ProceedsFromIssuanceOfWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.angn.com/role/SegmentReportingDetails",
     "longName": "9955546 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "entity",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "entity",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "angn_A2024RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "A2024RegistrationStatementMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Registration Statement",
        "label": "2024 Registration Statement [Member]",
        "documentation": "2024 Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r696"
     ]
    },
    "angn_AccruedInterestPremiumForConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "AccruedInterestPremiumForConvertiblePreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Accrued Interest Premium For Convertible Preferred Stock",
        "documentation": "Accrued Interest Premium For Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "angn_AccruedOtherOperatingLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "AccruedOtherOperatingLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "label": "Accrued Other Operating Liabilities, Current",
        "documentation": "Accrued Other Operating Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "angn_AccruedResearchAndDevelopmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued research and development",
        "label": "Accrued Research And Development, Current",
        "documentation": "Accrued Research And Development, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r115",
      "r496"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r66",
      "r120",
      "r493",
      "r530",
      "r531"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r9",
      "r17",
      "r375",
      "r378",
      "r434",
      "r526",
      "r527",
      "r816",
      "r817",
      "r818",
      "r826",
      "r827",
      "r828",
      "r829"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r696",
      "r936"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r826",
      "r827",
      "r828",
      "r829",
      "r881",
      "r938"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable",
        "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature",
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r87",
      "r355"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r309"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r87"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AdvancedProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "AdvancedProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advanced professional fees",
        "label": "Advanced Professional Fees",
        "documentation": "Advanced Professional Fees"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r731",
      "r741",
      "r751",
      "r783"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r734",
      "r744",
      "r754",
      "r786"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r745",
      "r755",
      "r779",
      "r787",
      "r791",
      "r799"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r343"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of debt discount",
        "terseLabel": "Other expense related to accretion of discount",
        "label": "Amortization of Debt Discount (Premium)",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r71",
      "r272",
      "r890"
     ]
    },
    "angn_AngionCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "AngionCommonStockMember",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Angion Common Stock",
        "label": "Angion Common Stock [Member]",
        "documentation": "Angion Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of office space (in sqft)",
        "label": "Area of Real Estate Property",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Total segment assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r103",
      "r116",
      "r136",
      "r168",
      "r176",
      "r194",
      "r198",
      "r207",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r370",
      "r372",
      "r406",
      "r489",
      "r582",
      "r665",
      "r666",
      "r696",
      "r722",
      "r849",
      "r850",
      "r895"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r121",
      "r136",
      "r207",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r370",
      "r372",
      "r406",
      "r696",
      "r849",
      "r850",
      "r895"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386",
      "r688"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets, Fair Value Disclosure [Abstract]",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreement2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "AtTheMarketEquityOfferingSalesAgreement2022Member",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement 2022",
        "label": "At-The-Market Equity Offering Sales Agreement 2022 [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement 2022"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreement2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "AtTheMarketEquityOfferingSalesAgreement2024Member",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement 2024",
        "label": "At-The-Market Equity Offering Sales Agreement 2024 [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement 2024"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "AtTheMarketEquityOfferingSalesAgreementMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement",
        "label": "At-The-Market Equity Offering Sales Agreement [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "angn_BostonMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "BostonMassachusettsMember",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Boston, Massachusetts",
        "label": "Boston, Massachusetts [Member]",
        "documentation": "Boston, Massachusetts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Project [Axis]",
        "label": "Project [Axis]",
        "documentation": "Information by project."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r483",
      "r904"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r113",
      "r653"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r882",
      "r883"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r74",
      "r132"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r74"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r117",
      "r118",
      "r119",
      "r136",
      "r158",
      "r159",
      "r161",
      "r163",
      "r170",
      "r171",
      "r207",
      "r241",
      "r243",
      "r244",
      "r245",
      "r248",
      "r249",
      "r279",
      "r280",
      "r283",
      "r286",
      "r293",
      "r406",
      "r536",
      "r537",
      "r538",
      "r539",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r570",
      "r591",
      "r614",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r810",
      "r823",
      "r830"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r170",
      "r279",
      "r280",
      "r281",
      "r283",
      "r286",
      "r291",
      "r293",
      "r536",
      "r537",
      "r538",
      "r539",
      "r678",
      "r810",
      "r823"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of equity-classified broker warrants (in dollars per share)",
        "periodStartLabel": "Outstanding beginning balance (in dollars per share)",
        "periodEndLabel": "Outstanding ending balance (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "angn_ClassOfWarrantOrRightExercisedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClassOfWarrantOrRightExercisedInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in shares)",
        "label": "Class Of Warrant Or Right, Exercised In Period",
        "documentation": "Class Of Warrant Or Right, Exercised In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClassOfWarrantOrRightIssuedInPeriod",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in shares)",
        "label": "Class Of Warrant Or Right, Issued In Period",
        "documentation": "Class Of Warrant Or Right, Issued In Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-classified broker warrants, number of shares of common stock to purchase (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded warrants outstanding (in shares)",
        "periodStartLabel": "Outstanding beginning balance (in shares)",
        "periodEndLabel": "Outstanding ending balance (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClassOfWarrantOrRightRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Class of Warrant or Right [Roll Forward]",
        "documentation": "Class of Warrant or Right"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Table]",
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period",
        "documentation": "Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in dollars per share)",
        "label": "Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period",
        "documentation": "Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Class of Warrant or Right, Weighted Average Exercise Price [Roll Forward]",
        "documentation": "Weighted Average Exercise Rollforward"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClassOfWarrantOrRightWeightedAverageLife",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding beginning balance (in years)",
        "periodEndLabel": "Outstanding ending balance (in years)",
        "label": "Class of Warrant Or Right, Weighted Average Life",
        "documentation": "Class of Warrant Or Right, Weighted Average Life"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClassOfWarrantOrRightWeightedAverageLifeRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Life (years)",
        "label": "Class of Warrant or Right, Weighted Average Life [Roll Forward]",
        "documentation": "Class of Warrant or Right, Weighted Average Life"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClinicalTrailMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ClinicalTrailMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical trial expenses",
        "label": "Clinical Trail [Member]",
        "documentation": "Clinical Trail"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies\u2014Note 10",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r97",
      "r490",
      "r569"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_CommitmentsAndContingenciesDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "CommitmentsAndContingenciesDisclosureLineItems",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Line Items]",
        "label": "Commitments and Contingencies Disclosure [Line Items]",
        "documentation": "Commitments and Contingencies Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "angn_CommitmentsAndContingenciesDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "CommitmentsAndContingenciesDisclosureTable",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Table]",
        "label": "Commitments and Contingencies Disclosure [Table]",
        "documentation": "Commitments and Contingencies Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r233",
      "r234",
      "r637",
      "r841",
      "r846"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r712",
      "r713",
      "r714",
      "r716",
      "r717",
      "r718",
      "r719",
      "r826",
      "r827",
      "r829",
      "r881",
      "r935",
      "r938"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r570"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "periodEndLabel": "Balance at end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r60",
      "r570",
      "r588",
      "r938",
      "r939"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.01 par value per share; 300,000,000 shares authorized; 15,983,191 shares and 11,043,837 shares issued at March\u00a031, 2025 and December\u00a031, 2024, respectively; 15,968,736 and 11,029,382 outstanding as of March\u00a031, 2025 and December\u00a031, 2024, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r492",
      "r696"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r123",
      "r125",
      "r129",
      "r485",
      "r500",
      "r501"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred research obligation",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r298"
     ]
    },
    "angn_ConversionOfConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ConversionOfConvertibleDebtMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Convertible Debt",
        "label": "Conversion Of Convertible Debt [Member]",
        "documentation": "Conversion Of Convertible Debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion Description [Axis]",
        "label": "Stock Conversion Description [Axis]",
        "documentation": "Information by description of stock conversions."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23"
     ]
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockNameDomain",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Stock, Name [Domain]",
        "label": "Conversion of Stock, Name [Domain]",
        "documentation": "The unique name of a noncash or part noncash stock conversion."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes Payable",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r251",
      "r252",
      "r262",
      "r263",
      "r264",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677"
     ]
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleLongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible note - related party",
        "label": "Convertible Notes Payable, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r138",
      "r139",
      "r254",
      "r281",
      "r440",
      "r448",
      "r488",
      "r655",
      "r657"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r134",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r239",
      "r240",
      "r250",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r266",
      "r273",
      "r274",
      "r276",
      "r419"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r51",
      "r52",
      "r95",
      "r96",
      "r140",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r694",
      "r824",
      "r842",
      "r843",
      "r844",
      "r889",
      "r891"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r419",
      "r420",
      "r674",
      "r675",
      "r694"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r252"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r275",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r694",
      "r824",
      "r889",
      "r891"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r140",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r694",
      "r824",
      "r842",
      "r843",
      "r844",
      "r889",
      "r891"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r33",
      "r36",
      "r48",
      "r85",
      "r86",
      "r140",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r275",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r694",
      "r824",
      "r889",
      "r891"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid and Other Current Assets",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r28"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r311",
      "r339",
      "r340",
      "r342",
      "r685"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Black-Scholes Option-Pricing Model Following Assumptions",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r40"
     ]
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sale of equipment",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r821",
      "r840"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share, basic (in dollars per share)",
        "verboseLabel": "Net loss per share, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r156",
      "r158",
      "r161",
      "r162",
      "r163",
      "r167",
      "r366",
      "r369",
      "r382",
      "r383",
      "r486",
      "r502",
      "r658"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share, diluted (in dollars per share)",
        "verboseLabel": "Net loss per share, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r158",
      "r161",
      "r162",
      "r163",
      "r167",
      "r366",
      "r369",
      "r382",
      "r383",
      "r486",
      "r502",
      "r658"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r164",
      "r165",
      "r166"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of foreign currency on cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "angn_EmployeeRelatedReasearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "EmployeeRelatedReasearchAndDevelopmentMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee related research and development expenses",
        "label": "Employee Related Reasearch and Development [Member]",
        "documentation": "Employee Related Reasearch and Development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation related to unvested stock option awards, period for recognition (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation related to unvested stock option awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option",
        "verboseLabel": "Shares issuable upon exercise of stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r108",
      "r126",
      "r127",
      "r128",
      "r141",
      "r142",
      "r143",
      "r145",
      "r150",
      "r152",
      "r154",
      "r169",
      "r208",
      "r209",
      "r220",
      "r295",
      "r356",
      "r357",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r421",
      "r423",
      "r434",
      "r499",
      "r526",
      "r527",
      "r528",
      "r545",
      "r614"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r731",
      "r741",
      "r751",
      "r783"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r728",
      "r738",
      "r748",
      "r780"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in fair value of warrant liabilities",
        "terseLabel": "Change in fair value of warrant liabilities",
        "negatedLabel": "Gain (loss) on fair value of warrants",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r6"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r690"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r690"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Measurement Inputs and Valuation Techniques",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r388",
      "r690"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r398",
      "r399",
      "r401",
      "r443",
      "r444",
      "r445",
      "r674",
      "r675",
      "r681",
      "r682",
      "r683",
      "r688",
      "r690"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r400"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r389",
      "r688",
      "r885",
      "r887"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r396",
      "r397",
      "r398",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r484",
      "r688",
      "r691"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r300",
      "r305",
      "r386",
      "r399",
      "r443",
      "r681",
      "r682",
      "r683",
      "r688"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r300",
      "r305",
      "r386",
      "r387",
      "r399",
      "r444",
      "r674",
      "r675",
      "r681",
      "r682",
      "r683",
      "r688"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r386",
      "r387",
      "r388",
      "r389",
      "r399",
      "r445",
      "r674",
      "r675",
      "r681",
      "r682",
      "r683",
      "r688",
      "r690"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r400"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r400"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r395",
      "r400"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r389",
      "r688",
      "r885",
      "r887"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r400"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of the period",
        "periodEndLabel": "Balance, end of the period",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r400"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r398",
      "r399",
      "r401",
      "r443",
      "r444",
      "r445",
      "r674",
      "r675",
      "r681",
      "r682",
      "r683",
      "r688",
      "r690"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value measurements, recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r688",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887"
     ]
    },
    "angn_FairValueOfCommonStockWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "FairValueOfCommonStockWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants upon settlement",
        "label": "Fair Value Of Common Stock Warrants",
        "documentation": "Fair Value Of Common Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_FairValueOfPreFundedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "FairValueOfPreFundedWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of pre-funded warrants at issuance date",
        "label": "Fair Value of Pre-Funded Warrants",
        "documentation": "Fair Value of Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange transaction gain",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r408",
      "r409",
      "r410",
      "r611"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r745",
      "r755",
      "r787"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r745",
      "r755",
      "r787"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r745",
      "r755",
      "r787"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r745",
      "r755",
      "r787"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r745",
      "r755",
      "r787"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "angn_GainLossOnIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "GainLossOnIssuanceOfWarrants",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on issuance of pre-funded warrants",
        "negatedTerseLabel": "Loss on issuance of warrants",
        "label": "Gain (Loss) On Issuance Of Warrants",
        "documentation": "Gain (Loss) On Issuance Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on disposal of property and equipment, net",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r593"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r229",
      "r230",
      "r391",
      "r395",
      "r400",
      "r523",
      "r525",
      "r598",
      "r650",
      "r689",
      "r906"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r391",
      "r395",
      "r400",
      "r523",
      "r525",
      "r598",
      "r650",
      "r689",
      "r906"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r358",
      "r360",
      "r361",
      "r362",
      "r541",
      "r687"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax provision (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r106",
      "r153",
      "r154",
      "r168",
      "r184",
      "r198",
      "r348",
      "r349",
      "r359",
      "r503",
      "r687"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "angn_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Increase (Decrease) In Accrued Expenses and Other Current Liabilities",
        "documentation": "Increase (Decrease) In Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred research obligation",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r820"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r811",
      "r820"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other long-term prepaid assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r745",
      "r755",
      "r779",
      "r787",
      "r791",
      "r799"
     ]
    },
    "angn_Inducement2024PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "Inducement2024PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement 2024 Plan",
        "label": "Inducement 2024 Plan [Member]",
        "documentation": "Inducement 2024 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r727",
      "r803"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r727",
      "r803"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r727",
      "r803"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense, debt",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r270",
      "r277",
      "r676",
      "r677"
     ]
    },
    "angn_InterestExpenseNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "InterestExpenseNoncash",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Interest Expense, Noncash",
        "documentation": "Interest Expense, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r819"
     ]
    },
    "us-gaap_InterestIncomeOperatingAndNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeOperatingAndNonoperating",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Operating and Nonoperating",
        "documentation": "Amount of interest income classified as operating and nonoperating."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r665"
     ]
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "angn_JanuaryCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "JanuaryCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Common Warrants",
        "label": "January Common Warrants [Member]",
        "documentation": "January Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JanuaryPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "JanuaryPublicOfferingMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Public Offering",
        "label": "January Public Offering [Member]",
        "documentation": "January Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan",
        "label": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member]",
        "documentation": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "JulyCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Common Warrants",
        "label": "July Common Warrants [Member]",
        "documentation": "July Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "JulyPreFundedWarrantsAndJulyCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Pre-Funded Warrants and July Common Warrants",
        "label": "July Pre-Funded Warrants and July Common Warrants [Member]",
        "documentation": "July Pre-Funded Warrants and July Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "JulyPreFundedWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Pre-Funded Warrants",
        "label": "July Pre-Funded Warrants [Member]",
        "documentation": "July Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "JulyPublicOfferingMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Public Offering",
        "label": "July Public Offering [Member]",
        "documentation": "Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulySharesAndJulyCommonWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "JulySharesAndJulyCommonWarrantMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Share And July Common Warrant",
        "label": "July Shares And July Common Warrant [Member]",
        "documentation": "July Shares And July Common Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r432"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r433"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r433"
     ]
    },
    "angn_LesseeOperatingLeaseAnnualRentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "LesseeOperatingLeaseAnnualRentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, payment per year",
        "label": "Lessee, Operating Lease, Annual Rent Expense",
        "documentation": "Lessee, Operating Lease, Annual Rent Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee\u200b Operating \u200bLease\u200b Liability\u200b Payments\u200b Due\u200b After\u200b Year\u200b Four",
        "documentation": "Lessee\u200b Operating \u200bLease\u200b Liability\u200b Payments\u200b Due\u200b After\u200b Year\u200b Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025 (remaining nine months)",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less present value discount",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.angn.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r51",
      "r52",
      "r53",
      "r55",
      "r56",
      "r57",
      "r58",
      "r136",
      "r207",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r371",
      "r372",
      "r373",
      "r406",
      "r568",
      "r659",
      "r722",
      "r849",
      "r895",
      "r896"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r98",
      "r495",
      "r696",
      "r825",
      "r838",
      "r888"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r112",
      "r136",
      "r207",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r371",
      "r372",
      "r373",
      "r406",
      "r696",
      "r849",
      "r895",
      "r896"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r882"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, Fair Value Disclosure [Abstract]",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_LicenseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "LicenseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License expense",
        "label": "License Expense",
        "documentation": "License Expense"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r842",
      "r843",
      "r844"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r30",
      "r842",
      "r843",
      "r844"
     ]
    },
    "angn_MarchSubscriptionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "MarchSubscriptionAgreementMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March Subscription Agreement",
        "label": "March Subscription Agreement [Member]",
        "documentation": "March Subscription Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r238",
      "r306",
      "r344",
      "r389",
      "r449",
      "r522",
      "r524",
      "r532",
      "r560",
      "r561",
      "r621",
      "r623",
      "r625",
      "r626",
      "r628",
      "r647",
      "r648",
      "r670",
      "r678",
      "r684",
      "r690",
      "r691",
      "r692",
      "r693",
      "r706",
      "r851",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield (per share)",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r885",
      "r886"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility (annual)",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r690",
      "r884",
      "r885",
      "r886"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r885",
      "r886"
     ]
    },
    "angn_MeasurementInputStrikePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "MeasurementInputStrikePriceMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average strike price",
        "label": "Measurement Input, Strike Price [Member]",
        "documentation": "Measurement Input, Strike Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r690"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r690"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r238",
      "r306",
      "r344",
      "r389",
      "r449",
      "r522",
      "r524",
      "r532",
      "r560",
      "r561",
      "r621",
      "r623",
      "r625",
      "r626",
      "r628",
      "r647",
      "r648",
      "r670",
      "r678",
      "r684",
      "r690",
      "r691",
      "r692",
      "r706",
      "r851",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r76"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails",
      "http://www.angn.com/role/SegmentReportingDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r76",
      "r99",
      "r110",
      "r122",
      "r124",
      "r128",
      "r136",
      "r144",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r153",
      "r154",
      "r160",
      "r207",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r366",
      "r369",
      "r383",
      "r406",
      "r498",
      "r590",
      "r612",
      "r613",
      "r720",
      "r849"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Standards Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "angn_NewtonMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "NewtonMassachusettsMember",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Newton, Massachusettes",
        "label": "Newton, Massachusetts [Member]",
        "documentation": "Newton, Massachusetts"
       }
      }
     },
     "auth_ref": []
    },
    "angn_NonCashVestingOfRestrictedCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "NonCashVestingOfRestrictedCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash vesting of restricted common stock",
        "label": "Non-cash Vesting of Restricted Common Stock",
        "documentation": "Non-cash Vesting of Restricted Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r745",
      "r755",
      "r779",
      "r787"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other expense, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r669",
      "r833"
     ]
    },
    "angn_NumberOfResearchGrantAgreements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "NumberOfResearchGrantAgreements",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of research grant agreements",
        "label": "Number Of Research Grant Agreements",
        "documentation": "Number Of Research Grant Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpensesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r660",
      "r832",
      "r834",
      "r835",
      "r836",
      "r837"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "angn_OperatingLeaseFutureMinimumAnnualMaintenancePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "OperatingLeaseFutureMinimumAnnualMaintenancePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future minimum payments",
        "label": "Operating Lease, Future Minimum, Annual Maintenance Payments",
        "documentation": "Operating Lease, Future Minimum, Annual Maintenance Payments"
       }
      }
     },
     "auth_ref": []
    },
    "angn_OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future minimum annual maintenance payments",
        "label": "Operating Lease, Future Minimum, Annual Maintenance Payments, Due Thereafter",
        "documentation": "Operating Lease, Future Minimum, Annual Maintenance Payments, Due Thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesNarrativeDetails",
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, current",
        "negatedLabel": "Less: operating lease liability, current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, noncurrent",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash outflows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r428"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets, operating leases",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate\u2014operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r695"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term\u2014operating leases (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r695"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business and Financial Condition",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r91",
      "r533",
      "r534"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation adjustment",
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r92"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive loss:",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees and other general and administrative expenses",
        "label": "Other General and Administrative Expense",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r937"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeAndExpensesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (expense) income",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "OtherMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other research and development expenses",
        "label": "Other [Member]",
        "documentation": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "angn_OtherPrepaidExpensesAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "OtherPrepaidExpensesAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other prepaid expenses and other current assets",
        "label": "Other Prepaid Expenses And Other Assets, Current",
        "documentation": "Other Prepaid Expenses And Other Assets, Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r733",
      "r743",
      "r753",
      "r785"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r736",
      "r746",
      "r756",
      "r788"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r736",
      "r746",
      "r756",
      "r788"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "angn_PreFundedWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "PreFundedWarrantMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrant",
        "label": "Pre-Funded Warrant [Member]",
        "documentation": "Pre-Funded Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r279"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r570"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseOtherNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term prepaid assets",
        "label": "Prepaid Expense Other, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r654",
      "r671",
      "r839"
     ]
    },
    "angn_PrepaidResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "PrepaidResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid research and development contract services",
        "label": "Prepaid Research And Development Expenses",
        "documentation": "Prepaid Research And Development Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock and common warrants from the January Offering",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common warrants",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of common warrants",
        "label": "Proceeds from Notes Payable",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of property and equipment",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ProceedsFromSecuredLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSecuredLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Secured Lines of Credit",
        "label": "Proceeds from Secured Lines of Credit",
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r14"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r201",
      "r451",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r651",
      "r679",
      "r705",
      "r706",
      "r707",
      "r710",
      "r711",
      "r847",
      "r848",
      "r852",
      "r905",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical trial expenses",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r201",
      "r451",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r651",
      "r679",
      "r705",
      "r706",
      "r707",
      "r710",
      "r711",
      "r847",
      "r848",
      "r852",
      "r905",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_ProjectMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProjectMember",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Project [Domain]",
        "label": "Project [Domain]",
        "documentation": "Planned program of work."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r483",
      "r904"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r432"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r114",
      "r497"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r432",
      "r487",
      "r497",
      "r696"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r432"
     ]
    },
    "angn_PurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "PurchaseAgreementMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase Agreement",
        "label": "Purchase Agreement [Member]",
        "documentation": "Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "angn_PurchaseOfWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "PurchaseOfWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of Warrants",
        "label": "Purchase Of Warrants [Member]",
        "documentation": "Purchase Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r238",
      "r299",
      "r306",
      "r334",
      "r335",
      "r336",
      "r344",
      "r389",
      "r446",
      "r447",
      "r449",
      "r522",
      "r524",
      "r532",
      "r560",
      "r561",
      "r621",
      "r623",
      "r625",
      "r626",
      "r628",
      "r647",
      "r648",
      "r670",
      "r678",
      "r684",
      "r690",
      "r691",
      "r692",
      "r693",
      "r706",
      "r714",
      "r845",
      "r851",
      "r885",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r238",
      "r299",
      "r306",
      "r334",
      "r335",
      "r336",
      "r344",
      "r389",
      "r446",
      "r447",
      "r449",
      "r522",
      "r524",
      "r532",
      "r560",
      "r561",
      "r621",
      "r623",
      "r625",
      "r626",
      "r628",
      "r647",
      "r648",
      "r670",
      "r678",
      "r684",
      "r690",
      "r691",
      "r692",
      "r693",
      "r706",
      "r714",
      "r845",
      "r851",
      "r885",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902"
     ]
    },
    "us-gaap_RecoveryOfDirectCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecoveryOfDirectCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract and grant reimbursements",
        "label": "Recovery of Direct Costs",
        "documentation": "Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r728",
      "r738",
      "r748",
      "r780"
     ]
    },
    "angn_RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "RegistrationStatementMember",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registration Statement",
        "label": "Registration Statement [Member]",
        "documentation": "Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r439",
      "r894"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r594",
      "r595",
      "r598"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r439",
      "r441",
      "r542",
      "r543",
      "r544",
      "r596",
      "r597",
      "r598",
      "r618",
      "r620"
     ]
    },
    "angn_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r138",
      "r139",
      "r254",
      "r281",
      "r440",
      "r448",
      "r488",
      "r656",
      "r657"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r880"
     ]
    },
    "angn_ResearchAndDevelopmentArrangementCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ResearchAndDevelopmentArrangementCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit",
        "label": "Research And Development Arrangement, Credit",
        "documentation": "Research And Development Arrangement, Credit"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchAndDevelopmentArrangementGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ResearchAndDevelopmentArrangementGrant",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant award",
        "label": "Research And Development Arrangement, Grant",
        "documentation": "Research And Development Arrangement, Grant"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchAndDevelopmentArrangementGrantReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ResearchAndDevelopmentArrangementGrantReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant award received",
        "label": "Research And Development Arrangement, Grant Received",
        "documentation": "Research And Development Arrangement, Grant Received"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ResearchAndDevelopmentArrangementReimbursementFromGrantFunds",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reimbursement from grant funds",
        "label": "Research And Development Arrangement, Reimbursement from Grant Funds",
        "documentation": "Research And Development Arrangement, Reimbursement from Grant Funds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/ResearchGrantDetails",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r650",
      "r665",
      "r903"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/ResearchGrant"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r649"
     ]
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Aug. 2024",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Sept. 2023",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Sept. 2022",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2022 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2022"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r729",
      "r739",
      "r749",
      "r781"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r730",
      "r740",
      "r750",
      "r782"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r747",
      "r757",
      "r789"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash and Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r93",
      "r113",
      "r132",
      "r491"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, current",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r813",
      "r822"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, noncurrent",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r814",
      "r822"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested common stock",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r87",
      "r494",
      "r529",
      "r531",
      "r540",
      "r571",
      "r696"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r141",
      "r142",
      "r143",
      "r145",
      "r150",
      "r152",
      "r154",
      "r208",
      "r209",
      "r220",
      "r356",
      "r357",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r374",
      "r376",
      "r377",
      "r379",
      "r381",
      "r421",
      "r423",
      "r526",
      "r528",
      "r545",
      "r938"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "angn_SaleOfStockAggregateInitialOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "SaleOfStockAggregateInitialOfferingPrice",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, aggregate initial offering price",
        "label": "Sale of Stock, Aggregate Initial Offering Price",
        "documentation": "Sale of Stock, Aggregate Initial Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "angn_SaleOfStockBeneficialOwnershipLimitationPercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "SaleOfStockBeneficialOwnershipLimitationPercentage",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, beneficial ownership limitation, percentage",
        "label": "Sale Of Stock, Beneficial Ownership Limitation, Percentage",
        "documentation": "Sale Of Stock, Beneficial Ownership Limitation, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sale of stock, consideration received on transaction",
        "terseLabel": "Sale of Stock, Consideration Received on Transaction",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares sold in offering (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Loss Per Share, Basic and Diluted",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r882",
      "r883"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r432"
     ]
    },
    "angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Quantitative Information Regarding Operating Leases",
        "label": "Schedule Of Quantitative Information On Operating Leases [Table Text Block]",
        "documentation": "Schedule Of Quantitative Information On Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r594",
      "r595",
      "r598"
     ]
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "label": "Research and Development, Contract to Perform for Others [Table]",
        "documentation": "Disclosure of information about research and development arrangement accounted for as contract to perform research and development for others. Includes, but is not limited to, royalty arrangement, purchase provision, license agreement, and commitment to provide additional funding."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r880"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r89"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r83",
      "r85",
      "r86",
      "r87",
      "r117",
      "r118",
      "r119",
      "r170",
      "r279",
      "r280",
      "r281",
      "r283",
      "r286",
      "r291",
      "r293",
      "r536",
      "r537",
      "r538",
      "r539",
      "r678",
      "r810",
      "r823"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.angn.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Outstanding Warrants",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r103",
      "r168",
      "r173",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r199",
      "r200",
      "r205",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r231",
      "r232",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r662",
      "r665",
      "r666",
      "r672",
      "r709",
      "r905",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r557",
      "r558",
      "r559",
      "r622",
      "r624",
      "r627",
      "r629",
      "r636",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r652",
      "r680",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r708",
      "r714",
      "r852",
      "r905",
      "r907",
      "r908",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r168",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r188",
      "r190",
      "r191",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r205",
      "r661",
      "r663",
      "r664",
      "r665",
      "r667",
      "r668",
      "r669"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r190",
      "r191",
      "r198",
      "r665"
     ]
    },
    "angn_SeniorSecuredConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "SeniorSecuredConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Convertible Promissory Note",
        "label": "Senior Secured Convertible Promissory Note [Member]",
        "documentation": "Senior Secured Convertible Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "angn_SettlementOfPromissoryNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "SettlementOfPromissoryNotesPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of related-party senior note payable into equity",
        "label": "Settlement Of Promissory Notes Payable",
        "documentation": "Settlement Of Promissory Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for future grants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r686"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option Activity, Additional Disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (unvested) (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, total intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (unvested) (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term in years (for employees)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, total intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share of shares issued (in dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r133"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r103",
      "r109",
      "r168",
      "r173",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r199",
      "r200",
      "r205",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r223",
      "r231",
      "r232",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r662",
      "r665",
      "r666",
      "r672",
      "r709",
      "r905",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r117",
      "r118",
      "r119",
      "r136",
      "r158",
      "r159",
      "r161",
      "r163",
      "r170",
      "r171",
      "r207",
      "r241",
      "r243",
      "r244",
      "r245",
      "r248",
      "r249",
      "r279",
      "r280",
      "r283",
      "r286",
      "r293",
      "r406",
      "r536",
      "r537",
      "r538",
      "r539",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r570",
      "r591",
      "r614",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r810",
      "r823",
      "r830"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r60",
      "r63",
      "r64",
      "r108",
      "r126",
      "r127",
      "r128",
      "r141",
      "r142",
      "r143",
      "r145",
      "r150",
      "r152",
      "r154",
      "r169",
      "r208",
      "r209",
      "r220",
      "r295",
      "r356",
      "r357",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r421",
      "r423",
      "r434",
      "r499",
      "r526",
      "r527",
      "r528",
      "r545",
      "r614"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r557",
      "r558",
      "r559",
      "r622",
      "r624",
      "r627",
      "r629",
      "r636",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r652",
      "r680",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r708",
      "r714",
      "r852",
      "r905",
      "r907",
      "r908",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r169",
      "r423",
      "r451",
      "r535",
      "r556",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r570",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r592",
      "r593",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r614",
      "r715"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity (deficit):",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r169",
      "r206",
      "r423",
      "r451",
      "r535",
      "r556",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r570",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r592",
      "r593",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r614",
      "r715"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r732",
      "r742",
      "r752",
      "r784"
     ]
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants (in shares)",
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable into common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r33",
      "r60",
      "r63",
      "r87",
      "r267"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r59",
      "r60",
      "r87",
      "r536",
      "r614",
      "r631"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon settlement of restricted stock (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r59",
      "r60",
      "r87"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options (in shares)",
        "negatedTerseLabel": "Options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r59",
      "r60",
      "r87",
      "r320"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable into common stock",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r60",
      "r63",
      "r64",
      "r87"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r59",
      "r60",
      "r87",
      "r545",
      "r614",
      "r631",
      "r721"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon the exercise of common warrants",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r87"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r60",
      "r63",
      "r64",
      "r87"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity (deficit)",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r63",
      "r64",
      "r78",
      "r572",
      "r588",
      "r615",
      "r616",
      "r696",
      "r722",
      "r825",
      "r838",
      "r888",
      "r938"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock, Common Stock and Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r135",
      "r278",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r295",
      "r380",
      "r617",
      "r619",
      "r635"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock split, conversion ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r442"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r442"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r442"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "angn_The2021PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "The2021PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2021 Plan",
        "label": "The 2021 Plan [Member]",
        "documentation": "The 2021 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_The2022PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "The2022PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2022 Plan",
        "label": "The 2022 Plan [Member]",
        "documentation": "The 2022 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "angn_TranslationalMedicineAndCMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "TranslationalMedicineAndCMCMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chemistry, manufacturing and controls expenses",
        "label": "Translational Medicine and CMC [Member]",
        "documentation": "Translational Medicine and CMC"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares outstanding (in shares)",
        "negatedPeriodStartLabel": "Treasury stock, beginning balance (in shares)",
        "negatedPeriodEndLabel": "Treasury stock, ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 14,455 shares outstanding",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r63"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "angn_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrant Liability",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liability",
        "label": "Warrant Liability [Member]",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issuable upon the exercise of warrants (excluding pre-funded warrants)",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r712",
      "r713",
      "r716",
      "r717",
      "r718",
      "r719"
     ]
    },
    "angn_WarrantsAndRightsOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "WarrantsAndRightsOutstandingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants And Rights Outstanding [Abstract]",
        "documentation": "Warrants And Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, measurement input",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r885",
      "r886"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.angn.com/role/ConvertiblePreferredStockCommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, contractual term",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r885",
      "r886"
     ]
    },
    "angn_WarrantsAndRightsOutstandingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "WarrantsAndRightsOutstandingTextBlock",
     "presentation": [
      "http://www.angn.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrants And Rights Outstanding [Text Block]",
        "documentation": "Warrants And Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "WarrantsFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liability",
        "label": "Warrants, Fair Value Disclosure",
        "documentation": "Warrants, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)",
        "verboseLabel": "Weighted average common shares outstanding, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r163"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares and pre-funded warrants outstanding, basic (in shares)",
        "verboseLabel": "Weighted average common shares outstanding, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r163"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_YekaterinaChudnovskyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250331",
     "localname": "YekaterinaChudnovskyMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Yekaterina Chudnovsky",
        "label": "Yekaterina Chudnovsky [Member]",
        "documentation": "Yekaterina Chudnovsky"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "51",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-51"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii)(B)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479664/932-10-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477385/932-360-S50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-1B"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>90
<FILENAME>0001601485-25-000074-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001601485-25-000074-xbrl.zip
M4$L#!!0    ( /"#K5HT79%G?0<! (F!#  1    86YG;BTR,#(U,#,S,2YH
M=&WLO6UWXDB2*/Q]?X4>9NYVU3E "?'NJN8>M\ON\6Z5[;%=T[O/ESF)E!A-
M"8G6BVWFU]^(3$D($" 9 2F<>V:K#:12F?$>D9$17_[OZ\12GJGKF8[]ZR^-
MNOJ+0FW=,4S[Z==?SA\NKJ]_^;^#__CR_]5J__/;_3?EJZ,'$VK[RH5+B4\-
MY<7TQXH_ILH?COO3?";*G47\D>-.:C7^V(4SG;GFT]A7-%5K1\.B7]VS1G/8
M)MVN6M-IOUEKT0:I]=KM1JW5Z71'>J/5[[2:U:<SVFZKP[;6@1_U8:W5;ZDU
M0IO]6K?3Z]!^?]0Q6J1JG/55VNOHW=[(,+162^WU>DVMHW8-=:@20]/Y>\<^
M[!GV;7MGKY[Y:V7L^].S3Y]>7E[J+\VZXSY]TE2U\>E_OG][T,=T0FJF[?G$
MUFDE?,KTG);6Z"X\^3ITK>C9YJ=P1/2 9=H_-XS&GX?$B^</O-H3(=/XB1'Q
MAFQT^ ,\I;6BP0:=;X%-ZU&]_N0\?X(?D@/3]MGH]_N?7A$>\=9>_1I,L# X
MFM"T8:$4Z>"3[Q+;0S03'P@'7M-HU]1>K=F(YO%<?W7Y\.7"T@/?70N5_B?X
M-1I(["=[821^4=>="4[75IOS][ZN@'IAJ_AK/!3>9F["X1+6J6ZD QI^6-@6
MP#!]VDT U-2:JM4:VGR2=4MK-!,3)3=C+!%"N)/.)_XC&WIF >A^K5"[]N.A
M,O@RIL08?)E0GRCX9(W^&9C/OU8N'-L'+J\]SJ:P?9U_^K7BTU?_$Z.63X/_
M^(__^.*;OD4'B(M:A(<OG_B77S[QJ8>.,1M\,<QGQ?-G%OVU8IC>U"*S,]NQ
M*2S ?#W#@=3E?YJ&06WV)_Q^ Z+&-77^_E?_GHY^K>@U0+5-)C@3-<\B>71E
M>CJQ_I<2]PJ^\2J*";@:U;1.98 K^_)I8<8WO^ .ACO&XBNZE<'?&V]_P47@
MN@L;N+2-KR!:*PJGCE\K0$YG!GQ3F\ LXYI!9O&[>Y5!0ZLU=WC]I0WXFEW
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M44)^:!T:3 D[*T(%&E'X,QY:*T: M6O8T*E+=<J41$-36'Z.IWR ^0!IBA>
M-/7&#AXQ16>__ICX2XM77LCB*MF)*7LXW,/'SPJQ#>6#QO<X!-3#[\-_P0YP
M/!N*!9A@%>$\["X!6P1;)/%\I:\J!IEY]=SQE(O =6$ZG@6!S.T3/_!BVNM5
M!O]+5X(D2I@GI]PX2IP5L=T"%9G(&.P![!/3]P%1X%;HONNP,BG63*$@BF;*
M-0H8K$P%SOM7XA,%3["727 ^1])TOP]@9$MM(Y6! Q/PF\_*0^U1^8 ) MW/
M6E.KAP/\L<E.+Z=X>KEO>N3K920X=8"2(GJCWL?\U)2 $ (H)*Z8FOKOAIH
M@42Q8+%4(;H.U.1BN0P&5_!18<EIWRH E%KJ#]X$R!#>XD9L"JB8P,YG*-U@
M-A )")<GY<EU7OQQ]&L=A!UE2S/HR+19G@H+1_WG7WJ:!KM<LT#V<^-S-&SK
M@+7+B\8A=85CURPU&FG:G%? .*MID<A.RNEZ)F<7?>ZR^+;=>K.]^6K0,<[3
MBUU5._T1 5(0=S<#OZ5ST9'S @M*K5P6R.(E.69#TOG[04^IF>DM283N!:#U
MR7%G*>X4&\00KH>#YIX5-GZ\25.Y!_1E#W=_)K[;4G).?EAG;)P$EO+2/X-&
M=,]\ZPVG1K8K3ADER-Y/(P6@MLMT<_5=TEH$B]\9*"XX)+;27,9K=<*&JD8;
M'"P\;DQU"\U16GR!115 R=@."PH$'G?. .C\4EG*;0+P[_!=U@Q?_F+"J]'K
ML^D+>GXN?38]IK1L8NNP4[1",<,3!V.)!X.XAJ=@&HQIK#M,;'X@'U,=K0@]
M&4']:$ZHI]S RNZ=";%W KJ2\]W;K*EL;\W-#Z_S:T3\=M_6:T38?G;;/2*!
M:#]_S,,;4\N*HQ,?@.A9Z(%GY6_V[#_6%18=>F=4MV3"EV#?NQ/6C?.NMIO;
MJ$,FVJ!?%T5*:[N"%4>DX)E9>%\,1("'C8:\2!C,90E& QO=SQX*$CR/]? \
M5G$"GRDUEMS#GOI.9OQZ79_?BF;1[1#:5RYO(J$$MLEAS=]668*_5@$1I9M@
M1WN_5JYOKE+.2.9]0UEG).]VOI!%],#.:H;CU\()P18$ P_F4F-DM2N#1KO:
M[W>J_6XGPE>TU$%=V-CFR=8]2M:?FCI<F9^Y6-[:?*8K%:GF2V#O5N>/D*'G
M6(&__I%U1]7KRUOEKK'5C(MLC=VY&_)$:T.7DI\U,H*WGA'KA<P\!$QZ):Y6
M^VV5N-90J@ Y9V^DW5ZOKFG%9(KUZ^UNL[2)8EFOD9__]NT2[WY?W-X\7MX\
M/N1PDI=O<BQQ9Z.UARLH0ET:&8T*Q@=?+RBB\+;4&?:U<G$4+((<>07*V$7E
M^Y<,,JU?&=R=WS\JU\K5]<WYS<7U^3<%M/3M_??S1U9CC>2_LR$R%]V!O-YC
M.#])IOLAQK18TV&),><*LA,CQK*N?3I1&G7E*HZYQ.4^O:*(433Y<N(H;:_!
MVX$4A&GCK<RS9J/>WN2+20RNP2!+VT488B@4_@([W#388=YOQ (>I0KXT]3W
ME ^!30+#A%\^2DXM)9XEIY89@]CR?@VGSG4HAG5NIY2_QF.98Q@)<^D8RVP_
M4^6;XTE6+C\A=([&R@ME?B0OOQ&%K6R\S+!<KFWQVS]CQX+'O3 27<9M7/X9
MF/ZLC"O_\)6.L/G!QU(N7JJFDLNUKK0R2XQ![*F:R<J\(!XK??,BS<GR8[PG
M>;;,&&QB3HA//<Q,^Q'Q(K]P9TZ4->PL0[ G@_S^P=E7HBGO29S:#$\_M+KR
MG=CDB7'<+Y[RU?3T@->#QG#-N4VLF6<R'3MG4>1AGMJ*8^ZI%UC+P1[)N^4D
M"JTAN5=X1&G=D'N;=>7OF 1N^BS%B;$C?&%%GY&;+<<+,#%/<F0Y$:T=WH65
MB,J+J*8:<F2KCMK1=P$?C!OO7$>GAF3 $N/U" PHD\X*1&$SRCJ[5FX?_W9Y
MOW/*V0&R#B6GYD9S9Y[/]8T^@9?"1"\KL2.]D9(BM*E*VT=\1/4CSCNO*_>F
M]U.Y(KKON)+K2HK,IHP!B(^HEC:/X/VP$U6F'XC%K^'QG(%DC41T2'YXE!>Q
M9\I1\FA)4=_4)(^*CZCV/$[WE8X("Y/_F&*Q2&J;CIO@3<F'Y42OY,,R(*HW
MC\XIW^%A4)(C"KHQ$1^7#%A.O$H&+ &BVHV0 =MUY9;5F[FV>:T%$QN)2<XK
M(T(EYY4!4:V0\SIUY?)U; ZQF[+DN'(BLMF4'"<^HKJ5P0. D?C2K"PO!INM
M3:R6I;9E6-II7:V=71]*5O@Y2JVC%'P66]>4U1C3"BFFU-ES,:6]T[9V=.[:
MO((\)PR5P2,K&877-N"-:S*](Q0?LFWCE>.^$->H?7.<GZR=7"(5?3OO+C5E
M_%?@^>9H]CEYIT#3-M\I*):!&AHKTF=ZF!.(O62LF<*; V$/.=CL1&FHM;\G
M^VQBZ3XOK";K8T.UN-?'/$LX+NA75*YPV"^DRHKY$=-F_9 8(JP0$=[\L@_6
MS35MMM ))3;^&I8<O'/-9RQPFCCP^ ;_>>+M>>XI.ISS[E!]<$7/+2LY=?AZ
M7M_4WPJWL+>]/V:H3-Y&@D=]QT5-K8R([B<!O/@ZG;I\!X&K#,/"WPJ63?3I
MTXSW\;$ ]U5E%* UH3@<9JQ]% <DCIF7#(ZD>A5K*KY@]5:LK0B3.ZP'%6@&
M_@1]G<+'\%H^UB7&,8OO</"U!#ZOQT6]R.J;#2T3.;^E/:H@G'@-[W$F5-&)
M1P&V,R> /VU08=C88#3;1/3#F0)D"+H(%@B$P?HZ 6:CGC[F9*7-#TR)/:I]
MNO*+YP63E6^'U#+I\\K7K+KF!&AP=1[\R;2#E.\#RUC^TE@=1P$GDY1Y.6DN
M?_OD$&OY.Q-UQ\JK)F2V_%5,_,L_('.M?.=2PUQ=P-1!166NKB)B.;JR$H_2
MGRO?C=/ XV/7F957OIC6RMM>%AY'5N9"R#.!3(F+C(UMRAE?LXYAR,'AEJ*&
M4<#N<:7SD.<!]78D3/@WO@NP!2H-&]/9](EGE'-9B\7.@1X]_)DO@%6)=IE>
M3U!J77ED@S>0-A>-M KRCZ\6"ZI;L!V?]32K)L>2H1/X9UDEP&)MB%@FA *@
MUN@=F/\9UCIYBT/O_.)%.#1:7.XQ@1_K#3U2TDE5A4/(T+0PB<!W0(6@<F34
M, IXX5Z;ZD!LQ&6_$^.9%6CB+<J>J>5,$6LL$^';=4U5-49?K-$9)QG>40YI
M*"2ZJ>L8 2AH'>OQXKU ),#%541B!\4?49X<WC.$*5+.#C!<Q\O ;F"#.9^I
M^YPDEBW$@BB-<( "!&$,3S(#Q\=7LKN>!IV A&'&B^+Q\S5F:XQ&,%"/GTQ#
M\ER0<7'Z3",#YW-FA2\QN(7=$UP4^/#GORG'!VAW9AHS%#*^!<Z:FE.*4R/6
M5C'&^=U 5:,$]H3Z( JH@<(<!P$S2K05QGA@)L'W5<3"$P,X,HL[]Z.6.1'-
M^5#@)ADKB[0%ET$!^RDB@S5^BPNV@!M[BWQYN!#6E)+$KAYK=4+91ZP.[\,\
ME!D,X3KY-BQV^QLL%+0>P&F:*2^.^[/*6Z3ROBEATU3>\YS7EH\WS_S5E:G1
M<E*&5$=KFSP3L(S +N' R )1Y KX2(F+9C;\EE1G["$RD8*I> KW=/ ]&< M
M\R=(G[$#V =\N+S)+A(';Y[,,4:FV P'\+T0P(C)\=I^1A^#N__ 'MAPXJL;
M/.%S%EJ_<4VZ'_6'.KCUCL$^L3'G!DS#&A@P OX0FM]77\]#V_MC_/HT R<+
MLTD"VA,! = 7Z0<D(LQB;Z4CB9%]V!JQ38&@#GT$9D&&/)*BAEC@*Y2SP-OH
M!>)77J"COS$*L(UWJ%Y K,<*,%0$$HV%H7%"[  CF$P#5UD'%^JBQVC^FX1Q
M1L +-I*BO'LCF7+,1]GF42Q3XJ0P88>6-O+5V 2U@H-"_0;6DN?8-K5B/SC!
MA,3WL2]-:.DP1YX%$>.')((*0Y#'/"MNFW+64)PIGAY@\Z)9'&Y/\X/G=DP4
M'HVMW'FCI2FP'C\*&3N Q=$(OAZYSH1'7DRP6SUNRF,TC8<684:)X$(0O'!R
MLN@)Q08A,EG K]FD(YKYR<YD:-K<O&2](+F;9H#UZ<FHU1Y1%4?R&2<F^T7/
M+?HHJHU3\/)E"=O1H!Y+[X%Y)5,59FJ@/0>"BL7^HC.5V&,/+3\6[N#C.,^Y
M9(J61GS2X;@L?K'L^DLT%6?8QP>+QOH8"7; >YX;@<!5_^+-<I&?\*0!,^,D
M4@J2<J879@0P"15'-18D5HP;3PG/<'[89EQ&%2R/R\"-@B]<]/T+;'XO.C:4
MN"K,.J38()IU;>8!S2?+&8+* 8EE.Q-3YPSCH N%+FT2<\MY.HX='W^-+$ 4
MB#W_A5);^?'3Q306GG"#"3J$QU.C@3$-?#<-PZ+*)?'\JO)$G?E[?6S0@)3$
M3).+,5@JR6#RPEA^>+R0<L)-7]UUXFW%)XP+VS!A0:$C^>S@7\Q?@=7AV3[(
M"%]Q.7DN*NUX5L]R7@SGQ>8-M'4Z3T::/_#D/%/71@ABB& <^/@ 3,F"Q 2L
M9\P(2N;?)!-@EH+K[#P\Y=A4&FQ%Z9<U1ALGNT62XBD*4C05!GMD.@O;V@<8
M3D!]X (WSG/*EM($>;"5'0_Z8<I@Z'3R-! 'G5CXT_3&89C(9/EUC(73W^7B
M*C$S#E@6WQ.?8Q5RAA6+7R]*A8F5)QHT*)594LL+O&OAX @?!+_ -,(#\(V+
M'U/+8 E;8],%.41<M(.J*T$93',!$($$Q)W"2R:FQQR0*2#8I[$/\@(.O?)L
MHG2D[&R!S5O#>6<;%R(9HT#?A">=L -+DT>P[44$A[DIC!@30;GEP]DM.1"C
M,-UJ'G?=%$7 T4LOV(#T=W)AH+G^PH#,_2]9[K^45SN?OHW)\X(X,5C$&%QX
M5'=>@$?A/,:,@<=8R"Q*%LIU9)C4L7@")+7,/K#&<RVY3K#ID^,SDV!$GIUY
MBBUBK<JS#;#)^C!DS*H"+AZ:.&@U1W%,XKK$?@KS=UBTC(?)$AF<,!8#FVYD
MN\7VTX(N<A<H@*[13)(HBO.'XG.@N3/$HFCL#D%H!;OH@@=X%$ZF)KJY+OTS
M,-TH:YH1$:;GL8#WW#@)'5EY-E0@ON:QSL2M'.JR8A=@-TI([R42'9ZV3<.B
M=OPX-!$SB@@]$9F6(9NB(IIAFB;Z[&%,$USP2&XI/*@3NMDL,Y_9$?@'"BEP
MJ\-K?2QE,VF=@!+"BP91DK*-%_/F%^ B(1A.Q^5>XGQA009*9!>&[)BIS,F4
M\,N424Z,KH:P:TBL['UTAL<C>Y1=","8*^-1EGH)O^#=2O2RX[KY/H%ECSQV
MQTDBKR#DS5%FD9>%4R(,B-7+>[7R#[Q5&; 0)%ZK9!8NNZCDP/[8(8D%$H@9
MO1AW"R_Z*L2RHO2:#3?4)L2@V6X$EQB"5YMNZ#T[%GB1/VT\:6')+3;_VS6]
MGV"%!GCC P$:G_ARKV/$RT#/'0[ D<<U N$ARS#IOIHTD126E3'&ZZBAO^*@
M8D!E@ML$R!LFYCRABF R!%V@V!#.,%]X1Q*UB8LL 1YP&+#=?-GY#Y9=A3?>
MPRN0;/M(&4\NQ=6!SP10L/ ;W..Y;>,>5^GDO^,XWXSBG4U NJ%\!4^,97@U
M&U5%4[66\@%'1(GGT:-Q^OG(Q,OY['B.'>>B(%TJ]7OYJH_1[<.FZQ.3GXU%
MF>P/EQ?Q5/#U=W:.'[ZZS>]M61[ED?!LM*_\;H(7$H)F@23X76=^]97Q'VAS
M'<<8 5V*J&Z^+(HW]CVGNHE978K(98<$/']UN6@!N^D\"C._\2[T-+P8:\.^
M2)QN9S#;991IXP!G.O7QX=#F8.0$(K;*#D38A6O8-WCU5E2- .]@3=D[MNU9
MF0;PF&[-^%W<Y'/P.N*QX_X%;E+8%>R02Y)\$R8).AY=4-GF=L!7V2&O8H[
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M/&&'3[N@"(!8 4!,K22+J<!V#8=)B#DH (B4:4R6K< ?Y)N+KI("6-@;\+^
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MA'#'Z>!MJ48MS*6HJLV=$SS%">=(TB\_Z6\SCXL@_;:*N<UJ\]2OD BOSMR
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M0F^7*DW2T!6&;-YNZ.8EFZ9:&71V*7$DS=J=PK*+%1^D#;M'B;IXUW\C4S3
M+FU(J_0D"&:'*&QV@M& 8%J[1 ?DC9.]Q8@/7'5U:Y6ZW>/#V2HRGPP'YRAT
MBO6/[USGV32H\=OL!V AP<;G,0KR!BJ:6 55K38:!=C7F<MIBVYYOS,JS%%U
M=%]4B*=]6K6A[1+OV#L5GDI=[6P%UDW[F7K%%5@/8;&' NL%93+NL\!Z:4-B
MP.NP=",D"8_PQD;I%P7>0XBLP'/A"+17 -F4_.YSVWC+18%F6UX4.#E*VG)/
M(!<EK5),)^VRP&EE+0KF0TU#"TH9SMZB9C/$.\IOP18H:=?8K=<1Y-?9K9L%
M;>$77(_O/A44;'M?Q+=%..<AOE4BZQ4@F_=.7J<2^<KF%X7-;V7CJ>-T=!#1
M+Z*OU-5-C_E&NC.9@,20I2=V=HINL%5UG-:X*AO[(!M;LOG#R9!&#B]GD30R
MVVRM4ZW>RRF@GT.''DE2)JOSA)+2PP)F+)*T)#H5_H@_ILI_$3L@[DRY'8U@
M$?:3##6]6:I>.#;;&G .%G7-&ZEO-2J#?K6QN]R5T25AJ_J\D7@VB]YW60)8
M1&,U101+8W5GL;I3L;26O"-[>L230ZQN(YX,:KE5&;2K_<Y[ZGY6$N'*[%MI
ML!8@62\80%G!XS06:%<&/=F@XG1HY$T"=(%&<LK0#LI0=7<9*@W4G60H.OS)
MB"H/$#A31(4T47=(,D$XWG(P7H;P-=+XH%L9R#85)T,A>9)'TBDDNQ_3$\V/
M.96CR1P))6\XGWP7*='[3RBYBB#_]D3H%NM&66UJ175=/7Y2B<S)/UA220$$
MV%:! !M5M; &%@*EG>R8+'@P0KD<C:CNH^D+N(,?[+ 0C#[#BNTH\'>Q@M\7
M(VV1Y!S4MZ/+5YV5;;XG/KVUD;?P_S%M]AD8Q/:]>^KYKJG[U, ?SFUC\8O$
MR#2FPM:9#>'SN&2:X/$D^EX(,;/AWB[N=.X4LPU%J*> MKX97N16/ACA5>Z/
M>!67N0 L@0+_H',*D/4:WZ 2=N*Y.UB]8ZQ>N->M .&8Y&[.\6G,V,0K]SN7
M/I6![-)=L#TTZ>5T#5@/4K6_2_40P4/C8H1U$+'5%6'.)+P;8S^4^CX+EP_I
MDVG;&/,!IP&_F#)BD/>(\FF&UAXU0VYN:P.W]:NM?E%'^M)O*"5-:GV1B+(#
M1-FJ-E7QG=E3B?ROOY243T50K"J\73GL,0Q[Z.!:.N3^NI\ 9F;2/.!6\XB9
MIDA2ILM47S>E^FV$O(.):M&"W@6X8Y+%WRF+"V5)](#'FU5-[4@>7V.Z1"L(
MU\K;6!ZO*%(3=F(XP="BPM5KVKJT0QN#A[,#G<G4L9GMAQG'J59A-<TL7'N"
M>( ;Y84_?[(GP1=;(_MOR*,20G.G[S>[YD[;5\D]_0PF.&C@);U[[E\0UYT!
M#/Y!K"!W^Y\VYAOUJLUV40Z] +$DR0LGP L9;-7"F:'#<Y]Z;5&*2IR V9).
M"O<9C9$3.C L4!.L>&4[^F*=!A[L-7L[ZP!YY"P,!6V1GX63$&M_W=Q=<I;T
M@/A@#M^CXQ-KC:.7Q<_;X^&:&*HEM]E4AN#?09R+@\7^.LVU\7W13A$/X(Y(
MCCM1CA,IW-YIK0VWB\9RZ='O=J[H=_&E+PN+?A]A::>2+9=N$3T$TZE%L;@Y
M&$:&Z>F6XP4NNSD.9,YLI$2-;;"0TBY(GNW>V>+8YR&G>.B1+H6OB.DJSQCA
MX<TH:&T$NP"#-ZX<2/QY)1:#^'07]^,D-&_:ODJN7]>D\;-6S$@A+ 2(K1#H
M%:..-]3EZIQB,PU)^^6G_367R7+2?@:SL5,9=*KM[FIS.!G6V:-*6RZ$&TRQ
MCACU?6[GR,/?TSOPRJC-$N6MYCR]RK;=RJ#9%>442Q[I2@K/KK-2*3R[Q?;N
M*Q =+C>)U8+V$.V@LEQJ@9]EU*8$^P)ZU#8=%_QOGRI37J8?G'#?8:<5_DRZ
M8Z=GDFY28 ^QZ<):TTW -W?<V?HF#AD,TWYEH*E5M5E4F1KIF$DNV+.2R\L%
M&Q5=M[A6)H?QS0S3FUIDA@NEZQEFGZ-.UGF\<>P:BW-'46ZFC^=I !OJ4$O#
MNOPR9Y/F!=+ D\-_<,*X'24.%-<52MXL=AJBV=?2NY1,L$7Q9F2"56+'I#91
M$N/+KE[E D]D@9]\-%6CD_)$=;0)<9],FZ4D+'6BT\'FI6[!_:_8-&>F#Z_0
M-PL33<7$R3%5B ZV$"P!;PBPX(2G$!>^MC$X09]<8BD8OPCK)'@4) X)#),;
M45CVS>-_L6P7#'=$N03PH.?#%VC<>_7%7(($A,(%X1:FCF>B-#EC@1/SF7Y^
M,0U_?-90<;')A[@(.%/GCY A+"#PUS^R)] WU&UBFT&ZMY1+D?@7UXC"U>RK
MM-?1N[V186BMEMKK]9I:1^T:ZE EAJ:3?V)+I/"A<9P+-"5/M#9T*?E9(R/8
MUAFQ7LC,0]),TB$08;B@K@8K7H;26EB,1D7" E08YP'02XY+&.;P,,[%44"/
M+"@&E':!>FRE6%\Z7[&W;L/N6A54%-I7\G 8VB^_75]<WRJ/?[N\/[^[_/%X
M??%05:YO+M:SPZ'(-'V]S/%6?$?Y$3/Y-2["G"!*0F:_2#+[5<SL#S&SY][<
MX,O0_31(8Y&8--.&Y."<3B7SC*L4UBFJJF4.+"B-R*7@EM9-,(')]%4W9S&!
M\M9](K;Y;\99<SS!AW/;N /_%S/"\./M*$;<'&]?XT2Q1WC%;Q:S ".[K\FM
M2],.J''NA]_A BC8B%-$KAL "W^%CZ[)VB5$I75^"SS8HL=3\>?T@@3%9'=D
M3(9;7$()_!:^ERU\OAYX]SKB^E< 5NUHMM#51=/J[;WA<570:<C]H(5-1P$M
MZP*$ K!A/>!^6Z\K'Q"YFOJ9CV ?&I\5QV7P"G^[X&HY_/&C8@( %1W>PDQA
M4*U/5!F:0"KZV(9M/,V44)$K4X 393UAV7P&?::6,T44(TK,R20 /<\690*W
M@Y\+&MXWV6V)%],?*Y8Y8:SO@U;Q^6.\_P7#X-2!!YS A[?!TUX0MI_E?6IT
M3"]SZTJX=1QOXK1CQ[)F->?%AFF]8.B9ADE<>'LU&OE ]<!E:8= &.XT5 YS
M0#U<1("H<ML$XSIL;>&NXYENIQ0?AA5=1+\LP/P*_'KJ*@N@_\CK 80SG /Y
M@-UC$N7.GRG??&,98?C]PG+B)^SY[F; &6@6FMX8C:(0N=, -N=15IK@SP >
M&3'#"W]&]B2N/E9TEQH(-?S2\T$.PW"TM0(6NC(3KZLR6PVHV**8MDFM&<P"
M^' 1>P!^3TDE-'\,JO!I#$@,;;I"++E%B?EYE1^+9KZUUNYJ4BRRXS?SSP P
M RA%7/_N<!)!>K7?OJ=CRQ@TX4,Z5\: ;_J*E<PH[,I0;.HK(,^1VG#'-GUB
M5C6_(S6RG)>PN903<\P\^5<!F:WC :5.&>_7E7-&L]^10KFWWVQ4%4W5VE5&
MV/-%&,@1X%8$DX"=?X( &@'U,>'SU[??SVFO+1%[3WT"@#$NB8OU/KWS^;N_
M\E?'@8S.7*&U\+2L75_-"%$ .1;;<A*X"%@=F-(?8R(MUA:)H98&X_FO"6B_
MP,2Q%HU% C8T\"AEMN\H\#%/FW@+,(T>8:99*,[9&J:N@U(!Q:[!>-:K*^6E
MY1P4MAL=O>G>_"H%83727GWUM#4BH(UUR!>HB]EZW<]>1$I)M@2!7-U"5SA_
M"L-5D8Y>*-!<2$\8;L,)V6W)*0I.F)@:7%E@OGCBG8P\@=0M2CQ0$S -O'T"
M<!WC3Q:\-[(ODOT]\7,.95)57((=[5!I^@2('*\K.,'05\@PU$XK(")#TT(A
M#DN.68F@;?3$)+K.)?H:YG50H@7NP@OQ1S1%@?$\1-D:GHS8==F<2F5#AA+&
M[B[BW%V _?RR17(/_A@LO,3DBSN86L!83*<;AHO&-!NN1S9TI-+9"CT2>=&1
M^)@?=J&1R8P_Q9M;7+#I:0"6B@Y/<6N.;> 36H8N$"QFK%A$CW!F4$!0O GX
M@D&&OY_/'5&7YP2NCE:>&97<!N,27#^/*1O,9'J*)L4@DTU=;VQ..?30J@$J
MB,B16:;A[&Q?N/#Y9L >\ND3[ #^L#W.B##KD!.1BU2JV&@1@7O#B)4;/ARL
M#%%#RB:VJ,]L5!W6[8T",%L5S@C$LF+;IPB9J&62B4J1K\PFAJ]'"^(6 !?8
MC!& ^IPAJMHT0?(RIC871%Y"J&S@4" *'R0EO!<D^C/E(LAEV 3S-4!YXG*A
MJV#T)JES0U<$Z=-B1AU2*/X.Z*51<2_< \L>]O!%+M4IR$\NUN9#D?2C*9C+
MZN)U*19*Q(^Z$U@&4@9:'B8(51 90! @_"B2/+&3;P'+&\UP;J(S^SW-?"ZQ
M?EX)%^>0]!S'0PI$,G4I,#N, P 3P*UGAE85,B?ZE.Q#D@07[:8T4GH9F^@X
MH=H'%F82&"< !]8*HR$H$$.<(W5X\*4W"HT'^ F<*:97S+D.L/$ &-\;N+SI
MZC ,9'#)G&?SAH.A]5 *8G =?! #L<I_YO%NK@_XLG7G&2@]U'1,&EJP>$:!
MT8IQD(MLQG:ED(D3L))W7$M%'].?3>Z609OS(1"Z35'NH??JC1GQ)_$PI E1
ML$GY+H7REF(XN2)W_<J6\&_O&-$Y[4W1N8>Y% $?!1$$0+MST#>G7DK,K9,2
M<^NLQMP>@LD$,0:(3;Q!F;]"B=[QME ;>V7*0K3*+O*KL%Y!&:77G<7:!+'X
M"-)OA2.214@:C<]* HJ_,9FT'9S52L2Q(8?\XF40!G%#9XQ$*0VU]M]SV]+T
M],#S$L'3^<0)%<2D<+B6:;B6^@HNL],EV^_M:(DF9_S?%+KL+E/@X0+G.6,^
M,2:3P>]M&C@\740B+I].WGH\:X8'.EFUM,F".:!JF-G,S/ ?]8>Z\D3!7"=H
M'\//=(I3)\D2O C=!&O:BV.G[*G?S\_OHM!I73FWPX E!JPBQ>O1\!P:O9WI
M%!#-5,X3&FFX! QY3BBR 0R(V3F>'?71"$_Z6*1TOJ('\/<,XAH88#;FVC!:
MW?D\PLR49NJ3/Z;,U)P_\R-^!GQ <+^?&(B',\[?,813)_O-@?_,P]+G#[_%
M@,ER@B80 6:GK\@"\D.R#<(JO4DK8_'00-EP:'#G8]C_X8(;_ N!_??AJIV#
M79S4"PSVT3'0D%B$L17SAA)N<8++*9[UV(@W9M1Z=#/ZD/7F H:7UF).#WK'
MD<'L8F"!'0DE;5QNX;NT&IG7SM2T0T4W(3;A@8!JP@"-XZ-X#S1>!(X'[WR\
M<:'<0O\*4TV&0!)A'+&U3B2&D *3EX(E#=\1Y85@,,8%E]'@"CO:="I<,,Q@
M.-1;M/*M9.T-+XH$,?$PEU:XRRCNL&$O"S)^/LRT>9HJ C(TV(?,[6'2#S;Y
MK\#F/@X3W/XRLZ9C&0/93NA#N32T]5F(/4)>;+JDF/I)^S*7&7)#7Q(FB.O8
M\&<8=-IBD/12[-/>JJ&\HZX_LBUS3S%I B3B-?C)=(V& J-6^5\@XG/#82JY
MO-&&*V8FFQ/F;.)_43:\+-H821)APLGDH(D4,.C49(R0 XG=&L?GAPX[6F5!
MJQ!<X8.Q*HJ5DS>E.DA9&$)9HT",Q2,+U97+5[1^6-C+85-0RWFI+OG-EDF?
M(U][,\>D.\N+R7*M]FEGR_779\N=9N+;%W+D%2AC%X7R7[8'9!K-U#P]DBF3
M2M!</=YA?EVNWGH9>@K)>LJ'BTAS?LR"PDUIS.OS^-:'EK3*^E][J8&G7N[
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M$C.'$KY"*^D<A!Z!XB7\1N8#FS[8W]" P.OR%[2[?K>=,1S4,RJ<>UP5?.P
M"ULF\=%W>,TOEC/Y$?D*7>ZK$$/?^N)ON @&?L42A=8-&%WQX(58EO-"-S,I
M-'$GPQEJ<(; B2LDP61NV$^,+OB(/LF[7G#!G;, 1EQ1:'[P'DQ,9P'6 C F
M+%$>2507I[VA!SD!\./4>_LN95;&!"E;A/CFJH0W.!HUNMRA+ (W.&@W!AM
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MDV?P."$L7%1YI!5P4O:G;.QCCBAP*1G$'P3V.MK/%.Y:!F"\&AY;_R#\V<]
MTM3C;(=JCMA?$T:7(AC08$$_X45H@F[!Z)C<#CS3G- &BCFL\7KI?LPO>#00
M:I 4SZU\\3U_[X-X[5=\:\&4>[>)0U\SU&PLY=[0'LU%8/F&S9S LU;KDDZV
M!E+NIZ1<+E+#C7C:;3P;]0A"RRQ=^V("AQJ!I_T_8[%\+]^@*W:&,$C^QW3]
M $T4V#-8'9\_WY'UX='#C2=T:W3.<C@OT$0[1CILDM5BG!8L\7"+'5>OE.-*
MGP@.'\TO@<+59ELEW%'WS06C$ K^7].6BL+@A[*@0Q$2&C*LIU%(G\BS1J-(
M9<2=1!ZL ?)Z2S;QX<RX"@N%?HL'J9J,BCIOO_\F[X.KMPWM0T LLTL%$ARR
M8!4/YT8:' X625;0^!GVUZ:\E8.6KCLW@.YI!??V=U! 'G]584NH=W73;_7T
M3C^C3#:'!Z*#3!*4!"!26E@N1]P/)X@JC1YE+.&__H+E^,Q:%12'G'+1#$)A
M<@%$DK.#K/!XB%,J+1;]JYO>FM) C;)YL(1I,*&R;JX+D#@F 4YY#2VZ?06[
MI&B$H1#$(C9M'C9>J5RUN8I4L5&JY^;=1V7&W5*,#T(/SQ;MBM@ )=[_XN\H
M B$8+K(9+7&%#QTCTT@-C16J1S8?!J<P'P9P695H/M 'QM(D76UK']@"Z%ZB
M)=MO= =;"$M&F00Z&]>=1G>8AAH> U?QA/SWWXYO=6=;5/]P;.:!1L6&--![
MP*M^X!/LGO8H(-)#JXGL)9UDA!M+Y=M*PU/PYO#J)A=L\TC6U!H5N:49M>X)
M*66L7&52 Q>RHI+ISH055=1T&IW.=!JA6]/7A^T=3:?N,4VGG/KKLDRG%L4%
MUW6';32=MC=\3AR6!TWQC&?TU3(F+#U7.+L*Y_0&&E7FD'F*TKBQL-,+QM@T
MLN0E(*'F5_4!?]*C^L7PBHA;9[_^\P[O 1M?@JXZY?L<R^+VKZ$M>.N1Z*T1
M*Z)DUN"]IXT=S(G"AU/3!07FN)XNKA'DI/R+)&Y:HX[%=8BP[C6FEYD2OTGO
M["M\ZQ/_UA_B6^&VTM^6%TFD%3_BL)R\1Z4TGR@UB3\,O@4&'7,GIL>K3GVB
M(O\+$V8<^S/ X20;+LR\D/0H5G#=3N4)+,/S'F9BU0_N-^2FCV(!=&F&'WKB
M4Z^5H2Y;K2TR!\!T6(^!>YF  60 38PIB@[/(B.M+',!DHJ_I,[$,/82J59T
MKCS)2[DGR0N?4,^&*E8:A])EH=LY?224=-Y#%X\V##?:6Q>WP:=O9*0U0EOY
M&_HCN%W*&@_YW3.=FL)Z,VU^$])WSV/JRM=@#%\,S^C(D?XC.-76*D-E8X)>
M^+@) LB*-S!"P"OBQ6XQ7B_J^O4WC TJR+3%S.P619 ;HPV&=EQ^]93-02KB
M!=UE^(^IZ4W0Y^=:13%$^"A3./F%P4?1"+$/BTZ6QHIT<3)R\SU]#.F1-G22
MC\(Z=/%8+),%^)'+G)D>?2=#9?&H1:P6D;XJ*BDBS4873_2FK7[&U1K=1+[S
MQ#CXH$^U.1AV4"FQ7? @][YIK[UO5/N<KI<U2<]6%P-V61E<O%,*$H!3EX6D
MR[BRJT7'3GET[($;VQBEY2NB8S8UR@Q%M*O:D+B9<:2N76(!F^T+E1P>>!@6
MY >^@::;.0P\)V]S$WH>W_1[Q['W^AOMO:0=&PZ8I-!F#HD*%82^EK:D3MV6
M5+<EU6U)E]^6E"YBK92_0F3^+DW8A%VJS8UGEA&^V-4 ZO<WE3B6=94-UIF9
MLN@1*]$7"S8U>4@@%K7!.B%P4M"',%VV'FFNWT_N0Z[QUI[R13X$ON?#0\%
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M/-C4L!2=KWHB2B?Y+ZL4"]QBCW.\'N=6]GY_<ER!UE30;$#H0[W9Z>F];AH
M,<]LB,/RA:Y/E$M.VG&,MQJ8-KKQJ*)!J=@>VM 3*Z!RA*+FU^A<" Q.<'<
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M??"U.?D<<(+ .Y2F#TBAH&S3]Q0] T:'(U*\ :9M$M9%-+R1GL_)I>3>(O'
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MR+',&EX\Q4O.'%/LE^H:9-.H+HA(7BA6W)(OC5VD>AB C'64J*PM5^!BF63
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M=M16"3D1./XT>X"P^V(U;&&''Z^AE#,4I.65,#\RUDEE5JJ9\XDB60::8+K
MIM$^?;B-ZL14R0_\N>,B1[XP46 E8#]"=!<R,'/#F#("%I;&XO0$;LB]J+A$
M2IN3M!?%FZ*$7CP,$+XBME\7=R3JYUR3+$&5G%0?16X LUU@<OH187.NTMY
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M1!R.%++T#+$3!#]A\J\AV1'R@?]I]S.QL=$=P83.\4-C7);,/B]X2G2M.+B
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M/<ZZ=5R10M-/1AMO+>*/2[2PYT5CT #]%/SC5.N4@+MRX1&OPM<Z_0&>1)3
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M<V3M75ESVS@2?L^OP&JK=K-5D6W)1V)OG"G%CE.>\K6V,YEY2D$D)*%"D1H
M]/'O%PV>X@60DC+,T/.0L4AT-[J_1J/1 ,GWOSS-'?1 &*>>>]P;;.WT$'$M
MSZ;N]+CWY?ZL_Z[WRX=7K][_H]___>/M!3KU+'].7(%.&,&"V.B1BAD2,X*^
M>NP[?<#HQL%BXK%YO_]!D9UXBV=&IS.!ACO#_:A9=)<=#7;'^_CMVYV^10YW
M^WMD@/OO]O<'_;V#@[<3:[!W>+"W^V9Z1/;W=\;[PP-YTQKW]P[W=OJ8[![V
MWQZ\.R"'AY,#>R]@^L2/N#4C<XRD:BX_>N+'O9D0BZ/M[<?'QZW'W2V/3;>'
M.SN#[=\O+^Y4TU[8UJ'N]Z763V/F1.UWM^'V&',2-<?NU%UJ#A>V+&^^#:KN
M[.X.HI; AU9PIBX7V+5BSK9@??&\(+R81M[>AML@9]C?V>TGDF+*@9YTI[\S
MZ ^7.FF+F"S=P_WMX&8/82$8'?N"G$F,3\D$^XXD\=T_?>S0"26V=""'@(LL
M-4C=%IA-B;C"<\(7V"(: WYXA1!@2N<+CPGDYL@FF(]5-SD30+;70P'^%YZ%
MA7)K:,DCC7+MMXDC./SJPZ^M)V[WMLVE^KP_Q7A12W*:)I >7JG3@RHG*NI&
M(0G\ZD=T?;C4'PRE-S7N0S)$ZO4AHENQ#X7>70:*CE+]YJMV(QZ?M;L14M;J
M1O&@-<0B(@ 0]NL(Y,3:FGH/VS:A)@,AVQS^J./Z2TR(9=>1&36'/PID8M?U
MA**'*^&UQ8*Z$R^X("^!KQY%#GM+)E'XS,T>X5PS.#P\W%9W9:15Q)A9S'-(
M=>/M!?,6A E*>'KF40QFC$R.>Q M^U&D_+9@9$OV)&J2$[ \ZN"VE$"XC-1*
MWXM$H8@%.-YQCTL<'!*8J,WZVV125W])0EWZM]#>P>.ZVDL2XOSTBEO8J:NX
M)+%\IXG7 _F]O(^H?=P[\63BW$-P[<OM>7$>H^0%#2-.$:_$^3[LJ/\&J)_D
MUWVDJ-YO9]MFN/B<V-?N!_5W=CB'Q&&3"L*,08SIEL=/(5EX,3)<I3E=F[B2
M6/[!/8?:L+[XB!U(3>YFA AN9FLMEPH@#@_WAX-] .).FI'$2(0\49HI"KFB
M@.T+4BD;WV FU9L1066'UP/;,DLMAL,F&*+72U+^TW5,8P-R;W(M@[+J(\>N
M;#27ZLXD 7T@%QYO/C1KB-!BOFN&>2(2>1.4"$52*EH2BT#NBQ,D"-T)S_H^
M\QR;,/[I3Y^*9[G"IQ85:\&_G+L6^KTFT*?E_>N?[X:#M_]%@5ST.I3\$@),
M\%E/N&\@2NL7^YORBY>IHAR\$\QG9X[WN)Y9(>&F1?N@"=K 'RD!'<+PE'"+
MT05P\R;2B3_ZG+J$P\1[1EV9$E'L@/64/!,8ZS'4(OD6UD*46X['?4;@1\(?
M0(,=ATB$FK=C(2B6TB$X[_SY'+-G&3?IU*4R0F%7C"S+\UU!W>F-]'Q+KJ=-
M<#3DI 7P71; D+&*KPEKE/!&$?,.X7:&*?L-.SZY)!CLI(*2"4S%A%I4#K.H
M !^D&*$TIPY!D%YD0O+ON:88E%#J0#C8R8*PM A%":L.H7 K.X^9-?O,9% P
M,?XR@=;F@ZS-(WJD&'3(TG)Z?(#RZM@A-XQ,"&.0;LF$5_K=W'/5GW)"S2?@
MALE<0^9:!(=9!%.R4"PLR-W?H$!>\$OE!VF1_PZS^0ZAKM3_B%6:/5_(G!B;
M)G8EE%J\=G,) ##J*TXHS:I#*'S%#**-T>P2M]5:>B]KZ8BT0Y:%\4Z%REU4
M[5!EE,0US7JKR+7VW\]'IIA;6%-,\>L0*!<RHS2S?]A2:^J#K*D#P@[9])2,
MC?(CU4YKSX)E]KA+R="Y*PU&[O&3F9NFFVMMFUL!!]1(D7?(QE=$P#;*#6%W
M,\R(B9VS)%I;Y]:UDH/:O$&2!U),.F3Q6^) G?,&,_%\+S,!CBVUP66VKBJA
MU6'P-K>L#5DAQ0NEF74(BSLRA43@EL!9-ID$&*7<61JM[7/+VY %BGETR>1&
M)<SU%T4-BZ/[^X,\7,;%4?0Z^JM+6TZ%Y<Y[+)?^S:NE(;D6K%SAH:1FBEX'
M'+N$2W$)U!R82GHM,KD20UDAM8O0%-=MS*&II-="DZM)E%5_N@A-5)\Q!R-#
MH35_KB01,>BBN8,:@;FQE]IK35U2DNBBH3/+-G.+%Q-J39^K7N17?5V$(;M\
MJ!'SBRFU0.0W^[/+CR[B4.M(S"D1F#I&*#7BJ\4P5T)I<.(&CL<I<5V"V6QQ
M> 43L* /I ;0#3GKH![F*C4UEI\RR$;R.HEVX5(2GB*W?8=XD_CVB'.B-I,N
M*!Y3A\+S3"&)[;FWQ/(9DX:5"3'E-5QBD^*U?I,K6Y2MA*5'A5T"ETI:O4%!
MOU3\2/4LHK:1C"%QYY#JW8N75<!L@.X7UQMSPAY@^CUW%[Z<W2U/QFV'XIKS
MSH_OE-8CC6LSY1Z9ZNV;*C]\@]*=1JK7:+G;+ZX:V;O);&?&2.L2N:)0N4N\
MS&0FPSEU6SD]S"IP(Z@'$6OFTC]]LHE)K*9DK6ODBE)UHT6Z51 !@JDL[A1*
M>M5)GRJNYR;0WC"RP-26-KN6ZPEV(@.L;! D!34<:!UBM-Z2JZ&55I>7W244
MKAQ#B4>A_"CY>7&,(L340__/TFAP-G,!(^R*B+7Z1*4$K3ODZGS&[A#(5?X0
M2WZC:E4OGA 9K4G"8,A)BVRNC%B!;+=3!MT8&UD6\XG]Z0FV=VJE! TY:['-
M528-1VTH#T4".PGWTC,6-< LI--"E2M +C^BT4D$&C]/40.ME67HD-W-U1M7
M?W2CD]Y0O"7?J+)LQDF+;/X@4]DV?]>GSF*+)Q.<VJV\5KLM(TM:J=X87H&[
M%N-<C:T"X_04&NR_!D)1)/4%^P)TDBPD?/%%KFV8AJS1(VK+U/J)\0-?&3])
MY6#1NS>*B,+NO#A0 9@CSOVY&FC\BVPDO$]<T#D6)"ZEA2"'(> 1,[M.=KY1
M^5K',C]+ELGADUXAZ!82'HHZEB[J15X7QRK5O4XZ6G1,K$E.44JK!;C\M%K7
MLX;($,E0N_8%O*T97M >W6R D1$_+6ZYDE@*M_1 3,E('43L()P5CYG66K!I
MN6BAR]6\*I]9[218P3G.)I&PA%(+2JY8%1XE[7H4#,R0Q*S_^3*"4*$,<N["
MQR94!_'8\T7X.D=W&A#51FTE*5J$<S6N&.%TO$Q+1BG12,E&L?#XJ/&+3TPN
ML?"9.L7A3=2]U+F.%9S A*T.];U<_:L0]404_%)-ELY(O:!L!,>WP89P_C9X
M07IS2,.+!VJ=@1X;[RSLY:J40-U)*Z=>8%##V 546IOGJH;IMQ]TTO:9AUR2
MV).Y :<-+9F"GU+'%\2N@=.*$K28YBI\!<_;+$>Z?(,WZC2EI=88H?P7;TAC
M-9*IGPV&D<G?'1Q!57/"IR?+\6UBGS%O#B4O/] [AG81\EF'MZRG!UIORI7U
MM-Z4[AA*>H:BKB'H&TIU;LD%%\DS81WTM[+W>M3:UJ]FH44\5^<K?T-()S'*
M/GY7IT)?0JK%)%?#*WAT[^\-Q?OMY6]\!;^7O@,&7P$+OVJH@ +;?PLKF5'B
M_MR3RW,NF'3@X]X$._#5(OAT65S$335TJ>/ 4P3'/<%\^+H1?![R2 8HZMGW
MZO-#P3?Y1'1K')Q:.NY9C-CPM07N2UE4^-##S\SS%\>]H"459-Y#P3>,@BMS
MSY7XL>=S>0>8)Q\[RZGT&5,78N6U>\ZY#Q*O)\D["TO4JR;2JVK[P?<W?K"N
M-SZS9G+E-9HRHFY=DOD8ON>4J!GT.-"RM'D=!8TTB;_@>61[<VE; UV"\S3P
M#=?K2>IL#2QSJK4R(-R<?@-S!<]=060\$>$F\)7G6IC/2EVRK/D*SFB3\>9\
M4:Z-&%0!3DGP_W,W<]YQM'R2/54LJ+#!"CS;:JAX/_D:SOB?^:[,^K0!JIKH
M)U U=1"OCK*%9*V-QW=$B. :P.3-*><>>[[R!.$W^!FZ7*JS"6E;89:Q"3Y
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M =*8\KBN[.BIBGXK9+0^L^+''CG[M@60-DV99&X;C9D#0.O8(&<5%/;VCN<
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MLIT9YOF78G:@3112Q-A:B-^G0*X".J:8>1"V731NPZMSH"857WJFH"Y:)\I
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MU O37[WUH_1Z_-)_&LW\U1*<2IDF21EQR3I<J(HD1*9(TE139:53W%:FP:.
MSH$*]23^D [\8#K$.+^>7Q4W_&+V$:9EX5/X6$[*S_!ZC(X[+(%RSU14F9(
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M[+QITT [+=)NFU'^I[^:PRU()CDW1F:26<Q$6F2[ QF(4D&J@$<AI/JUO .
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MM0Z$,Z:$1+?5R=H!H2-28:AA<"0F["/L%D;A@V&0(%-DY6#4EO9)#X>64$1
M7@=MM(=TOU#@<)OP]&,V*RCGOBUXD&1;C=E\W75S2#_.2ZCB+4Q'D[0P:'Z%
MW_M?=9>994U5N9_%>"Q3#S0)@2JDN'(9+6$6JO=R&(;LF907O*E2L-I &2W:
MIVX2P,5\ULW\."'H2S "<M"4F,P"XM.:.)[Q*T4I1[0L0NW+-+LPG15-JBK@
M6)6'O\Z+O-#G*E<R^AM!+_W5%:0?OJSRZ\L_["X#S>4:3R)4TA(F%>@L*5-R
M]M((I:3@IK8_<B#D\Z=7(_4U2(EOA/_3'^@&CCIX.QU%N/GE#69V&85BPAE&
MN&*E>R">Q3[E<E7+J@C*2J^.4A&["^CY,ZVJJAK$S=<R1SU$/*/[ _K2@C5<
M*4:T+)T9<BD,,F@AJI"L2]QSF6F[E/D=+&?%DBH";Q Z6</U<H)^)'[JZIXH
MC#Z7FZYK.<7+Q(W,5EF21 8BC??$"E#$,R>=X334'\ZU%\!SI4QEU3SDD3J8
M1[UYOS#[[Q(\E+"CBXRPB-N=5#(0;P,0(X4WVN+.%WQMSFP#<U[\J"+RAUS0
MAW)AK:1U<=RMF?6_P?3Z4FN(.0I.?"RC4K/TQ$F.#F " "7!.%X[.;<+TUDQ
MHZH"'A+$')2Z6]O6?H Q"KKTR;_X?0S3[N/HTYO1]6C6;W/(Y@CCF?\ EYY%
MP4"661DE<6&8)=Z(TCW*N"11*BG<"]MN2>3M_^RSX,4QY/Z0)K9B!/>MGUY,
M^P!VZF_XWVQU.089O%6$@E2EN8LL=V$R88H%PQ@UP=:N%Q\ ZRQ8TTH-#YGB
MJC4)>9'^:][-2I+CUNFZC#1:KY4D$!F:V)Q)XH4RA-MLDN79FE2;(X\".BMV
MU!/]AB >/='4@;5?+UJRX-E9?K'H7PSQXWCTWW/HCC!:8$\D1YH?<(A\:@\)
M6,Q40E/G\3Y-^ >_3L;3.[UT-D"^?2FDMBPHSDD9ETZD-V@C:9U)*9:*6EI\
M86I'0EJOJ=XV6Q7?LCI%.4A44P(ANT5#<!?!$3#):9XT=;%V\++E>HX^5. Y
MO ?;#X<3$^:YM+]9:[W\<*9[/X&]+\:@X+R/"HA@V:,#'QBQ&D]EE2A%V0>A
M[E<NUIPZ\ BRDX\?.#F1MH\BJ*708PTI?HAW544Z .P19Z1O!7KR60'5-#YD
MBG%5=9V<8R!-9!H"8:9D]\L@,@M.$NU%S$DJ)F,SZ^ITW!K>F/]Y4&L?+;6D
MU,+)Z"4@5M?07(K!.$&BI()((4KT,F2"F()1P*2SN16!'L)Y'I/4*RER&V4.
MU$*#*J[[?NAO^-_UKXBEGEN>)8F),B*ME*6/"2OW78P,(3&K9&5V;,/RI\DT
M::"T!C4WFW"M;M$.0-;((MJ.ZC3F3QWM#:#$ :)O<!0]@M!8W%,EGK]<"CR.
MO4<'.3-#DK9:!5 J._.5DV*'W7)L3NPC\>I-)>[!>C^;COZYJ/-:=3\ IU7B
MD3A99OAF'TD($G=)S<!GHP6/]XIDMG65V/6HXUL=M90R:2;1(U@9/;3_G)2&
M_FLSB(+R'G+ANK1 )!A) HA(A'4ZH,'N@JM=,#X(V%=/DG9J.,(Y\6[4_?/5
M%-!VGL$4NMD[/UNQ6B1/@Z2:\* M;HY:$2L])SHQT*'PW=>N$!^.[FQ94TDA
M1[ _?_KC$\09I!]'GT<)QFD-J7+6VZ E&MVBI%6Y(T%E16B2W%GT]!QO[=YL
M1W>VU*FDD ;EW(\5?-U?Q27Z^X&;H E+KEQM, QI+B3)04:J;=9:UIZCN0^^
M$X92GF,*K9EJ&QA*.^L.1?;.I<0(0$)!1,H)N@= M/746>EB9+5MI.=7^/G5
MTFUO%6ZUKZH5]/S@K_PXPON/ +/;"^VW%2MOIY-/,)U]P064>]"?RJOR*\P.
M*-PY\(D'%NC47&^E0IS5(]\BLMF+M>?>$E)GZ7!#,L190*\M@21><[2NT":'
M9%"^]SWB@U_[W:@.OO&P%/I%WOJL1:PT1VUC1K-2T4 7\P<]>B+HS#(.4 +E
MJ?H%B('8CE6D4IDC#VY"M%#%<RD9V;JD'[[<Q-FX3#&*$B!Q)2R2RKK*33))
M07-F1>:\MBLY -:I,A]MZ#!IJY8&L8CMJ[_UCX9 ;)39& #O-"F.ZJH=2IT#
M]7(B"C$7<]).E*)N5F9&2-RT62#&H,]!(TL M<^WDU%G1R+D.3!G'W4T:KSU
M:;T7M(2@-2L3A3SNL9[B">^M(9XFJFA**;+:V;%[$([OX557TX9^6T^5<0.W
M_]5\BA)%KQ67^FKT1_EJ-6>$,J>E4AH=Q=+F( N'JXR&<"T8, ?1\=K:WX[F
M_(A02?(-MH$WX#OX.+E*KZ\_32>?%^5)JVYA25K'<)T\EBZE6D3BA> D< 8Q
M!L.DK!T%>@3.^;&BENP;Y#BV+OWGZ:3K+D$D3ID'PJQ&=!P\;FDB$"&"L4Q(
M'43MFWJ/(WI&Y*CC*E=40(.3Y$6,\^OY5;E?^B-\FD)<C$#'KZ^@%_LXO;B>
M3&>C_UE<5=ZVF$LTI;@$8U'?%'>_9!3Q"1+)ED7.HQ&9UF[U6 O[V5'N)$H]
MIB_T*\PNG> N68EO2L!W1EI&B3>4(S;JG(X9ZM]#?PS/V9&HFO"W'FK5<A+O
MH(-2>_US2:0<D&G8^#D'Y@]V8ZN4%5@]"%7U8RD8G_3*>E&22Q\6TPDFX]G4
MQ]EOD[<PS9/I]:O)]&+V$:9KB:R ]JM/5!#'$QI!F0&Q+E(\C<#G0"5GNG9D
MH0;N>IF% ] L(IR1FS+L01'C?$97('M\Y4"02*-3WE'*&N8>#D5_K.S$T;FZ
M/7]Q5(4_EPS'2_]I-/-7H_^!]'+2S;J+_/=Q[[BDY:X_@NZG/^+5'+>E5ZB]
M=6OAAR^KD^%BBE_]%\3%_'.K- ?E(Q$271R))P1QLC2Y]E:);(/1N7:G]P;+
M.'T&Y;B$O-]YYL3$:&-$%BA+;WP(F';9EUL@I\FSG%R]#VW, W73G#"1"PG)
M"S1RC2YC?7+I%AJ(9%98J1S^NW;AYQ&(LB.K\KQYLH]*:E]&N6/.WTSA_,=H
M]O&WC_"S[V;32:ES[F:CL;]:_?&KR7R<>N'\_/K=J_?P:88ZYZOR>6F!)O31
M!)>^S(60Q&E6KEJXK% XZ,+Y78Y+&V@G<6F?JN?)LU%2Q2A=S=7\%9>SND0L
M2W&J9[ET^D?3V2M/K"KV,VZN.FIOI3PJY]:P?>ND>ZJ:GN%&]V+^8=Z5MT@N
MU^.$3SYK2CRN"X^ $H[B-!/ U3"%AX/C.V,TK<!]R[P[2%$5<U9WUK/5_^D7
M>IF4UI$F3B)$]'*""L26F_%:X$OA%97A_AW@'5QZ_'G'I\?)8B2MM-#J7'P<
MXJIW^Z4IXS*90TY;FXA4/!'O':!O3,$X#1D8JTB8U7/_)$XUK33P]3:C+=?.
MQAU<!NVS!.W*S5:+VZ##\Y>Y2')4!G=IX[*I'=)Z%- WQ*7Z"CKZ.?5R"FDT
MNZ32!Z:R)QH,X,&N-/%@ U$Q9RZIU@QLG7UG\<!OB"3-]-#@PNA*!L4P>XG6
MUN0:IJM;:%]>SJ?3DF^G5 L%(A,.Q;G$-9, .I,@5$[1Z:Q-[6L[0W!]0Y1J
MIJX&DX102+/IJ-R/?NF[CRM0+@@?+(O$4(T\3XGBJKGMLP$J"\.=JET7L1'(
M-TB:PQ52<4[0L,WQ'8RNPWS:]=^44&YOGKU"[["[9,E)8W,F-(-!>B=%K/"Q
M=" #3ZD(^?ZU]:>>7(^@^(9H=%R-51Q#U -?C7K<'(_H+J52(,N!RWQ)2X;2
M%Z),XC,&(.*V20WD06S:\:!OC3 UY;YU\E"U4BT4Q>>2/PI7\!:5#+A%IN7
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MF@K'2@H<0HL#I']L@L3 DG>4>)Y$B3,%XJCV)//DK&>)9UO;F#XZ,7:4$)Z
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MSHHQ=43^D NZ8A[DK9]>3/LT4.HWSAN(+@8\,UTF-B5#T&[2) 1K"7=46R;
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MQB';:1 D ,5_1/2BM1 BFD;3RYMK?V@^H;7R]Q%QB^-],9UR4Z'#\HCBQJL
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MS?Q$M^/!-$@:-SKHX<@+-CF">JN0*TS,UJ!60;\T"MH=2_1(.^PKK"&@JR[
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M3Q&86@];DJ"C"111/84ZB<FP3KF0U$RM#(745JXQ208RV.6KC6K)'W8:=7+
M691J3)Q.KT:?LZS$I3J)W\EW+[_FU<(+@RQ+1  ]KRX9G"10KG411&&D5KW0
MR[A6IM;1T2=6JIH64,3 ;XJ<8;QP'PB]!<I:/,-HG;9DYC6VCDG@JK;6WMCS
MUM0Z)M:K6EI''[)3H]OF(NF-ND=Z)]<]Z8*J?4![(X$&<1C'U(,BE8L4HG$(
M<1!FD#(<I(@2$9OU;QVD-K&:M;1!31STJ(]?9[! 3D\/G>%AII=G0&&LJ%HB
M.E+<85JS*K*6V(>*K?>211CJL./'EW69_X/?E#GMFM'$Q*/<RP+H>XQ"%-,
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MN5.^,DP3QJ6[3(,HPB@)$#;QCT_0F=C4U;4'=V3!;XHPJ"D;%BTXA9.>S^5
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MRV1W@<->IKN3 >UV"Y_D>E57/KEZK \>ZVIZ[4%6P")$$HRA\&D"41AAF/(
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M)4.!J+KV:'I$ZR8SP(Q&&(+#.NT,%Z"[ X<$-I  *N(U PNT:4TWT  J_L'
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M[?^1U9:4;[=UQ7;GA[;M4>(L\0L:ARCF.%:C)(2ZA6+21Q0DRZ*4!ER_:<\
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M<[I(";2/[.AI&Y8:VG:R,>^:S*XX\$KT,DYZ9MJ*]#"+VB?IM;<1/[14+=Y
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M$<H8RZ5!2$A (J,&]8-D'1N%7E/Q'>W:*'R]^8OWFV) \XX7"*:>;; /$<Q
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MZ/DZ3GB%_/B/.=;^_?]$EJHGU,PK^.-BM5(V8"WJ9E#-DH8C>JU^LX@S%I"
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M^H7@24TN$;25S^2$QVE3F5S"?)+%Y)28F=G_I;[BJ'_FGU<OVTT]UN<O:U6
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M19JG 6@RIC-.76>@M'PKAT$Q*$_"JAM[EVF!:LX/C\-CP^4F_I*:3LCW\'V
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M93A#!*LM/ H21/*(RWT\B;D(LS *8:,==*BZWM?5H"%UWJ^G,_$]&\"SO1:
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M]ZB%^ND[OH>GQ_?;+VO=&02N@&,+^%9!33=X6#_I7>#]A_MW@R%Y +4;%=]
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M5(0Z$3')4D1%RE$IHIC$!4YX9E1C=VEQWTY>6\VNZ04M06C1_@"':<-TK71
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MP</Z2;MT[S_<O]-9<0H8W;3&_/Y_1/!IU7,C,S!0F! W^%W3=M2<9UHPJPR
MD247RP"8%FF8 3#SI,<,@-?/<A6&D2BC+$0DS27"!=;;8ZRVQU#F)8NIS.,0
MDOUF2GB)9#@/U_@:,K,]T@<0,/6%7=$O?!$_D'S):W=-]L>[9!^ 876E/GP?
MOA&_:VWZ<2+;K^MM6R5EL">-O^SOA]W1#"X,XJN#WS4#0<.!H]UI7D2K'6IB
MV<5VJ7G1ACN5P=.V,=N7+YOF^]'-+W2C>Y]_^BSE_IA/6A^;ML<TQ+*0%&4D
M2I&*V1+$LI"A5!!)$XYY)HRZQM@0]^Q?=N2#AGYSF;_;ZA\U-+H#H&D:\/G!
M"!@##K@(3K$:,!+\[K1?_C40.(L: :07#B3AH)S'EA9KP'>Y04GP[>/C_DU5
M:?VZ?=J;1IRC"_C.NQJ4ORO"E7S4M5V*O+(-N^?Z1<[/D_E8FVE4YK=^)X#
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M>WG%Q0YC)P4:GKY./V@YQZ5^M=G5\F&GAUCHQKWOMN(#?3(:IS2WAF==TB2
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MR;D)V'SR?[Y.*+YIGFXR$]>64.6<*341O60\##%B0B\Y<D58<-XR=)V<]Q4
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MEW<#9_PV$R^GLTL,K2?:"PX6PSG#NKKR;(C33)$HHE$40S =:I_&>T@9MXO
M.8!SBLP;@,X_H,QRA?0,ST+_&=Y>7@18OLN/7KQL]H7Q03+ L]B:C?\02%!9
MD8#[Q5N6E NU^P<\B<"C8.9^))@-IY]VP7>]E1Z_NDK O09() >![#$7B1..
M=WUDM$W161O. []])!X7']"? (%5E/1#/F9ZW"#FII77 ZXJO6/:O]KP3YB.
MY+1^_XL#C7XRU308(TF&DE;FL5RLHIT#E?#H]5X.V@#CV)[,/;C_U/7S5U(R
MFR1#E[/T:1=.8LRN-0$79';"<\CU.XK=IZ"9OA:5L+"WP?33Y=W R7E+_48B
M)0!>S,NF??;G=#7107N@G!-NA49FT!=P@#&,549&P/]%7;LT]R!!C6#I!$WO
M TUOL3> H2T>7BXN_'0^83YK:3'TS91[(I6.Q,M2PJ*BR4981U/UF'$7(8U@
MIK^BM^/&WE)O #KW>B/\#8H_. '(7#+CB &'#*!+24+(N,FXDY$:Y[.O/V=S
MBXAQ(5-!L?L[4)P@Y09@LJ/CP34C,H8 5!J2<A&+,)QXFAR)@IH<$Z."UX[D
M]A(S;O5V?=C4D7H#\-G3*OV:&94R39(RXI)UY:5")"$R19)&KU!9Z12O'0@<
M)&C< NSZ,*HG_1:@]/WFY]>,<<]45)F2  $PIC"*.,\\"2XD+[CFVJ;:L#J6
MN'$+@@: V"!::0!NVTW/K[E@UD@1;43:46#H)CKB<O#$40 3LM&N^A"$W92,
M6]93'T@5Y-T :CY>AM4T33T>W7X&UYF/+N!(R1F?0R0L>(I^GPEH;7,@3D5P
M.4L476VCM)>81II25@CFJXB[!=S<D?_67^"7]VIPKC>7Y#8F&1A10:/]#%!>
MHI1AQS25CIK&^EA]DMUWJ1HYQ*^C_FU0U=7%B.CJWH"^OUS&+WX%SSXOH=MV
MUY95&Q:CX(I862Z4I)=E\ +^U2N(CE,+VVTC]CRKW;/ R-"HK,1%98DV8',V
M\XA7*)!K03V_^OM\^I^7\!)6<3G]VJFJ;"8#D!5EF6!04!JN4+30C (&GF"C
M55Z8ZFTBCJ6MD9:X_4^R0931(LC*;KS>@-%3W!YHI(U.&O=+Z9F)&X^DG**W
MQF5N:F>0#I SKKT:1O_? ]F)RAC[2+O/Q[VIZB\AW)AB:GC*+GIBLPW(#>["
MH&,B>.SS$"15(A[7,^*[2S4&FU,UNAA,O T8H5L[_08CS-?XY6H2I;,>A"6@
M.7+@T4OT*!:B=;(LAZ1R]8<\CZEHI/UVQ4O5TP3< $1>SV/)N2/(-W^^GC\N
M6OBPF,U>+99_^&5"]G)4V5N4D2M]!M$@.RHMB=(R+JUVV:C*^'DBB8W<OIZ(
MB$=/G8=33P/H.]BHGF;JN1,*8UD%&SON(IK=%)P047NC;'WWN^?,@"$[(0\'
MA*>,#WB*5DY&V%=83A>EGF^YKG00/AZ,YQGGCC.2=*;%[#OBK70DI"Q9DE90
M7KL]THD3"H=L'GDV3/740#-(VC\) =T%07U6Q)3>8N@;HI=8JMB9E3SX))/R
MM?.4C0XH/">NZNBC;R>0]T/8J\T8H)>72S2[UPMTG+V%/[H?K28<0DY,E?B&
ME:O%%$OBC1&M(.5R>Z1I[8*WXR@;O?W#>>U:74TUX)?MX:KKO7G'%).<&R,S
MR2SF,EN6$0<R$*6"5 '] $CU:W6/(&STS@]CHZ^'GMH%WV9+=3]\UZ4%5[_]
M"<LX74&:^!"\#K%<C]-230^E38"0A"?+D57%G*X]J^[I5([^>'UL6-;28+L8
M[3;>;@8QT _22T5X5NB..(X,<IZ(<LQ[C**45;6;1#^9R-'?R(^-T$KZ:Q>@
MFRVX)]']$2+^:IDE/W')Y&A*YQ+\H_1(1G_%95L2W>A7.ZZSJ5ZUTXOBT5_I
MCPW=(33;+HZ[C7H$LY$:'Y(FFI?:R^0!V>:>,).\4<QD7K_XK _!HS<!&!O%
M ^BU%1 _FZ>;%O1[^'Y_0][V[T]"T!8CR$"8H!SY#8%X7P:Q6$/!61J,KO]R
MN!_-X[<3."^6SZ7>!N!\-U-AFQ.4YD=8?IM&6+U;OICYZ<5J0A6RHO# B:SL
MU<P2<9K+$H)RQEG@4=2N=GD2@<<!]:>XV!E.<0V@\J!?] %6Z^4TKF\V7Q%E
MUV<-&<\P75^6C'%B+L50(D]IT,7/W!"OI"9)&I ^"Y;8(%:V#]''H??GN4(Z
MFX+;171WF!S%KRS-<;)Q)"M?)B()09Q$?K/1/C(J,O[LC.YO/3S_%%=79U5O
M W"^ZZ*Z^K38\T2SV\S!=XU]+DH?]D[U'P %OYJNX?J,V@CJ \3%YWGW*9W,
M)C&5$G9F2':LM&_R&N61<LG8*,MT2/7KM8?FZ;CM\%/<I#4%CP:VRWF;%INL
MA8\&T'@858;+1CP:NUG5V4D>==!YD)&8;76__BDN!=L%3@.[ZN$8!V>"M]8)
M8E0N)J$\L#6!$X 8-'6HA>H]WY\^)H/]%'>"IPN^ =0<K(@TEDK@P1(&U!$9
M%>X 3P6A5FLJ=7*"U:XD[%^G^E/<XE532\_RPM_F=69![2B21(\%5[.,Z. %
M^O@H(VLQ@LV<<R.2!0.UVZ>?6*;*?I[;M=-5T B0]E=%6BF%*M0;K669:J6(
M-\J55^)*^.P3"[7+$/I5J;*?XKJKCD+JE*D^!%D3[8<WON076$^CGSWD=NA>
MQ ^7'K$Q\0$9G+5+<6 IT.@ S9WR1 ;NB95X>"K-+ BFE8/!VO>>L4NQ98&*
M;JBRBKCO5-(8MXA0NC1)93U5M'H;OQ^O2_%3L/"=+L5/D7<#'O_^%BLV9:E-
M=NA7*G0'G)#$:I8(+3-Y>#0IT>JUIKT:&IVK._&3-'QT0Z.GB+L%W'R__TJ2
MQKD@?!FS$HD4N*E\IID$G4+JF(+JE: _;$.C)ZG_Z0V-GJ*+L;L_[&N_P[GR
MC&L449)E;(_CQ"9;<BG*)HH,0DS?\Y]^Z(9&3U+B,0V-GB+1%FS.XS?G&)=F
M'W4BAD(BDD9!@D2&%-@L= S<Z$;:/)RKW5ZOTZF?@!N R%&7:W?WT3>%0B\6
MJS7:8*Z5M!GW%R\]XQVU))@L"?/49 JXRTSMEZU]Z&W$*3H1*Z?<BM90W \"
MTJV^//^8KK_<E0N_ E\J(R8.E,3M[HBQR:' I4:^*2,F&V]<,(*KVAGY6K0W
M8C//!][J"OTA!W.]\*LOKV:+/U:#)+_N/GWX_-8>3NJGL&X7NLU6: U1,HYN
MF_.*2"LE\1(B49G)("UD4WU6\2%Z*EQ5E\]\OUQ\FZ+DGE_]'<7^>O[N*RQ1
M:?//S] '_M:]A[B;*L5QIS!IB-8<-VNB90QL!D)!<&9X#.CEU+_/?B*5C9S/
M?1&TXX)[2'4U<#X_O,('KZ(%47KA<72HO41?F@='@D!&T#"CP ; VE-K)X:"
MT=#:/E@]\131-X";!VY *<N;Q^D,'K#T:?%4:5+*3-*Q>+2E'VCRGCA!59G:
MF2/7(>7J51=#\#&NOW=F%(\.A 8VPTO E>.T4_&$:ZJ894"$,99(F0T)U$@2
M?=#2&<;P/*H,XOOKCVM"QT?#HI)J&H#5K4S>E%*&#V7N\;N,XGJV6L'ZV44I
MX/ROCK'?_BQUTS!A+'DM5"9*H[]3*C519!%(R;=S;6.93E.[X/>)-(YK&YN#
MYZ J'OMRX_4</PA6ZVO:WZ*T4;03Q@5+(A@B0(62P9+$)DF)"9%+/'S ZBV4
M[KG;V/WYX_;):P9AM330@!V\OP_>Y9)1>CE=Q<7E?/U^"1?3RXM)PJB.*9<)
M=UD3"4(3SW(@D;KDN?3*J-H=C+]+U+C]\IK!X3!*/!F5WV 9%I5P^<I/E]TS
MI#MAO\NW#0 <H]KZ1$EVL@P0*[%<:3-D)"A(R6H5:A<C'21HW YZS>&QGO(:
ML)!=W>GS[3=TDYBRR"9%HF@92 ^V7*)[3I@75$<HU?2U0Y'=E(S;)J\Y[%50
MU]B^W>]^.B^">S>_:T!QNWM,4)$"6+3?UA 9.T9 HW^AB]_!8Y#V* _OT"KC
M-K9K!E-UM=&W&OU3-9-VQ]*F6@CEB));7[V?(5.EI/5K$?[$&>=!^D"<\1C2
MEYDP07A!O,'_RPJD=+4K-X^C;-SF=<W <T!UMH/5QZ].;L5X?2-^=QN5M$,;
M9PG(+'$S9B#>YD2<X@":Z<A-[?O,XZD;MU5=<Y@=2*T-^(N/.<,@[*N?II?7
M]%PG#)[--Y.PNW34"H6I;<1-26)@H9PDB5AC)<D BE).H];5VWZ=1&EK<UWJ
MX.:[\*RNQ*9-;.&I9+2ZW@?K:^XT!QT4QFR\=.:7RG#B?6!$:\^TI8DY7SL%
M?B1IK<V%.1,F^ZNI91 ^BUT*:_7>7W45R3Z@E%*(1$B?RH 22YQVC BG=!;4
MFAQK/^W^+E&M#8XY$_#ZJ&;LZ'HG-\O+6Y.^NK'IF\8OZS=3'Z:S31]="1RL
MHXD8I3V1.6#@%TIG<Z ZQ@!&P''C0GL0T=JLF*J0.ZN&FG067RSFG?BZPE[T
MV=$[7]XP>#41,3N9G"/!@R:2VJXG5^G(* (/99@<U&X[]4026QLF<R:+6$]M
M3:+RX5WZ'6,YHVO!+2W#.5&(&DJ[6R^)]MYY-/K 8^T4T='$M38_YEQ.8055
M-8#!XTOM)B)D"=1"F2U2&LXPY$P'3IQQ 23CH=31CU7%/:Z'>/ZRVR&4=CH<
M%[C/AH3CZ_DW6.T1I+7>Z,0BL<FSDF_-Y6Z DZ!=I@8\,C) L[PG4MG(^ZDS
M/2ZHI:X&[".RAC8[K5ZA4'>D_=%%OLO\!RXR"#3]2@-*TAD\8,IS,!F%E!%"
MQHU7&8E/(*_)APG5D+(XC]H:0.3QDIQ0GIW+@1+C'$4))D,\2%ZNY!,X+;/=
MOL0^HVEL\HG!4'@<2&GMGMBOIG,_C[L%:60&L-J1F$IO7B]8<<0I2192*6[G
M-)X)E@>H'->A//>)74M=#=C'^Z;_[6(-M]E3XQAPQS#^LRP3*8K'+:0GU'$A
M9.)>\]K](O;1TN197 T#!\[BDQ72&+"VV@-,A(M)9(X,,-R(I2,G"10<,0E/
M#,<"!G2UG_T=(*?)H_4<\.JCEL80MJ,*3DE()I1"$($L262"V$@#"4[2F,O4
M;%;[9NXP14TF7<Z!LY[*:19J]SJ73T02(DF54%8^EB:;FKA.5HFQS!533->^
M _DN4>->RC4!N%-5U!CF=D^S%CQI769%"6LP]@'FB#4J8,2%N\J%($6JG6+^
M+E'CWK2-B+G^*FH <\?+;\*X3MI;1B*U%L.JH$DHX3[+WE!04<3JK1N.IV[<
M6[8SHW @I360+?DM9X@8U/_V9_SBYY_A X;Y[^:%V?*_DI/\YF>E?/ANTE[Y
MP;-Y>OB->[\YH1Z<,#H2(W57%<Q*E_[0O?OB*B857>VX=@ VQCW:!\NWC*WP
M!DQP+V8WLR$>7[_'V649IW-?K!M13S3UU'*T-$;8\NXQ)A+0$\+H3T5F;8R"
MU?9;S\OAN [)8#NE89@T<'#TLQA"@);6"E)FNJ#3%@QQ6D5"E1? F/?>U>[M
M/OQA,)BWTR;$GZ3$G@.?4 ++=0.X-3$SX[@ET;A$I..1V.+GQ>@D^*"D@NHS
M[ ;'[6 />AO%[5.4V,B@LEX,WXJ<,V]!)XLRYA@JJW*)FWPB^$TI4W#"R:;0
M^Z2KS\'>_;:)XI.4VHCSC7QM<X/Q]7)YA9[19@9U]BI;P1-AT6@B8^ D9"H)
M"MLS9G3.U9L/'478N/>D(P!F!V3K:J^)KD./I/C(U;&,,J4YR=ZP4I)EB"\3
M>36@_((0FJO:KW2_1].X=ZKC0[&JSAHQC*?[-$E*]+E5)IDS2_!K( $\)4G@
M=A,6@J5#&,QA'=/!;FK'1^_YM-U KN#CY=>OL\Z%\K,;%^KU/"^6%QN-WPA4
MN:B\SPPE6)Y+2<6(RP9YLUPZR6G6U8?N'DG:N%T\!O- AU#,V.]\;YO0E1)K
M>'59IFG<%D5081,XR"09=$I0/L@#"HA$%:WT)B6KMEK%['G(>VB5L6<$#J#3
MQ1 "'M7UVV;E7AG#+3.)4I," V(<<Z1TRR36IDBR+85:5(D@V%/1LF.=D=_B
MG!$O?84\MFWY".OU[-H2OT=)3E>KQ?+J00UI<"$%:QQQZ&(2R44D(8 CWCI)
ML['42WT49KZ_UL@5X4/CIK*PQ\;.VT5WR_KOF_<5[_(][^Y>!97D-DCAT;,#
MD_ T+T&+5D!H\#E%+2(R>11\CEINY#ONH1%47^0M#DU[":NXG'9E48N\_@+/
M+U?3.:Q6?IZN"U2ZZ7&;J7(/&3EN;MK3%N@].JT'/Y6FI[U;?O;SZ[[:=_/;
M"B3GZ?T]GM[E6X+N1KO=PA:"T0S-$XG9&2*-<L0&CR@V042T37BNU2Z#J4)X
M[Q$;?8@H#<QGB]7E$CZA,I_/N@TJ* ?I/:&*E@X&,J.]QS G<4>IC2*F[>X[
MXPIR!P_CA@3GQ_.CF1QC8J)%H_WQ\N+"+Z\6^>/T\WR:I[$\ MYTU\*CZCW*
M)Y8BRQ.L]9&?W-M,G\)!)?O\>)E;D#+)@4H?B;,E_BR7$(@&3JB@I6<S*,9K
M#_3>3TWOO-DAR=[MA1RC,HQCW,1Y&5\<# E,9X(NL#(^2JN@]C/_XR@;>6Y6
M'90\RIG55TJ+!NHV:O\;^&)Z.TM\BCW:_4&]S<\1]%6R-K<KW9U#]WHAJ]+A
M2UF2 Q0DA4"L5(IDJQU8I9*WM4LJ#M%3;?S*O<^^P[3A3(32Y#%K0?'0%<@L
M,%G>,0+K"GUS;4-SD*!Q[4LU7.P=H]);"2T:EN=^5AZ.??P"L"ZC.A;S4RW+
MGD_J;5J.H;"I2)/1J!4$1D)I[B]!R9(;B23HC.<." V^=@/\)B+-^PFD^TK;
MN6]2IBI$#%^X4+@C90KE/:PG,<7@DP:65.V6A4^A[V>($)^"PT-7D55UV:(-
M_( ?@11]^;U<@9QB^AY^0&^+=X">2H;N9@7$TTOX!K-%U^KJ%CD"M+922#S*
MN"!X<$:"!V4FGDN: OX@R-H]\PY35*&BK/OT^Q\][T9372*N/B[R^@_<F+LR
M&T(I+W+21(72(L+Y0+PSE%#/44:I#$NK[5&>3.RX1JLBIG84EYU!?2V:IGL=
M2][?T-3=D]R[,O'SS;>^+&:HX56I3%I?G6+&3E^LM\FKQ&<E\[CYZ+O*,LER
ML#*1Z*E&Z I/;%":9)9DM,%%)6J;PX<4]/;,'HFMW-ONVB\A9AK*" '.@B'2
M"DY\>;X?7,B)2_!L^\*SOUMV+''CFK<>F'CD7 VBCA;-5\?IXUF9I^31=W]2
M_[SY$116LBIW"NY*;VX7^P SWUV"K]:K;FYF*.2\]U</W?D@G#.* AZ;I<HT
M<73L1:;$,FMYTHSYZNUC^U'<UVH=O?KS^ZO?;1['(Z<8>I <.(8E-AD2( !Q
M4HKH3  A:L?A/4D>U\*=$9_;%O&<JF[13M[6'IY@&1_6+?:QA;NIZ&G]NM*?
MFT\N9?33SU_6JW>7Z]4:';K2K>7V1CM[K:3U).HRD3IE5*+)BD!6QD2?G9'?
M%<;1J_4J'CNTP+W80TOI779$A*B(#-D2Z[TDP4>*@0C#X_RXXK&CEAO'=@RC
MW0=E8_6%W:(%*''.=#,:U)?0MKO'A/FI90>'/JY"L'8DK94<IWOK/=M:[^[@
MN -:<DQ%)XDI31:E 4<"S4"B<PP2-W@:U&X2]R0">[],.V:Q>\E98SDS,:(0
MRKQA;@4).9<,K4@! X@H8^VWDD^C<.1'O(-AZ]$;L^'TUJ)!Z^8>G62[KO]E
M;S.UBX)*%FGST7<ET2(*! .>:,%@F"Y2&>H4*>$1K)8A4DBURYP>4M#7IKR!
MU0K@X<RJ>^XU=PIB](F$<K?3-77$8U43Q[+56HHLJW?D/TS1N#:CA_:WC4)%
MP;=H!+INXR>8@+LNY?U*U[=7KY7)P0_>=3J@58X!==2]_I418NEI*4ARR)FD
M+-+JUV:[*>F=>7GPJ7=P!):YQG.)4(K_D<H'$A*-A&H)@AOE JM=^KV'E)$S
M)?WU_R@#4D'D+5J UW/\$C[Y/T_S!>[_\][V8"\ME<S"[>?OP 8S/@51'C-1
M/"FDY+DTHM7$B)QX#@X0^)6WS@%R*HPFW?[H>R5Q,>4@T2LV!D*YZ<4H/,1$
MC LN!I?QXVI''(?H&==4U,+$CHFC=330HM%X"^LWBU7IVMDE?4\Q'-L?T=MX
M'*2IUKVS7\[1"[Q=Y!8I7E": QXJ.12D!,V)#2(31C%"M$E([FIOJ7VT]&YQ
MO?6Y=ZAERJLD;" ILM+ )7.,?='MU=[PP)6V0=4NM=E+S,AWS35P\*C5=!7!
MMV@NKF^)WOOE^NK3TL]7**HRE>"T4KX]GU6AJN\8*JL5^.U>[!9)29DH!90Q
M@A)U;GTF3CH@ G3.SEFE!ZAK.TQ3_R*_W9^_ZX2T,5OJ0R T,T8D,XY8RRFA
M)E$0*DK):O<V>@)Y8Q?R5<3.XU*^8934HEWZ")]+NO<#?%TL2W;GI+J7[<_H
M7_%RD*I*]F=[D;NZ*<=+#P==?-Y$)+A$/'.9V.AX F<\;#?QZ5]@MH>6WE5U
M6Y^["\(T>N5R5L3[,L,P4$_PY*:$,\9\DA*A' =FMSG[4@4;CVKJ*BNC27MR
MU!OOX5^KG_O5^EBOURV"T65F\< I)0O4<\1CP# : G,T)BZK;][A7J\_]ZOI
MZEW>6N!J\]][UXZ4LE Z-WDG./(L-+%*>1(M!*^SML+5OLHZCK)F7Z\_!27;
M5FL I330._<M_'&/H^5BCE_&S>.TW?S9+)PH^6V*KF-YDR\(6GN)46Z0D0<0
M@=<NV7@JC>-V!1P(?H,JJL43=&>;@D^E>5V]9@K7'S=,2X5=M)ZCL8),PL@L
M$W&VO-XR/A!'.1!M(S7:!,BN]FSA(1LK?(Q?(%W.X%V^7>79:@5=9<Z;J0_3
M63<^\%KRZ=W\ \3+Y1)W26>Q.RW<[0I%%8_.::)D*0!@R:.83$*_$N6$?S5!
MUQ9.508:;MSP%-P]"@E&4W(#9_ MRT=P^O?Y(JQ@^:TP_'K^]1*CJ+B81_Q7
M'0CN9*"-2"7-3,K90J1P0#">2D3%')5D4D99^W78$'R,>Y8/AO?15=X2[(_<
MZ?@+;Q?SY0/9E']_+87X93[]STO8M@7&4ITR*BAZE8C4G!++M2,@E;$V69I3
M[4*?LS V;@OCX3=&,Z!HT3?>W6?G=.?XX.<-U!5H0/>X3D\6Q"GS!L,F#@)!
MH@PKR4Y/O+"X)(9J--=.KS31&^CE-<B[EWPO_-?IVL^F_P6%@*]^FI"4=^LO
ML-QLT%VY6Z=8MAF/(& E-^RC(K8T] I!2*:<E #U:RO[T?PS]!!Z"EX?ES2>
M4><-^![OEXNOL%Q?O9_YKC])>=K?]2JY5\_-7+ NX]EE8AF"Y2WQS@,Q3(CL
M=-#(4F44?Y^J<=WA\7%:66\-(/$N\GT6X_(2[OL[VUZ+ Z]-Z8FJ/0HN<Y29
MD990S;ST4EM=_4 ZGKIQ_='QD3F0'EOT/G?WX3C=^SSX>0-U#1G0^^S9FX%&
M,-$R3V)&Z$G.$@E*=.T2+"BFE*C^0&W<WB%W.^>N;<1]*CH%OONZJ6N*Z^FW
MZ?IJ:T=!=$&7TFFM%-I\#QC/428(I49&JJ3GNO:CM_Y4_] =1)Z"TOVF\BP*
M;^J0_PT-XN(*X",LOTU+3+Q+ ,]FW4=VYU5)]GV>=[YX-Q>]4\R]:0Z9BLBI
M)LI&1Z0TZ.TH'DFR*4NG$[KC9C#D5V9F7.>VB0TQ)CP:V"?W=;"']])@Y//&
M;WM^]:C/T+,__#+=BTJ=],)13A*Z5$0:B@Y=&545G8:<;+"BNL=<F85QW>H1
M]\284&C1Z;YIK7.ZF[WU"=5:4 W@2A_?JL@ 4\X4LZ9#)))&2D),CH2D7/3)
MI2"/&S0Z9".J'8[/SK:2-S2\6VY(N'>U!UI'I!>9*Z\$0^F-J]"LFV"L##D;
M47TXS\G$MM[=ZBF0.>"Z#JC!%NW/=;N+DZW/@W]?J5_,@$'\5M^0$$.I.Q<D
M>(/Q1DZH1Z,M@4!U\J7 T[G*^Z].UYC-/-A;U/ZO2T3GM$C[&]P;&/INOMW6
M9"MC)35SC)K2(X'CX6F V(R'IS96V9RY]M0<967[4M)4,YFG@.+A?-YSZJ,!
MMWY7YYR;].C5W_SZ<ODXP@\IJ*0""E?%\@!$,^)2]*0\BG?"!0FJ?I^F)Y,Y
M;LA: 8_G4E&+1]I6FX#3S[;='U2[C<& I]W>1^R99PT<,A&LM+0!C89& B<4
MPR5PR@'CM=-+0S4SN)=DV5JA% W%,@IC.KO$J'8[U>@-4(..FW:LFZ'MB:4^
M$2,,BB-2&]APKO>32&VT$<)3,'0@,S:8TAHX(.]='J([D I+Z!!\+%5MW07B
M;W_&V25N\U<H]<THE>OTW_Y&$2%++1E0(KV5* %DWC&K26+)4NZ#R@->B=3B
M8MSC=6!$CZ+J%L_A[?? /6Z2=W]2]7?X Q[%>U]<JQ#1V[+HY#.-)LT;6JH&
M @D,F G.Q/3CO,:_RZ)LK7 O!GI^=?W#>Y.!72ED+U,#4GD_U\U13\7_9+8D
M=328^H,(3R.UT5?[3\'0@=378$IKT3J]A%5<3KO;Z$5>?X'GEZOI'*,E/T^W
MM40O%O,T+;_Q$M9^.CO)=IVT3H6^JWVY:ZIF.\G$(&9)#"OWG88+XKR-))O$
MO(=DJ*GM]311L_VA:&8.Z<9)>!;CY<5E=TGW$O(T3M<3P[W0WAO"@A-$LH#;
MOHQ !LDTRXQQ6WU<V/>I^AGJKI^"N<<MEJKJ[>GVTVW,P!P^ES6K!#,O_*H,
MEBQ_E(N1;W[6B6O]PB^75\AD][QGPJC/E)I,3"KMLKLQW]0'0ITP7 -R[&KO
MU*,(^QDJK/L@LK[V6CS4CVMF\[;<YI7PK,>Q?N)*9VK7<YC#,[3MR1A+9X;0
M% :(5#R14.8S>J J"!2B53].VYZMR^'G5R]F?K6YNIE8&95E6> .T:S,/-+$
M1YV)%5)XIP086_M-U %RVFW0\P0\?.=N_F3QMY /O+'I'0O7##W[<[J:T) @
MF!B(-C03:64FP3!*8F:!1:IU<+7;^N\E9N0@MY:Z'TU\K2'[!D!TG_Z7BPOT
M,R=,T8 > ".,:8S%HT(.BIB$LL"E81!X;?0\IF)DV-11[[;7U$_6(Z*E*TAX
M-O_<.9RW\[O_!A<!ELB#++GE0)(MF>7,-8K$*6*"9CSQG#*3WW. #BTP\CRQ
MGDI;5)9@8S8#?4UXC7ME-0D"[2:3EC!MT-MWQI9V"9Y$FJ2,B5&M:CLO.PD9
M-S8;ZL#I+_,&@+.['++[[L>OL^D:@]EO^*-2.UX4QB89C6P6GA/ANPBR$Y82
M));P-%,4F*[>;?>)-+9CG4Z$Q5&S["OIJ,4H?V=;OIMMO-AN->9W]II9;'5C
MZI$*&)*<85H8#B&K<[1 ]((&KITAF<HRD-/CJ9NU),#PV\$YJCBM;%R&;(%X
M^]G/K^[WTOE]N;C\>G,;/:$Z*R>!DJ =)U)*1:P'2[0K+9=LBLG4KE,ZAJZ&
M&Q8^!25[^U354DD#9_@]GFZ__.]36")17Z[>P#>8=7&22$E%XS))2J)+JW4B
MCHM4.K^P,NDAQ^J%",=1U@C4JB%B/^1JJ:<ET-T_=Q[S=QV?R42#UI*2#$5^
MP#D)O%0^)0=2.DU9]>FV3R*P&0A60\@^$%975TM8[-ILKCJ)L>M WG'/G*>.
MT% &W*3 B<_:$2ZTE#YP#.5K]ST_0$XC.*L/@GUPZZF11L'%KUGQ4EA@U!/A
MJ" RRD LRY)DIS-$JTQ.@QVIC\EII.?N*. Z12.-@DM<LZ)*"BH)3E)T9>8Y
ME\@*1XEY$84P@+%8[?EI!\AII&_M*. Z12,M@>OYU3VQO5K"?U["/%YU/H45
MG+%0!LL%="QD!B N>2#<@0I"4:U,[0>R1Y#5B"4[0T1013$M86T70]?;4E"E
MA6)X\'..<3N@"V =*Q7%63J6&&6^]GSN(\AJQ"6K!84C_/X^>FD4:JO;!.:U
MJ4XF\*"512=3*919S,3[:(C)PC"=7;1AL,/S %V-@*T6&(X),OMHIB6T[3H*
M'A=SOO";_G=W-S]62)FST$1 UNB"E&PE^@G$,\-$<MKJZM/>^M+<B*\W_/%[
M!I4V .'-U<^.E/I=X;$3.3AT9[TLK76D1VEJ3XDQ!K)))FE3NV?V=XEJQ%2>
M!2.+(176  )W%Z?O8!"/'VV8C9$D53JD.($[' -XHJUW/"5I0N:5D7@T<2-7
MW]8%Q5'/!_IJJ 'H[17;1',6C+"ZO+8(1-(R^CP:0406(5.P0OFS&;V11U\.
M"JTZ&C@=2HNUG]5IAW17.7%(5I8KJQ1H]*!S++WB!;$E#\5TX&C[E;"B-JZ.
MHZR5K,H()^H JAN[]O>F9>&NC649M2GP\ARC;%?!,[%*:Q*%]9%#CF)[6N9W
MNFLV=QH.H=#% -)MX 0\+*H)-1RE02T).0DBN=3$!1O0"&>CLA3,JMI7\X<I
M&KDWVW# &D AU4[%$:HWCRA$_,X(S3/4=-8C\FR5G@/)]2PCL 6ZDBX:/-A+
MGY.@T<UDI>=(0 ,+"<]]7KNX_"SUGQ6FQ799+X_615E(!*(K\G&6^&B@&Y^A
M>-(LT=KOP&KST$A:IR_ZAAP,_&15-^!DW$O:WK8?[5Y"=#=8 ;P'GH DY1V1
M*D*IV$4'"JCG2EE.TX"WS(\):@2$HV!E_UUT3\6UA,+^DMT6Q_7U&*4^"^ H
M8$HID;9K1^\244+1;(3A8;B*KZ&8:F0W] ?@<#:Y AH:R1?<-8?>7,?F8&S.
M5A!07)8V;X986IZH2>^B8IPE<UR+^-V?WPBVVD# C@1#'W7\7 ;W+M''M& ^
MF4@,Q>TNRT-&:RTE8'+FTIL(,;1K8Y]VBSY\NK4I)V,LF/Q<6^6%G\72;*Z\
M^%W,9J\6RS(S:Y)9!.]X)M+K8HLLQB\*PQGO S4@1:FM:7??[&;JISD_3L3M
M<!NI HA:VE7WDF+_F*Z_/&)^]9#[U4-9W1[#FS9Y6GLM8C!$EP-=&I&(,PJ(
MEYQ*&:5E<([G:KT9^6EV3PVP'E&L>%[DG+Q]OG8C0S^N_7(]ZB;:(XG?T3$N
M U!>SS<M\5_/;]JD3H!GR-8ZDFP61&:F,)RCG @;!4HN1Z"#)7B'9NZG\?<:
MVFS#(NSG/;^<M<RAEASUI8%[UJ5^&TV1LRY[)8(_RW/K\YQ?PQ<B_U1;JAYR
M>IY?O\W3&2^@:_0$/NZ#A[GH/4O'WX/78U90%HTW)(6$B%7)$L_PKSHI3E5@
MELK:,\6&O)R][M-UG8>['ORZ274(&T+D01,\,7 3E!X+CDE9IN1)!EKZ1^53
MM?KF[:"F$1^^+R+V=,_K*_X&CO"=G'27%XI[971FQ,GN\D*A62TOAZ.W4DO0
M2MG:O2?V$M-$4[S>VCX&1$\6?:L8NKYBX$(["):1 "$1*04G-@ Z"5)$BQ_E
M%#\+BEJX+*RD\&-@=(+TQ[[B>[^$5Y?%#;CFY*:7;?(I<"$)  ]$LE*KR)0E
M0>N@0%-#C?J>ZW/@\QM$Q"FZ6]05Y-A8^!^7LZMM-E;/YJE\?]/N^.:;U\Q)
M!390&PFEY3#WPB!SC)/L0V \.PO;<X;VH.2I*X^;-QD$/X,*OTED7?.AN0E6
M44UT>>$M2PSIC?1$2+"6:RCLG ZB,>W-&?3Z702=(.06P+)3,J;T&8B!$N%S
M*OF/TLQ.>1)H5IYEC!SH\>:F';,R DQZB[<!__?C95A-T]0OKS[ZVT[MFZ:'
MVFLN:29124VD58K8T@'%!"6*61:259\=NH^8!D^J_C%4'=&W@*$[\M_Z"_SR
M$\IIY6/WHF%SH%M?>@,G3;(#Y(AI6CK]!Y(S\]DSYF6J75GT?:I&GJM21_W;
MH*JKB[%/L;^5[G)%4C<S5Y]]7D*7E[TQMPJI-2Z23-%)E(PJ/))M1L=11IU4
M,>+QJ-/L>RN-#);*:ET,)>.Q =-Y )=A-HWO,JY^U_U(9&VR,QHWE3<E3<%)
M,,$3D,"MDH Q93[>0=ZQPLBS5@8$2!69MG!.[9UD%96B>)*7 %.51F]EBIXI
M![KP02NE1#2U,WW]AL0-=O4ZE*]31?0-8&C'""RJ$BLR(,$IB5&APZ^\*FU*
M$U<YJQ15]<XY/\R,N">I]_LSXIXBZQ:.HH]??+FWVQ&!WC;E,\[[,CZ/*8>^
M7@C$Z8QGJQ.!.RZ-D^GH8^E[JS61,#Y9G=M'4E79-F!:;C?19M04<O1U,2\5
M"-U&@F!]IHZ3R 5RI&TB7L5,J+<1CV\OZM>8'R3H*"S)'_68ZJV"!O"TQ<--
MBVZ74I+1D6 =;@J(@EBM ^&,*2'1U7>R=B2^DY!&#JS^BE[4EGH#T'D\EA-D
MBJP8:6UIE]9T>*)'9,#KH(WVD+:O,OL[.6T-/ZV@V&W_II>46X#)+BO\YO:]
M#3?,.["9Y"3P= ?&B',^D*! :0?H&;K:IN8P14<!2/U@9U9%)30 J6XWO%ZM
M+B&]O"RIAO>;)Q>=K_<6_NA^M)IDEC55Y0$7X[%,&]$D!*K00BN7,<!@H7I?
MB^,H:\+%KH*%7;-0ZRJF ;CM%-B[R_5J[><)F9R $9"#IL1D%I ?K8GC&;]2
ME'+DCD6H_6[F>S0U>!E6!V)5E=$JN-Y>EI,>P^#R&*![V?#"SV:0GE_=7"1?
M_^)J$F@NSQ$2H9*6]*K ^%69<CDMC5!*"FYJAWP]26XP=SD@- =29:O(_>U/
M6,;I"MXOIQ%N?WC+(YM$H9APAA&N6&G-B"ZL3[F\ +,J@K+2J[/4RWZ/T 93
M%P.BM*K:&L#FO9NNCB7T0SHG9&+!&JX4(UJ6CC"Y5-X8#,I42-8E[KG,M6=8
M[Z.EP4"CDA=80_AM@>C%8KZ:HD)NGKW"]%MY97CO_G22N)'9*DN2R$"D\9Y8
M 8IXYJ0SG(;Z P&?1.!1<-,_-MPJJ^ED#'Z#95C40F$7/&V"JH?;*92,@(N,
ML(B&62H9B+<!B)'"&VW11@=?&W'[B#D*7>9'1%<5\3=@S>Y5NFX.]7M!TR=8
M7DRTAIBCX,3',L Z2T^<Y!B:)P!0$HSCM:^HOT?34:BR/R"JJBIC[#OL>P;X
M.<PA3\NHB'=_S/'3OTR_OIE>3#<ZPYT3B_X^P\2S*!C(,J:FY#(-L\0;4?KT
M&9<D2C&%K:SOGAOMIZ]]%*;<#X2I<^B@ ?MU[R+DO5^^6W:W<ZE[_7QKDG,,
M,GBK" 6I2G\?69X$9<(4"X8Q:H*M78Y^!%G'I7OI#P2YH732 ,QNG]0_2__G
M<K4NU[]W\? DTFB]5I) 9!C!<":)%\H0;K-)EF=K4FV '23H.&C]B%<)]?3P
M=%"Y#:CF\+G ^=,6MD88QG'OQYNF,>@IE!]L&H!"_#*?_N<EK,XP<>.)E)QM
MK$8?"9VC/4N2/"9KR_2T+K=K'4:<G)&@A8[HTNGZSO599F=LQL>A&WNX"Q/^
MPMO%?/F@M]$.]5Q?="L'B6I*(&2WZ67K(C@")CG-DZ8NUDX1#\E/PRUBGH+*
M_09Z9 BTY#0\O[K]\K]/85D>S5R]@6\PZTK&*#COHP(B6/8H[L"(U7@HJD2I
MUCD(M5W'6W/0Q@'*&H'HZ$C:/WVCEEI; NO](_4Q?]>U:R!-9!H"8:9<IY=1
M9Q:<)-J+F)-43,;:%R9/(K 1Z%9$R!&=!.NHJR4L;IRV3F+BYN&82S$8)TB4
M5! I1,E^A4R0AV 4,.EL'@IYC\EI!&?U0; /;CTUT@"XMF."3_CONNUHJ><8
M)$H2$V5$6BE+BPY6'AT9&4)B5LG*R-I'2R-MB5L[>:NHKE$(7F]28W%S2CP$
MN!1X)GCOB<O,D*2M5@&4RJYVP\[]U(QKW>IH^P@(G2#ZL2]7MMGXN%Y._V-3
MIW/S\AZ<5HE'XF09=IM])"%(W'&:@<]&"QZW"@_V=3?XWE+MH>04A2X&DVZ#
M!J=CY=\7I;GUO3E607D/N>PK:8%(,)($$)$(ZW1 5]4%5[M@^2C"QCT-*P-L
M.)4TB+,/T]5_O%H">HVX!JS6'_SZ9@>)Y&F05!,>M$4C7@:W2L^)3@QT*'O+
MUZY0/IZZ<8N1SX2X2LII$':__?D5XAK2R^FW:8)YNL>9<M;;H"4ZG:)<$7%'
M@LJ*T"2YLQ@?.3ZTD[^?NG&KB\\$NTK*:0!V \5)=S>E4EL6%.>$\ZXAH$&Q
M:YU):8 1M;0.[&!9MH%X:F0Z2&N1;5-0:F!K':J$VS8HDYQDX"9HPI(K]U6&
MX6DE),E!1JIMUEK6GN_\%/H:R1$V@:PG%#SV4G/C$.Z*.47VSJ7$"$!"P47*
MB>49B+:>.BM=C*QVN%6ELO9'RSL.#]4GJ[,:/"M6'3WW,S^/\/$+P/JNJ<E=
M4<W[)7SUTX0<OUM_@>4+%#K^PD95/4J,:BS;NYZH.N^5BH?>+3_[^?2_-N/(
M%O/58H9$=-MQGM[?X_1=?C6=(P=3/[MM3W-7SZ$<5QJ8))Q%A<AT@5C*(NJA
M5/8R9E3U_D]5".\[5Z.H[ .N52[!<-V7Y=)J\;5KW8,QR'Q5>@YD'7,00(*7
M>*:P3<\!2Z)+LK3Q,<H?UP/VJ.7&]03.#Z;M^1R5%3)V$OY9^E:L!@IOD6&U
M0M'YV2M )D &F< SDEDJQ<T&V:$L$7"I%-%K$8T["E7[5ACWG!X92%7$WH"#
M>+TA7L_1KRD,36),QDBDFOJ02R-#='"M-D2I8"W*1(E0NU'6-@WCAN?C :N*
M3L:V1YUO<LW!C4%]=NVR;'R5:\=E$BDZO#8X$D4*R!4X8C&V(EIPEKEF/@AZ
ME($Z>LEQ4YLC6ZQA%-..";OF:3=+,F;!2O^2H!S&14QPX@PU).3,K LI^UR[
MQOT(LL9ML]",H:NFN=/!N%C[V5@1[>(K+-=7&-:5#HV=(_H6UH,&LP=7/$,<
M>SS'386P%'Q)_FEB>*E=5& 1BDP1K2VW7B@ 6OO:;M00]K;/P+7JWMVJ[CUJ
M>/WLGOXVEP\Y:ALSU4310,M[RD1\<.5Y.., I1(S5>_Z<"1M/T/4^Q3\/>H5
M,80.FSC\]W#S_.JV5(_+%*,H=5*N5$>EPE)I\",I:,ZLR)S73CT=0=;(#:0'
MP<.C\[VN<EK&V[U"!>9B3MJ)\N27E3&+$L,UW+'&1*II9 F@MAD\@JQQ\58=
M"L="[42]- "U6Q9NRCTE!*U9F1KL<2=Z=(*=MX9XFJBB*:7(:E=E;Y'0*(1.
M5?&.SO>GRKL!N+RZ7,ZGZ\MEB:->3?\L7]W,]*3,::F4QO"L=$C, @-Z&PWA
M6C!@#J+CM9&SGYIQT\9#@ZB2%AK TQOP*_BRF*77%U^7BV\;7_2FSW^2UC&4
M"X]E[HT6D7B!D7G@#&(,ADE9NVK@ #GCYHN'1E0M/30 J;VB>G-;':&S=,D9
M-+46B@\ DGC-%8K+:4@&8;']8F0XW^G-D^H%AQN-.*JK?IIJ6@;;[\O%:C4!
MD3AE'@BS&K<.!U]:2P0B1#"6":F#J-TNZ3!%C3I7)^K_6'@]71D-0.M9C)<7
ME[/2@>DE(!%QVND)OY[!=5;GV<5BN;[.^.QE?H)Q#9=@+&*%HDN0C"(^02+9
MLLAY-"+3VI>MM6AOU(VK ]=1%%R[&=@ IO,MK"=.<)>LQ,T9<)M*RRCQAG)D
MB3JG8X;ZC0P/T=.H\S>PV7RJ(GZ<F[&WI<1U/?T&U6_ 'GWR0#==ASEHZD:+
M"Z>M8HYX3\M,V^3+$SL@*$G%3$K2IY_R1NN^49]X!2$GSHCKXG(1*;&E:V.V
M441#:?:V]B%\?_V?X6;J*3C:MG$GZZ(!1_!A 4-7O?!V,8_7I0MHD96DP(BW
M!BT_BP(-M+4D6N]\%MES7OOEW$&"?H:"S3Y(JZ>M'_'I!/JTRTNX+?T:L,!D
MSTJ#%Y8<PV%3QR_C@6HN?*EH@M*T"D@PCA*JC:)*,T]9[2F031R_UXK:KIV^
M*?EB3F8%AJ+'[+LWK)($J2TQ $R88#U ;;MYF**?X8A^"M9VA,.U]-7 H?T;
MVKC%%:!9[0+\>\_[;AA2P6;*8B8@)'HA+ D2P'HBM.229ZT5KQWB?I>HG^'P
M[H/!NEH;NTK^>D?M?H=TPQ#7$(1Q0(Q*C$@I$[$,*(DT1>>9#6E['N&^%SQ'
MK/8S/+HX!5_#J*,1?'4^[KNOW=2Q^><=>P:T\X$C)T8Z2V1&][>;BN"9"I1Z
MFKAB3X'8]Q;\&5Y@]$595:4T<)Y>L[6#$6E=-PZ*V AEWC'&]3ZI2 Q#5GRB
M&*L-Y,B=B+S&WUI4\.%Z:JG%//*-U?Z]M$;H$=;N_)S>0>OWJ:L4DNX^O&ZQ
M XR+J&-YEYHIGE[9E3)+2C+Z1@+QXU2LW;+Z,$7U7B7L6:>TROC<[2#<<=V2
MGQ;O89D7RXM7BV5GA:^;)D5NO"P]OHSS&7= ]L1K$'BR1Z>\HY0-^&ZA+_7C
M!J<54;?_R<)9%=S B?K"?YVBN9S^%Z07B]5Z]2[_?=[5?J7K"T&TWK_]&6>7
M:#5>H4KNWT4_O[JY-'RWQ*_^#\3UIE^QTAR4CT1(@=&1*^_H9!3$>JM$ML'H
M'"IC?  V6GDT<5Y$;H^V&QD>#>R0:]*ORR C%Q*2%T1:H\NE0"[#N]&78598
MJ1S^6?L:\P$!XZ)R=#@\+EHX43=C1\T/?+5GGY?0;>5_3-=?/GV!WSV>:8O2
MIW:%<9N?W?SRJ\7E?./+__[ZPZN/\'6-8.$WK9.E!9J,(8)+3R1$29QFI46W
MRPJ%F:7SW_-+AR%M]'+#4S&R:$9A/PE<_XKLWXQ1D:6+H6>9F,P8D5YY8A4#
M8B%[';6W4IX5K_=H&[W@L"' GJJRGP"QSRX_7Z[*CI77_#OAD\^:$H]RP*.J
MU-=QF@D@]TSA(>;X=T/_H8@;O3BQ$<SV4EH#[F8/=__-;2%H4$K[1 5QO-P?
MY+)'7:1$"/ Y4,F9KIUEJ$%W*X]?1@VYS@Z 5BSU7H8[:S!)2NM($R<1(LHT
MJ$!L:3RN!9XZ7E$9MB=%?<?X'EZOR5S7@"#8988K:N3' -D'B##%:'9BN#2.
M.3PTK$U$*IZ(]PYP%U,P3B,#[+C+RJ>M.ZX!_!% =Y*&FCW6K^L')T'[+$&[
M,O;(HH_BT+%F+I(<E4$7RKAL:F=,#Q(TKC,Y&@[K*ZMYL_<""9JN)U3ZP!2Z
M*1I,N>Y5FGBP@:B8,Y=4:P:VCKW;+#AN<4;CANX$G31@X6YD5J*U%QB"+2Y@
M>5,"<'53 $"I%@I$)AQ*I@ME1 +H3()0.46GLS:UW]P?0]>X%1NCV[OJJFL
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M/%0):% 8J7)./,T8J6J>$D_>0*P]*/ A!?4*+SLY/K]Z,?.KZQP[>@:1<HS
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M!I^I( Q\(A(D(U[KA!%DT!)],Y?=L,[Z^[[0-DD\"AZJ"+,Y(FY\KIU\4&G
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M.#_XE]>'7:+66W"<<%[:JFJ#XK"<D1!C4BPH+J#VG,$'!'33(;NA'WFZ1CJ
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MT &P;D_JS82G]=[@#$QD&)^D=5?CTN+'42E)I&AD1;82(XW*4-I!1D]W[W7
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M41XH;;2O;B(#4<\&G7 .VFM72%DPK4WT>JT"#6##;=4=FPZ<T^U:*:ZO]N#
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M?&J;**JL&+J513O$SHTK,2\=(&2Y"(*^A-:"]EXX @95%OQXLKTV'?<+^Z9
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M9VXM,C R-3 S,S$N>'-D4$L! A0#%     @ \(.M6LB(?1S^%P  UN,  !4
M             ( !I1@! &%N9VXM,C R-3 S,S%?8V%L+GAM;%!+ 0(4 Q0
M   ( /"#K5H!/3%E;$\  &YX P 5              "  =8P 0!A;F=N+3(P
M,C4P,S,Q7V1E9BYX;6Q02P$"% ,4    " #P@ZU:6-CE,QGG  #&. D %0
M            @ %U@ $ 86YG;BTR,#(U,#,S,5]L86(N>&UL4$L! A0#%
M  @ \(.M6N;B 'VPE   %>L& !4              ( !P6<" &%N9VXM,C R
M-3 S,S%?<')E+GAM;%!+ 0(4 Q0    ( /"#K5HF%9I@$PP  #PG   <
M          "  :3\ @!E;&EC:6\M86UE;F1E9&%N9')E<W1A=&4N:'1M4$L!
M A0#%     @ \(.M6HD&_"N0!@  HA   !D              ( !\0@# &5L
M:6-I;S$P+7%X97AH:6)I=#,Q,2YH=&U02P$"% ,4    " #P@ZU: [J=@I0&
M  "Z$   &0              @ &X#P, 96QI8VEO,3 M<7AE>&AI8FET,S$R
M+FAT;5!+ 0(4 Q0    ( /"#K5HT0P!#4P,  -4%   9              "
M 8,6 P!E;&EC:6\Q,"UQ>&5X:&EB:70S,C$N:'1M4$L! A0#%     @ \(.M
M6F6V@U-9 P  \ 4  !D              ( !#1H# &5L:6-I;S$P+7%X97AH
A:6)I=#,R,BYH=&U02P4&      L "P#P @  G1T#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>angn-20250331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:angn="http://www.angn.com/20250331"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="angn-20250331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-05-09</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:AngionCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:A2024RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:JulySharesAndJulyCommonWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:The2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:Inducement2024PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-01</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-05</startDate>
            <endDate>2025-03-05</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-02</startDate>
            <endDate>2024-07-02</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-02</startDate>
            <endDate>2024-07-02</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-02</startDate>
            <endDate>2024-07-02</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="agreement">
        <measure>angn:agreement</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="entity">
        <measure>angn:entity</measure>
    </unit>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-26">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-28">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-29">0001601485</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-40"
      decimals="INF"
      id="f-279"
      unitRef="number">0.1</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39990</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">Elicio Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">11-3430072</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">451 D Street, 5th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">02210</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">209-0050</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">ELTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-23">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="c-1" id="f-24">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-25" unitRef="shares">15996976</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-31" unitRef="usd">18351000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-32" unitRef="usd">17618000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-3" decimals="-3" id="f-33" unitRef="usd">683000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-4" decimals="-3" id="f-34" unitRef="usd">1178000</us-gaap:RestrictedCashCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-35" unitRef="usd">1901000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-36" unitRef="usd">1897000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-37" unitRef="usd">20935000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-38" unitRef="usd">20693000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-39" unitRef="usd">430000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">483000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-41" unitRef="usd">5481000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">5706000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-3" decimals="-3" id="f-43" unitRef="usd">698000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">696000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-3" decimals="-3" id="f-45" unitRef="usd">600000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">600000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-47" unitRef="usd">28144000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">28178000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-49" unitRef="usd">4037000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">1038000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-51" unitRef="usd">5770000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">8415000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-53" unitRef="usd">680000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">1169000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-55" unitRef="usd">926000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">901000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-57" unitRef="usd">11413000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">11523000</us-gaap:LiabilitiesCurrent>
    <angn:WarrantLiability contextRef="c-3" decimals="-3" id="f-59" unitRef="usd">2962000</angn:WarrantLiability>
    <angn:WarrantLiability contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">2828000</angn:WarrantLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-61" unitRef="usd">4865000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">5105000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="c-3" decimals="-3" id="f-63" unitRef="usd">0</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">20034000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-65" unitRef="usd">19240000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">39490000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-67" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-68" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-69"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-70"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-71" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-72" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-73" unitRef="shares">15983191</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-74" unitRef="shares">11043837</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-75" unitRef="shares">15968736</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-76" unitRef="shares">11029382</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-77" unitRef="usd">160000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">110000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="INF" id="f-79" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-80" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-3" decimals="-3" id="f-81" unitRef="usd">150000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">150000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-83" unitRef="usd">214348000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">183004000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-85" unitRef="usd">-144000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">-175000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-87" unitRef="usd">-205310000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">-194101000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-89" unitRef="usd">8904000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-90" unitRef="usd">-11312000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-91" unitRef="usd">28144000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-92" unitRef="usd">28178000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-93" unitRef="usd">7778000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-94" unitRef="usd">7559000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-95" unitRef="usd">2958000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-96" unitRef="usd">2682000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-97" unitRef="usd">10736000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">10241000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-99" unitRef="usd">-10736000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-100" unitRef="usd">-10241000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-101" unitRef="usd">507000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">1278000</us-gaap:FairValueAdjustmentOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-103" unitRef="usd">0</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-5" decimals="-3" id="f-104" unitRef="usd">-578000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-1" decimals="-3" id="f-105" unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">3000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-107" unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-5" decimals="-3" id="f-108" unitRef="usd">153000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InterestIncomeOperatingAndNonoperating contextRef="c-1" decimals="-3" id="f-109" unitRef="usd">210000</us-gaap:InterestIncomeOperatingAndNonoperating>
    <us-gaap:InterestIncomeOperatingAndNonoperating contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">150000</us-gaap:InterestIncomeOperatingAndNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-111" unitRef="usd">176000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-3" id="f-112" unitRef="usd">36000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-113" unitRef="usd">-473000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-114" unitRef="usd">-1586000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-115" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-116" unitRef="usd">-11827000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-117" unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">-73000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-119" unitRef="usd">-11178000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-120" unitRef="usd">-11900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-121"
      unitRef="usdPerShare">-0.87</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-122"
      unitRef="usdPerShare">-0.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-123"
      unitRef="usdPerShare">-1.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-124"
      unitRef="usdPerShare">-1.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-125" unitRef="shares">12950574</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-126" unitRef="shares">12950574</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-127" unitRef="shares">10273925</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-128" unitRef="shares">10273925</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-129" unitRef="shares">11043837</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-130" unitRef="usd">110000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-7" decimals="INF" id="f-131" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-132" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-133" unitRef="usd">183004000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-134" unitRef="usd">-175000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-135" unitRef="usd">-194101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-136" unitRef="usd">-11312000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-1" decimals="-5" id="f-137" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-11"
      decimals="INF"
      id="f-138"
      unitRef="shares">106823</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-11" decimals="-3" id="f-139" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-12" decimals="-3" id="f-140" unitRef="usd">834000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-141" unitRef="usd">835000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-11"
      decimals="INF"
      id="f-142"
      unitRef="shares">1628</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-12" decimals="-3" id="f-143" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="c-1" decimals="-5" id="f-145" unitRef="usd">300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-13" decimals="0" id="f-146" unitRef="shares">3500573</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-13" decimals="-3" id="f-147" unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-14" decimals="-3" id="f-148" unitRef="usd">20141000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-15" decimals="-3" id="f-149" unitRef="usd">20176000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-16" decimals="-5" id="f-150" unitRef="usd">800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-11" decimals="INF" id="f-151" unitRef="usd">1261830</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-11" decimals="-3" id="f-152" unitRef="usd">13000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-12" decimals="-3" id="f-153" unitRef="usd">9130000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-1" decimals="-3" id="f-154" unitRef="usd">9143000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-11"
      decimals="INF"
      id="f-155"
      unitRef="shares">68500</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-11" decimals="-3" id="f-156" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-12" decimals="-3" id="f-157" unitRef="usd">715000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-1" decimals="-3" id="f-158" unitRef="usd">716000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-12" decimals="-3" id="f-159" unitRef="usd">517000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">517000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-17" decimals="-3" id="f-161" unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-18" decimals="-3" id="f-163" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-164" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-19"
      decimals="INF"
      id="f-165"
      unitRef="shares">15983191</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-166" unitRef="usd">160000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-20"
      decimals="INF"
      id="f-167"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-168" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-169" unitRef="usd">214348000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-170" unitRef="usd">-144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-171" unitRef="usd">-205310000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-172" unitRef="usd">8904000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-24"
      decimals="INF"
      id="f-173"
      unitRef="shares">9603723</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-174" unitRef="usd">96000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-25"
      decimals="INF"
      id="f-175"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-176" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-177" unitRef="usd">153827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-178" unitRef="usd">-197000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-179" unitRef="usd">-142203000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-180" unitRef="usd">11373000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-5" decimals="-5" id="f-181" unitRef="usd">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-30"
      decimals="INF"
      id="f-182"
      unitRef="shares">615363</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-30" decimals="-3" id="f-183" unitRef="usd">6000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-31" decimals="-3" id="f-184" unitRef="usd">5056000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-5" decimals="-3" id="f-185" unitRef="usd">5062000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-30"
      decimals="INF"
      id="f-186"
      unitRef="shares">903</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-31" decimals="-3" id="f-187" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-5" decimals="-3" id="f-188" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-31" decimals="-3" id="f-189" unitRef="usd">324000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-190" unitRef="usd">324000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-32" decimals="-3" id="f-191" unitRef="usd">-73000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-192" unitRef="usd">-73000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-3" id="f-193" unitRef="usd">-11827000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-194" unitRef="usd">-11827000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-34"
      decimals="INF"
      id="f-195"
      unitRef="shares">10219989</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-196" unitRef="usd">102000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-35"
      decimals="INF"
      id="f-197"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-198" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-199" unitRef="usd">159218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-200" unitRef="usd">-270000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-201" unitRef="usd">-154030000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-202" unitRef="usd">4870000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-203" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-204" unitRef="usd">-11827000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-205" unitRef="usd">53000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-3" id="f-206" unitRef="usd">82000</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-207" unitRef="usd">225000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-5" decimals="-3" id="f-208" unitRef="usd">208000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <angn:InterestExpenseNoncash contextRef="c-1" decimals="-3" id="f-209" unitRef="usd">107000</angn:InterestExpenseNoncash>
    <angn:InterestExpenseNoncash contextRef="c-5" decimals="-3" id="f-210" unitRef="usd">0</angn:InterestExpenseNoncash>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-1" decimals="-3" id="f-211" unitRef="usd">35000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-5" decimals="-3" id="f-212" unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-213" unitRef="usd">507000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-5" decimals="-3" id="f-214" unitRef="usd">1278000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-215" unitRef="usd">517000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-3" id="f-216" unitRef="usd">324000</us-gaap:ShareBasedCompensation>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-217" unitRef="usd">0</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-5" decimals="-3" id="f-218" unitRef="usd">-578000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-219" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-5" decimals="-3" id="f-220" unitRef="usd">3000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-221" unitRef="usd">4000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-5" decimals="-3" id="f-222" unitRef="usd">-1085000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-5" decimals="-3" id="f-224" unitRef="usd">-160000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">2999000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-5" decimals="-3" id="f-226" unitRef="usd">-3264000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <angn:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">-2645000</angn:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <angn:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities contextRef="c-5" decimals="-3" id="f-228" unitRef="usd">-432000</angn:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">-489000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-5" decimals="-3" id="f-230" unitRef="usd">-67000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">-215000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-5" decimals="-3" id="f-232" unitRef="usd">-244000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-233" unitRef="usd">-10119000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-3" id="f-234" unitRef="usd">-12122000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-236" unitRef="usd">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-3" id="f-238" unitRef="usd">3000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">343000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-5" decimals="-3" id="f-240" unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">9143000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-5" decimals="-3" id="f-242" unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-5" decimals="-3" id="f-244" unitRef="usd">5962000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-245" unitRef="usd">835000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-5" decimals="-3" id="f-246" unitRef="usd">5062000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-247" unitRef="usd">7000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-5" decimals="-3" id="f-248" unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">10328000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-3" id="f-250" unitRef="usd">11024000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-251" unitRef="usd">31000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-252" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-253" unitRef="usd">240000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-3" id="f-254" unitRef="usd">-1095000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-255" unitRef="usd">19492000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-29" decimals="-3" id="f-256" unitRef="usd">14301000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-257" unitRef="usd">19732000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-39" decimals="-3" id="f-258" unitRef="usd">13206000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-259" unitRef="usd">18351000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-39" decimals="-3" id="f-260" unitRef="usd">11853000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-3" decimals="-3" id="f-261" unitRef="usd">1381000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-39" decimals="-3" id="f-262" unitRef="usd">1353000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-263" unitRef="usd">19732000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-39" decimals="-3" id="f-264" unitRef="usd">13206000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <angn:FairValueOfPreFundedWarrants contextRef="c-1" decimals="-3" id="f-265" unitRef="usd">0</angn:FairValueOfPreFundedWarrants>
    <angn:FairValueOfPreFundedWarrants contextRef="c-5" decimals="-3" id="f-266" unitRef="usd">6579000</angn:FairValueOfPreFundedWarrants>
    <angn:FairValueOfCommonStockWarrants contextRef="c-1" decimals="-3" id="f-267" unitRef="usd">373000</angn:FairValueOfCommonStockWarrants>
    <angn:FairValueOfCommonStockWarrants contextRef="c-5" decimals="-3" id="f-268" unitRef="usd">0</angn:FairValueOfCommonStockWarrants>
    <angn:SettlementOfPromissoryNotesPayable contextRef="c-1" decimals="-3" id="f-269" unitRef="usd">20034000</angn:SettlementOfPromissoryNotesPayable>
    <angn:SettlementOfPromissoryNotesPayable contextRef="c-5" decimals="-3" id="f-270" unitRef="usd">0</angn:SettlementOfPromissoryNotesPayable>
    <angn:NonCashVestingOfRestrictedCommonStock contextRef="c-1" decimals="-3" id="f-271" unitRef="usd">0</angn:NonCashVestingOfRestrictedCommonStock>
    <angn:NonCashVestingOfRestrictedCommonStock contextRef="c-5" decimals="-3" id="f-272" unitRef="usd">11000</angn:NonCashVestingOfRestrictedCommonStock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-273">Description of the Business and Financial Condition&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Elicio Therapeutics, Inc. (&#x201c;Elicio&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biotechnology company pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#x201c;ESC&#x201d;), an investment company, Elicio Operating Company, Inc. (&#x201c;Former Elicio&#x201d;), and Elicio Australia Pty Ltd. (&#x201c;Elicio Pty&#x201d;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#x201c;Elicio&#x201d; throughout these condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Liquidity and Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has experienced net losses and negative cash flows from operating activities since inception. As of March&#160;31, 2025, the Company had an accumulated deficit of $205.3 million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of March&#160;31, 2025, the Company had $18.4 million in cash and cash equivalents. The Company&#x2019;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it might have to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-274" unitRef="usd">-205300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-275" unitRef="usd">18400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-276">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Please refer to "Note 2 &#x2013; Summary of Basis of Significant Accounting Policies," to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) promulgated by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The consolidated interim financial statements include the accounts of the Company and its wholly owned subsidiaries, Elicio Pty, ESC, and Former Elicio.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;This ASU requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#x2019;s consolidated financial statements, once adopted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2024-03&#x201d;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes of the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amount that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#x2019;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact of this adoption on the consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-277">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) promulgated by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The consolidated interim financial statements include the accounts of the Company and its wholly owned subsidiaries, Elicio Pty, ESC, and Former Elicio.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-278">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;This ASU requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#x2019;s consolidated financial statements, once adopted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2024-03&#x201d;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes of the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amount that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#x2019;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments&lt;/span&gt;. This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact of this adoption on the consolidated financial statements and related disclosures</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-280">Fair Value Measurements&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;&#160;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash equivalents at March&#160;31, 2025 and December&#160;31, 2024 were held in U.S. Treasury securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There were no transfers made among the three levels in the fair value hierarchy during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; The fair value of the warrants assumed in the merger (the &#x201c;Merger&#x201d;) with Angion Biomedica Corp. (&#x201c;Angion&#x201d; and the warrants, the &#x201c;Angion warrants&#x201d;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. The following table presents a summary of changes in Level 3 in the fair value of the Company&#x2019;s common stock warrant liability (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the Angion warrants issued by the Company has been estimated using Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the assumed Angion warrant liability was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average strike price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contractual term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Volatility (annual)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;79.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Risk-free rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dividend yield (per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2024, the Company closed an underwritten public offering (the &#x201c;Public Offering&#x201d;), consisting of (i) 500,000 shares of the Company&#x2019;s common stock (the &#x201c;July Shares&#x201d;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#x201c;July Pre-Funded Warrants&#x201d;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock (the &#x201c;July Common Warrants&#x201d;). Each July Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July Pre-Funded Warrants. As of reporting period end, the outstanding July Pre-Funded Warrants are equity classified. Refer to Note 6 and 8 for further discussion. Each July Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July Common Warrants. At the Company&#x2019;s annual stockholder&#x2019;s meeting in November 2024, the Company obtained stockholder approval for GKCC, LLC (&#x201c;GKCC&#x201d;), together with its affiliates, to exceed the 19.99% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) (&#x201c;Stockholder Approval&#x201d;). As a result of obtaining Stockholder Approval, certain July Common Warrants are equity classified while the remainder of the outstanding July Common Warrants are liability classified and are subsequently remeasured at each reporting period end. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company identified the July Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. For the three months ended March 31, 2025, the Company recognized a loss of $0.5 million in fair value remeasurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company records the change in the fair value of the outstanding warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-281">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;&#160;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-41" decimals="-3" id="f-282" unitRef="usd">11715000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-42" decimals="-3" id="f-283" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-43" decimals="-3" id="f-284" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-44" decimals="-3" id="f-285" unitRef="usd">11715000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-41" decimals="-3" id="f-286" unitRef="usd">11715000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-45" decimals="-3" id="f-287" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-46" decimals="-3" id="f-288" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-44" decimals="-3" id="f-289" unitRef="usd">11715000</us-gaap:AssetsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-47" decimals="-3" id="f-290" unitRef="usd">0</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-45" decimals="-3" id="f-291" unitRef="usd">2960000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-46" decimals="-3" id="f-292" unitRef="usd">2000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-44" decimals="-3" id="f-293" unitRef="usd">2962000</angn:WarrantsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-41" decimals="-3" id="f-294" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-45" decimals="-3" id="f-295" unitRef="usd">2960000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-46" decimals="-3" id="f-296" unitRef="usd">2000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-44" decimals="-3" id="f-297" unitRef="usd">2962000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-47" decimals="-3" id="f-298" unitRef="usd">12100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-42" decimals="-3" id="f-299" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-43" decimals="-3" id="f-300" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-48" decimals="-3" id="f-301" unitRef="usd">12100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-47" decimals="-3" id="f-302" unitRef="usd">12100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-42" decimals="-3" id="f-303" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-43" decimals="-3" id="f-304" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-48" decimals="-3" id="f-305" unitRef="usd">12100000</us-gaap:AssetsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-47" decimals="-3" id="f-306" unitRef="usd">0</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-42" decimals="-3" id="f-307" unitRef="usd">2827000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-43" decimals="-3" id="f-308" unitRef="usd">1000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-48" decimals="-3" id="f-309" unitRef="usd">2828000</angn:WarrantsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-47" decimals="-3" id="f-310" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-42" decimals="-3" id="f-311" unitRef="usd">2827000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-43" decimals="-3" id="f-312" unitRef="usd">1000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-48" decimals="-3" id="f-313" unitRef="usd">2828000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-314">The following table presents a summary of changes in Level 3 in the fair value of the Company&#x2019;s common stock warrant liability (in thousands):&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-49" decimals="-3" id="f-315" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-50" decimals="-3" id="f-316" unitRef="usd">11000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-51" decimals="-3" id="f-317" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-52" decimals="-3" id="f-318" unitRef="usd">-10000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-53" decimals="-3" id="f-319" unitRef="usd">2000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-49" decimals="-3" id="f-320" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-321">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the assumed Angion warrant liability was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average strike price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contractual term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Volatility (annual)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;79.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Risk-free rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dividend yield (per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-54"
      decimals="2"
      id="f-322"
      unitRef="usdPerShare">76.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-55"
      decimals="2"
      id="f-323"
      unitRef="usdPerShare">76.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-56" id="f-324">P3Y4M24D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-57" id="f-325">P3Y8M12D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-58" decimals="3" id="f-326" unitRef="number">0.791</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-59" decimals="3" id="f-327" unitRef="number">0.749</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-60" decimals="3" id="f-328" unitRef="number">0.040</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-61" decimals="3" id="f-329" unitRef="number">0.044</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-62" decimals="3" id="f-330" unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-63" decimals="3" id="f-331" unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-64" decimals="0" id="f-332" unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-65" decimals="0" id="f-333" unitRef="shares">1800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-66" decimals="0" id="f-334" unitRef="shares">2300000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-67"
      decimals="2"
      id="f-335"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-66"
      decimals="2"
      id="f-336"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:SaleOfStockBeneficialOwnershipLimitationPercentage contextRef="c-3" decimals="INF" id="f-337" unitRef="number">0.1999</angn:SaleOfStockBeneficialOwnershipLimitationPercentage>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-68" decimals="-5" id="f-338" unitRef="usd">-500000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-339">Balance Sheet Components&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Prepaid and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid research and development contract services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advanced professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid insurance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Depreciation expense for each of the three months ended March 31, 2025 and 2024 was $0.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Other long-term prepaid assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $0.6 million for both March&#160;31, 2025 and December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Accrued Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="c-1" id="f-340">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Prepaid and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid research and development contract services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advanced professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid insurance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <angn:PrepaidResearchAndDevelopmentExpenses contextRef="c-3" decimals="-3" id="f-341" unitRef="usd">1331000</angn:PrepaidResearchAndDevelopmentExpenses>
    <angn:PrepaidResearchAndDevelopmentExpenses contextRef="c-4" decimals="-3" id="f-342" unitRef="usd">1206000</angn:PrepaidResearchAndDevelopmentExpenses>
    <angn:AdvancedProfessionalFees contextRef="c-3" decimals="-3" id="f-343" unitRef="usd">297000</angn:AdvancedProfessionalFees>
    <angn:AdvancedProfessionalFees contextRef="c-4" decimals="-3" id="f-344" unitRef="usd">243000</angn:AdvancedProfessionalFees>
    <us-gaap:PrepaidInsurance contextRef="c-3" decimals="-3" id="f-345" unitRef="usd">157000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-4" decimals="-3" id="f-346" unitRef="usd">347000</us-gaap:PrepaidInsurance>
    <angn:OtherPrepaidExpensesAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-347" unitRef="usd">116000</angn:OtherPrepaidExpensesAndOtherAssetsCurrent>
    <angn:OtherPrepaidExpensesAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-348" unitRef="usd">101000</angn:OtherPrepaidExpensesAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-349" unitRef="usd">1901000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-350" unitRef="usd">1897000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-351">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-69" decimals="-3" id="f-352" unitRef="usd">1661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-70" decimals="-3" id="f-353" unitRef="usd">1661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-71" decimals="-3" id="f-354" unitRef="usd">242000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-72" decimals="-3" id="f-355" unitRef="usd">242000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-73" decimals="-3" id="f-356" unitRef="usd">132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-74" decimals="-3" id="f-357" unitRef="usd">132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-358" unitRef="usd">2035000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-359" unitRef="usd">2035000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-360" unitRef="usd">1605000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-361" unitRef="usd">1552000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-362" unitRef="usd">430000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-363" unitRef="usd">483000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-364" unitRef="usd">100000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-5" id="f-365" unitRef="usd">100000</us-gaap:Depreciation>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-3" decimals="-5" id="f-366" unitRef="usd">600000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-4" decimals="-5" id="f-367" unitRef="usd">600000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-368">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-3" id="f-369" unitRef="usd">740000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-370" unitRef="usd">1167000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-371" unitRef="usd">698000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-372" unitRef="usd">2312000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <angn:AccruedResearchAndDevelopmentCurrent contextRef="c-3" decimals="-3" id="f-373" unitRef="usd">4302000</angn:AccruedResearchAndDevelopmentCurrent>
    <angn:AccruedResearchAndDevelopmentCurrent contextRef="c-4" decimals="-3" id="f-374" unitRef="usd">4910000</angn:AccruedResearchAndDevelopmentCurrent>
    <angn:AccruedOtherOperatingLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-375" unitRef="usd">30000</angn:AccruedOtherOperatingLiabilitiesCurrent>
    <angn:AccruedOtherOperatingLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-376" unitRef="usd">26000</angn:AccruedOtherOperatingLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-377" unitRef="usd">5770000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-378" unitRef="usd">8415000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="c-1" id="f-379">Research Grant&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#x201c;GI&#x201d;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $2.8 million award, $2.3 million was received in September 2022 and the remaining $0.5 million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $0.5 million payment was applied as a credit to the second grant agreement described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $3.1 million, with such amount received net of the $0.5 million credit, described above.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; For the three months ended March 31, 2024, the Company incurred &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$1.4&#160;million in research and development expenses related to this project, of which $0.1&#160;million was reimbursed from available grant funds. As of March 31, 2024, the grant funds available for the second grant agreement were&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$0.7 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and the deferred research obligation was &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$0.6 million. The second grant agreement activities were completed in the third quarter of 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $1.5 million. The grant funds available as of March&#160;31, 2025 were $0.7 million which are reflected in restricted cash in the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;accompanying condensed consolidated balance sheets. The deferred research obligation as of March&#160;31, 2025 was $0.7 million, which was reflected in the deferred research obligation in the accompanying condensed consolidated balance sheets. For the three months ended March 31, 2025, the Company incurred $0.5 million in research and development expenses related to this project, of which $0.5 million was reimbursed from available grant funds. &lt;/span&gt;&lt;/div&gt;The award money for the three agreements was earned and recognized as a contra research and development expense as the expenses were incurred.</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-75" decimals="-5" id="f-380" unitRef="usd">2800000</angn:ResearchAndDevelopmentArrangementGrant>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-75" decimals="-5" id="f-381" unitRef="usd">2300000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-76" decimals="-5" id="f-382" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-76" decimals="-5" id="f-383" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-77" decimals="-5" id="f-384" unitRef="usd">3100000</angn:ResearchAndDevelopmentArrangementGrant>
    <angn:ResearchAndDevelopmentArrangementCredit contextRef="c-77" decimals="-5" id="f-385" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementCredit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-78" decimals="-5" id="f-386" unitRef="usd">1400000</us-gaap:ResearchAndDevelopmentExpense>
    <angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds contextRef="c-79" decimals="-5" id="f-387" unitRef="usd">100000</angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-80" decimals="-5" id="f-388" unitRef="usd">700000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-80" decimals="0" id="f-389" unitRef="usd">600000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-81" decimals="-5" id="f-390" unitRef="usd">1500000</angn:ResearchAndDevelopmentArrangementGrant>
    <us-gaap:RestrictedCashCurrent contextRef="c-82" decimals="-5" id="f-391" unitRef="usd">700000</us-gaap:RestrictedCashCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-82" decimals="-5" id="f-392" unitRef="usd">700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-83" decimals="-5" id="f-393" unitRef="usd">500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-83" decimals="-5" id="f-394" unitRef="usd">500000</us-gaap:ResearchAndDevelopmentExpense>
    <angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds contextRef="c-83" decimals="-5" id="f-395" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds>
    <angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds contextRef="c-83" decimals="-5" id="f-396" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds>
    <angn:NumberOfResearchGrantAgreements
      contextRef="c-3"
      decimals="INF"
      id="f-397"
      unitRef="agreement">3</angn:NumberOfResearchGrantAgreements>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-398">Convertible Preferred Stock, Common Stock and Stockholders' Equity&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Authorized Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes 300,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;At-The-Market Equity Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In May 2022, the Company filed a registration statement on Form S-3 (the &#x201c;Prior Shelf Registration St&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;atement&#x201d;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $100&#160;million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp;amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $21 million of shares of common stock from time to time in &#x201c;at-the-market&#x201d; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#x201c;2022 ATM Program"). During the three months ended March 31, 2024, the Company issued and sold a total of 615,363 shares of common stock under the 2022 ATM Program for aggregate net sale proceeds of approximately $5.1 million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2024, the Company filed a registration statement on Form S-3 (the &#x201c;2024 Registration Statement&#x201d;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, the Company entered into the Capital on Demand&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; Sales Agreement with JonesTrading Institutional Services LLC, as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#x201c;at-the-market&#x201d; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#x201c;2024 ATM Program&#x201d;). During the three months ended March 31, 2025, the Company issued and sold 106,823 shares of common stock under the 2024 ATM Program for aggregate net sale proceeds of approximately $0.8 million after deducting sales commissions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2024, the Company entered into a subscription agreement (the &#x201c;March Subscription Agreement&#x201d;) with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors, providing for the issuance and sale by the Company to GKCC of pre-funded warrants (the &#x201c;March Pre-Funded Warrants&#x201d;) (the &#x201c;March Offering&#x201d;). Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. The net proceeds to the Company from the March Offering were approximately $6.0 million. Refer to Note 8 for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Public Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2024, the Company closed the Public Offering, which resulted in net proceeds of $10.9&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Public Offering consisted of the July Shares or in lieu thereof, the July Pre-Funded Warrants, and accompanying July Common Warrants. Each July Share and accompanying July Common Warrant were sold together at a combined offering price of $5.00 per July Share and accompanying July Common Warrant, and each July Pre-Funded Warrant and accompanying July Common Warrant were sold together at a combined offering price of $4.99 per July Pre-Funded Warrant and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;accompanying July Common Warrant, which represented the combined purchase price per July Pre-Funded Warrant and accompanying July Common Warrant less the $0.01 per share exercise price for each such July Pre-Funded Warrant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The July Common Warrants have an exercise price of $5.00 per share, are immediately exercisable and will expire five years from the issuance date. Refer to Note 3 and 8 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#x201c;Investor&#x201d; and, collectively, the &#x201c;Investors&#x201d;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the &#x201c;January Offering&#x201d;): (i) an aggregate of 1,261,830 shares of the Company&#x2019;s common stock (the &#x201c;January Shares&#x201d;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#x201c;January Common Warrants&#x201d;). Each January Share and accompanying January Common Warrant were sold together at a combined offering price of $7.925. The January Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the initial exercise date. The January Offering resulted in net proceeds of $9.2&#160;million to the Company after deducting the placement agent&#x2019;s fees and related offering expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-399" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-400"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-401" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-402"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-84" decimals="-6" id="f-403" unitRef="usd">100000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-85" decimals="-6" id="f-404" unitRef="usd">21000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-86" decimals="0" id="f-405" unitRef="shares">615363</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-86" decimals="-5" id="f-406" unitRef="usd">5100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-87" decimals="-6" id="f-407" unitRef="usd">200000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-88" decimals="-6" id="f-408" unitRef="usd">40000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-89" decimals="0" id="f-409" unitRef="shares">106823</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-89" decimals="-5" id="f-410" unitRef="usd">800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-90"
      decimals="2"
      id="f-411"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-91" decimals="-5" id="f-412" unitRef="usd">6000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-64" decimals="-5" id="f-413" unitRef="usd">10900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-92"
      decimals="2"
      id="f-414"
      unitRef="usdPerShare">5.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-93"
      decimals="2"
      id="f-415"
      unitRef="usdPerShare">4.99</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-65"
      decimals="2"
      id="f-416"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-66"
      decimals="INF"
      id="f-417"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-66" id="f-418">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-94" decimals="0" id="f-419" unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-95"
      decimals="INF"
      id="f-420"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-96"
      decimals="3"
      id="f-421"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-96"
      decimals="1"
      id="f-422"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-97" id="f-423">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-98" decimals="-5" id="f-424" unitRef="usd">9200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-425">Stock-Based Compensation&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of March 31, 2025, there is an aggregate of 1,035,544 shares of common stock available for issuance under the Company&#x2019;s equity incentive plans, including 471,889 shares available for future grants under the Company&#x2019;s 2021 Incentive Award Plan, 176,323 shares available for future grants under the Company&#x2019;s 2022 Equity Incentive Plan, as amended, and 387,332 shares available for future grants issuance under the Company&#x2019;s 2024 Inducement Incentive Award Plan. Refer to "Note 8 &#x2013; Stock-Based Compensation," to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information and activity related to the Company&#x2019;s stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Remaining Contractual Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total &lt;br/&gt;Intrinsic Value &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,890,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;15.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;378,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options exercised &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Forfeited (unvested)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(2,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,265,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;14.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,060,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;23.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock price and the exercise price of the stock options. 378,375 stock options were granted during the three months ended March 31, 2025. The weighted average grant date fair value per share for the stock option grants during the three months ended March 31, 2025 was $8.92. As of March&#160;31, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $5.4 million, which the Company expects to recognize over a weighted-average period of approximately 2.93 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#x2019;s stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.245%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Expected term in years (for employees)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.50 - 6.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;106.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;79.5% - 79.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the condensed consolidated financial statements for the period ended March&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#x2019;s initial public offering. The offering period and purchase period was determined by Angion&#x2019;s board of directors. No offering periods or purchasing periods were active as of March&#160;31, 2025. As of March&#160;31, 2025, 275,309 shares remained available for purchase under the ESPP and no offerings have been authorized.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-3" decimals="INF" id="f-426" unitRef="shares">1035544</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-99"
      decimals="INF"
      id="f-427"
      unitRef="shares">471889</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-100"
      decimals="INF"
      id="f-428"
      unitRef="shares">176323</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-101"
      decimals="INF"
      id="f-429"
      unitRef="shares">387332</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-430">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information and activity related to the Company&#x2019;s stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Remaining Contractual Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total &lt;br/&gt;Intrinsic Value &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,890,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;15.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;378,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options exercised &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Forfeited (unvested)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(2,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,265,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;14.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,060,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;23.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="INF" id="f-431" unitRef="shares">1890932</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-432"
      unitRef="usdPerShare">15.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-102" id="f-433">P6Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-434" unitRef="usd">920000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-435" unitRef="shares">378375</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-436"
      unitRef="usdPerShare">8.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-437" unitRef="shares">1628</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-438"
      unitRef="usdPerShare">4.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-439" unitRef="shares">2226</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-440"
      unitRef="usdPerShare">6.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-3" decimals="INF" id="f-441" unitRef="shares">2265453</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-442"
      unitRef="usdPerShare">14.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-443">P7Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-3" decimals="-3" id="f-444" unitRef="usd">2248000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-3" decimals="INF" id="f-445" unitRef="shares">1060694</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-446"
      unitRef="usdPerShare">23.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-447">P5Y2M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-3" decimals="-3" id="f-448" unitRef="usd">1101000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-449" unitRef="shares">378375</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-450"
      unitRef="usdPerShare">8.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-3" decimals="-5" id="f-451" unitRef="usd">5400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-452">P2Y11M4D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-453">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-103" decimals="-3" id="f-454" unitRef="usd">288000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-104" decimals="-3" id="f-455" unitRef="usd">136000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-105" decimals="-3" id="f-456" unitRef="usd">229000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-106" decimals="-3" id="f-457" unitRef="usd">188000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-458" unitRef="usd">517000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-459" unitRef="usd">324000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-460">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.245%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Expected term in years (for employees)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.50 - 6.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;106.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;79.5% - 79.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-107" decimals="3" id="f-461" unitRef="number">0.044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-108" decimals="3" id="f-462" unitRef="number">0.038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-107" decimals="3" id="f-463" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-108" decimals="3" id="f-464" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-107" id="f-465">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-109" id="f-466">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-110" id="f-467">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-107" decimals="3" id="f-468" unitRef="number">1.069</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-5" decimals="3" id="f-469" unitRef="number">0.795</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-5" decimals="3" id="f-470" unitRef="number">0.797</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-111"
      decimals="INF"
      id="f-471"
      unitRef="shares">275309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-111"
      decimals="INF"
      id="f-472"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <angn:WarrantsAndRightsOutstandingTextBlock contextRef="c-1" id="f-473">Warrants&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In accordance with  FASB ASC Topic 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, certain of the Company&#x2019;s outstanding warrants, as discussed below, are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss at the end of each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors. Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon issuance, the fair value of the March Pre-Funded Warrants was $6.6 million. The Company recorded the $0.6 million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024. The fair value of the March Pre-Funded Warrants was measured using the Black-Scholes option pricing model as of the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of March 31, 2025, these warrants were classified as equity upon receipt of Stockholder Approval, as discussed in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Notes 3 and 6, in July 2024, the Company closed its Public Offering consisting of (i) the July Shares, (ii) the July Pre-Funded Warrants, and (iii) the July Common Warrants. Each July Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July Pre-Funded Warrants. Each July Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon issuance, the fair value of the July Pre-Funded Warrants and July Common Warrants was $6.8 million and $6.5 million, respectively. The Company recorded the $2.9 million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As of March 31, 2025, the July Pre-Funded Warrants are classified as equity, following Stockholder Approval in November 2024, as discussed in Note 3. The fair value of the July Common Warrants was measured using the Black-Scholes option pricing model as of the grant date. For the three months ended March 31, 2025, the Company recognized a loss of $0.5 million in fair value remeasurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Following receipt of Stockholder Approval, the Company remeasured the March Pre-Funded Warrants and the July Pre-Funded Warrants, held by GKCC, at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. As a result of obtaining Stockholder Approval, the March Pre-Funded Warrants and July Pre-Funded Warrants held by GKCC and its affiliates met the equity classification requirements under ASC 815. During the quarter ended December 31, 2024, the Company reclassified the July Common Warrants held by GKCC and its affiliates from a liability to equity. The Company will re-assess the equity classification for the remaining March Pre-Funded Warrants and July Pre-Funded Warrants at each reporting period end. As of the three months ended March 31, 2025, there were no changes to the equity classification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Note 6, in January 2025, the Company closed the January Offering pursuant to which the Company agreed to issue and sell: (i) the January Shares and (ii) the January Common Warrants. Each January Share and accompanying January Common Warrant were sold together at a combined offering price of $7.925. The January Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the initial exercise date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information regarding the warrants outstanding at March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.931%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.425%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.965%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.425%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,081,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,261,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;68,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,274,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</angn:WarrantsAndRightsOutstandingTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-112"
      decimals="2"
      id="f-474"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:FairValueOfCommonStockWarrants contextRef="c-91" decimals="-5" id="f-475" unitRef="usd">6600000</angn:FairValueOfCommonStockWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-113" decimals="-5" id="f-476" unitRef="usd">-600000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-67"
      decimals="2"
      id="f-477"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-66"
      decimals="2"
      id="f-478"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:FairValueOfCommonStockWarrants contextRef="c-114" decimals="-5" id="f-479" unitRef="usd">6800000</angn:FairValueOfCommonStockWarrants>
    <angn:FairValueOfCommonStockWarrants contextRef="c-115" decimals="-5" id="f-480" unitRef="usd">6500000</angn:FairValueOfCommonStockWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-116" decimals="-5" id="f-481" unitRef="usd">-2900000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-68" decimals="-5" id="f-482" unitRef="usd">-500000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-117"
      decimals="3"
      id="f-483"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-117"
      decimals="1"
      id="f-484"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-67" id="f-485">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c-1" id="f-486">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information regarding the warrants outstanding at March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.931%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.425%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.965%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.425%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,081,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,261,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;68,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,274,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-4" decimals="INF" id="f-487" unitRef="shares">5081466</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-4"
      decimals="INF"
      id="f-488"
      unitRef="usdPerShare">3.85</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageLife contextRef="c-4" id="f-489">P4Y6M</angn:ClassOfWarrantOrRightWeightedAverageLife>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-1" decimals="INF" id="f-490" unitRef="shares">1261830</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-491"
      unitRef="usdPerShare">7.80</angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod>
    <angn:ClassOfWarrantOrRightExercisedInPeriod contextRef="c-1" decimals="INF" id="f-492" unitRef="shares">68500</angn:ClassOfWarrantOrRightExercisedInPeriod>
    <angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-493"
      unitRef="usdPerShare">5.00</angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-3" decimals="INF" id="f-494" unitRef="shares">6274796</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-3"
      decimals="INF"
      id="f-495"
      unitRef="usdPerShare">4.64</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageLife contextRef="c-3" id="f-496">P4Y6M</angn:ClassOfWarrantOrRightWeightedAverageLife>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-497">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Legal Proceedings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company may be exposed to litigation in connection with its products under development and operations. The Company&#x2019;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2016, Former Elicio entered into a license agreement to license certain intellectual property from a university, which agreement has been amended from time to time to license additional intellectual property and to adjust fees, milestone dates, and diligence requirements. The Company is required to pay certain contractual maintenance and milestone payments related to clinical trials and royalties on product sales over the term of the contract, with minimum annual royalty payments commencing in the calendar year after commercialization. The license term for the license agreement extends until terminated by either party under certain provisions. During the three months ended March 31, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $0.4&#160;million. No such expenses were recorded in the three months ended March 31, 2025. No commercialization royalties have been achieved to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In addition, the Company is required to pay a total of up to $20.9&#160;million upon achievement of certain late-stage developmental and commercial milestones. The developmental milestone payment will be recorded when the milestone is achieved, and the commercial milestone payment and royalties will be recorded when the sales occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Future minimum annual maintenance payments are $0.1&#160;million for the year ended December&#160;31, 2025 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <angn:LicenseExpense contextRef="c-5" decimals="-5" id="f-498" unitRef="usd">400000</angn:LicenseExpense>
    <angn:OperatingLeaseFutureMinimumAnnualMaintenancePayments contextRef="c-1" decimals="-5" id="f-499" unitRef="usd">20900000</angn:OperatingLeaseFutureMinimumAnnualMaintenancePayments>
    <angn:OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter contextRef="c-118" decimals="-5" id="f-500" unitRef="usd">100000</angn:OperatingLeaseFutureMinimumAnnualMaintenancePaymentsDueThereafter>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-501">Leases&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#x201c;Boston Lease&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $11.1&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a ROU lease asset of $8.0&#160;million with a corresponding lease liability of $8.0&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the deposit on the Boston Lease and has a deposit in the amount of $0.7&#160;million, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of March&#160;31, 2025 and December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately 6,157 square feet for approximately $0.2&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Lease expense for all leases for the three months ended March 31, 2025 was $0.3 million. Lease expense for all leases for the three months ended March 31, 2024 was $0.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.229%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average remaining lease term&#x2014;operating leases (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2025 (remaining nine months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less present value discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liability, noncurrent portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseExpense contextRef="c-119" decimals="-5" id="f-502" unitRef="usd">11100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-120" decimals="-5" id="f-503" unitRef="usd">8000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-120" decimals="-5" id="f-504" unitRef="usd">8000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ProceedsFromSecuredLinesOfCredit contextRef="c-121" decimals="-5" id="f-505" unitRef="usd">700000</us-gaap:ProceedsFromSecuredLinesOfCredit>
    <us-gaap:AreaOfRealEstateProperty contextRef="c-122" decimals="0" id="f-506" unitRef="sqft">6157</us-gaap:AreaOfRealEstateProperty>
    <angn:LesseeOperatingLeaseAnnualRentExpense contextRef="c-123" decimals="-5" id="f-507" unitRef="usd">200000</angn:LesseeOperatingLeaseAnnualRentExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-5" id="f-508" unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-5" decimals="-5" id="f-509" unitRef="usd">400000</us-gaap:OperatingLeaseExpense>
    <angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock contextRef="c-1" id="f-510">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.229%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average remaining lease term&#x2014;operating leases (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-511" unitRef="usd">334000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-5" decimals="-3" id="f-512" unitRef="usd">379000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-513">P4Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-39" id="f-514">P5Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-515" unitRef="number">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-39" decimals="3" id="f-516" unitRef="number">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-517">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2025 (remaining nine months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less present value discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liability, noncurrent portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-518" unitRef="usd">1015000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-519" unitRef="usd">1383000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-520" unitRef="usd">1425000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-521" unitRef="usd">1467000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-522" unitRef="usd">1512000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <angn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour contextRef="c-3" decimals="-3" id="f-523" unitRef="usd">253000</angn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-524" unitRef="usd">7055000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-525" unitRef="usd">1264000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-526" unitRef="usd">5791000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-527" unitRef="usd">926000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-528" unitRef="usd">4865000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-529">Debt&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors, pursuant to which the Company issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#x201c;Convertible Note&#x201d;) in the principal amount of $20.0 million (the &#x201c;Note Financing&#x201d;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company received net proceeds of approximately $19.7 million from the Note Financing, after deducting debt issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the three months ended March&#160;31, 2025, the Company recorded other expense of $0.1 million related to the accretion of the discount of Convertible Note debt issuance costs. During the three months ended March&#160;31, 2025, the Company recorded accrued interest expense of $0.1 million related to the interest due on the Convertible Note but not yet payable.&lt;/span&gt;&lt;/div&gt;In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#x2019;s common stock. In March 2025, the Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. As of March 31, 2025, the Company has no outstanding debt</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-124" decimals="2" id="f-530" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-124" decimals="-6" id="f-531" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-125" decimals="-5" id="f-532" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-126" decimals="-3" id="f-533" unitRef="usd">100000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt contextRef="c-126" decimals="-5" id="f-534" unitRef="usd">100000</us-gaap:InterestExpenseDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-117"
      decimals="INF"
      id="f-535"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-124" decimals="-6" id="f-536" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <angn:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-127" decimals="-5" id="f-537" unitRef="usd">300000</angn:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-538">Income Taxes&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company did not record a provision or benefit for income taxes during the three months ended March&#160;31, 2025 or 2024. As of March&#160;31, 2025 and December&#160;31, 2024, the Company continues to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="INF" id="f-539" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="INF" id="f-540" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-541">Net Loss Per Share&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock and preferred stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be antidilutive. Because the Company has reported net losses since inception, these potential shares of common stock and preferred stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(11,209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(11,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,950,574&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,273,925&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(0.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.293%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.904%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.906%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,453&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687,204&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon the exercise of warrants (excluding pre-funded warrants)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642,099&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181,466&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Unvested common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,907,552&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,869,700&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-542">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(11,209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(11,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,950,574&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,273,925&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(0.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-543" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-544" unitRef="usd">-11827000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-545" unitRef="shares">12950574</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-546" unitRef="shares">12950574</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-547" unitRef="shares">10273925</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-548" unitRef="shares">10273925</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-549"
      unitRef="usdPerShare">-0.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-550"
      unitRef="usdPerShare">-0.87</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-551"
      unitRef="usdPerShare">-1.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-552"
      unitRef="usdPerShare">-1.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-553">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.293%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.904%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.906%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,453&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687,204&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon the exercise of warrants (excluding pre-funded warrants)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642,099&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181,466&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Unvested common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,907,552&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,869,700&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-128" decimals="0" id="f-554" unitRef="shares">2265453</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-129" decimals="0" id="f-555" unitRef="shares">687204</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-130" decimals="0" id="f-556" unitRef="shares">3642099</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-131" decimals="0" id="f-557" unitRef="shares">1181466</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-132" decimals="0" id="f-558" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-133" decimals="0" id="f-559" unitRef="shares">1030</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-560" unitRef="shares">5907552</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-5" decimals="0" id="f-561" unitRef="shares">1869700</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-562">Related Party Transactions&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Private Placement and Subscription Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors. Each March Pre-Funded Warrant issued and sold in the March Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March Pre-Funded Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The net proceeds to the Company from the March Offering were approximately $6.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#x2019;s board of directors,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;and Jay Venkatesan, a member of the Company&#x2019;s board of directors, and trusts affiliated with Jay Venkatesan, purchased 1,600,000 July Pre-Funded Warrants and accompanying July Common Warrants and 200,000 July Pre-Funded Warrants and accompanying July Common Warrants, respectively, with such July Pre-Funded Warrants and July Common Warrants subject to the terms and conditions of the July Pre-Funded Warrants and July Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The net proceeds to the Company from the Public Offering were approximately $10.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million pursuant to the Note Financing. The Company received net proceeds of approximately $19.7 million from the Note Financing, after deducting debt issuance costs. &lt;/span&gt;&lt;/div&gt;In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#x2019;s common stock. The Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. As of March 31, 2025, the Company has no outstanding deb</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-90"
      decimals="2"
      id="f-563"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-91" decimals="-5" id="f-564" unitRef="usd">6000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-134" decimals="0" id="f-565" unitRef="shares">1600000</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-135" decimals="0" id="f-566" unitRef="shares">200000</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-136" decimals="-5" id="f-567" unitRef="usd">10900000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-124" decimals="-6" id="f-568" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-125" decimals="-5" id="f-569" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-117"
      decimals="INF"
      id="f-570"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-124" decimals="-6" id="f-571" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <angn:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-127" decimals="-5" id="f-572" unitRef="usd">300000</angn:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-573">Segment Reporting&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has one reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#x2019;s Chief Operating Decision Maker &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(&#x201c;CODM&#x201d;), its Chief Executive Officer, manages the Company&#x2019;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Other segment items include interest income, interest expense, and change in the fair value of warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. The following table presents certain financial data for the Company&#x2019;s reportable segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.848%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trial expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemistry, manufacturing and controls expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and grant reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.848%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments contextRef="c-1" decimals="INF" id="f-574" unitRef="entity">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-575">The following table presents certain financial data for the Company&#x2019;s reportable segment (in thousands):&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.848%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trial expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemistry, manufacturing and controls expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and grant reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.848%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-137" decimals="-3" id="f-576" unitRef="usd">4192000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-138" decimals="-3" id="f-577" unitRef="usd">2302000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-139" decimals="-3" id="f-578" unitRef="usd">2298000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-140" decimals="-3" id="f-579" unitRef="usd">2243000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-141" decimals="-3" id="f-580" unitRef="usd">646000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-142" decimals="-3" id="f-581" unitRef="usd">1194000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-143" decimals="-3" id="f-582" unitRef="usd">1136000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-144" decimals="-3" id="f-583" unitRef="usd">1887000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-145" decimals="-3" id="f-584" unitRef="usd">-489000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-146" decimals="-3" id="f-585" unitRef="usd">-67000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-145" decimals="-3" id="f-586" unitRef="usd">1087000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-146" decimals="-3" id="f-587" unitRef="usd">919000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-145" decimals="-3" id="f-588" unitRef="usd">1866000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-146" decimals="-3" id="f-589" unitRef="usd">1762000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-145" decimals="-3" id="f-590" unitRef="usd">473000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-146" decimals="-3" id="f-591" unitRef="usd">1587000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:NetIncomeLoss contextRef="c-145" decimals="-3" id="f-592" unitRef="usd">11209000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-146" decimals="-3" id="f-593" unitRef="usd">11827000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets contextRef="c-147" decimals="-3" id="f-594" unitRef="usd">28144000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-148" decimals="-3" id="f-595" unitRef="usd">28178000</us-gaap:Assets>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-1" id="f-596">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-597">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-598">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-599">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
